Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.7075473598558103,2.03425744253956,0.0,0.05562589626106117,0.02,22/74,10.67%,NOX4;STOX1;SIRT2;GPX1;LRRC8D;HSPA1A;GSTP1;PRR5L;SLC25A24;PYCR1;PRDX1;ZFAND1;PRDX6;PPIA;PARP1;PRDX5;CAT;TMEM161A;TXNRD1;MT3;PRDX3;ATF4
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.8029120300847283,1.9796212162752145,0.0,0.09734531845685705,0.07,4/28,1.38%,EIF5A;UBB;BAD;STYXL1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.6604468378455731,1.8763282096025635,0.0,0.2642230072400406,0.28,25/73,14.40%,AURKAIP1;MRPL15;CHCHD1;MRPL11;MRPL10;MRPS33;MRPL28;MRPL44;MRPL36;MRPS26;MRPL47;MRPS16;MRPS12;MRPL40;MRPS18A;TUFM;MRPL4;MRPL14;MRPL18;MRPL52;MRPL27;MRPL13;MRPS7;MRPL24;MRPS10
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.7194611898295772,1.874017369452447,0.0,0.20164387394634672,0.28,15/53,6.98%,EIF5A;PPP1R14B;TUBG1;DHCR7;SLC25A1;KDELR1;TRIM28;NR2F6;PYCR1;TRAF4;TUBA1C;RPL8;NOC2L;CCT3;FKBP4
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.8390359548423485,1.8186572292975847,0.029411764705882353,0.44222587527543633,0.58,4/14,3.28%,THNSL2;AADAT;HSD17B10;HPD
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.9738350682510442,1.813159515603269,0.0,0.3916990195049725,0.61,1/7,0.30%,FERMT1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.6516895280483235,1.7978257924261845,0.0,0.4171942219579588,0.7,24/74,14.40%,AURKAIP1;MRPL15;CHCHD1;MRPL11;MRPL10;MRPS33;MRPL28;MRPL44;MRPL36;MRPS26;MRPL47;MRPS16;MRPS12;MRPL40;MRPS18A;MRPL4;MRPL14;MRPL18;MRPL52;MRPL27;MRPL13;MRPS7;MRPL24;MRPS10
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.6790575849854991,1.7871028443595598,0.0,0.4119792941834843,0.73,5/35,10.45%,POLR2J;POLR2L;LARP7;GTF2F1;POLR2K
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.6505541639594876,1.786194476317253,0.0,0.37083930840707446,0.74,25/80,14.40%,TRMT112;AURKAIP1;MRPL15;CHCHD1;MRPL11;MRPL10;MRPS33;MRPL28;MRPL44;MRPL36;MRPS26;MRPL47;MRPS16;MRPS12;MRPL40;MRPS18A;MRPL4;MRPL14;MRPL18;MRPL52;MRPL27;MRPL13;MRPS7;MRPL24;MRPS10
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.9532606950992978,1.783333854678834,0.0,0.35322444125773844,0.78,1/8,0.06%,NOX4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.8222133552122443,1.7785977704326796,0.0,0.3476618516316323,0.79,3/16,6.09%,EIF5A;UBB;PLA2R1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.6097613701060773,1.7752995313380344,0.0,0.33259650472759494,0.8,25/88,14.40%,AURKAIP1;MRPL15;CHCHD1;MRPL11;MRPL10;MRPS33;MRPL28;MRPL44;MRPL36;MRPS26;MRPL47;MRPS16;MRPS12;MRPL40;MRPS18A;TUFM;MRPL4;MRPL14;MRPL18;MRPL52;MRPL27;MRPL13;MRPS7;MRPL24;MRPS10
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.7942213049586683,1.7653684169941144,0.0,0.33803429266337176,0.86,5/19,5.89%,MMP2;COL12A1;LAMA3;COL8A1;ITGB5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.7237014231732669,1.7619389044041915,0.0,0.32382218180546324,0.87,8/31,11.21%,STOX1;UBB;BAD;PYCR1;SLC25A33;PRDX3;ARL6IP5;TUSC2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.9448546521070768,1.750171353094057,0.0,0.33746377065043776,0.87,3/7,1.45%,MMP2;CCND1;OPN3
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.764056353057385,1.7231730369730127,0.0,0.46065195341191284,0.96,5/22,5.89%,MMP2;COL12A1;LAMA3;COL8A1;ITGB5
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.9779291010981569,1.7226621363840908,0.0,0.43600886334037653,0.96,2/7,0.73%,NOX4;GPX1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.8949610594490642,1.7139775233602181,0.02857142857142857,0.4450071700884894,0.97,1/6,0.18%,NR0B1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6960552029143776,1.7127697680079668,0.0,0.43183261571086956,0.97,7/26,14.99%,CRB2;MSN;RAP2A;LIN7C;CAMSAP3;PARD3B;CDC42
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.8576657747764382,1.7062004547750986,0.0,0.44361652268196283,0.97,3/7,12.82%,PPIA;CBLL1;GRB2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.7289981489712417,1.700442648025131,0.0,0.45162930059575856,0.98,3/19,3.32%,TRMT112;SMYD2;CSKMT
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.8640003203546077,1.686209799246579,0.0,0.49494405423194204,0.99,4/12,3.63%,BANF1;RBM15B;NUTF2;NPM1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.8603281395183136,-1.68371560576062,0.0,0.30921766756387065,0.33,5/21,5.80%,HEY2;HES1;TTN;VEGFA;CAV3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.7267850950755576,1.6777036582248313,0.034482758620689655,0.5230043507154121,1.0,4/31,2.94%,GPC4;UGDH;HSPG2;GPC1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.8709604449869224,1.6775712951569617,0.0,0.4811640026581791,1.0,2/14,1.97%,CUBN;CD320
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.8709604449869224,1.6775712951569617,0.0,0.4811640026581791,1.0,2/14,1.97%,CUBN;CD320
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.7537184535617844,1.6750683038797545,0.0,0.4770990333160247,1.0,14/25,17.73%,DHCR7;ARV1;MSMO1;ACAA2;TM7SF2;SQLE;LBR;ACLY;HMGCS1;HMGCR;INSIG1;FDFT1;SC5D;ACAT2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.809738133754391,-1.672782712279612,0.0,0.20057362220359176,0.4,7/24,9.72%,HTR2C;GRIN2A;ITPR1;PTPRC;RYR3;GRIN2D;SLC24A2
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.5812621891939503,1.6721662996313222,0.0,0.4774556095741084,1.0,23/94,11.41%,NOX4;SIRT2;GPX1;HSPA1A;GSTP1;PRR5L;PDGFRA;SLC25A24;PYCR1;PRDX1;ZFAND1;PLA2R1;PRDX6;PPIA;PARP1;PRDX5;CAT;TMEM161A;TXNRD1;MT3;PRDX3;ATF4;JUN
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.7727788164851043,1.6688877585724011,0.0,0.4822566541918786,1.0,5/18,6.65%,VPS37B;TRIM28;TRIM35;PML;CHMP2A
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.8132335140502523,1.6641479472906167,0.0625,0.49823539840726344,1.0,1/12,0.01%,CPA1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.7680860741052888,1.663916495013875,0.0,0.48301819920021455,1.0,14/23,17.73%,DHCR7;ARV1;MSMO1;ACAA2;TM7SF2;SQLE;LBR;ACLY;HMGCS1;HMGCR;INSIG1;FDFT1;SC5D;ACAT2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.7252351673400731,1.6622898902814383,0.0,0.4759602897821444,1.0,2/27,1.24%,CRB2;CFL1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.5707633903612079,1.6588347258193399,0.0,0.47673131404987584,1.0,13/74,11.06%,SOX4;EIF5A;PLD1;PIWIL2;CNBP;NPM1;EIF3D;EEF2;FXR2;POLDIP3;EIF4A3;CDC123;NAT10
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.7693831372231039,1.6538824740787816,0.045454545454545456,0.4989474331295184,1.0,4/28,4.06%,SIRT2;UBB;PHB2;UBE2D1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7458259266879047,1.652477149492343,0.030303030303030304,0.49245278748762983,1.0,1/16,0.69%,CRB2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.7115023034039857,1.6502680972348844,0.03571428571428571,0.4930838375712637,1.0,4/24,10.45%,POLR2J;POLR2L;GTF2F1;POLR2K
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8392605873965205,1.6480925792772587,0.05555555555555555,0.4867265922842852,1.0,1/10,0.01%,CPA1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.757092514927835,1.6419388144696674,0.0,0.5130361378131655,1.0,3/18,9.11%,PCBP4;TMBIM6;SAP18
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7667738207187663,1.638116335793961,0.038461538461538464,0.5200289380721574,1.0,6/25,4.48%,UGDH;BGN;DSEL;CHST7;BCAN;VCAN
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.6269098459728544,1.6376762213651594,0.0,0.506694862736974,1.0,14/75,9.43%,SOX4;PLD1;AURKAIP1;BAD;PIWIL2;NR1H2;MSN;NPM1;EIF3D;EEF2;FXR2;PTTG1IP;POLDIP3;EIF4A3
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.7959645801258193,1.6325170797389545,0.0,0.5253170578153965,1.0,4/15,9.79%,GPNMB;FGL1;THY1;DUSP3
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8279013866008609,1.6228548199189539,0.0,0.564399337673206,1.0,3/10,1.50%,SOX4;SOX11;ASCL1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.6080997842584107,1.6223952271781392,0.0,0.553610110407704,1.0,15/65,13.63%,HSPA1A;C9ORF78;ERN1;HNRNPLL;TMBIM6;METTL4;RBM22;LARP7;RBM23;KHDRBS2;AFF2;JMJD6;SRSF3;CLK2;HNRNPH1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.8637749048092122,1.6209227979106635,0.0,0.5507610542592278,1.0,3/9,3.12%,SIRT2;BTC;TGFA
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.7784011162928612,1.619967934349838,0.0,0.5429846010028585,1.0,11/22,12.83%,DHCR7;ARV1;MSMO1;ACAA2;TM7SF2;SQLE;LBR;ACLY;HMGCS1;HMGCR;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.8472101302287065,1.615656702821972,0.0,0.5559499298536059,1.0,3/12,7.58%,SNF8;CHMP2A;SMPD3
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.7683159878221684,1.6042763969476879,0.0,0.6167218933291565,1.0,5/25,10.83%,UBB;CCDC88C;IKBKB;MAPK11;UBC
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8392589436517097,1.6031259994189915,0.0,0.6115889764447524,1.0,2/9,9.70%,CRB2;TENM4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.9437050931968733,1.6023410092193815,0.0,0.6031933125808822,1.0,1/5,1.01%,EYS
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8219118661220985,1.5936806780758823,0.029411764705882353,0.6476443636109265,1.0,2/10,0.72%,SOX4;SOX11
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6853455840320799,1.5931114928639258,0.0,0.6371946416704557,1.0,3/17,5.21%,AEN;HIPK1;PML
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5174095220043787,1.592116697546343,0.0,0.6317902041023468,1.0,23/113,6.57%,SYNDIG1;GPR17;CHRNA4;OLIG2;ASCL1;OLIG1;CNP;TCEAL6;PDGFRA;SOX10;CA10;ADGRA1;VCAN;CDO1;ZNF536;PCDH15;MAP2;GPR37L1;TMEM178A;CLIP3;BRINP1;LRRTM3;TCEAL7
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.6729820720391936,1.5919651174715308,0.029411764705882353,0.6207101212592451,1.0,3/21,4.03%,TRMT112;SMYD2;PRMT6
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.5291697777439908,1.589742092789299,0.0,0.6215931520870468,1.0,15/97,9.69%,STOX1;SIRT2;UBB;BAD;PSMD8;ZFP36L1;PSMB6;ACAA2;PSMB4;HP1BP3;ELOC;PSME3;PSMD10;MT3;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.8574137372075951,1.5879098439085848,0.025,0.6211558415818498,1.0,3/11,7.83%,GPX1;PPIF;PSMD10
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.8067885730956306,-1.5848140305713208,0.014705882352941176,1.0,0.98,3/25,4.66%,ABLIM1;VCL;P2RY12
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.628013391364438,1.5845364224204121,0.0,0.6311010775800395,1.0,14/48,13.60%,MMP2;OPN3;COPS9;NPM1;SMPD1;NOC2L;PARP1;SDE2;TMEM161A;RUVBL2;ZBTB1;ATF4;N4BP1;ERCC4
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.7249897517284154,1.5805721799657704,0.03571428571428571,0.646154384246791,1.0,4/32,4.14%,USP51;RFWD3;SMYD2;UBE2N
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.852191137309024,1.576588129130293,0.027777777777777776,0.6597036117978483,1.0,1/8,0.43%,MYH3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.7691778936113907,1.5705840192693428,0.038461538461538464,0.6876511658479459,1.0,4/9,11.41%,SIRT2;HSPA1A;BAG3;JUN
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.8853842798018494,1.568927853227898,0.02564102564102564,0.689666832457055,1.0,2/6,9.33%,PRDX1;MT3
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.8276581928274228,-1.5683510718960898,0.015384615384615385,1.0,1.0,3/22,4.66%,ABLIM1;VCL;P2RY12
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.8452096282387089,1.568011211453615,0.0,0.6841985240110524,1.0,4/12,3.07%,TSPO;DHCR7;FDX1;STARD3
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.8612487983418157,1.5645103176526007,0.023809523809523808,0.6966915531713236,1.0,4/11,9.51%,BANF1;H1-10;NOC2L;H1-4
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.7825237739768189,1.564019318088495,0.0967741935483871,0.6885947641994267,1.0,5/11,13.88%,LSM4;EDC3;LIMD1;RC3H1;PATL1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.8513088070041984,1.563531670799692,0.02631578947368421,0.6803135407801212,1.0,2/7,5.58%,PHB2;PPIF
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.8423340742874489,1.562882237135392,0.027777777777777776,0.6744639921653667,1.0,5/10,14.21%,BGN;BCAN;VCAN;CSPG5;CSPG4
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.89115109843077,1.5626019889860057,0.0,0.666441026358483,1.0,2/10,6.65%,VPS37B;CHMP2A
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7513863223153624,1.5617524690786895,0.03571428571428571,0.6628752637776456,1.0,5/19,4.48%,UGDH;BGN;CHST7;BCAN;VCAN
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.7535710962419828,1.5599298179412786,0.02702702702702703,0.6670956365039202,1.0,4/18,4.14%,UBB;TAB3;MAP2K6;UBE2N
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.809154008423105,-1.5578501124976418,0.014285714285714285,1.0,1.0,2/18,6.74%,TTN;NCAPD3
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.7742798640892782,-1.555471576896148,0.028169014084507043,1.0,1.0,6/27,5.13%,HEY2;HES1;TTN;SOX9;ZFPM1;VEGFA
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6626477637525161,1.5539107220003903,0.0,0.6910290568607562,1.0,4/30,3.91%,NR0B1;RNF6;CALR;ESR1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.5343989801704078,1.553020046177634,0.06666666666666667,0.6856496343482975,1.0,26/87,17.75%,SOX4;UBB;MALT1;HSPA1A;VPS28;UBE2D1;UBE2N;PRICKLE1;UBXN1;PSMD10;PTTG1IP;INAVA;CHP1;COMMD1;TGFBR1;BAG2;RCHY1;N4BP1;PRR7;RIPK2;MINAR1;SMAD7;DNAJA1;NDFIP2;SPRTN;NXN
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.6354230704557217,1.5528248918472014,0.058823529411764705,0.6764506313175475,1.0,6/38,5.89%,TRMT112;HSPA1A;ERN1;HNRNPLL;MYCN;RBM22
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.8412171000654219,-1.5524617630873967,0.0,1.0,1.0,3/14,1.40%,FABP3;NR4A3;SOX9
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.7471167442795142,1.5515841582438605,0.03333333333333333,0.6743660592494142,1.0,3/15,4.76%,SOX4;BAD;NLGN2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6963201999243511,1.5509024600875247,0.0,0.6678970460789914,1.0,2/12,8.88%,BICD2;CAMSAP3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.8026624331151158,1.5508683667563619,0.06896551724137931,0.659128770764629,1.0,2/10,4.04%,DSEL;B3GAT2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7443485946332078,1.5502319590662448,0.043478260869565216,0.6558593849699442,1.0,6/25,4.48%,UGDH;BGN;CHST7;BCAN;B3GAT2;VCAN
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.8073007936010956,1.5438642340253192,0.05263157894736842,0.6890194350203444,1.0,2/17,5.30%,USP51;ATXN7L3
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.74678423318537,1.5426280912810744,0.0,0.6891023859182775,1.0,3/14,16.08%,PCBP4;SAP18;SRSF9
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6238594763835843,1.5419041659924684,0.0,0.6864741288580959,1.0,6/31,7.87%,PMEPA1;ESR1;WBP2;DDX54;YAP1;NR3C1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.7335348469943678,1.5412725112152779,0.03125,0.6821303817141668,1.0,8/20,14.98%,UBB;TAB3;MAP2K6;UBE2N;INAVA;UBC;OTULIN;RIPK2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.6925812936173443,1.5411352684662505,0.038461538461538464,0.6743759765067259,1.0,5/21,6.73%,TUBG1;RAN;CHAMP1;KIF25;WRAP73
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.9387911652630122,1.5411168387264325,0.02702702702702703,0.6659462768003918,1.0,1/5,1.55%,LRRC8D
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8840786135281951,-1.5404149386460473,0.0,1.0,1.0,2/15,1.16%,CD44;NR4A3
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.8580054550246403,1.5399639665571185,0.046511627906976744,0.6578440597459033,1.0,2/6,7.70%,BLVRB;ABCG2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.8580054550246403,1.5399639665571185,0.046511627906976744,0.6578440597459033,1.0,2/6,7.70%,BLVRB;ABCG2
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7768673904273824,1.5399591901904324,0.0625,0.6502533234613808,1.0,2/10,2.90%,GPX1;NT5E
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.7109989340274253,1.5394484382533236,0.05405405405405406,0.6378981456525809,1.0,4/15,4.10%,UBB;IKBKB;UBE2D1;IRF3
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.7109989340274253,1.5394484382533236,0.05405405405405406,0.6378981456525809,1.0,4/15,4.10%,UBB;IKBKB;UBE2D1;IRF3
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.8067386253749913,1.538791043048167,0.058823529411764705,0.6338764922772088,1.0,2/9,3.32%,SMYD2;CSKMT
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.9545952574193273,1.538654997833931,0.02857142857142857,0.6273897782317962,1.0,1/5,1.71%,SLC30A10
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8006250474266218,-1.5369263347129845,0.014705882352941176,1.0,1.0,7/20,8.98%,MAP3K19;DUOX1;FMO3;FMO6P;TMC4;FUT2;CP
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.833965846241987,1.5364260728239543,0.04878048780487805,0.6319544293976808,1.0,1/7,0.49%,SIRT2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.7055143931346802,1.5358561642028918,0.03125,0.6276663631479852,1.0,5/26,10.36%,COPZ1;COG3;GOSR1;COG6;RAB6A
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6580176854503017,1.5331600363853153,0.09090909090909091,0.6384616759741799,1.0,3/23,7.62%,SOX4;MAP2;CEND1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.7240440701347993,-1.5329058396854705,0.012345679012345678,1.0,1.0,12/41,15.00%,ENPP2;SOX9;EMP2;RHOJ;DOCK5;RAB11A;GLUL;PTPRR;PFN2;MACF1;VIL1;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.7844140704584684,-1.5323397617988042,0.0,1.0,1.0,4/22,11.14%,STMN2;ANKRD53;CAV3;PAK1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.9138308006472077,-1.5323210865463515,0.0,1.0,1.0,2/10,1.00%,HEY2;HES1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.6149919505445572,1.531170522672999,0.0,0.6450464508734594,1.0,18/60,14.86%,POLR2J;POLR2L;NT5E;LSM1;RAN;KPNA2;PCBP2;HNRNPA0;HNRNPC;DDX54;PCBP1;GTF2F1;EXD2;POLR2K;SETMAR;HNRNPH1;POLR2E;WDR74
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.7764456589079403,-1.5308583613970292,0.0,1.0,1.0,2/37,1.37%,IL5;PIP4K2C
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.5350420417753117,1.5300293578856456,0.05,0.6449883134400762,1.0,26/87,13.65%,AURKAIP1;MRPL15;CHCHD1;MRPL11;MRPL10;MRPS33;MRPL28;MRPL44;MRPL36;MRPS26;MRPL47;EEF2;EEF1A1;MRPS16;MRPS12;MRPL40;MRPS18A;TUFM;MRPL4;MRPL14;MRPL18;MRPL52;MRPL27;MRPL13;MRPS7;MRPL24
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6885968353100771,1.527923305405694,0.043478260869565216,0.6513613013795228,1.0,6/26,8.89%,LSM4;LSM1;LSM7;DCPS;EXOSC8;EDC3
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.7031063477824591,-1.5255685613837957,0.0,1.0,1.0,15/53,15.07%,SLC28A2;NAAA;SYT1;SLC6A15;SLC29A2;RAB3A;GLUL;CPLX1;PPFIA4;RIMS1;SNAP25;SYN3;PPFIA1;GABRA2;SLC17A7
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.958362398176113,1.525118000503854,0.0,0.6618889890212439,1.0,2/5,2.33%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.7294784269162283,1.5236754150358498,0.034482758620689655,0.6629728530693316,1.0,3/19,6.40%,CRB2;SOX11;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.6411545810817966,1.5226890288921948,0.0,0.6621509682534131,1.0,10/45,9.33%,DAPL1;SIRT2;LZTS1;TAB3;RRAGA;KIF25;LEPR;ZKSCAN3;MT3;CTSA
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.8780726995100012,-1.521371526464181,0.0,1.0,1.0,3/7,7.61%,OCIAD2;LRRC19;LPCAT3
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.8542767960225421,-1.521006830192855,0.014705882352941176,0.9887652782067687,1.0,3/15,5.66%,SLC6A6;SLC22A4;SFXN3
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.6628015016057578,1.52037903959511,0.045454545454545456,0.6709515322210471,1.0,5/37,4.04%,GPC4;UGDH;HSPG2;GPC1;B3GAT2
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.7919512250798391,1.519616450895505,0.05263157894736842,0.6686459775054088,1.0,2/8,5.55%,FNBP1L;MICALL1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.8166506463131817,1.5179395605039256,0.06666666666666667,0.6708820215727983,1.0,2/11,2.92%,IDH1;AADAT
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.6828843066581428,1.5166179084341973,0.038461538461538464,0.6730733447588401,1.0,6/28,8.89%,LSM4;LSM1;LSM7;DCPS;EXOSC8;EDC3
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5875297527858753,1.5151763910606977,0.047619047619047616,0.6754966511306092,1.0,13/43,17.75%,SOX4;HSPA1A;COPS9;VPS28;UBXN1;CHP1;BAG2;N4BP1;PRR7;MINAR1;SMAD7;DNAJA1;NXN
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.847833251330463,1.5149014408326067,0.10256410256410256,0.6703738527344063,1.0,2/5,12.82%,CBLL1;GRB2
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.7624273086092717,1.5146884750730873,0.038461538461538464,0.6652155118404087,1.0,2/10,4.95%,CFL1;KIF25
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.8573570086808744,1.513921554788135,0.029411764705882353,0.6620283951646968,1.0,4/7,11.65%,EIF5A;UBB;PTTG1IP;ARMC10
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.871690886021522,1.513482215735684,0.08571428571428572,0.6579748872022665,1.0,2/6,2.84%,LAMA3;CD151
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.8014061024844288,1.5134765153437097,0.06521739130434782,0.6517675769456412,1.0,1/12,0.19%,SYNDIG1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.836454185263159,1.5133166827584545,0.0,0.6468459946058445,1.0,3/9,8.69%,NT5E;MSN;CERCAM
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.8614030212755468,1.5110688853414302,0.0,0.6534755174187163,1.0,1/8,0.30%,FERMT1
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6934415819069555,1.5103536334645964,0.0,0.6514353814426109,1.0,5/16,8.99%,CUBN;CD320;ABCG2;SLC2A10;SLC5A6
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.5173581745827701,1.5102797101542234,0.0,0.6458925090858216,1.0,32/174,10.52%,NDUFB1;IDH1;MRPL15;MRPL11;PHB2;FDX1;HSD17B10;ACAA2;ACADVL;ECH1;ATP5MC1;NDUFS3;NDUFS6;ATP6V0E1;SLC25A20;ATP5F1A;ATP6V1G1;NDUFB7;NDUFA5;OAT;UQCRC1;MRPS12;TIMM13;DLD;ALDH6A1;NDUFS8;UQCR10;ATP5F1D;GRPEL1;PRDX3;SUCLA2;MTX2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.7529283607601029,1.5098527201498446,0.027777777777777776,0.6427046122055041,1.0,3/15,7.58%,SNF8;CHMP2A;SMPD3
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.6969255493312723,1.5093014147099324,0.125,0.6394494771081808,1.0,4/21,3.83%,ZNF488;SOX4;SOX11;SOX10
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.5253646342494463,1.5091566551653928,0.0,0.6345290290310429,1.0,17/74,14.98%,UBB;PSMD8;PSMB6;TAB3;PSMB4;IKBKB;UBE2N;PSME3;TOLLIP;PSMD10;PELI1;UBC;PLCB1;PSMD12;PSMB2;PSMD4;RIPK2
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.958149073835024,-1.508781217597562,0.0,1.0,1.0,1/5,0.35%,ENPP2
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.6965001908547234,-1.5071632988006844,0.02666666666666667,1.0,1.0,13/38,18.18%,MAP3K19;DNAH7;MROH9;TMCO5A;FMO6P;FUT2;DNAH5;CFAP52;DNAH9;CHST9;CFAP43;VWA3B;SHROOM3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.6896103712985906,-1.5070675438274135,0.0,1.0,1.0,23/50,22.75%,SLC6A6;SLC6A15;HCN3;SLC6A11;SLC6A9;SLC6A17;SCN8A;SCN9A;SLC24A2;SLC4A4;SLC9B2;HCN1;ASIC4;SLC5A9;SLC4A8;ANO6;NEDD4L;HCN2;SLC6A7;SLC6A8;ATP1B1;NALCN;SLC24A4
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5646261497700222,1.5058076448672588,0.05,0.649090776326988,1.0,13/64,9.43%,SOX4;PLD1;PIWIL2;NPM1;EIF3D;CHRNA7;EEF2;LRRTM3;SP1;SMPD3;FXR2;POLDIP3;EIF4A3
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5284914436319432,1.504915692735021,0.0,0.649855579362919,1.0,8/153,3.15%,CPA1;MMP2;MMP16;MALT1;CUL7;NCSTN;CTSV;CTSC
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.778483178430165,1.5040813820240442,0.029411764705882353,0.6480896448002084,1.0,1/9,0.55%,UBB
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.8756384529805203,1.5036458167804065,0.0,0.6445710158626812,1.0,1/9,2.12%,TSR1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7979758473632577,1.5026300615218906,0.05263157894736842,0.6453546778084132,1.0,3/12,2.82%,MOSPD2;CALR;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.9470060041147066,1.502064208914867,0.024390243902439025,0.6421518906607797,1.0,1/5,3.57%,IL15
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.562328604759733,1.4991217298090431,0.0,0.6529089573642055,1.0,8/65,6.17%,GPC4;UBB;TCF7L1;CCDC88C;KLHL12;PORCN;FRZB;WNT3
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5986533958676685,1.4987876484793314,0.0,0.6498116063223963,1.0,15/56,10.15%,EMILIN3;SOX11;TUBB2B;RND2;GAL3ST3;CXCL12;TOX3;SALL2;SEMA5B;MYCN;DNMT3B;MEX3A;LINGO1;TRIM71;SALL3
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.8130431771903436,-1.4983175288278336,0.029850746268656716,1.0,1.0,4/16,8.09%,IHO1;SYCE2;STAG3;RNF212B
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.8167608226918189,1.4981355716706621,0.06060606060606061,0.6479049064505568,1.0,4/11,4.48%,BGN;DSEL;BCAN;VCAN
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.7873889330167754,1.495901349716214,0.02702702702702703,0.6533781595379523,1.0,1/10,0.82%,PMEPA1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.7855998001595534,1.494868267408084,0.1,0.6542771749738525,1.0,2/10,2.90%,GPX1;NT5E
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.8490449597957102,-1.494750366477803,0.016666666666666666,1.0,1.0,4/16,4.71%,HEY2;EFNA1;SOX9;ROBO2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7244874876544607,1.4945716277328809,0.03225806451612903,0.6512679934245043,1.0,1/13,0.43%,MYH3
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.5703636547498111,1.4939887739776772,0.0,0.648637683187017,1.0,9/32,11.54%,C9ORF78;ZFP36L1;LARP7;RBM23;KHDRBS2;PTCD2;CPSF4;JMJD6;SRSF3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.7463008428778861,1.4939027077632532,0.034482758620689655,0.6437492994464146,1.0,5/10,9.98%,SOX11;GPNMB;LYN;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.8451563395124471,1.492567783825293,0.07894736842105263,0.6466510440348361,1.0,2/7,7.34%,WBP2;YAP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7594831873286695,1.4925012884809556,0.07692307692307693,0.6420694537420162,1.0,4/12,11.93%,PRR5L;ZC3HAV1;RC3H1;KHSRP
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.8637373295842274,1.4924202224146466,0.05263157894736842,0.6377722952085514,1.0,1/9,0.69%,SMDT1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.7424029746769205,1.4919479227036783,0.08571428571428572,0.6360884931226689,1.0,4/14,9.74%,SOX4;SOX11;ZNF358;TRIM71
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7548931192206411,1.4912931543605465,0.0,0.6355890760283751,1.0,3/14,8.40%,GPC4;SLITRK2;PTPRF
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.6003956249971424,1.4910858373852203,0.0,0.6322740501703702,1.0,5/36,4.14%,STOX1;WDR18;KPNA2;SUB1;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.8579382921441561,1.4900083173909993,0.0,0.633678586884402,1.0,1/7,0.89%,PIWIL2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.8247109641341132,-1.4890261821047917,0.046875,1.0,1.0,4/19,4.71%,HEY2;EFNA1;SOX9;ROBO2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.7724749839766367,-1.4889991174847599,0.014492753623188406,1.0,1.0,9/28,9.70%,SYT1;UNC13C;RAB3A;SYT2;CPLX1;STX1B;STX19;RIMS1;SNAP25
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7960779864534453,1.4888837581821266,0.12,0.6362984466751387,1.0,5/10,10.31%,SOX11;TGFBR2;PDGFRA;EIF4A3;TGFBR1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7888703995753592,1.4881163615978368,0.0,0.6353009071139211,1.0,4/13,4.48%,BGN;DSEL;BCAN;VCAN
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.8106629668132288,1.4877637651398536,0.07142857142857142,0.6280083070632848,1.0,1/6,1.45%,OPN3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.8106629668132288,1.4877637651398536,0.07142857142857142,0.6280083070632848,1.0,1/6,1.45%,OPN3
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.7942159851243539,-1.4850762286070687,0.014705882352941176,1.0,1.0,8/16,15.19%,SOX9;PTPRC;SPI1;KLF6;CAMK2B;AOAH;AVIL;DCLK1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.7046673530216245,-1.4850026806526275,0.024691358024691357,1.0,1.0,9/55,6.23%,DEPP1;ITPR1;PIP4K2C;WDR91;DRAM1;DAPK1;USP13;CISD2;TPCN2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7701261354967572,1.484457356151646,0.14285714285714285,0.6398979001542218,1.0,4/8,18.08%,ZDHHC21;FUT9;ETS1;RHOA
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.6866442251497421,-1.4843173995936685,0.012658227848101266,1.0,1.0,20/50,22.75%,SLC6A6;SLC6A15;HCN3;SLC6A11;SLC6A9;SLC6A17;SCN8A;SCN9A;SLC24A2;SLC4A4;HCN1;ASIC4;SLC4A8;ANO6;HCN2;SLC6A7;SLC6A8;ATP1B1;NALCN;SLC24A4
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.8045932724962862,1.4841157218403378,0.05405405405405406,0.6382078276380679,1.0,4/11,3.07%,TSPO;FDX1;HSD17B10;STARD3
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.7568954083636324,1.4833166033656056,0.06976744186046512,0.6379225124406802,1.0,3/8,8.34%,PIH1D1;NUFIP1;RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.8947421434150703,1.4823364629350122,0.06060606060606061,0.6374453499352943,1.0,3/7,2.05%,SOX11;GPNMB;FGL1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.6571681662671159,-1.4820528765681222,0.043478260869565216,1.0,1.0,20/63,20.02%,HEY2;FABP3;SGCA;TTN;LAMA2;CKMT2;CAV3;EDNRA;CTNNA3;SORBS1;TPM1;BDNF;RYR2;MYOM2;CRYAB;ZFPM2;SYNPO2;LMOD1;CORO6;PDE1A
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.8396822135963729,1.4816683002144546,0.0,0.6359051322571311,1.0,3/8,9.13%,SIRT2;BOK;FZD3
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.7149972465749571,1.4813379714003732,0.08823529411764706,0.6328411427061351,1.0,4/14,9.28%,PPT1;SLC25A1;SCD5;ACLY
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.6490999148896296,1.4812696988215848,0.0,0.6286685344676827,1.0,17/42,15.12%,DHCR7;ARV1;MSMO1;FDX1;ACAA2;STARD3;TM7SF2;SQLE;LBR;SNX17;ACLY;MT3;HMGCS1;HMGCR;INSIG1;SOAT1;FDFT1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.7210496530896189,1.4798885530311374,0.1,0.6316015721011928,1.0,2/13,2.90%,GPX1;NT5E
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.755044386955593,1.4791664912748534,0.02857142857142857,0.6302376205632475,1.0,3/13,16.08%,PCBP4;SAP18;SRSF9
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.755664507509331,-1.4791566084776677,0.0,1.0,1.0,5/20,10.24%,SLC6A6;SLC6A15;SLC6A9;SLC6A17;SLC1A4
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.7667426488394244,-1.4788842827466981,0.057971014492753624,1.0,1.0,2/21,1.00%,HEY2;HES1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.8105001184342345,1.4787725660654183,0.05405405405405406,0.624391352326341,1.0,4/8,10.43%,ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.8105001184342345,1.4787725660654183,0.05405405405405406,0.624391352326341,1.0,4/8,10.43%,ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7166059474155408,1.4783558070605427,0.07692307692307693,0.6221756496799693,1.0,7/17,13.43%,SOX11;WTIP;MOB3B;LIMD1;SHANK2;WWC2;WWC1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.8389130818579288,-1.4780739177651954,0.034482758620689655,1.0,1.0,2/9,5.25%,SOX9;SRF
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.78827862439474,1.4757806914687739,0.12121212121212122,0.6313170842211496,1.0,2/12,3.76%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.9026940235936799,-1.4742281514667,0.0,1.0,1.0,2/9,1.99%,HEY2;EMP2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.898641022514493,-1.4738304341248827,0.03333333333333333,1.0,1.0,2/8,1.40%,HEY2;SOX9
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.8885109275566557,1.4738270687749455,0.023255813953488372,0.6386914174316909,1.0,1/6,3.81%,EIF3D
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.7882486831326351,1.4719580705617323,0.05405405405405406,0.6435152704710998,1.0,4/8,13.88%,LSM1;DCPS;EDC3;PATL1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.5514739581345263,1.471407865114909,0.0625,0.6419553514933181,1.0,12/62,10.79%,POLR2J;POLR2L;ADRM1;EAF2;ELOC;TCEA1;GTF2H2;GTF2F1;SSRP1;EAF1;POLR2K;CDC73
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.5091462936427849,1.4695833047975593,0.0,0.6497463560042017,1.0,25/94,13.12%,BANF1;LSM4;YIF1A;CALR;ERN1;LSM1;NPM1;PREB;EEF2;POP4;BAG3;NHP2;PSAT1;IMP3;EIF4A3;PDIA6;NFYA;ATF4;SEC11A;ATP6V0D1;KHSRP;EIF4E;MTREX;PDIA5;SSR1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.9305497137777041,-1.467820820096008,0.018867924528301886,1.0,1.0,2/6,2.05%,DNAH7;CCDC39
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7324302512929213,-1.466811175028737,0.0273972602739726,1.0,1.0,6/24,9.17%,EPN1;FGF1;VEGFA;RHOJ;GLUL;ADAMTS9
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.8389193135012956,-1.4661731093301917,0.014492753623188406,1.0,1.0,2/10,4.71%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.6812325311082094,1.4656552360950328,0.05263157894736842,0.6683130517134225,1.0,3/25,4.14%,UBB;DYNLL2;UBE2N
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.7481976535559272,1.464295278582396,0.08333333333333333,0.6726481786727683,1.0,1/9,1.45%,OPN3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.615315095080979,1.464137782626325,0.05,0.6690950369882707,1.0,4/26,3.69%,USP51;PPP4C;H1-10;KPNA2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.6209514510820574,1.4638190482509505,0.043478260869565216,0.6665486720213006,1.0,6/26,10.12%,SIRT2;HNRNPA0;SRR;PELI1;INAVA;PRDX3
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.8331024791260553,-1.4627888309315804,0.017241379310344827,1.0,1.0,2/12,6.09%,DUOX1;KCNJ11
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.6155208052743132,1.462667040290541,0.15,0.6679453324472736,1.0,4/29,6.51%,USP51;PPP4C;PML;MGMT
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.9281226480625843,1.4625391581417346,0.07317073170731707,0.6604716756675998,1.0,1/5,4.56%,KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.9281226480625843,1.4625391581417346,0.07317073170731707,0.6604716756675998,1.0,1/5,4.56%,KMT5B
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.782180619469031,1.4623830279270906,0.12903225806451613,0.6572728601153609,1.0,1/10,0.42%,STOX1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.7714859341638334,-1.4623432546436714,0.057971014492753624,1.0,1.0,5/18,9.17%,HEY2;HES1;VEGFA;LRP2;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.8380462588631212,1.4620480861086569,0.02631578947368421,0.6541130545088809,1.0,2/7,4.35%,FBLN5;DHFR
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.896980594548743,-1.4610304784893056,0.014705882352941176,1.0,1.0,4/9,4.22%,HEY2;TTN;MYLK;ZFPM1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.9369940877099552,-1.4609344934401103,0.0,1.0,1.0,2/7,4.22%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8308522565202764,1.4605298726634797,0.05405405405405406,0.6584083357445604,1.0,4/8,14.87%,NR0B1;TGFBR1;PAX8;SALL1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.7173435974124062,1.459340105165666,0.1,0.6617303532622322,1.0,4/17,14.24%,UBB;RNF139;UBC;UGGT1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.9017569970771876,1.4593389946393605,0.08333333333333333,0.6577678960570692,1.0,3/6,3.07%,TSPO;FDX1;STARD3
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.9039513533503294,1.4592369373369556,0.022727272727272728,0.6545976006435591,1.0,1/7,1.94%,UNC119B
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.9043719543108927,1.4592222692230221,0.047619047619047616,0.6507242420598695,1.0,2/6,6.65%,FNBP1L;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.8350939086597474,1.4591713993032644,0.09090909090909091,0.6471418607665513,1.0,3/8,9.79%,GPNMB;FGL1;DUSP3
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.9222013859530522,-1.458978628747031,0.016129032258064516,1.0,1.0,1/6,3.80%,BRCA1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7256080176748374,1.4588941012486691,0.03333333333333333,0.6445772715865071,1.0,5/16,15.37%,ESR1;PIH1D1;RUVBL2;LRWD1;PPHLN1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.6615569294932021,-1.4584422797758068,0.0,1.0,1.0,9/74,5.13%,TMSB4X;TTN;GTPBP2;F8;TUBA4A;VCL;TIMP3;A2M;VEGFA
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.7825748154697139,-1.4581161772541504,0.041666666666666664,1.0,1.0,4/15,10.24%,SLC6A6;SLC22A4;SLC6A9;SLC1A4
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.6689339291214177,1.4578207848320153,0.07407407407407407,0.6467318956282389,1.0,3/22,2.94%,GPC4;ACTB;GPC1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.8416805662020365,1.4560394149434788,0.07142857142857142,0.652559285906495,1.0,2/5,6.03%,TGFBR2;LYN
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6321002485988122,1.4551640313612633,0.05,0.6534444365379829,1.0,11/25,18.68%,OSTC;UBE2J1;DDOST;ALG8;DPM2;FUT8;UGGT1;DPM3;MAGT1;STT3A;OST4
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.7728322884337733,1.4539538359897093,0.0625,0.6556703857857369,1.0,4/10,17.36%,VEZF1;LGALS3BP;KLRG1;KLRC2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.7680420512101813,1.4533411420110618,0.0625,0.655026534096871,1.0,2/10,5.06%,NOL11;PIH1D1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.5494011791550683,1.452872169003744,0.06666666666666667,0.6539971193178999,1.0,12/63,10.79%,POLR2J;POLR2L;ADRM1;EAF2;ELOC;TCEA1;GTF2H2;GTF2F1;SSRP1;EAF1;POLR2K;CDC73
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.5174417055244852,1.4525738733262623,0.1,0.651885503374009,1.0,15/89,10.31%,SOX4;UGDH;SOX11;OLIG2;ASCL1;OLIG1;MYT1L;PPT1;POU3F2;EPHA5;WNT3;ATP8A2;FZD3;TENM4;TGFBR1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8110869534092704,1.4521760020266934,0.030303030303030304,0.6501859299005879,1.0,2/8,5.59%,WDR18;METTL4
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.9565446289177071,-1.4513691275306242,0.0,1.0,1.0,1/5,1.56%,DUOX1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.9172479209438731,1.4512829055594834,0.08571428571428572,0.6503594371189069,1.0,2/5,3.76%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7845738514533437,1.4504566301653772,0.047619047619047616,0.6500700390398323,1.0,2/11,8.12%,CXCL12;TMEM161A
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8762760160048326,1.4503613978496195,0.029411764705882353,0.6469566808274794,1.0,1/6,0.64%,RFWD3
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6461109039206681,1.4490504482512452,0.05263157894736842,0.6500326729742039,1.0,11/24,18.68%,OSTC;UBE2J1;DDOST;ALG8;DPM2;FUT8;UGGT1;DPM3;MAGT1;STT3A;OST4
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.885940354942083,-1.4488179399335224,0.02857142857142857,1.0,1.0,2/9,0.35%,CD44;ENPP2
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6841036696032801,1.4484158419231041,0.06451612903225806,0.6494474545805689,1.0,3/14,2.81%,ODC1;TMEM9;SNF8
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.8116738866623613,1.4483844523626808,0.0967741935483871,0.6460120979291347,1.0,4/9,10.77%,SPCS2;SEC11C;HM13;SEC11A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.7599074077388638,1.4483002292903209,0.0,0.6428379785653279,1.0,4/16,8.88%,FERMT1;MSN;RAP2A;CAMSAP3
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.885654993233585,1.4474592937334747,0.075,0.6423749891751956,1.0,2/5,9.33%,PRDX1;MT3
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.5512403625584231,1.4470329567789841,0.11764705882352941,0.641103248530076,1.0,5/45,3.42%,SIRT2;BAD;ZFP36L1;ACAA2;HP1BP3
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.7754010886194297,-1.4469627225131019,0.04411764705882353,1.0,1.0,1/18,0.30%,HEY2
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.8989617323692118,-1.4463943549341527,0.0,1.0,1.0,3/10,5.42%,GLRA2;GRIN2A;GLRA1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6779535569126984,1.4452924947702694,0.05555555555555555,0.6465406751930484,1.0,1/13,2.84%,DSCC1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.6906469142958808,1.4447144259993974,0.043478260869565216,0.6462118922222488,1.0,3/22,4.76%,SOX4;BAD;NLGN2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.8217548618501314,-1.4436182644314006,0.014285714285714285,1.0,1.0,2/12,4.71%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.9489417343878015,-1.4425910502420216,0.03225806451612903,1.0,1.0,1/5,1.00%,ART4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8891993830506565,1.4422733510253867,0.0,0.655060456362261,1.0,3/6,9.31%,NR1H2;MID1IP1;ABCD2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.5696204717957122,1.4416995823718646,0.043478260869565216,0.6545458652489712,1.0,11/35,16.11%,TSPO;DNAJC15;MFF;AIP;TIMM13;TIMM22;GRPEL1;FIS1;DNAJC19;TIMM23;TIMM50
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.7978157769854695,-1.4414145239634004,0.05555555555555555,1.0,1.0,1/13,0.62%,FABP3
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.8965719609588476,1.4395221804363363,0.02564102564102564,0.661746413551277,1.0,2/8,5.10%,UNC119B;ZDHHC3
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.886143278026212,-1.438655747939054,0.030303030303030304,1.0,1.0,2/6,6.40%,INTU;COL5A1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.8569487759987189,-1.4386503080839912,0.04838709677419355,1.0,1.0,1/8,1.00%,HES1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.7842702971058125,-1.4384086890429608,0.01694915254237288,1.0,1.0,1/14,0.51%,CMTR1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.4800687144087144,1.437021721227256,0.0,0.6698762893809492,1.0,23/112,14.86%,POLR2J;POLR2L;NOVA1;PCBP3;LSM1;MRPL44;PCBP2;TBRG4;HNRNPA0;HNRNPC;DDX54;PCBP1;SNRNP40;GTF2F1;NUFIP1;PPP1R8;RNASEH2C;POLR2K;LAGE3;MTREX;HNRNPH1;POLR2E;WDR74
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.663630762926957,-1.4364459123110707,0.013513513513513514,1.0,1.0,24/60,22.30%,NLRC5;IRF1;PTPRC;MX1;TRIM52;AGBL4;STAT2;PLSCR1;TRIM56;IFIH1;MAP3K14;AGBL5;OAS1;IFIT1;IFIT3;ATG7;BNIP3L;IRF2;STAT1;TRIM5;CGAS;IFI6;RSAD2;DDIT4
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.9133983265907433,1.4352667159595383,0.025,0.6713421306405114,1.0,2/5,3.47%,SNF8;VPS28
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.9133983265907433,1.4352667159595383,0.025,0.6713421306405114,1.0,2/5,3.47%,SNF8;VPS28
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.7861084497274567,-1.4344027404207775,0.07142857142857142,1.0,1.0,8/18,10.09%,SCEL;CYP2E1;AHR;DUOX1;STEAP4;TMC4;SYT2;RAB3D
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6924979925574332,1.4342954233375682,0.09090909090909091,0.6735816016789921,1.0,4/18,4.14%,UBB;TAB3;MAP2K6;UBE2N
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5955893482700905,1.4341564843870969,0.0,0.6711629604428038,1.0,8/30,11.68%,NDUFB1;NDUFB11;NDUFS3;NDUFS6;NDUFB7;NDUFA5;NDUFS8;NDUFB10
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.8550845171968244,-1.4338017897320583,0.09090909090909091,1.0,1.0,2/7,1.99%,SCEL;EMP2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.8006567963124642,1.4337715241870215,0.1875,0.6695373267301847,1.0,3/6,16.44%,GPR37L1;PRCP;RNLS
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.7483418909907353,-1.4335900850048544,0.04411764705882353,1.0,1.0,5/21,13.21%,HES1;OCIAD2;PTPRC;CRLF3;CYP1B1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.8189941658113328,1.431775591764857,0.1,0.6763413661641775,1.0,2/11,6.94%,TIPARP;PARP1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7834349420897999,-1.430628931967143,0.08196721311475409,1.0,1.0,4/13,13.21%,HES1;OCIAD2;CRLF3;CYP1B1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7816273868696765,1.4303734332000133,0.05,0.673128148597521,1.0,2/5,16.93%,XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7816273868696765,1.4303734332000133,0.05,0.673128148597521,1.0,2/5,16.93%,XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7816273868696765,1.4303734332000133,0.05,0.673128148597521,1.0,2/5,16.93%,XYLB;DCXR
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7447502236046832,-1.4298180292957527,0.030303030303030304,1.0,1.0,3/22,7.45%,PON1;SLC2A3;ST3GAL1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.7674539972537625,-1.428307352075695,0.06060606060606061,1.0,1.0,5/23,9.17%,HEY2;TTN;ZFPM1;GJA1;ADAMTS9
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.5470302371919734,1.4279774758896102,0.047619047619047616,0.6805992013118073,1.0,14/41,16.11%,TSPO;DNAJC15;MFF;AIP;IMMP2L;TIMM13;TIMM22;GRPEL1;IMMP1L;FIS1;DNAJC19;HSPA4;TIMM23;TIMM50
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6803324885865847,1.4275761747017681,0.05263157894736842,0.6795856448089156,1.0,3/18,3.74%,UBB;TAB3;TLR1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.7233440399430412,-1.427572487618064,0.012987012987012988,1.0,1.0,8/48,5.13%,CD44;ENPP2;IL5;EFNA1;PTPRC;AGT;EFNA5;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.8201700655972771,-1.4274780039709285,0.06060606060606061,1.0,1.0,5/9,10.63%,HHIP;OPRM1;GLRA1;UBASH3B;NLRP12
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.5689163189726234,1.4274606418482776,0.09090909090909091,0.6767592354576921,1.0,14/47,16.01%,BAD;TSPO;STARD3;SLC25A24;MFF;PPIF;AIP;TIMM13;TIMM22;MTX2;SLC25A4;FIS1;DNAJC19;TIMM23
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.6591506399667777,1.4265092683021017,0.0,0.6787299878327308,1.0,6/25,7.83%,BAD;GPX1;MFF;PPIF;PLAUR;PSMD10
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.8138125403788187,-1.4225520893510666,0.029411764705882353,1.0,1.0,4/14,5.43%,HTR2C;ITPR1;PTPRC;RYR3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.834150185635459,-1.4224251177171072,0.0,1.0,1.0,4/13,5.43%,HTR2C;ITPR1;PTPRC;RYR3
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.8526169275250991,1.4222992058074364,0.15151515151515152,0.6986666056827996,1.0,2/6,7.91%,GPX1;CAT
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.650494035018337,1.4216822425666,0.09523809523809523,0.6983844583206915,1.0,2/25,0.73%,CPA1;GPX1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.5319090491448496,1.4213342142836165,0.0,0.6966481293647185,1.0,12/58,13.36%,DAPL1;RRAGA;TFEB;ATP6V0E1;ATP6V1G1;MLST8;ATP6V1B2;ATF4;ATP6V0D1;LAMTOR2;MIOS;LAMTOR1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.8636174934893748,1.4208187589364745,0.0,0.6959827778635141,1.0,3/7,9.17%,GSTP1;MID1IP1;SLC25A33
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6982717564097182,1.420523486665642,0.0,0.6942741580507918,1.0,3/15,2.01%,TSPO;ARV1;NR1H2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7187292722874508,1.4203814820584033,0.08695652173913043,0.6914063866251617,1.0,2/9,8.36%,SIRT2;SMARCAD1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5860868056590938,-1.4200096245523806,0.0,1.0,1.0,45/178,15.65%,GABRA4;HTR2C;HTR1F;GLRA2;GRIN2A;NAAA;CAMK1;AKAP5;GABRG3;SYT1;GRM1;KCNMB4;PCDHB5;SNCB;GLRA1;GABRG2;UNC13C;NRGN;HAP1;SST;RAB3A;GRIK5;APBA2;GRIN2D;CPLX1;CACNA1B;APOE;SHISA6;RIMS1;SNAP25;GRM3;SLC1A4;CBLN2;KCNC4;SYN3;CHRM3;CACNB1;NPTX1;PCDHB4;HTR4;PLP1;GABRA2;SLC17A7;DLG4;CDH8
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.903766294827202,1.419461833158662,0.0,0.6916846259377747,1.0,1/6,0.56%,TRMT112
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7600322344073513,-1.4193848870484063,0.02631578947368421,1.0,1.0,7/21,13.68%,CD44;PTPRC;TCF7;AOAH;TRAF3IP3;MYO1F;GPR171
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.8421861421835672,1.418702683606769,0.05128205128205128,0.6916368706041014,1.0,1/5,7.98%,RPRD1B
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.6739769881240675,1.418604402148732,0.12121212121212122,0.6889499026500181,1.0,4/9,20.30%,PPIF;SLC25A33;VCP;PINK1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.9424750199378032,-1.4184960963265911,0.016129032258064516,1.0,1.0,1/5,1.17%,CRYM
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.9424750199378032,-1.4184960963265911,0.016129032258064516,1.0,1.0,1/5,1.17%,CRYM
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.682220148748332,-1.417596236919988,0.03896103896103896,1.0,1.0,8/30,17.35%,CD44;SOX9;SLC39A14;RUNX2;SULF1;TGFB1;DDRGK1;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5892718343112191,1.4174340155532859,0.05555555555555555,0.6922476168340816,1.0,13/52,11.71%,UBB;PMEPA1;HSPA1A;TGFBR2;PPM1A;BAMBI;SPRY1;SLC2A10;SMAD3;TGFBR1;UBC;SMURF2;PEG10
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.6926629628707409,-1.4173867908799527,0.0684931506849315,1.0,1.0,6/36,9.70%,HTR2C;ITPR1;G6PC2;KCNJ11;CACNA1C;SNAP25
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.784025481089742,-1.417149216710606,0.045454545454545456,1.0,1.0,3/14,9.62%,KCNMB4;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5144938986441967,1.4146112733775669,0.0,0.7038717194318223,1.0,10/63,7.83%,STOX1;SIRT2;UBB;PSMD8;PSMB6;PSMB4;ELOC;RBPJ;PSME3;PSMD10
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.6876571673538208,-1.4143364463161996,0.05128205128205128,1.0,1.0,10/37,14.69%,CD44;IRF1;IFNGR2;IL3RA;A2M;STAT2;IL7;OSMR;STAT3;TGFB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4543362339594559,1.4141850520247896,0.0,0.7030071889340277,1.0,16/147,8.54%,COPZ1;YIF1A;DYNLL2;KLHL12;PEF1;TGFA;CTSC;TMED2;KDELR1;YIF1B;PREB;SEC24D;TMED5;COG3;RAB1B;GOSR1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8656842623147664,-1.4141767070273086,0.013888888888888888,1.0,1.0,3/7,7.25%,PMS2;POLQ;MSH6
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.8617649956929845,-1.4139370858232407,0.0,1.0,1.0,1/7,1.04%,ALOX12
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.9579735835799988,1.4133164261035545,0.024390243902439025,0.7044261226514383,1.0,1/5,1.51%,CUL7
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.7629983342433362,1.4130192189757989,0.08823529411764706,0.7026859542389934,1.0,2/8,9.51%,H1-10;H1-4
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5502114227532199,1.4128709974227103,0.043478260869565216,0.7002724034936969,1.0,16/37,26.13%,HSPA1A;ERN1;TMBIM6;BAG3;HSPA8;TM7SF3;HSPA4;DNAJA1;HSPA5;PTPN1;HERPUD1;STT3B;OPTN;HSPA13;HSF1;HSPH1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.6913384268145514,1.4124404365517713,0.08,0.699501881569869,1.0,3/11,15.35%,ACTB;ZDHHC2;STX7
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7907642532106516,1.4122275003995397,0.05555555555555555,0.6972482599419397,1.0,2/11,6.36%,MAP2;B4GALT6
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.847514612274485,-1.4120122112044347,0.07575757575757576,1.0,1.0,2/10,8.73%,HEY2;GJA1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5330613306538883,1.4118939821463976,0.05555555555555555,0.6953855098146658,1.0,19/62,17.74%,UBB;MALT1;PEF1;UBE2D1;UBE2N;PRICKLE1;RPS2;PSMD10;BMI1;PTTG1IP;INAVA;COMMD1;RCHY1;ARRDC4;RIPK2;MARCHF7;SMAD7;NDFIP2;SPRTN
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.8404704669735888,-1.4115904994683213,0.016129032258064516,1.0,1.0,2/10,8.16%,PON1;PDZK1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.5464268133792602,1.4114698671993382,0.045454545454545456,0.6947083725524122,1.0,12/57,7.83%,GPX1;HSPA1A;GSTP1;ACAA2;PIH1D1;TMBIM6;PPIF;NDUFS3;NOC2L;PSME3;PLAUR;PSMD10
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.7008850217274021,1.4113055755019106,0.02857142857142857,0.6895293390694041,1.0,2/17,1.26%,POLR2J;POLR2L
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.7008850217274021,1.4113055755019106,0.02857142857142857,0.6895293390694041,1.0,2/17,1.26%,POLR2J;POLR2L
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.7647126296508193,-1.4111669160225664,0.05555555555555555,1.0,1.0,3/13,7.66%,PHKG1;PYGL;PYGB
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.8975134199987375,-1.4110204249103793,0.016129032258064516,1.0,1.0,2/6,5.80%,EMP2;CAV3
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.8954934481800965,-1.4107447550986836,0.029411764705882353,1.0,1.0,1/6,0.30%,HEY2
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.9007953762254445,1.4101186807317907,0.0851063829787234,0.6926517169799822,1.0,1/5,0.98%,LPCAT1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6469785251124482,1.409938914413018,0.08695652173913043,0.6904262058750626,1.0,6/24,11.37%,GPX1;HSPA1A;ACAA2;PPIF;PSMD10;MUL1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.8568241981771192,-1.4097014953057196,0.03076923076923077,1.0,1.0,1/11,0.58%,STMN2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.8442207594950951,1.4093743804824472,0.0975609756097561,0.6869318654652598,1.0,2/6,6.48%,SIRT2;BCAR1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.8442207594950951,1.4093743804824472,0.0975609756097561,0.6869318654652598,1.0,2/6,6.48%,SIRT2;BCAR1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.8680724205720424,1.4091736649026918,0.058823529411764705,0.6848192421667553,1.0,2/7,1.55%,UGDH;LRRC8D
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.7726756129905644,1.4080824162546413,0.08333333333333333,0.6863498674348243,1.0,7/10,17.76%,NEU1;NEU3;GBA3;GM2A;ACER2;ACER3;NEU4
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5176909481280084,1.4074091544662048,0.10526315789473684,0.6864472304556486,1.0,17/79,11.71%,UBB;PMEPA1;HSPA1A;TGFBR2;UBE2D1;PPM1A;BAMBI;BMPER;SPRY1;SLC2A10;SMAD9;GREM1;SMAD3;TGFBR1;UBC;SMURF2;PEG10
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.7502324033585571,-1.4072527410499978,0.04,1.0,1.0,6/21,13.68%,IL5;AHR;PTPRC;STAT6;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.8398727455947603,-1.4071655775581786,0.057971014492753624,1.0,1.0,2/9,4.22%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.6758588744625227,1.4060684994543362,0.07407407407407407,0.6888418721311494,1.0,6/20,10.97%,GPC4;HSPG2;GPC1;SDC2;SGSH;GUSB
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5478146486998872,1.4055970968765021,0.04,0.6883411276777517,1.0,7/37,7.72%,BAD;STYXL1;PPIF;NDUFS3;NOC2L;BOK;PLAUR
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9577779765679033,-1.4055599446754263,0.017241379310344827,1.0,1.0,1/5,0.61%,CYP2E1
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.9392171010333352,-1.4044935554222027,0.015873015873015872,1.0,1.0,2/5,5.80%,EMP2;CAV3
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.870413520848125,1.4038547866040862,0.08108108108108109,0.6940382308706772,1.0,1/5,0.93%,IDH1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.9029185604073657,-1.4037842873578925,0.08064516129032258,1.0,1.0,1/6,5.32%,RNF213
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.49214543410702954,1.4037497454071852,0.0,0.6915416078061842,1.0,17/116,7.75%,UGDH;G0S2;ODC1;IDH1;OSTC;ACADS;AADAT;HSD17B10;ACAA2;PCBD1;ACADVL;ALAD;ECH1;S100A10;PRDX6;ACOT8;MGLL
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.7644361929971686,-1.4034172841581039,0.06153846153846154,1.0,1.0,4/11,12.91%,CD160;HLA-F;RASGRP1;PVR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.7644361929971686,-1.4034172841581039,0.06153846153846154,1.0,1.0,4/11,12.91%,CD160;HLA-F;RASGRP1;PVR
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.7413588441335563,1.403251422199416,0.03333333333333333,0.6920788593147027,1.0,3/7,14.38%,TBRG4;TRMT10A;TRMT10C
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.8350404365772579,1.402678706341371,0.1,0.6921500266093659,1.0,2/6,3.06%,TMEM9;PPT1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.8082699691005412,1.4025688585821574,0.1702127659574468,0.6901518740654388,1.0,1/5,0.49%,SIRT2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.8107898679021307,-1.4019778992731668,0.04285714285714286,1.0,1.0,5/11,10.63%,HHIP;OPRM1;GLRA1;UBASH3B;NLRP12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8201010791197567,-1.400752684034996,0.09333333333333334,1.0,1.0,4/10,13.45%,ALOX12;FLG;HRNR;TMEM79
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8201010791197567,-1.400752684034996,0.09333333333333334,1.0,1.0,4/10,13.45%,ALOX12;FLG;HRNR;TMEM79
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.9064149454761992,-1.4002444048278186,0.0,1.0,1.0,3/6,5.13%,HEY2;HES1;VEGFA
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.8168069000400264,1.399667968664778,0.06666666666666667,0.7013899018267138,1.0,4/10,4.48%,BGN;DSEL;BCAN;VCAN
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.8060806201316911,1.399667001159597,0.1,0.6985153530487355,1.0,3/7,8.20%,PCGF2;BMI1;RNF2
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7857455026264399,1.3987167985135274,0.075,0.7000916372284985,1.0,2/7,4.03%,COPRS;PRMT6
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.8891993766937839,-1.3979118503600851,0.028169014084507043,1.0,1.0,1/7,1.22%,MYLK
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.8033752272667972,-1.397696483794245,0.06060606060606061,1.0,1.0,2/9,8.51%,ANGPTL4;APOE
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.8621077458018008,-1.3959435049826299,0.07575757575757576,1.0,1.0,2/7,5.13%,TTN;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.8010887711581117,1.3958252075885533,0.07894736842105263,0.7104173153584916,1.0,1/10,5.91%,THY1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.9066623923890911,-1.3944171812044104,0.03333333333333333,1.0,1.0,4/6,7.07%,NR4A3;FGF9;DOCK5;DOCK7
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.6969625267628023,1.3940530807125482,0.08333333333333333,0.7134918387356274,1.0,2/17,2.11%,GPC4;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.6969625267628023,1.3940530807125482,0.08333333333333333,0.7134918387356274,1.0,2/17,2.11%,GPC4;SLITRK2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.839762003242256,1.3939202656364733,0.02857142857142857,0.7113524504790524,1.0,2/5,11.10%,CMPK1;DHODH
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.8981053777852813,-1.3938341667185965,0.015873015873015872,1.0,1.0,1/6,1.04%,ALOX12
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6530475389712457,-1.3933897557429142,0.04838709677419355,1.0,1.0,4/27,5.25%,SOX9;FOS;SPI1;SRF
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.7332199935038227,-1.3930662308758113,0.06349206349206349,1.0,1.0,5/14,16.62%,PARP9;LIFR;IFIH1;IRAK2;MAP2K5
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.8129854353137365,-1.3929497735743543,0.028985507246376812,1.0,1.0,7/11,11.19%,IL5;PTPRC;SPI1;NR1D1;AOAH;TRAF3IP3;MYO1F
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7632916426811654,-1.3928352216612225,0.029411764705882353,1.0,1.0,5/20,9.31%,FGF1;CCDC39;FGF9;VEGFA;LOXL3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.7876728651366559,-1.3924429290142228,0.07246376811594203,1.0,1.0,2/12,1.40%,FAM161A;CAMK1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.778144399618954,-1.3916639566587021,0.06060606060606061,1.0,1.0,3/14,7.90%,HEY2;SOX9;ASPN
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.7586858124555409,1.3899856139252131,0.1111111111111111,0.7277536007834633,1.0,3/8,11.13%,PIH1D1;RUVBL2;LRWD1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7002755737459094,-1.3893581884752182,0.056338028169014086,1.0,1.0,5/17,12.91%,CD160;SPI1;HLA-F;RASGRP1;PVR
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.876367249885995,-1.3893368658424743,0.01818181818181818,1.0,1.0,1/10,0.49%,IHO1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.7477004436503327,1.389167616057029,0.16216216216216217,0.7286770793082437,1.0,3/10,5.21%,TRIM28;TRIM35;PML
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.8545915092308966,1.3890857853844714,0.08108108108108109,0.7261717945429603,1.0,3/6,11.13%,PIH1D1;RUVBL2;LRWD1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.8045665998144491,1.3890455095537728,0.047619047619047616,0.7234664491977145,1.0,3/9,13.91%,CFL1;TENM4;PLCB1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8699111988608571,-1.388964451865434,0.043478260869565216,1.0,1.0,1/7,0.68%,ARIH2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.9304488792627721,-1.3875322822586718,0.0,1.0,1.0,1/6,5.32%,RNF213
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6820541828928205,1.3869428965087287,0.14814814814814814,0.7314038859759018,1.0,5/15,17.44%,SIRT2;CALM3;CALM1;SMAD7;CADM4
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.7344288109635058,1.3863657502986748,0.08108108108108109,0.7308806487164136,1.0,5/7,20.64%,PCBP2;MUL1;TSPAN6;TRAF3IP1;ILRUN
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7699395721397632,1.38554800784127,0.08333333333333333,0.7311763317127766,1.0,2/7,5.01%,SOX11;LIN7C
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.8452415563721098,1.3853493518555833,0.10810810810810811,0.7293593927070464,1.0,2/5,13.62%,MST1;CLK2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.5729560441973673,1.3842177890806038,0.15384615384615385,0.7323537330417037,1.0,2/26,2.61%,TRMT112;SMYD2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5797489705165354,-1.3839374112970666,0.01098901098901099,1.0,1.0,33/136,15.23%,GABRA4;HTR2C;HTR1F;GLRA2;GRIN2A;CAMK1;AKAP5;GABRG3;SYT1;GRM1;KCNMB4;PCDHB5;SNCB;GLRA1;GABRG2;UNC13C;NRGN;HAP1;SST;APBA2;CPLX1;CACNA1B;SNAP25;GRM3;KCNC4;CHRM3;CACNB1;NPTX1;PCDHB4;HTR4;PLP1;GABRA2;DLG4
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.8408316399464231,-1.3822241287528663,0.03225806451612903,1.0,1.0,1/9,4.25%,SPI1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7457843769536828,1.3819322388626167,0.11764705882352941,0.7423587275148955,1.0,2/9,4.02%,ACADS;ACADVL
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7601129622132685,1.3816847948255455,0.23809523809523808,0.7407871761689397,1.0,2/6,3.28%,AADAT;HPD
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.5908200807321377,1.3816367457309446,0.09090909090909091,0.7381087556556326,1.0,13/47,16.68%,TAF1A;ACTB;POLR2L;H1-10;POLR1F;WBP2;H1-4;POLR2K;BAZ1B;POLR2E;MYBBP1A;POLR1A;DDX21
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.703295225166281,-1.3809077957429796,0.04225352112676056,1.0,1.0,10/28,14.69%,AHR;HSD11B1;PTPRC;ITGA2;CD27;AOAH;TRAF3IP3;MYO1F;GPR171;TGFB1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7538174112328866,1.3807665517735785,0.1111111111111111,0.7391662512705514,1.0,1/9,0.36%,DGKB
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.8170834003906999,-1.3806416118485592,0.03076923076923077,1.0,1.0,2/13,5.63%,CHAC2;ADAMTS13
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.8130046985725519,-1.3805491563348011,0.058823529411764705,1.0,1.0,3/10,9.70%,SLC29A2;GLUL;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5346171632558139,1.38012635820585,0.07407407407407407,0.7386822916036355,1.0,13/29,22.96%,SOX11;ASCL1;BRINP1;NGF;BEND6;BMP2;ZEB1;RHOA;VWC2;TCF3;BRINP3;CPNE1;TCF4
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.9314090126672707,-1.3801111806252837,0.06666666666666667,1.0,1.0,1/5,5.32%,RNF213
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.616940595441569,1.379467875098221,0.03571428571428571,0.7392028430222267,1.0,3/20,10.67%,NOL11;PIH1D1;ATF4
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.7569534231996619,1.3794284636179406,0.06060606060606061,0.736518352852824,1.0,2/8,7.93%,ACOT8;SLC2A10
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.7938211604704115,-1.3790282051797425,0.05555555555555555,1.0,1.0,2/14,1.40%,HEY2;SOX9
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.9104430229621292,-1.378875226288227,0.02040816326530612,1.0,1.0,2/5,0.40%,HTR2C;HTR1F
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.8121516925439161,1.3784112233429724,0.09090909090909091,0.7357931053183625,1.0,1/6,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.8121516925439161,1.3784112233429724,0.09090909090909091,0.7357931053183625,1.0,1/6,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.7081541258870923,-1.3782285487791115,0.08333333333333333,1.0,1.0,8/20,15.65%,CDH7;CDH12;CDH9;PCDHB5;CDH19;PCDHB4;CDHR3;CDH8
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6189918531049518,-1.377997066765932,0.060240963855421686,1.0,1.0,27/67,20.66%,CMTR1;PROCR;IRF1;MX1;PARP9;PARP14;PSMB8;STAT2;TMEM140;PLSCR1;HLA-C;IL7;B2M;TENT5A;LPAR6;IFIH1;OAS1;HERC6;IFIT3;C1S;PSMA3;IFI35;IRF2;TRIM25;WARS1;TRIM5;NCOA7
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.689867201236395,-1.377770562324503,0.06097560975609756,1.0,1.0,8/27,15.23%,GRIN2A;DAPK1;OPRM1;SLC6A9;CAMK2B;CAMK2A;NEFL;DLG4
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.8096149979564972,1.3775822436939118,0.19444444444444445,0.7378733627166884,1.0,3/8,8.49%,MOXD1;SNCAIP;COMT
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.6737401473863923,-1.3775081414931918,0.05333333333333334,1.0,1.0,10/32,12.48%,SLC6A6;SLC6A15;SLC16A3;SLC6A11;SLC6A9;SLC7A6;SLC6A17;SLC1A4;SLC13A3;SLC16A4
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.8700438518145286,1.3771688800982342,0.02631578947368421,0.7369397315998393,1.0,1/7,2.01%,NR1H2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.8258402305026369,-1.376294455888133,0.06153846153846154,1.0,1.0,5/9,12.27%,NR4A3;FGF9;DOCK5;DOCK7;TPM1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.7592747530867116,-1.3755170657962954,0.05333333333333334,1.0,1.0,5/17,9.31%,FGF1;CCDC39;FGF9;VEGFA;LOXL3
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.8052569143233278,1.37484429230164,0.1111111111111111,0.7455930317362236,1.0,1/5,4.96%,MAP2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.5363293063721264,1.3744013920247016,0.047619047619047616,0.7450996436444726,1.0,12/57,13.36%,DAPL1;RRAGA;TFEB;ATP6V0E1;ATP6V1G1;MLST8;ATP6V1B2;ATF4;ATP6V0D1;LAMTOR2;MIOS;LAMTOR1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.5964079539461982,1.3743860551117548,0.07407407407407407,0.742564813690857,1.0,2/25,1.41%,TUBG1;MAP7D3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.808858222672021,1.3742929561937511,0.1111111111111111,0.740150432850933,1.0,3/8,6.55%,POP5;HSD17B10;POP4
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.850984885570893,1.3737400041199577,0.08333333333333333,0.7395808032081966,1.0,2/5,6.03%,CXCL12;LYN
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.6340365251770224,1.373669660633692,0.06896551724137931,0.7371948324488635,1.0,7/28,13.02%,UBB;TAB3;TLR1;CNPY3;INAVA;UBC;S100A1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6847046940897707,1.3736192955045896,0.09375,0.7345238366791212,1.0,2/14,5.06%,NOL11;PIH1D1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.7965825786225402,1.3733375438816524,0.15789473684210525,0.7330770191371979,1.0,2/5,8.05%,ZNF830;RAD17
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.8743039403558828,-1.3730472246343997,0.07936507936507936,1.0,1.0,5/7,11.19%,PTPRC;IGSF6;SPI1;AOAH;MYO1F
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7645900668348646,-1.371813375394236,0.09859154929577464,1.0,1.0,7/15,15.26%,SLC28A2;SLC3A1;FMO5;CYP3A5;PBLD;VIL1;SLC5A9
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.6564553431978742,-1.3717446183013096,0.07246376811594203,1.0,1.0,12/33,16.60%,MAP3K19;FAM161A;CCDC39;ECT2L;CFAP77;ANKUB1;CFAP70;CFAP52;DNAH9;CDHR3;CFAP43;VWA3B
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.6453718993577627,-1.3716350407817515,0.05555555555555555,1.0,1.0,11/40,18.37%,FGF1;TPD52L1;VEGFA;DVL2;RASGRP1;PAK1;TGFB1;PDGFRB;IL34;DAB2IP;HTR2B
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.7414813232124202,-1.3707584464457057,0.07692307692307693,1.0,1.0,5/12,15.92%,CD160;HLA-F;RASGRP1;PVR;ARRB2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.7879873064351548,1.3707194687642033,0.2,0.7420954775475203,1.0,1/5,7.41%,NDP
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.7548400090767631,1.3706402563796283,0.07692307692307693,0.7396350130984648,1.0,3/15,7.88%,ASPM;S100B;GPR174
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.6876204759197522,1.3706398458274944,0.16666666666666666,0.736993459480256,1.0,5/15,23.65%,NR1H2;MCTP1;RUBCN;PRKD1;SYT11
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6992791696245577,1.3702601955444986,0.058823529411764705,0.7360038515965318,1.0,3/14,16.12%,TNFAIP1;KCTD10;KCTD13
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6277368409248197,1.369709800603944,0.06896551724137931,0.7354157721109975,1.0,7/25,11.55%,LAMA3;CD151;TRIP6;THY1;RCC2;THSD1;PEAK1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.7221655215931655,1.3692006374315606,0.07142857142857142,0.7352249645388669,1.0,3/13,6.65%,VPS37B;KPNA2;CHMP2A
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.691884437104411,1.369181324615743,0.1111111111111111,0.7327830436151237,1.0,3/13,19.07%,LARP7;NELFA;RNF168
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.754201557152144,-1.3690607215381962,0.0958904109589041,1.0,1.0,4/14,10.21%,PHKG1;PYGL;PYGB;AOAH
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.655136191738051,1.3689217932252289,0.09375,0.7315781251246405,1.0,4/15,9.23%,FBLN5;LTBP3;GPM6B;NTNG2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8147359077842833,1.3686534598521276,0.08108108108108109,0.7304788807079737,1.0,2/6,5.97%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.6679420450173733,1.3686380450783777,0.06451612903225806,0.7280305673540454,1.0,5/13,3.83%,SOX4;SOX11;ASCL1;SOX8;SOX10
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.6785463104561403,1.3684430159768197,0.18518518518518517,0.7266132699101115,1.0,2/7,17.86%,BMP2;LRP6
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5018873730577857,1.3672957473624627,0.06666666666666667,0.7293440394713703,1.0,17/78,11.54%,RBM15B;PCBP4;NOVA1;SMU1;C9ORF78;LARP7;PRDX6;RBM23;KHDRBS2;RBFOX1;PUF60;FXR2;SAP18;RBM8A;MAGOH;JMJD6;SRSF3
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.7772458301209644,-1.367286099518549,0.06451612903225806,1.0,1.0,9/16,17.24%,MYLK;DOCK8;IGSF6;SPI1;AOAH;MYO1F;PILRA;TBXAS1;ARG2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7262542332319784,-1.3668640079588847,0.057971014492753624,1.0,1.0,5/25,12.84%,DND1;PARN;THRAP3;TENT5A;MEIOC
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.7518226141672016,1.36657330684035,0.15789473684210525,0.7306653287325767,1.0,2/9,10.85%,DHFR;RTN4RL2
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.8752929009938669,1.3664269256670747,0.10256410256410256,0.7291102227276722,1.0,2/6,5.97%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.8222704287744929,-1.3663430271641754,0.046153846153846156,1.0,1.0,4/11,5.82%,PTPRC;P2RY12;SHTN1;ITGA2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6329843294175346,1.3660343895611182,0.12121212121212122,0.7283277667126786,1.0,4/19,10.72%,NOX4;CDO1;TXN2;ADI1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.6534751245409522,1.3660046126537504,0.13043478260869565,0.7260318558920246,1.0,6/28,7.73%,NOX4;AADAT;THAP4;PYCR1;SRR;OAT
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.845087537016795,1.3655335068019394,0.07407407407407407,0.7252651933425603,1.0,4/6,10.31%,ASCL1;MYT1L;POU3F2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.7338697183220371,1.365494466797635,0.11428571428571428,0.7228538078534847,1.0,2/12,7.02%,NR1H2;SCARB1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.8341679090967864,-1.3645788276905906,0.08333333333333333,1.0,1.0,4/9,8.93%,SYT1;UNC13C;SYT2;RIMS1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.8090936139608509,1.364405121999625,0.13043478260869565,0.7244991100015408,1.0,2/6,15.77%,GAL3ST3;B3GALT2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.730267241511812,1.364239074578801,0.15789473684210525,0.7226684199437863,1.0,1/9,0.36%,DGKB
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.7009996931293646,-1.3635040081833607,0.09333333333333334,1.0,1.0,4/21,8.03%,PHKG1;PYGL;PYGB;NR1D1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.7019659812909469,1.3633816830691143,0.19444444444444445,0.723883307719447,1.0,4/12,8.60%,MOSPD2;CXCL12;LYN;GREM1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.6419346543012687,1.363204651802205,0.0967741935483871,0.7224390021931966,1.0,6/21,15.13%,HSPA1A;ERN1;TMBIM6;BAG3;HSPA8;TM7SF3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.6126252695498374,1.363071267104185,0.08108108108108109,0.7206798409755985,1.0,6/23,9.41%,GPX1;ADCY6;CXCL12;MEOX2;GUCY1B1;MYOF
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.7217167655998884,-1.3630206442548147,0.03278688524590164,1.0,1.0,2/20,6.54%,CMTR1;PUS7
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7866893776853112,-1.36296346191977,0.11290322580645161,1.0,1.0,4/11,13.21%,HES1;OCIAD2;CRLF3;CYP1B1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.8424311409788605,-1.3624634210785547,0.09375,1.0,1.0,2/9,5.51%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.8424311409788605,-1.3624634210785547,0.09375,1.0,1.0,2/9,5.51%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.7263476183473841,1.3622861180100039,0.07894736842105263,0.7217044231678045,1.0,4/10,22.15%,LRRC8D;SLC25A14;SLC1A2;SLC25A30
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.7997532556253906,-1.3618546181907922,0.06944444444444445,1.0,1.0,1/9,0.19%,PON1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.8039458063869984,-1.3615695480729375,0.05263157894736842,1.0,1.0,5/14,9.28%,GADD45B;GADD45A;SPI1;VEGFA;RELL1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8993468371556624,1.360306934281145,0.02702702702702703,0.7283400671864276,1.0,2/5,7.48%,SIRT2;BOK
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.8053401951766691,1.3602436766205581,0.13953488372093023,0.726073992450485,1.0,3/6,15.03%,NLGN2;NLGN3;MTG2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.8006983637456877,1.3595456606416167,0.07142857142857142,0.726796249832023,1.0,3/6,3.63%,LTV1;RAN;NPM1
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.7259956967004003,1.3595443139030006,0.10256410256410256,0.7244133113079836,1.0,2/11,8.85%,TRIR;EXOSC8
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.702543122233355,-1.358655983205878,0.05128205128205128,1.0,1.0,6/28,4.52%,SCEL;CLDN18;CEBPD;CRLF1;FPR3;STEAP4
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.8203244344252457,1.3586290453059682,0.08823529411764706,0.7263178709512088,1.0,4/9,14.31%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.9122434893625211,-1.3573663070417255,0.01694915254237288,1.0,1.0,2/7,2.87%,AHR;IRF1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5961261996979625,1.3568850718755352,0.07407407407407407,0.7320150517742251,1.0,5/22,10.43%,SIRT2;ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7417679174430162,1.3568523795787815,0.11538461538461539,0.7298641339773164,1.0,1/8,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.8335620066697706,-1.3567653411451255,0.06451612903225806,1.0,1.0,1/7,1.51%,TESPA1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.7826359360402514,-1.3560298323619788,0.08571428571428572,1.0,1.0,1/13,0.27%,RFC4
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.8102035655513306,-1.3557459924340654,0.056338028169014086,1.0,1.0,1/10,0.20%,CD44
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.8729924320590354,-1.3555594200735384,0.046875,1.0,1.0,1/8,1.96%,GALNTL6
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.8407251150626062,1.3555562297204427,0.0967741935483871,0.7329026865787874,1.0,5/8,10.12%,GPX1;PRDX1;PRDX5;CAT;PRDX3
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.8081408055442301,-1.3553055616748955,0.06349206349206349,1.0,1.0,3/10,10.65%,AKAP5;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8175704423014877,-1.3549999247497198,0.057971014492753624,1.0,1.0,1/10,1.16%,NR4A3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.44050874705909476,1.3549246943074427,0.0,0.7333646387708291,1.0,19/136,9.08%,NR0B1;TAF1A;POLR2J;POLR2L;NR1H2;POLR1F;TAF9B;ESR1;NR2F6;GTF2A2;MED23;MAML2;RBPJ;YAP1;GTF2H2;NR3C1;GTF2F1;ESRRG;NR2E1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.7992916816987184,-1.3548761491555739,0.05,1.0,1.0,2/10,2.87%,VSIR;IRF1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7621566947110516,1.3546741803544173,0.11764705882352941,0.731945575480153,1.0,3/10,14.43%,MRPL44;SMAD3;DGCR8
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.7823052951851364,-1.3543615438265784,0.14492753623188406,1.0,1.0,3/12,5.13%,HEY2;TTN;VEGFA
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.7428364097731546,1.353987158785328,0.15625,0.7323184900394512,1.0,4/13,3.02%,SOX11;SOX8;KLHL12;PEF1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6532446413912839,1.3535254257605847,0.1935483870967742,0.7322002958324986,1.0,3/11,9.98%,GPNMB;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5152388733970596,1.353513533937763,0.045454545454545456,0.7298684477565989,1.0,15/56,17.73%,ACADS;HSD17B10;ACAA2;ACADVL;ACOT8;NUDT19;ABCD2;PCCB;ECHDC1;ABHD2;PEX13;CROT;GLYATL2;ACOX1;ACAT2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.857658667005281,-1.3534448091213631,0.05333333333333334,1.0,1.0,3/7,12.47%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.6970413546236369,1.3531677870761787,0.11764705882352941,0.7291848639237677,1.0,2/9,3.94%,HSPA1A;SNCAIP
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.5479699619392514,1.3530998167144348,0.0,0.7270973560326367,1.0,11/42,17.73%,ACADS;HSD17B10;ACAA2;ACADVL;ACOT8;ABCD2;ECHDC1;CROT;ACOX1;CRAT;ACAT2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.8293178742031377,1.3506698535854351,0.15,0.7361218763884909,1.0,2/5,11.58%,GPX1;MST1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.636242935646661,-1.350642167080285,0.024691358024691357,1.0,1.0,11/60,11.37%,SLC28A2;SLC2A3;SLC6A6;SLC29A2;LRP2;ABCC3;SLC6A9;SLC6A17;SLC1A4;SLC13A3;SLC4A4
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.7570319153934355,1.348695732921872,0.15384615384615385,0.7401382968027402,1.0,2/9,12.02%,CHMP2A;VTA1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.7570319153934355,1.348695732921872,0.15384615384615385,0.7401382968027402,1.0,2/9,12.02%,CHMP2A;VTA1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.8174715225313753,-1.3486895181156164,0.05,1.0,1.0,1/8,1.32%,SLC2A3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.6257914387645298,-1.3486760622372551,0.058823529411764705,1.0,1.0,13/65,5.13%,CD44;ENPP2;IL5;HES1;EFNA1;PTPRC;NEDD9;PARP9;AGT;CRLF1;PARP14;EFNA5;VEGFA
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.7478414656033097,1.348531904334057,0.07692307692307693,0.7387379769857648,1.0,2/7,3.06%,NR1H2;PPT1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6739017922102718,-1.3484895018574743,0.09333333333333334,1.0,1.0,17/31,20.60%,CD44;IRF1;IFNGR2;CAMK2B;HLA-F;HLA-C;B2M;CAMK2A;JAK1;OAS1;CIITA;CAMK2D;IRF2;STAT1;HLA-B;TRIM25;TRIM5
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.6840103123628268,-1.3484479300029122,0.05063291139240506,1.0,1.0,7/28,9.70%,SLC6A6;SLC39A14;SLC22A4;SLC29A2;LRP2;GLUL;SNAP25
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.7392480440526321,1.3483158312700423,0.16279069767441862,0.7369564807608345,1.0,2/6,15.80%,LIG4;ERCC8
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.8326121732340175,-1.348249876293341,0.07352941176470588,1.0,1.0,1/7,0.30%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7795288441962039,1.348131031447371,0.1388888888888889,0.7354019887681286,1.0,1/8,2.01%,NR1H2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.9052788236848537,-1.3479472883645418,0.06349206349206349,1.0,1.0,2/5,4.59%,F8;A2M
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.7097100774659818,-1.3472706211032723,0.07894736842105263,1.0,1.0,5/22,10.25%,CCDC39;ENKUR;MMP21;DNAH11;DNAH5
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.7831753351447356,1.3467562014138432,0.1935483870967742,0.7394111009190902,1.0,3/7,10.69%,SOX11;PDGFRA;EPHB3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.6986209933712398,-1.3465280377460707,0.07042253521126761,1.0,1.0,7/23,14.40%,GADD45B;GADD45A;SPI1;VEGFA;RELL1;RASGRP1;PER1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7000584730230978,1.3465180895268343,0.14285714285714285,0.7384166043790866,1.0,3/10,14.71%,ARV1;STARD4;OSBP
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.7494839227527039,-1.3458715779582557,0.08196721311475409,1.0,1.0,11/19,17.38%,PAH;SLC3A1;FMO3;SPATA6L;PDZK1;FMO5;CYP3A5;TSHR;SLC5A9;KNG1;PON3
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.8873947006799753,-1.3454148713653271,0.07042253521126761,1.0,1.0,1/6,2.27%,PHF19
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.8470989726992421,1.345381776381016,0.13043478260869565,0.7382375465444209,1.0,2/7,5.01%,CRB2;LIN7C
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.8470989726992421,1.345381776381016,0.13043478260869565,0.7382375465444209,1.0,2/7,5.01%,CRB2;LIN7C
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.7929511424422073,-1.3453239081003683,0.09523809523809523,1.0,1.0,1/11,1.00%,HES1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.6147392090729218,1.3451386589242236,0.1875,0.7372132352335592,1.0,3/17,7.15%,SHROOM2;AP1M1;BLOC1S4
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7555286564728464,-1.3451101439736632,0.09210526315789473,1.0,1.0,3/12,9.17%,HEY2;MYLK;ADAMTS9
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.523713281460268,1.3450208029072706,0.045454545454545456,0.7357287940687458,1.0,2/29,0.74%,UBB;BICD2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.8351366783346774,-1.3448181737105933,0.017543859649122806,1.0,1.0,1/7,2.05%,NDST3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.8398054433907728,-1.3445442640476641,0.08064516129032258,1.0,1.0,2/6,3.28%,HEY2;FGF9
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.7802431385032061,-1.3444570621166247,0.029411764705882353,1.0,1.0,7/14,16.05%,PTPRC;AOAH;TRAF3IP3;MYO1F;IL6R;GPR171;BCL6
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.7341121839451404,-1.344143199536629,0.04,1.0,1.0,7/17,19.04%,STAT6;STAT4;STAT2;STAT5A;STAT3;STAT5B;STAT1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8221726398963627,1.3440035866679683,0.09523809523809523,0.7372122011315866,1.0,1/5,2.47%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4967876522718436,1.343670337713046,0.15384615384615385,0.7362003088490444,1.0,14/74,11.71%,UBB;SOX11;PMEPA1;HSPA1A;TGFBR2;PPM1A;BAMBI;SPRY1;SLC2A10;SMAD3;TGFBR1;UBC;SMURF2;PEG10
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7839015077379716,1.343629941856996,0.10810810810810811,0.7340181522484892,1.0,3/8,14.38%,HSD17B10;TRMT5;TRMT10C
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.9395185275958067,-1.3434005487042673,0.015625,1.0,1.0,1/5,1.97%,MCCC1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8274069122769796,1.3424985221229662,0.16666666666666666,0.7362891599976906,1.0,2/5,10.18%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.7603479122925882,1.3417510073035774,0.13157894736842105,0.7368760807255439,1.0,3/10,14.30%,CMPK1;ENPP3;SMPDL3A
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8719509092038759,1.341639458659053,0.11764705882352941,0.7351278625638444,1.0,1/5,1.55%,LRRC8D
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.7537037356158757,-1.3415617167489489,0.1076923076923077,1.0,1.0,2/12,9.33%,ATAD5;BCAR3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.7221281485664117,-1.341392857422163,0.1232876712328767,1.0,1.0,6/15,17.81%,DUOX1;P2RY12;AKT2;TGFB1;PDGFRB;CCDC25
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7613542836952374,-1.3413584083156607,0.16417910447761194,1.0,1.0,5/11,17.48%,IHO1;RNF212B;SGO2;CENPC;ZCWPW1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8213034957086702,1.3408349718010593,0.1111111111111111,0.7356317221210934,1.0,1/5,1.50%,ASCL1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.735118055383624,-1.340774450226822,0.14492753623188406,1.0,1.0,4/16,9.42%,ARHGAP24;P2RY12;PLEKHM1;PFN2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.8658605042306102,-1.340436985406971,0.09375,1.0,1.0,1/5,1.11%,TTN
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.7302901176318446,-1.339861713764814,0.08108108108108109,1.0,1.0,3/13,7.66%,PHKG1;PYGL;PYGB
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.71763455874148,1.3397530295260873,0.0967741935483871,0.737663950194117,1.0,5/10,18.08%,MSN;RAP2A;CAMSAP3;CDC42;RHOA
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.6862134722250487,1.3395373294918167,0.2631578947368421,0.7318333254405097,1.0,1/6,3.41%,TMED2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.6862134722250487,1.3395373294918167,0.2631578947368421,0.7318333254405097,1.0,1/6,3.41%,TMED2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.6862134722250487,1.3395373294918167,0.2631578947368421,0.7318333254405097,1.0,1/6,3.41%,TMED2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.7652328265421418,1.3386241994666428,0.18181818181818182,0.7339755208858402,1.0,3/6,10.97%,ABHD10;GBA3;GUSB
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.8763428426149693,-1.3381163646070715,0.05970149253731343,1.0,1.0,2/7,3.12%,HES1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.6653906024324064,-1.3377184051920439,0.0945945945945946,1.0,1.0,4/26,17.01%,MYLK;AHCYL1;CAMK2A;ANO6
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8170752734057127,-1.3375508412814447,0.1206896551724138,1.0,1.0,2/6,11.42%,CCDC39;SRP54
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.6593225492949647,-1.3375214910298223,0.05405405405405406,1.0,1.0,8/23,11.50%,EFNA1;SOX9;RAB17;OVOL2;TMC4;SLC44A3;GPRC5C;SPP1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.630957398018215,1.3367897015164036,0.10344827586206896,0.7386336019650586,1.0,9/32,9.34%,SOX11;SOX8;KLHL12;PEF1;SEMA5B;SEMA5A;SOX10;SEMA4F;SEMA3B
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6523394905279291,-1.3366222873334568,0.09210526315789473,1.0,1.0,20/44,20.60%,CD44;IRF1;IFNGR2;DAPK1;CAMK2B;HLA-F;HLA-C;B2M;CAMK2A;JAK1;DAPK3;OAS1;CIITA;CAMK2D;IRF2;STAT1;HLA-B;AQP4;TRIM25;TRIM5
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.7928203634794226,1.3363524702253176,0.1,0.7382629916051365,1.0,1/6,0.55%,UBB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7403671310542943,1.3362908002843366,0.18421052631578946,0.7362322523357215,1.0,2/7,20.57%,FIS1;MCU
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.548080789841675,1.3355958429969006,0.05263157894736842,0.7371644028491645,1.0,9/47,10.41%,DAPL1;SIRT2;TAB3;RRAGA;KIF25;LEPR;ZKSCAN3;MT3;TIMP4
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6673245132969007,-1.335044987257968,0.05194805194805195,1.0,1.0,14/33,16.14%,CD44;NAAA;PTPRC;MX1;IGSF6;SPI1;PLSCR1;AOAH;MYO1F;PILRA;OAS1;IFIT1;IFIT3;TYMP
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6563237636370046,-1.334674135806243,0.09210526315789473,1.0,1.0,6/34,7.50%,NR4A3;PDHX;ENO4;LDHA;SLC16A3;GPI
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.8749264567520689,-1.3346611329168634,0.07272727272727272,1.0,1.0,3/5,8.77%,GRIN2A;GRIN2D;SHISA6
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.8828833205017368,-1.3345459671039932,0.06349206349206349,1.0,1.0,2/5,10.09%,IL7;RAB3D
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.8416148726110231,-1.3345314794763623,0.08571428571428572,1.0,1.0,3/8,12.92%,RAB11A;STX1B;GRIPAP1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.8908330897856865,-1.3344400401607133,0.05970149253731343,1.0,1.0,2/6,3.40%,ABHD12B;CHAC2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5877122079115412,1.3342575887878532,0.0967741935483871,0.7414770737117539,1.0,5/30,7.72%,AURKAIP1;BAD;RNF139;CSTB;PLAUR
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.7571765679004177,-1.3332989368530528,0.1111111111111111,1.0,1.0,3/16,5.13%,HES1;ROBO2;VEGFA
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.7883221680459546,-1.3331888174208075,0.1044776119402985,1.0,1.0,3/10,15.17%,ROBO2;ADAMTS9;PDGFRB
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.8708773841011721,-1.333050529991649,0.04054054054054054,1.0,1.0,3/6,12.47%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.8201715950866164,1.3314522243720894,0.13793103448275862,0.7502663334575354,1.0,2/6,13.53%,TGFBR1;BMP2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.80545724881428,-1.3312616537007893,0.10294117647058823,1.0,1.0,2/11,1.40%,FAM161A;CAMK1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.8484102473966959,-1.3309411201947516,0.05,1.0,1.0,2/7,5.71%,P2RY12;SHTN1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.6217106469390111,1.3306362439465624,0.2727272727272727,0.7521118120542759,1.0,6/13,14.46%,ENPP6;PRDX6;MGLL;GPCPD1;GDE1;ABHD2
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.8188185571684488,-1.330567797069369,0.08333333333333333,1.0,1.0,1/8,0.19%,PON1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.8237499066240482,-1.3302946529513686,0.07575757575757576,1.0,1.0,4/11,10.32%,P2RY12;RYR3;KCNJ11;TAF1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.6067504889826589,-1.329619242279991,0.07142857142857142,1.0,1.0,17/53,16.34%,TAF7L;HOOK1;SPATA12;GGNBP1;BRCA1;MAEL;TSSK3;TMCO5A;ACYP1;PARN;BCL2L14;SPATA20;ZMYND19;MEIOC;GAPDHS;KIAA2012;SMC1B
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.9021343441938391,-1.3293945243607526,0.078125,1.0,1.0,2/5,5.80%,TTN;CAV3
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7837807606018307,-1.3292815129689075,0.10606060606060606,1.0,1.0,3/10,5.66%,SRPX2;VEGFA;RHOJ
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6918578631123798,-1.3291950581429715,0.14084507042253522,1.0,1.0,4/14,17.64%,CAV3;UBASH3B;CACNB1;CAMK2D
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.7209863714960637,1.3282620872787556,0.10810810810810811,0.7603005044992455,1.0,3/11,2.44%,ACTB;ACTG1;LAMA3
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.7440142840208159,-1.327931667153429,0.11764705882352941,1.0,1.0,2/12,8.51%,ANGPTL4;APOE
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.7630759178630641,-1.3276111859038338,0.14516129032258066,1.0,1.0,1/10,1.40%,SOX9
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.7093925536528294,1.327484620915445,0.14705882352941177,0.7609909504253196,1.0,5/10,20.06%,ARPC5;JMY;ARPC5L;ARPC2;WHAMM
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5801323748534832,1.3273291122407018,0.1111111111111111,0.7594921478787031,1.0,5/32,5.87%,HSPA1A;GSTP1;HIPK1;IKBKB;CLIP3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8111340688220259,1.326846068754889,0.1794871794871795,0.7588735163706308,1.0,1/5,1.18%,DSEL
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.5901977934719504,-1.3261438763272992,0.07228915662650602,1.0,1.0,14/57,14.90%,SLC6A6;SLC38A4;SLC6A15;SLC3A1;SLC51A;NCOA1;ABCC3;SLC7A6;ACSL1;SLC1A4;SLC13A3;ATP8B1;PDPN;SLC25A45
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7213526419469701,1.3257213078412424,0.175,0.7615374831876528,1.0,6/9,24.87%,NLGN2;NLGN3;NLGN4X;NLGN1;NLGN4Y;IL1RAPL1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.8844391964530295,-1.3254008769707484,0.07936507936507936,1.0,1.0,2/5,8.43%,SLC6A15;SLC6A17
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6544961229605389,1.3245301063882353,0.16666666666666666,0.7647772833682581,1.0,4/17,12.41%,UGDH;UAP1;GNPNAT1;SLC35D1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.7071968275066238,1.3238520823455084,0.24390243902439024,0.765131060364893,1.0,3/10,3.63%,LTV1;RAN;NPM1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.5878354475337524,1.3238362448703207,0.1111111111111111,0.7630932811024448,1.0,4/14,16.11%,SIRT2;SMARCAD1;HDAC9;SIRT1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7131610136517219,1.3230062519234522,0.18421052631578946,0.7645045054250198,1.0,1/10,0.47%,PODXL2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8609457194851602,-1.3224825371317386,0.10714285714285714,1.0,1.0,2/6,10.84%,CYP2E1;CYP3A5
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.6576075276151964,-1.3223305905063363,0.10144927536231885,1.0,1.0,6/23,17.35%,SOX9;SLC39A14;RUNX2;SULF1;TGFB1;WNT7A
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.7883111227020024,-1.3216640242157096,0.1267605633802817,1.0,1.0,2/10,3.17%,SOX9;MAFF
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7922282046611177,1.3213641002904937,0.15789473684210525,0.7698811020333424,1.0,3/6,13.88%,LSM1;DCPS;PATL1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.8011585795221576,1.320868401226243,0.21951219512195122,0.7698670656410415,1.0,2/5,9.60%,NLGN2;INAVA
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5975787248726241,1.3203749923479793,0.12121212121212122,0.7695044771768665,1.0,5/24,10.94%,HSPA1A;NR1H2;TMBIM6;UBXN1;CREB3L1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.6920274431566318,-1.3195903859852784,0.10126582278481013,1.0,1.0,5/28,12.47%,GCA;MX1;DNM1;RIMS1;DNM2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7847084899892897,-1.3191902447698376,0.17391304347826086,1.0,1.0,1/9,1.00%,ART4
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7744521607791033,1.3183197143572656,0.14285714285714285,0.7775650457214586,1.0,1/6,5.14%,ARFIP1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.506724875625179,1.3181820008913103,0.05263157894736842,0.7761815677036854,1.0,13/67,13.65%,COPZ1;BICD2;TMED2;KDELR1;SURF4;COG3;RAB1B;ARF5;RAB6A;TMED3;KIF15;SCYL1;ARCN1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7974174019723188,-1.3178836018779723,0.08955223880597014,1.0,1.0,4/8,16.62%,TMSB4X;OTUD7B;ARRB1;MAP2K5
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.5732916970802854,1.317728772600093,0.1111111111111111,0.7757661250662081,1.0,5/19,12.64%,HSPA1A;ST13;DNAJB12;BAG1;HSPA8
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.5229141446535083,1.3176015317150833,0.15384615384615385,0.7740887464538582,1.0,17/52,20.94%,NDUFB1;NDUFB11;NDUFS3;NDUFS6;NDUFB7;NDUFA5;UQCRC1;NDUFS8;UQCR10;NDUFB10;COX6B1;COX6C;NDUFB3;COX5A;NDUFA6;NDUFA3;NDUFA12
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5970393741966423,-1.3172924372634183,0.023255813953488372,1.0,1.0,12/84,10.84%,NAAA;ALOX12;PDHX;MCCC1;CKMT2;LDHA;SLC16A3;GPAM;PTGR1;BTD;AOAH;CYP3A5
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7520340789752585,1.317031519809714,0.21875,0.7744836325578517,1.0,5/13,10.83%,TMEM9;ATP6V0A4;PPT1;ATP6V0E1;ATP6V0D1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6455506683288803,-1.316622543659537,0.1267605633802817,1.0,1.0,15/36,16.33%,AHR;NAAA;NR4A3;PTPRC;PARP14;IGSF6;SPI1;AOAH;GPR34;MYO1F;GPR171;RAB20;CHIT1;NRP2;F13A1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.8749881458362576,-1.3164830826462328,0.09090909090909091,1.0,1.0,1/5,1.48%,FGF1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.8579675346495239,-1.316353660194821,0.047619047619047616,1.0,1.0,2/5,6.40%,DHDDS;DPAGT1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.8579675346495239,-1.316353660194821,0.047619047619047616,1.0,1.0,2/5,6.40%,DHDDS;DPAGT1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.8159681139694617,1.3161380894638413,0.15789473684210525,0.776209852415479,1.0,4/5,17.76%,NEU1;NEU3;GM2A;NEU4
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7530631315939252,-1.3159024950809266,0.13636363636363635,1.0,1.0,10/15,18.37%,HTR2C;HTR1F;AGT;OPRM1;CHRM3;TSHR;HTR4;CHRM2;CHRM5;HTR2B
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.6967769522071445,1.315704196417213,0.1794871794871795,0.7756848853617239,1.0,3/13,7.48%,BAD;MFF;BOK
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8195420135024751,-1.315607399523811,0.01818181818181818,1.0,1.0,1/6,1.51%,APIP
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.8510036454589915,-1.3154394482357061,0.04838709677419355,1.0,1.0,2/6,14.30%,CDKN2A;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.754251052996515,-1.315309682339348,0.057971014492753624,1.0,1.0,4/19,12.84%,DND1;THRAP3;TENT5A;MEIOC
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6173843821174236,1.3149861294927963,0.15384615384615385,0.7766405788601566,1.0,11/20,28.17%,HNRNPC;PARP1;NAT10;ERCC4;CTC1;SLX4;XRN1;POT1;TERF2;TERF1;PIF1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.852328682456544,-1.3149701597452348,0.1267605633802817,1.0,1.0,1/5,4.79%,LMBR1L
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.9050680075433747,-1.3148704710609258,0.06557377049180328,1.0,1.0,1/5,0.38%,IL5
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.8090993384122833,1.314699060528363,0.15789473684210525,0.7759661371091238,1.0,1/5,6.97%,COLGALT1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.803414653969266,-1.3143135796150036,0.10344827586206896,1.0,1.0,2/7,9.17%,EPN1;ADAMTS9
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5328248226162342,1.313940108956865,0.08,0.77680282773238,1.0,7/45,7.97%,SOX4;RFWD3;CCND1;PCBP4;PML;CNOT9;SDE2
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.7784397549059157,1.313586770421895,0.11764705882352941,0.7762443482970921,1.0,2/10,4.26%,LRRC8D;SLC25A24
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.77608062051387,1.313158785966254,0.09090909090909091,0.7752015906839663,1.0,2/11,4.26%,LRRC8D;SLC25A24
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5583646384425429,1.3130794119150162,0.05555555555555555,0.7733793964037861,1.0,6/22,10.83%,UBB;PARP1;GPS1;COPS2;COPS7B;UBC
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.8056828974601714,1.3130759342403089,0.15151515151515152,0.7713059931962691,1.0,5/7,17.50%,B4GALT3;GBA3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4936476057894504,1.3125612590348275,0.12903225806451613,0.7713631135933917,1.0,12/51,11.65%,HSPA1A;CXCL12;TMBIM6;PPIF;NDUFS3;NOC2L;PPIA;PLAUR;TMEM161A;PTTG1IP;CREB3L1;ARMC10
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.6854843301092074,-1.3125230264591419,0.08955223880597014,1.0,1.0,3/18,6.39%,SEPTIN9;CEP135;HAP1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.7829117525988314,-1.3124171306188697,0.09523809523809523,1.0,1.0,2/10,8.00%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.9016144688953729,-1.3115007344321765,0.07272727272727272,1.0,1.0,2/5,8.43%,SLC6A9;SLC6A17
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5371243916877763,1.3114409019889215,0.07692307692307693,0.7722161489592396,1.0,7/43,10.44%,BANF1;SIRT2;RAN;CHMP2A;UBE2I;LBR;PPP2R1A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5371243916877763,1.3114409019889215,0.07692307692307693,0.7722161489592396,1.0,7/43,10.44%,BANF1;SIRT2;RAN;CHMP2A;UBE2I;LBR;PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.6697138509557561,1.31095026760625,0.18518518518518517,0.7720859646155647,1.0,5/12,14.44%,GPNMB;FGL1;TNFRSF21;DUSP3;HAVCR2
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.8315363434968308,-1.3107178315862178,0.11940298507462686,1.0,1.0,1/6,0.19%,PON1
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.7550745221108097,1.310596402684244,0.20930232558139536,0.7713678352550725,1.0,1/5,1.81%,ADCY6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.8597798136712522,1.3103901535401878,0.10526315789473684,0.7705067253205959,1.0,1/5,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.7473100550367872,-1.310177123958985,0.0821917808219178,1.0,1.0,2/12,2.10%,RASGRF1;ARHGAP24
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.7590929259125229,-1.3089319574315017,0.1111111111111111,1.0,1.0,3/15,5.42%,GLRA2;OPRM1;GLRA1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4572192830471807,1.308915557367958,0.05,0.7741880496070717,1.0,9/80,6.76%,AURKAIP1;U2AF1;HSPA1A;PCBP3;ERN1;PCBP2;TBRG4;HNRNPA0;NUDT16L1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.9168291508686187,-1.308534347105485,0.04838709677419355,1.0,1.0,2/5,0.62%,HTR2C;FABP3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.6627047842005169,1.3084007993784335,0.10714285714285714,0.7746380553467855,1.0,4/11,10.50%,ERN1;CPSF1;CSTF2T;CPSF4
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.8301012345053934,-1.3080270873763118,0.13793103448275862,1.0,1.0,4/8,7.07%,NR4A3;FGF9;DOCK5;DOCK7
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.7035018562294496,-1.3080119618531934,0.1267605633802817,1.0,1.0,9/20,17.18%,IRF1;PTPRC;IGSF6;FPR3;APOL6;IL6R;IFIH1;TYMP;CIITA
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7938605601725459,1.3079920687639885,0.12195121951219512,0.7740299779467819,1.0,3/5,17.86%,WNT3;WNT5A;LRP6
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.6288818076416761,1.3078931298554317,0.11428571428571428,0.7723721052645517,1.0,3/17,7.70%,TSPO;ALAD;ABCG2
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.7521260097782022,1.3069610649473415,0.13157894736842105,0.7736200494328053,1.0,2/6,14.69%,CAND2;FBXL7
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.730866746456652,1.306916670698232,0.1590909090909091,0.7718273709781528,1.0,3/7,16.11%,LIG4;ERCC8;SIRT1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.6826738143053825,-1.306530828007696,0.14705882352941177,1.0,1.0,4/18,17.90%,STMN2;NTRK3;BDNF;RAB35
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7209623296583375,-1.3063612237568076,0.17333333333333334,1.0,1.0,2/14,1.56%,MYLK;DUOX1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.9018111753558502,-1.3062295572593583,0.12727272727272726,1.0,1.0,2/5,1.99%,MYLK;EMP2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5613012115372633,1.3062063818850558,0.14285714285714285,0.772890124668747,1.0,11/20,28.17%,HNRNPC;DACH1;NAT10;ERCC4;CTC1;XRN1;POT1;TERF2;TP53;TERF1;PIF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.7611629379778859,-1.3061126152131046,0.15873015873015872,1.0,1.0,2/10,1.48%,TMSB4X;FGF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5043643380572048,1.3060938977264,0.1111111111111111,0.7712882670202953,1.0,9/29,18.12%,AEN;HIPK1;PML;BOK;JMY;MYBBP1A;PHLDA3;SIRT1;FHIT
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.7117588382105554,-1.3056154226147447,0.07692307692307693,1.0,1.0,4/18,12.14%,ELOVL2;FAR2;ACSL1;ACSBG1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.604178223995742,1.305331273081089,0.14285714285714285,0.7723110906142695,1.0,4/17,14.48%,TRMT112;MRM3;METTL5;TFB2M
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.6157081725563814,-1.3050961298933612,0.0375,1.0,1.0,11/61,11.37%,SLC28A2;SLC2A3;SLC6A6;SLC29A2;LRP2;ABCC3;SLC6A9;SLC6A17;SLC1A4;SLC13A3;SLC4A4
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.5655266229789705,-1.304866695736365,0.08235294117647059,1.0,1.0,16/101,14.69%,HEY2;CAMK1;SLC6A6;EMP2;CEBPD;SRF;YWHAH;TCFL5;NR1D1;ALK;RUNX2;TIAM1;SUZ12;MBOAT2;BDNF;TGFB1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5191422478680701,1.304739555097212,0.17647058823529413,0.7723991739180511,1.0,11/69,6.36%,GPC4;UGDH;BGN;DSEL;HSPG2;CHST7;GPC1;BCAN;B4GALT3;VCAN;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.8650292554642598,-1.3045660886113666,0.13114754098360656,1.0,1.0,1/6,0.35%,ENPP2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.7054403682758532,-1.3045300503182473,0.11940298507462686,1.0,1.0,1/15,2.05%,NDST3
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.6146505752938691,-1.3042248111191501,0.09523809523809523,1.0,1.0,5/45,5.54%,GABRA4;GLRA2;GABRG3;GLRA1;GABRG2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.579158920825289,1.3041857648350899,0.10344827586206896,0.7729146970222833,1.0,5/25,7.32%,HSPA1A;ERN1;DNAJB12;TMBIM6;BAG3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.8448081150366525,-1.3038017225807461,0.078125,1.0,1.0,1/5,4.71%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.7188894337328205,1.3035851085933574,0.2,0.7734987160393596,1.0,1/10,0.56%,TRMT112
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.8225581244237006,1.3034074503472235,0.14634146341463414,0.7702346589787015,1.0,4/5,17.50%,B4GALT3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.8225581244237006,1.3034074503472235,0.14634146341463414,0.7702346589787015,1.0,4/5,17.50%,B4GALT3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4830978427419458,1.3033462386224686,0.0,0.76859740925182,1.0,13/69,10.83%,STOX1;UBB;HSPA1A;PSMD8;PSMB6;PSMB4;ELOC;PSME3;BAG3;PSMD10;LIMD1;ATF4;UBC
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.8428045444731711,-1.3021060715799602,0.09375,1.0,1.0,1/6,2.30%,AKAP5
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.5230099093767928,1.302063107538975,0.07692307692307693,0.7722845951788847,1.0,17/51,20.94%,NDUFB1;NDUFB11;NDUFS3;NDUFS6;NDUFB7;NDUFA5;UQCRC1;NDUFS8;UQCR10;NDUFB10;COX6B1;COX6C;NDUFB3;COX5A;NDUFA6;NDUFA3;NDUFA12
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.7489135531083331,-1.3020127370394812,0.08108108108108109,1.0,1.0,6/15,12.84%,BRME1;TDRD9;SGO2;BTBD18;BCL2L11;MEIOC
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8176468014259746,1.3018700631735498,0.15789473684210525,0.7712825502409638,1.0,1/5,2.78%,CAP1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.6471327765302798,1.3018420982732029,0.21875,0.7694098308401817,1.0,2/18,1.77%,SMDT1;PHB2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.6830999526405499,-1.3013614235725122,0.06666666666666667,1.0,1.0,3/19,3.30%,HOOK1;EMP2;WDR91
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.7244233674894658,1.300985722779981,0.23333333333333334,0.7706213203754423,1.0,3/10,4.98%,ARV1;STARD3;LDLR
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.7973637812163887,1.3009692147046206,0.23529411764705882,0.7687247919385747,1.0,2/5,7.84%,METTL4;NHP2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.8832904200850541,-1.3008042137591858,0.14705882352941177,1.0,1.0,3/5,6.40%,PLET1;ARHGAP24;COL5A1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6975708211109956,1.30078424836733,0.21052631578947367,0.7674635374768284,1.0,3/7,11.58%,SIRT2;BCAR1;MST1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.5207959009892642,1.2999769875290894,0.0,0.7689829324767895,1.0,22/58,17.73%,DHCR7;ACTG1;ECH1;FABP5;LDLR;TM7SF2;ANTXR2;SQLE;PLAUR;SEMA3B;GUSB;HMGCS1;STARD4;NFIL3;HMGCR;GNAI1;GSTM2;FDFT1;SC5D;ERRFI1;ANXA5;ACAT2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.7576973186104221,1.2995670290716124,0.21428571428571427,0.7686959209061197,1.0,2/5,16.59%,GNAI1;EPB41
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6652749617465533,-1.2994935611617093,0.07894736842105263,1.0,1.0,5/33,5.54%,GABRA4;GLRA2;GABRG3;GLRA1;GABRG2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6454054534812014,1.2994383878464866,0.22580645161290322,0.7673751123160536,1.0,8/14,25.60%,NLGN2;NLGN3;NLGN4X;NRXN3;NLGN1;NLGN4Y;NRXN1;NCAM2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.6009631544059555,-1.2992778325134233,0.08045977011494253,1.0,1.0,20/51,24.56%,GRIN2A;DAPK1;OPRM1;CAMK2B;SHISA6;CAMK2A;BEGAIN;SHISA9;NEFL;NPTX1;CACNG8;DLG4;CACNG2;CNIH2;RELN;MEF2C;GRIN1;MAPK8IP2;CACNG7;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),-0.7639087087711212,-1.2991902617258633,0.1724137931034483,1.0,1.0,1/8,1.40%,SOX9
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7310156184069643,-1.29891037384134,0.13559322033898305,1.0,1.0,4/14,10.72%,SLC51A;NCOA1;ABCC3;ATP8B1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.6914210287050531,-1.2985811731279007,0.15,1.0,1.0,2/19,0.56%,JADE2;MSL3
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.6331907227050578,1.298422978056016,0.1794871794871795,0.7693309291056418,1.0,6/11,22.45%,ATP7B;COX19;COMMD1;MT2A;SLC31A1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.6327188975715609,1.298380033897554,0.13636363636363635,0.7675343574836422,1.0,2/17,3.12%,BTC;TGFA
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8073559990892474,1.2983740104177655,0.23076923076923078,0.7656438787706283,1.0,3/5,16.38%,MALT1;RC3H1;SMAD7
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7577467012942274,-1.2983577512459672,0.16666666666666666,1.0,1.0,3/10,11.53%,SRF;APOE;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.6997577751281711,-1.2983452959387178,0.125,1.0,1.0,7/21,12.58%,HES1;PARP9;CRLF1;PARP14;VEGFA;IL6R;STAT3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.763162499818582,-1.2981889110508933,0.07575757575757576,1.0,1.0,3/11,7.62%,MYLK;TPCN2;EDNRA
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.8844129118766539,-1.297647660304865,0.09523809523809523,1.0,1.0,1/5,8.15%,ATG14
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.61572788102902,-1.2973202996969067,0.11538461538461539,1.0,1.0,6/36,13.54%,STMN2;ANKRD53;CAV3;PRUNE1;PAK1;TBCD
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7148282331042833,1.2970893469930935,0.16216216216216217,0.76868291657561,1.0,6/10,24.87%,NLGN2;NLGN3;NLGN4X;NLGN1;NLGN4Y;IL1RAPL1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.7670510766049671,-1.296798689249952,0.1076923076923077,1.0,1.0,3/10,16.00%,HAP1;NEFL;SYBU
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.7252679526928612,-1.2967912594617341,0.11842105263157894,1.0,1.0,4/13,16.56%,SLC22A4;PDZK1;SEC14L1;SLC25A19
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.6710690140201809,-1.2967715347291657,0.171875,1.0,1.0,8/22,17.07%,KCNJ13;KCNJ11;AHCYL1;KCNQ1;CHRM3;WWP2;ANO6;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.5898265563259248,-1.2962338754603944,0.1411764705882353,1.0,1.0,15/63,19.08%,ENPP2;SOX9;FGF1;AGT;VEGFA;DOCK5;RAB11A;GPI;VIL1;ITGB1BP1;HDAC6;NRP2;ADAM9;PRKD2;PIK3CB
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.7645567749250071,1.2956849441962601,0.2222222222222222,0.7721160710795457,1.0,2/8,10.85%,DHFR;RTN4RL2
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.5808582018259645,1.2948827670948242,0.20588235294117646,0.7738663807467924,1.0,3/19,4.30%,CTSV;ZFP36L1;SGPP1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.5406467522006443,1.2947676165953472,0.08333333333333333,0.7724198387519184,1.0,12/46,16.02%,BANF1;SIRT2;RAN;CHMP2A;UBE2I;LBR;PPP2R1A;SUMO1;NUP35;NSFL1C;SEH1L;LMNA
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.624265064971125,1.2943112094822153,0.19444444444444445,0.7723675997270337,1.0,3/15,10.67%,POLR2L;POLR2K;ATF4
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.6440291704809493,-1.2938324402316386,0.15584415584415584,1.0,1.0,5/24,14.28%,PTPRC;KLF6;BLNK;PTPRJ;HDAC4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.6279625535956004,-1.293260883326258,0.08536585365853659,1.0,1.0,5/45,5.54%,GABRA4;GLRA2;GABRG3;GLRA1;GABRG2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.574975280805891,-1.292791567921683,0.09195402298850575,1.0,1.0,24/113,17.06%,TMSB4X;TTN;GTPBP2;F8;TUBA4A;SYT1;VCL;TIMP3;A2M;VEGFA;RAB3A;SYT2;CPLX1;RIMS1;SNAP25;STEAP2;SYT4;RAB11FIP5;SYNGR2;TMEM79;TGFB1;KNG1;F13A1;PROS1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.809225601114177,-1.2927906134028182,0.10909090909090909,1.0,1.0,3/8,10.65%,AKAP5;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.809225601114177,-1.2927906134028182,0.10909090909090909,1.0,1.0,3/8,10.65%,AKAP5;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5582222229757645,1.2925734301507479,0.14285714285714285,0.7775136652752088,1.0,4/19,10.13%,TSPO;LRRC8D;ABCG2;SLC26A3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6709843903421131,1.2920459973252174,0.14285714285714285,0.7781564543541911,1.0,2/15,3.12%,BTC;TGFA
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.7466455783655118,1.2915607951682806,0.21052631578947367,0.778157918347671,1.0,1/6,2.94%,GPC1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.6686831218118892,-1.2912578615179189,0.17105263157894737,1.0,1.0,7/27,12.58%,HES1;PARP9;CRLF1;PARP14;VEGFA;IL6R;STAT3
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.8202166921845353,1.2910567003256612,0.24324324324324326,0.778058846557578,1.0,2/5,10.36%,PRDX3;RAB6A
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.8418833716095395,-1.290334316741005,0.09375,1.0,1.0,1/5,6.54%,PUS7
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.709774244595658,-1.2898373923276338,0.08974358974358974,1.0,1.0,4/15,18.96%,HAP1;KIF1C;NEFL;KIF1A
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7231082144502973,1.2896353788199566,0.20930232558139536,0.7804633394470113,1.0,3/5,26.61%,DUSP3;MAP4K4;IQSEC1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7231082144502973,1.2896353788199566,0.20930232558139536,0.7804633394470113,1.0,3/5,26.61%,DUSP3;MAP4K4;IQSEC1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7511612432128374,1.2896192364285586,0.16666666666666666,0.7785962022713007,1.0,3/7,17.19%,NT5E;NT5C1A;PNP
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.8464521766302588,-1.2891884011560508,0.10869565217391304,1.0,1.0,2/6,14.19%,SOX9;SULF1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.6933825920552038,1.2888939050556156,0.17142857142857143,0.7793599618151781,1.0,3/12,19.07%,LARP7;NELFA;RNF168
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.8093622940309252,-1.2884527805062902,0.12698412698412698,1.0,1.0,1/7,1.04%,ALOX12
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7504786170335439,1.2883831432169466,0.11764705882352941,0.7794247607055834,1.0,1/5,7.50%,ATP8A2
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7400306039027311,-1.2880506983087425,0.2,1.0,1.0,4/11,19.04%,DUOX1;KCNJ11;RYR2;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.7558974005339244,-1.2877969320863452,0.1111111111111111,1.0,1.0,5/9,15.87%,IL7;STAT5A;STAT3;JAK1;STAT5B
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.7558974005339244,-1.2877969320863452,0.1111111111111111,1.0,1.0,5/9,15.87%,IL7;STAT5A;STAT3;JAK1;STAT5B
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7383152764984457,1.287480034806964,0.17073170731707318,0.7807774999540992,1.0,6/8,23.35%,NLGN2;NLGN3;NLGN4X;NLGN1;NLGN4Y;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.7003200853941334,-1.2869990212380864,0.16666666666666666,1.0,1.0,1/12,1.40%,SOX9
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5765337747722268,-1.2867333825915588,0.11392405063291139,1.0,1.0,25/67,22.30%,NLRC5;IRF1;PTPRC;MX1;TRIM52;AGBL4;STAT2;PLSCR1;AKAP1;TRIM56;IFIH1;MAP3K14;AGBL5;OAS1;IFIT1;IFIT3;ATG7;BNIP3L;IRF2;STAT1;TRIM5;CGAS;IFI6;RSAD2;DDIT4
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.7544332578710101,1.286477659152862,0.2619047619047619,0.7830465325564784,1.0,2/8,2.82%,MOSPD2;CXCL12
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5890871154391094,1.285333464595457,0.2,0.7850089544454011,1.0,5/26,7.55%,RND2;RHOBTB1;IKBKB;RHOC;EPB41L3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.767496941130911,1.284611263911958,0.20588235294117646,0.7862405572937254,1.0,2/7,9.31%,SLC30A10;ABCD2
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.7212697259718229,-1.284112908940491,0.12857142857142856,1.0,1.0,4/16,9.62%,YWHAH;CACNA1C;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.8016400764413792,1.2841063837049602,0.14285714285714285,0.7861575197460328,1.0,2/7,9.53%,MRPL44;HENMT1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6970762508335868,1.2839593162323273,0.10714285714285714,0.784964965665186,1.0,5/10,18.08%,MSN;RAP2A;CAMSAP3;CDC42;RHOA
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.8182950651400731,-1.2834696861138002,0.14285714285714285,1.0,1.0,1/7,1.00%,HES1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.8850074895810199,-1.2833565982726793,0.109375,1.0,1.0,2/5,2.87%,VSIR;IRF1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.7551666560802053,-1.2830519719948772,0.11764705882352941,1.0,1.0,1/11,3.05%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6466415867204123,1.2827859475778778,0.22580645161290322,0.7876861399121929,1.0,2/12,7.02%,PLIN2;SCARB1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.822816156794951,-1.2827478217889126,0.15,1.0,1.0,1/5,1.99%,VSIR
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.6567538697042989,-1.2826022306478801,0.0963855421686747,1.0,1.0,9/36,13.74%,GLRA2;AHR;BRCA1;GLRA1;KLF9;GRAMD1C;AKR1C2;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.8436889615185026,1.2825501431907385,0.08571428571428572,0.786333128162349,1.0,2/6,6.55%,POP5;POP4
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.7191143396584302,1.282297240556796,0.3,0.7856023286053716,1.0,2/5,21.61%,MSRB3;MSRB2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.7317617615732401,-1.2821514326450072,0.16666666666666666,1.0,1.0,2/12,8.00%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5627140869482465,1.2818907508807293,0.14285714285714285,0.7855217408633226,1.0,2/29,0.49%,STOX1;SIRT2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7471450106188122,1.2818731630906344,0.23333333333333334,0.7837959814232587,1.0,2/7,8.01%,ADRA1A;ZDHHC21
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.5217159997428215,1.2812803468511886,0.10526315789473684,0.7845247209365288,1.0,10/37,11.06%,NOVA1;NR1H2;GSTP1;PLCL2;MAP2K6;IL15;PLCL1;RBPJ;ATF4;ACOT13
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.5199266998424736,1.2812764549657794,0.14285714285714285,0.7827128855533035,1.0,3/32,0.98%,DGKB;PLD1;LPCAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.7892033243454369,-1.2812161936618416,0.15151515151515152,1.0,1.0,1/10,1.09%,DCAKD
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.7892033243454369,-1.2812161936618416,0.15151515151515152,1.0,1.0,1/10,1.09%,DCAKD
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.7892033243454369,-1.2812161936618416,0.15151515151515152,1.0,1.0,1/10,1.09%,DCAKD
prerank,PanglaoDB_Augmented_2021__Microglia,-0.6135443583736605,-1.2806041316679275,0.1,1.0,1.0,9/29,12.26%,FOS;PTPRC;IGSF6;SPI1;P2RY12;AOAH;GPR34;MYO1F;IL6R
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.5946617905235478,-1.280046198474287,0.10465116279069768,1.0,1.0,12/51,17.44%,SYCP2L;CKMT2;KCNJ11;HIF3A;CTNNA3;KBTBD12;WIPF3;CECR2;SORBS1;ACACB;RYR2;TMEM266
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.7148739933974402,-1.2799443114257127,0.16666666666666666,1.0,1.0,2/11,1.98%,HES1;OPALIN
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.8145802774415167,1.2795685582491014,0.2,0.787317913036022,1.0,2/5,9.26%,PRR5L;SYAP1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6430498302268726,-1.2794738229681684,0.09210526315789473,1.0,1.0,4/30,11.13%,ARIH2;SAE1;SREBF1;MICALL2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.40758715520500705,1.2781333386399225,0.0,0.7908148251780864,1.0,38/258,10.79%,NR0B1;GMEB2;TAF1A;PRRX1;POLR2J;POLR2L;ADRM1;NR1H2;TAF9B;ESR1;CPSF1;NR2F6;GTF2A2;EAF2;MED23;ELOC;TCEA1;MAML2;RBPJ;PARP1;SP1;YAP1;GTF2H2;NR3C1;RPRD1B;GTF2F1;ESRRG;NR2E1;ZBTB1;SSRP1;EAF1;COPS2;CSTF2T;POLR2K;CPSF4;NFYA;ATF4;CDC73
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.7631589123711078,-1.2779481019938594,0.10714285714285714,1.0,1.0,1/10,1.40%,SOX9
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.7828269867953028,-1.2777359418419778,0.1323529411764706,1.0,1.0,2/11,5.80%,TTN;CAV3
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6835341823736624,-1.277709933259245,0.18666666666666668,1.0,1.0,5/16,12.27%,AGT;KCNMB4;CAV3;KCNQ1;TPM1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7693859665512993,-1.277323413589569,0.17333333333333334,1.0,1.0,3/8,16.11%,ENPP4;APOE;KNG1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7091440872076902,-1.2773203706054626,0.16,1.0,1.0,4/18,6.40%,CD44;PLET1;ARHGAP24;COL5A1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.5964387109719927,1.277319672810536,0.14285714285714285,0.7920949012311888,1.0,3/26,2.37%,PANX1;MALT1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7382359640358758,-1.2771588172997326,0.140625,1.0,1.0,3/9,9.16%,CAV3;FOXO1;MLIP
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6200860449276755,-1.2765196308412308,0.15,1.0,1.0,9/33,14.90%,SLC6A6;SLC38A4;SLC6A15;SLC3A1;SLC7A6;SLC6A17;SLC1A4;PDPN;SLC25A45
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.6145751398401516,1.2763962169025498,0.1,0.7933372962175372,1.0,3/15,14.02%,KPNA2;KPNA4;NUP35
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7393646653115573,1.2761200939882835,0.2727272727272727,0.7926690217201217,1.0,2/7,10.90%,PLOD1;JMJD6
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5937831519655151,1.2760992237522393,0.20833333333333334,0.7909901079947025,1.0,4/14,8.68%,STYXL1;IKBKB;TIPRL;PPP1R11
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.609305684249586,1.2760737130933844,0.13157894736842105,0.7893188256953078,1.0,4/19,10.17%,TSPO;ALAD;ABCG2;SUCLA2
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.6374305973641958,-1.275836429751709,0.1875,1.0,1.0,6/20,14.68%,EFNA1;RAB17;PAH;SLC44A3;GPRC5C;TOM1L1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.719328722404428,-1.2753067723995546,0.14492753623188406,1.0,1.0,3/14,5.25%,EMP2;VEGFA;SRF
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.4830706389103332,1.2750945523325892,0.15789473684210525,0.7910923239802956,1.0,7/59,5.70%,IPO13;PHB2;NUTF2;RAN;KPNA2;PRICKLE1;PPP1R10
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.43567018135818514,1.275084156295649,0.0,0.7893025223423312,1.0,38/174,16.14%,SIRT2;TNFAIP1;GID8;PSMD8;PSMB6;PSMB4;KBTBD6;RNF139;PCBP2;DNAJB12;PML;FBXO45;UBXN1;PSME3;KLHL42;PSMD10;PELI1;KBTBD7;AREL1;UBE2G1;TRIM71;HECTD3;SMURF2;KCTD10;FBXO44;FBXW5;PSMD12;PSMB2;KCTD5;PSMD4;CDC34;NSFL1C;SPSB1;PRPF19;ERCC8;SIRT1;KCTD13;RAD23A
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.8122780676046082,-1.274729989097923,0.08333333333333333,1.0,1.0,1/6,4.25%,SPI1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.7812498307762613,-1.2743626430880002,0.16417910447761194,1.0,1.0,2/7,10.82%,SYT1;SYT4
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.7552978024520887,-1.2741830876327314,0.2608695652173913,1.0,1.0,3/8,12.61%,APOE;DNM2;OLFM1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.7692868614830773,-1.2739485287904158,0.20588235294117646,1.0,1.0,2/8,14.85%,WDR91;RBL2
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5399278055213829,1.273425646593422,0.10344827586206896,0.7934224198636125,1.0,13/33,16.15%,DHCR7;MSMO1;HSD17B10;TM7SF2;SQLE;ACOT8;LBR;HMGCR;INSIG1;OSBPL7;OSBP;FDFT1;SC5D
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6641857269872128,-1.2727096239392728,0.16,1.0,1.0,10/24,16.33%,ALOX12;SPI1;VEGFA;AOAH;MYO1F;PILRA;PDE6B;TGFB1;TBXAS1;F13A1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.704149708789389,1.2725112098479818,0.20930232558139536,0.7951746927228722,1.0,3/9,3.97%,CHRNA4;ACHE;CHRNA7
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.7053111740533242,-1.2724536179614852,0.16129032258064516,1.0,1.0,1/18,1.52%,RAB17
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6163774188638266,-1.2723775886825182,0.14102564102564102,1.0,1.0,7/33,12.64%,NAAA;SYT1;RAB3A;CPLX1;RIMS1;SNAP25;SYN3
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.6688230748627987,-1.2722790938739141,0.10294117647058823,1.0,1.0,6/31,11.22%,ITPR1;AGT;RYR3;KCNJ11;AHCYL1;ATP2B3
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.7361864792713412,-1.2722667902305853,0.16923076923076924,1.0,1.0,3/10,18.62%,TESPA1;CARD11;PRKD2
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8099881796690307,-1.2722309311133169,0.234375,1.0,1.0,5/5,19.04%,STAT5A;STAT3;JAK1;STAT5B;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8099881796690307,-1.2722309311133169,0.234375,1.0,1.0,5/5,19.04%,STAT5A;STAT3;JAK1;STAT5B;STAT1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.5200096488214754,1.272110610443286,0.13636363636363635,0.7951065609944827,1.0,3/31,0.98%,DGKB;PLD1;LPCAT1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.5666387967532963,1.2720623067067223,0.1111111111111111,0.7934173521630956,1.0,6/23,14.24%,HSPA1A;ST13;DNAJB12;BAG1;HSPA8;UGGT1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.8171353047162788,1.2719073987618943,0.11428571428571428,0.7922645828770604,1.0,5/6,17.76%,NEU1;NEU3;GBA3;GM2A;NEU4
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.7532263774283889,-1.2717353753897753,0.2028985507246377,1.0,1.0,2/7,7.55%,DONSON;ZRANB3
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.7173052617674394,1.2717227704393348,0.11428571428571428,0.7912100835927389,1.0,5/11,18.08%,SOX8;MN1;GREM1;BMP2;RHOA
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.852114661936559,-1.2716738570116872,0.13846153846153847,1.0,1.0,3/6,8.54%,AHR;PTPRC;HLA-F
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6525359703661064,1.271637901903161,0.15384615384615385,0.7896956998709781,1.0,1/8,0.42%,STOX1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.7257095825348574,-1.2714608556195497,0.10606060606060606,1.0,1.0,4/14,12.15%,PTPRC;RFTN1;VAV3;BLNK
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.8081543059420105,1.2711329033582737,0.21951219512195122,0.7894550810472603,1.0,2/6,14.07%,SLC25A24;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5726079633769765,1.2709324974409653,0.1724137931034483,0.7885679994347996,1.0,3/21,7.64%,NR0B1;CALR;CNOT9
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.7521382547121329,1.2706463521805582,0.25,0.7879309752465579,1.0,5/7,19.56%,KIF25;CEP85;RANBP1;NSFL1C;MAP9
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.6726077727731368,1.2704216231576402,0.2571428571428571,0.7870511745811735,1.0,4/6,14.67%,MFF;ACOT8;PEX11A;FIS1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8721554094599637,-1.2703703717852137,0.1016949152542373,1.0,1.0,1/5,0.20%,CD44
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.727573606731378,-1.2699139324784383,0.16666666666666666,1.0,1.0,3/11,14.55%,VSIR;RARA;PDCD1LG2
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6568583315412218,-1.2695206218077357,0.18309859154929578,1.0,1.0,7/17,21.78%,ENO4;LDHA;GPI;GAPDHS;ENO1;HK1;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7378839378187947,-1.2688804824557949,0.15789473684210525,1.0,1.0,5/13,10.82%,SYT1;SYT2;RIMS1;RNF157;SYT4
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.7445016880286845,1.2686376206445158,0.19444444444444445,0.7916888297155216,1.0,3/7,22.14%,DHFR;CALM1;AKT1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7288010069258842,-1.2685627454144015,0.13513513513513514,1.0,1.0,1/16,0.13%,TUFT1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.7235807318331601,-1.268355281615053,0.16923076923076924,1.0,1.0,1/12,0.47%,FHDC1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.6620341827060835,-1.268131871287365,0.1282051282051282,1.0,1.0,6/32,14.55%,VSIR;ZFPM1;RARA;BTN3A1;RASGRP1;PDCD1LG2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.7271385568274549,1.2680802462959113,0.1875,0.7921800028518926,1.0,5/7,23.83%,ZNF830;RAD17;SETMAR;STK33;NAE1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.7289459292395667,-1.2680402911560662,0.15942028985507245,1.0,1.0,2/12,10.61%,CDKN2A;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.723525331312397,1.2679386793522212,0.18604651162790697,0.7911136923838749,1.0,5/7,25.93%,BOK;PPP1R15B;HSPA5;PTPN1;TMEM33
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.788257471855508,1.2677974906953384,0.23684210526315788,0.7899911886397205,1.0,4/6,17.50%,B4GALT3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7931500211783301,1.267285745521228,0.23684210526315788,0.7902399432807741,1.0,1/6,4.57%,CMPK1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6406082681383803,1.2672080885259898,0.23809523809523808,0.7887303689347525,1.0,1/9,3.14%,MSN
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7466875189515649,-1.267016960296938,0.208955223880597,1.0,1.0,1/13,0.20%,CD44
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.788275948169259,-1.2669556595087528,0.21875,1.0,1.0,1/9,1.37%,PIP4K2C
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.49655108156961575,1.2668227590430168,0.05555555555555555,0.7883156907083866,1.0,8/56,6.77%,SIRT2;BTC;TGFA;MAP10;SVIL;RCC2;PKP4;RANBP1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6236560963518966,-1.2664190453463153,0.21621621621621623,1.0,1.0,3/29,10.02%,GRIN2A;GRM1;GRM3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.42590428476605113,1.266365002301463,0.0,0.7885664610414317,1.0,15/145,8.66%,SIRT2;UBB;TUBG1;SSNA1;PSMD8;ZFP36L1;PSMB6;KCNH5;PSMB4;UBE2D1;HAUS8;PSME3;PRKAR2B;PSMD10;TUBA1A
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.7331806732733768,-1.266260626237261,0.1746031746031746,1.0,1.0,6/9,24.74%,KLF9;LMO2;RDX;BRD8;MED1;GAS2L1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7331806732733768,-1.266260626237261,0.1746031746031746,1.0,1.0,6/9,24.74%,KLF9;LMO2;RDX;BRD8;MED1;GAS2L1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.8385936042542709,-1.2660210247126562,0.1076923076923077,1.0,1.0,3/6,9.70%,UNC13C;STX1B;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.7880319893564187,-1.265770473063354,0.1875,1.0,1.0,1/10,1.37%,PIP4K2C
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.739866703396697,1.2655264062676872,0.2647058823529412,0.7903512760425776,1.0,2/8,6.67%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.699648710211452,-1.265402247504393,0.14285714285714285,1.0,1.0,4/16,4.43%,NLRC5;PARP9;PARP14;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.8521797644366238,-1.2651706157416847,0.1875,1.0,1.0,1/5,0.30%,HEY2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.8258670300783418,-1.2651660662082538,0.13333333333333333,1.0,1.0,1/5,2.05%,CCDC39
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6164757653778027,-1.2647954324906605,0.1794871794871795,1.0,1.0,7/32,12.64%,NAAA;SYT1;RAB3A;CPLX1;RIMS1;SNAP25;SYN3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5847835280961959,1.2639975892940853,0.16,0.7944110854259216,1.0,2/22,1.28%,PANX1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.8819895437199283,-1.2628169273389656,0.11475409836065574,1.0,1.0,1/5,2.27%,PHF19
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.6724209271341021,1.2623360061827205,0.14285714285714285,0.7988130458222324,1.0,4/10,9.52%,CFL1;TWF1;MICAL1;CFL2
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7942950828405805,-1.2617820628890828,0.16666666666666666,1.0,1.0,2/8,5.46%,ZFPM1;RARA
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6893582633969483,1.261645450787752,0.2222222222222222,0.7999063695132275,1.0,3/10,20.45%,SMAD3;TGFBR1;GDF6
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8018761963769041,1.261474588568753,0.1875,0.7988463610581258,1.0,1/5,2.97%,NUTF2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5441987361503458,1.2612876040498533,0.10714285714285714,0.7976122223514579,1.0,4/24,4.76%,SYNDIG1;SLITRK2;CLSTN2;NLGN2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.6387238362828395,1.2612701477480748,0.25,0.7959673521073962,1.0,1/15,0.56%,TRMT112
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.7841295591793718,1.2612187409984494,0.1951219512195122,0.7943294962353773,1.0,2/5,8.60%,PMEPA1;GREM1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.7137113593092242,1.2610874082650654,0.16216216216216217,0.7931424336031946,1.0,1/9,0.47%,PODXL2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.5634577813721529,1.2610685548731373,0.13043478260869565,0.7915765810822983,1.0,10/35,12.83%,DHCR7;ARV1;MSMO1;FDX1;STARD3;TM7SF2;SQLE;LBR;HMGCR;INSIG1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.6554409417450352,-1.2609243148825156,0.17391304347826086,1.0,1.0,7/17,21.39%,ABHD12B;LPCAT3;PLSCR1;MBOAT2;OSBPL10;ABHD12;SERINC1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.5015534818398574,1.2608611013793933,0.038461538461538464,0.789170352769241,1.0,3/51,1.26%,NUP42;POLR2J;POLR2L
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.5015534818398574,1.2608611013793933,0.038461538461538464,0.789170352769241,1.0,3/51,1.26%,NUP42;POLR2J;POLR2L
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.8079716148497225,-1.2607514089105167,0.19117647058823528,1.0,1.0,2/7,15.59%,MCCC1;BCAT2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.6293389488657112,-1.2605994281073842,0.10256410256410256,1.0,1.0,11/31,17.69%,HTR1F;AKAP5;P2RY12;OPRM1;AKAP12;CHRM3;ADCY1;ADCY5;HTR4;CHRM2;CHRM5
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.5846857985983958,1.2602990705032022,0.1111111111111111,0.7892364110331258,1.0,6/28,16.11%,BAD;PPIF;MTX2;SLC25A4;MICOS13;TIMM50
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.6328769988882881,-1.260145359172865,0.1935483870967742,1.0,1.0,5/20,14.69%,FOS;SPI1;SRF;STAT3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7409512094702321,-1.2599894911797769,0.2054794520547945,1.0,1.0,6/11,17.01%,AZIN2;NR4A3;ACSL1;CA2;AZIN1;ANO6
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.7069523066621934,-1.2599311060470475,0.14285714285714285,1.0,1.0,2/18,2.54%,EFNA1;OVOL2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.6847329919666497,-1.259669705729645,0.15714285714285714,1.0,1.0,5/13,15.47%,GRIN2A;GRIN2D;CACNA1C;JPH3;RYR2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7052631021638659,1.2596153473989704,0.1891891891891892,0.7905318162321967,1.0,3/8,18.96%,WWC2;WWC1;LATS1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6519975161304745,1.259560317565208,0.17142857142857143,0.789133972640506,1.0,5/11,20.76%,ACOT8;NUDT19;LDHD;ACOX1;ACBD5
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.5483889261997384,-1.2592634812817465,0.09195402298850575,1.0,1.0,18/89,12.83%,ENPP2;STMN2;ARX;PCSK2;OLFM3;VEGFA;KCNC1;SST;CACNA1B;CALY;ACTL6B;CELF4;SNAP25;UNC5D;SYT4;LRRTM1;SULT4A1;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.6962732110123425,1.2589224242923955,0.2647058823529412,0.790278390958378,1.0,4/8,23.14%,SPRY1;ZEB1;SPRED1;DLL1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.776872431582842,1.2586936813837433,0.21621621621621623,0.789410601018637,1.0,3/6,8.57%,SRR;PSPH;PSAT1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7840647095525171,-1.2584481714772096,0.23636363636363636,1.0,1.0,1/5,8.05%,PARN
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.7925460992442328,-1.2584109635881686,0.18181818181818182,1.0,1.0,1/8,5.46%,RARA
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.7558194179765251,-1.2583536921017602,0.14925373134328357,1.0,1.0,6/10,15.88%,IGSF6;SPI1;AOAH;MYO1F;PILRA;TBXAS1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.5968743473471242,-1.2579660481732524,0.1232876712328767,1.0,1.0,8/42,11.04%,HES1;EFNA1;RAB17;OVOL2;TMC4;SLC44A3;KIAA1217;GPRC5C
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7348932426889764,-1.257775421531284,0.15789473684210525,1.0,1.0,5/14,10.82%,SYT1;SYT2;RIMS1;RNF157;SYT4
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7795403742862381,1.2577300932365125,0.14705882352941177,0.791072244948536,1.0,2/6,8.67%,SOX4;SOX6
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.8025833323064681,-1.2570107273764097,0.1791044776119403,1.0,1.0,3/5,18.20%,P4HA3;P4HTM;EGLN3
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7337065737916648,-1.2568255910518518,0.1323529411764706,1.0,1.0,4/13,13.68%,IL5;PTPRC;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6561497143652161,-1.2568086229412436,0.15384615384615385,1.0,1.0,4/13,24.45%,CAV3;NEDD4L;CAMK2D;PLN
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.547633008332469,1.2566144515520732,0.17647058823529413,0.7934512608862928,1.0,12/44,13.12%,EXTL1;CUL7;YIF1A;ERN1;ACADVL;PREB;TLN1;PDIA6;ATP6V0D1;VAPB;PDIA5;SSR1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5049892117183561,1.2564353755067883,0.1,0.7922931710697092,1.0,4/37,1.67%,STOX1;CCND1;ACTB;CNPPD1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.8210844466178713,-1.2564093020523075,0.2222222222222222,1.0,1.0,1/6,0.95%,TMSB4X
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.7167825088107638,1.2554444864841714,0.15384615384615385,0.7942847116530156,1.0,2/5,16.11%,PLA2R1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.5376516636764543,1.2553990930549916,0.23809523809523808,0.7927841892072046,1.0,10/32,11.48%,AURKAIP1;ZFP36L1;TRIM35;BTG1;BTG3;BRINP1;GAS1;SMAD3;FZD3;HECA
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.672992518168499,-1.255287829511582,0.1267605633802817,1.0,1.0,10/21,27.36%,BRCA1;DONSON;FZR1;ATM;ABRAXAS1;BABAM2;NOP53;BRSK1;BRCC3;TAOK1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.7328306636629333,-1.2550884910277753,0.13636363636363635,1.0,1.0,7/12,16.05%,PTPRC;CD27;AOAH;TRAF3IP3;MYO1F;TSHR;BCL6
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.46006838092655467,1.2550789975980017,0.09090909090909091,0.7922380359536362,1.0,16/122,7.55%,CPA1;TCF7L1;PODN;CYBRD1;CXCL12;ACHE;RAB27B;PDGFRA;PCBD1;STARD13;CALCRL;ENPP3;LDB2;IGFBP7;RBFOX1;EPB41L3
prerank,PanglaoDB_Augmented_2021__T Cells,-0.6414193420499267,-1.2548893514968336,0.10810810810810811,1.0,1.0,8/31,16.05%,CD160;PTPRC;MAFF;TCF7;JUNB;TRAF3IP3;GPR171;IFIT3
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.8149950645308932,-1.2548169300696677,0.18461538461538463,1.0,1.0,2/5,10.84%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.8149950645308932,-1.2548169300696677,0.18461538461538463,1.0,1.0,2/5,10.84%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.8149950645308932,-1.2548169300696677,0.18461538461538463,1.0,1.0,2/5,10.84%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.806924445933171,-1.2546427864661533,0.25,1.0,1.0,3/5,17.18%,NLRC5;NLRP12;CIITA
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7105537701766097,-1.2544315955586396,0.14084507042253522,1.0,1.0,3/11,11.32%,RAB3A;SHISA6;SHISA9
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.7004139928771446,1.25391146836839,0.16216216216216217,0.7947334879731096,1.0,3/10,7.66%,ERN1;SEMA5A;BMPER
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.7623992175696711,-1.2534324240522492,0.22727272727272727,1.0,1.0,1/8,1.68%,SLC39A14
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.8158609877932135,-1.253209261398004,0.23529411764705882,1.0,1.0,3/5,15.98%,PDZK1;ATP8B1;CA2
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.732018359078987,-1.253174005190714,0.1388888888888889,1.0,1.0,2/11,4.78%,CD44;CEMIP
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6128791609585136,-1.2531128559948013,0.19230769230769232,1.0,1.0,9/36,13.84%,SYT1;LIMK1;SHTN1;SYT2;RIMS1;RNF157;SYT4;MACF1;BDNF
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.44837966813672414,1.2523933684794424,0.06666666666666667,0.7986207637069019,1.0,18/99,9.73%,TSPO;VPS37B;SPCS2;YIF1B;ZDHHC1;GOLGA7;MFF;ZDHHC3;ZDHHC6;AP4E1;MICALL1;AIP;ZDHHC11B;ZDHHC4;ZDHHC21;TIMM13;SRP14;TIMM22
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.4372842920651019,1.2522618521164586,0.13333333333333333,0.7974377715535905,1.0,11/77,11.13%,HDAC11;UBB;RFWD3;TCF7L1;PARP1;GPS1;COPS2;COPS7B;LIG4;UBC;LRWD1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.8128170624400082,-1.2522387663030683,0.15254237288135594,1.0,1.0,1/6,14.30%,PDCD4
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7361680118435715,1.251542443253517,0.1891891891891892,0.794967847024788,1.0,1/8,3.72%,RAB27B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7361680118435715,1.251542443253517,0.1891891891891892,0.794967847024788,1.0,1/8,3.72%,RAB27B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7361680118435715,1.251542443253517,0.1891891891891892,0.794967847024788,1.0,1/8,3.72%,RAB27B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.8592109142392352,-1.251482998406,0.08064516129032258,1.0,1.0,2/5,12.92%,RAB11A;GRIPAP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5990176446151088,1.2510563820194993,0.19230769230769232,0.7948781968262127,1.0,2/20,1.28%,PANX1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.8152677352174733,-1.2500716462871206,0.18333333333333332,1.0,1.0,3/5,6.39%,SEPTIN9;CEP135;HAP1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.603762965836488,-1.2497425174227728,0.15789473684210525,1.0,1.0,8/44,12.54%,CYP2E1;ALOX12;ELOVL2;ACSM6;LIPI;LIPH;ACSBG1;EPHX2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5138762328488995,1.249254639470222,0.15789473684210525,0.8001592973853561,1.0,10/52,11.43%,CRB2;SOX11;UBE2D1;RBPJ;BAMBI;BMPER;SMAD9;GREM1;SMURF2;TWSG1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.8471247834422126,-1.2487715439576292,0.125,1.0,1.0,1/5,0.30%,HEY2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.8471247834422126,-1.2487715439576292,0.125,1.0,1.0,1/5,0.30%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6757887790967696,-1.2486346964818436,0.12987012987012986,1.0,1.0,6/26,14.15%,PLET1;CDKN2A;DUSP22;RASA1;ITGB1BP1;FAM107A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.6587458472959974,-1.2485774079789487,0.136986301369863,1.0,1.0,3/21,8.51%,PON1;LPCAT3;APOE
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.7651324087274173,1.2482041266168198,0.225,0.8023443170637039,1.0,3/6,8.34%,PIH1D1;NUFIP1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.7177547645053025,1.2479971478723968,0.225,0.8015646610007368,1.0,3/6,21.90%,GNAI1;EPB41;SAPCD2
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.7968332644846329,-1.2478712647501111,0.171875,1.0,1.0,1/9,0.20%,CD44
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.7434666339790154,1.2472967071568806,0.2413793103448276,0.8023052249613055,1.0,7/8,25.52%,PDE4B;CALM3;SRI;CALM1;CACNA2D1;NOS1AP;NIPSNAP2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7011269001357734,1.2464320247346483,0.22580645161290322,0.803211026253468,1.0,3/9,4.76%,ACTB;ACTG1;CGNL1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.5344005749070797,-1.2463358946483105,0.0989010989010989,1.0,1.0,25/112,16.03%,ABLIM1;FABP3;GADD45B;SGCA;MYLK;TPD52L1;LAMA2;PTP4A3;CKMT2;CAV3;IFRD1;CAMK2B;PPFIA4;KCNH1;ACSL1;MEF2D;SORBS1;SYNGR2;AKT2;MYL6B;BHLHE40;TGFB1;COL4A2;MYOM2;CRYAB
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.6258308863949524,-1.2462243434377123,0.15714285714285714,1.0,1.0,6/30,13.40%,B3GNT5;PIGH;MPPE1;PIGL;ST6GALNAC5;PIGC
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.6257435538482705,-1.2459560030815398,0.13924050632911392,1.0,1.0,5/29,7.95%,SLC6A6;SLC38A4;SLC22A4;SFXN3;SLC7A6
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.6411431942038023,1.2459529598592753,0.21875,0.8033017383092581,1.0,6/10,29.67%,CNTN6;PALLD;DSCAML1;DSCAM;BSG;ROBO3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6504322680186027,1.2458495815656447,0.21621621621621623,0.8019958537237335,1.0,3/14,9.31%,SLC30A10;SLC25A33;ABCD2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.44340371658791405,1.2449220171089033,0.0,0.8034820716947167,1.0,34/176,11.54%,ODC1;U2AF1;EIF4H;PHB2;PSMD8;CNBP;CCT5;RAN;NPM1;ILF2;KPNA2;EIF3D;SRM;TRIM28;MCM4;YWHAQ;EIF1AX;HNRNPC;PCBP1;PPIA;CCT3;LSM7;RANBP1;RPS2;NHP2;RUVBL2;CANX;ERH;TUFM;PRDX3;VBP1;PA2G4;SNRPB2;SRSF3
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.7348554574874953,-1.2448810180217544,0.18571428571428572,1.0,1.0,1/11,0.30%,HEY2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.53903717867392,1.244827183467186,0.25806451612903225,0.8022923017732853,1.0,11/32,19.92%,LSM4;CD2BP2;GEMIN8;AAR2;SNRPB;SNRPD2;PRPF19;STRAP;SNRPE;SNRPF;COIL
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7896166721625865,-1.244566054628547,0.1724137931034483,1.0,1.0,2/7,13.15%,PLEKHA4;CSNK1D
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.6903932698010069,1.2443844614076551,0.2571428571428571,0.8022175787629385,1.0,5/9,17.33%,OXSM;ABHD2;CROT;GLYATL2;CRAT
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5999791388339187,1.2442714035605937,0.14814814814814814,0.8011458764292276,1.0,1/10,1.36%,ACTG1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8025231433362445,-1.2430819189447753,0.13043478260869565,1.0,1.0,3/7,16.51%,TMSB4X;TAF1;DDRGK1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7590765132685642,-1.2427735068709118,0.18840579710144928,1.0,1.0,8/10,23.11%,RNF213;TIAM1;CSNK1D;DAAM2;GPC3;SFRP4;ZNRF3;WNT5B
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.7412075879607846,1.2427364449076408,0.3548387096774194,0.8049996130384284,1.0,2/7,6.67%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.6347349482030252,-1.2426590844907572,0.24,1.0,1.0,10/20,26.09%,CAMK1;CAMK2B;APOE;FOXO6;SHANK3;KIF1A;PSEN1;MEF2C;SHANK1;CPEB3
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.7313840859069468,-1.2423651958493032,0.1388888888888889,1.0,1.0,2/13,4.78%,CD44;CEMIP
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.5519587240125929,-1.2423562554094845,0.08536585365853659,1.0,1.0,13/100,10.82%,NEFM;GNRHR;STMN2;FAM13C;PCSK2;OLFM3;ROBO2;GMPPA;SST;CACNA1C;CELF4;UNC5D;SYT4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.696275071087018,1.2418685797291935,0.23076923076923078,0.8066858646271748,1.0,2/9,11.37%,ZDHHC6;MUL1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5654555379087453,-1.2412162378447011,0.14473684210526316,1.0,1.0,9/47,19.50%,ANKRD53;CAV3;PFN2;CDC42EP3;PAK1;VASP;BAIAP2;DCTN1;LMOD1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.6599658437116565,1.2411402215299452,0.2619047619047619,0.8074566981023938,1.0,3/7,15.97%,TGFBR2;TGFBR1;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.7401348304582618,1.2411199326184326,0.2631578947368421,0.8058884170272217,1.0,3/7,20.44%,BAG2;MAD2L2;RPS7
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.7200088124372995,-1.2403753112275098,0.23728813559322035,1.0,1.0,1/8,5.18%,MTHFD1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.8043096048128472,-1.240371147669248,0.20270270270270271,1.0,1.0,3/6,15.98%,AHCYL1;CAMK2A;CA2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.6719212940226442,1.240114986443004,0.18421052631578946,0.8077549403313563,1.0,2/7,8.60%,MN1;GREM1
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.8503286715500807,-1.2396147394251802,0.1774193548387097,1.0,1.0,1/5,4.70%,RFTN1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.73346568975649,-1.2394596951600043,0.21212121212121213,1.0,1.0,2/15,6.89%,TMEM43;EMD
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6909680295469808,-1.2393750063155824,0.15714285714285714,1.0,1.0,7/13,23.71%,GRIN2A;GRIN2D;ARRB2;MPP2;MEF2C;GRIN1;MAPK8IP2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.5541952932930961,-1.239183503074208,0.14285714285714285,1.0,1.0,11/52,9.14%,MAP3K19;ALDH1L1;FPR3;TMCO5A;FMO3;APOL6;FMO5;RASSF4;HVCN1;CP;ANKUB1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5994449786392463,1.2389351111175346,0.16666666666666666,0.8105174884338087,1.0,2/16,4.02%,NR0B1;ACADVL
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6158288441581176,1.23845938031882,0.25,0.81048242268388,1.0,2/9,16.98%,LDLR;CDH13
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5033376593042086,1.2380526485482017,0.16666666666666666,0.8102020860808385,1.0,7/51,8.11%,UBB;ZFP36L1;TAB3;IKBKB;UBE2N;GPS1;MAPK11
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.7262487683459716,-1.2379522841753279,0.23880597014925373,1.0,1.0,3/13,9.52%,SCEL;BRCA1;CELF4
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8328798883273965,-1.23769010580427,0.22033898305084745,1.0,1.0,1/5,3.52%,TIMP3
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7841372538175538,1.2375025725957043,0.2894736842105263,0.8090471542618305,1.0,1/5,11.93%,KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7841372538175538,1.2375025725957043,0.2894736842105263,0.8090471542618305,1.0,1/5,11.93%,KHSRP
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.8281524729755729,-1.2369894436280697,0.15,1.0,1.0,1/5,14.30%,PDCD4
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.8362567881773281,-1.2368219477909836,0.21311475409836064,1.0,1.0,1/5,10.24%,SLC1A4
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.629861772712904,-1.2367559693536785,0.2631578947368421,1.0,1.0,12/25,27.75%,TMSB4X;PRXL2C;SLC4A4;GAPDHS;ENO1;PFKFB3;PSEN1;PFKFB2;PPARGC1A;PRKAA1;PRKAA2;PFKFB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.7687054297629732,-1.2367520510597694,0.15151515151515152,1.0,1.0,2/7,17.64%,CAV3;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.7932324078026985,-1.2365113200266005,0.23880597014925373,1.0,1.0,1/7,0.20%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.7932324078026985,-1.2365113200266005,0.23880597014925373,1.0,1.0,1/7,0.20%,CD44
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6926098467054053,-1.2360774727250152,0.18181818181818182,1.0,1.0,5/16,15.27%,POLQ;HELB;FANCB;SHLD2;RIF1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.6337769488627889,-1.2356350728904963,0.18055555555555555,1.0,1.0,8/29,13.08%,SYNJ2;MX1;SYT1;SNCB;SYT2;DNM1;DNM2;GAK
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.5391732081585319,1.2354675877146313,0.08695652173913043,0.8147079367592264,1.0,4/27,3.12%,AURKAIP1;BTC;CUL7;TGFA
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.716482825464369,-1.2353553270092277,0.21428571428571427,1.0,1.0,2/11,5.98%,PTP4A3;CEP135
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.4457448338055829,1.2346533726262479,0.11764705882352941,0.8130975243198719,1.0,9/72,7.83%,MALT1;PSMD8;PSMB6;TAB3;PSMB4;IKBKB;LYN;PSME3;PSMD10
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4457448338055829,1.2346533726262479,0.11764705882352941,0.8130975243198719,1.0,9/72,7.83%,MALT1;PSMD8;PSMB6;TAB3;PSMB4;IKBKB;LYN;PSME3;PSMD10
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4457448338055829,1.2346533726262479,0.11764705882352941,0.8130975243198719,1.0,9/72,7.83%,MALT1;PSMD8;PSMB6;TAB3;PSMB4;IKBKB;LYN;PSME3;PSMD10
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.5946882063479629,-1.2341532266094304,0.125,1.0,1.0,16/54,19.19%,DNAH7;TMEM213;ALDH1L1;WDR93;AGBL4;FMO6P;CFAP221;EFHC1;TMEM150C;P2RY14;RHCG;DNAH9;VWA3B;SLC4A8;ATP13A5;TCTN1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.6668820835007515,-1.234033008408405,0.2,1.0,1.0,4/17,10.72%,SLC51A;NCOA1;ABCC3;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.7814903835355194,-1.2339419361618202,0.21666666666666667,1.0,1.0,2/5,16.05%,VSIR;BCL6
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6517661574475626,-1.2339375193292879,0.0945945945945946,1.0,1.0,8/27,11.82%,GPR18;DOCK8;PTPRC;STAG3;SP140;TRAF3IP3;MYO1F;P2RY14
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.705677948302756,1.2336220363448267,0.3333333333333333,0.8152636797758719,1.0,3/5,13.24%,TLR1;LYN;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7676384351910872,-1.233084327534021,0.23333333333333334,1.0,1.0,2/7,5.62%,A2M;C4BPA
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.6630345538078237,1.2330741812624948,0.25806451612903225,0.8153274466449941,1.0,5/7,30.59%,RIOX2;KDM5D;KDM1B;KDM5A;KDM1A
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.8099498773008447,-1.2328946684927218,0.19402985074626866,1.0,1.0,3/8,10.32%,P2RY12;RYR3;TAF1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7410211183361497,1.232552897736522,0.2631578947368421,0.8139031378890076,1.0,4/7,14.79%,CALM3;SRI;GSTM2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7410211183361497,1.232552897736522,0.2631578947368421,0.8139031378890076,1.0,4/7,14.79%,CALM3;SRI;GSTM2;CALM1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.5706529005111094,-1.2324716071391228,0.125,1.0,1.0,18/76,14.28%,ENPP2;GRIN2A;OPALIN;A2M;P2RY12;TNS1;GLUL;GALNT15;RASSF4;SHISA6;BAALC;SPARCL1;SPP1;MMD2;PLXDC2;TMEM132C;FAM107A;PLP1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.7148083935188687,-1.23244857129098,0.203125,1.0,1.0,1/12,2.05%,CCDC39
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.47686954171111073,1.2314896081754974,0.13636363636363635,0.8161578838649076,1.0,15/58,8.01%,MMP2;PRRX1;BGN;FIBIN;PODN;FBLN2;CYBRD1;CXCL12;VSTM4;PDGFRA;LDB2;THY1;IGFBP7;MSRB3;ZNF521
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.6507424443848451,1.2314843335355643,0.23529411764705882,0.8145943630145918,1.0,5/8,31.37%,PINK1;LANCL1;REST;FYN;P4HB
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4678690418499901,1.231464855392932,0.2,0.8131165906612098,1.0,14/64,14.98%,SOX4;UBB;SOX11;HSPA1A;CHRNA7;SLC25A24;CHMP2A;MT3;CHP1;ACER2;ACER3;PRR7;RRAS2;RIPK2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.7100794240177247,-1.2314472523023805,0.22033898305084745,1.0,1.0,2/9,13.04%,SOX9;ZIC1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.8156915909690174,-1.2314150394685783,0.2222222222222222,1.0,1.0,1/7,5.83%,ACSS3
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.8205745926754593,-1.231017914194975,0.23636363636363636,1.0,1.0,1/5,1.00%,HES1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.8205745926754593,-1.231017914194975,0.23636363636363636,1.0,1.0,1/5,1.00%,HES1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.691293259431766,-1.230718926123566,0.21518987341772153,1.0,1.0,1/15,0.27%,RFC4
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.7662952594561506,-1.230038476899363,0.2647058823529412,1.0,1.0,1/7,6.10%,RAB11A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.6526608009874565,1.2297820420035706,0.2857142857142857,0.8171911248428414,1.0,5/13,14.07%,BAD;PPIF;THEM4;MUL1;SLC25A4
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5394007834244303,1.2293464441597186,0.17857142857142858,0.8170649505089015,1.0,4/18,7.47%,SOX8;GPC1;SOX10;NGF
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6925187650016762,1.2291119909131347,0.13333333333333333,0.8165162453073256,1.0,4/11,9.33%,SIRT2;ZFP36L1;THEM4;MT3
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.7723276875754042,-1.2290873138125278,0.16393442622950818,1.0,1.0,3/8,5.54%,GABRA4;GABRG3;GABRG2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.5720161212984968,1.2289199331949503,0.1724137931034483,0.8156001905298287,1.0,4/23,5.68%,IDH1;FDX1;STARD3;SQLE
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.7903364263326097,-1.2285655047890456,0.21875,1.0,1.0,1/7,2.50%,OTUD7B
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.6413036203518897,-1.228534633246977,0.1643835616438356,1.0,1.0,10/23,20.00%,CARD14;RPS6KB2;TMC4;SYNGR2;TMEM79;SLC14A1;PRKD2;TMCO4;PIEZO1;TRIM25
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.6372997955543134,1.2283194481704385,0.2413793103448276,0.8162678868005718,1.0,4/9,10.58%,ACTB;SHROOM2;INSC;MAL
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.7532327810822008,-1.2280511206961435,0.19480519480519481,1.0,1.0,1/11,2.10%,NECAB1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7190556708608189,-1.227842542918038,0.26865671641791045,1.0,1.0,1/11,0.95%,TMSB4X
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.6830929223845336,1.2275230380406505,0.3448275862068966,0.8171433645457588,1.0,5/7,29.71%,JUN;PSMC3;ZNF639;REST;TARDBP
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.7935614681030272,-1.2273475931474347,0.2413793103448276,1.0,1.0,3/5,20.10%,PAH;BCAT2;GAD2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6934065866504416,1.2272563411826956,0.1891891891891892,0.8164936980432553,1.0,3/14,10.94%,HSPA1A;TMBIM6;CREB3L1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.6995681309106988,-1.2270574369635188,0.2564102564102564,1.0,1.0,1/9,1.32%,SLC2A3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6150653665786409,1.2269962280956572,0.3,0.8156893431953913,1.0,3/12,7.29%,GPNMB;IL15;LEPR
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.7200196617863538,1.2262056387328895,0.2727272727272727,0.8169007913789581,1.0,2/9,3.88%,ODC1;SRM
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7331146977875964,-1.2261691129215837,0.19672131147540983,1.0,1.0,5/11,21.88%,SOX9;FOXO1;PPP5C;GLDC;PDK3
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.7184512464038845,-1.2261289760494642,0.1896551724137931,1.0,1.0,2/10,10.02%,GRM1;GRM3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.7587392953464533,-1.2258933195326311,0.1875,1.0,1.0,2/6,20.35%,TPCN2;EPS15
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.681994110390058,-1.225664803483516,0.1891891891891892,1.0,1.0,4/19,9.16%,NR4A3;AGT;CAV3;MLIP
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.7261269170397848,1.2255473133619412,0.2894736842105263,0.8174293292021795,1.0,5/6,25.15%,DDX1;YBX1;DCP1A;DDX3X;SSB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.4861751925717624,1.225515924001632,0.11538461538461539,0.8159766889268866,1.0,6/39,7.72%,BAD;MFF;ZDHHC6;PPIF;BOK;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.6126077074692976,-1.2252831160201827,0.19230769230769232,1.0,1.0,2/35,1.87%,SLC6A6;FOS
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.8475720636127637,-1.225107143468369,0.16666666666666666,1.0,1.0,3/6,12.69%,SLC22A4;VEGFA;OXTR
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.5667811024868421,-1.2251058611003132,0.1282051282051282,1.0,1.0,12/48,18.12%,GADD45B;TPD52L1;GADD45A;DUSP22;TNFRSF19;CD27;RASGRP1;TRAF3;RIPK1;SEMA3A;WNT7A;DAB2IP
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5793568960084508,-1.2245748547044915,0.15,1.0,1.0,18/62,16.03%,SGCA;TTN;MYLK;TMOD3;VCL;CKMT2;GLRA1;CAV3;TPCN2;EMD;EDNRA;SORBS1;TPM1;SNTA1;OXTR;MYL6B;MYOM2;CRYAB
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.7336649329166353,-1.2245408856295796,0.22727272727272727,1.0,1.0,4/10,13.68%,PTPRC;CD27;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.7631475991815839,-1.224505689227145,0.13333333333333333,1.0,1.0,5/10,17.07%,CAV3;KCNQ1;SNTA1;RYR2;NEDD4L
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.7038875072708577,1.2238490769111356,0.275,0.82050796326012,1.0,2/7,14.61%,PPT1;SNX5
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.7784504292975379,-1.223154822022521,0.2602739726027397,1.0,1.0,2/6,9.90%,CLDN18;CLDN12
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.4006046975780548,1.2230058627129927,0.16666666666666666,0.8220386647087045,1.0,36/259,10.63%,COPZ1;SYNDIG1;IPO13;NUP42;ARL4A;PHB2;EVI5L;CALR;SNF8;NUTF2;RAN;TMED2;VPS28;NPM1;PREB;VPS26B;PRICKLE1;ARFIP1;RAB5B;AP4E1;STX6;PPP1R10;CLIP3;SURF4;TBC1D25;TMED5;BAG3;RAB1B;ARF5;PTTG1IP;CAMSAP3;SNX17;CTSA;CHP1;RAB6A;RABL3
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.8302320489142425,-1.222695264965869,0.3076923076923077,1.0,1.0,2/5,7.95%,SLC3A1;SLC7A6
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.7291906043297675,-1.2225280639009766,0.203125,1.0,1.0,5/11,16.86%,RAB3A;RAB3D;SYT4;RAB15;SLC4A8
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.6947519154131861,-1.2224047361157246,0.21428571428571427,1.0,1.0,5/12,18.12%,SHTN1;KIF20B;NSMF;SEMA3A;DAB2IP
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.8181116889833854,-1.2218466128802492,0.21428571428571427,1.0,1.0,4/5,17.58%,CAMK1;CAMK2B;SHANK3;FRMPD4
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5491420299691201,1.2218436117865707,0.3333333333333333,0.824677219010006,1.0,4/23,9.70%,CRB2;NECTIN1;DCHS1;TENM4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.7477127920910714,1.2217992597171614,0.21621621621621623,0.8233511494440434,1.0,1/6,0.66%,BAD
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.8378845132652757,-1.2217441764261454,0.22580645161290322,1.0,1.0,2/5,11.53%,APOE;LRPAP1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4741350210607411,1.221733719663065,0.05263157894736842,0.8221074018842547,1.0,8/80,5.70%,IPO13;PHB2;CALR;NUTF2;RAN;PRICKLE1;PML;PPP1R10
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.546484223491128,-1.2215953267200352,0.10714285714285714,1.0,1.0,25/79,29.16%,PLEKHA4;SYNJ2;PIP4K2C;INPP5E;INPP4B;PDGFRB;PIP4P1;PIP5K1B;PIK3CB;INPP4A;IMPA1;PITPNM2;TPTE2;PIP4K2A;SACM1L;PLCG1;MTMR4;PGAP1;PLEKHA2;PIK3CD;PLAAT3;SBF1;PLA2G12A;CDS1;FGF2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.6150377072992945,-1.2215451002376307,0.18181818181818182,1.0,1.0,9/25,21.38%,SHTN1;CAMK2B;IGSF10;CAMK2A;KIF20B;NSMF;SEMA3A;DAB2IP;PHACTR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.7978093789016767,-1.2215399342065318,0.23809523809523808,1.0,1.0,2/5,9.16%,FOXO1;MLIP
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.6492963708774377,1.2215176352241661,0.24242424242424243,0.8214863263109214,1.0,2/8,4.04%,GAL3ST3;B3GAT2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.6994278797562464,-1.2214406244145106,0.16470588235294117,1.0,1.0,1/17,0.58%,STMN2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6981629998671052,-1.221438779729673,0.2,1.0,1.0,6/15,21.31%,TTN;KCNQ1;TPM1;RYR2;CAMK2D;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.7253717021136049,-1.2213556639514407,0.18461538461538463,1.0,1.0,1/9,1.16%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.8110459485494083,1.2213490923791859,0.2682926829268293,0.8206876108719502,1.0,1/5,2.01%,NR1H2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.5662696590847673,1.2211656713147958,0.20833333333333334,0.8198918427224214,1.0,3/22,8.11%,EIF5A;IRF3;MAPK11
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.8016961492554044,-1.2208893142613777,0.234375,1.0,1.0,4/5,19.39%,PROCR;APOE;KNG1;HS3ST5
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7021833635009127,-1.220607269580249,0.26153846153846155,1.0,1.0,3/10,13.62%,NMT1;GRK4;PDE6B
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.7659287144230703,-1.2198656134403953,0.24242424242424243,1.0,1.0,2/7,5.81%,APIP;NLRC4
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5604298245423199,1.219526038827874,0.21739130434782608,0.8241954850246183,1.0,10/28,18.56%,MALT1;RBM15B;NUTF2;NPM1;GEMIN8;LSG1;SNRPB;SNRPD2;SNRPE;SNRPF
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.684309835954532,-1.2189331994557544,0.22058823529411764,1.0,1.0,6/17,13.03%,FGF1;SREBF1;LPCAT3;APOE;SEC14L2;MBTPS1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6741995606174818,-1.2185514982085155,0.1774193548387097,1.0,1.0,2/16,7.53%,FOS;BAZ2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6741995606174818,-1.2185514982085155,0.1774193548387097,1.0,1.0,2/16,7.53%,FOS;BAZ2A
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5738588383096799,1.218453626841389,0.18518518518518517,0.8261826016825533,1.0,2/18,1.00%,STOX1;CCND1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5326956597546487,1.2181905683664642,0.07692307692307693,0.8256618124841364,1.0,8/38,9.34%,AMOTL2;SOX8;AMOT;SEMA5B;SEMA5A;SOX10;SEMA4F;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.6885207319645692,-1.2181559277018486,0.2459016393442623,1.0,1.0,4/13,8.73%,SOX9;AGT;VEGFA;GJA1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.7570281377906025,-1.2180473454595324,0.25,1.0,1.0,2/6,14.90%,SLC22A4;SLC25A45
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5274990281897328,1.2179059934790017,0.16,0.8251174612057407,1.0,12/36,14.45%,NEU1;SMPD1;B4GALT6;SMPD3;NEU3;CTSA;GBA3;ST6GALNAC3;GM2A;ESYT2;UGT8;GLTP
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.44938980546760837,1.2176879498612165,0.15789473684210525,0.8229435172673143,1.0,9/50,9.39%,NDUFB1;NDUFAF8;DMAC2;NDUFB11;NDUFS3;NDUFS6;NDUFB7;NDUFA5;NDUFS8
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.44938980546760837,1.2176879498612165,0.15789473684210525,0.8229435172673143,1.0,9/50,9.39%,NDUFB1;NDUFAF8;DMAC2;NDUFB11;NDUFS3;NDUFS6;NDUFB7;NDUFA5;NDUFS8
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.7835965815438766,-1.2174401841839912,0.2786885245901639,1.0,1.0,1/7,4.71%,ROBO2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7535542300127467,1.2172717456376023,0.32142857142857145,0.8227110585897112,1.0,3/8,14.19%,PPP1R3B;PPP1R3D;PPP1R3F
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7376357878330709,-1.217242071167662,0.23076923076923078,1.0,1.0,2/7,1.04%,PON1;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5080848573350938,1.2170715013400195,0.19047619047619047,0.8217461947656765,1.0,9/33,11.06%,NOVA1;NR1H2;PLCL2;MAP2K6;IL15;PLCL1;RBPJ;ATF4;ACOT13
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.6148382694590893,-1.2168422806698023,0.2112676056338028,1.0,1.0,7/25,15.17%,TMSB4X;P2RY12;VEGFA;IL6R;NTRK3;TGFB1;PDGFRB
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.776877622217098,-1.2166491918922326,0.31746031746031744,1.0,1.0,2/5,5.71%,RHOJ;SHTN1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.5645108166050626,-1.2159645449970307,0.20253164556962025,1.0,1.0,4/42,9.72%,KCNJ13;SLC39A14;KCNJ11;SLC24A2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6776127417334787,-1.2158638515595594,0.2222222222222222,1.0,1.0,4/15,12.16%,STX1B;STX19;SNAP25;SYNGR2
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7615695268364484,1.2157058289352094,0.25,0.8248482493666067,1.0,5/7,18.08%,MSN;RAP2A;CAMSAP3;CDC42;RHOA
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5603687619460166,-1.2154973910364615,0.18292682926829268,1.0,1.0,10/45,18.37%,PTPRC;P2RY12;TPCN2;ACKR4;CACNA1C;CHRM3;PTPRJ;RYR2;PPP3CC;HTR2B
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.6600618532412118,1.215332815554141,0.22727272727272727,0.8249411109911451,1.0,3/9,7.97%,RFWD3;CCND1;SDE2
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.6731541145213469,-1.2151675766700345,0.2714285714285714,1.0,1.0,2/14,1.99%,NLRC5;EMP2
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.43518905121733276,1.214562353452665,0.10526315789473684,0.82601438267951,1.0,5/52,6.73%,TUBG1;RAN;KIF25;CHMP2A;WRAP73
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.6009838839612682,-1.2138205021678585,0.2112676056338028,1.0,1.0,1/22,1.31%,SYNJ2
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7770032507229742,1.2137102649006148,0.2222222222222222,0.8278870417807124,1.0,1/8,0.16%,MYRFL
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7678043735224584,1.2135032934109922,0.2903225806451613,0.8273725651082161,1.0,5/5,23.25%,XYLB;RPIA;DCXR;RPE;FGGY
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7325685327391674,1.213305165222545,0.325,0.8266598459192144,1.0,2/5,10.31%,TGFBR2;TGFBR1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6259788547671259,-1.2133042233661255,0.16666666666666666,1.0,1.0,6/24,13.68%,PTPRC;CD27;ARHGAP15;TCF7;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6548039541910121,1.2131293730379824,0.20512820512820512,0.8256251182482192,1.0,3/11,10.63%,PML;PPP1R10;LIG4
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7681011836825811,-1.2127614587280047,0.14545454545454545,1.0,1.0,3/8,12.61%,CAV3;KCNQ1;SNTA1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.5070399987788787,1.2125695642275687,0.25,0.8259648090878536,1.0,5/37,9.14%,LTV1;NOL11;NPM1;RPS19;RPSA
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5735213374658941,-1.2123952434402092,0.15294117647058825,1.0,1.0,11/42,12.28%,PON1;ARX;AGT;PAH;ELOVL2;A2M;ACSS3;ACSL1;THSD4;SORBS1;MATN2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5538621891314899,1.212253372021173,0.22857142857142856,0.8253579428681693,1.0,3/21,3.47%,VPS37B;SNF8;VPS28
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.8029786487105863,-1.2118668446193908,0.1896551724137931,1.0,1.0,1/5,1.82%,PDHX
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.8458603110429821,-1.2118638603800573,0.15384615384615385,1.0,1.0,1/5,7.02%,PLEKHM1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.6328196027314061,-1.2115778503057952,0.14285714285714285,1.0,1.0,9/28,12.15%,DOCK8;PTPRC;SPI1;IL3RA;AOAH;TRAF3IP3;BCL11A;MYO1F;BLNK
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.7532956795972217,1.2115465051746483,0.2857142857142857,0.8263673883389877,1.0,1/6,0.56%,TRMT112
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.5271816818076214,-1.2110741389466317,0.14814814814814814,1.0,1.0,15/67,18.12%,GADD45B;TPD52L1;GADD45A;SPI1;VEGFA;DUSP22;TNFRSF19;CD27;RELL1;RASGRP1;TRAF3;RIPK1;SEMA3A;WNT7A;DAB2IP
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.666976116329681,-1.2105999312122395,0.1794871794871795,1.0,1.0,3/20,10.21%,PMS2;MSH6;RPA3
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.7222795198598508,-1.2103963063121723,0.22857142857142856,1.0,1.0,3/10,9.70%,STX1B;STX19;SNAP25
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.575260286857137,1.2101137833693882,0.36363636363636365,0.8299016849037733,1.0,1/10,0.74%,BICD2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.5646169502460274,-1.2100181239516254,0.20930232558139536,1.0,1.0,13/53,15.38%,CD44;CAMK1;MTCP1;VEGFA;DOCK7;BCAR3;PFN2;PAK1;NTRK3;BDNF;TGFB1;HDAC6;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6536592250772465,-1.20969184077223,0.2054794520547945,1.0,1.0,3/25,13.59%,ENPP2;AVIL;VIL1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7406994986773828,1.209603481816146,0.3611111111111111,0.8301571146184792,1.0,1/5,4.96%,MAP2
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.8126083045870132,-1.2093775401974707,0.22033898305084745,1.0,1.0,4/5,18.71%,HOOK1;HOOK2;HOOK3;AKTIP
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.7329646959360231,1.2088232690428113,0.34285714285714286,0.8314490648506129,1.0,1/5,3.14%,MSN
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.5740826487855268,-1.2084590402573883,0.24675324675324675,1.0,1.0,9/48,12.27%,ITPR1;AGT;RYR3;CAV3;KCNJ11;AHCYL1;KCNQ1;ATP2B3;TPM1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.7943303804885892,-1.2079255393564163,0.3157894736842105,1.0,1.0,2/5,19.35%,ITPK1;IMPA1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.5229929253993987,-1.2076049920372733,0.1411764705882353,1.0,1.0,20/96,23.43%,PLEKHA4;SYNJ2;PIP4K2C;PIGH;INPP5E;ITPKC;MPPE1;PIGL;PIGC;INPP4B;PIP5K1B;PIK3CB;INPP4A;IMPA1;PITPNM2;TPTE2;PIGG;SOCS4;PIP4K2A;SACM1L
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.5657122637173455,-1.2075303617069972,0.13580246913580246,1.0,1.0,7/54,13.48%,BRCA1;TRIM52;DDB2;RNF213;RNF157;DTX3L;WWP2
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.7600423508363222,1.2075059237218257,0.36666666666666664,0.8345856988671979,1.0,3/6,14.19%,PPP1R3B;PPP1R3D;PPP1R3F
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5652454523066812,1.2074009575335103,0.23333333333333334,0.8334285280069879,1.0,1/18,0.69%,SMDT1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.7546162446699991,1.2071325548911869,0.36585365853658536,0.8326194224800535,1.0,1/6,9.38%,UNC80
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.697502797297947,-1.2070040791155632,0.24615384615384617,1.0,1.0,4/9,26.98%,ETV4;SFRP4;MED1;PRKCH
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.7679780213766967,-1.206863459382183,0.203125,1.0,1.0,4/6,22.97%,PTPRC;RASGRP1;CTPS1;MEF2C
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.8235363413975565,-1.2064450647557883,0.23728813559322035,1.0,1.0,2/5,12.58%,STAT4;STAT3
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6920887401973272,-1.2063701955098842,0.2542372881355932,1.0,1.0,5/11,24.38%,CAMK1D;MPP1;IL34;CXCL17;CSF1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.710955255197429,1.2063004664131876,0.1875,0.8339224421394802,1.0,1/9,2.01%,NR1H2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.8157880203053454,1.2052069413443618,0.2222222222222222,0.8361267531740758,1.0,2/5,8.89%,ZFP36L1;EDC3
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.6470423196011642,1.2051047078686037,0.3333333333333333,0.8349505685266401,1.0,2/8,5.79%,ATP7B;COX19
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.6745530815071126,1.2049708094620797,0.2222222222222222,0.8338761001345658,1.0,1/7,5.72%,RO60
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6818931532576714,-1.2049639137269035,0.171875,1.0,1.0,4/14,9.59%,OVOL2;TMC4;FUT2;LIPH
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7678870821527718,1.2049121404190466,0.30303030303030304,0.8327079768222165,1.0,2/5,9.69%,ACHE;LIMD1
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7709332602650876,-1.2042753444113945,0.16901408450704225,1.0,1.0,2/7,6.06%,RFC4;RFC2
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7709332602650876,-1.2042753444113945,0.16901408450704225,1.0,1.0,2/7,6.06%,RFC4;RFC2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6143759963227412,-1.2042715485889128,0.21052631578947367,1.0,1.0,5/27,14.71%,NLRC5;A2M;STAT2;TYRO3;OAS1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.5932905833754898,-1.2038361838104696,0.22857142857142856,1.0,1.0,8/35,12.15%,PTPRC;EBF1;CD27;HVCN1;SP140;TRAF3IP3;BCL11A;BLNK
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.7442657983574701,-1.2036497259100314,0.2962962962962963,1.0,1.0,2/7,14.87%,SLIRP;NRDE2
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.7868849498670227,-1.2033734933131834,0.24285714285714285,1.0,1.0,3/7,10.24%,SLC6A6;SLC6A17;SLC1A4
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.7724260660392166,-1.2033441246458918,0.21739130434782608,1.0,1.0,1/6,5.13%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.639487567504389,-1.2032069372270862,0.24242424242424243,1.0,1.0,5/19,15.42%,GRIN2A;GJA1;CACNB1;EPHA4;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.6120513398757531,-1.203154490599458,0.18181818181818182,1.0,1.0,6/30,14.12%,PLET1;CDKN2A;EFNA5;RASA1;TBCD;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.6959380328445821,-1.2029967501243963,0.2647058823529412,1.0,1.0,3/7,18.62%,VEGFA;CAMK2D;PRKD2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6273902173639039,1.2028782942677325,0.19444444444444445,0.8374517581330914,1.0,5/11,22.24%,LDLR;STARD4;OSBP;LRP6;OSBPL2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.5473548814131176,1.2027799818175486,0.18181818181818182,0.8363300109756406,1.0,4/24,3.37%,NUP42;CALR;NUTF2;RAN
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5994126355551654,1.2020593294731392,0.23529411764705882,0.8375864484047939,1.0,3/15,10.18%,ARFIP1;WASF3;BRK1
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.7617571638528304,1.2018987614853591,0.34782608695652173,0.8365892945940727,1.0,3/5,14.79%,CALM3;GSTM2;CALM1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.4677992663923173,1.20175876077687,0.1111111111111111,0.8356197463071129,1.0,4/41,6.94%,GPC4;GPC1;MAP2;PARP1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.6151389131141821,-1.2016555525287926,0.208955223880597,1.0,1.0,3/19,8.60%,NLRC5;SPI1;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.6738867158153278,-1.2015725426532549,0.25675675675675674,1.0,1.0,3/15,14.71%,NLRC5;STAT2;OAS1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.6065334253615604,1.201532547439841,0.3125,0.8349668761127398,1.0,6/15,22.24%,HSD17B10;ACOT8;OSBPL7;OSBP;CYP7B1;OSBPL2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.6546490120259664,-1.2014600971414067,0.24615384615384617,1.0,1.0,3/15,15.04%,RAB11A;DNM2;CCDC186
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.7916694864921269,-1.201090628214478,0.29310344827586204,1.0,1.0,2/6,10.46%,VEGFA;THOC5
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.6677267691379937,-1.2010842128722314,0.208955223880597,1.0,1.0,8/15,26.57%,PARP9;NUDT12;NAXE;NMNAT3;NNMT;NMNAT2;PARP10;HAAO
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.7667372300157154,1.20087426666055,0.3235294117647059,0.835495187526648,1.0,1/5,10.70%,BCL11B
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.8071912837402339,-1.200690468135464,0.18181818181818182,1.0,1.0,2/6,13.84%,DUSP22;BDNF
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.5633261026459915,-1.2004452569818225,0.13580246913580246,1.0,1.0,7/50,14.69%,HEY2;SOX9;SPI1;KIAA0319;BCL11A;SUZ12;TGFB1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.7859287227371771,-1.2003389452351232,0.2037037037037037,1.0,1.0,3/6,17.05%,RAB3A;CBLN2;DCTN1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.553857134544441,-1.1999583625430623,0.24,1.0,1.0,13/56,16.33%,MMP19;SLC39A14;CEBPD;FPR3;ITGA2;TNS1;RASSF4;FAM20C;SPP1;NRP2;CTSZ;CA2;F13A1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7122476116677701,-1.1998207465579285,0.24615384615384617,1.0,1.0,4/11,10.66%,DNAH7;CCDC39;EFHC1;DNAH17
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.49171162475280344,1.1994281383974539,0.14285714285714285,0.8391920619004652,1.0,11/51,14.96%,UBB;PSMD8;PSMB6;PSMB4;MCM4;PSME3;PSMD10;UBC;PSMD12;PSMB2;PSMD4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6292705126162144,-1.1993079311790276,0.2,1.0,1.0,5/23,11.12%,KCNMB4;CPLX1;STX1B;RIMS1;CAMK2A
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.778184955742786,-1.198831706307909,0.24242424242424243,1.0,1.0,3/7,18.96%,KIF1C;SYT4;KIF1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6589479990779669,-1.1988285916815453,0.24675324675324675,1.0,1.0,7/24,20.26%,NR4A3;TRIB1;IL6R;PDGFRB;OGN;STAT1;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7139656336424686,-1.198124258673618,0.25,1.0,1.0,2/14,3.50%,NR4A3;AGT
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.7079865172101558,-1.198002551244884,0.23529411764705882,1.0,1.0,4/11,13.68%,PTPRC;AOAH;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.6907814156622754,-1.197870040550637,0.2916666666666667,1.0,1.0,1/10,0.20%,CD44
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.7286596981033511,-1.1977349551387806,0.2903225806451613,1.0,1.0,1/8,1.00%,HES1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.771311660634886,-1.1977284013513254,0.26153846153846155,1.0,1.0,1/5,9.90%,FANCB
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7646738036943955,-1.197696660533101,0.296875,1.0,1.0,1/7,3.50%,AGT
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.8026854264148545,-1.197467769311001,0.21818181818181817,1.0,1.0,3/6,11.50%,HSD11B1;YWHAH;SPP1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5941921996064825,-1.1972867356915111,0.2222222222222222,1.0,1.0,9/36,17.41%,SCEL;ALOX12;FLG;COL5A1;HRNR;COL5A3;TMEM79;BCR;ADAM9
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.5002978091353106,-1.1972675713118945,0.10526315789473684,1.0,1.0,44/235,13.16%,GABRA4;NEFM;ZIC4;STMN2;ARX;PDE4A;PCSK2;OLFM3;SYT1;GRM1;CALB1;OPRM1;SNCB;GABRG2;KCNC1;NRGN;HAP1;SST;ADGRL2;GRIN2D;CPLX1;CACNA1B;ACTL6B;SV2B;SHISA6;NRIP3;HPCAL4;SCN8A;CELF4;SNAP25;PSD2;GRM3;SRGAP3;SYT4;RAB15;CAMK2A;ATP2B3;SHISA9;MMD2;LRRTM1;SULT4A1;CACNB1;PARM1;ADCY1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6409673313554995,-1.1972153635252307,0.2222222222222222,1.0,1.0,5/22,11.73%,OPRM1;KCNJ11;BMP8A;APOE;RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.42361129971001177,1.1965747311088262,0.2222222222222222,0.8474317575219595,1.0,15/117,8.66%,STOX1;TUBG1;CCND1;SSNA1;PSMD8;PSMB6;KCNH5;PSMB4;RCC2;HAUS8;RAD51B;PSME3;PRKAR2B;PSMD10;TUBA1A
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6498979281711282,1.1959661238456656,0.2222222222222222,0.847935886809102,1.0,4/10,12.89%,DHFR;SPTLC1;ACER2;ACER3
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5700562248365953,1.1958736101189573,0.21875,0.8468134722903815,1.0,2/14,2.01%,LPCAT1;NR1H2
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.5036494250595039,-1.195335534779105,0.16470588235294117,1.0,1.0,22/118,16.31%,CD44;GADD45B;AHR;SLC2A3;MAFF;IL3RA;KLF6;SLC29A2;ETV4;PLSCR1;SCN9A;SPP1;SYNGR2;TIAM1;BHLHE40;PTRH2;GALM;IGF2R;IGF1R;CTSZ;CA2;IKZF4
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5030771805566769,1.1952912006453817,0.25,0.847340785969844,1.0,6/37,12.05%,PRR5L;ZFP36L1;ZC3HAV1;RC3H1;KHSRP;TOB1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.5590742625515459,1.1946966846015223,0.24,0.8479139186917236,1.0,4/17,11.37%,SIRT2;PCBP2;NFKBIL1;MUL1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.5163476902231208,-1.1945441259437592,0.16091954022988506,1.0,1.0,24/116,18.62%,MAK;DAPK1;EEF2K;MAP3K12;ALK;CAMK2B;TAF1;CAMK2A;PAK1;VRK1;TYRO3;VRK2;PAK2;NEK6;MKNK1;DAPK3;EPHA4;PDGFRB;IGF1R;RIPK1;CAMK2D;ATM;TNIK;PRKD2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.5917772560339256,-1.1945252614950452,0.25,1.0,1.0,6/29,16.52%,OTUD7B;PARP9;GLUL;DTX3L;TGFB1;CTNNA1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.8001382255679633,-1.1935755370999865,0.27419354838709675,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.8001382255679633,-1.1935755370999865,0.27419354838709675,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.8001382255679633,-1.1935755370999865,0.27419354838709675,1.0,1.0,1/5,8.51%,APOE
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.44800323640781464,1.193471978859963,0.15,0.8508622670393856,1.0,12/82,6.57%,MMP2;PRRX1;AMOTL2;BGN;FIBIN;MAGI1;TNS2;CXCL12;PDGFRA;FRZB;THY1;TCEAL7
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5292247012678797,-1.1932783687947757,0.12222222222222222,1.0,1.0,31/113,16.78%,STMN2;GRIN2A;OLFM3;GRM1;CALB1;SPINK8;SNCB;GABRG2;KCNC1;NRGN;GRIN2D;STX1B;CACNA1B;CALY;ACTL6B;CELF4;SNAP25;PSD2;GRM3;SYT4;CAMK2A;ATP2B3;MMD2;LRRTM1;OXTR;KCNB2;CCK;DLG4;CELF3;DAB1;GFAP
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.533786348966416,1.192845168408866,0.14285714285714285,0.8511901224794123,1.0,7/19,13.49%,STYXL1;PPP1R35;TIPRL;PPP1R11;CHP1;GPATCH2;PPP1R26
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.576721250380457,-1.1928191332976394,0.16049382716049382,1.0,1.0,10/56,6.70%,ENPP2;GRIN2A;MYLK;FGF1;FAM13C;TREH;AGT;A2M;RHOJ;SST
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.42079315652195975,1.1920197506547092,0.15,0.852843543229106,1.0,13/72,9.39%,NDUFB1;NDUFAF8;DMAC2;NDUFB11;SDHAF3;NDUFS3;COX19;NDUFS6;NDUFB7;NDUFA5;IMMP2L;SLC25A33;NDUFS8
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.6842972711182157,-1.1916823129394407,0.22388059701492538,1.0,1.0,4/16,5.81%,GRIN2A;VSIR;C1RL;NLRC4
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6746184324633814,-1.191369615478396,0.24242424242424243,1.0,1.0,4/15,17.05%,ANKRD53;TACC3;BORA;DCTN1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.567021865766013,1.1912444356829701,0.3103448275862069,0.8541838840394329,1.0,4/16,12.19%,MRPL44;HENMT1;TRIM71;SNIP1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7219106472157917,-1.1907701218849205,0.25396825396825395,1.0,1.0,1/9,1.99%,EMP2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.6277843425562895,-1.1905020650940512,0.265625,1.0,1.0,8/18,24.53%,PPFIA1;ITGB1BP1;TGFB1;MRAP;AP2M1;CLTC;DMTN;LZTFL1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.7881645689038073,-1.1903884663707693,0.27692307692307694,1.0,1.0,4/6,18.37%,TTN;HDAC4;RYR2;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.6826751713173045,-1.1903789258730368,0.18840579710144928,1.0,1.0,2/14,6.51%,VEGFA;LRP2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.7638697935789454,-1.1903485053129772,0.26666666666666666,1.0,1.0,3/6,14.82%,APOE;FAM107A;EPHA4
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.5977464930286853,-1.1902586840724563,0.2631578947368421,1.0,1.0,3/27,5.35%,PHF19;SPI1;AEBP2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7137901507044491,-1.1899157170446315,0.2647058823529412,1.0,1.0,1/9,2.08%,TSPYL2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6261358452894064,-1.1899142773995102,0.27941176470588236,1.0,1.0,7/19,16.02%,NLRC5;PARP9;PARP14;TRIM44;IL7;C1QTNF4;RIPK1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.6076014747798328,-1.1898531718501786,0.2328767123287671,1.0,1.0,2/22,6.09%,KCNJ13;KCNJ11
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.6169134370621919,-1.1898237323642067,0.26865671641791045,1.0,1.0,5/24,7.19%,SYNJ2;SYT1;SNCB;RAB3A;SYT2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7146212200299782,-1.1896865249141457,0.2535211267605634,1.0,1.0,2/12,3.50%,NR4A3;AGT
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6711606371751548,1.1894629274947108,0.25,0.8584709626707063,1.0,1/7,0.49%,SIRT2
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.5398129583164434,-1.18936817979731,0.20652173913043478,1.0,1.0,18/74,17.98%,GLRA2;AHR;SOX9;BRCA1;P2RY12;GLRA1;RYR3;GABRG2;HCN3;KCNQ1;TAF1;TSHR;HCN1;RPTOR;NSMF;CTNNA1;CAPN2;HCN2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3816630413554348,1.189349464824755,0.0,0.8574873330412734,1.0,40/225,13.63%,LSM4;POLR2J;U2AF1;POLR2L;RBM15B;NOVA1;SMU1;SF3B6;SF3B5;CPSF1;PCBP2;RBM22;RBM41;HNRNPA0;HNRNPC;PCBP1;LSM7;SNRNP40;PUF60;GTF2F1;CD2BP2;UBL5;EIF4A3;RBM8A;MAGOH;CSTF2T;POLR2K;PPWD1;CPSF4;SNRPB2;SRSF3;ZMAT2;SNIP1;MTREX;HSPA8;RAVER2;PHF5A;SNRPB;DNAJC8;HNRNPH1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.6988426248496843,-1.1890299190611326,0.25,1.0,1.0,2/7,15.47%,UBASH3B;RYR2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7090197273293637,-1.1890022157652869,0.21875,1.0,1.0,4/11,19.04%,PARP9;IFNGR2;JAK1;STAT1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.6331972383892712,1.188716886549622,0.2,0.8577070831691798,1.0,2/10,4.95%,SYNE2;KIF25
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.5787826181837676,1.1887024539375157,0.28125,0.8562817443024502,1.0,2/13,2.04%,CUBN;RBP1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6283244050501189,-1.1884412945777896,0.20833333333333334,1.0,1.0,4/11,11.12%,KCNMB4;CPLX1;RIMS1;CAMK2A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6380147524484789,1.1883797504852398,0.38095238095238093,0.855869607902061,1.0,2/10,9.53%,UQCRC1;UQCR10
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5050200402497936,1.188326094195846,0.19230769230769232,0.8546394541288039,1.0,11/32,12.84%,DHCR7;MSMO1;HSD17B10;TM7SF2;SQLE;ACOT8;PSAT1;LBR;HMGCR;INSIG1;OSBPL7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7277203770024674,-1.1883094335966409,0.26865671641791045,1.0,1.0,3/8,17.01%,CD160;PDCD4;ANO6
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.6516354945576861,-1.1880087217446516,0.22950819672131148,1.0,1.0,4/16,10.66%,DNAH7;CCDC39;DNAH5;DNAH17
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.5518579617735936,1.1868079117102173,0.2222222222222222,0.8586721860231624,1.0,9/19,20.83%,TRMT112;NHP2;NAT10;METTL5;TFB2M;THUMPD1;TSR3;NOP10;TFB1M
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.5265862592049192,1.186796399589754,0.23809523809523808,0.857301459909358,1.0,5/26,12.19%,WTIP;RAN;LIMD1;TRIM71;SNIP1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.8023380165187155,-1.186740147239271,0.27586206896551724,1.0,1.0,2/5,4.22%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6494330326286196,1.1866999393130602,0.26666666666666666,0.8561216772540959,1.0,2/6,10.18%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.80132242856339,-1.1866178109690506,0.06153846153846154,1.0,1.0,1/5,4.71%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.5366516273336166,1.1865496574705077,0.25925925925925924,0.8552249000404623,1.0,3/29,3.15%,AURKAIP1;BAD;CTSC
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.7490259430929629,1.1863877752504945,0.2894736842105263,0.8544936301271358,1.0,3/6,20.30%,ISCU;VCP;PINK1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.7994657158154352,-1.1862743659182795,0.27419354838709675,1.0,1.0,2/6,12.92%,RAB11A;GRIPAP1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.7535610467235462,1.1862037393921474,0.3333333333333333,0.8535793781259838,1.0,2/6,9.06%,SNX12;GAS1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.5683179475065653,-1.1860527968310384,0.2125,1.0,1.0,15/47,14.75%,CDH7;SLC6A6;GABRG3;OPRM1;UNC13C;CATSPERG;SV2B;MGAT4C;RBFOX3;SLC24A2;SV2C;PDE6B;HCN1;MCF2L2;KCNG4
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.635615360894895,1.1860032877368,0.3125,0.8527838630205531,1.0,3/8,9.98%,LYN;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.7695677740743075,1.1858528951526626,0.35294117647058826,0.851806187180386,1.0,1/6,4.57%,CMPK1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.4888532633310584,1.185831513612935,0.2,0.850439697563388,1.0,6/57,7.04%,SOX4;SOX11;GPNMB;HSPA1A;CHMP2A;DCPS
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.7946488540312048,-1.1857351281758097,0.25757575757575757,1.0,1.0,4/5,18.07%,SLC6A15;SLC6A17;SLC1A4;SLC6A7
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.7266002745224094,-1.1856261581297478,0.35,1.0,1.0,2/9,7.02%,P2RY12;PLEKHM1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6529875273796938,1.1854824166367166,0.2,0.8502519548943411,1.0,6/10,24.60%,KDELR1;INSIG1;HSPA5;PDIA2;GPAA1;OS9
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.6622082539097511,-1.185404138174433,0.20833333333333334,1.0,1.0,1/16,0.56%,MSL3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6926585388466364,-1.185318948596042,0.22666666666666666,1.0,1.0,3/14,12.14%,ELOVL2;ACSL1;ACSBG1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6583501099720621,-1.1853023106811613,0.2898550724637681,1.0,1.0,2/16,2.28%,ENPP2;ABHD12B
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.5061162639421216,-1.185191709791031,0.10752688172043011,1.0,1.0,48/221,18.98%,CD44;ENPP2;IL5;CARD14;EFNA1;CAMK1;SOX9;FGF1;SPDYA;PTPRC;FGF9;AGT;MTCP1;CEMIP;EFNA5;VEGFA;BRAT1;DOCK7;BMP8A;ATG14;DVL2;PDE8A;BCAR3;PFN2;RASGRP1;PAK1;MMD2;ARRB1;IL6R;PAK2;CSNK1D;NTRK3;BDNF;PTPRJ;AKT2;TOM1L1;TGFB1;HDAC6;RPTOR;RIPK1;DDRGK1;IL34;TERF2IP;TNIK;FAM20A;PRKD2;AKTIP;RB1CC1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.7121759825962698,-1.1848584190358875,0.25,1.0,1.0,3/10,18.91%,VEGFA;STAT3;RORB
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.7524124427128446,-1.1848325486117053,0.3064516129032258,1.0,1.0,3/6,6.39%,SEPTIN9;CEP135;HAP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6278343822000563,-1.1838449385153231,0.24,1.0,1.0,3/24,11.13%,ARIH2;SAE1;MICALL2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.41413775419972515,1.1836567705941272,0.16666666666666666,0.8546620143713952,1.0,41/154,20.83%,UTP11;NOL11;WDR18;SBDS;POP5;PIH1D1;MPHOSPH6;RPL8;RPS19;DDX54;RPL15;POP4;RPL29;RPS2;NHP2;EXOSC8;IMP3;WDR46;NAT10;RPL23A;EBNA1BP2;MTREX;WDR36;RPF1;WDR74;DDX49;RPL27;WDR43;HELQ;UTP14A;RPL18;C1D;MRTO4;RPL7A;WDR3;BOP1;RIOK2;THUMPD1;RPS7;TSR3;TFB1M
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.4300503713024031,1.1835503173740367,0.14285714285714285,0.8536876925774491,1.0,36/141,19.17%,UTP11;NOL11;WDR18;SBDS;TRIR;POP5;PIH1D1;MPHOSPH6;RPL8;RPS19;DDX54;RPL15;POP4;RPL29;RPS2;EXOSC8;IMP3;WDR46;NIFK;RPL23A;EBNA1BP2;MTREX;WDR36;RPF1;WDR74;DDX49;RPL27;WDR43;HELQ;UTP14A;RPL18;C1D;MRTO4;RPL7A;WDR3;BOP1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.5757612174533135,-1.1822387765031375,0.21518987341772153,1.0,1.0,8/25,15.77%,RAB3A;CAMK2B;APOE;SHISA6;CAMK2A;SHISA9;DLG4;NSMF
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.6280464757106222,1.182181880344139,0.23076923076923078,0.8570236933005669,1.0,2/12,8.34%,ESR1;RUVBL2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.5849764762282673,-1.1818852461346374,0.22077922077922077,1.0,1.0,6/25,17.21%,GLRA2;VEGFA;GLRA1;RPTOR;NSMF;CAPN2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.6011425902768505,1.1817734256615777,0.22580645161290322,0.8568034843500623,1.0,1/16,0.66%,BAD
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.48429462850529725,-1.181599335632747,0.08421052631578947,1.0,1.0,68/354,20.78%,NUAK1;CAMK1;STK17A;RPS6KB2;MAK;CDK7;TSSK3;DAPK1;LIMK1;EEF2K;RARA;NEK3;TLK1;CDK19;GRK4;MAP3K12;ALK;CAMK2B;NEK11;CDK4;FAM20C;TAF1;TRIB1;CDC7;CAMK2A;PAK1;VRK1;CIT;PDK1;COQ8B;TYRO3;PLK2;VRK2;PAK2;CAMK1D;CSNK1D;NEK6;AKT2;PDK2;MASTL;MKNK1;MAP2K1;JAK1;DAPK3;TGFB1;EPHA4;STRADB;PDGFRB;DCLK1;IGF1R;CTBP1;RIPK1;CDC42BPB;BCR;MAPK12;CAMK2D;ATM;TNIK;DAB2IP;PRKAR1B;FAM20A;PRKD2;CDKL1;TGFBR3;RELN;CSNK1G2;MERTK;DDR2
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.7907672801382853,-1.1815850682291282,0.26785714285714285,1.0,1.0,3/5,16.25%,CCDC39;DNAH11;CFAP43
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.7907672801382853,-1.1815850682291282,0.26785714285714285,1.0,1.0,3/5,16.25%,CCDC39;DNAH11;CFAP43
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.625518316563293,1.1815184915847787,0.2903225806451613,0.856172969791555,1.0,5/10,25.94%,ESR1;PSMC3;ATF7IP;HMGB1;TP53
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6465646108666555,1.1809925471504361,0.24324324324324326,0.8564336249341332,1.0,7/12,27.41%,TRIM28;PPHLN1;MORC2;ATF7IP;TET1;ZNF304;RESF1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6555697826288194,1.1806841643443096,0.30952380952380953,0.8557602592142549,1.0,1/6,3.14%,MSN
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.7386743632845486,1.1801014979578663,0.3235294117647059,0.8563843048557489,1.0,2/5,8.60%,LEPR;GREM1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.583603760283902,1.1798421671404713,0.2647058823529412,0.8561896210394412,1.0,3/16,3.60%,BAD;SOX11;PDE3A
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.8008396051170111,-1.1796339345085507,0.23076923076923078,1.0,1.0,4/6,19.27%,MX1;DNM1;DNM2;DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.8008396051170111,-1.1796339345085507,0.23076923076923078,1.0,1.0,4/6,19.27%,MX1;DNM1;DNM2;DNM1L
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5815213429040663,-1.1795885196348623,0.275,1.0,1.0,11/39,18.00%,RFC4;POLQ;RFC2;RFC1;RPA3;PNKP;WRN;PARG;LIG3;NTHL1;NEIL2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5236528985449074,-1.179227073330147,0.24691358024691357,1.0,1.0,12/77,16.04%,RFC4;BRCA1;DONSON;RFC2;RFC1;HELB;RPA3;CDC7;ORC2;ING5;PNKP;WRN
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.56475145100057,-1.1791831786042097,0.18181818181818182,1.0,1.0,11/42,22.80%,CD44;LMO2;BCL11A;STAT5A;VASP;WRN;MPP1;PIEZO1;IGBP1;FAM117A;ENG
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.765607932919197,-1.1790213911910938,0.2972972972972973,1.0,1.0,1/7,1.32%,SLC2A3
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7821688550851884,-1.1788195157510863,0.28125,1.0,1.0,2/5,4.70%,EMP2;RFTN1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5356649210011055,-1.1787470694516877,0.21951219512195122,1.0,1.0,12/42,19.27%,TMSB4X;LRRC19;PTP4A3;SPI1;CD27;TRIM44;NLRP12;C1QTNF4;PDCD4;IFI35;TERF2IP;HDAC7
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7141795837076715,-1.178607500373404,0.34285714285714286,1.0,1.0,6/11,19.04%,MX1;CRLF1;STAT3;JAK1;OAS1;STAT1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6547394623844209,-1.1784371590000497,0.30434782608695654,1.0,1.0,5/14,17.41%,EFNA1;P2RY12;CYP1B1;ITGB1BP1;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.6424168978344617,-1.178359700533718,0.29850746268656714,1.0,1.0,1/15,0.20%,CD44
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5453570635811134,-1.178287271162116,0.24096385542168675,1.0,1.0,12/63,9.20%,CD44;PROCR;PTPRC;MAFF;FPR3;SPI1;IL3RA;MGST1;TNS1;LMO2;BAALC;KITLG
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4878967671259972,1.1781743839358152,0.23076923076923078,0.859868547048529,1.0,9/28,15.97%,CRB2;TGFBR2;BAMBI;SMAD3;TGFBR1;GLIPR2;BMP2;EZH2;NOTCH1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7009772565907004,-1.1779881785944126,0.375,1.0,1.0,4/10,21.31%,CACNA1C;GJA1;RYR2;ATP1B1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.577020854405356,-1.1779549489691,0.20512820512820512,1.0,1.0,9/43,15.37%,SLC39A14;G6PC2;KCNJ11;BRAT1;GPI;GAPDHS;OAS1;GALM;ENO1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5855466661612474,1.177533239096637,0.2,0.860528092728026,1.0,8/11,27.51%,PPIF;ZFAND1;VCP;GSTO2;DDX3X;MAPK13;HSF1;MKNK2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5277435736446702,-1.1773318456066948,0.18666666666666668,1.0,1.0,14/55,18.03%,MAP3K19;DNAH7;ENKUR;CFAP221;EFHC1;CFAP77;NME9;CFAP70;CFAP52;DNAH9;CFAP43;VWA3B;GFAP;DNAH6
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5686921345819111,1.177230419068427,0.25925925925925924,0.8603276301188232,1.0,4/13,6.42%,STOX1;CCND1;RCC2;RAD51B
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5899260453217873,-1.177133254192978,0.2647058823529412,1.0,1.0,5/20,23.15%,SLC6A9;PDZK1;GLRX;ATP1B1;TCAF1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.7067764882779101,-1.177099268908293,0.23943661971830985,1.0,1.0,4/10,15.47%,DSC2;CACNA1C;CTNNA3;RYR2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.778926603040187,-1.17700156040965,0.3220338983050847,1.0,1.0,4/5,21.82%,PTPRC;HLA-F;ARRB2;CEACAM1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.5271740216995191,-1.1769491461156303,0.2413793103448276,1.0,1.0,11/88,11.62%,ABLIM1;HOOK1;SLC22A23;RAPGEF5;KIAA1671;MYRIP;CP;KCNQ1;CHDH;SPARCL1;SORBS1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.46813448216647224,1.1768129696813312,0.2608695652173913,0.8602855892983972,1.0,8/45,8.52%,BANF1;TRIM28;TRIM35;PML;LARP7;BTBD17;PPIA;ZC3HAV1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6785825053032035,1.1766423321708006,0.3,0.8594335986645264,1.0,2/7,13.85%,TXN2;ADO
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6237900674152377,-1.176607989186725,0.17567567567567569,1.0,1.0,4/20,7.41%,SCEL;MAFF;MLANA;ABCC3
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.5831774346180333,-1.1762149130211434,0.22077922077922077,1.0,1.0,9/37,15.26%,EFNA1;OVOL2;DSC2;TMC4;SLC44A3;KCNQ1;RAB3D;CHRM3;SLC5A9
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.7686768271099006,-1.175993446850292,0.23809523809523808,1.0,1.0,1/7,1.68%,SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5409102963362284,-1.1759818797529267,0.16216216216216217,1.0,1.0,12/49,18.12%,TMSB4X;NLRC5;CDKN2A;SPI1;NLRP12;ARRB1;CYP1B1;TRAF3;ARRB2;IRAK2;MAP2K5;DAB2IP
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.6212362880429456,-1.1758882515160352,0.23076923076923078,1.0,1.0,3/24,5.49%,SCEL;OVOL2;FLG
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6835428296738886,-1.1755081663872082,0.30158730158730157,1.0,1.0,2/13,11.34%,NR4A3;RTN2
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.746378950193085,-1.1748878326076175,0.34375,1.0,1.0,1/7,1.48%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.7490630225515451,-1.1744893817333657,0.3442622950819672,1.0,1.0,1/5,10.48%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.7490630225515451,-1.1744893817333657,0.3442622950819672,1.0,1.0,1/5,10.48%,XRCC3
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5232528121048702,1.1743680113759605,0.3142857142857143,0.8643581311583471,1.0,6/22,13.43%,AMOTL2;AMOT;YAP1;DCHS1;YWHAB;WWC1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.7162848737391283,-1.17405929288876,0.2857142857142857,1.0,1.0,1/8,10.57%,CDC7
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.5008161720919078,-1.1739472573937384,0.17204301075268819,1.0,1.0,24/118,17.92%,NEFM;STMN2;PCSK2;OLFM3;GRM1;GABRG2;KCNC1;CACNA1B;ACTL6B;SV2B;CELF4;SNAP25;SLC24A2;SYT4;ATP2B3;LRTM1;MMD2;NTRK3;HCN1;VWC2L;CELF3;RNF152;HSPA12A;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.6692136650948914,1.173926427647023,0.29411764705882354,0.8642649333593585,1.0,1/7,3.91%,ESR1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.7473533036099225,-1.1735714649011921,0.35,1.0,1.0,1/7,8.51%,APOE
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.6489603133566053,-1.1734031906516467,0.234375,1.0,1.0,2/16,6.58%,HAP1;BRAT1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.63666433298388,-1.1733632262019897,0.2727272727272727,1.0,1.0,2/12,13.15%,SOX9;MBOAT2
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.7779633937696013,-1.1732333054836375,0.2786885245901639,1.0,1.0,2/5,9.45%,DSC2;CTNNA3
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.7872321555579571,-1.1731623525594461,0.2692307692307692,1.0,1.0,1/5,8.05%,PARN
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.6066852916745934,-1.1729710750172135,0.25,1.0,1.0,2/26,1.40%,CD44;SOX9
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.5906751167934663,1.172442380523511,0.26666666666666666,0.867419119030678,1.0,3/10,9.95%,GPS1;COPS2;COPS7B
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.7068792850393444,1.1721064683338434,0.35,0.86687414619378,1.0,2/5,9.19%,EYS;GNA11
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5801580975200339,-1.1718157732347927,0.24050632911392406,1.0,1.0,4/36,10.84%,ENPP2;ADAMTS13;PDXDC1;CYP3A5
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.3684763870708245,1.1718033793508402,0.0,0.8664648535977575,1.0,42/244,13.63%,LSM4;POLR2J;U2AF1;POLR2L;RBM15B;NOVA1;SMU1;SF3B6;SF3B5;CPSF1;PCBP2;RBM22;RBM41;HNRNPA0;HNRNPC;PCBP1;LSM7;DCPS;SNRNP40;PUF60;GTF2F1;CD2BP2;UBL5;EIF4A3;RBM8A;MAGOH;CSTF2T;POLR2K;PPWD1;GEMIN8;CPSF4;SNRPB2;SRSF3;ZMAT2;SNIP1;MTREX;HSPA8;RAVER2;PHF5A;SNRPB;DNAJC8;HNRNPH1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7853073586417143,-1.1717079015319467,0.25757575757575757,1.0,1.0,1/5,6.98%,GLUL
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.5151399609520113,-1.171683529270658,0.19101123595505617,1.0,1.0,29/108,17.72%,CMTR1;NLRC5;GPR18;IRF1;MX1;PARP14;RNF213;PSMB8;STAT4;STAT2;APOL6;PLSCR1;IL7;B2M;PFKP;TAPBP;P2RY14;STAT3;IFIH1;IFIT1;HLA-DMA;HERC6;RIPK1;IFIT3;C1S;PSMA3;IFI35;CIITA;IRF2
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.7023170519164319,-1.1716243103758939,0.2898550724637681,1.0,1.0,1/8,0.95%,TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.5011341273253186,-1.1715986119029222,0.18604651162790697,1.0,1.0,17/117,11.73%,PON1;HEY2;EFNA1;SOX9;PROCR;OVOL2;SPI1;SRF;DOCK7;PTPRR;NR1D1;GJA1;PCTP;PFN2;NLRP12;LRPAP1;RAB11FIP5
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7185279317312897,1.1712376588960445,0.23684210526315788,0.8667477393370157,1.0,1/6,1.77%,PLIN2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.5231241659092402,-1.171232023986618,0.1511627906976744,1.0,1.0,16/82,15.80%,DEPP1;STMN2;ARX;FAM13C;PCSK2;AGT;RGS4;SST;ACTL6B;SNAP25;CAMK2N1;SYT4;KCNB2;PCDHB4;SMARCA1;CELF3
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.6951354758361212,1.171068362019821,0.23076923076923078,0.8662509572942534,1.0,4/6,24.92%,MARCHF7;SPSB4;BIRC2;DDX3X
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7379577613485241,1.1710633650010287,0.32142857142857145,0.8649560290817403,1.0,2/6,10.67%,MT3;ATF4
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.5601855559831701,1.1707698727932,0.18518518518518517,0.8643527923404366,1.0,3/17,4.53%,EIF4H;EIF3D;EIF5
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.7323441038146721,1.1704977988809513,0.375,0.8639507733380977,1.0,4/5,23.35%,NLGN2;NLGN1;LRRC4;NRXN1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.5324913601391558,-1.17033737697021,0.2987012987012987,1.0,1.0,6/49,9.07%,HEY2;SOX9;CDKN2A;SRF;RUNX2;CDK4
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.779960304411711,-1.170083895709338,0.2153846153846154,1.0,1.0,1/5,2.05%,CCDC39
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5393361378428071,1.1700818010869036,0.25,0.8640364275749332,1.0,4/17,25.22%,PML;SUN2;SUPT7L;ARL2BP
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.5389748362747366,-1.1699359406353957,0.2159090909090909,1.0,1.0,17/66,18.50%,RASGRF1;ARHGAP24;RAP1GAP2;USP6;DOCK7;TBC1D4;RASGRP1;TBC1D10B;TIAM1;NTRK3;TBC1D2B;TSC1;TBC1D8;TBC1D13;BCR;SIPA1L3;NGEF
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.6504412668832057,1.1697370343791738,0.2631578947368421,0.8637024082947625,1.0,4/10,13.87%,SLC30A10;GSTP1;ABCD2;ASXL3
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.5939912918423442,1.1697082402746752,0.25,0.8623777023357067,1.0,3/10,11.23%,CHAMP1;RCC2;SPDL1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.5084031499994653,1.1687595551367804,0.20833333333333334,0.8646878344030543,1.0,5/20,9.10%,RAN;TRIM28;RBM22;BAG3;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.7456030150439816,-1.1685797110938305,0.27419354838709675,1.0,1.0,1/8,1.37%,PIP4K2C
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5403861349827734,1.1685318397023654,0.3125,0.8638271093937304,1.0,4/13,14.99%,CLIP3;BAG3;CAMSAP3;CDC42
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.7424473866191579,-1.1684949264976052,0.27419354838709675,1.0,1.0,1/8,0.95%,TMSB4X
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.729241127185118,-1.1683445135727215,0.2549019607843137,1.0,1.0,3/6,13.90%,AGBL4;AGBL3;AGBL5
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.4069146172534699,1.168048240048449,0.07692307692307693,0.8639780866825467,1.0,17/116,9.91%,SOX4;PLD1;PIWIL2;OPN3;NR1H2;NPM1;EIF3D;MID1IP1;LDLR;EEF2;SCARB1;SP1;FXR2;SMAD3;POLDIP3;EIF4A3;CHP1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.7286080685559349,1.1679748360842033,0.3,0.8628364908620272,1.0,3/5,21.04%,SF3A2;SF1;SLU7
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.681537975083547,1.1675624624510104,0.3142857142857143,0.8627042991274249,1.0,1/9,0.64%,RFWD3
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5473593810587576,1.1671557359017979,0.2608695652173913,0.8625070288390914,1.0,5/19,22.70%,SMAD3;KHSRP;AKT1;NOS1AP;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6102941632572915,-1.1667359547698162,0.2777777777777778,1.0,1.0,3/15,11.33%,TESPA1;PTPRC;CARD11
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5699524477372917,1.1665958099266063,0.25925925925925924,0.8629642863917214,1.0,4/31,2.94%,GPC4;HSPG2;RBP1;GPC1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3606178809424271,1.1663863906280543,0.0,0.8620925776953897,1.0,37/270,11.22%,COPZ1;SYNDIG1;ARL4A;UNC119B;EVI5L;ATP6V0A4;TVP23B;PPT1;RAB26;TMED2;NPM1;PREB;VPS26B;GOLGA7;SCAMP4;SCAMP3;MCOLN1;ARFIP1;CALCRL;RAB5B;STX6;TBC1D25;ATP6V0E1;TMED5;CHMP2A;ATP6V1G1;RAB1B;ARF5;SNX17;CANX;CTSA;ATP6V1B2;RAB6A;RABL3;ARL6IP5;ATP6V0D1;TMED3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.6453119477750695,-1.1661096641829152,0.2916666666666667,1.0,1.0,7/17,26.62%,TRIB1;TPM1;PDCD4;OGN;MEF2C;TGFB3;NDRG4
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.7043642681757865,-1.1659094298768622,0.2835820895522388,1.0,1.0,2/12,7.52%,NAAA;DEGS2
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.749731761641139,-1.1653304987870368,0.2459016393442623,1.0,1.0,1/7,0.95%,TMSB4X
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4866232873791688,1.1651674942365193,0.2608695652173913,0.8645481095449618,1.0,8/46,9.98%,LSM4;LSM1;LSM7;DCPS;CNOT9;EXOSC8;EDC3;RC3H1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.763176443254903,-1.1651360955238474,0.30158730158730157,1.0,1.0,1/5,6.76%,RAB3A
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.691149302432891,-1.165095829578254,0.2727272727272727,1.0,1.0,1/8,1.40%,CAMK1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.7287251176694163,-1.164914245830438,0.3283582089552239,1.0,1.0,2/8,22.98%,ST3GAL1;ST6GAL1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.5683804756307433,-1.1648086024368036,0.25609756097560976,1.0,1.0,11/39,16.52%,CDH7;CDH12;CDH9;VCL;CDH19;PAK2;PVR;TBCD;CDHR3;CDH8;CTNNA1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.7054527755794502,-1.1648062643042125,0.3333333333333333,1.0,1.0,3/13,8.51%,RASGRF1;CALB1;APOE
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6134468927432712,-1.1646828555358717,0.30434782608695654,1.0,1.0,7/16,30.75%,CIITA;HS3ST5;TRIM25;TRIM5;MID2;GSN;NECTIN2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.6534426641653055,1.1646599643964506,0.2727272727272727,0.8649132629640117,1.0,3/9,16.06%,PHB2;DNAJC19;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7481768067089853,-1.1643635040921507,0.2857142857142857,1.0,1.0,2/6,9.16%,CAV3;MLIP
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.59712419320152,1.1641790460713113,0.28,0.8649740223896787,1.0,4/14,14.31%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.6496787093050018,-1.1635879842435972,0.27710843373493976,1.0,1.0,1/20,0.58%,STMN2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.6146529780138235,-1.1635350951160632,0.2692307692307692,1.0,1.0,5/18,17.40%,SLC9B1;SLC4A4;CA2;SLC4A8;SLC4A3
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.7087299800407006,-1.1632867923755652,0.35384615384615387,1.0,1.0,4/9,19.40%,PARP9;NUDT12;NAXE;NNMT
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.6272414694153553,-1.1627982650474276,0.25757575757575757,1.0,1.0,4/19,7.19%,SYNJ2;SYT1;SNCB;SYT2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.7263436251677825,-1.1623182454685304,0.3728813559322034,1.0,1.0,1/8,3.26%,CDK7
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.7599683090056876,-1.162151520573688,0.2571428571428571,1.0,1.0,2/6,18.11%,GPAM;TAMM41
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.49303273628565025,-1.1618425058224353,0.13636363636363635,1.0,1.0,47/149,23.13%,SLC6A6;SLC39A14;TRPC5;SLC6A15;RHCE;KCNH7;RYR3;KCNC1;KCNJ11;KCNN3;HCN3;SLC6A11;SLC6A9;SLC6A17;CACNA1C;KCNH1;HVCN1;KCNQ1;SCN8A;SCN9A;SLC24A2;KCNC4;SLC4A4;SLC39A11;KCNB2;HCN1;RHCG;KCNG4;ASIC4;SLC41A1;KCNK10;KCNQ5;SLC4A8;ANO6;HCN2;SLC6A7;DMAC2L;SLC6A8;SLC24A5;TRPM3;KCNC2;ATP1B1;KCNK12;KCNA5;NALCN;SLC24A4;TRPC4AP
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.7215553630356261,-1.1617936471647294,0.26666666666666666,1.0,1.0,1/7,1.05%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5778710126102808,1.161478911986947,0.23529411764705882,0.8720202710909746,1.0,4/15,7.72%,BAD;MFF;PPIF;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.7305716184366038,-1.1614233956257929,0.2857142857142857,1.0,1.0,3/7,17.01%,ENPP4;USF1;ANO6
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.7087554025707746,1.161026117967543,0.3142857142857143,0.8719834304805555,1.0,3/5,26.93%,LAPTM4B;FURIN;CDH3
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.7343330700593167,-1.16099220049248,0.31746031746031744,1.0,1.0,1/7,5.13%,VEGFA
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.7513288770069358,-1.1607311310009798,0.23809523809523808,1.0,1.0,1/6,2.66%,GUK1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5738219725728935,1.160511530835925,0.37037037037037035,0.8707261037025551,1.0,8/20,8.01%,ZDHHC1;GOLGA7;ZDHHC3;ZDHHC6;CLIP3;ZDHHC11B;ZDHHC4;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5738219725728935,1.160511530835925,0.37037037037037035,0.8707261037025551,1.0,8/20,8.01%,ZDHHC1;GOLGA7;ZDHHC3;ZDHHC6;CLIP3;ZDHHC11B;ZDHHC4;ZDHHC21
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.38255220215788666,1.1604164136839723,0.0,0.8697027204062282,1.0,48/303,12.36%,NOX4;NUP42;POLR2J;U2AF1;POLR2L;RBM15B;MRPL11;NOVA1;MRPL10;MRPS33;MRPL28;CPSF1;MRPL44;MRPL36;TSPAN14;RPL8;RPS19;DDX54;TSPAN17;RPL15;EEF1A1;PTMA;MRPS16;RPL29;RPS2;SNRNP40;RPS15A;MRPS12;NUFIP1;MRPS18A;RPSA;POLDIP3;EIF4A3;RBM8A;MAGOH;AGFG1;NXF1;POLR2K;CPSF4;MRPL18;MRPL52;RPL23A;SRSF3;EIF4EBP2;MRPL27;TSPAN33;MRPL13;EIF4E
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5439055299512443,-1.1601075896317112,0.25925925925925924,1.0,1.0,6/54,10.21%,RFC4;IHO1;DDB2;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.48252276289813795,1.1597887972747163,0.2,0.8703778837422291,1.0,13/37,13.60%,OPN3;COPS9;NPM1;SMPD1;NOC2L;PARP1;SDE2;TMEM161A;RUVBL2;ZBTB1;ATF4;N4BP1;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.6351957715762061,-1.159394505209747,0.32051282051282054,1.0,1.0,4/19,11.65%,RASGRF1;RASGRP1;MMD2;RASGEF1A
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.7792534589249697,-1.15935826212737,0.3508771929824561,1.0,1.0,4/5,20.78%,ITGA2;UBASH3B;COL4A2;DDR2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.666564434709807,1.1590047243655501,0.25806451612903225,0.8715223723521344,1.0,4/9,14.44%,ENPP3;RPS19;RC3H1;HAVCR2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.6545428600541768,1.15877932943655,0.2777777777777778,0.8707378276649725,1.0,1/7,1.82%,NCSTN
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.690818964711027,-1.1584871548761488,0.29310344827586204,1.0,1.0,3/8,26.98%,ETV4;MED1;PRKCH
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5873456658514351,-1.1583367381561225,0.3088235294117647,1.0,1.0,10/25,15.43%,DNAH7;CCDC39;DNAH11;DNHD1;CFAP70;DNAH5;DNAH17;CFAP251;CABYR;DNAH9
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6975002390650608,-1.157612152063442,0.32,1.0,1.0,3/10,19.04%,IRF1;OAS1;STAT1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.7660835092658813,-1.157004370587223,0.2835820895522388,1.0,1.0,1/6,2.86%,LFNG
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.6243206486924164,-1.1568351578774885,0.2702702702702703,1.0,1.0,5/18,9.31%,FGF1;CCDC39;FGF9;VEGFA;LOXL3
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.7376040100503247,-1.15680493891065,0.25862068965517243,1.0,1.0,1/6,1.00%,HES1
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.746441786597875,-1.1567921563755956,0.2830188679245283,1.0,1.0,3/8,5.13%,SOX9;AGT;VEGFA
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.746441786597875,-1.1567921563755956,0.2830188679245283,1.0,1.0,3/8,5.13%,SOX9;AGT;VEGFA
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6751262455465745,1.1567491049317977,0.4,0.8758088021533207,1.0,1/7,0.66%,BAD
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.7402033849379167,-1.156651640316753,0.2153846153846154,1.0,1.0,1/7,7.20%,AHCYL1
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.6853971940466022,-1.156567417260912,0.2857142857142857,1.0,1.0,1/13,1.09%,DCAKD
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.790960342382523,-1.156429019224082,0.31746031746031744,1.0,1.0,2/5,9.14%,GJA1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.7457784540092405,-1.1563461855065529,0.3114754098360656,1.0,1.0,1/6,10.57%,CDC7
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.616955223470579,-1.156164703305583,0.3508771929824561,1.0,1.0,6/15,24.53%,PPFIA1;TGFB1;MRAP;AP2M1;CLTC;LZTFL1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.4268720851446559,1.1559465797519344,0.21052631578947367,0.8768543792900637,1.0,8/57,10.49%,IPO13;PHB2;NUTF2;RAN;PRICKLE1;PPP1R10;PTTG1IP;GEMIN8
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5361899878890248,-1.1558967741944963,0.2413793103448276,1.0,1.0,13/69,15.38%,CD44;CAMK1;MTCP1;VEGFA;DOCK7;BCAR3;PFN2;PAK1;NTRK3;BDNF;TGFB1;HDAC6;RPTOR
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.7065086836741813,1.1558029052197478,0.2978723404255319,0.8718680874332789,1.0,1/5,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.7065086836741813,1.1558029052197478,0.2978723404255319,0.8718680874332789,1.0,1/5,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.7065086836741813,1.1558029052197478,0.2978723404255319,0.8718680874332789,1.0,1/5,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.7065086836741813,1.1558029052197478,0.2978723404255319,0.8718680874332789,1.0,1/5,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6222369487099235,-1.1557909123035746,0.24675324675324675,1.0,1.0,2/21,1.56%,MYLK;DUOX1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.8327874519990506,-1.1555422253466754,0.2982456140350877,1.0,1.0,1/5,1.06%,LETM2
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.72678698149894,-1.1554929932572493,0.28,1.0,1.0,1/7,3.86%,VAMP1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5519498430671244,-1.1551019761310664,0.2839506172839506,1.0,1.0,9/42,11.12%,SYT1;KCNMB4;HAP1;RAB3A;CPLX1;RIMS1;RAB3D;RAB15;CAMK2A
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.7431801426266444,-1.1548299195038858,0.3076923076923077,1.0,1.0,3/6,19.50%,TMOD3;PGM5;LMOD1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7295351253103084,-1.1546347384199223,0.27586206896551724,1.0,1.0,1/7,10.57%,CDC7
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6072459268152794,-1.1545738227724895,0.2972972972972973,1.0,1.0,6/20,17.64%,DSC2;CAV3;CACNA1C;CTNNA3;RYR2;CAMK2D
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7217124394761483,-1.154347373546715,0.34375,1.0,1.0,3/6,19.27%,ITPK1;RIPK1;DNM1L
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.7502262524863224,-1.1542445477560817,0.28169014084507044,1.0,1.0,1/8,5.83%,ACSS3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7170663237285547,-1.154197128280806,0.2727272727272727,1.0,1.0,1/11,0.20%,CD44
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5657745254606852,1.1541352663181716,0.25,0.876065532857329,1.0,7/22,18.36%,UBB;RNF139;UBC;MAN1A2;UGGT1;EDEM1;DERL2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.5925965138959252,1.153964157843047,0.3333333333333333,0.875114546535623,1.0,6/19,22.24%,HSD17B10;ACOT8;OSBPL7;OSBP;CYP7B1;OSBPL2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.404496531171603,1.1536762051109617,0.2727272727272727,0.8744618798035334,1.0,40/175,19.17%,UTP11;NOL11;WDR18;SBDS;POP5;MRPL44;PIH1D1;MPHOSPH6;RPL8;RPS19;DDX54;RPL15;POP4;AARS1;RPL29;RPS2;EXOSC8;SMAD3;IMP3;WDR46;RPL23A;EBNA1BP2;INTS9;MTREX;INTS7;WDR36;RPF1;DGCR8;WDR74;DDX49;RPL27;WDR43;HELQ;UTP14A;RPL18;C1D;MRTO4;RPL7A;WDR3;BOP1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.6546404310336178,-1.1533999677091604,0.2222222222222222,1.0,1.0,1/20,0.58%,STMN2
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.6826762551868006,1.153371710304443,0.3181818181818182,0.8740640358324244,1.0,1/5,7.69%,SPRY1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.42615759072706566,1.1533418218619167,0.1,0.8728258540781562,1.0,17/69,14.67%,VPS37B;YIF1B;ZDHHC1;GOLGA7;ZDHHC3;ZDHHC6;MICALL1;ZDHHC11B;ZDHHC4;ZDHHC21;SRP14;ABCD2;SSR2;SSR1;ZDHHC2;PEX13;FIS1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.606696822542177,-1.1531434233297528,0.3013698630136986,1.0,1.0,3/24,1.40%,HTR2C;AHR;SOX9
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.708108372696056,-1.1528686121711484,0.30303030303030304,1.0,1.0,4/6,24.47%,ATP10A;DNM2;PLEKHM2;ASAP1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5286588335937754,-1.1528296578504442,0.2413793103448276,1.0,1.0,16/62,20.60%,TMSB4X;IRF1;LRRC19;P2RY12;NMT1;GRK4;PDE6B;TRAF3;BCL6;BRD4;CD55;USP14;TIRAP;FOXP1;SEMA7A;TRIM5
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5622343173269416,1.1524761958287326,0.3,0.8739861835126322,1.0,5/20,3.83%,SOX4;SOX11;SOX8;GPC1;SOX10
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.731024458232966,-1.1521784737396472,0.3384615384615385,1.0,1.0,1/6,3.82%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.731024458232966,-1.1521784737396472,0.3384615384615385,1.0,1.0,1/6,3.82%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.731024458232966,-1.1521784737396472,0.3384615384615385,1.0,1.0,1/6,3.82%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.731024458232966,-1.1521784737396472,0.3384615384615385,1.0,1.0,1/6,3.82%,ELOVL2
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5491680101659799,-1.1519388758593008,0.23863636363636365,1.0,1.0,6/47,7.08%,SCEL;MYLK;SRPX2;TMEM14A;ITGA2;SLC16A3
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.6109605360855568,1.1518996311327452,0.19444444444444445,0.874555710635349,1.0,5/9,20.51%,MICALL1;TOLLIP;WASHC2A;NRP1;VPS35
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.42361776498919734,1.151668558987456,0.1875,0.8740135176079085,1.0,7/64,6.23%,STOX1;MSN;PRMT6;PREB;MFF;SURF4;TBC1D25
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.48546305478354024,1.1512375256926084,0.25925925925925924,0.8741839629327596,1.0,9/28,8.01%,ZDHHC1;PORCN;GOLGA7;ZDHHC3;ZDHHC6;CLIP3;ZDHHC11B;ZDHHC4;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6355687565492569,1.1509094751406654,0.3684210526315789,0.8741450904928924,1.0,2/9,9.06%,RNF139;GAS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.7289687652150585,1.150879648218892,0.37142857142857144,0.8730638702893315,1.0,2/6,15.03%,METTL4;MTG2
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.39161307976468224,1.1505754851495937,0.14285714285714285,0.8726937018202412,1.0,23/110,9.34%,SYNDIG1;EXTL1;BCHE;CD82;OLIG1;TNS2;SLC22A17;CNP;TCEAL6;SOX10;BCAS1;GPR37L1;TMEM178A;CMTM5;CLIP3;THY1;S100B;TCEAL7;RBFOX1;BAG3;RGS11;MT3;SEMA3B
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.6707243911002053,1.1504588658607122,0.4,0.8716386704106193,1.0,3/6,30.58%,ATP2C1;PKDCC;CSK
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.6027306786935746,1.150271799563686,0.2608695652173913,0.8710226629087434,1.0,4/18,9.47%,MSN;RAB1B;RAP2C;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.6360010927753206,-1.1501847835017045,0.25,1.0,1.0,2/18,8.51%,PON1;APOE
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.7215748496088734,-1.1500167279261073,0.23809523809523808,1.0,1.0,2/7,22.63%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.6957102731924257,1.1498330518867335,0.36,0.8712789414362934,1.0,4/6,17.19%,SLC16A9;ABCG2;PRPS1;PNP
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.6984029623734479,-1.149647366281829,0.27941176470588236,1.0,1.0,3/12,6.10%,RAB17;MREG;RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.6984029623734479,-1.149647366281829,0.27941176470588236,1.0,1.0,3/12,6.10%,RAB17;MREG;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6858792250726149,-1.1495125289378252,0.32,1.0,1.0,2/9,8.51%,ALOX12;APOE
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.7204440997004871,-1.1494288486071664,0.3230769230769231,1.0,1.0,2/6,17.01%,PDZK1;ANO6
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.5779888223928022,1.149374131270788,0.3103448275862069,0.8714930689144602,1.0,2/15,7.04%,RBM22;DCPS
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.6829768402886343,-1.1489953945476596,0.3235294117647059,1.0,1.0,1/6,8.51%,APOE
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5317868936450689,1.1489383151269708,0.26666666666666666,0.8713552821072393,1.0,4/19,10.83%,UBB;PARP1;GTF2H2;UBC
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.6155588652355191,-1.148842895673227,0.3333333333333333,1.0,1.0,5/15,23.36%,PPFIA1;TGFB1;MRAP;AP2M1;CLTC
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.5591391285155605,-1.1487987724742703,0.3493975903614458,1.0,1.0,7/39,15.92%,MX1;GRK4;DNM1;ARFGEF2;DNM2;TGFB1;ARRB2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.6878308528865706,-1.148767683889126,0.22727272727272727,1.0,1.0,2/12,5.13%,TTN;VEGFA
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6874920909326718,-1.1486674007443984,0.3492063492063492,1.0,1.0,4/8,10.83%,DOCK8;LMBR1L;BTN3A1;RASGRP1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.4029555738953643,1.1484035981544822,0.36363636363636365,0.8716924574322377,1.0,19/85,19.16%,RFWD3;TSR1;EIF3D;TBRG4;CEP85;RCC2;NEU3;GANAB;SSRP1;STIP1;NAT10;LSG1;UGGT1;DDX21;RUVBL1;ZDHHC5;DHX15;SF3B3;POLG
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.509760491342461,1.14827840721598,0.2692307692307692,0.8709779223454157,1.0,5/19,9.10%,RAN;TRIM28;RBM22;BAG3;SMAD3
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.665907780994045,1.1480557336386585,0.2894736842105263,0.870388931510909,1.0,1/6,3.70%,KDELR1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.7191049516932412,-1.1478892633094098,0.3064516129032258,1.0,1.0,2/9,14.87%,GABRG2;GABRA2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6251143887879786,-1.1477691409213016,0.2345679012345679,1.0,1.0,4/17,13.59%,TMSB4X;PFN2;TMSB15B;VIL1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.5611061661092045,1.1477087361807428,0.23076923076923078,0.8700481765264059,1.0,7/24,16.11%,BAD;MFF;BOK;THEM4;FIS1;AIFM2;TIMM50
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4944410659102885,-1.1475571312168444,0.23595505617977527,1.0,1.0,23/123,13.16%,ABLIM1;CD44;HES1;RAB17;FOS;TPD52L1;OVOL2;ELOVL2;ITPK1;MREG;RARA;FKBP5;PDZK1;GJA1;SEC14L2;SLC1A4;RASGRP1;AKAP1;SH3BP5;THSD4;TIAM1;OLFM1;ADCY1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.5999913056334355,-1.1472661550835888,0.3125,1.0,1.0,4/20,9.42%,PTPRR;APOE;ADAMTS9;PFN2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.39198875545767703,1.1469069131084106,0.26666666666666666,0.8715954408987955,1.0,9/61,9.47%,RND2;RHOBTB1;PDGFRA;TWF1;RHOC;EPHA5;MLST8;GPM6B;RAPGEF3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.7038208638208201,-1.1466630727018416,0.29577464788732394,1.0,1.0,4/9,21.35%,TK2;TYMP;UCK1;PUDP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.7038208638208201,-1.1466630727018416,0.29577464788732394,1.0,1.0,4/9,21.35%,TK2;TYMP;UCK1;PUDP
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.6155674615685222,-1.1461139425523648,0.3698630136986301,1.0,1.0,4/16,12.21%,GRIN2A;GRIN2D;SLC24A2;PLK2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.6860072770062027,-1.1457305833554288,0.3125,1.0,1.0,2/12,3.80%,SOX9;BRCA1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6558712343147117,1.1457098162722004,0.36585365853658536,0.8740802653275289,1.0,2/8,8.77%,RAB1B;RAP2C
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.4401044004544465,1.1451446674846288,0.10526315789473684,0.8745127117336389,1.0,5/41,10.83%,UBB;MCM4;PARP1;GTF2H2;UBC
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.46907171054935415,1.1450121526283035,0.2,0.8736369654334505,1.0,5/39,6.64%,SOX4;BAD;ACHE;NLGN2;PPIA
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5653748431433695,-1.1449973285323765,0.2857142857142857,1.0,1.0,8/33,19.27%,TMSB4X;SRPX2;VEGFA;RHOJ;STAT5A;TGFB1;PRKD2;HDAC7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6966200719364493,-1.1449337075879598,0.3188405797101449,1.0,1.0,2/10,5.13%,TMSB4X;VEGFA
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6873949829415555,-1.1446953101503459,0.3333333333333333,1.0,1.0,3/9,20.78%,PDPN;TGFB1;DDR2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.43634574007075105,1.1446144347651106,0.07142857142857142,0.8732123832418195,1.0,13/62,15.47%,UBB;PSMD8;PSMB6;PSMB4;UBE2D1;PSME3;PSMD10;UBC;CDC26;PSMD12;PSMB2;PSMD4;ANAPC11
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.45102685836303896,1.1445029679888532,0.16129032258064516,0.8721985791124003,1.0,6/46,11.26%,GPX1;HSPA1A;GSTP1;PSME3;TGFBR1;PEA15
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.47901154160754916,-1.144360416220509,0.20430107526881722,1.0,1.0,21/210,11.58%,ABLIM1;FHDC1;FAM161A;MYLK;RAB17;EMP2;MAK;VCL;INTU;P2RY12;CFAP221;RPGR;SHTN1;RAB11A;INPP5E;AHI1;CCDC57;CFAP70;DNAH5;B9D1;AVIL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.5246655315582708,1.1436106876810734,0.30434782608695654,0.8738104515366039,1.0,3/18,3.74%,AFAP1L2;HSPA1A;TLR1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.7392117521169248,-1.1434215819589104,0.29411764705882354,1.0,1.0,3/5,19.67%,YME1L1;BNIP3L;AFG1L
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5867890825010841,1.1433856843881525,0.3055555555555556,0.8733265712986604,1.0,5/9,20.33%,UBE2J1;INSIG1;YOD1;DERL2;UBAC2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.4187039948968915,1.1433777560555867,0.17391304347826086,0.8720737723231016,1.0,4/53,4.14%,UBB;PHB2;DYNLL2;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6842019464252386,-1.143256089117688,0.36,1.0,1.0,3/10,18.62%,VEGFA;CTBP1;PRKD2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.6380556095248481,-1.1432126546959271,0.3380281690140845,1.0,1.0,4/14,10.00%,F8;A2M;APOE;CPB2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4503109583853115,1.1428839373863435,0.125,0.8722010982884293,1.0,10/71,10.69%,GPC4;FREM1;LRRN1;LGR5;AMOT;TOX3;FRZB;BMI1;HID1;EPHB3
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6059533859358393,-1.1428595435996722,0.3,1.0,1.0,6/20,18.62%,CD160;TESPA1;CARD11;PTPRJ;DGKZ;PRKD2
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.4775657514587379,1.142474138277562,0.16666666666666666,0.8720248606448769,1.0,6/42,7.83%,ODC1;PSMD8;PSMB6;PSMB4;PSME3;PSMD10
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.5745351202670674,-1.1424687521923071,0.2564102564102564,1.0,1.0,3/26,4.25%,CAMK1;BRCA1;SPI1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.5743836133732728,-1.1424549357224396,0.24691358024691357,1.0,1.0,10/34,18.12%,RAB17;RTN4IP1;KIAA0319;ALK;BCL11A;CAMK1D;NSMF;NEDD4L;TNIK;DAB2IP
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.7426550062600127,-1.1424103833430108,0.29850746268656714,1.0,1.0,3/5,21.82%,PTPRR;TENM3;CEACAM1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4627616294714733,1.1419999908558436,0.2857142857142857,0.8724748249916151,1.0,7/68,5.07%,PANX1;CHRNA4;TSPO;KCNN2;CHRNA7;SLC15A2;MCOLN1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.5916005238417301,-1.1419740184705163,0.2571428571428571,1.0,1.0,2/20,3.49%,EMP2;VCL
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.6126750801958076,-1.1418290672558427,0.25675675675675674,1.0,1.0,2/17,8.45%,MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.6872968611127468,-1.14158185106897,0.3181818181818182,1.0,1.0,4/9,25.68%,VRK1;NEK6;DCTN1;PRKCA
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.6934855524157462,-1.1412582472729291,0.34375,1.0,1.0,2/8,3.96%,PARP9;PARP14
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.7169788711159097,1.1412327914286897,0.2894736842105263,0.8732661083679418,1.0,3/5,21.78%,GLTP;TTPA;CERT1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.7140117155259882,1.1407416279913214,0.45098039215686275,0.8733708466140636,1.0,1/5,0.57%,PLD1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.601305044173979,-1.140699462944043,0.3150684931506849,1.0,1.0,7/24,11.06%,SYT1;RAB3A;SYT2;RIMS1;RAB3D;SYT4;RAB15
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7081875147074872,-1.1403549732302762,0.3880597014925373,1.0,1.0,3/8,18.12%,EFNA1;EPHA4;DAB2IP
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6514929000629675,-1.14022870654217,0.2835820895522388,1.0,1.0,4/18,16.14%,HTR2C;BEGAIN;NPTX1;TYMP
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.7667595414627713,-1.1399878642791423,0.2857142857142857,1.0,1.0,2/5,12.54%,HSD11B1;EPHX2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.7653494028178609,-1.1398914168630492,0.27419354838709675,1.0,1.0,1/5,8.71%,USP50
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6100728706301163,-1.1396784492857892,0.33766233766233766,1.0,1.0,7/19,19.04%,STAT6;STAT4;STAT2;STAT5A;STAT3;STAT5B;STAT1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.5963384647502922,-1.1392103498620516,0.24358974358974358,1.0,1.0,4/22,13.98%,NR4A3;CLTCL1;SORBS1;AKT2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6883431439185339,-1.138916924199394,0.35384615384615387,1.0,1.0,2/9,16.04%,XRCC3;WRN
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6883431439185339,-1.138916924199394,0.35384615384615387,1.0,1.0,2/9,16.04%,XRCC3;WRN
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6883431439185339,-1.138916924199394,0.35384615384615387,1.0,1.0,2/9,16.04%,XRCC3;WRN
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.405539974748294,1.1388222521380804,0.0,0.8776351667315981,1.0,18/156,11.93%,AURKAIP1;LSM4;PIWIL2;U2AF1;NOVA1;SMU1;LSM1;MRPL44;HNRNPA0;HNRNPC;DDX54;SNRNP40;NUFIP1;RBM8A;MAGOH;PPP2R1A;TSEN34;KHSRP
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5983160670376584,1.138554360330868,0.25,0.8771714204053052,1.0,1/12,0.55%,UBB
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6480682782611759,-1.1382934966694618,0.26153846153846155,1.0,1.0,7/16,11.19%,AHR;PTPRC;IGSF6;SPI1;HLA-F;AOAH;MYO1F
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.7774015466722797,-1.138151785195138,0.3103448275862069,1.0,1.0,1/5,5.13%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6150484896101575,1.1380324866956923,0.2727272727272727,0.877169887906323,1.0,3/10,16.11%,SLC30A10;ZKSCAN3;SIRT1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.6699632227929097,-1.1379380684960956,0.3333333333333333,1.0,1.0,2/10,3.80%,CAMK1;BRCA1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7068156407780879,-1.137555785654745,0.32075471698113206,1.0,1.0,4/6,24.16%,ZFPM1;CDKN2B;UBA5;MED1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6039371718517003,-1.13727499543225,0.3188405797101449,1.0,1.0,4/14,14.69%,BRCA1;CYP1B1;SULF1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7562994997556997,-1.1372422863498028,0.2698412698412698,1.0,1.0,5/6,23.88%,HLA-F;ARRB2;HLA-B;CEACAM1;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.6982950673520413,-1.1372389546665287,0.3283582089552239,1.0,1.0,3/7,24.33%,TGFB1;DDR2;DMTN
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5510481329264284,1.1371928317785354,0.37037037037037035,0.8782688721535101,1.0,5/16,22.13%,HSPA1A;TGFBR1;PINK1;DCUN1D1;DCUN1D5
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.48836384516542075,1.1371479601955319,0.25,0.8771468555533712,1.0,5/34,4.76%,SYNDIG1;SOX11;SLITRK2;CLSTN2;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6647718453114401,-1.1370959441368154,0.3333333333333333,1.0,1.0,2/8,17.64%,NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.673962112053729,-1.1369967229328615,0.27692307692307694,1.0,1.0,2/7,9.31%,EMP2;LOXL3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.502463202176265,1.136984514675387,0.3,0.8763672408073353,1.0,2/23,1.77%,CCND1;PHB2
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.6655931417639741,1.1361443888157605,0.3611111111111111,0.8780005810632896,1.0,1/6,0.30%,FERMT1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.6549548006229807,-1.1360436253429806,0.38095238095238093,1.0,1.0,6/11,10.72%,CLDN18;ABCC3;SLC44A3;PTGR1;LIPH;ATP8B1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.4765151988237953,1.1359885319461425,0.14285714285714285,0.8771423963712182,1.0,6/45,7.83%,ODC1;PSMD8;PSMB6;PSMB4;PSME3;PSMD10
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.7499991365219312,-1.1359318698567415,0.29411764705882354,1.0,1.0,1/6,5.18%,MTHFD1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.5072221729536772,1.1358594360976708,0.25,0.8763462628099753,1.0,5/37,5.82%,UBB;HSPG2;NCSTN;SNCAIP;TSPAN14
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5655617782783438,1.1357629776415055,0.32,0.8754135343110225,1.0,5/16,18.78%,SMYD2;CSKMT;SETMAR;KMT2D;SETD3
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.6413160000432322,1.1356384216212574,0.2702702702702703,0.874562702326684,1.0,6/11,27.41%,TRIM28;PPHLN1;MORC2;ATF7IP;ZNF304;RESF1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7681793689050771,-1.135612412830606,0.39285714285714285,1.0,1.0,1/5,6.12%,SREBF1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.7178493530006986,-1.1356023997761597,0.3380281690140845,1.0,1.0,1/7,2.86%,LFNG
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5861864551233182,-1.1355366480677496,0.3076923076923077,1.0,1.0,7/25,18.71%,HOOK1;TPCN2;CLVS1;MBTPS1;HOOK2;HOOK3;AKTIP
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6394482747748518,1.1353720755894152,0.3939393939393939,0.8729473038241532,1.0,2/8,7.20%,SIRT2;PDE4B
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6394482747748518,1.1353720755894152,0.3939393939393939,0.8729473038241532,1.0,2/8,7.20%,SIRT2;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5242628518495817,1.1353239903252577,0.25925925925925924,0.8717485316884176,1.0,5/21,11.69%,BTC;TGFA;ARC;GREM1;NLGN3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5026426882925122,1.1352351444278643,0.20833333333333334,0.8707698286164062,1.0,3/29,5.02%,FERMT1;PLEKHG5;STARD13
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5073378111581661,1.1350388827924283,0.2916666666666667,0.8700889395714431,1.0,5/25,14.43%,MRPL44;SMAD3;TRIM71;SNIP1;DGCR8
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5923876113997316,1.1350168340459539,0.3076923076923077,0.8689189261288222,1.0,4/15,14.31%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.5274558002831982,-1.1347772895468495,0.25301204819277107,1.0,1.0,8/60,6.93%,HTR1F;GNA12;AKAP5;CALCB;P2RY12;AKAP12;ADGRL2;GNA14
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.6412958506405991,-1.134669857675909,0.2631578947368421,1.0,1.0,3/20,14.76%,OTUD7B;USP50;USP8
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5827538731896929,1.1346124759782643,0.2857142857142857,0.8687917662156008,1.0,5/12,7.84%,THNSL2;CDO1;SEPHS2;SRR;PSPH
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6768685121399608,1.1344621815158835,0.3404255319148936,0.8667586472605225,1.0,1/5,0.55%,UBB
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6768685121399608,1.1344621815158835,0.3404255319148936,0.8667586472605225,1.0,1/5,0.55%,UBB
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.7323470375504236,-1.1343740844458452,0.32857142857142857,1.0,1.0,2/8,4.84%,MREG;USP13
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.6302997454948408,1.1340483855066732,0.20689655172413793,0.866615525668288,1.0,2/10,3.88%,ODC1;SRM
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.5498164057968303,-1.1335735689825535,0.22784810126582278,1.0,1.0,7/44,15.18%,JADE2;MSL3;ACTL6B;PER1;KANSL1;ING5;MORF4L2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.7276378615648011,1.133290814943056,0.38461538461538464,0.8675845432975187,1.0,2/5,15.57%,ENPP3;PRPS1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6843354753521547,-1.133177260516039,0.3384615384615385,1.0,1.0,7/13,16.14%,IGSF6;SPI1;AOAH;MYO1F;PILRA;CHIT1;TYMP
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.3786402778927525,1.133128016544006,0.15384615384615385,0.866914790819269,1.0,25/114,11.88%,AMOTL2;PIWIL2;FNBP1L;MAGI1;NACC1;PIWIL4;TRIM28;PAWR;PML;DNMT3B;PCGF2;THY1;PTPN14;YAP1;ABCG2;LAPTM4B;SMAD9;PTPRF;SMAD3;LRIG3;CDK8;MDFI;RAI14;WWC2;TSPAN6
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6752071911264201,-1.1330308788142587,0.3548387096774194,1.0,1.0,2/9,10.32%,TAF7L;TAF1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.6042922026049522,-1.1327486672668985,0.3333333333333333,1.0,1.0,1/18,0.20%,CD44
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.592179073453383,-1.1327464464508168,0.2948717948717949,1.0,1.0,8/30,17.54%,RFC4;RFC2;RFC1;RPA3;PNKP;PARG;LIG3;NTHL1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.6378384169086078,-1.1326133600437835,0.29411764705882354,1.0,1.0,5/14,19.89%,VEGFA;AHI1;ARRB1;ARRB2;SFRP4
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5120840578011867,-1.1325200956744945,0.27472527472527475,1.0,1.0,22/65,24.56%,GRIN2A;DAPK1;OPRM1;CAMK2B;SHISA6;CAMK2A;SHISA9;NEFL;CACNB1;JPH3;CACNG8;DLG4;CAMK2D;CACNG2;CNIH2;RELN;MEF2C;GRIN1;SELENON;MAPK8IP2;CACNG7;SHANK1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5209428988346042,-1.1325030634259836,0.2692307692307692,1.0,1.0,11/60,10.00%,PON1;CYP2E1;AHR;HSD11B1;SLBP;PAH;GLUL;ABCC3;PLSCR1;CP;CPB2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6111219199771035,1.1324389914222108,0.3684210526315789,0.8673944390050857,1.0,2/8,13.53%,GREM1;BMP2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.34825505068257495,1.1323194693956176,0.0,0.8667268228526028,1.0,46/265,13.63%,AURKAIP1;LSM4;POLR2J;U2AF1;POLR2L;RBM15B;NOVA1;SMU1;ERN1;SF3B6;SF3B5;CPSF1;PCBP2;TBRG4;RBM22;RBM41;HNRNPA0;HNRNPC;PCBP1;LSM7;GTF2H2;SNRNP40;PUF60;RPRD1B;GTF2F1;CD2BP2;UBL5;POLDIP3;EIF4A3;RBM8A;MAGOH;CSTF2T;POLR2K;PPWD1;CPSF4;SNRPB2;SRSF3;ZMAT2;SNIP1;MTREX;HSPA8;RAVER2;PHF5A;SNRPB;DNAJC8;HNRNPH1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.421176236416477,1.1320660344624531,0.2,0.8661968364780307,1.0,15/96,5.91%,NOX4;MMP2;PRRX1;BGN;FIBIN;FBLN5;PODN;FBLN2;COL12A1;TNS2;CXCL12;PDGFRA;SEC24D;LDB2;THY1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.6876588903807526,-1.131896095235087,0.36507936507936506,1.0,1.0,1/8,5.13%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.6912113765274701,1.1318841767601644,0.4,0.8655521162989426,1.0,1/5,2.82%,CXCL12
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.6126098084369163,-1.13188369302571,0.28125,1.0,1.0,6/15,29.81%,DVL2;PAK1;DAB2IP;SASH1;DVL3;MAP3K10
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6446379836704044,-1.131696527823331,0.359375,1.0,1.0,1/10,1.16%,NR4A3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.682045277717877,-1.1316073134857947,0.4,1.0,1.0,3/9,23.09%,XRCC3;LCMT1;DUSP1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.5959432619191616,-1.131423430333119,0.2898550724637681,1.0,1.0,4/23,8.44%,HES1;CCDC39;SRF;AHI1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.4993709991424531,-1.131280283956304,0.2891566265060241,1.0,1.0,16/66,16.40%,KCNJ13;KCNMB4;KCNH7;KCNC1;KCNJ11;KCNN3;HCN3;KCNH1;KCNQ1;SLC24A2;KCNC4;KCNB2;HCN1;KCNG4;KCNK10;KCNQ5
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.5797657193227194,1.130846078683587,0.3103448275862069,0.8672495001563707,1.0,8/15,28.17%,HNRNPC;NAT10;CTC1;XRN1;POT1;TERF2;TERF1;PIF1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5987613443177741,-1.1306145154053397,0.3333333333333333,1.0,1.0,4/15,14.69%,BRCA1;CYP1B1;SULF1;TGFB1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6023487066575912,1.1305737707769659,0.3055555555555556,0.8667209961176595,1.0,2/10,17.95%,INSIG1;SAR1B
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.6850174079874497,-1.1305556930416942,0.3283582089552239,1.0,1.0,2/9,14.69%,VSIR;TGFB1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.6090162414511991,-1.130491750242622,0.34782608695652173,1.0,1.0,5/18,9.03%,G6PC2;PCSK2;SST;LMO2;FOXO1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.517630857117595,1.1304908530021007,0.28125,0.865846778451906,1.0,4/25,8.30%,CFL1;ARC;LZTS3;ABHD17B
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.7481746575939765,1.1301131980171981,0.3548387096774194,0.8647018645616411,1.0,1/5,4.48%,MCM4
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.7481746575939765,1.1301131980171981,0.3548387096774194,0.8647018645616411,1.0,1/5,4.48%,MCM4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.49405276763752215,-1.1299421605225968,0.24444444444444444,1.0,1.0,33/133,19.40%,CARD14;EFNA1;FAM161A;CAMK1;SOX9;FGF1;FGF9;EFNA5;VEGFA;BRAT1;ATG14;DVL2;PTPA;PDE8A;ALG10B;RASGRP1;PAK1;ARRB1;CSNK1D;NTRK3;AKT2;SVIP;TGFB1;NSMF;RIPK1;ATG7;IL34;TERF2IP;TNIK;FAM20A;AKTIP;RB1CC1;NNMT
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.5726502412877512,1.129682645858177,0.2962962962962963,0.8649481127527092,1.0,4/13,16.62%,NT5E;ERH;DHODH;NT5C1A
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5599264064111258,-1.1296492259806632,0.3116883116883117,1.0,1.0,6/31,16.99%,MYLK;CAV3;CAMK2B;CAMK2A;SLC8B1;PLPP4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5570799678806853,-1.1295114690255705,0.29333333333333333,1.0,1.0,11/31,20.55%,PTPRC;RASGRP1;ARFGEF2;STAT3;IFIH1;PTPRJ;C1QTNF4;OAS1;RIPK1;TIRAP;PSEN1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.4375955711103081,1.1294939948024723,0.25,0.8641962517744312,1.0,10/36,10.58%,SIRT2;GPC1;SOX10;BCAS1;B4GALT6;EPB41L3;TNFRSF21;ABCD2;PLLP;MAL
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.6644125405581195,-1.1292875232284858,0.3387096774193548,1.0,1.0,5/11,17.69%,SRF;CHRM3;KCNB2;DAPK3;CHRM2
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.462142137735694,1.1291766640414258,0.23529411764705882,0.8637529408057959,1.0,10/46,7.66%,MMP2;BGN;FIBIN;FBLN5;COL12A1;CXCL12;PDGFRA;IGFBP7;MSRB3;BMPER
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.6957293418996532,1.1289107208726286,0.2857142857142857,0.8631769493742729,1.0,4/5,30.18%,HAVCR2;LRFN5;CD200;NR1H3
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.4888958824211282,1.128878286634431,0.32142857142857145,0.8620676759496667,1.0,10/23,21.93%,ARFIP1;SNX12;CHP1;HSPA8;DNAJA1;NDFIP2;LLGL1;RHBDF2;PTPN1;P3H1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.6578171088424449,1.1286877197549927,0.34146341463414637,0.8601058959544219,1.0,1/5,0.58%,AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.6578171088424449,1.1286877197549927,0.34146341463414637,0.8601058959544219,1.0,1/5,0.58%,AURKAIP1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.40605607255821474,1.1286829302401693,0.125,0.8589292805016798,1.0,29/170,13.64%,UTP11;LTV1;NOL11;WDR18;SBDS;ZNF658;POP5;RAN;NPM1;MRPL36;PIH1D1;MPHOSPH6;RPL8;NOC2L;RPS19;DDX54;RPL15;POP4;RPL29;RPS2;EXOSC8;IMP3;WDR46;RPL23A;EBNA1BP2;LSG1;MTREX;WDR36;RPF1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.5197061581984422,1.1286439511914341,0.2222222222222222,0.8578508694222052,1.0,5/24,18.78%,CSKMT;KMT5B;VCPKMT;KMT2D;SETD3
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.6947460216712367,-1.128616625281141,0.39285714285714285,1.0,1.0,2/6,16.78%,NEFL;GFAP
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.4992189441481325,-1.12826351646075,0.21348314606741572,1.0,1.0,22/106,12.83%,STMN2;G6PC2;PCSK2;NKX6-2;ROBO2;EFNA5;KCNC1;SST;CACNA1B;ACTL6B;CAMK2B;SHISA6;RIMS1;CELF4;SNAP25;UNC5D;SYT4;EDARADD;LRRTM1;SULT4A1;EZH1;KCNB2
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.705560250135491,-1.127870689556347,0.30434782608695654,1.0,1.0,1/9,7.50%,GPAM
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5255848014986263,-1.1277593377987798,0.34210526315789475,1.0,1.0,9/56,9.17%,FGF1;EMP2;AGT;VEGFA;RHOJ;GLUL;GPI;APOE;ADAMTS9
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.7380993085321401,-1.1275092371034712,0.3392857142857143,1.0,1.0,2/5,9.47%,PRUNE1;PRUNE2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5304273109151435,1.1273112858209986,0.2857142857142857,0.8606836322576061,1.0,6/17,13.24%,STYXL1;TIPRL;PPP1R8;PPP1R11;YWHAB;MFHAS1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4286951960632162,1.1272829790712098,0.23529411764705882,0.8596057695029314,1.0,8/57,6.41%,IPO13;PHB2;NUTF2;RAN;LAMP5;PRICKLE1;PPP1R10;TSPAN17
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.6832183987268488,1.1272121474775072,0.38235294117647056,0.8586065211996449,1.0,3/5,26.90%,FUT9;AKT1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.6211241910044619,-1.1272038303102843,0.375,1.0,1.0,3/14,22.94%,EVC;TUBD1;TXNDC15
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.4964719959358539,-1.1269747964440457,0.2804878048780488,1.0,1.0,17/108,5.80%,CD44;GADD45B;HES1;EFNA1;NR4A3;SLC2A3;FOS;TNC;IRF1;CEBPD;MAFF;DRAM1;GADD45A;IFNGR2;KLF6;VEGFA;KLF9
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6246025990327061,1.1264282963766947,0.29411764705882354,0.8597261908201578,1.0,3/9,24.54%,ARL6IP5;SLC1A2;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.6207362925316892,1.1262970323087238,0.3157894736842105,0.8588049669016073,1.0,1/8,0.66%,BAD
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.7101367588706488,1.1260534258441357,0.4117647058823529,0.8583573260446676,1.0,3/5,23.68%,SLC15A2;ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5996740913306285,1.1259983907313176,0.3055555555555556,0.8573087218746364,1.0,4/10,15.99%,GPC1;SPRY1;CREB3L1;SPRY4
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.5934331332205163,-1.125934139603356,0.375,1.0,1.0,5/21,15.87%,APOE;STAT5A;DNM2;OLFM1;STAT5B
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.649445749295878,1.1257179550228231,0.3,0.8570334456032753,1.0,1/6,0.49%,SIRT2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.646234457289165,-1.1257066398271287,0.2535211267605634,1.0,1.0,2/15,1.04%,CYP2E1;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.7310077588193379,-1.1256382250959793,0.29508196721311475,1.0,1.0,4/7,20.73%,CDKN2A;B2M;ARG2;CGAS
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.47381503589851176,1.1255984113651367,0.27586206896551724,0.8561771300019809,1.0,11/33,18.00%,MRPL47;MRPS16;MRPS12;MRPS18A;SLC25A33;TEFM;MRPS7;TFB2M;RARS2;MRPS2;GATC
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.6243610325751289,-1.1255447848068705,0.30434782608695654,1.0,1.0,4/22,9.45%,DSC2;CACNA1C;KCNQ1;CTNNA3
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5934729935657653,-1.1254770675742227,0.3194444444444444,1.0,1.0,6/20,13.68%,PTPRC;HLA-F;SP140;AOAH;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6450799315555878,1.1253550625258888,0.25,0.8556792182260812,1.0,3/11,18.47%,IKBKB;LLGL1;FHOD3
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.706824130745751,-1.125221215217116,0.3333333333333333,1.0,1.0,4/9,23.40%,PTPRN;LTBP4;RAB1A;CDK16
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.6637615395053797,1.1251358995360896,0.4117647058823529,0.8549018969112485,1.0,3/5,16.66%,PHB2;RNF135;CLPB
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.744964327814629,-1.1250421223185911,0.3090909090909091,1.0,1.0,3/6,21.58%,RAB3A;CAST;PCLO
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6024598900924163,1.1250411281468566,0.3333333333333333,0.8540892821750433,1.0,4/9,10.43%,ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6048324461973988,1.1249015575006294,0.3448275862068966,0.8533535145874741,1.0,1/8,4.48%,MCM4
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.6848693455528245,-1.124609658139188,0.2714285714285714,1.0,1.0,4/10,21.35%,TK2;TYMP;UCK1;PUDP
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.43727352611665116,1.1244457251815663,0.25,0.8535704302606334,1.0,3/37,3.63%,NUP42;RAN;NPM1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.5886176186775823,-1.1240991189988803,0.35714285714285715,1.0,1.0,3/20,8.23%,B3GNT5;ALG6;GCNT1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.7028009624113867,1.1238247864032187,0.32432432432432434,0.8542335595164167,1.0,3/7,17.67%,CEND1;GRID2;FAIM2
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.4900805526404288,1.123622590574679,0.2222222222222222,0.8538351977558474,1.0,7/25,10.83%,TMEM9;ATP6V0A4;ATP6V0E1;ATP6V1G1;ATP6V1B2;CLCN3;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7089842356116169,-1.1236106089881008,0.38596491228070173,1.0,1.0,1/7,3.96%,PARP14
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.48791372201396394,-1.1236054963876196,0.2808988764044944,1.0,1.0,17/75,20.91%,GADD45B;TPD52L1;GADD45A;DUSP22;TNFRSF19;CD27;RASGRP1;PER1;TRAF3;IGF1R;RIPK1;SEMA3A;WNT7A;DAB2IP;TGFBR3;TIRAP;NCOR1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.7783518633112114,-1.1235069905529464,0.36538461538461536,1.0,1.0,1/5,11.28%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.7783518633112114,-1.1235069905529464,0.36538461538461536,1.0,1.0,1/5,11.28%,DPH6
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5589676093764794,-1.1234447681407593,0.2727272727272727,1.0,1.0,10/34,20.40%,AGT;P2RY12;TPCN2;ACKR4;APOE;CHRM3;INPP5A;RYR2;HTR2B;HRH1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.484055308087721,1.1232911675127562,0.34615384615384615,0.8539392011799021,1.0,2/25,1.85%,BANF1;H1-10
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4935652100343245,-1.1229921723443912,0.3048780487804878,1.0,1.0,13/85,14.88%,TMSB4X;NLRC5;VSIR;OTUD7B;PTPRC;ZFPM1;RARA;NLRP12;ARRB1;IFIH1;PDCD4;PDCD1LG2;UFD1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.7254153489576933,-1.122761611224977,0.423728813559322,1.0,1.0,4/5,26.68%,GPAM;PNPLA2;MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.5238965579010626,-1.1226430491513844,0.2948717948717949,1.0,1.0,9/48,12.21%,SPDYA;CDKN2A;CDK7;MAX;CDK4;CDC7;CAMK2A;CRLF3;PLK2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.5777859771450999,-1.1226035736684323,0.3333333333333333,1.0,1.0,6/25,7.21%,GABRA4;GRIN2A;GABRG3;GLRA1;GABRG2;GRIN2D
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6490593401559895,1.1222911188375215,0.3870967741935484,0.8554706585988598,1.0,6/8,29.50%,AGPS;FAR1;DHRS7B;PLA2G4C;LPCAT2;GNPAT
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.48651280919882034,-1.122004506733378,0.3,1.0,1.0,20/81,15.47%,IL5;PLAG1;NRIP2;LFNG;MX1;CALCB;SNCB;ARHGDIG;STAG3;KLHDC8A;MFSD6;GPRC5C;EFHD1;CAMK1D;ZC2HC1C;PDE6B;PTPRJ;PDK2;NUDT11;RYR2
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.6820610718279695,-1.1219733747210816,0.3382352941176471,1.0,1.0,6/10,26.51%,TDRD9;BTBD18;MEIOC;MYBL1;SYCP3;HSF2BP
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6494637965386566,-1.1219306743607902,0.359375,1.0,1.0,4/12,22.15%,NAAA;CYP1B1;RDH12;GDPD1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.6689930651995504,-1.1218614624851602,0.34782608695652173,1.0,1.0,2/11,0.95%,HEY2;TMSB4X
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.6837737907766899,-1.1218343021816548,0.3181818181818182,1.0,1.0,5/8,29.47%,ST3GAL1;NAGK;ST6GAL1;GNPDA2;AMDHD2
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.6365300885755205,-1.1215360339626592,0.3088235294117647,1.0,1.0,1/13,4.71%,ROBO2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6548836830649499,1.1213794112916895,0.4444444444444444,0.857405417635125,1.0,4/10,21.14%,HIRA;RBBP4;UBN1;H3-3A
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.7449136176651031,-1.121310944963877,0.29310344827586204,1.0,1.0,1/6,4.71%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6355367972761794,-1.1211443642023662,0.38028169014084506,1.0,1.0,10/17,29.21%,PRXL2C;SLC4A4;GAPDHS;PFKFB3;PSEN1;PFKFB2;PRKAA1;PRKAA2;PFKFB1;APP
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6355367972761794,-1.1211443642023662,0.38028169014084506,1.0,1.0,10/17,29.21%,PRXL2C;SLC4A4;GAPDHS;PFKFB3;PSEN1;PFKFB2;PRKAA1;PRKAA2;PFKFB1;APP
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6479825247365218,-1.1209348138582285,0.29411764705882354,1.0,1.0,4/14,26.01%,SHTN1;KIF20B;BCAS3;GSN
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.4711385396408841,-1.1209231238544186,0.1935483870967742,1.0,1.0,23/170,16.25%,ABLIM1;FHDC1;FAM161A;RAB17;MAK;INTU;CFAP221;RPGR;RAB11A;INPP5E;AHI1;CCDC57;CFAP70;DNAH5;B9D1;AVIL;MNS1;CFAP52;RILPL1;HDAC6;TRAPPC14;HYLS1;CFAP43
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.6285287872364144,1.1208269235674242,0.35135135135135137,0.8579480821594655,1.0,2/6,21.31%,PPTC7;H6PD
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.7523915056726425,-1.1204281840207024,0.36507936507936506,1.0,1.0,2/5,17.07%,CAV3;NEDD4L
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.4467660456816615,1.119964715761141,0.23529411764705882,0.8593757738100796,1.0,11/36,15.09%,SIRT2;ACTB;CNP;YWHAQ;NDUFS3;CALM3;S100A1;COX6B1;CALM1;CDC42;RAD1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.4694421844040151,1.1199391257170592,0.32,0.8583651233387888,1.0,6/49,4.06%,UBB;TAB3;TLR1;IKBKB;CNPY3;UBE2D1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3434285175037009,1.119792062447515,0.07142857142857142,0.8576886951643422,1.0,28/129,17.24%,CUL7;AFAP1L2;PSMD8;PSMB6;PSMB4;UBE2D1;TRIM35;BTG1;BTG3;BRINP1;PSME3;PSMD10;GAS1;SMAD3;DUSP3;ZNF268;HECA;EIF4E;CDC26;CUL9;PSMD12;PSMB2;PSMD4;ANAPC11;SIRT1;USP22;USP2;ERCC3
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5499395340642617,-1.119710633842168,0.34146341463414637,1.0,1.0,10/40,20.46%,TMSB4X;IRF1;LRRC19;APOE;TRAF3;BCL6;BRD4;TIRAP;FOXP1;SEMA7A
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.6460411650583764,1.119612492119863,0.36585365853658536,0.8570692409033146,1.0,1/6,3.21%,STIM1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6153086268380339,1.1193902085335408,0.3939393939393939,0.8566534988262234,1.0,3/9,16.11%,SLC30A10;ZKSCAN3;SIRT1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5575771045695834,-1.1190772637345114,0.3291139240506329,1.0,1.0,11/37,15.67%,NAAA;NR4A3;PTPRC;IGSF6;SPI1;HLA-C;AOAH;MYO1F;PDCD1LG2;PDPN;HLA-DMA
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.511417140143269,-1.118785562750167,0.3333333333333333,1.0,1.0,5/44,9.12%,PON1;ENPP2;LPCAT3;SLC44A3;PCTP
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.6341795547787155,-1.1178613446866872,0.3194444444444444,1.0,1.0,3/11,25.57%,RAB11FIP5;PTPRN;RAB11FIP2
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.6055664459110156,-1.117688284183731,0.2898550724637681,1.0,1.0,6/19,22.97%,HES1;PAK1;RYR2;PRKD2;COL4A1;MEF2C
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.5619566906508718,-1.1176446935247792,0.35526315789473684,1.0,1.0,7/31,15.92%,MX1;CAV3;GRK4;DNM1;ARRB1;DNM2;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.7247140714835119,1.1171723239985598,0.4358974358974359,0.8615042337159995,1.0,1/5,2.37%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.5648448028278655,1.1170485923179003,0.2647058823529412,0.8607356240290289,1.0,2/14,9.22%,NR1H2;ABHD5
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.6928634170019874,-1.117045432694023,0.359375,1.0,1.0,2/7,13.27%,VRK1;NEK6
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.5205091159447219,-1.1165389208079923,0.2926829268292683,1.0,1.0,2/32,8.15%,NUAK1;ATG14
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6838129868557729,1.11651676206174,0.4523809523809524,0.8612864924368913,1.0,3/6,14.87%,PAX8;BMP2;SALL1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.4851266466176169,-1.116489148199239,0.2413793103448276,1.0,1.0,24/90,17.07%,KCNJ13;PANX2;SLC6A6;SLC22A4;KCNMB4;KCNC1;LRP2;SLC6A9;SLC7A6;SLC6A17;KCNH1;SCN8A;SCN9A;KCNC4;SLC4A4;SLC9B2;KCNB2;RHCG;SLC5A9;SLC41A1;TMEM63C;SLC8B1;ANO6;NEDD4L
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.45222808228006395,1.11644801271945,0.2631578947368421,0.8604105451891604,1.0,10/46,10.00%,RBM15B;NOVA1;SMU1;KHDRBS2;RBFOX1;PUF60;FXR2;SAP18;RBM8A;MAGOH
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.6207828421697162,1.1161871627110067,0.35714285714285715,0.8600113961306584,1.0,2/11,9.89%,GREM1;MDFI
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.607428952450471,1.1161206792900964,0.34375,0.8590300598218661,1.0,2/8,14.89%,CALR;EZH2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.5967485256560392,-1.115947051056622,0.2987012987012987,1.0,1.0,8/25,26.88%,OTUD7B;USP13;USP50;USP8;ABRAXAS1;BABAM2;BRCC3;CYLD
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5938971436448057,1.1157609802068795,0.4117647058823529,0.8587975822948714,1.0,2/12,6.03%,SLC39A10;LYN
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.5960475694182726,1.1152678459227556,0.36363636363636365,0.8588202101168543,1.0,5/12,13.43%,WTIP;LIMD1;SHANK2;WWC2;WWC1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.7639415686435068,-1.1152459395312095,0.3389830508474576,1.0,1.0,1/5,4.66%,P2RY12
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.5999421210504328,1.1151795359125007,0.3157894736842105,0.8579350455642846,1.0,6/11,26.27%,POLD3;PNP;GMPR2;AMPD2;POLL;DGUOK
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.6350132607991604,-1.1151146200037763,0.3287671232876712,1.0,1.0,3/19,10.83%,ZFPM1;BTN3A1;RASGRP1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.6074317211780461,-1.1148392102806757,0.37333333333333335,1.0,1.0,5/16,15.65%,UNC13C;GRIK5;SLC1A4;SLC17A7;CDH8
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.5308284110234022,1.1145994086016842,0.3235294117647059,0.8583032278690922,1.0,5/13,16.11%,DNAJC15;GRPEL1;DNAJC19;TIMM23;TIMM50
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.588051737374758,1.1145560807027655,0.3103448275862069,0.8561975566892724,1.0,4/11,22.70%,SMAD3;AKT1;NOS1AP;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.588051737374758,1.1145560807027655,0.3103448275862069,0.8561975566892724,1.0,4/11,22.70%,SMAD3;AKT1;NOS1AP;DDAH1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5322168388124142,1.114512071026466,0.36666666666666664,0.855139792878242,1.0,5/18,11.55%,TRIP6;THY1;RCC2;THSD1;PEAK1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.5656061220804374,-1.1141820156559588,0.3088235294117647,1.0,1.0,10/21,26.09%,CAMK1;CAMK2B;APOE;FOXO6;SHANK3;RELN;PSEN1;DHX36;SHANK1;CPEB3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.6753324203959394,-1.114090582335787,0.4142857142857143,1.0,1.0,1/8,11.85%,ZC3H12B
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.4804593659513983,-1.114052158256352,0.2967032967032967,1.0,1.0,10/91,14.28%,RASGRF1;STMN2;FAM161A;RAB11A;DOCK7;APOE;MICALL2;TPM1;MNS1;PLP1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.6483963473846176,-1.1140465853463586,0.3333333333333333,1.0,1.0,2/12,5.13%,FGF1;VEGFA
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.6314559640251101,1.113688169339165,0.3333333333333333,0.856880497300335,1.0,4/8,21.66%,QRICH1;ATF4;HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.664085885680487,-1.1134291742416347,0.35294117647058826,1.0,1.0,5/13,26.68%,GPAM;DGAT2L6;PNPLA2;MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.7738099171793013,-1.113028877587454,0.3181818181818182,1.0,1.0,2/5,8.79%,MAP3K12;NEK11
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.6869985539616876,1.1128959312435802,0.3548387096774194,0.8582924479115226,1.0,4/8,25.94%,NOC2L;RBBP4;SUV39H2;TP53
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.4384431495702439,1.1128767884064252,0.15789473684210525,0.8572000986568702,1.0,5/60,1.82%,MYRFL;MMP16;TMEM208;SPCS2;NCSTN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6330870883747536,-1.1128356369574983,0.39705882352941174,1.0,1.0,5/11,24.15%,CAV3;KCNQ1;SNTA1;KCNA5;FLNA
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6217893226905676,1.112701465025977,0.3225806451612903,0.8566136485912834,1.0,7/13,29.50%,TRIM28;PPHLN1;MORC2;ATF7IP;ZNF304;RESF1;TPR
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.493097226740131,-1.112696347838243,0.26666666666666666,1.0,1.0,27/125,15.63%,NEFM;STMN2;FAM13C;OLFM3;VAMP1;CALCB;KCNC1;CACNA1B;ACTL6B;SYNM;SHISA6;PRUNE2;SCN9A;SNAP25;SYT4;ATP2B3;CREBRF;MMD2;AVIL;LRRTM1;SULT4A1;PARM1;NKAIN2;PLP1;DCLK1;CRMP1;DGKZ
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6072505647789559,-1.1122374226315919,0.359375,1.0,1.0,1/12,1.40%,SOX9
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6689780127854206,-1.1122134645328814,0.4,1.0,1.0,2/9,13.27%,NUAK1;NEK6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.5610181310399004,-1.1118578322233386,0.3055555555555556,1.0,1.0,11/30,20.55%,PTPRC;RASGRP1;ARFGEF2;STAT3;IFIH1;PTPRJ;C1QTNF4;OAS1;RIPK1;TIRAP;PSEN1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.6159567434696532,-1.1117887960374222,0.3611111111111111,1.0,1.0,1/16,0.58%,STMN2
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.696227229416802,-1.1117188440223151,0.423728813559322,1.0,1.0,1/6,1.40%,SOX9
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.42843758325377407,1.1115637676826473,0.2222222222222222,0.8587561752457632,1.0,6/51,7.83%,ODC1;PSMD8;PSMB6;PSMB4;PSME3;PSMD10
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.7666401453686069,-1.1112812672257986,0.3333333333333333,1.0,1.0,3/5,20.26%,UBASH3B;PRXL2A;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5413427902239826,-1.1112464748865154,0.345679012345679,1.0,1.0,3/28,5.80%,OTUD7B;SPI1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.6465512943317455,-1.1110709178342437,0.3384615384615385,1.0,1.0,2/13,11.62%,APOE;SORBS1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5605180065356749,1.110991955385223,0.3,0.8592265535221776,1.0,3/10,10.50%,CPSF1;CSTF2T;CPSF4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.7118244528812069,-1.1109642766253438,0.34375,1.0,1.0,2/8,12.08%,NLRP12;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.6359621949388935,-1.1109147743002876,0.36923076923076925,1.0,1.0,3/15,13.48%,LFNG;ARRB1;WWP2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.75199494594146,-1.1106651438679138,0.42857142857142855,1.0,1.0,2/5,20.78%,PDPN;DDR2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.7400583779544075,-1.1106186661947994,0.4230769230769231,1.0,1.0,1/6,1.16%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.729358059119547,-1.109958205529858,0.3,1.0,1.0,1/6,1.05%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6389438321897671,1.109910315011906,0.3939393939393939,0.8616286672458195,1.0,2/8,10.18%,WASF3;BRK1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5871618163568412,1.1097238648864156,0.2894736842105263,0.8611646626174181,1.0,4/15,10.69%,LYN;KLHDC10;INAVA;ARL6IP5
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.6041050998574842,-1.109258757621516,0.3037974683544304,1.0,1.0,7/25,19.04%,AHR;DUOX1;HCN3;KCNQ1;HCN1;HCN2;STAT1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6519789275649616,-1.1092346691595596,0.3382352941176471,1.0,1.0,3/10,16.68%,DONSON;ZRANB3;LIG3
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.733637943441737,-1.108927569924559,0.3333333333333333,1.0,1.0,4/5,22.44%,PDK2;USF1;CDKN2B;XBP1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.6876657011500933,-1.108732453023496,0.4307692307692308,1.0,1.0,1/7,6.98%,GLUL
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.690065387810507,-1.1084300778238416,0.43548387096774194,1.0,1.0,1/11,4.37%,DDB2
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.6853230052623638,-1.1081889837141712,0.39344262295081966,1.0,1.0,4/8,20.73%,CDKN2A;B2M;ARG2;CGAS
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6513516761790586,-1.108172936014213,0.43548387096774194,1.0,1.0,4/11,24.38%,P2RY12;IL34;CXCL17;CSF1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.661358146468721,1.1077957156665004,0.425,0.8652183292955238,1.0,1/6,9.26%,SYAP1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.4180004518579297,1.107335396773153,0.1875,0.8655888664982436,1.0,14/72,10.67%,GPX1;CCND1;COPS9;NPM1;SMPD1;NOC2L;PARP1;GTF2H2;CAT;SDE2;TMEM161A;RUVBL2;ZBTB1;ATF4
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6536722150332548,1.1069836694160924,0.4146341463414634,0.8655489171735543,1.0,2/6,3.63%,RAN;NPM1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.7769364267825662,-1.1066996247752765,0.4126984126984127,1.0,1.0,2/5,13.85%,PTPRC;PTPRJ
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7465352720186679,-1.1061654460973853,0.34375,1.0,1.0,5/6,23.88%,HLA-F;HLA-C;B2M;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.7247212110855202,-1.1059981127233252,0.3548387096774194,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.6750876289445011,1.1059070433537994,0.4146341463414634,0.8676430558111171,1.0,3/6,16.38%,DACH1;MAD2L2;SMAD7
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4960101405899943,1.1058537448528893,0.23076923076923078,0.8667303203818794,1.0,10/23,25.58%,UBE2D4;CDC26;ANAPC11;UBE2E3;ANAPC7;ANAPC1;UBE2A;ANAPC4;UBE2E2;ANAPC13
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.5943478285115452,-1.1057100304202128,0.3333333333333333,1.0,1.0,3/16,14.59%,GJA1;SLC13A3;PDPN
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.49905957396353073,1.1054604516209223,0.3448275862068966,0.8669019221833045,1.0,4/37,2.94%,GPC4;HSPG2;RBP1;GPC1
prerank,MSigDB_Hallmark_2020__Apical Junction,0.38240253592565054,1.105240939350063,0.16666666666666666,0.866382191892821,1.0,28/129,13.55%,MMP2;TUBG1;ACTB;ACTG1;PARD6G;LAMA3;CAP1;MSN;VCAN;NLGN2;SHROOM2;THY1;NECTIN1;GTF2F1;MAPK11;CERCAM;LIMA1;SPEG;CDK8;ADAM23;TSPAN4;NEGR1;NLGN3;COL9A1;GNAI1;INSIG1;MPZL1;ZYX
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.52634173753952,-1.1050541033467567,0.35,1.0,1.0,8/49,12.01%,CRYM;LHFPL5;CEMIP;LRP2;KCNQ1;ADGRV1;NDUFB9;SLC26A5
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.7302674850644021,-1.1049126172495878,0.3709677419354839,1.0,1.0,1/6,1.04%,ALOX12
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6291798399281248,-1.1048621923425166,0.35,1.0,1.0,1/11,8.60%,PLSCR1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.6264159295167634,-1.1048039357993997,0.4,1.0,1.0,5/13,25.20%,KCNH1;SORT1;MEF2C;ADAM12;ERVW-1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.6521031000876659,-1.1047563593888163,0.38571428571428573,1.0,1.0,4/13,12.74%,AGT;KCNMB4;OXTR;CHRM3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6857375598968323,-1.1043692270208043,0.3582089552238806,1.0,1.0,3/9,17.64%,CAV3;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6347518642848161,-1.1041013521748793,0.390625,1.0,1.0,5/15,19.27%,TMSB4X;SPI1;NLRP12;IFI35;HDAC7
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7627448631582361,-1.1039895443931158,0.40350877192982454,1.0,1.0,1/5,4.25%,SPI1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6603400812791773,-1.1037921514954632,0.38571428571428573,1.0,1.0,4/12,14.69%,TTN;ZFPM1;TPM1;TGFB1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7024283178622313,1.1035676369840512,0.3783783783783784,0.8692164748976684,1.0,4/7,27.92%,ATF4;GABPA;LRRK2;ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7024283178622313,1.1035676369840512,0.3783783783783784,0.8692164748976684,1.0,4/7,27.92%,ATF4;GABPA;LRRK2;ABL1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.6416994665406985,-1.1035300243505852,0.4,1.0,1.0,3/13,10.25%,MMP21;DNAH11;DNAH5
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6792104112040263,-1.1035246206073084,0.36764705882352944,1.0,1.0,2/8,8.56%,VEGFA;EIF2B4
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.4241325440084596,1.1034885325296737,0.25,0.8684134210705261,1.0,7/54,11.88%,POLR2J;POLR2L;KPNA2;PPIA;GTF2F1;POLR2K;VAPB
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5322252676517365,1.1033367113517905,0.4642857142857143,0.8679649117160828,1.0,3/15,9.31%,MID1IP1;SLC25A20;ABCD2
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.729482413211228,1.1031867402393756,0.4722222222222222,0.867447125301447,1.0,1/5,9.98%,RC3H1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.5785641842972393,-1.1031093452219873,0.3472222222222222,1.0,1.0,2/21,6.62%,HAP1;KIF1C
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.6819476018990258,1.1027792406664836,0.32432432432432434,0.8674229126499675,1.0,2/6,14.54%,NPM1;DUSP26
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.7004871146265478,-1.1027572590602945,0.38571428571428573,1.0,1.0,3/7,24.08%,WRN;DDX11;DHX36
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.6477398932789615,-1.1027510138722996,0.36363636363636365,1.0,1.0,3/15,5.80%,TTN;LHFPL5;CAV3
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.7304010644973697,-1.1027358594268424,0.3333333333333333,1.0,1.0,1/5,1.00%,HES1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.6650639690753288,-1.1026932385194523,0.45161290322580644,1.0,1.0,2/8,8.51%,AGT;APOE
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.5850283323683727,-1.1025045018847224,0.36486486486486486,1.0,1.0,3/16,8.82%,GLRA2;GLRA1;HVCN1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5880228584829449,-1.101678532378749,0.37037037037037035,1.0,1.0,2/21,3.80%,PHF19;BRCA1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5279116446093961,-1.1016659946164908,0.35,1.0,1.0,13/52,16.33%,ALOX12;SLC2A3;SPI1;P2RY12;VEGFA;ITGA2;NRGN;AOAH;MYO1F;PREX1;TBXAS1;CA2;F13A1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.586433844820027,-1.101525512922906,0.3684210526315789,1.0,1.0,6/22,16.11%,EFNA1;TIMP3;CAMK2N1;EPHA4;HDAC6;KNG1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5403360017105379,-1.1012862968322112,0.34177215189873417,1.0,1.0,9/49,14.41%,PLET1;EMP2;CDKN2A;VCL;EFNA5;RASA1;MACF1;TSC1;DAPK3
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.7653117118793414,-1.1009464055828562,0.4067796610169492,1.0,1.0,1/6,5.13%,VEGFA
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5566734663138394,1.100683037178775,0.3333333333333333,0.8724556608016437,1.0,3/12,9.55%,SLC30A10;STIM1;SRI
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6399161591018157,-1.100652398578677,0.37681159420289856,1.0,1.0,4/11,25.94%,TPM1;PDCD4;MEF2C;TGFB3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.4778487064694518,-1.1000807683370748,0.3058823529411765,1.0,1.0,23/134,15.80%,NEFM;STMN2;IGF2BP3;FAM13C;OLFM3;FSTL5;EFNA5;KCNC1;ARHGAP26;CACNA1B;ACTL6B;SHISA6;MFSD6;SNAP25;SYT4;ATP2B3;LRRTM1;SULT4A1;JPH3;CCK;DCLK1;CRMP1;CELF3
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6862628827023673,-1.1000757709440834,0.359375,1.0,1.0,5/9,23.88%,PTPRC;HLA-F;HLA-B;CEACAM1;HLA-A
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.7306647788959766,-1.1000180615151613,0.4426229508196721,1.0,1.0,1/5,3.68%,CNTNAP1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.572198392796994,-1.0999698153709172,0.3561643835616438,1.0,1.0,5/28,9.03%,HEY2;HES1;PRUNE1;DOCK7;FOXO1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.6093464533648034,1.0998433461706272,0.37142857142857144,0.8737404335785347,1.0,4/10,9.81%,ATP7B;MT1E;MT3;ATP5F1D
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.38416811014476454,1.0998084438293108,0.2727272727272727,0.8727626059776258,1.0,17/112,9.08%,NR0B1;POLR2J;POLR2L;NR1H2;TAF9B;ESR1;NR2F6;GTF2A2;MED23;MAML2;RBPJ;YAP1;GTF2H2;NR3C1;GTF2F1;ESRRG;NR2E1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5709591815026126,-1.0998016913259117,0.38571428571428573,1.0,1.0,8/24,6.93%,HTR2C;GPR18;AGT;GRM1;FPR3;P2RY12;OPRM1;GNA14
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.5825025200025881,-1.0996757551477723,0.35526315789473684,1.0,1.0,4/25,15.46%,PON1;APOE;NAXE;ABCA8
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.4006272102291682,1.0996713750837832,0.2631578947368421,0.8720146397830694,1.0,11/65,5.91%,MMP2;PRRX1;BGN;FIBIN;PODN;COL12A1;TNS2;CXCL12;PDGFRA;LDB2;THY1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4378743455554055,1.0994971129789395,0.2,0.8714956686830325,1.0,5/45,7.88%,GPR17;TNFAIP1;RIT2;STARD13;GPR174
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.49249126934584697,1.0991327526047634,0.37037037037037035,0.8717806320236511,1.0,4/27,8.63%,ASCL1;BTBD3;BTBD6;DCHS1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5240232614716622,1.0990478330142721,0.3333333333333333,0.8708972950020464,1.0,7/26,16.14%,CCDC88C;RNF139;CDC73;MUL1;SERF2;SIRT1;RAD23A
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.7158004116696683,-1.0988524885571633,0.38596491228070173,1.0,1.0,1/6,7.24%,APOBEC2
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7555132878784918,-1.0984405865235545,0.42857142857142855,1.0,1.0,2/5,18.26%,PLSCR1;PPP5C
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.38301933966065427,1.098350073672491,0.14285714285714285,0.8716348200106206,1.0,18/78,17.45%,CUBN;CD320;PPT1;SCAMP4;SCAMP3;CALCRL;CHMP2A;ABCG2;ABCD2;ARL6IP5;SLC50A1;GM2A;ARRDC4;TOM1;ABCA3;MYH9;HSP90B1;ABCA6
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.7097991888596654,-1.0980839372819646,0.38235294117647056,1.0,1.0,2/5,22.98%,ST3GAL1;ST6GAL1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.629032348691212,-1.0976670736682574,0.3968253968253968,1.0,1.0,1/13,0.95%,TMSB4X
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.4862816140138198,-1.0976546013067046,0.313953488372093,1.0,1.0,14/90,17.13%,TMSB4X;LRRC19;AGT;LPCAT3;NR1D1;APOE;AOAH;NLRP12;TYRO3;PDCD4;RIPK1;BCL6;BRD4;IFI35
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.7439023127869553,-1.0974927736874676,0.36065573770491804,1.0,1.0,2/6,13.26%,ITGA2;ITGA8
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.6298061811091287,-1.0972148737055698,0.42028985507246375,1.0,1.0,10/18,29.21%,PRXL2C;SLC4A4;GAPDHS;PFKFB3;PSEN1;PFKFB2;PRKAA1;PRKAA2;PFKFB1;APP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6701719619119252,-1.0971642654173583,0.36764705882352944,1.0,1.0,1/9,3.12%,PTPRC
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6749271730148529,-1.0966564424940102,0.3880597014925373,1.0,1.0,2/7,8.03%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.7316590344560707,-1.096048156727166,0.3898305084745763,1.0,1.0,1/5,5.80%,KLF9
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.6816290720719943,-1.0960261168580454,0.4262295081967213,1.0,1.0,3/6,24.38%,ADAM9;FOXP1;CSF1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.5741294877452734,-1.0959922549429464,0.34210526315789475,1.0,1.0,7/27,18.71%,HOOK1;TPCN2;CLVS1;MBTPS1;HOOK2;HOOK3;AKTIP
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.531074257592129,-1.0959729313259565,0.2876712328767123,1.0,1.0,4/33,7.37%,NLRC5;PTPRC;PARP14;STAT2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.6623999516593374,-1.0959515375174371,0.38461538461538464,1.0,1.0,2/9,4.70%,VSIR;RFTN1
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.7134940610156744,-1.0959430641559917,0.42857142857142855,1.0,1.0,1/5,6.09%,KCNJ11
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5632469513530958,-1.0956274401513832,0.35714285714285715,1.0,1.0,4/18,21.31%,CAV3;WWP2;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.6546920883441203,-1.0956238752520524,0.3142857142857143,1.0,1.0,5/12,20.05%,AKAP5;AKAP12;ADGRV1;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.6044414674953955,-1.095513394261207,0.38461538461538464,1.0,1.0,7/19,26.72%,UNC13C;CACNB1;DCTN1;DVL1;UNC13A;CACNB4;PDZRN3
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.5184814137545806,-1.095429487166707,0.32,1.0,1.0,9/62,16.94%,JADE2;MSL3;SPI1;ACTL6B;PER1;MRGBP;ING5;MORF4L2;TAF6L
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.6739600348555593,1.0950901808074731,0.38095238095238093,0.8798104648315903,1.0,1/5,1.82%,NCSTN
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.5334897867053413,-1.0945360060558547,0.37333333333333335,1.0,1.0,2/29,10.29%,FOS;EPHA7
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.49915916106326985,-1.0944543578479111,0.3563218390804598,1.0,1.0,19/61,17.52%,CD44;EMP2;VCL;ADAMTS13;ITGA2;THBS3;ADAMTS9;ECM2;SORBS1;TIAM1;ITGA8;PPFIA1;ITGB1BP1;TSC1;MKLN1;SGCE;BCR;ADAM9;ITGBL1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5898776095047462,-1.094105428203656,0.36764705882352944,1.0,1.0,8/14,25.54%,PARP9;TRIM44;DTX3L;TOMM70;STAT1;CGAS;MAVS;SIN3A
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.5958592744949469,-1.0938669797079112,0.38961038961038963,1.0,1.0,7/21,19.04%,SPI1;IL6R;STAT3;JAK1;ST18;ST3GAL6;STAT1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5642475511750009,-1.093686737503022,0.36585365853658536,1.0,1.0,7/24,25.77%,NLRC5;STAT2;OAS1;TTLL12;MAVS;ISG15;ABCE1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6406559437168311,-1.0934932918336877,0.39705882352941174,1.0,1.0,1/11,0.58%,STMN2
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5528285181821213,1.093438440083106,0.34210526315789475,0.8835559027833724,1.0,6/13,17.89%,GPC1;FGFBP3;SPRY1;CREB3L1;SPRY4;DSTYK
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.6729301107959591,-1.0934075462484083,0.3484848484848485,1.0,1.0,2/10,17.07%,CAV3;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.5308499403292728,-1.0931700864436924,0.2911392405063291,1.0,1.0,10/46,18.62%,RFC4;RFC2;PARN;CCT8;CCT6A;PARM1;PNKP;PDGFRB;ATM;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3900023854914045,1.092970315500079,0.3,0.8838413915894047,1.0,10/55,10.63%,SOX11;PLXNA3;CUL7;SOX8;CAPRIN1;NGF;CHODL;PLXNC1;FZD3;LIG4
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.4659507302832937,1.0928120754428845,0.28125,0.8831217166676693,1.0,5/20,14.89%,PHB2;PSME3;MN1;CDC73;EZH2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5849583749150665,-1.09277566817603,0.4,1.0,1.0,5/16,20.13%,GPI;PFKP;GAPDHS;ENO1;HK1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.6480341750735664,1.0926242414255367,0.4473684210526316,0.8826113912964644,1.0,2/6,18.94%,PTPRF;FRS2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.545996323295533,1.0924708030122783,0.3157894736842105,0.8818777572145688,1.0,5/12,20.33%,UBE2J1;YOD1;EDEM1;DERL2;UBAC2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.49300864652888626,1.0921872993181068,0.3333333333333333,0.8819568669902804,1.0,5/26,6.59%,HSPA1A;ERN1;HNRNPLL;RBM22;PRDX6
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.49350765690044957,1.0916461465990497,0.32142857142857145,0.8821047099465491,1.0,3/27,2.96%,TAF1A;POLR2L;POLR1F
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.5669812118864117,-1.0915455536197762,0.36486486486486486,1.0,1.0,5/26,14.69%,MTHFD1;LRP2;DVL2;VASP;TGFB1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.5669812118864117,-1.0915455536197762,0.36486486486486486,1.0,1.0,5/26,14.69%,MTHFD1;LRP2;DVL2;VASP;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.740490805720902,-1.0915199275902199,0.38596491228070173,1.0,1.0,1/7,1.05%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.66973932286861,-1.09138359086248,0.4246575342465753,1.0,1.0,1/7,5.13%,VEGFA
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5409843337135183,1.091298289576817,0.2571428571428571,0.8820112331963497,1.0,1/13,3.37%,RAN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5678185899041743,-1.0908572142558122,0.3582089552238806,1.0,1.0,6/23,18.12%,WDR91;P2RY12;ATG14;TGFB1;PDGFRB;DAB2IP
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.37963990282568216,1.0902516932827813,0.07692307692307693,0.8840151319584652,1.0,11/77,6.36%,UGDH;BGN;DSEL;GSTP1;CHST7;BCAN;B4GALT3;VCAN;CDO1;CNDP2;B4GALT6
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6833407046258955,-1.0901354362693054,0.410958904109589,1.0,1.0,4/7,24.27%,NLRP12;FOXP1;CEACAM1;TMED10
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4913634216136485,-1.0900698932503934,0.3048780487804878,1.0,1.0,22/72,26.23%,TTN;ITPR1;G6PC2;KCNJ11;APOE;CACNA1C;SNAP25;TGFB1;SLC8B1;ADAM9;GOLPH3L;DNM1L;KCNC2;RSAD2;KCNA5;TMED10;ENSA;SYT7;CACNA1E;PRKCA;TGFB3;SERGEF
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6195533100869897,-1.0900191187409691,0.3880597014925373,1.0,1.0,3/15,21.90%,SHTN1;KIF20B;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6554828883857791,-1.0895869200939754,0.3793103448275862,1.0,1.0,4/9,26.01%,CIITA;TRIM5;MID2;GSN
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.5736362918028762,-1.0891936378772673,0.36923076923076925,1.0,1.0,5/17,17.21%,PRELP;ST3GAL1;ACAN;OGN;ST3GAL6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4640350955719225,1.0888533556064277,0.3076923076923077,0.8864776319579112,1.0,4/37,7.64%,SOX4;PCBP4;PML;CNOT9
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5186718947211283,-1.0887763717803007,0.3291139240506329,1.0,1.0,13/49,17.07%,KCNJ13;SYT1;YWHAH;KCNJ11;SYT2;PDZK1;B2M;SYT4;WWP2;NKAIN2;PER1;CA2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.5046898780278672,1.0887224585566542,0.29411764705882354,0.8855903323978931,1.0,6/25,9.91%,RAN;TRIM28;RBM22;BAG3;SMAD3;CHP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.6904562822019571,1.0885241996242963,0.3870967741935484,0.885184751893229,1.0,1/5,10.69%,ARL6IP5
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5936652265182615,-1.0884978252567357,0.42028985507246375,1.0,1.0,8/25,13.57%,GPR18;PTPRC;CD27;HVCN1;SP140;IL7;TRAF3IP3;GNG7
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.6556990418187201,-1.0882387198187398,0.38235294117647056,1.0,1.0,2/8,10.04%,STK17A;BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6921355362723625,-1.088089820249641,0.3088235294117647,1.0,1.0,2/8,17.07%,CAV3;NEDD4L
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5332325439039648,1.0878938951451678,0.3125,0.8859604233830454,1.0,1/18,0.36%,DGKB
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.6337123707178731,-1.0878603862591403,0.4714285714285714,1.0,1.0,2/10,8.52%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6212681561063222,-1.0867976836394448,0.42028985507246375,1.0,1.0,5/12,21.59%,TPST1;SULT4A1;BPNT1;PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6397022144825685,-1.0867598441906376,0.421875,1.0,1.0,3/12,9.98%,ALOX12;ELOVL2;ACSL1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6148575577589422,-1.0867262044743973,0.3972602739726027,1.0,1.0,6/15,19.04%,SPI1;IL6R;STAT3;JAK1;ST18;STAT1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.5933077347977012,-1.0865462591109873,0.359375,1.0,1.0,1/20,0.20%,CD44
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.6444991866537677,-1.0864004077214795,0.4262295081967213,1.0,1.0,4/10,11.42%,SPI1;RARA;CDK4;SRP54
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5789776664563127,-1.0863713173385563,0.4230769230769231,1.0,1.0,3/18,11.30%,PTPRC;PARP14;SH3BP5
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.6304253515593548,-1.0861355651657445,0.38571428571428573,1.0,1.0,2/10,4.25%,BRCA1;SPI1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.6199463488921033,1.0858852064420328,0.358974358974359,0.8902876861045514,1.0,2/8,8.05%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.6885414663495648,-1.0857539848078719,0.42857142857142855,1.0,1.0,1/6,3.80%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6891891679470867,-1.0856845984414019,0.4666666666666667,1.0,1.0,6/7,27.68%,TGFB1;RIPK1;IL34;CSF1;PRKCA;ID2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6760469527099007,1.0856796033591383,0.43902439024390244,0.8896730770097331,1.0,3/5,19.26%,WNT5A;DNAJC19;CHD7
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.5680908328616289,1.0854241176573711,0.36363636363636365,0.8893496925194476,1.0,2/9,10.69%,SEMA5A;EPHB3
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6409196281063639,-1.0854141223192224,0.36923076923076925,1.0,1.0,4/8,20.26%,OAS1;MAP2K5;TIRAP;FOXP1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3460904030045144,1.0852817337228426,0.0,0.8887036932944508,1.0,56/292,16.14%,SIRT2;RNF144A;VPS37B;TNFAIP1;ADRM1;UBE2D4;GID8;PSMD8;RNF6;PSMB6;PSMB4;VPS28;KBTBD6;UBE2D1;PCBP2;PML;KLHL8;FBXO45;ELOC;UBXN1;UBA1;PSME3;KLHL42;UBE2I;TOLLIP;PSMD10;PELI1;KBTBD7;PPP1R11;AREL1;UBE2G1;TRIM71;HECTD3;RC3H1;SMURF2;UBQLN2;RCHY1;RNF128;KCTD10;CDC26;FBXW5;PSMD12;PSMB2;FBXL7;KCTD5;PSMD4;CDC34;NSFL1C;FBXL14;SPSB1;UBE2D2;ANAPC11;ERCC8;SIRT1;KCTD13;RAD23A
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.39518491577365905,1.0852080364629872,0.23529411764705882,0.8877362625183657,1.0,16/101,9.50%,SYNDIG1;OLIG2;NOVA1;SEMA5B;ADGRA1;ZNF536;MAP2;TMEM178A;BRINP1;TCEAL7;PCDH17;SPRY1;RGS7BP;DOK5;GPM6B;PDGFD
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.4830605420067725,1.085203227293411,0.4,0.8866693152797172,1.0,6/32,7.72%,ODC1;TMEM9;SNF8;CHRNA7;LDLR;PLAUR
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.5049284611437523,-1.0851477637602525,0.38271604938271603,1.0,1.0,12/63,15.42%,TTN;NLRC5;EMP2;TSPYL2;ALK;EPHA7;TYRO3;NTRK3;EPHA4;RBL2;PDGFRB;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.6098557111201464,1.0850862543510646,0.41025641025641024,0.8858763161868267,1.0,2/5,3.00%,HSPA1A;ACAA2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.45118558468869735,-1.0850514418006458,0.25,1.0,1.0,48/221,18.12%,IL5;SOX9;DUOX1;FOS;IRF1;DOCK8;CEBPD;CRLF1;BRCA1;IFNGR2;IL3RA;DAPK1;OPRM1;VEGFA;STAT6;LIFR;STAT4;STAT2;NR1D1;SHMT1;FOXO1;IL7;BCL2L11;TCF7;OSMR;JUNB;NLRP12;STAT5A;IL6R;STAT3;PTPRJ;JAK1;DAPK3;TGFB1;OAS1;IFIT1;GRB10;STAT5B;RIPK1;BCL6;F13A1;IRAK2;IL34;YBX3;ST3GAL6;TXLNA;ZFP36L2;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.6943550133741494,-1.085027409381679,0.3548387096774194,1.0,1.0,1/8,6.12%,SREBF1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.6943550133741494,-1.085027409381679,0.3548387096774194,1.0,1.0,1/8,6.12%,SREBF1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5767936964241752,1.084947601699236,0.25,0.8840761742440005,1.0,2/10,8.77%,RAP2A;RAP2C
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5767936964241752,1.084947601699236,0.25,0.8840761742440005,1.0,2/10,8.77%,RAP2A;RAP2C
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.6937628679403097,-1.0848097280322924,0.4461538461538462,1.0,1.0,1/6,4.25%,SPI1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.5124680127161894,-1.083731433270936,0.3157894736842105,1.0,1.0,14/56,16.38%,TRPC5;CALB1;FPR3;CALCB;CAV3;ACKR4;EDNRA;CACNA1C;ATP2B3;ADCY5;DLG4;RYR2;KNG1;SLC8B1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6966406641368814,-1.0831334362379192,0.4727272727272727,1.0,1.0,2/8,15.42%,CALCOCO2;IGF1R
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5181238333393537,1.0831277066141567,0.3125,0.8880035620314543,1.0,6/26,9.34%,SOX8;SEMA5B;SEMA5A;SOX10;SEMA4F;SEMA3B
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5795620384960882,-1.083102573581964,0.390625,1.0,1.0,4/14,23.40%,MTHFD1;NMNAT3;RRM1;NMNAT2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5635391497925366,1.0830346615698052,0.3333333333333333,0.8871284092726579,1.0,1/9,2.92%,CHST7
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.7037649738387841,-1.0826431348386565,0.32786885245901637,1.0,1.0,2/7,21.31%,SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.5630194354255376,-1.0826360570095142,0.38028169014084506,1.0,1.0,4/18,12.10%,LIMK1;VEGFA;SHTN1;MACF1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5904167750568013,1.0822155305274876,0.2702702702702703,0.8881264309705428,1.0,3/8,22.14%,FPGS;CALM1;AKT1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.38846941833750065,1.0821081387922191,0.23529411764705882,0.8872532484739478,1.0,8/69,9.31%,IPO13;PHB2;NUTF2;RAN;PRICKLE1;PPP1R10;PTTG1IP;ABCD2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.5581382472548315,-1.0820171579159101,0.38571428571428573,1.0,1.0,2/21,2.54%,SCEL;OVOL2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4472102524728196,1.081984039514038,0.3333333333333333,0.8865335177688652,1.0,12/80,8.04%,EMILIN3;AMOTL2;TUBB2B;MAGI1;AADAT;IGDCC4;GPR161;PCGF2;MEX3A;BCAR1;YAP1;LAPTM4B
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6269238229755376,-1.0818222837046598,0.40789473684210525,1.0,1.0,4/13,12.47%,EMP2;RFTN1;CAV3;NAXE
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5477368439301584,-1.0818133090382216,0.3783783783783784,1.0,1.0,6/27,20.06%,DND1;THRAP3;TENT5A;MEIOC;YBX3;TIRAP
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5658874739376011,-1.0817536519540325,0.4383561643835616,1.0,1.0,2/23,1.04%,CYP2E1;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.7287651993450335,-1.0816145527393832,0.45161290322580644,1.0,1.0,1/5,3.52%,TIMP3
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5687859865313674,-1.081446236371678,0.4375,1.0,1.0,8/21,25.79%,TGFB1;AP2A2;ZNRF3;AP2A1;AP2M1;CLTC;CLTA;SNX25
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.3675511069871935,1.0813640731437903,0.3,0.8870751699337162,1.0,20/120,13.37%,THNSL2;DUSP7;PLPPR2;SGPP1;PPM1A;PTPN14;PPM1H;PSPH;HDHD2;PTPRF;DUSP3;DUSP15;FBP1;PPM1E;PPP2R1A;PPP1CC;PPP1R12A;PLPPR1;PTPRO;PPP6C
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.6729749454514091,1.0808542407873754,0.35555555555555557,0.8874645403483656,1.0,2/5,14.45%,SULT1C4;ALDH2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.7004168527231138,-1.0806515141853144,0.417910447761194,1.0,1.0,2/6,10.24%,SFXN3;SLC1A4
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.4094550366023492,1.080523968569278,0.2222222222222222,0.8874341028202909,1.0,9/65,12.73%,POLR2J;POLR2L;GTF2A2;SP1;RPRD1B;GTF2F1;POLR2K;INTS9;INTS7
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5242611597409985,-1.0803953528156116,0.4166666666666667,1.0,1.0,2/31,5.13%,CD44;VEGFA
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5417380579396714,1.080312513642928,0.35294117647058826,0.8870188421532935,1.0,2/10,5.91%,CRB2;THY1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6870128607945335,-1.0799244954209217,0.4264705882352941,1.0,1.0,2/9,9.40%,HLA-F;B2M
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2969650345191983,1.079788273669059,0.0,0.8876074504349135,1.0,59/311,16.18%,UBB;NUP42;RFWD3;RNF144A;TNFAIP1;CUL7;UBE2D4;CAND2;RNF6;TRIM28;UBE2D1;UBE2N;RNF139;RRAGA;KLHL13;TRIM35;KLHL8;FBXO45;ELOC;UBA1;TSPAN17;DTX4;UBE2I;SDE2;UBE2Q2;AREL1;CBLL1;UBE2G1;COMMD1;KLHL2;CDC73;UBC;SMURF2;RNF25;MUL1;RCHY1;KCTD10;TRIM4;MKRN2;ARRDC4;FBXW5;OTULIN;SUMO1;TRIM24;NUP35;CUL9;TRPM4;PEX13;FBXL7;RNF135;CDC34;SPSB1;UBE2D2;ANAPC11;SEH1L;SUMO3;SIRT1;KCTD13;NUP214
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5850348359209219,-1.0796112922889667,0.4,1.0,1.0,5/15,20.13%,GPI;PFKP;GAPDHS;ENO1;HK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5850348359209219,-1.0796112922889667,0.4,1.0,1.0,5/15,20.13%,GPI;PFKP;GAPDHS;ENO1;HK1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.751125633287415,-1.0796004198956441,0.43283582089552236,1.0,1.0,1/6,2.10%,NECAB1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.385261685443118,1.0793030895519267,0.2727272727272727,0.888061089918112,1.0,20/95,15.11%,VANGL1;CCDC88C;PSMD8;ROR2;PSMB6;PSMB4;PRICKLE1;FRZB;PSME3;PSMD10;FZD3;SMURF2;NFATC1;PLCB1;PSMD12;PSMB2;CALM1;PSMD4;CDC42;WNT5A
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5289438601965335,-1.0792754471863257,0.38461538461538464,1.0,1.0,16/33,21.70%,IRF1;MX1;PSMB8;STAT2;HLA-F;HLA-C;JAK1;OAS1;IFIT1;IFIT3;IFI35;IRF2;STAT1;HLA-B;IFI6;RSAD2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5289438601965335,-1.0792754471863257,0.38461538461538464,1.0,1.0,16/33,21.70%,IRF1;MX1;PSMB8;STAT2;HLA-F;HLA-C;JAK1;OAS1;IFIT1;IFIT3;IFI35;IRF2;STAT1;HLA-B;IFI6;RSAD2
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.43948303638457015,-1.0792479323920587,0.30927835051546393,1.0,1.0,59/297,20.75%,NUAK1;CAMK1;STK17A;MAK;CDK7;TSSK3;DAPK1;LIMK1;RARA;NEK3;TLK1;CDK19;GRK4;MAP3K12;ALK;CAMK2B;NEK11;CDK4;FAM20C;EPHA7;TAF1;TRIB1;CAMK2A;PAK1;VRK1;PDK1;COQ8B;PLK2;VRK2;PAK2;STAT3;CSNK1D;NEK6;PDK2;MKNK1;MAP2K1;JAK1;DAPK3;TGFB1;STRADB;PNKP;DCLK1;DGKZ;CTBP1;CDC42BPB;BCR;CAMK2D;ATM;TNIK;PRKAR1B;HTR2B;FAM20A;PRKD2;PIK3CB;CDKL1;AGK;HK1;CSNK1G2;MERTK
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.7160461131684979,-1.0788293230725627,0.4098360655737705,1.0,1.0,2/6,16.33%,FLG;F13A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.5745829228654354,-1.0787682028565084,0.37037037037037035,1.0,1.0,6/20,17.64%,DSC2;CAV3;CACNA1C;CTNNA3;RYR2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.695407037517083,-1.0786120025425239,0.45454545454545453,1.0,1.0,4/6,24.10%,P2RY12;ADAM9;PIEZO1;RAC3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3292734804100866,1.0784171228942256,0.0,0.8893140141449151,1.0,55/302,12.24%,ZNF488;SOX4;TCF7L1;SOX11;POU6F2;SLC2A4RG;ZNF676;ONECUT1;RNF6;CNBP;CALR;ZNF117;WTIP;HP1BP3;ESR1;SOX21;ZNF536;POFUT1;PML;TFEB;ZNF22;BTG1;MED23;GPBP1L1;ZNF114;ZNF519;RYBP;SP1;HES6;ZNF195;ZNF678;NR3C1;SOX6;ZFPL1;ESRRG;LIMD1;COPS2;SP3;KAT6B;FOXN2;TGFBR1;PPP2R1A;NFYA;ACTR8;ATF4;WWC2;ZBTB11;ZNF268;ZNF212;ZNF460;NFIL3;TRIP4;FADS1;ZNF516;SPIN2B
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6392760541811323,1.0779527226002135,0.42857142857142855,0.8894980519182684,1.0,4/6,34.37%,VCP;CHMP2B;UBXN6;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.6477853749322808,-1.0779034291617104,0.4375,1.0,1.0,2/9,8.03%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5770436896811184,1.0776381605268006,0.2647058823529412,0.8893323241044,1.0,2/11,9.22%,PLIN2;ABHD5
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.4078184311827268,1.077623964387086,0.26666666666666666,0.8883030297483977,1.0,7/72,5.94%,TAF1A;GPX1;ACTB;POLR2L;POLR1F;DNMT3B;WBP2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5084816100627805,-1.076426787466372,0.37662337662337664,1.0,1.0,14/44,16.11%,HTR2C;GPR18;GRM1;FPR3;CAV3;ACKR4;EDNRA;CACNA1C;LPAR6;ADCY5;JPH3;DLG4;RYR2;KNG1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.609366688457281,-1.0764252320314553,0.40625,1.0,1.0,3/10,16.25%,CAMK2B;DLG4;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5595975342919136,1.0758760391939544,0.45,0.8917899878201571,1.0,4/15,9.33%,SIRT2;SLC30A10;ABCD2;MT3
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5682482595929581,1.0758408530360937,0.358974358974359,0.8908596681594919,1.0,3/13,12.02%,SNF8;VPS28;VTA1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.7136006658888624,-1.075420063628571,0.4032258064516129,1.0,1.0,1/6,6.54%,PUS7
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.6321540287602677,1.0751902749633657,0.3783783783783784,0.8914546535623098,1.0,3/7,13.34%,PLXNA3;PLXNC1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.7271415860487195,-1.075130678366144,0.3793103448275862,1.0,1.0,1/5,7.53%,STX1B
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5295735973035325,1.0747771838312683,0.4,0.8915356191472575,1.0,3/14,7.93%,SOX11;PDGFRA;SLC2A10
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.49729970958065156,-1.074734588874809,0.4155844155844156,1.0,1.0,5/48,12.55%,NR4A3;ZFPM1;SPI1;MEIS2;RBM15
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6543932620765918,1.0743323877381363,0.45652173913043476,0.8915833604099956,1.0,1/5,15.77%,B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.48594374040752686,-1.0739240552632132,0.32051282051282054,1.0,1.0,15/62,20.55%,STMN2;ANKRD53;LIMK1;CAV3;APOE;PFN2;CDC42EP3;PAK1;VASP;VIL1;BAIAP2;DCTN1;SYNPO2;LMOD1;PSEN1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.6344879202478055,-1.073808445403776,0.4153846153846154,1.0,1.0,7/17,20.40%,ANGPTL4;CEBPD;ABCC3;RAB20;RBM47;RDH12;HRH1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.4865130995388336,1.0736129098264235,0.3684210526315789,0.8922743484177159,1.0,4/25,10.45%,POLR2L;RO60;GTF3C6;POLR2K
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.7189443579116244,-1.0735943578602636,0.4603174603174603,1.0,1.0,5/6,28.08%,ADCY3;SHANK1;SLC6A1;BRSK1;MAP1A
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.544568853913429,1.0734612820104237,0.3333333333333333,0.8916455498125964,1.0,1/12,3.37%,RAN
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5262040609907828,-1.0733892007390289,0.39473684210526316,1.0,1.0,9/29,17.86%,LRRC19;PTP4A3;CD27;TRIM44;NLRP12;C1QTNF4;PDCD4;IFI35;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.48520292508781737,1.073309980511912,0.4,0.8909359526594106,1.0,7/15,13.49%,PPP1R35;PPP1R8;CHP1;GPATCH2;YWHAB;MFHAS1;PPP1R26
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.7106465690598753,-1.0728900655474491,0.4716981132075472,1.0,1.0,2/5,11.03%,SOX9;PBLD
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.7040357780388442,1.072771200459224,0.5238095238095238,0.8916745693502551,1.0,3/5,24.95%,REL;PTPRS;YY1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.674447637578123,-1.072746227169686,0.421875,1.0,1.0,2/6,29.00%,DDX11;WAPL
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.7051407618069518,-1.072637212419166,0.4307692307692308,1.0,1.0,3/7,12.81%,TPST1;SULT4A1;BPNT1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.7295468655344222,-1.072610604561717,0.3939393939393939,1.0,1.0,1/5,1.05%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.6011187688388084,-1.072381432039533,0.36619718309859156,1.0,1.0,1/15,2.64%,RPS6KB2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.4140708190450464,1.0723035206871954,0.25,0.8916561907159711,1.0,5/54,2.23%,MMP2;PRRX1;AMOTL2;TCF7L1;COL12A1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.6211431475826372,1.072260825238661,0.4444444444444444,0.8906375076468845,1.0,3/11,24.45%,RNF128;LAMTOR5;LAMTOR4
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.7113737957773894,-1.0722379287472135,0.375,1.0,1.0,2/5,25.68%,VRK1;PRKCA
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.7328672695396647,-1.0720158958588448,0.421875,1.0,1.0,1/5,1.45%,SLC6A6
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.540975484770996,1.0719807205221277,0.42105263157894735,0.8902764174267365,1.0,4/12,11.37%,HSPA1A;ACAA2;BOK;MUL1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5594071266241122,1.0715425310654496,0.3103448275862069,0.8905705991395894,1.0,2/11,9.28%,IDH1;ACLY
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.49522088587506086,-1.0712939643077064,0.36585365853658536,1.0,1.0,8/46,9.59%,SCEL;OVOL2;CDKN2A;BRCA1;ITGA2;TMC4;FMO5;LIPH
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.627352098145368,-1.0710417910545997,0.4657534246575342,1.0,1.0,1/11,1.04%,ALOX12
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5400630922845343,-1.0710399438438705,0.32894736842105265,1.0,1.0,10/26,21.78%,ENO4;LDHA;MAN2B2;GPI;GAPDHS;ENO1;MAN2C1;ENOSF1;HK1;PFKFB2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6672590969195261,-1.0707694022058205,0.44776119402985076,1.0,1.0,1/9,1.24%,ITPR1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.6028848538118485,-1.070726956312485,0.36363636363636365,1.0,1.0,3/12,15.26%,SLC2A3;SLC2A12;SLC5A9
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7042613340842225,-1.0707085097432272,0.44285714285714284,1.0,1.0,3/6,24.41%,RARA;RSAD2;PRKCZ
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.49011165170474885,1.0705642730711051,0.2962962962962963,0.8922857854120808,1.0,1/14,2.90%,NT5E
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.3466000543419187,1.0705247972677203,0.25,0.891303790237021,1.0,39/270,9.56%,SOX4;TAF1A;STOX1;PLD1;SOX11;PIWIL2;ACTB;POLR2L;ACTG1;HSPA1A;SNF8;POLR1F;ERN1;MSN;IL15;NPM1;EIF3D;HNRNPLL;EEF2;MYCN;DNMT3B;MED23;RBM22;WBP2;PLA2R1;WNT3;RBPJ;SP1;YAP1;NGF;SLC2A10;MAPK11;LIMS1;FXR2;SMAD3;MT3;POLDIP3;EIF4A3;LRP3
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.35508297496987784,1.0704145559636176,0.25,0.890601248812793,1.0,21/95,15.15%,PPP1R14B;MALT1;PHB2;IKBKB;TRIM28;ZDHHC1;TRIM35;PML;SMPD1;LYN;S100B;TNK2;COLEC12;INAVA;MASP1;TRIM4;MFHAS1;OTULIN;RNF135;RIPK2;REL
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5284078129285078,-1.070355665842905,0.38271604938271603,1.0,1.0,11/36,19.25%,KIAA0040;IRF1;HLA-F;HLA-C;JUNB;VASP;IFIH1;TYMP;IFI35;PRKD2;CD55
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7249513690961702,-1.070268162033048,0.5,1.0,1.0,1/5,1.40%,SOX9
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5029422839420502,1.070162055300372,0.41379310344827586,0.8903563026539935,1.0,3/17,6.66%,SOX4;ERN1;ZNF236
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.38301089161478175,1.0698572375135849,0.16666666666666666,0.8900793997047695,1.0,30/224,8.60%,NOX4;SOX4;SIRT2;FABP7;SOX11;PODN;GPNMB;HSPA1A;GSTP1;ROR2;TNS2;SMYD2;CGRRF1;NPM1;RNF139;PML;BTG1;FRZB;BTG3;LYN;IGFBP7;PTPN14;NGF;ATP8A2;ADRA1A;P3H2;MTSS1;MN1;CDKN2C;GREM1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.6803439745597095,-1.0696924815054374,0.4576271186440678,1.0,1.0,3/6,25.57%,RAB11FIP5;PTPRN;RAB11FIP2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.5896183606193379,1.0695640671115034,0.4,0.8897219143204662,1.0,1/8,2.78%,ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6500087989810686,-1.0694825871334395,0.4482758620689655,1.0,1.0,2/7,11.50%,APOE;SPP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.671859948042152,1.0694543663088274,0.45161290322580644,0.8888622285566359,1.0,1/5,2.78%,ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5630209669145504,-1.0692555567174835,0.3424657534246575,1.0,1.0,7/26,20.73%,POLQ;HELB;FANCB;SHLD2;RIF1;RNF169;CGAS
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.45106794152874147,-1.0691131805839404,0.3068181818181818,1.0,1.0,19/138,13.73%,CD44;ANGPTL4;SOX9;NDST3;PYGL;TPST1;DSC2;VEGFA;GMPPA;LDHA;COL5A1;SLC16A3;PYGB;PPFIA4;PFKP;GLRX;GCLC;BPNT1;GAPDHS
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.43946470634913304,1.069012718460883,0.35294117647058826,0.8893173956725424,1.0,8/39,4.41%,TSPO;CUBN;ARV1;MSMO1;FDX1;HSD17B10;STARD3;DHRS4
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.7193304691110024,-1.0688978410605494,0.4,1.0,1.0,3/5,23.00%,RHCE;RHCG;SLC12A4
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.630463299547088,1.0688625660819344,0.3939393939393939,0.8885573172830626,1.0,4/11,3.02%,SOX11;SOX8;KLHL12;PEF1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6426834498585026,-1.0686883825949929,0.391304347826087,1.0,1.0,3/9,13.02%,TRIM44;IL7;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.6644683180815503,-1.068456172893579,0.4098360655737705,1.0,1.0,1/7,0.82%,DND1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.589712383787719,-1.0682209692188884,0.4,1.0,1.0,4/17,19.27%,SREBF1;HDAC6;USP36;DNM1L
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.7121577842979971,-1.0681346423219906,0.4482758620689655,1.0,1.0,3/5,18.25%,GLRA1;SPINK13;POMZP3
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.6737142454581366,-1.0677525413270148,0.5211267605633803,1.0,1.0,2/9,17.35%,INTU;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5144434527452278,1.067694053191748,0.3333333333333333,0.8913726469461442,1.0,8/18,14.79%,GPNMB;RAP2A;CALM3;GREM1;RAP2C;PDGFD;PDGFC;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5048564358120962,1.0676409318426605,0.37037037037037035,0.8905634924629475,1.0,5/15,6.42%,STOX1;CCND1;NPM1;RCC2;RAD51B
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.616657018275859,1.0674419736731973,0.3870967741935484,0.8898852777726607,1.0,2/6,16.82%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.7037620832331386,-1.0673220574876536,0.49122807017543857,1.0,1.0,1/5,7.72%,SLC6A9
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.6966473056133029,1.0671905924534664,0.4791666666666667,0.8895953734032861,1.0,2/5,10.83%,ATP6V1G1;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.493241633331573,1.0671033114943325,0.3076923076923077,0.8888232764260185,1.0,7/15,20.57%,MFF;MUL1;FIS1;RALA;PINK1;VPS35;MCU
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.6241520646688645,-1.0669247571386975,0.40298507462686567,1.0,1.0,1/13,0.20%,CD44
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.5511385907925769,1.066884987283901,0.28125,0.8883584247680512,1.0,2/9,4.53%,EIF4H;EIF5
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4181573816253864,1.0666669944870937,0.28,0.8868545069695309,1.0,2/33,3.37%,NUP42;RAN
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4181573816253864,1.0666669944870937,0.28,0.8868545069695309,1.0,2/33,3.37%,NUP42;RAN
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.5787794370407034,-1.0662184149552691,0.410958904109589,1.0,1.0,6/25,9.59%,FABP3;CAV3;LIPI;GPAM;APOE;LIPH
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.39626310813821153,1.0661901350565672,0.3125,0.8868741686138545,1.0,19/93,14.98%,UBB;PSMD8;PSMB6;TAB3;PSMB4;IKBKB;UBE2N;PSME3;TOLLIP;PSMD10;PELI1;MAPK11;RC3H1;UBC;PLCB1;PSMD12;PSMB2;PSMD4;RIPK2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.47343141211222206,-1.0661468512983945,0.35714285714285715,1.0,1.0,19/86,17.02%,IQSEC2;SYT1;GRM1;KCNMB4;GRIK5;CPLX1;STX1B;CACNA1B;RIMS1;GRM3;CAMK2A;BEGAIN;SYN3;NPTX1;BDNF;DLG4;DGKZ;SLC4A8;BCR
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.5744909414231395,-1.0658394104963753,0.38095238095238093,1.0,1.0,1/11,10.48%,XRCC3
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.6615757937623574,-1.0655150522140027,0.4383561643835616,1.0,1.0,2/7,17.27%,ENTPD3;ENTPD7
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5406791707439121,-1.0655127034461689,0.375,1.0,1.0,4/27,4.79%,CD44;LFNG;PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.5083444380190855,-1.0654822367584604,0.375,1.0,1.0,9/38,25.54%,NR4A3;ZFPM1;RBM15;KMT2A;AGO1;AGO4;MEF2C;ZNF16;SIN3A
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6788644880339638,1.0654663549155206,0.46511627906976744,0.8876939273582637,1.0,1/5,12.41%,LAGE3
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.4979166296804395,1.0653476448895158,0.4,0.8869293407579028,1.0,3/17,7.02%,PRELID3B;LDLR;SCARB1
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.7180893568409211,-1.0650661856487644,0.4714285714285714,1.0,1.0,2/5,8.16%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.6810248350648078,-1.0649489991725327,0.5362318840579711,1.0,1.0,2/7,24.76%,RAB20;SYT7
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5453054870377343,1.0648497860792603,0.3888888888888889,0.8873799334941214,1.0,4/12,9.22%,NR1H2;LDLR;SCARB1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5548726778437126,1.064724708144626,0.375,0.8865377216606625,1.0,5/13,26.37%,SP1;JUN;ZNF639;SMARCB1;CCNT1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4828665790491011,1.06440747339289,0.46153846153846156,0.8861753249997405,1.0,5/41,6.42%,STOX1;CCND1;PHB2;RCC2;RAD51B
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5563555386554655,1.064313664582556,0.45161290322580644,0.8854796203730879,1.0,4/19,10.94%,HSPA1A;TMBIM6;BOK;CREB3L1
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.4053220534460078,1.0641984656135195,0.3333333333333333,0.8847696128152215,1.0,9/73,3.35%,MMP2;PRRX1;AMOTL2;BGN;HSPG2;COL12A1;TNS2;GPC1;ACHE
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.5664962509536904,-1.0641402702337763,0.36486486486486486,1.0,1.0,6/22,19.73%,DAPK1;CALCOCO2;DAPK3;CIITA;STAT1;AQP4
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.5946332661123976,1.0639499292706636,0.3783783783783784,0.8844422255686362,1.0,3/8,9.52%,SEMA5A;LIMA1;CFL2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.45757523660493954,1.0638190139028763,0.34615384615384615,0.8838935887639887,1.0,3/26,3.12%,NOX4;BTC;TGFA
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6543108746536078,-1.0635037035945327,0.5294117647058824,1.0,1.0,2/11,10.65%,LHFPL5;ADGRV1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.689609151786873,-1.0631481446994582,0.4032258064516129,1.0,1.0,3/5,27.70%,CHDH;DMGDH;ALDH7A1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.4865974601266984,1.0630347876916706,0.37037037037037035,0.8850409542356423,1.0,5/23,13.60%,UBB;PARP1;GTF2H2;UBC;ERCC4
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.6367823248192864,-1.0627537280265096,0.4852941176470588,1.0,1.0,1/8,2.39%,PYGL
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.5303432830859887,-1.0627287188655627,0.36363636363636365,1.0,1.0,1/26,1.40%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.71022020235582,-1.0626896290805634,0.53125,1.0,1.0,2/5,15.00%,CLEC16A;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.5426311328052195,-1.0625136302127591,0.3783783783783784,1.0,1.0,3/19,15.17%,MYLK;CAMK2A;PDGFRB
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.7114215665849655,-1.0623655419843543,0.49206349206349204,1.0,1.0,3/7,13.21%,ENPP2;PDXDC1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6591805483001308,-1.0618489558884465,0.38571428571428573,1.0,1.0,2/7,10.04%,STK17A;BCL2L11
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.4110501478426104,1.0617555823595628,0.23076923076923078,0.8875937593669838,1.0,2/35,3.37%,NUP42;RAN
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.7249835125471125,-1.0616224760126192,0.45614035087719296,1.0,1.0,1/5,5.13%,VEGFA
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.559818290107884,-1.0614219937593796,0.34375,1.0,1.0,5/14,24.02%,CALY;FCHO1;EPS15;CLTC;CLTA
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.5340405596927976,-1.0614012633922836,0.375,1.0,1.0,8/31,22.44%,GLRA2;GLRA1;RPTOR;NSMF;CASTOR2;CAPN2;CPEB1;XBP1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.40393258103910423,1.06102405314976,0.21052631578947367,0.8889397489992082,1.0,9/66,12.73%,POLR2J;POLR2L;GTF2A2;SP1;RPRD1B;GTF2F1;POLR2K;INTS9;INTS7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.6702773054674569,-1.0608324597196261,0.5081967213114754,1.0,1.0,1/7,6.12%,SREBF1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.5518532556354706,-1.0605547087540186,0.40789473684210525,1.0,1.0,2/24,5.42%,GLRA2;GLRA1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5626479970614083,-1.0604316306322563,0.4266666666666667,1.0,1.0,3/20,8.28%,NUBP1;CIAO2A;MMS19
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.6616097428177687,1.0603614904096776,0.45,0.8894145149619048,1.0,2/5,10.67%,ZBTB1;ATF4
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4017588276843098,1.06029163514185,0.32,0.88864261314333,1.0,9/50,14.96%,PSMD8;PSMB6;PSMB4;PSME3;PSMD10;PSMD12;PSMB2;FBXL7;PSMD4
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5328497444443395,-1.0602506986274183,0.4383561643835616,1.0,1.0,6/35,9.91%,GNA12;ARHGDIG;LIMK1;RHOJ;SHTN1;CDC42EP3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.6562984216041754,1.0586335488082934,0.42105263157894735,0.8924554539709947,1.0,2/5,17.69%,PML;ETS1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6475696519876741,-1.058467553630359,0.47692307692307695,1.0,1.0,3/6,20.27%,EDNRA;HTR2B;ACTA2
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.7007466251407523,-1.0583478069678105,0.4576271186440678,1.0,1.0,2/5,13.22%,AGT;NTRK3
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5935146897720255,1.0582946375288478,0.38461538461538464,0.8923268420860216,1.0,2/5,17.86%,WNT5A;LRP6
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5071261111427134,-1.0582164890350656,0.42857142857142855,1.0,1.0,8/51,12.01%,CRYM;LHFPL5;CEMIP;LRP2;KCNQ1;ADGRV1;NDUFB9;SLC26A5
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.35718189469129247,1.058010715801388,0.3181818181818182,0.8920099584891694,1.0,1/38,0.61%,NUP42
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5032768042606339,-1.05766138822579,0.4470588235294118,1.0,1.0,13/48,17.51%,NR4A3;ROBO2;RARA;ARID5A;KLF9;NCOA1;LMO2;AKR1C2;STAT3;SRA1;NSMF;STAT5B;RDX
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.48144472790541054,-1.0575936034704272,0.3614457831325301,1.0,1.0,12/47,19.04%,PTPRC;IFNGR2;LIFR;TRIM44;IL7;VRK2;JAK1;RIPK1;IRAK2;MADD;SPPL2B;STAT1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.6798115150777253,-1.057378100947575,0.4375,1.0,1.0,2/8,8.85%,MCCC1;BTD
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.46614653719211785,-1.0568608458597584,0.35365853658536583,1.0,1.0,23/73,23.00%,KCNJ13;KCNH7;KCNC1;KCNJ11;KCNN3;HCN3;KCNH1;KCNQ1;SLC24A2;KCNC4;KCNB2;HCN1;KCNG4;KCNK10;KCNQ5;HCN2;KCNC2;ATP1B1;KCNK12;KCNA5;NALCN;SLC24A4;SLC12A4
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.571425817479683,-1.056733835699302,0.3815789473684211,1.0,1.0,1/15,0.30%,HEY2
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.46923350662314456,1.0560067371059312,0.28125,0.8965751823432101,1.0,7/24,14.91%,STARD3;LDLR;SCARB1;LIMA1;STARD4;OSBP;SOAT1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.630541738322762,-1.0559881115421297,0.37681159420289856,1.0,1.0,3/13,6.10%,RAB17;MREG;RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.630541738322762,-1.0559881115421297,0.37681159420289856,1.0,1.0,3/13,6.10%,RAB17;MREG;RAB11A
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5681940107376845,-1.0559190746237574,0.4383561643835616,1.0,1.0,4/21,8.44%,CCDC39;SRF;MMP21;AHI1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.6769067210854705,-1.0558083690961926,0.4107142857142857,1.0,1.0,1/5,8.60%,PLSCR1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5382240323988936,1.0556969917803924,0.4375,0.8962855798907399,1.0,3/29,3.58%,FLRT3;SEMA5B;SEMA5A
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.37348258143004204,1.0556864403805013,0.2,0.8953075701702893,1.0,26/94,20.51%,LZTS1;ERN1;VPS26B;RRAGA;CAPNS1;TBC1D25;ATP6V0E1;ATP6V1G1;MLST8;GPSM1;ATP6V1B2;ATP6V0D1;LAMTOR2;UBQLN2;LAMTOR1;ATG101;SCOC;SNX5;SIRT1;EXOC7;CAPN1;GAPDH;ATP6V1H;PINK1;EPM2A;VPS35
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5628157944480863,-1.0552623985030651,0.4246575342465753,1.0,1.0,3/19,8.28%,NUBP1;CIAO2A;MMS19
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.4860627680684718,-1.0552037938708954,0.3783783783783784,1.0,1.0,15/67,18.37%,CAMK1;FGF1;SPDYA;TPD52L1;MTCP1;CEMIP;VEGFA;RASGRP1;MAP2K1;TGFB1;PDGFRB;RPTOR;IL34;DAB2IP;HTR2B
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.7059061866537901,1.0551417818708562,0.5238095238095238,0.8958178293538218,1.0,4/5,22.12%,RBP1;ALDH1A2;BCO1;RLBP1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.564334047856054,1.0551372733263815,0.5,0.8948112924669074,1.0,4/8,20.33%,UBE2J1;YOD1;DERL2;UBAC2
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.6797118363544244,1.0549193353587467,0.5,0.8942908540870603,1.0,2/5,19.27%,MECP2;KDM1B
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.6061704212260328,-1.0548841287400743,0.4153846153846154,1.0,1.0,2/11,8.79%,EME2;NEK11
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.620761630324197,-1.0546254101005694,0.44776119402985076,1.0,1.0,2/13,6.89%,CAMK1;EMD
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4228860475241153,1.0544529013078723,0.2916666666666667,0.8945510934875082,1.0,4/51,7.64%,SOX4;PCBP4;PML;CNOT9
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.38801124685884036,1.054346809717043,0.35714285714285715,0.8938608117269459,1.0,6/93,5.30%,USP51;SIRT2;HDAC11;PRMT6;UBE2N;ATXN7L3
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6395087649077784,-1.0542886387272998,0.5151515151515151,1.0,1.0,2/9,21.31%,NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.41990142634014516,1.0541579866214417,0.375,0.8933431829621764,1.0,9/46,14.96%,PSMD8;PSMB6;PSMB4;PSME3;PSMD10;PSMD12;PSMB2;FBXL7;PSMD4
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.5446891662163563,1.0541491666832028,0.32432432432432434,0.892360572114247,1.0,4/11,21.66%,QRICH1;ATF4;HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.65223437480024,-1.0540292498187496,0.4166666666666667,1.0,1.0,2/8,18.41%,SRP54;CLMP
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.6222047752288852,1.0539979479114696,0.4883720930232558,0.8918147319086426,1.0,1/7,3.58%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5458915721355007,-1.0538915641143594,0.3918918918918919,1.0,1.0,8/17,25.54%,PARP9;TRIM44;DTX3L;TOMM70;STAT1;CGAS;MAVS;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5875174096226106,-1.0537910773342591,0.4264705882352941,1.0,1.0,3/16,9.40%,HES1;SOX9;B2M
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.48889600576720804,-1.0537581929234914,0.39473684210526316,1.0,1.0,18/53,18.51%,AHR;CEBPD;ABCC3;HLA-C;JUNB;DTX3L;TAPBP;SYNGR2;IFIH1;RAB20;BHLHE40;OAS1;CTSZ;TYMP;SLC8B1;RBM47;IRF2;NFIC
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.4842972821210884,-1.0536216277198402,0.379746835443038,1.0,1.0,13/70,17.07%,SYT1;LIMK1;SHTN1;BRAT1;SYT2;RIMS1;RNF157;SYT4;MACF1;BDNF;NCBP1;RPTOR;NEDD4L
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.4794098963715637,1.0533375132909744,0.3888888888888889,0.892618897192547,1.0,2/23,3.09%,FGF12;KCNN2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.6333094695279559,-1.053272877998725,0.4666666666666667,1.0,1.0,5/8,28.28%,LPCAT3;MBOAT2;OSBPL10;PLAAT3;PLA2G12A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.627272759772421,-1.0531464811547924,0.4603174603174603,1.0,1.0,1/11,3.96%,PARP14
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5328699712759095,-1.0527756274292528,0.36585365853658536,1.0,1.0,12/35,22.86%,STAT6;STAT4;STAT2;EIF2B4;STAT5A;STAT3;TSC1;STAT5B;STAT1;TGFBR3;XBP1;SORT1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5621328109702011,-1.0527106134722544,0.40789473684210525,1.0,1.0,1/18,1.16%,NR4A3
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.555080369066862,-1.0524237093123154,0.4142857142857143,1.0,1.0,6/18,17.64%,SLC4A4;RHCG;SLC4A8;NEDD4L;SLC4A3;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.6558438952547296,-1.0523821648860188,0.4057971014492754,1.0,1.0,3/7,20.09%,CAMK2B;DAB2IP;RELN
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.6303133826703219,-1.0522055578569187,0.4142857142857143,1.0,1.0,2/8,7.52%,NAAA;DEGS2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.48939972754830013,-1.0521431139246027,0.3684210526315789,1.0,1.0,18/60,22.16%,AHR;CD160;IRF1;HLA-F;PLSCR1;HLA-C;B2M;PILRA;PVR;TRAF3;BCL6;SPPL2B;HLA-B;NPDC1;TIRAP;FOXP1;RSAD2;SPINK5
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.5092097480323688,-1.0520800768171636,0.37681159420289856,1.0,1.0,5/36,7.55%,RRH;DDB2;UVSSA;MSH6;ZRANB3
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6565963712822036,-1.0519130350135768,0.373134328358209,1.0,1.0,1/7,0.30%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.6685131496457757,-1.0518313721034478,0.45901639344262296,1.0,1.0,2/7,8.03%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.7040669047873205,-1.0516098632094473,0.49122807017543857,1.0,1.0,2/5,14.55%,VSIR;PDCD1LG2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6178707751084777,-1.051592471228627,0.43661971830985913,1.0,1.0,3/8,16.72%,PRELP;ACAN;OGN
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.681426248883979,-1.0513059040355175,0.4603174603174603,1.0,1.0,2/6,8.03%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.6076895917425496,-1.0512925687902663,0.40298507462686567,1.0,1.0,2/10,11.69%,SHMT1;TMLHE
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.44457271075778404,1.051263656975368,0.30434782608695654,0.8972927842868615,1.0,2/34,0.96%,USP51;PPP4C
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.5859852838581748,1.051246699005128,0.375,0.8953606068731806,1.0,1/6,0.49%,SIRT2
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.5859852838581748,1.051246699005128,0.375,0.8953606068731806,1.0,1/6,0.49%,SIRT2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.6178331431433786,1.051186640474976,0.43243243243243246,0.8935140847588139,1.0,3/6,26.07%,CHP1;PRNP;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6178331431433786,1.051186640474976,0.43243243243243246,0.8935140847588139,1.0,3/6,26.07%,CHP1;PRNP;DYRK2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4934355671394859,1.0510964110705137,0.4166666666666667,0.8927247935939076,1.0,3/26,4.04%,UGDH;GAL3ST3;B3GAT2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.61810818981237,-1.0509281631706424,0.5076923076923077,1.0,1.0,2/12,5.25%,VEGFA;SRF
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.5704601703150358,-1.0507830937509313,0.4583333333333333,1.0,1.0,5/19,15.63%,P2RY12;ATG14;TGFB1;PDGFRB;DGKZ
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5664562437333432,-1.0507415009518546,0.39705882352941174,1.0,1.0,1/13,0.87%,NAAA
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.6350905210503148,-1.050393937857604,0.39622641509433965,1.0,1.0,2/6,16.25%,APOE;SHANK3
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5565113521214178,1.0496707459415389,0.42857142857142855,0.8955523165746508,1.0,6/15,12.45%,RAP2A;RBM22;PDE4B;FBP1;PPM1E;ACER2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6272822121339083,1.049613962779773,0.42857142857142855,0.8947164187007038,1.0,3/6,36.26%,FBXW7;NONO;PARK7
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.603114285056573,-1.0492787924324198,0.45161290322580644,1.0,1.0,3/12,16.82%,HES1;TGFB1;IL34
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5602144135926834,1.0492586016842886,0.4,0.8947572766959269,1.0,2/12,6.03%,MSN;LYN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6213767618568891,1.0491996076782921,0.5121951219512195,0.8938474366668534,1.0,1/8,2.37%,GSTP1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5229145283101222,-1.0488948197704966,0.3835616438356164,1.0,1.0,5/29,15.37%,SLC39A14;G6PC2;GPI;GAPDHS;ENO1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.5526128192028377,-1.048875174734906,0.38235294117647056,1.0,1.0,6/24,14.19%,PTPRC;RANBP3L;GJA1;PLS3;SH3PXD2B;SULF1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.6088820164011959,-1.0488399623758133,0.4166666666666667,1.0,1.0,2/9,14.28%,SAE1;HDAC4
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5009040439058473,-1.048696791543992,0.4050632911392405,1.0,1.0,7/40,15.80%,CRNKL1;SRSF5;CELF4;TXNL4A;NCBP1;LUC7L3;CELF3
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.6744424728330363,-1.048368841511368,0.5,1.0,1.0,1/6,6.98%,GLUL
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.5440913039613331,-1.0483496686307432,0.41025641025641024,1.0,1.0,3/22,5.83%,ALOX12;FAR2;ACSS3
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.5406116848173652,-1.0477317209484134,0.42028985507246375,1.0,1.0,4/25,8.46%,SOX9;IRF1;GADD45A;TMEM150C
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.6048806191603547,-1.0476385226257383,0.4153846153846154,1.0,1.0,3/16,11.30%,PTPRC;DUSP22;SH3BP5
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5561122904098096,-1.0475855961948368,0.4927536231884058,1.0,1.0,4/20,13.57%,CD27;MAN1A1;PDK1;GNG7
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.4539122943746111,1.0475251869729942,0.3225806451612903,0.8977027212130615,1.0,5/41,4.76%,SYNDIG1;GPC4;SLITRK2;CLSTN2;NLGN2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.40820289340201343,1.0473918342775599,0.3333333333333333,0.8968987332785952,1.0,4/40,7.20%,SIRT2;GSTP1;NFKBIL1;PDE4B
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6892179891440372,-1.047366968195977,0.49230769230769234,1.0,1.0,2/6,8.45%,MTHFD1;SHMT1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5332913956207829,-1.0473662449556644,0.45714285714285713,1.0,1.0,6/26,8.60%,SCEL;OVOL2;NEDD9;BTN3A1;RUNX2;SLC44A3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.45958396243498106,1.047072655208004,0.2857142857142857,0.8966772222566003,1.0,3/31,2.96%,TAF1A;POLR2L;POLR1F
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.594803037043658,-1.0469492649777516,0.39655172413793105,1.0,1.0,2/14,8.05%,IHO1;PARN
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4355558988291944,1.0468756448789673,0.4,0.896440932472782,1.0,8/34,14.99%,BTBD3;ARC;CHRNA7;MAP2;SDC2;EPHB3;TMEM106B;CDC42
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.7072826182348917,-1.0467715708368543,0.47619047619047616,1.0,1.0,2/5,28.84%,PER1;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5807042875890964,-1.0467005699578549,0.3698630136986301,1.0,1.0,3/18,11.34%,HAP1;APOE;RTN2
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.5594997280455373,-1.0464034218253102,0.4666666666666667,1.0,1.0,4/24,16.94%,MSL3;MRGBP;MORF4L2;TAF6L
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5060423421397221,-1.0457799359665196,0.3698630136986301,1.0,1.0,10/33,11.37%,PON1;CYP2E1;HSD11B1;PAH;LRP2;PDZK1;APOE;AOAH;SLC13A3;SLC4A4
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.6301800935198973,-1.0456530730183584,0.4852941176470588,1.0,1.0,3/10,12.55%,LRIF1;BRCA1;RBM15
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.43061723587518946,1.0455713832845357,0.3333333333333333,0.8988126247555512,1.0,13/43,17.75%,SOX4;HSPA1A;VPS28;UBXN1;CHP1;BAG2;N4BP1;PRR7;MARCHF7;MINAR1;SMAD7;DNAJA1;NXN
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.6032534742129536,-1.0454365397627665,0.4507042253521127,1.0,1.0,2/10,21.31%,NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.6718302855804666,-1.0453680701704955,0.42105263157894735,1.0,1.0,1/5,24.16%,MED1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.4647994151984456,-1.0453550541383867,0.4146341463414634,1.0,1.0,20/99,15.80%,STMN2;GRIN2A;OLFM3;GRM1;GABRG2;KCNC1;CACNA1B;ACTL6B;CELF4;SNAP25;PSD2;GRM3;CAMK2A;ATP2B3;MMD2;MEIS2;NTRK3;GABRA2;SLC17A7;CELF3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.6285349627415504,1.0453549301240361,0.43243243243243246,0.8982851128138234,1.0,3/5,36.26%,PINK1;NONO;PARK7
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.43587200815761096,1.0450129283647618,0.35714285714285715,0.8980782693395505,1.0,3/23,6.66%,SOX4;ERN1;ZNF236
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.570496636220703,-1.0443018679178977,0.43548387096774194,1.0,1.0,2/18,7.53%,FOS;BAZ2A
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.718410933614741,-1.0442801773453656,0.5573770491803278,1.0,1.0,1/5,8.39%,THRAP3
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.354229062265218,1.0441457919677168,0.5217391304347826,0.8993765128810263,1.0,1/42,0.61%,NUP42
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.6800586969312841,-1.0440517757294745,0.40625,1.0,1.0,2/6,20.40%,GABRG2;HRH1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.6800586969312841,-1.0440517757294745,0.40625,1.0,1.0,2/6,20.40%,GABRG2;HRH1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.6819817538443216,-1.0438182326781775,0.45454545454545453,1.0,1.0,3/5,29.47%,CHIT1;GNPDA2;AMDHD2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.6671627652998942,-1.0437731510128523,0.4909090909090909,1.0,1.0,4/5,29.01%,CYP1B1;RDH12;RDH11;RDH10
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.5984787458552268,-1.0437681288064993,0.4852941176470588,1.0,1.0,4/17,17.05%,TMEM43;EMD;CHMP4B;DCTN1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.733297746408527,-1.0435513618915875,0.47619047619047616,1.0,1.0,4/5,23.88%,HLA-F;HLA-C;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.733297746408527,-1.0435513618915875,0.47619047619047616,1.0,1.0,4/5,23.88%,HLA-F;HLA-C;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5439770182453838,1.0432863195398623,0.40625,0.9006415583491246,1.0,2/12,12.72%,NAA11;NAA30
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.43278798848461714,1.0432744943262546,0.37037037037037035,0.8996745626192623,1.0,3/37,4.63%,STOX1;PRMT6;MFF
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.6117150127992945,-1.0432078802050824,0.40625,1.0,1.0,3/11,16.27%,AGBL4;LCMT1;ATG7
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5691336780283635,-1.043185470486193,0.4142857142857143,1.0,1.0,4/15,14.69%,OVOL2;KIAA0319;PBLD;TGFB1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.6197755974192833,-1.0429026946342692,0.4393939393939394,1.0,1.0,3/10,10.83%,PTPRC;LMBR1L;RASGRP1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.6670100348367684,-1.0428337703181931,0.5076923076923077,1.0,1.0,1/7,5.18%,MTHFD1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.6815033541728334,-1.042772156629306,0.46551724137931033,1.0,1.0,1/6,7.72%,SLC6A9
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.44132515324216826,1.0426950764921838,0.3870967741935484,0.9001336481024659,1.0,6/33,14.81%,POLR2J;POLR2L;PTMA;POLR2K;PAX8;POLR2E
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4981305370383326,1.0423131239301722,0.32142857142857145,0.9000621081631986,1.0,3/18,7.84%,TRIR;ERN1;NHP2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.626521764087568,-1.042229196567423,0.47692307692307695,1.0,1.0,2/11,10.32%,TAF7L;TAF1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5235157533252033,-1.042176501484866,0.44155844155844154,1.0,1.0,6/27,17.27%,NR4A3;RAB3A;PLEKHM1;HDAC6;PIP4P1;PLEKHM2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.6368000314232943,1.0418785427808348,0.5,0.9003686170625296,1.0,3/5,9.25%,ACAA2;THEM4;STPG1
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.6867238535645023,-1.0417891574495342,0.47692307692307695,1.0,1.0,2/5,28.17%,KCNA5;CACNA1D
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.646720115266022,-1.0417212382300107,0.4857142857142857,1.0,1.0,4/8,27.76%,OAS1;TIRAP;RAB11FIP2;SCIMP
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6048714046626147,-1.041092255671128,0.4838709677419355,1.0,1.0,1/9,15.42%,IGF1R
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.4590726941636457,-1.0410562319411925,0.449438202247191,1.0,1.0,21/124,18.50%,RASGRF1;ARHGAP24;DOCK8;RAP1GAP2;ZC3H15;USP6;DOCK7;TBC1D4;BCAR3;RASGRP1;TBC1D10B;TIAM1;NTRK3;TBC1D2B;TSC1;TBC1D8;TBC1D13;BCR;DOCK11;SIPA1L3;NGEF
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.5049040307889833,-1.0409932285142387,0.4625,1.0,1.0,7/39,9.40%,HEY2;HES1;OPRM1;LRP2;PRUNE1;DOCK7;B2M
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.36180917472555696,1.0409897783679907,0.391304347826087,0.9014445257007635,1.0,1/37,0.61%,NUP42
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.5142620452073414,1.0408727167065583,0.45714285714285713,0.9007835619585399,1.0,4/9,22.49%,MFF;FIS1;VPS35;ERBB4
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.6172324574826364,-1.0407726195560256,0.46875,1.0,1.0,2/11,5.49%,SCEL;FLG
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.48420102003938736,1.0403560293923524,0.34782608695652173,0.9011033595833008,1.0,4/24,7.32%,HSBP1;HSPA1A;ZFAND1;BAG3
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5760081903780729,-1.040191039205314,0.4805194805194805,1.0,1.0,6/16,18.37%,AGT;KCNMB4;EDNRA;GCLC;ITGB1BP1;HTR2B
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.5648220394853521,1.0399013484394575,0.4772727272727273,0.9011816602596918,1.0,1/6,7.69%,SPRY1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6514511204003071,1.0397340648594124,0.4358974358974359,0.9007787028047949,1.0,1/5,2.37%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.5240994876563416,1.0390383554591913,0.46875,0.9018633769345321,1.0,3/15,9.03%,TMED2;RCC2;GPSM1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5675796586077871,-1.0389558862511883,0.5,1.0,1.0,2/23,6.81%,STMN2;PRUNE1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.4726115594005095,-1.0386436588125978,0.38095238095238093,1.0,1.0,17/95,13.76%,STMN2;GADD45B;OLFM3;SNCB;GABRG2;KCNC1;SST;ACTL6B;CAMK2B;SNAP25;PSD2;CAMK2A;ATP2B3;MMD2;SULT4A1;PARM1;NKAIN2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.5794920261344877,-1.0383335134187481,0.4225352112676056,1.0,1.0,2/16,5.49%,SCEL;FLG
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.544641255250553,-1.0382175267186222,0.4189189189189189,1.0,1.0,6/22,19.33%,ATP10A;PLSCR1;ATP8B1;ATP8B2;ANO6;PLSCR4
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4811395349807076,1.0381195017949554,0.37037037037037035,0.9036057808491799,1.0,11/24,25.51%,UBE2N;RPS2;BMI1;ARRDC4;PINK1;GORASP1;DCUN1D1;FBXW7;DCUN1D5;BTRC;PIN1
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.6748561921548308,-1.038075114026916,0.42857142857142855,1.0,1.0,3/5,29.47%,NAGK;GNPDA2;AMDHD2
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.6748561921548308,-1.038075114026916,0.42857142857142855,1.0,1.0,3/5,29.47%,NAGK;GNPDA2;AMDHD2
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.67976799434097,-1.0379660699249937,0.4576271186440678,1.0,1.0,1/6,5.80%,CAV3
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.6243134390566236,-1.037935400764081,0.4264705882352941,1.0,1.0,2/8,8.51%,HTR2C;APOE
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.6257357048565757,-1.037861730589989,0.4594594594594595,1.0,1.0,4/8,19.93%,MGST1;SLC1A4;PDPN;SLC6A8
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.44832466001259375,-1.0377381369059115,0.3977272727272727,1.0,1.0,26/118,18.62%,CD44;HTR2C;APIP;PTPRC;TIMP3;OPRM1;PRXL2C;MAP3K12;PTPRR;APOE;PDE8A;EPHA7;CAMK2N1;RASGRP1;TRAF7;ARRB1;NTRK3;MAP2K1;ITGB1BP1;TGFB1;PDGFRB;ARRB2;ROR1;DAB2IP;HTR2B;PRKD2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.569437561865573,-1.037614358134569,0.4647887323943662,1.0,1.0,2/13,13.33%,VEGFA;DENND6A
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.42633758617161965,-1.0373965616598273,0.4105263157894737,1.0,1.0,35/165,18.12%,ENPP2;PLET1;MYLK;SOX9;FGF1;VSIR;PTPRC;NEDD9;CEMIP;VEGFA;SHTN1;DOCK5;RAB11A;SEMA4B;PAK1;TIAM1;STAT3;NTRK3;TMSB15B;VIL1;AKT2;FAM107A;KIF20B;PDPN;TGFB1;HDAC6;PDGFRB;IGF1R;NSMF;DDRGK1;SEMA3A;ADAM9;RDX;ATM;DAB2IP
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3913162616157749,1.0373279365037669,0.391304347826087,0.904939823117716,1.0,16/57,18.65%,TAF1A;POLR2L;POLR1F;CPSF1;GTF2H2;CSTF2T;POLR2K;CPSF4;SNRPB;POLR2E;POLR1A;ERCC3;SNRPE;LSM11;SNRPF;PAPOLA
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.6235737006342308,-1.0372115661882038,0.4492753623188406,1.0,1.0,3/16,10.21%,FBXO6;ADAMTS9;AOAH
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.5440563909003721,-1.0371465479993245,0.4788732394366197,1.0,1.0,4/21,13.40%,PIGH;MPPE1;PIGL;PIGC
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5814619311883605,-1.0370016122345935,0.3972602739726027,1.0,1.0,3/16,11.34%,HAP1;APOE;RTN2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6241027120055345,1.0369617130934368,0.4642857142857143,0.90487884905406,1.0,4/5,27.24%,ATF4;PINK1;LANCL1;REST
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.5362182981985433,1.0367461184030107,0.35294117647058826,0.9043544569819136,1.0,3/12,7.02%,NR1H2;LDLR;SCARB1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.525008315724917,-1.036745381569529,0.4444444444444444,1.0,1.0,4/24,13.40%,PIGH;MPPE1;PIGL;PIGC
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.5234888912047864,1.0364368481891686,0.4,0.9041149970165173,1.0,2/12,14.46%,NR3C1;ABHD2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6022223003951067,-1.0363179178478539,0.45714285714285713,1.0,1.0,3/15,11.82%,G6PC2;GPI;RBKS
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6444350342185516,-1.035955108488799,0.5333333333333333,1.0,1.0,4/7,24.30%,NBR1;ATM;MAP1LC3B;USP30
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.5229942328110686,-1.0354044749017224,0.4,1.0,1.0,9/27,19.78%,FSIP2;NPHP4;TULP3;CSNK1D;WDR19;TCTN1;TUB;ODAD4;IFT122
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.4997895932705959,1.0351337035706067,0.2857142857142857,0.9062783495451537,1.0,3/21,13.60%,PML;PPP1R10;ERCC4
prerank,PanglaoDB_Augmented_2021__Neurons,-0.4259281034547301,-1.0349367726702001,0.37894736842105264,1.0,1.0,51/237,19.14%,NWD2;RASGRF1;NEFM;STMN2;PCSK2;OLFM3;CALB1;SNCB;ARHGDIG;NMT1;GABRG2;KCNC1;NRGN;HAP1;CPLX1;CACNA1B;CALY;ACTL6B;VSNL1;SLC6A17;SCN8A;PRUNE2;CELF4;RBFOX3;SNAP25;PSD2;GRM3;CAMK2N1;SYT4;ATP2B3;MMD2;LRRTM1;MATN2;SULT4A1;ZIC1;CCK;SLC17A7;DLG4;RYR2;CELF3;IFIT3;BEX2;NRSN2;SLC30A9;RERE;SRRM4;CACNG2;RNPC3;KIF1A;RB1CC1;DYNC2I1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5875710511984877,-1.0348437403057709,0.44285714285714284,1.0,1.0,5/13,15.27%,PARP9;SHLD2;DTX3L;PNKP;RIF1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.49266405695119186,-1.0347970608488746,0.36486486486486486,1.0,1.0,14/43,24.16%,SOX9;KLF9;APOE;B2M;SULF1;TGFB1;CDKN2B;DAB2IP;STAT1;TGFBR3;CEACAM1;SCG2;CNMD;MED1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5784502004488914,-1.0347812036823054,0.4520547945205479,1.0,1.0,3/16,12.07%,GSTM5;MGST1;GSTK1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5784502004488914,-1.0347812036823054,0.4520547945205479,1.0,1.0,3/16,12.07%,GSTM5;MGST1;GSTK1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.45846817573803644,-1.0343884095646956,0.4044943820224719,1.0,1.0,19/96,19.22%,NEFM;STMN2;ROBO2;CACNA1B;ACTL6B;SHISA6;SNAP25;UNC5D;LRRTM1;NEFL;SULT4A1;NTRK3;PLP1;DCLK1;CRMP1;SRRM4;TMEM132B;KIF1A;INA
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6317501824678818,-1.0338350220530408,0.4852941176470588,1.0,1.0,1/7,4.66%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6774460246786439,-1.0336037584837878,0.5,1.0,1.0,1/6,5.46%,RARA
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.4989219757363842,-1.033360851618789,0.4634146341463415,1.0,1.0,13/45,16.52%,CDH7;CDH12;CDH9;VCL;CNTNAP1;CDH19;GJA1;CLDN12;PAK2;TBCD;CDHR3;CDH8;CTNNA1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.40655344621593503,1.0332736700415468,0.3157894736842105,0.9101958684560455,1.0,10/60,11.94%,UBB;MALT1;UBE2D1;PRICKLE1;PSMD10;PTTG1IP;INAVA;COMMD1;MUL1;RCHY1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.6678868307375982,-1.0329446450826072,0.5076923076923077,1.0,1.0,1/6,9.03%,FOXO1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.627725326679492,1.0326398339250318,0.5142857142857142,0.9109336079089891,1.0,4/7,26.05%,SEC61G;SEC61B;HSPA5;SEC61A2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.407689368860576,1.0320689465590924,0.3333333333333333,0.911773881949688,1.0,11/74,3.76%,MMP2;PRRX1;BGN;FIBIN;HSPG2;PODN;FBLN2;COL12A1;TNS2;CXCL12;PDGFRA
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.5102439986814483,-1.0319222435176734,0.37037037037037035,1.0,1.0,6/28,9.62%,KCNMB4;YWHAH;GNA14;KCNQ1;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.5618408540110675,1.03184919718282,0.3684210526315789,0.9114089156620023,1.0,3/8,15.11%,INAVA;TRPM4;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4701689052080891,-1.031774815667177,0.42857142857142855,1.0,1.0,15/58,18.73%,GRIN2A;AKAP5;SYT1;HAP1;GRIN2D;STX1B;RIMS1;SLC24A2;PLK2;ADCY1;CACNG8;DLG4;SHANK3;CACNG2;MPP2
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.5782528818605329,-1.0314339809235502,0.43661971830985913,1.0,1.0,1/13,0.30%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4281123609235697,-1.0309502866900766,0.42857142857142855,1.0,1.0,49/166,26.55%,FGF1;SLC39A14;TPD52L1;EMP2;PTPRC;RSPO4;HAP1;STX1B;TRIM44;RIMS1;IL7;LOXL3;TRAF7;SORBS1;MACF1;STAT3;NTRK3;BDNF;MYORG;ITGB1BP1;SULF1;ING5;DLG4;GRB10;SHANK3;MAML3;WNT7A;RSPO2;DAB2IP;ASXL2;PRKD2;EVC;RELN;TUBD1;MYO1C;XBP1;TXNDC15;GRIN1;ASXL1;FLNA;DMTN;PRKCZ;SHANK1;SASH1;PRKCA;AGPAT1;ATP6AP2;TSPAN5;TM2D3
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.6225478438040766,1.0308939982689378,0.4482758620689655,0.9129889632858695,1.0,1/8,0.49%,SIRT2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6205413769271431,-1.0306258328654547,0.4098360655737705,1.0,1.0,7/10,36.59%,STAT3;CD55;CD46;GNL1;JAG1;BACH2;MSH2
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4825621488238956,1.030563338693993,0.43478260869565216,0.9129348187536315,1.0,6/23,9.47%,RNF6;MCF2;MAP2;THY1;MT3;LINGO1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.51915678209597,-1.0304959358520562,0.421875,1.0,1.0,2/20,6.39%,TMSB4X;HAP1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.4649987674793806,-1.0304445843995624,0.40963855421686746,1.0,1.0,11/77,13.63%,PON1;NAAA;ALOX12;ACSM6;LIPI;GPAM;LIPH;ACSL1;AOAH;ACSBG1;ACOT11
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.498362656729722,1.0303579686224813,0.4358974358974359,0.9124513031257295,1.0,2/11,13.00%,RFK;PFAS
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.4486323612512269,-1.0303077424592781,0.43956043956043955,1.0,1.0,38/153,20.78%,CARD14;EFNA1;SOX9;FGF1;FGF9;PRXL2C;EFNA5;VEGFA;BRAT1;ALK;ATG14;DVL2;PDE8A;EPHA7;RASGRP1;PAK1;SLC4A4;TYRO3;ARRB1;CSNK1D;NTRK3;GAPDHS;AKT2;TGFB1;EPHA4;PDGFRB;IGF1R;RIPK1;IL34;ROR1;TNIK;FAM20A;AKTIP;RB1CC1;PFKFB3;PSEN1;MERTK;DDR2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.6030879837239109,-1.0300883613374996,0.4782608695652174,1.0,1.0,2/8,24.27%,TAMM41;HADHA
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6702223395409186,-1.0297048438011336,0.4461538461538462,1.0,1.0,1/6,8.15%,ATG14
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.5574463895870323,-1.0295109053783036,0.4305555555555556,1.0,1.0,7/23,16.25%,AKAP5;CALB1;APOE;ADCY1;FAM107A;EPHA4;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.5114469333107644,-1.0292792710357348,0.4647887323943662,1.0,1.0,4/24,17.05%,ANKRD53;CAV3;PAK1;DCTN1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.6854776659673731,-1.0292114995973034,0.5084745762711864,1.0,1.0,4/5,30.25%,TGFB1;MEF2C;FLOT1;USP19
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.6714511739827715,1.0291107916062288,0.5476190476190477,0.9146909345821517,1.0,1/6,1.77%,PHB2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5475587385946264,-1.028806740868682,0.44594594594594594,1.0,1.0,2/20,6.89%,CAMK1;EMD
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.5273217057753073,-1.0286363087052284,0.4305555555555556,1.0,1.0,1/24,0.20%,CD44
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6322591749700134,-1.0283723485868455,0.4603174603174603,1.0,1.0,1/7,1.40%,SOX9
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.5121808869635359,-1.028198937355793,0.43243243243243246,1.0,1.0,5/40,11.65%,ABLIM1;CRYBG3;RPGR;ADGRV1;PITPNA
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.47281515288344395,-1.0280135822981955,0.43902439024390244,1.0,1.0,17/58,22.75%,HTR2C;LETM2;CALCB;TPCN2;SLC24A2;ATP2B3;RYR2;SLC41A1;SLC8B1;NEDD4L;HTR2B;ATP13A5;SLC24A5;ATP1B1;ATP13A4;ATP2B2;SLC24A4
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.6701981730985351,-1.0280083097907573,0.5303030303030303,1.0,1.0,1/6,8.08%,ALK
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.4285107242977136,-1.0279338160851625,0.4479166666666667,1.0,1.0,47/235,23.08%,ABLIM1;FHDC1;FAM161A;RAB17;TUBA4A;CCDC39;MAK;INTU;CFAP221;RPGR;CEP135;RAB11A;INPP5E;AHI1;NPHP4;CCDC57;CFAP70;DNAH5;B9D1;AVIL;HAUS5;CFAP52;CSNK1D;RILPL1;HDAC6;TRAPPC14;HYLS1;CFAP43;DCTN1;CEP72;WDR19;CC2D2A;DYNC2I1;TCTN1;IFT27;IFT122;BBOF1;BBS7;KIF3C;LRGUK;WDR11;RAB8B;RAB11FIP3;CEP131;TXNDC15;RAB1A;ARL13B
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.44559460314400523,-1.0279044132456003,0.42857142857142855,1.0,1.0,30/135,15.80%,STMN2;PDE5A;OLFM3;CALB1;SNCB;GABRG2;KCNC1;SYT2;CPLX1;CACNA1B;CALY;ACTL6B;SHISA6;NRIP3;CELF4;SNAP25;SLC24A2;PSD2;GRM3;SYT4;CAMK2A;ATP2B3;MMD2;LRRTM1;SULT4A1;HCN1;PLP1;HDAC6;DLG4;CELF3
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3570350801130829,1.0278500744403325,0.35714285714285715,0.9172361523217382,1.0,16/102,9.73%,AMOTL2;DHCR7;MAGI1;ADCY6;AADAT;GPC1;EPDR1;NR2F6;ITGB5;BCAR1;YAP1;BOK;PTPRF;GNA11;LRIG3;S100A16
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.6986194741593232,-1.0275397673569238,0.576271186440678,1.0,1.0,1/5,12.61%,SNTA1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.5675550141594891,1.0273862636728854,0.4,0.917428695101817,1.0,3/14,10.15%,ATP6V0A4;SLC12A8;CLCN3
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6408280263958619,-1.0272881098022961,0.47619047619047616,1.0,1.0,2/8,17.07%,KCNQ1;NEDD4L
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.5298035167660133,1.0271650912760386,0.46153846153846156,0.9169424649311403,1.0,5/18,13.54%,UQCRC1;NDUFS8;UQCR10;ATP5F1D;SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.6898238700810547,-1.0268505379257673,0.5230769230769231,1.0,1.0,1/5,13.84%,BDNF
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.4497008021572467,-1.0266339311228045,0.45652173913043476,1.0,1.0,18/123,16.25%,ENPP2;CAMK1;SOX9;SLC6A6;VEGFA;SRF;ALK;CAMK2B;APOE;GJA1;DVL2;SHLD2;TMEM79;VIL1;FOXO6;DLG4;RIF1;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.5101617954171409,1.0265443214787218,0.4444444444444444,0.9157545474584581,1.0,1/10,1.35%,MOSPD2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.5101617954171409,1.0265443214787218,0.4444444444444444,0.9157545474584581,1.0,1/10,1.35%,MOSPD2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.5101617954171409,1.0265443214787218,0.4444444444444444,0.9157545474584581,1.0,1/10,1.35%,MOSPD2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.697271724953111,-1.0264032211957743,0.5573770491803278,1.0,1.0,2/5,22.89%,AGO1;AGO4
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.48427270248618376,1.02638933262423,0.34375,0.9153161932017434,1.0,4/16,9.28%,PPT1;SLC25A1;SCD5;ACLY
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.4553727075455627,1.0262923977563208,0.3783783783783784,0.9145560396613551,1.0,2/14,5.41%,ESR1;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.6364505935585991,-1.0261280901810257,0.48484848484848486,1.0,1.0,1/8,5.13%,VEGFA
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5708477057477384,-1.0259196332399874,0.5,1.0,1.0,4/17,10.82%,SYT1;SYT2;RIMS1;SYT4
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.5290108987733508,-1.0258794470645667,0.5138888888888888,1.0,1.0,7/29,20.86%,MTHFD1;LRP2;DVL2;VASP;TGFB1;IFT122;DVL1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.6977738812787515,-1.0258064157641418,0.5538461538461539,1.0,1.0,1/5,7.61%,LPCAT3
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.5477116247091556,1.0255747910589255,0.4827586206896552,0.9150577165495166,1.0,1/7,4.82%,PIK3C2G
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3190969716769448,1.0251865243616078,0.5,0.9149874399194446,1.0,66/270,19.36%,SIRT2;UBB;TNFAIP1;UBE2J1;GID8;PSMD8;PSMB6;PSMB4;KBTBD6;UBE2D1;DMAC2;PCBP2;DNAJB12;PML;FBXO45;UBXN1;PSME3;KLHL42;PSMD10;PELI1;KBTBD7;RHBDD2;AREL1;UBE2G1;TRIM71;HECTD3;UBC;SMURF2;UBQLN2;KCTD10;FBXO44;FOXRED2;CDC26;FBXW5;TMUB2;SEC61B;PSMD12;PSMB2;FBXL7;KCTD5;PSMD4;YOD1;CDC34;NSFL1C;FBXL14;SPSB1;ANAPC11;UBXN4;ERCC8;SIRT1;KCTD13;RAD23A;FEM1A;EDEM1;HSP90B1;AUP1;DERL2;ANAPC7;UBE2J2;HSPA5;RBCK1;PSMC1;PSMC3;TBL1XR1;RNF126;VCP
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6692749195018511,1.0251056549335251,0.62,0.9142738990353122,1.0,1/5,5.06%,PIH1D1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4921899988984205,1.0244868148299493,0.4666666666666667,0.9147450760934643,1.0,1/17,0.35%,UGDH
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.46557117068675125,-1.024284820507452,0.46511627906976744,1.0,1.0,3/86,1.70%,RASGRF1;ITPR1;TTC23L
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5626649301778992,-1.0239131501099488,0.463768115942029,1.0,1.0,2/15,10.51%,BCL2L2;MOAP1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.6030488442002175,-1.0236817680504662,0.4576271186440678,1.0,1.0,2/13,14.28%,SAE1;HDAC4
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5839478543014629,1.023647267801628,0.43333333333333335,0.9158281414586726,1.0,1/11,1.82%,NCSTN
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.7086903381731219,-1.0235516972720333,0.5352112676056338,1.0,1.0,1/6,0.70%,AHR
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.4643218209319654,-1.0235232984091964,0.42168674698795183,1.0,1.0,15/58,19.08%,FGF1;TPD52L1;AGT;VEGFA;CAV3;APOE;TRIB1;RASGRP1;PTPRJ;TGFB1;PDGFRB;IL34;DAB2IP;HTR2B;PIK3CB
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.606052336837122,-1.0232137934948435,0.4411764705882353,1.0,1.0,3/10,8.82%,GLRA2;GLRA1;HVCN1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.6362609147534257,-1.023182193787609,0.5072463768115942,1.0,1.0,3/8,21.88%,PDK1;PDK2;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.6362609147534257,-1.023182193787609,0.5072463768115942,1.0,1.0,3/8,21.88%,PDK1;PDK2;PDK3
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.6958661114288159,-1.0231578013215352,0.5072463768115942,1.0,1.0,2/5,19.93%,CKMT2;SLC6A8
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.462267263147967,1.0226669869403617,0.35714285714285715,0.917448285869672,1.0,3/29,2.96%,TAF1A;POLR2L;POLR1F
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6188114560100927,-1.0225967520580879,0.4915254237288136,1.0,1.0,2/9,21.31%,KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.6416422221646532,-1.0225729763753437,0.484375,1.0,1.0,2/7,22.30%,EEFSEC;SEPSECS
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.6416422221646532,-1.0225729763753437,0.484375,1.0,1.0,2/7,22.30%,EEFSEC;SEPSECS
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.48824166765156873,-1.0222443151483316,0.45121951219512196,1.0,1.0,10/47,15.58%,SLC39A14;RGS4;NMT1;GRK4;RNF157;TULP3;CAMK2A;GNG7;PDE6B;RGS5
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.6469311363085775,-1.0220031450160079,0.5263157894736842,1.0,1.0,1/5,1.40%,SOX9
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.5104899320517285,-1.021872338982137,0.4634146341463415,1.0,1.0,6/29,22.32%,HAP1;NEFL;SYBU;DCTN1;KIF1A;BLOC1S2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5859386236914336,1.0217067417670695,0.4473684210526316,0.9186718699784888,1.0,4/8,20.08%,SPOCK3;DUSP3;CRK;FRMD5
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.3917619735511495,1.0215185887065605,0.2727272727272727,0.9180891256853072,1.0,8/66,6.40%,MMP2;ACTB;ACTG1;ARPC5;NCSTN;LYN;EPHA5;EFNA2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.49776865448554514,-1.0214807897299576,0.38666666666666666,1.0,1.0,5/32,15.37%,SLC39A14;G6PC2;GPI;GAPDHS;ENO1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.43920326370502705,-1.021155497260487,0.4939759036144578,1.0,1.0,15/92,12.83%,STMN2;FAM13C;PCSK2;AGT;GABRG2;SST;ACTL6B;SHISA6;SNAP25;UNC5D;SYT4;SPARCL1;SORBS1;LRRTM1;KCNB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5676768456463579,1.021059188814948,0.42857142857142855,0.9183794785002785,1.0,2/7,5.61%,VEZF1;BTG1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.6119335840566033,-1.020958455605833,0.5,1.0,1.0,2/10,10.15%,BRCA1;CENATAC
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.5792769006223868,-1.0206146929641802,0.4852941176470588,1.0,1.0,4/12,13.03%,SREBF1;LPCAT3;SEC14L2;MBTPS1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.5349048510464418,1.0206093624278383,0.4642857142857143,0.9184369667112057,1.0,1/11,6.31%,LARP7
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4434191570605841,-1.0202836629559455,0.4588235294117647,1.0,1.0,27/127,18.62%,CD44;HTR2C;FGF1;TPD52L1;PTPRC;OPRM1;PRXL2C;VEGFA;MAP3K12;APOE;PDE8A;BCAR3;RASGRP1;TRAF7;ARRB1;NTRK3;PTPRJ;MAP2K1;TGFB1;PDGFRB;IGF1R;ARRB2;IL34;ROR1;DAB2IP;HTR2B;PRKD2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.5402010629879823,-1.020062791838282,0.48484848484848486,1.0,1.0,5/20,16.01%,CDKN2A;SPI1;SRF;MAP2K1;CDKN2B
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6570496369039172,-1.019983920221574,0.5,1.0,1.0,3/6,17.01%,PLSCR1;IL6R;ANO6
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.6377550736057298,-1.0197741046897506,0.5344827586206896,1.0,1.0,2/8,8.05%,ST3GAL1;PARN
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.6336884289245879,-1.0196624398804792,0.515625,1.0,1.0,1/10,0.44%,ANGPTL4
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5064354740324333,-1.0196013286635186,0.4794520547945205,1.0,1.0,11/28,27.36%,BRCA1;DONSON;FZR1;ATM;ABRAXAS1;BABAM2;NOP53;BRSK1;BRCC3;INTS3;TAOK1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5378041028355323,-1.0191049796366112,0.4722222222222222,1.0,1.0,1/19,0.87%,NAAA
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5508211049870984,1.0189238828872889,0.4,0.921974578800383,1.0,2/11,10.38%,POLDIP3;NXF1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.35957531400951426,1.0189039944392118,0.26666666666666666,0.9211445618084945,1.0,9/102,8.19%,USP51;HSBP1;NUP42;HSPA1A;NPM1;FKBP4;BAG3;MLST8;VASH1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.3474536411049395,1.0188695980824038,0.3333333333333333,0.9202149763624197,1.0,10/101,6.57%,SYNDIG1;AMOTL2;BGN;FIBIN;MAGI1;GPC1;FRZB;THY1;BCAR1;TCEAL7
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5569076179696926,1.0187798666513501,0.48484848484848486,0.9194174256746395,1.0,2/9,9.69%,WTIP;LIMD1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5145332183289584,-1.0187526696003466,0.4868421052631579,1.0,1.0,5/33,10.21%,RFC4;DDB2;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.6877019918860339,-1.018237436331814,0.5576923076923077,1.0,1.0,1/5,5.80%,CAV3
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6410434687494907,1.0180797012242266,0.4523809523809524,0.91948625564932,1.0,4/5,29.50%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6410434687494907,1.0180797012242266,0.4523809523809524,0.91948625564932,1.0,4/5,29.50%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.49220123688397904,-1.0180510117843833,0.43902439024390244,1.0,1.0,3/46,6.10%,KATNAL2;HOOK1;RAB11A
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5014825820092191,-1.017859433134726,0.47297297297297297,1.0,1.0,11/40,22.94%,HHIP;INTU;TULP3;ZIC1;GPC3;FBXL17;EVC;IFT122;TUBD1;WDR11;TXNDC15
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5821970661427944,1.017782158726215,0.5142857142857142,0.9193260171186882,1.0,1/11,6.36%,B4GALT6
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.46149961793989214,1.0173314451401843,0.45454545454545453,0.9196843640367218,1.0,3/23,6.76%,USP51;KMT5B;NUDT16L1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.6990124986161058,-1.0171753360357623,0.5161290322580645,1.0,1.0,3/5,19.64%,VEGFA;NTRK3;ANGPT2
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.525428613853519,-1.0170242344388092,0.4473684210526316,1.0,1.0,6/32,15.09%,ANKRD53;EML3;RAB11A;CHMP4B;CENPC;NUF2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.391153196769217,1.0169547572395463,0.45,0.9195961572940943,1.0,14/66,6.12%,MMP2;PRRX1;BGN;FIBIN;FBLN5;PODN;FBLN2;CYBRD1;CXCL12;TLR1;PDGFRA;LDB2;THY1;IGFBP7
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.6595323246311656,-1.0167359775881613,0.4909090909090909,1.0,1.0,3/5,33.27%,PODXL;JAG1;IQGAP1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.6595323246311656,-1.0167359775881613,0.4909090909090909,1.0,1.0,3/5,33.27%,PODXL;JAG1;IQGAP1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.38189482997318436,1.0162162593928779,0.375,0.9205855972130165,1.0,15/69,15.11%,VANGL1;PSMD8;ROR2;PSMB6;PSMB4;PRICKLE1;PSME3;PSMD10;FZD3;SMURF2;PSMD12;PSMB2;PSMD4;CDC42;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.7012362535893866,-1.0160749034001817,0.5079365079365079,1.0,1.0,3/5,20.81%,APOE;DTX3L;ABCA2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5180317417453235,-1.0159382462741593,0.45454545454545453,1.0,1.0,5/31,10.21%,RFC4;DDB2;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.49021888639622135,-1.0156774847332024,0.4878048780487805,1.0,1.0,8/28,23.41%,GLRA2;GLRA1;RPTOR;NSMF;CAPN2;CPEB1;XBP1;GRIN1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5864901996168761,-1.0155811550102913,0.5147058823529411,1.0,1.0,3/10,15.47%,PTPRC;PTPRJ;RYR2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5775245884158684,1.0154921671061117,0.40625,0.9217452113413767,1.0,1/11,1.82%,NCSTN
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6478443333225293,-1.0154839202992623,0.5079365079365079,1.0,1.0,2/5,17.51%,CAV3;RDX
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.5064797574523126,1.0154212474968578,0.375,0.9210100071141989,1.0,3/17,10.16%,DUSP7;PPM1A;PPM1E
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.4807133326281165,-1.0154175439592519,0.4578313253012048,1.0,1.0,13/48,18.50%,STMN2;EFNA1;KIAA0319;STX1B;APOE;BCL11A;GAK;MAG;EPHA4;CRMP1;BAG5;SEMA3A;NGEF
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.636704456171981,-1.0152787066091224,0.5079365079365079,1.0,1.0,2/7,6.51%,VEGFA;LRP2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.4469751284579921,-1.0150526278858067,0.40229885057471265,1.0,1.0,17/81,18.62%,EFNA1;NUAK1;EFNA5;ARHGDIG;VEGFA;FUT2;PLXNA4;EPHA7;RASA1;TPM1;PTPRJ;ITGB1BP1;EPHA4;KNG1;ZFHX3;ATM;PRKD2
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6467185516703197,-1.0149996500184968,0.48484848484848486,1.0,1.0,2/6,20.59%,PNKP;WARS1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.6260230401423437,-1.0145857547038688,0.4918032786885246,1.0,1.0,1/7,5.15%,DHDDS
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.6127006397952335,-1.014548684639995,0.5070422535211268,1.0,1.0,3/8,23.90%,PLS3;SPIRE1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.593143085133764,-1.0144009552950126,0.4857142857142857,1.0,1.0,3/13,17.41%,TIMP3;APOE;ADAM9
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5354732674647054,1.014322786994325,0.4,0.9228685641787487,1.0,5/11,14.98%,ATG16L1;WNT3;FBP1;SLC26A3;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.6933004224681873,-1.0141529291012077,0.5294117647058824,1.0,1.0,2/5,16.86%,STX1B;SLC4A8
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5605914460676131,1.01403421307028,0.45161290322580644,0.9224484725905142,1.0,3/9,9.47%,RAP2A;RAP2C;RAPGEF3
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.46124199069585103,-1.014028342624575,0.5116279069767442,1.0,1.0,11/61,21.39%,PIGH;USP6;ST3GAL1;CHRM3;LCMT1;WWP2;AKT2;ST3GAL6;FBXO22;RABGGTB;SLC35A1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.4319145369210352,1.0139112796833312,0.43478260869565216,0.9219149055558812,1.0,9/51,6.48%,TUBB2B;DLL3;AADAT;POU3F2;IGDCC4;PCGF2;MEX3A;EFNA2;BCAR1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.3788121094802056,1.0137763470130619,0.35714285714285715,0.9212396572003209,1.0,6/38,9.52%,CFL1;TWF1;SVIL;MICAL1;WASF3;CFL2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.7064928585280001,-1.0137085391086118,0.4696969696969697,1.0,1.0,3/5,28.65%,ANO6;C3;APPL2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5752632524890754,1.0135876253702947,0.46153846153846156,0.9208510549760593,1.0,3/9,7.02%,NR1H2;LDLR;SCARB1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.5209554297971162,1.0131018933450813,0.42857142857142855,0.9210616834026069,1.0,1/10,2.90%,NT5E
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.45609394483853277,-1.0126915243841308,0.4805194805194805,1.0,1.0,17/95,15.80%,STMN2;OLFM3;SNCB;GABRG2;KCNC1;CACNA1B;CALY;ACTL6B;CELF4;SNAP25;SYT4;LRRTM1;SULT4A1;KCNB2;ADCY1;JPH3;CELF3
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.6172984827795126,-1.0125851087592945,0.5254237288135594,1.0,1.0,1/7,1.40%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.5376254414662818,-1.01245986595991,0.43243243243243246,1.0,1.0,3/19,2.50%,MYLK;DUOX1;ENPP4
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4658092872674519,-1.0124554211257362,0.5180722891566265,1.0,1.0,9/68,12.38%,PON1;HES1;PARP9;RARA;APOE;B2M;TAF1;DTX3L;TIAM1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5474065343774748,1.0124026159538153,0.475,0.921841234762376,1.0,7/9,22.63%,NLGN2;LRRTM3;NLGN3;WNT5A;NLGN4X;NLGN1;NLGN4Y
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.49237013048577,-1.0123220124445353,0.4155844155844156,1.0,1.0,8/33,22.53%,SOX9;NR1D1;HDAC4;IRAK2;DAB2IP;IGBP1;ADAMTS7;USP10
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.5530075099447482,-1.012258653450716,0.49295774647887325,1.0,1.0,4/15,10.49%,PTP4A3;CEP135;CCT8;CCT6A
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.41598083427880894,1.0122304693048243,0.4166666666666667,0.9213394550704138,1.0,4/32,10.12%,GPX1;PPIF;CAT;PRDX3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.6655361139537974,-1.0120841801799372,0.5483870967741935,1.0,1.0,1/6,7.13%,TLK1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.5832575040115332,-1.0120488759765125,0.4864864864864865,1.0,1.0,2/11,9.98%,ELOVL2;ACSL1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.6625487100327582,-1.0118177956094663,0.5230769230769231,1.0,1.0,3/6,22.28%,CENPC;NUF2;CENPH
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.36207443163300124,1.0117895611505214,0.3333333333333333,0.9216909869242124,1.0,6/70,5.25%,PANX1;CHRNA4;STIM1;CHRNA7;MCOLN1;CALCRL
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.5883249853796897,-1.011767664123959,0.5,1.0,1.0,1/11,3.50%,AGT
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.6400911740562285,-1.011742327616466,0.45454545454545453,1.0,1.0,1/6,5.18%,MTHFD1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.5202259476019987,-1.011706012458375,0.5,1.0,1.0,8/30,15.79%,HOOK1;PLEKHF1;DNM1;USP50;ARFGEF2;USP8;HOOK2;HOOK3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.5137582827146546,-1.0115855513279575,0.48148148148148145,1.0,1.0,5/30,14.82%,EFNA1;HAP1;APOE;RTN2;EPHA4
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.44254394084136756,-1.0114819536462956,0.48936170212765956,1.0,1.0,21/127,12.41%,NEFM;STMN2;LHFPL5;GALNTL6;OLFM3;SNCB;KCNC1;KLHDC8A;CACNA1B;CALY;ACTL6B;SNAP25;PSD2;SYT4;NARF;ATP2B3;RTN2;MMD2;LRRTM1;NEFL;SULT4A1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.6125060938531628,-1.0111668332794186,0.515625,1.0,1.0,2/10,12.97%,BEGAIN;NPTX1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5795767794752998,1.0110292055101002,0.5294117647058824,0.9225810319930847,1.0,2/8,18.08%,ETS1;RHOA
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.5551712239333619,-1.0106825890601203,0.47297297297297297,1.0,1.0,3/12,14.12%,EMP2;LOXL3;ITGB1BP1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5887798522837782,-1.0106137859860858,0.46153846153846156,1.0,1.0,3/11,9.98%,FABP3;APOE;ACSL1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.6137460429354615,-1.010543659917871,0.47692307692307695,1.0,1.0,5/11,17.69%,TPM1;KCNB2;DAPK3;ENO1;CHRM2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5399565496131984,-1.0104609797238038,0.4507042253521127,1.0,1.0,4/19,13.66%,ATP10A;ATP8B1;ATP8B2;RFT1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.4984645765815842,-1.0103586880768294,0.45121951219512196,1.0,1.0,10/41,17.33%,STMN2;YWHAH;STX1B;APOE;GAK;MAG;EPHA4;CRMP1;BAG5;SEMA3A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4965215024837299,-1.0102599288807852,0.5285714285714286,1.0,1.0,12/34,24.49%,SYT1;GRM1;GRM3;CACNG8;DGKZ;SHANK3;CACNG2;RELN;MEF2C;UNC13A;MAPK8IP2;CACNG7
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.489500036300296,-1.0102367582602878,0.4578313253012048,1.0,1.0,5/38,10.73%,TMSB4X;GADD45A;VEGFA;APOE;STAT5A
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4875854064642583,-1.0100860505342004,0.5176470588235295,1.0,1.0,7/46,13.21%,CYP2E1;ALOX12;ELOVL2;ACSL1;ACSBG1;EPHX2;CYP1B1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.561794093456931,-1.0100289684635961,0.5,1.0,1.0,4/18,9.24%,AHR;PTPRC;VAV3;IL7
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.370770043260786,1.0098299962867876,0.42857142857142855,0.9246458551019973,1.0,9/100,7.42%,VPS37B;DYNLL2;MTERF3;SNF8;VPS28;ATG16L1;MAP1LC3A;CHMP2A;EI24
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5109058469464608,-1.009579592625237,0.4935064935064935,1.0,1.0,10/32,23.41%,GRIN2A;GJA1;TRIM41;CACNB1;EPHA4;IGF1R;PSEN1;DDX11;XBP1;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.48497468412668443,-1.009516586335798,0.3974358974358974,1.0,1.0,9/28,26.01%,PFN2;CDC42EP3;VASP;BAIAP2;LMOD1;SPIRE1;CRACD;CARMIL1;GSN
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.5613669967998277,1.0092572032360396,0.47368421052631576,0.9250495915389608,1.0,2/9,10.67%,ZBTB1;ATF4
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4911481292893777,-1.0091898366168333,0.53125,1.0,1.0,1/29,0.17%,EPN1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5795717147614593,1.0090982999602067,0.4444444444444444,0.9244763654292537,1.0,1/8,0.49%,SIRT2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.6228528948762981,-1.0090901706685311,0.5316455696202531,1.0,1.0,3/8,15.61%,MX1;TRIM56;IFIT1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.6144016982811008,-1.0089090243677346,0.5079365079365079,1.0,1.0,1/8,9.72%,SLC24A2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.6144016982811008,-1.0089090243677346,0.5079365079365079,1.0,1.0,1/8,9.72%,SLC24A2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.3632986781333657,1.0087532787920828,0.3333333333333333,0.9245261386194359,1.0,19/119,6.75%,NOX4;MMP2;PRRX1;BGN;FIBIN;FBLN5;PODN;FBLN2;COL12A1;CYBRD1;COL8A1;CXCL12;NT5E;PDGFRA;NR2F6;FRZB;THY1;IGFBP7;COL4A4
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5448906288084162,-1.0086415062988705,0.43478260869565216,1.0,1.0,6/21,27.32%,ZRANB3;WRN;RECQL;DDX11;DHX36;MTERF1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.6611394861457522,-1.008480903494948,0.5396825396825397,1.0,1.0,1/5,3.05%,CDKN2A
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.6391513586981458,-1.0084545120021144,0.5283018867924528,1.0,1.0,2/7,21.31%,KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6956024516848844,-1.0082873636433418,0.45714285714285713,1.0,1.0,2/5,21.25%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6956024516848844,-1.0082873636433418,0.45714285714285713,1.0,1.0,2/5,21.25%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6956024516848844,-1.0082873636433418,0.45714285714285713,1.0,1.0,2/5,21.25%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6020597300542283,-1.0081526130627503,0.5714285714285714,1.0,1.0,2/9,13.15%,LPCAT3;MBOAT2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4537080039989724,-1.0081126801793416,0.449438202247191,1.0,1.0,15/82,15.75%,GLRA2;FOS;SYT1;GLRA1;RYR3;SYT2;KCNH1;HVCN1;B2M;ADGRV1;SYT4;ADCY1;MT1M;DLG4;SLC41A1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.4708636794729194,-1.0079495774019502,0.49411764705882355,1.0,1.0,3/36,9.33%,TSPYL2;ATAD5;BCAR3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.68113469987678,-1.0076672659578108,0.5370370370370371,1.0,1.0,3/6,22.13%,DENND3;MADD;DENND4B
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6331231486078354,-1.0075166320514115,0.5333333333333333,1.0,1.0,4/9,29.21%,STAT5A;STAT5B;GHR;APP
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.5488378756873472,-1.0074852880214495,0.4594594594594595,1.0,1.0,2/16,16.86%,RIMS1;SLC4A8
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.47374908513898073,1.0073192026120927,0.43243243243243246,0.9272441595781001,1.0,4/15,9.34%,SEMA5B;SEMA5A;SEMA4F;SEMA3B
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.3562974625277233,1.0071008176177478,0.5,0.92681149112655,1.0,43/348,9.33%,NOX4;SOX4;SIRT2;FABP7;SOX11;PIWIL2;PLXNA3;PODN;GPNMB;HSPA1A;NR1H2;ROR2;TNS2;SMYD2;PPT1;CGRRF1;SEMA5A;NPM1;PIWIL4;RNF139;PML;TMBIM6;BTG1;NDUFS3;FRZB;IP6K2;BTG3;LYN;IGFBP7;BRINP1;PTPN14;CHMP2A;EI24;NGF;ATP8A2;ADRA1A;P3H2;PLXNC1;CDKN2C;TNFRSF21;CBLL1;SMAD3;MT3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.5230989217673733,-1.0070932734737315,0.4935064935064935,1.0,1.0,3/20,11.54%,HES1;CCDC57;MEIS2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.524143277256145,-1.0070394560474842,0.52,1.0,1.0,5/26,17.99%,CAMK1;SRF;CTNNA1;MAPK12;RBM4
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6479096179513206,-1.0069950719054797,0.47692307692307695,1.0,1.0,3/6,29.59%,DAB2IP;NOP53;STAMBP
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5112528373140667,-1.0068259165728466,0.4594594594594595,1.0,1.0,5/27,7.07%,HEY2;HES1;NKX6-2;PRUNE1;DOCK7
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.5861670913598598,-1.0067219980266955,0.5074626865671642,1.0,1.0,2/11,9.43%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.6664433448157472,-1.0066313534831453,0.5,1.0,1.0,1/6,0.58%,STMN2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.47638143120705767,1.0065457429782882,0.5,0.9274927809202469,1.0,4/11,14.67%,PPIF;PARP1;FBP1;FIS1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4729958819055309,-1.0064930489076676,0.5,1.0,1.0,2/48,0.97%,EPN1;CD160
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.31975470714217,1.0063961507789816,0.375,0.92686368137421,1.0,29/167,15.47%,UBB;RNF144A;ADRM1;UBE2D4;RNF6;UBE2D1;KLHL8;FBXO45;ELOC;UBA1;UBE2I;TOLLIP;PPP1R11;AREL1;UBE2G1;RC3H1;UBC;SMURF2;UBQLN2;RCHY1;RNF128;KCTD10;CDC26;FBXL7;CDC34;FBXL14;SPSB1;UBE2D2;ANAPC11
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.3518195150919622,1.0063677269502393,0.29411764705882354,0.9260249368212097,1.0,18/102,6.29%,MMP2;PRRX1;AMOTL2;BGN;FIBIN;HSPG2;PODN;COL12A1;TNS2;CXCL12;PDE3A;PDGFRA;PAWR;PML;LDB2;THY1;PLA2R1;CSTB
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.6778255046862267,-1.006326924288228,0.543859649122807,1.0,1.0,2/6,26.09%,CPEB1;CPEB3
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6327211544507647,-1.0059704113745958,0.5660377358490566,1.0,1.0,1/8,0.49%,IHO1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.49052383624808615,-1.0057482502116337,0.4583333333333333,1.0,1.0,3/37,9.20%,HEY2;ZFPM1;KITLG
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6484431217528797,1.0056322350873184,0.5641025641025641,0.9270701771306857,1.0,1/5,3.46%,SLC39A10
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.4075695497419896,1.005465429485692,0.36,0.9266118016928334,1.0,2/24,2.87%,SOX11;CLSTN2
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.5487027856794984,1.0054618221822613,0.4634146341463415,0.9257057544614198,1.0,4/8,10.31%,TGFBR2;PDGFRA;EIF4A3;TGFBR1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.40657870285321146,1.0054090112532375,0.4827586206896552,0.9249975951770116,1.0,7/39,13.26%,SBDS;MTERF3;NPM1;RPS19;RPSA;RPL23A;MRPS7
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.3680730526306818,1.0052021202095909,0.5,0.9245566786751076,1.0,4/60,3.23%,NUP42;POLR2J;POLR2L;WTIP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.5553214804912324,-1.00500502433549,0.45454545454545453,1.0,1.0,2/10,12.26%,VEGFA;IL6R
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.4906190807228523,1.0049375961709084,0.42857142857142855,0.9242703883518182,1.0,3/13,8.05%,SIRT2;IKBKB;RAD17
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.6531863862049894,-1.0048260688372632,0.5084745762711864,1.0,1.0,1/7,1.40%,SOX9
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.35345634908636536,1.004739597147727,0.2,0.9238869366451853,1.0,18/104,12.64%,UBB;PCBP4;HSPA1A;PSMD8;PRR5L;ZFP36L1;PSMB6;PSMB4;PSME3;PSMD10;ZC3HAV1;FXR2;EXOSC8;RC3H1;UBC;KHSRP;YWHAB;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.6248502453084355,-1.004225730123103,0.5272727272727272,1.0,1.0,3/8,24.38%,IL34;CXCL17;CSF1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.536762816997692,1.004125597947365,0.4827586206896552,0.9248014478186756,1.0,5/13,20.06%,ARPC5;JMY;ARPC5L;ARPC2;WHAMM
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.5442427846504319,1.0040534961170542,0.5,0.923158799385584,1.0,1/7,1.81%,ADCY6
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.5442427846504319,1.0040534961170542,0.5,0.923158799385584,1.0,1/7,1.81%,ADCY6
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.6011293558138686,-1.0036617499621925,0.5277777777777778,1.0,1.0,4/9,13.03%,SREBF1;LPCAT3;SEC14L2;MBTPS1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.5799081691762386,1.0035750579858658,0.5294117647058824,0.9235428491483335,1.0,1/8,0.55%,UBB
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.5690276924217642,-1.003296340504516,0.5217391304347826,1.0,1.0,2/18,1.40%,AHR;SOX9
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.5042783978632178,-1.0032589781264782,0.48717948717948717,1.0,1.0,5/25,15.70%,CLTCL1;RTN2;SORBS1;AKT2;GRB10
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.533172948193219,1.0031395712971096,0.42105263157894735,0.9237733131825678,1.0,3/7,16.44%,SRI;GRK2;RNLS
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.557491790272814,-1.0027164364479701,0.4936708860759494,1.0,1.0,1/15,0.54%,JADE2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.557491790272814,-1.0027164364479701,0.4936708860759494,1.0,1.0,1/15,0.54%,JADE2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.6330135615586486,-1.0025810908893455,0.5849056603773585,1.0,1.0,2/5,15.47%,RYR3;RYR2
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.6330135615586486,-1.0025810908893455,0.5849056603773585,1.0,1.0,2/5,15.47%,RYR3;RYR2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.6330135615586486,-1.0025810908893455,0.5849056603773585,1.0,1.0,2/5,15.47%,RYR3;RYR2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5680561430943295,-1.0024101992599765,0.45714285714285713,1.0,1.0,3/21,16.41%,BTBD18;THOC5;BRD4
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.44879238459568743,1.002379257266935,0.4782608695652174,0.9247388891902459,1.0,3/24,10.36%,BICD2;IFT20;RAB6A
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.666827686414456,-1.0021558797723482,0.5686274509803921,1.0,1.0,1/5,8.94%,DVL2
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.3382569558778296,1.0021228130756759,0.3333333333333333,0.9243160518793381,1.0,23/179,10.79%,GMEB2;TAF1A;POLR2J;POLR2L;TAF9B;GTF2A2;EAF2;RO60;ELOC;TCEA1;GTF3C6;PARP1;PTMA;GTF2H2;GTF2F1;SLC25A33;SSRP1;EAF1;COPS2;POLR2K;NFYA;ATF4;CDC73
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.5850554045852825,1.0020685438340298,0.5365853658536586,0.9235339290593911,1.0,1/7,4.36%,PYCR1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.601991873344778,1.001826301259094,0.5454545454545454,0.9231684813315814,1.0,3/8,25.75%,AKT1;WASL;CD200
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5157380454596556,1.0016432346998654,0.47058823529411764,0.9227484660085375,1.0,3/12,8.73%,POP5;AARS1;DTD1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.6061396919187,-1.0016168124731624,0.5,1.0,1.0,1/9,0.84%,CARD14
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.5647972036175584,-1.0014105618716034,0.47619047619047616,1.0,1.0,2/14,5.46%,ZFPM1;RARA
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.6495405962317378,-1.0012896892416605,0.5172413793103449,1.0,1.0,1/5,7.41%,ABCC3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.493754500816063,-1.0012384000992414,0.45,1.0,1.0,2/31,1.40%,HEY2;SOX9
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.6763807018668989,-1.0010533012851048,0.5409836065573771,1.0,1.0,2/5,11.50%,PLEKHM1;SPP1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5606681218396518,-1.0004170192981268,0.5142857142857142,1.0,1.0,4/20,10.21%,RFC4;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.48400495306213387,-1.0001469721453842,0.5189873417721519,1.0,1.0,4/37,12.05%,IRF1;PARP9;PLSCR1;TYRO3
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.4912960029196085,-0.9994812262877222,0.5324675324675324,1.0,1.0,6/40,11.06%,SYT1;HAP1;RAB3A;CPLX1;RAB3D;RAB15
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.4182727582421759,0.9991628040875523,0.4074074074074074,0.9282675012105289,1.0,12/34,20.49%,TRMT112;CSKMT;PRMT6;VCPKMT;RAB6A;SNRPB;EZH2;PRMT1;SETD3;FAM98A;ICMT;GSPT1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.6204307251095512,0.9991539509416749,0.47619047619047616,0.9273741931221557,1.0,4/6,22.14%,NPM1;SIRT1;HMGB1;AKT1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.5625403047344313,-0.9985126873158305,0.5507246376811594,1.0,1.0,4/17,19.60%,RBSN;MAP2K1;ARMH3;STX5
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5402275964998009,-0.9982682952339176,0.4461538461538462,1.0,1.0,2/15,4.79%,PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5732366809888709,-0.9982666169474061,0.4857142857142857,1.0,1.0,5/12,24.30%,NBR1;ATM;RB1CC1;MAP1LC3B;USP30
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.4678375275793575,-0.998260835883219,0.5180722891566265,1.0,1.0,5/45,9.56%,FBXO6;ADAMTS13;GCNT1;ADAMTS9;MAN1A1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.6734876062708229,-0.99798859114471,0.5735294117647058,1.0,1.0,2/6,8.51%,AGT;APOE
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5363938081676408,-0.9978160955833834,0.4594594594594595,1.0,1.0,4/17,15.17%,P2RY12;ATG14;TGFB1;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3492687162869767,0.9976748509563067,0.4090909090909091,0.9301074353760439,1.0,13/70,16.55%,BAD;MALT1;NGF;BOK;SMAD3;ARL6IP5;MUL1;ACER2;PRR7;FIS1;CRADD;SIRT1;GRAMD4
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.375733934318792,0.9975978835840209,0.5,0.9294756814354443,1.0,8/54,7.83%,PSMD8;CALR;PSMB6;PSMB4;IKBKB;ITGB5;PSME3;PSMD10
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5553823905385928,0.9974249082388366,0.5161290322580645,0.9290927702654246,1.0,1/9,2.90%,NT5E
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.6682480042508623,-0.9973793398757456,0.5555555555555556,1.0,1.0,3/6,25.77%,SHMT1;CTPS1;PAICS
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6127444094908299,-0.9973013481093669,0.5753424657534246,1.0,1.0,4/11,15.87%,STAT6;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.6371848513604841,0.9971994618767434,0.5609756097560976,0.9288617731636438,1.0,2/5,25.20%,PFAS;AMPD2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.3916838136706516,0.9971188330044016,0.47619047619047616,0.928082111729773,1.0,10/60,3.76%,MMP2;PRRX1;BGN;FIBIN;PODN;FBLN2;COL12A1;CXCL12;DYNLT1;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5560404782284416,-0.9969290923285439,0.4782608695652174,1.0,1.0,2/16,16.01%,CDKN2A;CDKN2B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.6298395570409907,-0.996595100784253,0.4788732394366197,1.0,1.0,3/7,26.31%,AGO1;AGO4;ADAR
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.519880162048378,-0.9964693991703609,0.4722222222222222,1.0,1.0,5/22,19.13%,ZER1;UFD1;HDAC6;YME1L1;FBXL17
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.4286913189475627,-0.9963634242675431,0.5280898876404494,1.0,1.0,17/124,9.67%,ANGPTL4;EFNA1;SRPX;PHKG1;SLC2A3;SLC6A6;FOS;MAFF;KLF6;VEGFA;AKAP12;LDHA;COL5A1;GPI;PPFIA4;CP;PFKP
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.5057987125821456,-0.9963175183855382,0.4857142857142857,1.0,1.0,6/27,17.05%,ANKRD53;EML3;TACC3;BORA;CHMP4B;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.6106819141069331,-0.9962614709885764,0.5072463768115942,1.0,1.0,2/9,8.52%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.5894352365152974,0.9962317722174828,0.46511627906976744,0.9294708745810895,1.0,2/7,4.10%,PHB2;IRF3
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.4344023521065144,-0.995593595099317,0.5057471264367817,1.0,1.0,22/130,18.62%,CAMK1;RPS6KB2;TLK1;MAP3K12;TAF1;CDC7;CAMK2A;VRK1;PLK2;VRK2;PAK2;CAMK1D;CSNK1D;NEK6;AKT2;MASTL;MKNK1;RIPK1;MAPK12;CAMK2D;ATM;PRKD2
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.6816709972733249,-0.9954189577647601,0.5344827586206896,1.0,1.0,2/7,12.58%,NR4A3;STAT3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.5506673901262176,-0.9953770022165773,0.5064935064935064,1.0,1.0,5/20,14.82%,EFNA1;VSIR;USP50;STAT3;EPHA4
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.4560722581314315,-0.9950425849368493,0.48717948717948717,1.0,1.0,10/59,12.21%,SPDYA;CDKN2A;CDK7;MAX;CDK4;BACH1;CDC7;CAMK2A;CRLF3;PLK2
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.5055076525427462,-0.9948929339558473,0.5466666666666666,1.0,1.0,12/37,26.20%,STK17A;ACACB;CYP1B1;PDK2;MKLN1;CNDP1;ABCA2;PDK3;PANK2;GNB3;AGPAT1;FLOT1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.454503921896615,0.9948389257922268,0.5151515151515151,0.9322269969209023,1.0,7/29,13.48%,ASCL1;HIPK1;SALL2;SHROOM2;MEIS3;PAX8;ZDHHC16
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.567343994300376,-0.9948114710411871,0.5138888888888888,1.0,1.0,2/11,21.31%,NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5150546932220451,-0.9945522272380422,0.5,1.0,1.0,3/25,5.13%,EMP2;PTP4A3;VEGFA
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.7154155486762446,-0.9945244317168636,0.5892857142857143,1.0,1.0,2/5,5.25%,VEGFA;SRF
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5697918450869128,0.9944850937872711,0.425531914893617,0.9321717615559326,1.0,3/7,19.51%,RPS19;FAM3A;GAPDH
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.5276608676288983,-0.9944006068669594,0.5,1.0,1.0,1/21,3.26%,LRRC19
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.5308575786402971,0.9941810825262811,0.5,0.9320482647360991,1.0,2/8,11.23%,CHAMP1;SPDL1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5776092857964135,0.9940392465691222,0.43243243243243246,0.9314195689508679,1.0,2/7,2.33%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5390378645840012,-0.9940304217784248,0.4166666666666667,1.0,1.0,8/25,24.95%,KCNJ11;BRAT1;OAS1;GALM;HK1;PMM1;IRS2;FUCA2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.4957467180283006,-0.9938469461280623,0.47297297297297297,1.0,1.0,5/28,14.59%,CD44;EFNA5;MACF1;VIL1;PDPN
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.5404211922173314,0.993811879806742,0.5142857142857142,0.9311059921990728,1.0,1/8,2.82%,CXCL12
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4990147339813131,-0.9935757076964865,0.5316455696202531,1.0,1.0,4/35,13.92%,GNA12;CAV3;TAF1;XPO1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.45178837285604717,-0.9935220385946077,0.47126436781609193,1.0,1.0,13/66,16.05%,IGF2BP2;IGF2BP3;PTPRC;LRRC19;AGT;BTN3A1;NLRP12;TRIM56;IFIH1;PER1;BTNL2;TRAF3;BCL6
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.6518369990317545,-0.9935102937911908,0.5423728813559322,1.0,1.0,2/7,24.92%,B2M;ACO1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.44816892267285025,0.9934677187420016,0.36363636363636365,0.9310520724676146,1.0,4/33,7.25%,UBB;TAB3;UBE2N;GPS1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3725804787918324,0.9933788332353405,0.46153846153846156,0.9304261996790769,1.0,9/46,9.10%,CCT5;RAN;TRIM28;RBM22;LARP7;CCT3;BAG3;YAP1;SMAD3
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.7034649044647061,-0.9933666220934076,0.5625,1.0,1.0,1/5,1.39%,NUAK1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.42081609444559803,-0.9930183892311659,0.5638297872340425,1.0,1.0,23/131,18.14%,RASGRF1;STMN2;CNTNAP1;SHTN1;RAB11A;DOCK7;APOE;ADGRV1;MICALL2;PAK1;DNM2;BDNF;KIF20B;PLP1;EPHA4;DCLK1;DLG4;SHANK3;WNT7A;RAB35;TNIK;DAB2IP;MAP4
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.36016244450772705,0.9929553590082246,0.4,0.9304955146820318,1.0,9/79,10.64%,BICD2;RND2;RHOBTB1;RHOC;EPHA5;MLST8;GPM6B;CAMSAP3;PFDN2
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.6050666652197282,0.9926367695655552,0.5161290322580645,0.9301976611319389,1.0,4/5,28.17%,TDG;ALKBH3;ALKBH1;ALKBH2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.604138493398603,-0.9923122985898842,0.532258064516129,1.0,1.0,3/7,3.69%,HTR2C;GPR18;GRM1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.5525017719544772,-0.9919819870504757,0.4647887323943662,1.0,1.0,3/16,4.22%,HEY2;EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.34424723854441436,0.9919068889277283,0.5,0.9312856045171557,1.0,12/90,9.69%,FGD3;CFL1;RND2;RHOBTB1;WTIP;ARC;RHOC;THY1;MICAL1;EPB41L3;WASF3;LIMD1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.5039400120465085,-0.9916963101903972,0.5342465753424658,1.0,1.0,11/31,20.46%,LIMK1;KIAA0319;SHTN1;APOE;MACF1;DNM2;OLFM1;MAG;SEMA3A;TRIM46;SEMA7A
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.49046172454818915,0.9916748410675894,0.5,0.9308518884076603,1.0,3/19,4.52%,NR1H2;ACADVL;MID1IP1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.38016424589323183,0.9916456840430863,0.5,0.9299581794268198,1.0,15/68,15.11%,VANGL1;PSMD8;ROR2;PSMB6;PSMB4;PRICKLE1;PSME3;PSMD10;FZD3;SMURF2;PSMD12;PSMB2;PSMD4;CDC42;WNT5A
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6688997130454241,-0.9912718651261625,0.5238095238095238,1.0,1.0,1/5,0.95%,TMSB4X
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5646679229546285,-0.9912378775857815,0.5147058823529411,1.0,1.0,2/14,14.22%,MTHFD1;ASPA
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.47622004870837864,0.9912364429508418,0.5,0.930244266611159,1.0,1/11,2.92%,CHST7
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.42738242445828456,-0.9912046311944085,0.4772727272727273,1.0,1.0,21/91,18.28%,PCSK2;UNC13C;ACTL6B;SV2B;MOBP;KCNQ1;CELF4;RBFOX3;SLC24A2;GNG7;RPH3A;ASPA;HCN1;MCF2L2;ST18;CCK;CELF3;CNDP1;SRRM4;SLC7A14;CACNG2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5792318744979423,-0.9911755642004096,0.5072463768115942,1.0,1.0,3/11,15.63%,CD160;PTPRJ;DGKZ
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6301988756215048,-0.9911523855686593,0.55,1.0,1.0,5/8,27.68%,RIPK1;IL34;CSF1;PRKCA;ID2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.5283403296163078,-0.9910886966025152,0.4935064935064935,1.0,1.0,1/25,1.06%,LETM2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.641483009758595,-0.9910357274852419,0.5333333333333333,1.0,1.0,2/6,22.35%,KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.5703183052376289,-0.9909473764229912,0.47297297297297297,1.0,1.0,3/15,12.75%,CHAC2;PLSCR1;GCLC
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.41363581718326325,0.9906240121573046,0.5,0.9308138788742941,1.0,5/25,16.03%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD;MICOS13
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5748279326265342,-0.9905165821954194,0.5074626865671642,1.0,1.0,2/10,21.31%,GLRX;ATP1B1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.48998436568390424,-0.9902296220605447,0.3918918918918919,1.0,1.0,7/28,12.48%,SLC51A;NCOA1;SLC16A3;ABCC3;SLC6A11;ATP8B1;SLC16A4
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.46561186227431467,-0.9902226120890326,0.4567901234567901,1.0,1.0,4/50,5.13%,ANGPTL4;FGF1;BRCA1;VEGFA
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5187672354441565,-0.990188177578661,0.5,1.0,1.0,6/28,14.69%,HEY2;HES1;VEGFA;RASA1;CYP1B1;TGFB1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.48306684413426687,-0.9897251986041685,0.4878048780487805,1.0,1.0,15/48,20.55%,VSIR;PTPRC;RARA;RASGRP1;ARFGEF2;STAT3;IFIH1;PTPRJ;C1QTNF4;OAS1;RIPK1;ARG2;TIRAP;FOXP1;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.6498548880710939,-0.9896922426314823,0.5441176470588235,1.0,1.0,2/6,8.52%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5704126331565577,0.989647482372096,0.4634146341463415,0.9321391989344442,1.0,2/7,9.13%,ASCL1;FZD3
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.5418542642178915,-0.9894031714442266,0.5074626865671642,1.0,1.0,2/19,6.09%,KCNJ13;KCNJ11
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5320374326465538,-0.9893933160773661,0.4714285714285714,1.0,1.0,2/16,9.45%,DSC2;CTNNA3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.6205634945315162,-0.9890389558945626,0.47692307692307695,1.0,1.0,2/10,9.24%,CD27;IL7
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3510122049035227,0.9889691025282016,0.4666666666666667,0.932786874001018,1.0,14/76,12.20%,SIRT2;ODC1;TIPARP;TMEM9;SNF8;RAB26;VPS28;EEF1A1;SNX12;AREL1;CTSA;SMURF2;HMGCR;MAD2L2
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.49008280868685083,0.9887731372803628,0.5,0.9323812024844454,1.0,1/18,0.65%,TUBG1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5799648673165327,-0.9886585613033718,0.5675675675675675,1.0,1.0,9/12,30.84%,CD160;PDCD4;ANO6;SFRP4;PLCG1;GSN;ITGA4;PIAS4;PRKCI
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.3601657810476379,0.9885374574895691,0.4166666666666667,0.9320436934808184,1.0,20/89,19.88%,PPT1;CTSC;TMED2;SCAMP3;ARFIP1;SEC24D;SSPN;TMX1;CLCN3;SNX2;SGMS1;GNAS;ARCN1;STX7;YIPF6;ERGIC3;RAB14;TSPAN8;OCRL;ATP6V1H
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5346829636019257,-0.9883187935067691,0.5068493150684932,1.0,1.0,10/16,16.26%,PLET1;KLHDC4;IGSF6;SPI1;NR1D1;AOAH;MYO1F;PILRA;TYMP;MPP1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.5968483442351525,-0.9882849951335839,0.5192307692307693,1.0,1.0,2/8,21.31%,KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.4444302273902549,0.9876935090428287,0.40625,0.9331069088922878,1.0,4/17,14.43%,RAN;TRIM71;KHSRP;DGCR8
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.5961416182670074,-0.987544129956035,0.5483870967741935,1.0,1.0,2/9,15.47%,RYR3;RYR2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.6064853334034607,-0.9874205936403028,0.5573770491803278,1.0,1.0,3/8,24.74%,BAIAP2;FLNA;GAS2L1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.48078294619815254,-0.9874048366531996,0.5540540540540541,1.0,1.0,7/35,12.37%,RASGRF1;GPR18;RASGRP1;MMD2;RASGEF1A;ARRB1;LPAR6
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.5498944475245613,0.9873779648616622,0.5294117647058824,0.9330921316963644,1.0,3/8,12.83%,TGFBR2;TGFBR1;INSIG1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.4595152109040104,-0.9872233953111134,0.5119047619047619,1.0,1.0,10/54,15.70%,SLC39A14;ATP6V1E2;FOXO1;BCAR3;SORBS1;AKT2;PDK2;IGF1R;BAIAP2;GRB10
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6354677281023859,0.9871659180042557,0.5806451612903226,0.9327011692642713,1.0,4/5,35.38%,SH3GL2;TMEM108;LLPH;AUTS2
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.5964190277623715,-0.9869567223347611,0.5373134328358209,1.0,1.0,2/12,3.53%,SLC39A14;TRPC5
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.5685780630471116,0.9869213991307771,0.5833333333333334,0.9323109615859083,1.0,7/10,23.35%,NLGN2;NLGN3;WNT5A;NLGN4X;NLGN1;NLGN4Y;NRXN1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.6227908426984223,-0.9869135153467054,0.578125,1.0,1.0,2/9,15.61%,MSH6;IFIT1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.6115874862705992,0.9867275932494172,0.5526315789473685,0.9317739932524234,1.0,3/8,18.62%,ERN1;FICD;HSPA5
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4234864405310392,-0.9866215499037186,0.5301204819277109,1.0,1.0,21/108,18.62%,CD44;STMN2;SOX9;OVOL2;VEGFA;DUSP22;LRP2;EMD;RUNX2;PDE8A;NTRK3;VIL1;ITGB1BP1;TGFB1;STAT5B;MAP2K5;WNT7A;RAB35;ZFP36L2;DAB2IP;PRKD2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.4462501749331408,0.9863869278789507,0.4642857142857143,0.9317069676250573,1.0,5/26,9.34%,PLXNA3;SEMA5B;SEMA5A;SEMA4F;SEMA3B
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5752540879046746,0.9862834442285371,0.47058823529411764,0.931037769445543,1.0,6/10,30.18%,MFHAS1;WNT5A;LRFN5;CD200;GPR137B;NR1H3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.42337260173449887,-0.9861928744807208,0.4186046511627907,1.0,1.0,10/66,11.65%,FABP3;SLC51A;NCOA1;ABCC3;APOE;PCTP;ACSL1;PITPNC1;ATP8B1;PITPNA
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.5376694312616627,-0.9853034019736434,0.5633802816901409,1.0,1.0,2/20,5.66%,P2RY12;RHOJ
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.46015226372607076,-0.985243859108335,0.46835443037974683,1.0,1.0,8/47,9.40%,NR4A3;SOX9;FGF1;FGF9;VEGFA;NR1D1;FUT2;B2M
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.502999130599681,-0.9851349231959068,0.5217391304347826,1.0,1.0,6/27,19.44%,AGT;VEGFA;ITGA8;SULF1;STAT1;IFT27
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.4922585075914459,0.9850120583429196,0.45161290322580644,0.9329372072438072,1.0,4/15,8.34%,CCT5;CCT3;NHP2;RUVBL2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.44711207320658264,-0.9848924967635863,0.4880952380952381,1.0,1.0,18/75,18.62%,CD44;HTR2C;PTPRC;OPRM1;PRXL2C;MAP3K12;APOE;PDE8A;RASGRP1;ARRB1;NTRK3;MAP2K1;TGFB1;PDGFRB;ARRB2;ROR1;HTR2B;PRKD2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.4857037439522428,-0.9845556725618038,0.4675324675324675,1.0,1.0,4/34,9.31%,HEY2;SOX9;RANBP3L;LOXL3
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.4630040622667297,-0.9845446891358464,0.5,1.0,1.0,10/63,17.13%,AGT;P2RY12;PLSCR1;NLRP12;USF1;PDCD4;TGFB1;PDGFRB;RIPK1;IFI35
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.6303255100996996,-0.9844387433158484,0.5423728813559322,1.0,1.0,3/6,26.57%,NMNAT3;NMNAT2;HAAO
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.5993591806597582,-0.9844026996930675,0.5178571428571429,1.0,1.0,1/7,1.40%,SOX9
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.6593398816569014,-0.9842461679389173,0.55,1.0,1.0,1/6,17.13%,IFI35
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6653661883142472,0.9839903275495043,0.5142857142857142,0.934645973080006,1.0,1/5,2.47%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.5232158204074593,-0.9839775458923418,0.53125,1.0,1.0,8/22,24.78%,GADD45A;APOE;ADAMTS9;TGFB1;DAB2IP;ANGPT2;MEF2C;ADGRB1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5938668151783889,-0.9839542696243458,0.5384615384615384,1.0,1.0,3/8,15.84%,BRCA1;KLF15;CTBP1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.5744661841834605,0.9838498698880653,0.48484848484848486,0.9340826485872532,1.0,1/7,3.14%,MSN
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.6113890384422104,-0.9838137474592749,0.5081967213114754,1.0,1.0,4/6,36.55%,DENND6A;FLOT1;PTPRU;TJP1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4107618795676308,-0.9835997223681534,0.4945054945054945,1.0,1.0,27/125,17.96%,PLET1;MYLK;FGF1;DUOX1;VSIR;NEDD9;CEMIP;VEGFA;SEMA4B;PAK1;TIAM1;STAT3;NTRK3;TMSB15B;VIL1;AKT2;FAM107A;PDPN;TGFB1;PDGFRB;IGF1R;DDRGK1;SEMA3A;ADAM9;RDX;CCDC25;ATM
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.43740283948939973,0.9833636418416788,0.3793103448275862,0.9344670578506072,1.0,7/24,9.34%,RNF6;SEMA5B;SEMA5A;MAP2;SEMA4F;MT3;SEMA3B
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.42559755779859726,-0.9831874614681027,0.5957446808510638,1.0,1.0,32/172,18.98%,CARD14;EFNA1;TTN;SOX9;FGF1;TSPYL2;FGF9;EFNA5;VEGFA;BRAT1;STAT2;ATG14;DVL2;PDE8A;EPHA7;RASGRP1;DNAJC10;PAK1;ARRB1;CSNK1D;NTRK3;AKT2;TGFB1;RIPK1;BRD4;IL34;TERF2IP;TNIK;DAB2IP;FAM20A;AKTIP;RB1CC1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4384354240764746,0.9825718468174415,0.45161290322580644,0.9356632737226341,1.0,4/25,6.65%,VPS37B;SNF8;VPS28;CHMP2A
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3662727631779352,0.9825022419245575,0.47368421052631576,0.9348876708449927,1.0,8/44,12.84%,UBB;GPX1;ALAD;PSME3;COMMD1;TMTC3;BAG2;OSBPL7
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.5750589810301483,0.982189004528578,0.5,0.9348447709112758,1.0,2/6,14.76%,SRM;SAT1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.305109197385137,0.9821034300844018,0.6,0.9342175356776501,1.0,28/202,11.41%,SOX4;UTP11;UBB;BAD;FGD3;NCSTN;MCF2;PLEKHG5;TRIM35;PAWR;FRZB;IP6K2;SMPD1;CLIP3;RYBP;NGF;BOK;PHLDA1;QRICH1;SAP18;STPG1;ATF4;ARL6IP5;UBC;PNMA1;JMY;ZNF268;JUN
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.48195343392821255,-0.9818557018715602,0.5633802816901409,1.0,1.0,5/38,10.21%,RFC4;BRCA1;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.5335605407766766,0.9815802389569849,0.5,0.9337885797990053,1.0,1/6,9.91%,CHP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.5335605407766766,0.9815802389569849,0.5,0.9337885797990053,1.0,1/6,9.91%,CHP1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5119604360276702,0.9815621031769676,0.41025641025641024,0.9329389901250976,1.0,2/10,6.10%,HNRNPA0;HNRNPC
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.40555092985866065,-0.9815412191449594,0.5773195876288659,1.0,1.0,62/298,17.95%,CD44;IL5;CARD14;TMSB4X;DUOX1;FOS;IRF1;CEBPD;MX1;CRLF1;SPI1;IFNGR2;IL3RA;OPRM1;VEGFA;STAT6;PSMB8;CD27;LIFR;STAT4;STAT2;CAMK2B;HLA-F;HLA-C;FOXO1;IL7;B2M;BCL2L11;OSMR;JUNB;STAT5A;CAMK2A;EDARADD;PITPNA;SNRPA1;IL6R;PAK2;STAT3;PSMA4;MAP3K14;PTPRJ;JAK1;PDCD4;ST18;TGFB1;OAS1;TRAF3;IFIT1;GRB10;STAT5B;RIPK1;BCL6;IFIT3;F13A1;IRAK2;PSMA3;IL34;IFI35;CIITA;CAMK2D;IRF2;TXLNA
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.46570221048250426,0.9815204410836661,0.4827586206896552,0.9321836387935349,1.0,4/17,8.25%,ADCY6;CAP1;LGR5;RXFP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.6363252504414197,-0.9810564360205972,0.5789473684210527,1.0,1.0,2/5,14.69%,AGT;TGFB1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.606653519808672,0.9808948779127642,0.5526315789473685,0.9329499178993949,1.0,1/6,1.81%,ADCY6
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.5885832423339573,-0.9807527168781635,0.5454545454545454,1.0,1.0,2/8,21.88%,AKR1C2;PDK3
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.6139708060428231,0.9806811143861442,0.5555555555555556,0.9325525671135596,1.0,1/7,1.82%,NCSTN
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.6327843309363527,-0.9806098795121712,0.46296296296296297,1.0,1.0,1/6,6.11%,UBASH3B
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.6827340358503905,-0.9804859021377414,0.6129032258064516,1.0,1.0,2/5,25.94%,ADGRV1;WHRN
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.3632839586836507,0.980427235446178,0.46153846153846156,0.9322351343030214,1.0,10/58,11.69%,ACTB;ACTG1;SDK1;CHRNA7;NLGN2;RAB39B;LIMS1;SMAD3;GRM5;NLGN3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6065912928431139,0.9803818365085879,0.5,0.9314964955166848,1.0,3/5,37.62%,RPS6KA3;DDIT3;RELA
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.6002554042830095,-0.9803726317231433,0.5409836065573771,1.0,1.0,1/8,3.12%,PTPRC
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.604410216470708,-0.9803437200154305,0.509090909090909,1.0,1.0,1/6,3.05%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.34901970787255654,0.9800587534915808,0.5384615384615384,0.9315230582202705,1.0,13/107,7.83%,SOX4;GID8;PSMD8;TMEM9;GSKIP;PSMB6;LGR5;PSMB4;SEMA5A;PPM1A;BAMBI;PSME3;PSMD10
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5790769187468535,-0.9799767547390711,0.5454545454545454,1.0,1.0,6/11,40.09%,TGFBR3;XBP1;PROX1;PRKCSH;ARID5B;PHF2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.6693268149414464,-0.9796792107028245,0.5757575757575758,1.0,1.0,1/6,7.20%,AHCYL1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.6021801338447885,0.9796494487111969,0.5135135135135135,0.931852171328865,1.0,2/7,10.15%,ATP6V0A4;CLCN3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.32589373801198845,0.978383792653435,0.3333333333333333,0.9342837207552523,1.0,33/177,15.11%,BAD;CRB2;G0S2;SOX11;CFL1;SOX8;TGFBR2;ACHE;IL15;KMT5B;FABP5;PLA2R1;RPS19;BAMBI;LEPR;ADRA1A;SOX6;ESRRG;SMAD3;TGFBR1;SMURF2;MST1;GLIPR2;ZNF516;MAD2L2;PAX8;GNAS;BMP2;PLCB1;TRPM4;PDGFC;EZH2;WNT5A
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.6572704265235216,-0.9783709551751355,0.631578947368421,1.0,1.0,2/5,33.11%,MEF2C;INPPL1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.6386627827079852,-0.978253401625315,0.6417910447761194,1.0,1.0,5/8,30.47%,CACNG8;DLG4;CACNG2;CACNG7;CACNG5
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.6386627827079852,-0.978253401625315,0.6417910447761194,1.0,1.0,5/8,30.47%,CACNG8;DLG4;CACNG2;CACNG7;CACNG5
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.5574331640161677,-0.9774322924616965,0.5,1.0,1.0,2/12,7.14%,OVOL2;TMC4
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.5445091067895762,0.9773880483972474,0.5517241379310345,0.9357914587714214,1.0,2/9,14.45%,SGPP1;GLTP
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5065915663461664,0.9773397058494984,0.5277777777777778,0.9349742332162845,1.0,1/10,0.66%,BAD
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6448200181548218,-0.9773330781074264,0.6376811594202898,1.0,1.0,3/6,26.31%,AGO1;AGO4;ADAR
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5322192496061873,-0.9772547791749532,0.5135135135135135,1.0,1.0,7/19,17.07%,CAV3;CACNA1C;GJA1;KCNQ1;SNTA1;RYR2;NEDD4L
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.611937216164145,-0.9772433387942807,0.5588235294117647,1.0,1.0,3/7,24.08%,AGO1;AGO4;DHX36
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5591970124469521,-0.977197575443824,0.5735294117647058,1.0,1.0,4/14,15.46%,SLC22A4;ABCC3;GJA1;ABCA8
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.6262527061216118,0.977067041993663,0.525,0.9347483608977615,1.0,4/5,37.11%,PSMC3;CCNK;EIF2AK4;VAPA
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.37668046268561567,0.9769568263264736,0.46153846153846156,0.9341169810920574,1.0,9/66,3.76%,MMP2;PRRX1;BGN;FIBIN;PODN;COL12A1;CXCL12;VSTM4;PDGFRA
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.4294633962484879,0.9764049361167523,0.5294117647058824,0.9346903598692469,1.0,5/25,10.69%,TIPARP;ESR1;DHFR;LOC400499;ARL6IP5
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3946619497943722,0.9763184910932508,0.5217391304347826,0.934021011396667,1.0,8/26,11.93%,PIWIL2;RAN;PIWIL4;DTD1;HENMT1;TRIM71;NIFK;KHSRP
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.5429457612329979,0.9760525583077214,0.4473684210526316,0.9329600368213065,1.0,3/8,12.89%,SPTLC1;ACER2;ACER3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.5429457612329979,0.9760525583077214,0.4473684210526316,0.9329600368213065,1.0,3/8,12.89%,SPTLC1;ACER2;ACER3
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.44403891672706697,-0.9760090192044222,0.5,1.0,1.0,13/55,21.87%,CRYM;MCCC1;GLUL;SHMT1;ASPA;AASS;BCAT2;AUH;GCDH;GLDC;ACMSD;SLC25A21;HIBADH
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5137314046853587,-0.9759449185695215,0.5064935064935064,1.0,1.0,1/22,0.30%,HEY2
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.689427001583714,-0.9758211001704253,0.6440677966101694,1.0,1.0,1/5,9.98%,ACSL1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.47914970855488637,-0.9758128046763808,0.5441176470588235,1.0,1.0,1/32,0.17%,EPN1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5420470558600692,0.9757022487457523,0.5,0.9329979872877986,1.0,3/8,13.46%,PIH1D1;PLAUR;PRR7
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.42897527116850986,0.975569353164148,0.45454545454545453,0.9325410670469755,1.0,4/29,4.93%,CUL7;LZTS1;CAPRIN1;RAP2A
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.5825244518717774,-0.9750022308246971,0.59375,1.0,1.0,1/9,1.31%,SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.5825244518717774,-0.9750022308246971,0.59375,1.0,1.0,1/9,1.31%,SYNJ2
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5978411025043535,-0.9749703981812274,0.5522388059701493,1.0,1.0,2/8,17.41%,APOE;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.31692772260704904,0.9749546031514804,0.6,0.9327744713767234,1.0,16/106,11.88%,MALT1;TRAF5;TAB3;PLEKHG5;IKBKB;UBE2N;RHOC;PPM1A;S100B;TMEM9B;PELI1;INAVA;ATP2C1;MUL1;LITAF;TSPAN6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5157048488515036,-0.9748414273129224,0.5324675324675324,1.0,1.0,4/21,10.21%,RFC4;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5814338158033644,-0.9746965160290534,0.5571428571428572,1.0,1.0,1/16,4.24%,GADD45A
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4261699585650877,-0.9744265499937295,0.5287356321839081,1.0,1.0,10/78,12.91%,SLC28A2;AHR;IRF1;IFNGR2;KLF6;OSMR;RASGRP1;SLC4A4;TAPBP;PVR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.4482594163694189,-0.9743491496275435,0.5432098765432098,1.0,1.0,9/59,15.28%,TMSB4X;FGF1;AGT;VEGFA;GPI;STAT5A;ITGB1BP1;TGFB1;NRP2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.4569996184179014,0.974342660034608,0.4411764705882353,0.9333453537597773,1.0,3/15,4.81%,FNBP1L;SYNE2;MYO1D
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6827535331846668,0.9743350299839152,0.6052631578947368,0.9324868674108563,1.0,3/5,26.89%,PGM2;GALE;GALK1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5054079797467819,0.974109298768652,0.55,0.9322656331159423,1.0,1/18,0.27%,SOX4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.6492027278394041,-0.9737630105050015,0.6140350877192983,1.0,1.0,2/7,26.09%,DPH6;CPEB3
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.47152951363937906,0.9737531857529187,0.45454545454545453,0.9322521770629988,1.0,4/17,15.53%,HSPA1A;MKKS;PSMG1;HSPA4
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5029533484336705,0.9736465806754918,0.45454545454545453,0.931552486174531,1.0,1/10,2.33%,SPOCK3
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5920256083076276,-0.9735774051467626,0.5625,1.0,1.0,3/9,15.63%,CD160;PTPRJ;DGKZ
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5913888416962193,-0.9734914496362632,0.5833333333333334,1.0,1.0,1/9,1.11%,TTN
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5694883392634715,0.9732955534426956,0.5384615384615384,0.9315655910584971,1.0,2/7,25.05%,ZDHHC5;PUM2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4075244984092807,0.9732010524116828,0.5,0.929282714068136,1.0,8/54,7.67%,KLHL12;PEF1;TGFA;CTSC;TMED2;PREB;SEC24D;RAB1B
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.4075244984092807,0.9732010524116828,0.5,0.929282714068136,1.0,8/54,7.67%,KLHL12;PEF1;TGFA;CTSC;TMED2;PREB;SEC24D;RAB1B
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.4075244984092807,0.9732010524116828,0.5,0.929282714068136,1.0,8/54,7.67%,KLHL12;PEF1;TGFA;CTSC;TMED2;PREB;SEC24D;RAB1B
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.36018049818977127,0.9731835898337876,0.4666666666666667,0.9284472462591116,1.0,10/49,14.81%,POLR2J;POLR2L;FLRT3;GTF2F1;TRIM71;POLR2K;FLRT2;GRB2;HNRNPH1;POLR2E
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.40175609763956166,-0.9727119496114829,0.5591397849462365,1.0,1.0,22/186,13.08%,EPN1;GCA;AZIN2;SYNJ2;MX1;SYT1;TMEM43;KIAA0319;CAV3;LRP2;EMD;SYT2;LPCAT3;DNM1;CLTCL1;RIMS1;DVL2;ARRB1;SYNGR2;DNM2;CHMP4B;GAK
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.567882437982384,-0.9725918110090335,0.5303030303030303,1.0,1.0,1/10,1.31%,SYNJ2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.6154633551522563,-0.9725155813187564,0.5846153846153846,1.0,1.0,2/5,20.27%,EDNRA;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.36109258318071785,0.9722670451115218,0.5,0.9295061512493572,1.0,9/85,9.43%,SOX4;PLD1;PIWIL2;NPM1;EIF3D;EEF2;FXR2;POLDIP3;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.6030733494567169,-0.9717339824389828,0.5901639344262295,1.0,1.0,4/8,23.88%,HLA-F;PVR;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5935411813136892,-0.971385837015929,0.5428571428571428,1.0,1.0,2/10,9.09%,NR4A3;PDE8A
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.41260631699899214,-0.9710253212516361,0.4943820224719101,1.0,1.0,24/139,16.18%,AHR;IRF1;MX1;TRPC5;GADD45A;DAPK1;EFNA5;TNFRSF19;BRAT1;AHCYL1;PLSCR1;BCL2L14;FOXO1;PRUNE2;BCL2L11;TRAF7;AKAP1;CIT;TCHP;YARS1;PDCD4;DAPK3;RIPK1;MAGEH1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5759802554513764,0.9708068581647773,0.5714285714285714,0.9319010002662513,1.0,2/8,10.83%,ATP6V1G1;ATP6V0D1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.647475614370582,-0.9707115960297009,0.5538461538461539,1.0,1.0,4/7,33.29%,B2M;HLA-A;ERAP1;TAP1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5471916221886389,-0.9705375872562573,0.5942028985507246,1.0,1.0,7/19,25.93%,CAV3;CACNB1;JPH3;CAMK2D;SELENON;PLN;CACNB4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3522668289669597,0.9702560792229734,0.6666666666666666,0.931553992624932,1.0,13/51,17.89%,ACTB;ACTG1;ARPC5;LYN;BRK1;GRB2;MYO10;CDC42;WIPF1;CRK;CYFIP2;ELMO1;ARPC2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3522668289669597,0.9702560792229734,0.6666666666666666,0.931553992624932,1.0,13/51,17.89%,ACTB;ACTG1;ARPC5;LYN;BRK1;GRB2;MYO10;CDC42;WIPF1;CRK;CYFIP2;ELMO1;ARPC2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.470596442436411,-0.9702144348688703,0.5657894736842105,1.0,1.0,2/35,5.13%,CD44;VEGFA
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.5503706809874266,-0.9701768490342042,0.5147058823529411,1.0,1.0,2/14,9.17%,FBXO6;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4506660677427455,0.9699960394307573,0.5833333333333334,0.9314386988086593,1.0,4/22,7.10%,UBB;GPX1;CTSC;PSME3
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.5804790690308516,-0.9699660544890432,0.5362318840579711,1.0,1.0,1/10,3.82%,ELOVL2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.5804790690308516,-0.9699660544890432,0.5362318840579711,1.0,1.0,1/10,3.82%,ELOVL2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5021173179034011,0.9698937246230867,0.5581395348837209,0.9308493875243845,1.0,3/12,18.72%,PYCR1;FDFT1;DHRS11
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.5932225519668728,-0.9698269705004969,0.5857142857142857,1.0,1.0,3/8,20.09%,CAMK2B;DAB2IP;RELN
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.6267463037203738,-0.9697856711502962,0.5396825396825397,1.0,1.0,2/6,14.69%,HLA-F;TGFB1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.38103559367293344,0.9697803128979737,0.42105263157894735,0.9301971354042371,1.0,10/57,8.01%,VPS37B;YIF1B;ZDHHC1;GOLGA7;ZDHHC3;ZDHHC6;MICALL1;ZDHHC11B;ZDHHC4;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4621423956747442,0.9697754607348926,0.4827586206896552,0.9293669751583551,1.0,1/16,0.42%,STOX1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4982529276090102,0.9696055850305173,0.5161290322580645,0.9288578830853806,1.0,1/13,3.20%,LSM1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5546669797802237,-0.9694772906314107,0.5342465753424658,1.0,1.0,4/15,15.80%,THRAP3;CELF4;NCBP1;CELF3
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.6258934823982605,-0.9693685719750647,0.5714285714285714,1.0,1.0,4/7,22.73%,ABHD12B;DGAT2L6;ABHD12;ABHD6
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.5975496393649234,-0.9692515722808223,0.5671641791044776,1.0,1.0,5/12,25.52%,MAPK12;EPAS1;NRG1;HINFP;PLEKHM3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4314593489767569,-0.9691669253386098,0.5116279069767442,1.0,1.0,11/72,14.41%,IGF2BP2;IGF2BP3;DAPK1;HAP1;PUS7;SHMT1;APOE;ZNF540;RTN2;TSC1;DAPK3
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.4596387455660427,0.9687946792895066,0.5333333333333333,0.9301247488445621,1.0,1/10,1.81%,ADCY6
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.4356274117267628,0.9687440268096663,0.4583333333333333,0.9293862474846931,1.0,7/19,19.30%,MAP10;SVIL;PKP4;CDC42;CENPV;RHOA;CDC25B
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5328074893683604,0.9687215915841001,0.5365853658536586,0.9285853672360923,1.0,3/9,8.60%,GSTP1;LYN;GREM1
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.6340471703359021,-0.9686238978542611,0.5652173913043478,1.0,1.0,1/6,0.54%,JADE2
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.44142702620830226,-0.9685238873542877,0.5121951219512195,1.0,1.0,7/67,12.88%,TTN;ANKRD53;EML3;RAB11A;NCAPD3;SGO2;CHMP4B
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.5791143940346761,-0.9683867236965903,0.5625,1.0,1.0,2/12,3.80%,LRIF1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4737402424377856,0.9682659224276216,0.5,0.9290085009717062,1.0,3/24,2.82%,MOSPD2;CALR;CXCL12
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.6213198319507589,-0.9679753471036362,0.5909090909090909,1.0,1.0,2/5,26.14%,RORB;RPGRIP1L
prerank,PanglaoDB_Augmented_2021__Basophils,-0.4524031107326367,-0.9674779911318068,0.4810126582278481,1.0,1.0,12/39,16.33%,CD44;SPI1;IL3RA;FAR2;AOAH;TULP3;MYO1F;ST6GALNAC5;CABLES1;TBXAS1;WRN;F13A1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.44510506183625215,-0.9672925084779815,0.48,1.0,1.0,8/38,14.69%,BRCA1;VEGFA;PTPRR;ARNT2;KIAA1217;ZNF568;SULF1;TGFB1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5188834587811779,-0.9672743729556401,0.4714285714285714,1.0,1.0,3/17,14.69%,GNA12;ITGB1BP1;TGFB1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.3871050124539297,0.9672380530731629,0.41379310344827586,0.9305759498019245,1.0,6/33,11.06%,NOL11;TSR1;RPS19;NGDN;WDR46;NAT10
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.36945219319657074,0.9670447632895292,0.5833333333333334,0.9301956605794501,1.0,11/63,11.37%,SIRT2;ADCY6;VIPR2;PCBP2;CALCRL;ENPP3;LYN;PRKAR2B;RXFP1;RC3H1;MUL1
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.5089400739195532,-0.9666673800311035,0.5641025641025641,1.0,1.0,5/31,6.30%,CD160;SRPX;BRCA1;EFNA5;CRYBG1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.32992229873767837,0.9665927176321254,0.625,0.9304764647175588,1.0,39/208,17.43%,USP51;UBB;ACTB;ADRM1;PSMD8;USP12;PSMB6;TAF9B;PSMB4;ESR1;JOSD2;UBE2D1;ATXN7L3;OTULINL;PSME3;PSMD10;SMAD3;TGFBR1;ACTR8;UBC;SMURF2;INO80D;RNF128;USP31;OTULIN;PSMD12;POLB;PSMB2;PSMD4;YOD1;RAD23A;SMAD7;MBD6;USP22;USP2;OTUD5;SENP8;RUVBL1;ACTL6A
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.49272580605059635,0.96659228669105,0.4523809523809524,0.9296274898409919,1.0,2/9,9.51%,H1-10;H1-4
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.4823676578771361,0.9665408709652574,0.5161290322580645,0.9289195078217366,1.0,3/16,4.30%,CTSV;ZFP36L1;SGPP1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.4906984207510678,-0.9663557354459424,0.5783132530120482,1.0,1.0,4/31,4.59%,CD44;MMP19;SCUBE3;A2M
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.4906984207510678,-0.9663557354459424,0.5783132530120482,1.0,1.0,4/31,4.59%,CD44;MMP19;SCUBE3;A2M
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.6700006930215878,-0.9660658244181641,0.6507936507936508,1.0,1.0,1/5,2.28%,ABHD12B
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.42481088137711287,-0.9654828090911297,0.5232558139534884,1.0,1.0,23/111,19.04%,SOX9;AGT;ANP32E;DAPK1;NLRC4;ALK;FANK1;BCL2L14;BCL2L11;MOAP1;TOMM70;LCMT1;SRA1;DAPK3;RIPK1;WRN;BCL6;BEX2;BNIP3L;MADD;ATM;USP36;STAT1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.36728094777863807,0.9654554453552524,0.5263157894736842,0.9305178957878333,1.0,5/41,9.13%,TCF7L1;PORCN;FRZB;WNT3;FZD3
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.3268951774729176,0.9654303282865584,0.4,0.9297218157154705,1.0,8/94,5.27%,GPC4;SLITRK2;FLRT3;ACHE;SDK1;CHRNA7;NLGN2;RAB39B
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.4921967252089641,-0.9654178157473043,0.5394736842105263,1.0,1.0,2/27,7.23%,PIP4K2C;ITPKC
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.5507015729634798,-0.9652309336154427,0.5384615384615384,1.0,1.0,5/20,17.98%,AHR;HCN3;KCNQ1;HCN1;HCN2
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.603391516656423,0.9647686796424676,0.6111111111111112,0.9304189684611496,1.0,1/9,3.06%,COPS9
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.505480803855524,-0.9647449296642778,0.5769230769230769,1.0,1.0,3/22,13.54%,STMN2;PFN2;TBCD
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.6535478897168636,-0.9647200256037178,0.6451612903225806,1.0,1.0,3/5,27.55%,PANK2;GNB3;C3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5099540103107034,0.9645084413372215,0.4888888888888889,0.9302180703765605,1.0,2/11,7.34%,EVI5L;YAP1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3582121756309157,0.9643450180144334,0.42105263157894735,0.9297777701040666,1.0,14/77,9.19%,AMOTL2;MAGI1;ADCY6;COL12A1;GPC1;NLGN2;PCGF2;BCAR1;YAP1;BOK;MCAM;PTPRF;GLIS2;GNA11
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.5442636639774011,0.9642464251497901,0.5588235294117647,0.9292247974235562,1.0,1/9,2.90%,NT5E
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.5715729260867429,0.964014338784279,0.5853658536585366,0.9289247553831422,1.0,2/7,11.10%,CMPK1;DHODH
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.4788391481386432,-0.9639698813278671,0.5526315789473685,1.0,1.0,7/27,11.50%,EFNA1;RAB17;SLC3A1;SLC44A3;ATP8B1;GPRC5C;SPP1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5840312333633872,-0.9638486334287615,0.6197183098591549,1.0,1.0,3/10,15.17%,PTPRC;PTPA;PDGFRB
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.647700310306833,-0.9638391166655335,0.5689655172413793,1.0,1.0,2/5,21.59%,PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.647700310306833,-0.9638391166655335,0.5689655172413793,1.0,1.0,2/5,21.59%,PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.5747274270871086,-0.9637732482040994,0.5384615384615384,1.0,1.0,4/11,28.34%,COQ8B;COQ6;COQ3;PDSS1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.5747274270871086,-0.9637732482040994,0.5384615384615384,1.0,1.0,4/11,28.34%,COQ8B;COQ6;COQ3;PDSS1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.47152697729591936,-0.9636895579723362,0.56,1.0,1.0,12/32,27.16%,IRF1;TRIM56;TOMM70;IFIH1;OAS1;TRAF3;TIRAP;POLR3A;MAVS;ISG15;FLOT1;POLR3D
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.4849229347023698,-0.9636213927150205,0.5066666666666667,1.0,1.0,5/38,11.65%,ABLIM1;CRYBG3;RPGR;ADGRV1;PITPNA
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.6240623316882459,-0.9635410207501776,0.6379310344827587,1.0,1.0,3/6,16.02%,RFTN1;OAS1;RIPK1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.48600928083790707,0.9633856326415752,0.6,0.9297704954459137,1.0,3/14,12.09%,ESR1;DDX54;TRIP4
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5300544733295597,0.9633509172140263,0.5111111111111111,0.9290304242859463,1.0,2/7,21.66%,UBQLN2;HERPUD1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.46604527961534764,0.9633048612042776,0.4375,0.9282665655868549,1.0,6/15,25.22%,PML;HSPA5;PINK1;SUPT7L;AKT1;ARL2BP
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3639582202181395,0.963269436089941,0.5714285714285714,0.9274538818165875,1.0,24/150,12.36%,SOX4;PLD1;PIWIL2;EIF4H;EIF1;CALR;NPM1;EIF3D;RNF139;CAPRIN1;DHFR;EIF5;EEF2;EIF4E2;CNOT9;FXR2;POLDIP3;EIF4A3;TRIM71;GRM5;NAT10;TOB1;MRPL13;EIF4E
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.5095361214110495,0.9628789581442043,0.4482758620689655,0.9274953599976081,1.0,2/10,2.44%,SOX11;LTBP3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.427745801287821,0.9628331152934589,0.4,0.9267725337873286,1.0,2/24,4.42%,RAB26;GOLGA7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.466757707204695,-0.9624166571028301,0.5205479452054794,1.0,1.0,6/27,21.84%,CAV3;RAB11FIP5;BDNF;NEDD4L;ABCA2;STX4
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.36483415923115065,0.9623182928181057,0.5333333333333333,0.9271775458473414,1.0,16/65,12.36%,NUP42;U2AF1;MALT1;CALR;NUTF2;RAN;POLDIP3;EIF4A3;RBM8A;CHP1;MAGOH;NXF1;WASHC4;SRSF3;LSG1;EIF4E
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.45475925291756664,-0.9622187517130587,0.5595238095238095,1.0,1.0,4/40,5.52%,ARIH2;NMT1;SAE1;YWHAH
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.6711135178364901,-0.9619258155708127,0.5625,1.0,1.0,1/5,23.90%,CARMIL1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.5216785556581575,0.9617108438197537,0.5161290322580645,0.927856957552422,1.0,2/11,11.23%,CHAMP1;SPDL1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.5396268223332914,0.961694898126286,0.4878048780487805,0.9270857764318233,1.0,4/5,30.68%,BMP2;H6PD;REST;DGKQ
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.45829716865127335,-0.9616849089795347,0.5357142857142857,1.0,1.0,10/46,20.86%,CAMK1;BORA;MMD2;STX10;USP8;PLEKHM2;TRIM46;TRIM25;TRIM5;DVL1
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.4189936502987989,-0.9616042929713411,0.5595238095238095,1.0,1.0,17/108,15.80%,STMN2;FAM13C;RGS4;AKAP12;LIFR;CACNA1B;ACTL6B;SHISA6;ARNT2;SNAP25;UNC5D;SYT4;LRRTM1;SULT4A1;DCLK1;CRMP1;CELF3
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.317251733585798,0.9614092355013903,1.0,0.9268777314828393,1.0,58/334,12.36%,ZNF488;SOX4;TCF7L1;SOX11;POU6F2;SLC2A4RG;ZNF676;ONECUT1;RNF6;CNBP;CALR;ZNF117;DSCC1;WTIP;HP1BP3;ESR1;SOX21;ZNF536;POFUT1;PML;TFEB;ZNF22;BTG1;MED23;GPBP1L1;ZNF114;ZNF519;RYBP;SP1;HES6;ZNF195;ZNF678;NR3C1;SOX6;ZFPL1;ESRRG;LIMD1;GRM5;SP3;KAT6B;FOXN2;TGFBR1;PPP2R1A;NFYA;ACTR8;RABL3;ATF4;WWC2;ZBTB11;ZNF268;ZNF212;ZNF460;NFIL3;TRIP4;FADS1;ZNF516;SPIN2B;EIF4E
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5019581187666238,-0.9612488095053424,0.5394736842105263,1.0,1.0,3/20,14.82%,EFNA1;TAF1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.5402884200773485,-0.96120853386639,0.5797101449275363,1.0,1.0,3/13,9.24%,PTPRC;VAV3;IL7
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.3360926831977661,0.9609484023501264,0.47619047619047616,0.927480751021873,1.0,8/74,2.82%,AMOTL2;BGN;FIBIN;HSPG2;COL12A1;LAMA3;TNS2;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.6369170901448777,0.9609452268562081,0.625,0.9266621360783633,1.0,1/5,9.71%,MKKS
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.613277652643579,-0.9609054515489724,0.5901639344262295,1.0,1.0,1/7,14.12%,ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5406974031540774,-0.9608687284381464,0.5454545454545454,1.0,1.0,3/13,17.30%,LIMK1;DTX3L;BAG5
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.4885183138277159,0.9608180798671837,0.5454545454545454,0.9262558316756244,1.0,1/11,5.72%,RO60
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.6258127706326233,-0.9607048433800284,0.576271186440678,1.0,1.0,1/7,10.83%,RASGRP1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3789209995345187,0.9601523870451412,0.5263157894736842,0.9271687570221911,1.0,8/61,7.67%,KLHL12;PEF1;TGFA;CTSC;TMED2;PREB;SEC24D;RAB1B
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5750198494191745,-0.9597527827138534,0.5535714285714286,1.0,1.0,1/10,1.40%,SOX9
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.4146480911154119,-0.9596053733498514,0.5376344086021505,1.0,1.0,13/105,14.12%,RAB40A;EMP2;RAB40B;CAV3;RAB11A;PLEKHF1;RAB3A;PDZK1;RAB3D;RAB15;KCNB2;GAK;ITGB1BP1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.4716437716875555,0.9595087073774867,0.39473684210526316,0.9280303403250095,1.0,1/12,7.24%,NDUFA5
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.3902091113495526,0.9594826710816545,0.4782608695652174,0.9272389912909655,1.0,11/44,10.20%,FERMT1;AMOTL2;HSPG2;COL12A1;LAMA3;YAP1;MYOF;LRIG3;S100A16;MDFI;CA3
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.559104336370583,0.9592430773211045,0.5294117647058824,0.9271065412966428,1.0,2/7,17.07%,SQLE;AUP1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.6142804518763112,-0.9588755192425622,0.5694444444444444,1.0,1.0,3/7,20.86%,DVL2;DLG4;DVL1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.5793122994099574,-0.9588570719087802,0.5522388059701493,1.0,1.0,3/8,15.84%,SPI1;ARRB1;CTBP1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.4982980903393661,0.9587337367179215,0.5,0.9276436229418142,1.0,2/12,8.10%,PLOD1;P3H2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.41246475664259324,0.9586207419938102,0.47619047619047616,0.9270528654923914,1.0,3/31,6.66%,SOX4;ERN1;ZNF236
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5889248017294082,0.9583252166761452,0.5142857142857142,0.9268095838336504,1.0,2/6,9.60%,CAMSAP3;INAVA
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.5083288979551052,0.9582504792687847,0.4642857142857143,0.9261093661952674,1.0,2/11,10.69%,SEMA5A;EPHB3
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.46418554603844464,-0.9575722153874094,0.5285714285714286,1.0,1.0,13/40,24.16%,NR4A3;STEAP4;PSMB8;FOXO1;AKT2;CTBP1;CBY1;TMEM120B;OSBPL11;BBS7;WNT5B;PPARGC1A;MED1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.5335237899336469,0.9573204046629789,0.4666666666666667,0.9275717004189608,1.0,2/9,6.63%,MID1IP1;SLC25A20
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.603785390255487,-0.9568937554740791,0.5606060606060606,1.0,1.0,1/7,4.56%,ITPK1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.5963798411953649,-0.9568036351267285,0.5942028985507246,1.0,1.0,5/9,26.05%,ALK;NCOR1;CEACAM1;CCDC3;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.40702835053226905,0.9566053055716127,0.375,0.9284391496172948,1.0,6/30,18.12%,ALAD;UBXN1;RYBP;N4BP1;MARCHF7;FHIT
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4795211978444373,0.9565503461782661,0.5,0.9278009917816225,1.0,4/21,12.59%,TRIR;NUDT16L1;EXOSC8;MTREX
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.48359448430641105,0.9565027990051443,0.45714285714285713,0.9271023768559105,1.0,4/10,14.96%,ADRM1;PSMD10;PSMG1;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5708087282529175,-0.9565014031452085,0.5294117647058824,1.0,1.0,2/12,14.84%,BRCA1;AASS
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.6176319180651142,-0.9562666491418425,0.6153846153846154,1.0,1.0,1/5,5.46%,RARA
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.6332331104472974,0.95621161582765,0.5476190476190477,0.9271926217266835,1.0,3/5,31.19%,KIFAP3;KIF13A;KIF3B
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.4634601862800426,-0.9559468683346403,0.6341463414634146,1.0,1.0,8/55,17.51%,PON1;VEGFA;DNM2;LCMT1;SVIP;HDAC6;CRYAB;RDX
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.4374069548514677,-0.9558094409516694,0.5238095238095238,1.0,1.0,9/51,16.52%,CDH7;CDH12;CDH9;CDH19;PVR;TGFB1;CDHR3;CDH8;CTNNA1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.6073502631879988,0.9556178179461162,0.6170212765957447,0.927860606466003,1.0,1/5,3.81%,EIF3D
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.4728412044041468,0.9551919488845598,0.56,0.9280237313058931,1.0,5/13,10.12%,GPX1;PRDX1;PRDX5;CAT;PRDX3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.4993537593924904,-0.9550676414228065,0.5131578947368421,1.0,1.0,7/22,26.01%,MICALL2;PREX1;VIL1;FAM107A;SPIRE1;GAS7;GSN
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.5352936149733107,-0.9550129513328234,0.5714285714285714,1.0,1.0,3/17,22.69%,CSNK1D;HOOK3;CEP131
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4999905716086417,-0.9550069558913893,0.546875,1.0,1.0,5/16,22.44%,IL7;TCF7;FANCA;SPINK5;XBP1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5493429519855703,0.9549564497098982,0.525,0.9278183473446903,1.0,4/8,31.11%,DCUN1D1;DCUN1D5;NAE1;UBE2M
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.40759086955899276,-0.9548984072574089,0.5795454545454546,1.0,1.0,30/99,27.90%,HOOK1;EMP2;WDR91;RBSN;CLTCL1;TBC1D10B;GAK;STX10;RAB6B;TMEM87B;HOOK2;HOOK3;VPS52;DCTN1;AKTIP;STX5;ANKFY1;EPS15;AP2A1;SORT1;CLTC;VPS51;VPS53;EEA1;ANKRD27;VPS13C;RGP1;RAB29;WASHC1;SPAG9
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.5711702814380275,0.9548138528798835,0.5348837209302325,0.9274293775430497,1.0,2/6,9.13%,ASCL1;FZD3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.48221236073380747,-0.9547874652627671,0.547945205479452,1.0,1.0,5/21,16.96%,RAB17;CAMK2B;GRIPAP1;EPHA4;MDGA1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.36165283032864176,0.9545156184967538,0.625,0.9273351507521311,1.0,6/49,12.45%,BAD;NGF;BOK;SMAD3;MUL1;ACER2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.49241354199975007,-0.9543444425628205,0.56,1.0,1.0,4/26,4.71%,HEY2;HES1;ZFPM1;ROBO2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.43383550561543976,-0.9541156442522706,0.5753424657534246,1.0,1.0,12/57,20.79%,ARIH2;PTPRC;ZFPM1;RUNX2;KITLG;ZNF160;TGFB1;ZFP36L2;KMT2A;TGFBR3;TIRAP;ETV6
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5725346526788887,-0.9537808908046268,0.5901639344262295,1.0,1.0,4/10,26.62%,TRIB1;TPM1;MEF2C;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.30815172929223744,0.9534834589085787,0.5,0.9287957748941976,1.0,31/221,11.41%,SOX4;UTP11;SIRT2;UBB;BAD;FGD3;NCSTN;MCF2;PLEKHG5;TRIM35;PAWR;BTG1;FRZB;IP6K2;SMPD1;CLIP3;RYBP;NGF;BOK;PHLDA1;QRICH1;SAP18;STPG1;TGFBR1;ATF4;ARL6IP5;UBC;PNMA1;JMY;ZNF268;JUN
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3809388284431123,0.9534361560469906,0.5,0.928040046306187,1.0,3/37,1.77%,CHRNA4;MALT1;PHB2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.576395040398341,-0.9533886313099273,0.5555555555555556,1.0,1.0,3/9,9.14%,CACNA1C;GJA1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5302397046809176,-0.9533818685053611,0.5970149253731343,1.0,1.0,5/18,17.51%,RAP1GAP2;CAV3;VAV3;RPTOR;RDX
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6013700219555056,0.9532600592601882,0.5945945945945946,0.9275667081932883,1.0,2/7,18.08%,RHOC;RHOA
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4177722199459459,-0.9530272116755365,0.6385542168674698,1.0,1.0,9/98,5.46%,CD44;GADD45B;IRF1;NEDD9;TIMP3;BRCA1;BCL2L2;GADD45A;RARA
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.48276115583845897,-0.952999061717588,0.589041095890411,1.0,1.0,6/27,21.31%,SFXN3;KCNJ11;SLC6A9;SLC25A19;TRPM3;ATP1B1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.5053321487035848,0.9529734817221421,0.4864864864864865,0.9274238542559717,1.0,1/8,1.77%,PHB2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4983256470418796,-0.9529359839113136,0.631578947368421,1.0,1.0,4/20,15.32%,SLC39A14;CP;B2M;FBXL5
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.6197687271879938,-0.952924416356603,0.6031746031746031,1.0,1.0,2/6,24.39%,AKT2;IRS2
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.6191178545450264,-0.952843390254231,0.6031746031746031,1.0,1.0,4/7,37.02%,RAB29;SNCA;VAMP3;INPP5F
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.4307545614393858,-0.9526272256497432,0.6025641025641025,1.0,1.0,17/51,23.51%,HTR2C;CALCB;TPCN2;SLC24A2;ATP2B3;RYR2;SLC8B1;HTR2B;FAM20A;ATP13A5;SLC24A5;ATP1B1;ATP13A4;ATP2B2;SLC24A4;GRIN1;SELENON
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.5006278318500774,-0.9523177612970102,0.6086956521739131,1.0,1.0,1/21,2.05%,CCDC39
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5286440201234349,0.9521314727648121,0.5,0.9291232488201723,1.0,1/12,0.98%,LPCAT1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.33012494758193694,0.9520977638886723,0.625,0.9283576946110932,1.0,18/90,9.06%,MMP2;PRRX1;BGN;FIBIN;PODN;COL12A1;CXCL12;SEMA5A;CHAD;PDGFRA;FRZB;THY1;IGFBP7;COL9A3;CHODL;CRTAC1;SOX6;GAS1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.488174222091211,-0.9520777443137903,0.5333333333333333,1.0,1.0,4/23,11.62%,FABP3;SREBF1;APOE;SORBS1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.437087400501779,0.9520075266851028,0.45161290322580644,0.9277396087007894,1.0,4/26,6.65%,VPS37B;SNF8;VPS28;CHMP2A
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.5313961589794375,-0.9517388415021407,0.6052631578947368,1.0,1.0,3/15,12.47%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6142370906732473,-0.9515413940293366,0.640625,1.0,1.0,3/6,23.80%,P2RY12;TAFA4;CXCL17
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5695873969259533,-0.9514868628968904,0.5797101449275363,1.0,1.0,2/8,17.64%,CACNB1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.5464165189257448,-0.9514503956595228,0.6153846153846154,1.0,1.0,6/15,21.20%,VEGFA;CAMK1D;ADCY1;PRKD2;RELN;CRTC3
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.6044279409395618,-0.9513488203660633,0.6056338028169014,1.0,1.0,3/8,15.38%,CLEC16A;CARD11;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.4726179404954208,0.951003762106356,0.53125,0.9293247668654059,1.0,4/14,12.13%,MSN;CTSC;PTTG1IP;RNF128
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.6826745297516966,-0.9505089068537276,0.6333333333333333,1.0,1.0,2/5,18.12%,BCL2L11;DAB2IP
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.3819454096000321,0.9501543221112646,0.4583333333333333,0.9304938494753471,1.0,3/38,6.03%,IL15;PDGFRA;LYN
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.40748559439534027,-0.9499651427195857,0.5806451612903226,1.0,1.0,22/164,14.02%,TUBA4A;SPDYA;TPD52L1;CDKN2A;CDK7;MAX;CEP135;CCNI2;CDK4;CCDC57;CDC7;TACC3;BORA;CAMK2A;CRLF3;PLK2;DNM2;HAUS5;CHMP4B;LCMT1;CSNK1D;MASTL
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6274248631685083,-0.949747911060268,0.5909090909090909,1.0,1.0,1/6,13.68%,GPR171
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.47437366226829586,0.9496085961925759,0.4857142857142857,0.9311386381551344,1.0,6/17,5.01%,ACTB;ACTG1;SOX8;LAMA3;SOX10;LIN7C
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.46463309849045226,-0.949481866837909,0.569620253164557,1.0,1.0,2/34,4.25%,JADE2;SPI1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.3505895512703399,0.9493059827991331,0.625,0.9309814051371321,1.0,6/47,8.51%,RND2;RHOBTB1;RHOC;EPHA5;MLST8;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.48223477829514466,-0.9487339416715281,0.5487804878048781,1.0,1.0,5/26,9.93%,PTPRC;VAV3;CD27;IL7;SHLD2
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.45740841443842534,0.9485560555816593,0.5416666666666666,0.9319277498052457,1.0,1/11,4.39%,MRPL44
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.42990122468975694,-0.9485139796878406,0.5316455696202531,1.0,1.0,8/29,16.99%,CYP2E1;ALOX12;LPCAT3;CYP3A5;EPHX2;MBOAT2;DGKZ;PLPP4
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.6272161571475248,-0.948204686399268,0.6060606060606061,1.0,1.0,2/6,15.75%,RYR3;SLC41A1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.5498216304432718,-0.948181611065428,0.49230769230769234,1.0,1.0,1/13,4.84%,USP13
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5318151221404773,0.9480818212967733,0.5172413793103449,0.9322546494675538,1.0,3/10,13.17%,EMC6;EMC8;EMC4
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.46800032496221955,0.9479041505224935,0.5666666666666667,0.931794277925713,1.0,2/11,13.85%,FARSA;KRT10
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.4702126525498115,0.9478938581319658,0.5483870967741935,0.9309961146180086,1.0,1/9,1.81%,ADCY6
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.47773446756374943,-0.9477761245336419,0.5555555555555556,1.0,1.0,5/21,17.21%,PRELP;ST3GAL1;ACAN;OGN;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.4904239009722158,-0.9474971755970045,0.5833333333333334,1.0,1.0,10/24,27.16%,IRF1;TRIM56;TOMM70;IFIH1;OAS1;POLR3A;MAVS;ISG15;FLOT1;POLR3D
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.49197510097470665,-0.9471095994851855,0.5822784810126582,1.0,1.0,5/25,19.13%,PTPRC;LMBR1L;WNT7A;HTR2B;FBXL17
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5407146582684268,0.9471095106947314,0.5277777777777778,0.9320116502124801,1.0,2/8,21.98%,EXOSC8;XRN1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.5603330031993139,-0.9466017661554815,0.5714285714285714,1.0,1.0,3/12,13.40%,PIGH;PIGL;PIGC
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.4893248292605119,0.9465400852726598,0.5277777777777778,0.9323856283445839,1.0,2/12,7.34%,SEMA5A;YAP1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.43865118237681,0.9464493167488273,0.5217391304347826,0.931794067984506,1.0,4/29,6.66%,SOX4;LRRC8D;ERN1;ZNF236
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.6322373919026545,-0.9463616496882912,0.639344262295082,1.0,1.0,2/5,12.74%,DOCK5;CHRM3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.37506431395761375,0.9457317445841338,0.48,0.9321796371911584,1.0,8/40,4.77%,GPC4;BGN;HSPG2;GPC1;BCAN;GALNS;VCAN;STAB2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5128889927608751,-0.9455493730933036,0.5584415584415584,1.0,1.0,5/17,15.17%,HEY2;VEGFA;RASA1;TGFB1;PDGFRB
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5551103281619296,-0.9454372382133518,0.5737704918032787,1.0,1.0,4/11,17.69%,OPRM1;CHRM3;CHRM2;CHRM5
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.4092210051026103,0.9454263845073341,0.3181818181818182,0.9319866073557794,1.0,2/25,2.10%,SIRT2;ANKRD13D
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.440721351230431,-0.9451348377841277,0.6551724137931034,1.0,1.0,11/83,14.12%,TTN;SPDYA;TSPYL2;PTPRC;CAV3;UBASH3B;TRIB1;CAMK2N1;MMD2;PAK2;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.4253444951925639,-0.9449588249160934,0.5185185185185185,1.0,1.0,17/73,19.81%,IGF2BP2;IGF2BP3;DAPK1;PUS7;SHMT1;APOE;ZNF540;CAMK2N1;TSC1;DAPK3;HDAC6;KNG1;SAMD4A;RBM4;DAB2IP;GIGYF2;ENC1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.42486403515784904,-0.944456782648503,0.5764705882352941,1.0,1.0,13/84,14.69%,ENPP2;TMSB4X;FGF1;DUOX1;FGF9;NRG4;SST;PLXNA4;MACF1;TMSB15B;AKT2;DAPK3;TGFB1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.4098357541424528,-0.9444324246137027,0.6413043478260869,1.0,1.0,22/139,19.05%,CAMK1;RPS6KB2;TLK1;MAP3K12;TAF1;CDC7;CAMK2A;VRK1;PLK2;VRK2;PAK2;CAMK1D;CSNK1D;NEK6;AKT2;MASTL;MKNK1;MAPK12;CAMK2D;ATM;PRKD2;NTMT1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.43826971910083184,-0.9442892991022123,0.6125,1.0,1.0,12/54,12.27%,FABP3;SGCA;TTN;LAMA2;CKMT2;CAV3;ARHGAP26;DOCK5;EDNRA;MEF2D;NBR1;TPM1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.5003140963152659,-0.9441779072769041,0.5394736842105263,1.0,1.0,5/23,17.40%,SLC9B1;SLC4A4;CA2;SLC4A8;SLC4A3
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5728881391991673,-0.9438941589371929,0.5538461538461539,1.0,1.0,2/9,16.51%,TGFB1;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6341237714713247,-0.9437841993998157,0.6,1.0,1.0,1/5,8.60%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6341237714713247,-0.9437841993998157,0.6,1.0,1.0,1/5,8.60%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.6341237714713247,-0.9437841993998157,0.6,1.0,1.0,1/5,8.60%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.6023654517122077,-0.9437826750439869,0.6229508196721312,1.0,1.0,2/6,18.62%,VEGFA;PRKD2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.5519117963950245,0.9437742488891361,0.3953488372093023,0.9348254265897064,1.0,1/5,3.14%,MSN
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.4980363333991783,-0.9432373518616177,0.5555555555555556,1.0,1.0,4/22,4.71%,HEY2;HES1;ZFPM1;ROBO2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5119706111124062,-0.9431704345391458,0.5671641791044776,1.0,1.0,6/18,19.27%,SRPX2;VEGFA;RHOJ;ITGB1BP1;MAP2K5;HDAC7
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.462558379416539,0.9430289177548988,0.5945945945945946,0.935868444376622,1.0,2/18,3.91%,PDGFRA;ESR1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.5569292746659213,-0.9428948811160884,0.6,1.0,1.0,2/9,9.98%,CALCOCO2;CLEC16A
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6215713166964528,-0.9427200034385487,0.6470588235294118,1.0,1.0,2/7,16.04%,XRCC3;WRN
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3571178302366674,0.9427145806511142,0.65,0.9359129100193312,1.0,11/55,10.83%,SLC30A10;CYBRD1;SLC22A17;ATP7B;SLC39A10;COX19;ATP6V1G1;ABCG2;MT1E;MT3;ATP6V0D1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.5732298631620868,0.942446771192716,0.6,0.935717325262911,1.0,1/5,1.15%,CUBN
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.37597836376409416,0.9420896103373879,0.5454545454545454,0.9357019028172597,1.0,5/29,13.62%,OPN3;ACADVL;MST1;KHSRP;CLK2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.46611930197533286,-0.9420464463388444,0.5974025974025974,1.0,1.0,4/38,13.26%,EFNA1;MICALL2;TYRO3;ITGA8
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.44669469824514324,0.9418218826945786,0.5862068965517241,0.935518814745405,1.0,8/23,22.49%,FNBP1L;ARAP1;CDC42;NRP1;RALA;NLGN1;AGRN;WASL
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.4017856256258075,-0.9414216083532604,0.6125,1.0,1.0,27/84,27.74%,HES1;SOX9;SKAP2;FANCC;RIMS1;TAPBP;VIL1;NDUFAF1;DLG4;PEX14;WDR19;KMT2A;DNM1L;FANCA;ZW10;PPARGC1A;DMTN;LIN7A;SHANK1;DARS1;SPG7;RANBP9;TEAD1;AFG3L2;TUBGCP2;PPID;PPIH
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.581757728837617,0.9413748621290589,0.6176470588235294,0.9358865562631766,1.0,1/5,6.76%,NUDT16L1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.5849874918437727,-0.9412889899065925,0.582089552238806,1.0,1.0,4/7,32.01%,DCTN1;UBA5;SHANK1;PAFAH1B1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.38512420893563354,0.9409997193500081,0.48,0.935930815164613,1.0,4/41,6.69%,UBB;TAB3;IKBKB;NFKBIL1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4702838224081209,0.9407691440176759,0.5,0.9356643723104657,1.0,4/12,15.97%,MAML2;RBPJ;WWC1;NOTCH1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.42647773321938576,0.940615911147132,0.5,0.9353028917680659,1.0,1/19,3.06%,PPT1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.5466191176862916,0.9403988843807114,0.6052631578947368,0.9349301046107601,1.0,2/8,12.72%,METAP1D;NAA30
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.35141814398665255,0.9402232522984773,0.6153846153846154,0.9344387920324277,1.0,8/56,7.83%,PSMD8;CALR;PSMB6;PSMB4;IKBKB;ITGB5;PSME3;PSMD10
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5700683289354533,-0.9401518136557488,0.532258064516129,1.0,1.0,2/8,8.44%,VEGFA;AHI1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.60120211892757,-0.9399211044532252,0.6607142857142857,1.0,1.0,3/8,17.35%,DOCK7;HOOK3;WNT7A
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.44152841666139975,-0.9398674077954856,0.6103896103896104,1.0,1.0,10/52,16.76%,FHDC1;TTN;TMOD3;CIT;SORBS1;ARRB1;TPM1;PGM5;MYOM2;CDC42BPB
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.5118864079854998,0.9398383509598296,0.5641025641025641,0.9343531324878076,1.0,4/9,14.67%,NTNG2;FLRT2;NID1;NTN4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.46778937840719204,0.9397217462103551,0.5,0.9330649804029538,1.0,1/13,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.46778937840719204,0.9397217462103551,0.5,0.9330649804029538,1.0,1/13,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5188485463524373,-0.9393937958592675,0.6268656716417911,1.0,1.0,2/17,12.47%,NOSTRIN;DNM2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.4767068881480082,-0.9385104406357248,0.6052631578947368,1.0,1.0,7/37,18.12%,FBXO6;SIDT2;ADAMTS9;DENND3;NCBP1;RIPK1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.6377693199613672,-0.9384797509352818,0.6290322580645161,1.0,1.0,2/5,10.65%,VEGFA;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.43602494297050065,0.9384007076881014,0.5294117647058824,0.9352014740952833,1.0,1/19,1.00%,CCND1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.5235113869754235,-0.9383390078153822,0.6164383561643836,1.0,1.0,3/17,13.98%,CLTCL1;SORBS1;AKT2
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.5466058085392346,0.9381783704336739,0.5777777777777777,0.9348900098995329,1.0,2/7,3.35%,MOXD1;ACHE
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.31860827315961815,0.9380385704604067,0.6428571428571429,0.9343893891337461,1.0,15/102,10.05%,MALT1;PSMD8;PSMB6;PSMB4;IKBKB;UBE2N;ERMAP;THY1;BCAR1;PSME3;PDE4B;PSMD10;TNFRSF21;RC3H1;EIF2B1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.5079363717192172,-0.937911319435518,0.5694444444444444,1.0,1.0,6/19,20.60%,IRF1;TRAF3;CD55;TIRAP;FOXP1;TRIM5
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.5593728962076867,-0.9378460036585997,0.6216216216216216,1.0,1.0,5/12,28.34%,DDRGK1;RB1CC1;UBA5;RETREG1;ULK1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.6453224196739586,-0.9377643949245608,0.6037735849056604,1.0,1.0,1/5,18.12%,DAB2IP
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.5821724731381729,-0.9377544894717232,0.6307692307692307,1.0,1.0,2/11,9.39%,TTLL6;TTLL4
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.57385466204451,-0.9376581375467431,0.6056338028169014,1.0,1.0,2/7,4.22%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5313377085780816,-0.937450810804511,0.6,1.0,1.0,4/16,9.59%,FABP3;ABHD12B;LIPI;LIPH
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.4652575381354593,0.9371902258632118,0.5277777777777778,0.9355005926562111,1.0,2/13,7.51%,ADCY6;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.5756909455929997,-0.9371209281185405,0.6166666666666667,1.0,1.0,1/8,1.40%,SOX9
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.31028327736779615,0.9370763375627058,0.6666666666666666,0.9349411278805932,1.0,20/119,9.90%,FABP7;BICD2;LRRTM2;SLITRK2;GABRG1;TCEAL6;CA10;ADGRA1;HEPACAM;GPR37L1;LRRTM3;S100B;BTBD17;RBFOX1;SPHKAP;FAM181B;RGS7BP;GPM6B;MT3;GRM5
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.6396312881845717,-0.9370403549904983,0.5757575757575758,1.0,1.0,1/5,17.96%,ATM
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.337361415844926,0.9367818957514122,0.5555555555555556,0.9348556238976301,1.0,12/54,16.11%,SIRT2;ZFP36L1;FRZB;YAP1;SMAD3;SYAP1;LRP3;PTPRQ;BMP2;TRPM4;WNT5A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.5798079421066322,-0.9367541830361347,0.6086956521739131,1.0,1.0,3/9,15.37%,NLRC4;LPCAT3;ENO1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.480380998899431,-0.936708074369547,0.6097560975609756,1.0,1.0,10/31,19.84%,PARP9;MMS19;FANCB;SHLD2;DTX3L;PNKP;RIF1;SLF1;ZCWPW1;SPIRE1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.3670654494865748,0.9366316215781325,0.4782608695652174,0.9344039944362835,1.0,9/52,4.68%,FERMT1;G0S2;PMEPA1;SLC30A10;PLIN2;CYBRD1;SOX10;FAHD1;CDO1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.40417566190479726,-0.936561765725179,0.6404494382022472,1.0,1.0,14/111,12.07%,GSTM5;PAH;ELOVL2;RHCE;MGST1;DEGS2;LPCAT3;GCNT1;APOE;SLC44A3;PCTP;TYW1;NMRAL1;GSTK1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.5348042775938937,0.9363426040232067,0.4857142857142857,0.9341892348732629,1.0,4/6,22.47%,CPNE3;HDHD5;CPNE1;FAR1
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.5516718285602287,0.9361994885411248,0.6666666666666666,0.9328887068290425,1.0,1/5,3.14%,MSN
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.5516718285602287,0.9361994885411248,0.6666666666666666,0.9328887068290425,1.0,1/5,3.14%,MSN
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.4607270919048814,-0.9360838564732789,0.6266666666666667,1.0,1.0,10/41,25.94%,SOX9;BMP8A;RUNX2;PDCD4;TGFB1;TGFBR3;ADAMTS7;ENG;SMAD4;TGFB3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.43335020996877366,-0.9358671308209627,0.5679012345679012,1.0,1.0,5/55,6.87%,SPDYA;CDKN2A;CDK7;GADD45A;CCNI2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.5488064708918006,-0.9357381285010322,0.5384615384615384,1.0,1.0,3/14,14.55%,VSIR;STAT3;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.4007010131509574,0.9357375586607322,0.6060606060606061,0.9334058363078022,1.0,4/22,9.69%,WTIP;MYCN;EIF4E2;LIMD1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.4975127128118886,-0.93569339212508,0.6111111111111112,1.0,1.0,4/18,9.90%,VCL;LAMA2;GJA1;CLDN12
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6181318463097113,-0.9356086052260477,0.6527777777777778,1.0,1.0,4/8,15.87%,STAT6;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.6493212604722391,-0.935252757271542,0.7166666666666667,1.0,1.0,1/7,9.98%,ACSL1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.5873857299181855,-0.9351904763166647,0.6029411764705882,1.0,1.0,4/10,19.91%,ADAMTS9;TPM1;TGFB1;TGFBR3
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.3275009581666589,0.93492083864917,0.6,0.9346397683745687,1.0,23/218,10.91%,USP51;UBB;ACTB;ADRM1;PSMD8;USP12;PSMB6;TAF9B;PSMB4;ESR1;JOSD2;UBE2D1;OTULINL;PSME3;GPS1;PSMD10;SMAD3;COPS2;COPS7B;TGFBR1;ACTR8;UBC;SMURF2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.4753694062451637,0.9347124389721866,0.6153846153846154,0.9342964093264753,1.0,6/22,15.21%,GPX1;CHRNA7;MAP2;CAMSAP3;HSPA8;MAP1S
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.6331396515586323,-0.934695611558864,0.6538461538461539,1.0,1.0,3/5,30.61%,KDM7A;KDM6B;KDM6A
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5190712767869476,-0.9344178532748766,0.5882352941176471,1.0,1.0,3/19,8.44%,CCDC39;SRF;AHI1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.507052006909732,-0.9344143168735123,0.5396825396825397,1.0,1.0,4/15,8.24%,DHDDS;DPAGT1;ALG6;ALG14
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.34032438114712316,0.9341925460645615,0.5263157894736842,0.9348345302386784,1.0,8/64,10.44%,TUBG1;SSNA1;KCNH5;NPM1;HAUS8;PRKAR2B;TUBA1A;PPP2R1A
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.5959517565949993,-0.9341028909470277,0.640625,1.0,1.0,2/8,18.19%,ROBO2;GPC3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.42750472124667366,0.9338183001763738,0.5555555555555556,0.934925796926152,1.0,6/25,10.83%,ATP6V0A4;MCOLN1;ATP6V0E1;ATP6V1G1;ATP6V1B2;ATP6V0D1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5515244411858609,-0.9333515157417348,0.55,1.0,1.0,2/9,4.36%,SYT1;KCNMB4
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5889248501780227,-0.933208707226776,0.6349206349206349,1.0,1.0,3/8,19.44%,HOOK3;DCTN1;CCDC120
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.3975406023331999,-0.9330596150935967,0.6224489795918368,1.0,1.0,30/175,18.12%,GLRA2;AHR;NR4A3;SOX9;FOS;DAPK1;P2RY12;GLRA1;RYR3;HCN3;NR1D1;SHMT1;FOXO1;KCNQ1;TAF1;TRIM41;TPM1;TSHR;PDK2;PTK7;HCN1;PDCD4;PDCD1LG2;RPTOR;NSMF;CAPN2;ADAM9;ATM;HCN2;DAB2IP
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.5273140181778602,0.9329524134637399,0.5714285714285714,0.9360018539071394,1.0,2/8,5.62%,CCDC88C;RILPL2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.4814964902184125,-0.9328725063004147,0.581081081081081,1.0,1.0,6/29,13.74%,AHR;KLF9;AKR1C2;SPP1;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5501623982035683,-0.93286426105063,0.671875,1.0,1.0,2/10,13.85%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5896021405804824,-0.9327530319123575,0.6323529411764706,1.0,1.0,2/8,15.00%,ECSIT;HDAC6
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.6178911253502317,-0.9326269764752143,0.6349206349206349,1.0,1.0,2/5,15.86%,ENO1;CTSZ
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5802287616208539,-0.9323808826005235,0.6515151515151515,1.0,1.0,3/5,37.74%,ITCH;TNIP1;OTUD4
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5213286406200888,-0.9319944962386884,0.59375,1.0,1.0,4/20,10.21%,RFC4;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.5686582926502651,-0.9316461569470683,0.625,1.0,1.0,3/9,17.96%,CASTOR2;RNF152;ATM
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3565681884914279,0.9315185675116125,0.5384615384615384,0.938962317131215,1.0,10/88,10.44%,LSM4;U2AF1;NOVA1;SMU1;LSM1;HNRNPC;SNRNP40;RBM8A;MAGOH;PPP2R1A
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.548997337088412,0.931418086816428,0.6097560975609756,0.9383826489629015,1.0,1/5,0.27%,SOX4
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.3599169104867342,0.9314010344984168,0.5416666666666666,0.9376402126696283,1.0,4/30,15.11%,SOX11;GPM6B;BMP2;WNT5A
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.4149996889261303,0.9313830022984059,0.6,0.9369223963937644,1.0,5/24,6.48%,CXCL12;PLEKHG5;SEMA5A;PDGFRA;BCAR1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.6188133386952142,-0.9312835764541497,0.6417910447761194,1.0,1.0,1/6,12.58%,STAT3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5272521612928135,-0.9310586307116386,0.6052631578947368,1.0,1.0,6/12,29.98%,TK2;TYMP;UCK1;PUDP;UCKL1;CAD
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.5223680376266531,-0.9309935164328772,0.6229508196721312,1.0,1.0,2/13,12.21%,BRCA1;PLK2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.6307569612269719,-0.9309143523839253,0.6181818181818182,1.0,1.0,3/5,34.85%,RNF20;CDK9;CTR9
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.5372719638826823,0.9307274187621927,0.5882352941176471,0.9376419704979,1.0,4/7,22.49%,GREM1;PLCB1;AKT1;WASL
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5542521522421571,-0.9307144929775848,0.6774193548387096,1.0,1.0,4/12,29.55%,SEC14L1;UFD1;NOP53;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5772564055354859,-0.930618383738225,0.6231884057971014,1.0,1.0,2/9,9.90%,MMS19;FANCB
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.43800694647870375,-0.9305107641739176,0.6375,1.0,1.0,3/57,3.28%,CD44;FGF1;FGF9
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.6285795435129318,-0.9304792045873281,0.676923076923077,1.0,1.0,2/7,12.75%,CHAC2;GCLC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.6285795435129318,-0.9304792045873281,0.676923076923077,1.0,1.0,2/7,12.75%,CHAC2;GCLC
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.41840916544758067,-0.9303768459558385,0.6629213483146067,1.0,1.0,18/75,20.06%,CARD14;FGF1;EMP2;VEGFA;BORA;PAK1;PAK2;ADCY1;NTRK3;ADCY5;ITGB1BP1;TOM1L1;STRADB;TNIK;PRKAR1B;ADCY3;PRKAR2A;TIRAP
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.5156032412154907,-0.9300916189964904,0.5964912280701754,1.0,1.0,1/10,12.47%,DNM2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.5383451131402024,0.9299736980414377,0.631578947368421,0.9370098367040688,1.0,2/7,9.51%,H1-10;H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.5383451131402024,0.9299736980414377,0.631578947368421,0.9370098367040688,1.0,2/7,9.51%,H1-10;H1-4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.5383451131402024,0.9299736980414377,0.631578947368421,0.9370098367040688,1.0,2/7,9.51%,H1-10;H1-4
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.5462412018415794,-0.929878153731198,0.6176470588235294,1.0,1.0,2/17,5.42%,GRIN2A;GLRA1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.3537912163867384,0.9296445003836826,0.5909090909090909,0.9370403332294783,1.0,11/50,14.38%,POP5;CPSF1;TRMT10A;AARS1;CPSF4;TSEN34;TYW5;ANKRD16;DTWD1;RTRAF;TRMT10C
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.615974113813152,-0.9295422121893933,0.647887323943662,1.0,1.0,1/7,10.82%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.48210568189374353,-0.9294995731478178,0.6301369863013698,1.0,1.0,7/22,24.19%,SOX9;RANBP3L;NBR1;RORB;HDAC7;CRIM1;MEN1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.5701489690015135,-0.929476577155107,0.609375,1.0,1.0,1/7,3.21%,NEDD9
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.36212729872098093,0.9292574349973127,0.7222222222222222,0.9371521711640902,1.0,6/54,6.26%,LTV1;ZNF658;NPM1;MRPL36;NOC2L;RPS19
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.42198630754535876,-0.9287574222669928,0.6395348837209303,1.0,1.0,20/70,25.01%,SPDYA;PTPRC;ALK;EPHA7;MMD2;TYRO3;NTRK3;EPHA4;PDGFRB;IGF1R;ROR1;CACUL1;RELN;MERTK;DDR2;ZNF622;MMD;ZNF16;CSF1;MAPRE3
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6083430757986305,-0.9283160761629068,0.6349206349206349,1.0,1.0,4/9,19.04%,STAT4;STAT3;JAK1;STAT1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5916213832261211,0.9281029488605992,0.5833333333333334,0.9392388436143465,1.0,2/7,6.40%,STARD13;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.5244005279581041,0.9280620367954469,0.5517241379310345,0.9385477025032511,1.0,1/6,3.06%,PPT1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.39530844959227696,0.9279371105009198,0.5294117647058824,0.9381708708850534,1.0,5/29,13.53%,SOX11;YAP1;LRP3;CTNNBIP1;BMP2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.5825832687247163,-0.9276937616745508,0.6101694915254238,1.0,1.0,4/9,22.86%,RBSN;GAK;ANKFY1;SORT1
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6296590069303574,-0.9276273781730815,0.6296296296296297,1.0,1.0,1/5,4.56%,DAPK1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5137570119656578,0.9275307141166134,0.575,0.9383393375537757,1.0,3/9,16.77%,GSTP1;MAPK8IP1;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.5603548719711042,-0.9274051852959899,0.5428571428571428,1.0,1.0,3/9,24.14%,ALK;DAB2IP;PACSIN1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3122024795489444,0.9273456013747194,0.7142857142857143,0.938079097749765,1.0,8/92,4.14%,UBB;MALT1;HSPA1A;TRAF5;TAB3;NPM1;IKBKB;UBE2N
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.5883457512894213,-0.9273261363471517,0.6212121212121212,1.0,1.0,2/7,22.67%,IRAK2;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.5307226118057866,-0.9272817007763813,0.5352112676056338,1.0,1.0,4/13,20.09%,AKAP5;ADCY1;SHANK3;RELN
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.4042675762668455,0.9272147067031035,0.48,0.9376110409294758,1.0,7/46,9.10%,BAD;G0S2;HIPK1;BAG3;NGF;BOK;SMAD3
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.5199777675675216,-0.9271188887491677,0.6486486486486487,1.0,1.0,3/14,12.08%,FHDC1;SORBS1;ARRB1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.5199777675675216,-0.9271188887491677,0.6486486486486487,1.0,1.0,3/14,12.08%,FHDC1;SORBS1;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.5946348507723764,-0.9270957384845432,0.6301369863013698,1.0,1.0,1/7,8.08%,ALK
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5508156976474996,0.9270495774784034,0.5897435897435898,0.9372478007178549,1.0,3/8,25.94%,MAD2L2;ING4;TP53
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.4319983886190665,0.9268385016965739,0.5416666666666666,0.9370122163992084,1.0,5/20,14.67%,MFF;ACOT8;PEX11A;ABCD2;FIS1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.5886404855181254,0.9267459235271895,0.6176470588235294,0.9364077225357891,1.0,1/5,2.64%,CNBP
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.40991217421388965,-0.9266910652036017,0.625,1.0,1.0,20/110,12.41%,STMN2;OLFM3;SNCB;ARHGDIG;GABRG2;KCNC1;NRGN;SST;ACTL6B;SHISA6;CELF4;SNAP25;PSD2;GRM3;SYT4;CAMK2A;ATP2B3;MMD2;LRRTM1;SULT4A1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.5376810718957331,-0.926520085696424,0.6714285714285714,1.0,1.0,3/15,22.69%,CSNK1D;HOOK3;CEP131
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.5427639862444101,0.9264350250841797,0.5714285714285714,0.9362770051436822,1.0,3/8,14.79%,CALM3;SRI;CALM1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.46663673742768125,-0.9263652098116731,0.6075949367088608,1.0,1.0,5/31,15.28%,HEY2;VEGFA;RASA1;CRMP1;NRP2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4749415115775218,-0.9263230453692172,0.6086956521739131,1.0,1.0,5/24,17.64%,YWHAH;CAV3;GLRX;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5141523335756214,0.9262870812387429,0.6296296296296297,0.9342412986392988,1.0,2/10,10.08%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5141523335756214,0.9262870812387429,0.6296296296296297,0.9342412986392988,1.0,2/10,10.08%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5141523335756214,0.9262870812387429,0.6296296296296297,0.9342412986392988,1.0,2/10,10.08%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.5223265967547406,-0.9260233461392214,0.5909090909090909,1.0,1.0,4/10,26.99%,INPP5A;PPP3CC;HRH1;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.5044813329338201,-0.9259020176904567,0.5571428571428572,1.0,1.0,3/17,9.40%,CD160;HLA-F;B2M
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.37407847892534807,-0.9256409967235925,0.6888888888888889,1.0,1.0,35/213,18.37%,RASGRF1;IL5;SOX9;FGF1;FGF9;NRG4;IL3RA;ZDHHC9;SPTBN5;PSMB8;CAMK2B;RASA3;WDR83;KITLG;RASGRP1;RASA1;CAMK2A;PAK1;RASGEF1A;NEFL;PSMA4;MAP2K1;JAK1;TGFB1;PDGFRB;DLG4;SYNGAP1;SHANK3;PSMA3;MAPK12;ZFP36L2;TNIK;DAB2IP;PPP5C;HTR2B
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.493369626385038,0.9256368923702166,0.5675675675675675,0.9347334233075135,1.0,6/12,25.93%,ZFYVE27;LNPK;REEP1;ATL2;REEP2;TMEM33
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.36889517593715615,0.925592389691462,0.5238095238095238,0.9340074881076406,1.0,7/41,10.63%,CCDC88C;PML;LYN;PPP1R16A;MT3;GRM5;RABL3
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.4366118775202505,0.9254242232434352,0.5555555555555556,0.9335925485102111,1.0,1/21,3.09%,KCNN2
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.41271220825473914,-0.9254142148526413,0.7023809523809523,1.0,1.0,23/144,15.80%,NEFM;STMN2;OLFM3;SYT1;RNF138;KCNH7;SNCB;KCNC1;CACNA1B;TRIM44;ACTL6B;SNAP25;EPHA7;SRGAP3;SYT4;NEFL;SULT4A1;LINGO2;INSYN2A;ELAVL2;DCLK1;CRMP1;CELF3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.45196430203606613,0.9252300952420413,0.5454545454545454,0.9331668285377855,1.0,5/18,10.05%,ZNF488;SOX8;SOX10;SOX6;EIF2B1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.4436977169806948,0.9251887895299716,0.5161290322580645,0.9325127082018011,1.0,4/16,14.34%,CRPPA;TMTC3;DPM2;DPM3
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.46885553588768936,-0.9249020570497314,0.6285714285714286,1.0,1.0,4/26,8.23%,B3GNT5;GALNT15;ST3GAL1;GCNT1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.5029167898317539,0.9248913912764065,0.6,0.9324433931481215,1.0,2/10,10.34%,NAA11;METAP1D
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.5390096814449548,-0.9247904813003649,0.6056338028169014,1.0,1.0,2/10,20.31%,LPCAT3;MOSPD3
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.5100493060709936,0.9242838631420132,0.5,0.932980313090796,1.0,2/9,21.98%,EXOSC8;XRN1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.44996200632567923,-0.924102588901133,0.6133333333333333,1.0,1.0,9/34,23.28%,DCAKD;ADCY1;ADCY5;ADSS2;ADCY3;PAPSS2;SLC26A2;PANK4;PANK2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.4280971334409227,-0.9240700229456034,0.5357142857142857,1.0,1.0,4/59,5.13%,ANGPTL4;FGF1;BRCA1;VEGFA
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.6356414847963751,-0.9240551836718435,0.6935483870967742,1.0,1.0,2/6,12.58%,NR4A3;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.41344842644556357,0.9237470546110119,0.5,0.9335620580592515,1.0,4/23,6.45%,SIRT2;MAP10;SVIL;PKP4
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.4558737407724729,-0.923737421116596,0.5915492957746479,1.0,1.0,7/32,15.99%,APIP;RYR3;SHMT1;B2M;ACACB;HCN1;CBY1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.48006870258681633,0.923560381640401,0.6176470588235294,0.9334121299323758,1.0,3/12,11.84%,TNK2;NEU3;UBQLN2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.4289452824975254,-0.9234316959268153,0.5609756097560976,1.0,1.0,12/56,23.56%,EFNA1;SPI1;MICALL2;TYRO3;ITGA8;TBCD;RILPL1;SIPA1L3;RELN;MEF2C;ARL13B;LAMB1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.443985047696925,0.9232938510661878,0.5172413793103449,0.9332168153903994,1.0,1/19,0.69%,SMDT1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.560506745539264,-0.923152546806829,0.6,1.0,1.0,5/9,24.02%,AP2A2;AP2A1;AP2M1;CLTC;CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.560506745539264,-0.923152546806829,0.6,1.0,1.0,5/9,24.02%,AP2A2;AP2A1;AP2M1;CLTC;CLTA
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.38802533184856247,0.923060643347713,0.5714285714285714,0.9330332197854305,1.0,3/25,10.79%,TCF7L1;TLE4;CDC73
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.3691945433898478,0.9220146130524539,0.5833333333333334,0.9344444428212046,1.0,14/77,6.12%,MMP2;PRRX1;BGN;FIBIN;PODN;RBP1;COL12A1;TNS2;CXCL12;PDGFRA;FRZB;LDB2;THY1;IGFBP7
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.47869119040137464,-0.921991146610527,0.5857142857142857,1.0,1.0,2/19,10.97%,ITPR1;DNAJC10
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3351319571228467,0.9218841300789821,0.6956521739130435,0.9338049393612184,1.0,13/69,14.96%,GPNMB;PSMD8;ZFP36L1;PSMB6;PSMB4;PSME3;PSMD10;CDKN2C;CDC73;PSMD12;PSMB2;FBXL7;PSMD4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.455385442614721,0.9217196327234493,0.47368421052631576,0.9333711558849562,1.0,1/17,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.39509470014488957,0.9216694422920861,0.4838709677419355,0.9327449357320953,1.0,2/24,3.35%,LPCAT1;ACHE
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.5693413844215002,-0.9213881446963663,0.6612903225806451,1.0,1.0,1/9,1.40%,SOX9
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.5005830266705615,0.9213201439664652,0.5384615384615384,0.9328803369691762,1.0,1/9,5.52%,ENPP3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.5342655158197229,-0.921219971768001,0.6617647058823529,1.0,1.0,2/14,12.05%,IRF1;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.4134417378635768,-0.9211809283531451,0.6551724137931034,1.0,1.0,14/82,15.42%,FGF1;FGF9;NRG4;P2RY12;LRP2;KITLG;AKR1C2;PTPRJ;AKT2;MYORG;ITGB1BP1;TGFB1;PDGFRB;IGF1R
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6088169898438205,-0.920964834522105,0.6785714285714286,1.0,1.0,3/5,33.75%,ATG7;ULK1;ULK2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.5890227918272636,-0.9209467662932255,0.6833333333333333,1.0,1.0,4/7,33.75%,ATG7;RB1CC1;ULK1;ULK2
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.5890227918272636,-0.9209467662932255,0.6833333333333333,1.0,1.0,4/7,33.75%,ATG7;RB1CC1;ULK1;ULK2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5150143639748462,-0.920879954618805,0.6578947368421053,1.0,1.0,3/15,10.63%,USP50;EPHA7;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.4237307534697782,0.9208034702489607,0.5555555555555556,0.9333898351407426,1.0,2/18,2.87%,SOX11;CLSTN2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.5512702116554061,-0.920794557406449,0.5671641791044776,1.0,1.0,3/8,18.20%,P4HA3;P4HTM;EGLN3
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.5241563424952327,-0.9207580927095071,0.6764705882352942,1.0,1.0,2/14,8.73%,SLC6A6;GJA1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.5056551481963091,-0.9207161380806062,0.5774647887323944,1.0,1.0,6/20,22.97%,CAMK1;CTNNA1;MAPK12;RBM4;NRG1;MEF2C
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.582449351988185,0.9206641351831505,0.5686274509803921,0.9329238029407069,1.0,2/5,15.87%,CHMP2A;CEP120
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.43324798908503337,-0.9206494912140609,0.5657894736842105,1.0,1.0,9/35,21.17%,DARS2;GATB;YARS1;PPA1;CARS1;GARS1;NARS1;WARS1;HARS1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.6045610516065849,-0.9203923828086854,0.6885245901639344,1.0,1.0,2/6,12.08%,BRCA1;ARRB1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5206905849542971,0.9203428220449087,0.5294117647058824,0.9329001848717341,1.0,1/9,0.69%,CRB2
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3330639241516394,0.920334120233546,0.625,0.9322203192359207,1.0,15/86,12.36%,NUP42;U2AF1;RBM15B;ZFP36L1;ARC;CPSF1;POLDIP3;EIF4A3;RBM8A;MAGOH;AGFG1;NXF1;CPSF4;SRSF3;EIF4E
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.49293695612415755,0.9199562198560917,0.6206896551724138,0.9321407811259045,1.0,1/11,1.24%,CFL1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.5437037707754528,-0.9199275908052993,0.6176470588235294,1.0,1.0,3/8,27.75%,VRK1;STX5;STK25
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3384231512135323,0.9198320964897715,0.5,0.9317337623727746,1.0,9/32,21.46%,PML;UBXN1;RYBP;N4BP1;CSNK2A2;QRICH2;FHIT;RPS7;EIF3H
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5984565497401969,-0.9197430645962719,0.65,1.0,1.0,2/6,22.83%,PLK2;ZW10
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5168978068876354,-0.9193664303872566,0.6075949367088608,1.0,1.0,1/13,2.88%,DOCK8
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4494676154259031,-0.9191304804347429,0.5616438356164384,1.0,1.0,4/35,10.21%,RFC4;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.5044660088658677,0.9187259039157731,0.5348837209302325,0.9335510856881218,1.0,2/9,12.94%,TMEM178A;TCTA
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.37437782069570036,0.9186559511425676,0.4444444444444444,0.9329518476923601,1.0,5/36,7.48%,BAD;G0S2;STYXL1;PML;BOK
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.35351213834532347,0.9184534578883594,0.5555555555555556,0.9326127777512923,1.0,5/31,11.95%,BICD2;MAP10;KLHL42;CAMSAP3;MEMO1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.5335812798370297,0.9182881029274598,0.6046511627906976,0.9322066950940224,1.0,1/7,11.37%,MUL1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.5057221226753029,-0.9180715735818351,0.6164383561643836,1.0,1.0,1/16,1.87%,FOS
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.504111554356648,0.9180137630440947,0.6388888888888888,0.9321950612697617,1.0,2/9,9.76%,GSTP1;TMEFF2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.46654841742516834,-0.9179135043286468,0.6233766233766234,1.0,1.0,10/33,20.35%,HOOK1;PLEKHF1;DNM1;USP50;ARFGEF2;USP8;HOOK2;HOOK3;AKTIP;EPS15
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.5023733738304829,-0.917583597541167,0.5806451612903226,1.0,1.0,1/15,1.40%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6105331268967726,-0.9171685976717369,0.703125,1.0,1.0,1/6,8.51%,APOE
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.39336120389984847,-0.9171505454085777,0.6144578313253012,1.0,1.0,11/69,13.99%,ITPR1;BRCA1;BCL2L2;MSH6;BCL2L11;MOAP1;DNAJC10;PDK1;ZNF385B;CYP1B1;PDK2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5121966738066889,-0.916715702043774,0.6133333333333333,1.0,1.0,1/14,2.50%,OTUD7B
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.5530385757397382,-0.9165730248790577,0.6111111111111112,1.0,1.0,1/9,8.51%,APOE
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4876706592492777,-0.9164600777441343,0.6351351351351351,1.0,1.0,7/25,15.92%,VEGFA;AHI1;LRPAP1;ARRB1;DLG4;MKLN1;ARRB2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.45612627487557567,0.9163655575507481,0.5625,0.9351401177824558,1.0,3/9,20.30%,SLC25A33;VCP;PINK1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.48476524572234264,-0.9162662328117505,0.5909090909090909,1.0,1.0,7/21,18.12%,SOX9;DUSP22;PDE8A;VIL1;STAT5B;ZFP36L2;DAB2IP
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.49513098511304204,-0.9162071134093738,0.5942028985507246,1.0,1.0,6/20,26.24%,EFNA5;NR1D1;ADCY5;STX4;CDK16;PIM3
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4249791519041227,0.9161278068181211,0.5666666666666667,0.9348228418299215,1.0,5/32,9.90%,CHRNA4;CHRNA7;C12ORF57;DGCR2;GRM5
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.5164898325255688,-0.9160817948545836,0.5753424657534246,1.0,1.0,3/15,8.45%,ALDH1L1;MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.4739380390928565,0.9160492266657374,0.6060606060606061,0.9341356876754112,1.0,2/10,10.18%,WASF3;BRK1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5128389547395572,-0.9158704942746636,0.6666666666666666,1.0,1.0,1/12,2.05%,CCDC39
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.5760999976482626,-0.9157689369390689,0.6610169491525424,1.0,1.0,2/7,12.21%,SLC24A2;PLK2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5056329425244885,-0.915731613820837,0.6119402985074627,1.0,1.0,5/17,19.78%,VEGFA;COL5A1;STAT3;TENM3;IFT122
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.4138848763949564,0.9155016393327665,0.6111111111111112,0.934716925357743,1.0,6/18,22.54%,DNAJB12;UGGT1;AUP1;RNF126;VCP;STUB1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.49921665482962563,0.9154113668339178,0.5862068965517241,0.9341206108626227,1.0,4/10,11.81%,NEU1;NEU3;ST6GALNAC3;GM2A
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.5095897895472651,-0.9153633778852499,0.6153846153846154,1.0,1.0,2/13,16.51%,RYR2;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.4847504068790642,-0.9152199861858479,0.6103896103896104,1.0,1.0,4/26,21.48%,PARN;PARM1;PNKP;HMBOX1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.32676473438222586,0.9152061218162332,0.8888888888888888,0.9338723586259675,1.0,17/81,14.73%,PLD1;CCDC88C;RIT2;TRIM28;TNK2;MAPK11;CHP1;ARL3;NRAS;RIT1;JUN;NUCB1;RUNDC3A;GRB2;RALB;RRAS2;SHC3
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5716023876286827,-0.9150743298119305,0.6031746031746031,1.0,1.0,1/7,3.12%,PTPRC
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.607639663416865,-0.9146812845599044,0.6274509803921569,1.0,1.0,1/5,17.41%,ADAM9
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5847943050758977,0.9138318478111738,0.574468085106383,0.9362424583086572,1.0,2/5,2.32%,CHRNA4;INSYN1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.4905750204148988,-0.9137599478699433,0.625,1.0,1.0,3/19,14.40%,STAT3;PDCD4;PER1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.4577368471253438,0.9136353672589129,0.6111111111111112,0.9358252169611083,1.0,3/15,10.85%,FLRT3;DHFR;RTN4RL2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.3853377305416591,0.9136283575090913,0.5,0.9351182295549236,1.0,2/38,0.64%,UBB;RFWD3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.4226698384469361,-0.9132961294614337,0.5903614457831325,1.0,1.0,9/75,8.85%,NAAA;MCCC1;ALDH1L1;MTHFD1;ACSM6;ST3GAL1;DNPEP;SHMT1;BTD
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5701496966286341,-0.9132949484027938,0.6567164179104478,1.0,1.0,5/9,25.94%,KIAA0319;TGFB1;RBPMS;SMAD4;TGFB3
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4029492377919984,-0.9132024741344114,0.6136363636363636,1.0,1.0,18/81,20.65%,APIP;POLQ;STEAP4;RNF213;RYR3;NLRC4;SHMT1;B2M;CARD11;ACACB;HCN1;CBY1;IKZF4;CLYBL;MPP2;PRMT8;AQP4;KCNC2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5622621461877644,0.9131542842094839,0.5675675675675675,0.935439179218415,1.0,3/6,14.79%,CALM3;SRI;CALM1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.43874058144255274,-0.9131032372299196,0.6455696202531646,1.0,1.0,7/35,13.84%,ROBO2;LIMK1;SHTN1;PLXNA4;MACF1;TIAM1;BDNF
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.4641095484096174,-0.9130846005861357,0.6172839506172839,1.0,1.0,2/31,5.04%,STMN2;EFNA5
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.4184684380102501,0.9130622075183881,0.5142857142857142,0.9348674586136244,1.0,2/19,2.94%,UGDH;GPC1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.5921131183551254,-0.9130537547546513,0.7213114754098361,1.0,1.0,1/7,7.25%,MSH6
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.5918374806858004,-0.9127962616018834,0.6515151515151515,1.0,1.0,2/5,25.00%,ADGRV1;CAPN7
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.386271078270599,0.9126900018230466,0.5172413793103449,0.9348760906471375,1.0,6/22,17.37%,DYNLT1;KIF25;INSC;SPDL1;NSFL1C;LLGL1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.3673062515215584,-0.9126282715090671,0.8282828282828283,1.0,1.0,105/754,18.75%,ART4;NUAK1;CAMK1;B3GNT5;FBXL13;STK17A;TNC;ASB16;MAK;PTPRC;CDK7;PTPRB;PARP9;PIGH;PARP14;TSSK3;DDB2;DAPK1;LIMK1;FBXO31;FBXO6;RARA;FLG;NEK3;RAB11A;PSMB8;ASB14;USP6;RAB3A;TLK1;CDK19;GRK4;HIF3A;ST3GAL1;MAP3K12;PTPRR;FUT2;CAMK2B;APOE;NEK11;CP;CDK4;FAM20C;TAF1;TRIB1;ALG10B;ASB18;CAMK2A;PAK1;VRK1;SPARCL1;SPP1;PDK1;COQ8B;PLK2;GLRX;VRK2;PAK2;PSMA4;CHRM3;LCMT1;MBTPS1;DUSP8;CSNK1D;EVA1A;NEK6;WWP2;FN3KRP;PTPRJ;AKT2;PDK2;MKNK1;MAP2K1;JAK1;DAPK3;TGFB1;STRADB;DCLK1;PPP2R3A;FBXL5;UBXN7;PPP3CC;NEURL2;CTBP1;KNG1;ATG7;F13A1;PSMA3;CDC42BPB;SERPIND1;BCR;FBXL18;ST3GAL6;CAMK2D;SUMF1;ATM;TNIK;GPC3;EGLN3;PRKAR1B;EPAS1;PPP5C;FAM20A;PRKD2;FBXW12
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.4134746554004874,-0.9126250272319139,0.6777777777777778,1.0,1.0,13/67,18.12%,STMN2;CAMK1;ALK;CAMK2B;APOE;AVIL;CAMK1D;NTRK3;BDNF;PTK7;ROR1;TENM3;DAB2IP
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.6117474313123952,-0.9126028410321009,0.6909090909090909,1.0,1.0,1/6,12.44%,ARFGEF2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.45701232080517773,-0.9124751015096695,0.647887323943662,1.0,1.0,4/26,9.14%,KCNMB4;KCNN3;PDZK1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3257592379247142,0.911869174022557,0.6428571428571429,0.9359535811643963,1.0,16/72,18.91%,PSMD8;PSMB6;PSMB4;UBE2D1;PSME3;PSMD10;MN1;CDC26;PSMD12;PSMB2;PSMD4;ANAPC11;ERCC3;ANAPC7;PSMC1;PSMC3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4301181285224916,-0.911743089084658,0.6410256410256411,1.0,1.0,5/43,8.82%,TTN;SNCB;AHCYL1;PLSCR1;HVCN1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.44794709132577293,0.9115889903464278,0.5666666666666667,0.9358612038753455,1.0,3/16,6.36%,ZNF488;SOX10;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.37267698625100976,0.9113243520863938,0.5625,0.9356800439820226,1.0,9/53,15.97%,CRB2;SOX11;RBPJ;SLC2A10;TGFBR1;TWSG1;BMP2;ZEB2;NOTCH1
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.6117715245943943,-0.9111936878539144,0.6491228070175439,1.0,1.0,1/5,21.88%,PDK3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.43672471189074613,-0.9110794910748049,0.6385542168674698,1.0,1.0,2/42,1.00%,HEY2;HES1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.5692692530894339,-0.9109418990760406,0.6,1.0,1.0,3/7,19.24%,DNAH5;DNAH17;ODAD4
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.40960898467732887,-0.9108683853584157,0.6363636363636364,1.0,1.0,2/50,4.22%,SOX9;ANP32E
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.554325189418954,-0.9106773403091923,0.6666666666666666,1.0,1.0,2/10,3.96%,PARP9;PARP14
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5947284343029925,-0.9106737641965303,0.7,1.0,1.0,1/6,7.25%,MSH6
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3731565516179334,0.9101171915773701,0.6538461538461539,0.9377317623689754,1.0,3/31,10.79%,KLHL12;ATXN7L3;CDC73
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5402649945896768,-0.9099486359233074,0.6086956521739131,1.0,1.0,1/11,1.16%,NR4A3
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.38650165865814357,-0.9096899695162702,0.7448979591836735,1.0,1.0,21/163,17.78%,TUBA4A;NEDD9;VCL;SEPTIN9;RAPGEF5;TLK1;RFC1;KLC1;BCL2L11;RASA1;PREX1;TIAM1;CSNK1D;TBCD;TSC1;KIF20B;HDAC6;UXT;HOOK3;BCR;CEP72
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4735891333631289,0.9096878076889731,0.5555555555555556,0.9381265229965519,1.0,4/15,14.79%,CALM3;SRI;GSTM2;CALM1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.39654574938148773,-0.909610357398059,0.6,1.0,1.0,17/64,23.41%,GRIN2A;TRPC5;RYR3;GRIN2D;CACNA1C;SLC24A2;ATP2B3;YME1L1;SLC8B1;ANO6;PMPCB;SLC24A5;TRPM3;NALCN;SLC24A4;TRPC4AP;GRIN1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5931523604128426,-0.9094454825525199,0.6153846153846154,1.0,1.0,2/9,5.13%,VCL;VEGFA
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.3862496474318007,0.9094056858219598,0.6153846153846154,0.9380770663323694,1.0,9/18,20.96%,PPP1R35;TIPRL;CHP1;GPATCH2;PPP1R26;BMP2;HSP90B1;ZCCHC9;PPP1R2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.4618033013815559,-0.9093772640599191,0.5945945945945946,1.0,1.0,5/25,14.40%,YWHAH;AHCYL1;SNTA1;NKAIN2;PER1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.5574639615394049,-0.909264337246993,0.6567164179104478,1.0,1.0,3/10,24.39%,SORBS1;AKT2;IRS2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3603292077028422,0.9091989880136863,0.5625,0.9377839096553522,1.0,10/70,11.93%,PTPN20;TIPARP;TGFBR2;PTPN14;DCPS;CPNE3;SMAD3;TGFBR1;ARL6IP5;KHSRP
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.581092993005487,0.9091099623225944,0.6363636363636364,0.9372033469175525,1.0,2/5,20.06%,BOK;CASP9
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.618913311673025,-0.9089976437000856,0.6956521739130435,1.0,1.0,4/5,26.93%,APOE;XBP1;PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.41499517407436737,0.9089030291457618,0.5517241379310345,0.9368117827355089,1.0,5/19,10.83%,ATP6V0A4;ATP6V0E1;ATP6V1G1;ATP6V1B2;ATP6V0D1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.46961236263365036,-0.9088329748984977,0.6301369863013698,1.0,1.0,9/28,23.38%,KLC1;MCTS1;VRK1;DDRGK1;RB1CC1;STX5;UBA5;EIF2D;RETREG1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5641579164003578,-0.9087470643574275,0.6363636363636364,1.0,1.0,2/8,22.50%,KCNQ1;NRG1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.45260292048886996,-0.9087071324486707,0.631578947368421,1.0,1.0,9/18,34.30%,IL7;IL6R;OAS1;TIRAP;MAVS;APP;OAS3;LPL;IL17RA
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.4216311230364779,0.9085864241086182,0.5384615384615384,0.9368519638769224,1.0,2/15,7.12%,MSN;SNX12
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.524976993194917,-0.9080673764805987,0.5970149253731343,1.0,1.0,9/15,30.84%,CD160;PDCD4;ANO6;SCG2;PLCG1;ITGA4;NFE2L2;PDPK1;PRKCI
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.5794901441583105,-0.9080122843220216,0.7121212121212122,1.0,1.0,2/7,15.76%,MSH6;XRCC4
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.37514318294665294,-0.9079692636626141,0.717391304347826,1.0,1.0,38/251,15.42%,ENPP2;PLET1;GNA12;TMSB4X;MYLK;FGF1;VSIR;NEDD9;FGF9;VCL;CEMIP;VEGFA;DUSP22;SST;SEMA4B;CAMK2B;PLXNA4;IGSF10;SRGAP3;CAMK2A;PAK1;MACF1;TPM1;TIAM1;STAT3;CYP1B1;NTRK3;TMSB15B;VIL1;PTPRJ;AKT2;FAM107A;SULF1;PDPN;TGFB1;EPHA4;PDGFRB;IGF1R
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.49257063358576425,-0.9079071630085397,0.6133333333333333,1.0,1.0,3/17,11.53%,VEGFA;SPP1;LRPAP1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5437074489803011,-0.9077376833743388,0.6557377049180327,1.0,1.0,2/11,19.27%,HAP1;DNM1L
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.5321237789372486,-0.9077344463022874,0.5873015873015873,1.0,1.0,1/13,0.35%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.45225551504089156,-0.9076471494417298,0.6,1.0,1.0,9/32,21.31%,MSH6;PLSCR1;PFN2;DNAJC10;TPM1;RYR2;DNAJC9;DNAJB1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.41304271205676735,0.9075762759588137,0.6451612903225806,0.9384716092193289,1.0,6/19,8.98%,BTC;AFAP1L2;TGFA;CNOT9;PLAUR;NEU3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4775355649846553,-0.9074302965757033,0.6428571428571429,1.0,1.0,4/26,14.55%,DOCK8;PTPRC;IL7;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.5900443457471397,0.9073744143843758,0.6060606060606061,0.9382124133857196,1.0,1/5,14.07%,SLC25A4
prerank,PanglaoDB_Augmented_2021__Pericytes,0.3476976177341467,0.9071225824029375,0.5454545454545454,0.9379315723844155,1.0,13/80,5.91%,MMP2;PRRX1;BGN;FIBIN;PODN;FBLN2;TNS2;CXCL12;NT5E;PDGFRA;FRZB;LDB2;THY1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.5506291581658305,-0.9069642660331642,0.7142857142857143,1.0,1.0,1/12,5.13%,VEGFA
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.38807291523733506,0.9069087886340401,0.64,0.9377062734214069,1.0,8/31,12.89%,SMPD1;SPTLC1;PPP2R1A;SGMS1;ST6GALNAC3;ACER2;CERS2;ACER3
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.6501684082623397,-0.9066186919671907,0.75,1.0,1.0,3/5,23.88%,NLRC4;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.49531284016994237,0.9065641895523596,0.5757575757575758,0.9376795232557859,1.0,1/7,3.66%,DYNLT1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.49185679342196814,-0.9063205880167483,0.6119402985074627,1.0,1.0,2/17,4.62%,BRCA1;RNF138
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.5772370201073046,-0.9060980674794014,0.6060606060606061,1.0,1.0,2/9,10.46%,VEGFA;THOC5
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.5070978339761358,0.9059553727153439,0.5483870967741935,0.938268925026863,1.0,3/6,20.54%,LIN7C;AP4M1;LIN7B
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.33164869890238735,0.9059533356140886,0.625,0.9375272104616243,1.0,9/43,14.07%,LRRC8D;SLC25A24;ABCG2;SLC2A10;CA3;SLCO3A1;SLC35B4;SLC2A8;SLC25A4
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.5585155820135455,-0.905679380718987,0.625,1.0,1.0,1/6,9.39%,TTLL4
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5674270630856447,0.9056734161536826,0.6451612903225806,0.9373249118982249,1.0,1/6,10.69%,ARL6IP5
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.3971120916245659,0.9055157846612532,0.6521739130434783,0.936925366345048,1.0,4/30,11.40%,RAB26;GOLGA7;RILPL2;GORASP2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.5268929347210978,-0.9054473325957342,0.6875,1.0,1.0,5/14,17.35%,CAV3;B2M;RFLNA;HOOK3;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.4010936159460504,-0.9052755748766752,0.6162790697674418,1.0,1.0,20/99,15.38%,EFNA1;CAMK1;SPDYA;EMP2;PTPRC;NEDD9;AGT;MTCP1;VEGFA;BORA;PAK1;MMD2;IL6R;PAK2;MAP2K1;TOM1L1;EPHA4;STRADB;DLG4;RPTOR
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5782927420029531,-0.9052395487268294,0.6388888888888888,1.0,1.0,1/7,20.80%,IFI6
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.33859737625002395,0.9050701723697461,0.5294117647058824,0.9371296497861111,1.0,7/63,7.97%,MMP16;NCSTN;NAA11;CIAO2B;TSPAN14;TSPAN17;SDE2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.387644575661604,-0.9046730125842314,0.6595744680851063,1.0,1.0,25/108,24.62%,RAB40A;EMP2;RAB40B;CAV3;RAB11A;PLEKHF1;RAB3A;PDZK1;RAB3D;RAB15;KCNB2;GAK;ITGB1BP1;RDX;WDR19;TNIK;MRAP;MAP7;ATP1B1;RAB8B;PACSIN1;FLNA;RAB10;LIN7A;RAB40C
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.39078158568275895,-0.9046472963345359,0.7045454545454546,1.0,1.0,25/129,14.28%,STMN2;GRIN2A;SOX9;FGF1;OPALIN;AGT;ALDH1L1;SLC6A11;SYNM;APOE;GJA1;SHISA6;BAALC;SNAP25;PSD2;CAMK2A;SLC4A4;SPARCL1;MMD2;SORBS1;ACSBG1;ADCY5;TMEM132C;FAM107A;PLP1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.5955266941997901,-0.9043807079041376,0.6875,1.0,1.0,1/5,3.80%,BRCA1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.4742512179513581,0.904177366851634,0.5294117647058824,0.9384294721079024,1.0,1/11,2.01%,NR1H2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.3129892516576972,0.9041636917147061,0.7142857142857143,0.9376905512637228,1.0,1/47,0.61%,NUP42
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.37901492964624733,0.9038723429388879,0.5625,0.9375436268327713,1.0,6/44,5.91%,SYNDIG1;SLITRK2;CLSTN2;NLGN2;S100A10;THY1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.3888142611489564,0.9037335357566816,0.5757575757575758,0.9370470850109185,1.0,3/25,6.58%,PRR5L;ZFAND1;PTPN14
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5442104455400161,0.9036561553342858,0.6176470588235294,0.9364967024296919,1.0,2/5,18.78%,SETMAR;SETD3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.5443913758232006,0.9036197798399526,0.5333333333333333,0.9358380278739832,1.0,2/6,14.20%,GREM1;C5
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.43574310926556975,0.9034950086355876,0.5625,0.9354966906492582,1.0,3/15,15.82%,EXOSC8;INTS7;INTS6L
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.35248722732507287,0.9033977608259834,0.6,0.9349815125855091,1.0,20/82,11.56%,TUBB2B;NKX2-2;MAGI1;ONECUT1;FLRT3;SOWAHA;TOX3;PCGF2;EFNA2;BCAR1;YAP1;PTPRF;CAMSAP3;LINGO1;LRIG3;DUSP15;PRR36;CXXC4;RPL23A;SLC7A2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.43548492311958287,-0.9032330760137565,0.6282051282051282,1.0,1.0,8/46,15.99%,APIP;RYR3;KCNC1;SHMT1;B2M;ACACB;HCN1;CBY1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.5212698546533998,-0.903130170097963,0.6323529411764706,1.0,1.0,4/12,19.73%,CCDC39;CABYR;ODAD4;AQP4
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.4067774632628734,-0.9030797872029067,0.7349397590361446,1.0,1.0,17/101,17.18%,GRIN2A;SYNJ2;B3GNT5;ROBO2;HAP1;ADGRL2;GRIN2D;SLC6A17;ARNT2;EPHA7;MEIS2;ZIC1;SMARCA1;SHANK3;DHX37;MDGA1;ZFHX3
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5340669976386416,-0.9024786248108831,0.6438356164383562,1.0,1.0,1/11,2.88%,DOCK8
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.5299469375955727,0.9024732238097138,0.6097560975609756,0.9363075439760725,1.0,4/7,28.19%,NOMO3;SKI;LEMD3;IGSF1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4031501742283202,-0.9024631576035629,0.6774193548387096,1.0,1.0,28/93,19.50%,SRPX;MYLK;F8;PROCR;NOSTRIN;PTPRB;TIMP3;A2M;ELK3;RHOJ;TNS1;LIFR;USHBP1;SPARCL1;CYP1B1;PDPN;PDGFRB;NRP2;APOLD1;ABCA8;RGS5;C1S;COL15A1;EPAS1;CD55;PLSCR4;NNMT;LMOD1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.5386703503005926,-0.9024385412503788,0.625,1.0,1.0,3/8,25.91%,DVL2;CD55;CD59
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.49732805647897693,-0.9022316625067375,0.6756756756756757,1.0,1.0,1/12,3.80%,BRCA1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5195156494536898,-0.9021897216502731,0.5735294117647058,1.0,1.0,4/12,21.11%,BCL2L11;DDRGK1;DAB2IP;BFAR
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.29616136921236286,0.9021809110040304,1.0,0.9362604393768046,1.0,36/161,14.33%,TUBG1;DHCR7;IDH1;CALR;CTSC;DHFR;MCM4;PRDX1;ATP5MC1;LDLR;TM7SF2;SQLE;TCEA1;PPIA;PSME3;PSPH;NUFIP1;PSAT1;CANX;TXNRD1;MTHFD2L;ACLY;STIP1;SEC11A;PSMG1;RIT1;HMGCS1;STARD4;NFIL3;HMGCR;FADS1;INSIG1;SSR1;VLDLR;ARPC5L;PSMD12
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4975066214131029,0.9020060337702365,0.5517241379310345,0.9360611874532873,1.0,4/10,16.38%,TGFBR2;TGFBR1;BMP2;SMAD7
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.38706462652630874,-0.9017603978423596,0.6136363636363636,1.0,1.0,10/92,10.21%,RFC4;CDK7;PPIE;DDB2;FANCC;RFC2;UVSSA;RFC1;MMS19;RPA3
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.41726520517687016,0.9014311884215631,0.6666666666666666,0.9364380618026652,1.0,1/23,0.43%,MYH3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4717001371166152,-0.9012507620379681,0.6142857142857143,1.0,1.0,2/16,6.39%,CEMIP;HAP1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.49276996446956933,0.9009739208551781,0.6666666666666666,0.9367492120356572,1.0,3/10,7.34%,SOX11;ZFP36L1;YAP1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.45051956471766724,0.9004452835633403,0.5333333333333333,0.9370381818875289,1.0,3/14,13.17%,EMC6;EMC8;EMC4
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.29317931602582037,0.9000719957809398,1.0,0.9369473352686379,1.0,22/245,8.03%,COPZ1;SYNDIG1;BICD2;FBLN5;ARL4A;EVI5L;AMOT;TMED2;NPM1;VPS26B;RRAGA;RAP2A;ARFIP1;RAB5B;STX6;TBC1D25;SEPTIN3;TMED5;COG3;EPB41L3;RAB1B;ARF5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.36355061901041413,-0.8997304098836184,0.7216494845360825,1.0,1.0,24/205,14.69%,HEY2;TTN;SOX9;FGF1;VSIR;OVOL2;FGF9;BRCA1;VEGFA;FAM98B;AHI1;PLSCR1;GJA1;RIMS1;DTX3L;CAMK2N1;HMGN5;ARRB1;EPHX2;STAT3;OLFM1;NTRK3;MAP2K1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.5585555577625497,-0.8996115497382308,0.6271186440677966,1.0,1.0,2/11,16.41%,BTBD18;BRD4
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.5608753410649341,0.8995043382823291,0.6666666666666666,0.937387328932018,1.0,2/5,17.17%,ABCD2;ACOX1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5415957129979501,-0.899438029431178,0.6129032258064516,1.0,1.0,5/11,30.75%,HS3ST5;TRIM25;TRIM5;FUCA2;NECTIN2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.41410103167702567,-0.8988823318043935,0.625,1.0,1.0,10/62,14.12%,PTPRC;AGT;TIMP3;CAV3;PTPRR;APOE;FOXO1;CAMK2N1;PTPRJ;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.321369275635282,0.8987788506747498,0.6666666666666666,0.9383569235618349,1.0,13/99,10.69%,CRB2;CFL1;GPNMB;LZTS1;WTIP;ARC;RAP2A;LZTS3;BMPER;VASH1;RC3H1;SDC2;EPHB3
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.3369341468484937,0.8986895320416669,0.6190476190476191,0.9377894586997955,1.0,4/56,3.15%,UBB;MALT1;CTSV;CTSC
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.47241631198557543,0.8982041206848858,0.52,0.9380981083125114,1.0,2/9,10.10%,SDHAF3;FBP1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5314799743284132,0.8981801974758583,0.625,0.9374021621276382,1.0,1/8,0.35%,UGDH
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.4870451557378962,-0.8981241963477254,0.6142857142857143,1.0,1.0,1/14,5.80%,CAV3
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.4568152224112281,0.8980068757550068,0.5526315789473685,0.9370093758855093,1.0,5/12,21.15%,SLC25A33;TEFM;TFB2M;TFB1M;FASTKD1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.47171576814661276,0.8974901235430481,0.6071428571428571,0.9366995908344999,1.0,2/11,12.05%,ZFP36L1;TOB1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.47171576814661276,0.8974901235430481,0.6071428571428571,0.9366995908344999,1.0,2/11,12.05%,ZFP36L1;TOB1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.4479171339341876,0.8974687134751828,0.68,0.9360391723001013,1.0,2/14,4.51%,NOX4;PRDX1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.6156671244829146,-0.897421954027154,0.7575757575757576,1.0,1.0,1/5,8.45%,SHMT1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.3675764988041007,0.8972695405611699,0.5,0.9356486553037543,1.0,3/33,8.52%,BANF1;BTBD17;ZC3HAV1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.45640915644760705,-0.8970334804504091,0.6329113924050633,1.0,1.0,4/28,14.13%,EMP2;VEGFA;PTPRJ;TSC1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5483862371409121,0.8968725854835679,0.71875,0.9351378954065113,1.0,1/7,6.90%,SLC12A8
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5483862371409121,0.8968725854835679,0.71875,0.9351378954065113,1.0,1/7,6.90%,SLC12A8
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.345888315165735,0.8967903982972371,0.6666666666666666,0.934588023253454,1.0,6/37,11.25%,ACTB;HNRNPC;ZNHIT1;SMARCAD1;ACTR8;VPS72
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.5562235932878774,-0.8967706890584506,0.6875,1.0,1.0,1/6,2.88%,DOCK8
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.5956953607444245,-0.8967148155745717,0.7272727272727273,1.0,1.0,2/5,13.84%,B2M;BDNF
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.4293419040446491,-0.8965802025592539,0.6190476190476191,1.0,1.0,13/40,25.80%,WDR91;AGT;APOE;EIF2B4;TSC1;TGFB1;CNDP1;WNT7A;RBM4B;CSF1;EIF2A;RBM3;NFKBIA
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.5197060212707665,-0.8965319286651036,0.6615384615384615,1.0,1.0,4/10,29.01%,CYP1B1;DHRS13;RDH11;RDH10
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4083493155224129,-0.8965293480577933,0.6746987951807228,1.0,1.0,16/77,21.73%,IGF2BP2;IGF2BP3;DAPK1;PUS7;SHMT1;ZNF540;TSC1;DAPK3;SAMD4A;RBM4;GIGYF2;ENC1;CPEB1;EIF4EBP1;MALSU1;SAMD4B
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5149654643617814,-0.8959394853423985,0.6527777777777778,1.0,1.0,3/13,17.16%,PSMB8;PSMA3;MAPK12
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.4761355238367336,-0.8959288851593877,0.6621621621621622,1.0,1.0,2/26,4.24%,RRH;GADD45A
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.47191909139775085,-0.8957863689752184,0.5797101449275363,1.0,1.0,2/17,5.74%,PPIE;FKBP5
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.47270447658799153,-0.895490898862423,0.6190476190476191,1.0,1.0,1/27,0.58%,STMN2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.47172021881544407,-0.8954309962654544,0.6233766233766234,1.0,1.0,3/21,14.12%,FGF1;NTRK3;ITGB1BP1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5707771197752582,-0.8954139152874817,0.6551724137931034,1.0,1.0,2/8,5.81%,GRIN2A;NLRC4
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.4596462813213129,-0.8953433895649245,0.6103896103896104,1.0,1.0,5/26,17.64%,TSPYL2;GRK4;RYR2;TYMP;CAMK2D
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.36979882620592003,-0.8952328168880511,0.6770833333333334,1.0,1.0,20/152,18.10%,RAB40A;EMP2;RFTN1;RAB40B;CAV3;RAB11A;PLEKHF1;RAB3A;PDZK1;RAB3D;SH3PXD2B;RAB15;KCNB2;GAK;ITGB1BP1;DLG4;SHANK3;RDX;WDR19;TNIK
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.5122967452769358,-0.895005476545648,0.6388888888888888,1.0,1.0,3/15,8.45%,ALDH1L1;MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.37530580661414026,0.894576214383721,0.5,0.9392713500889516,1.0,2/40,0.52%,SIRT2;HDAC11
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.3762081260874572,-0.8945691561540186,0.6506024096385542,1.0,1.0,12/92,10.33%,SRPX;NUAK1;SOX9;SRPX2;TIMP3;FKBP9;LIFR;EDNRA;KITLG;KIAA1217;PLS3;SH3PXD2B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.46192735887683994,0.8945463931212724,0.53125,0.938644144323542,1.0,1/11,2.64%,CNBP
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.5137106798810731,0.8943855527646132,0.5526315789473685,0.9382855423019064,1.0,2/5,6.03%,NOC2L;LYN
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.4588285040569576,-0.8943787790124202,0.6575342465753424,1.0,1.0,9/27,20.06%,TMSB4X;OTUD7B;PTPRC;ARRB1;STAT3;RIPK1;MAP2K5;PRKD2;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.6073699463936417,-0.894366291043305,0.6825396825396826,1.0,1.0,1/5,12.58%,STAT3
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.39845486493657195,-0.8942057801411369,0.6705882352941176,1.0,1.0,8/106,6.98%,ANGPTL4;CD160;FGF1;EMP2;BRCA1;VEGFA;RHOJ;GLUL
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6160766837978326,-0.8933555970628217,0.6984126984126984,1.0,1.0,1/5,0.87%,NAAA
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.5928449477491173,-0.8932142536766285,0.6607142857142857,1.0,1.0,2/5,21.43%,MMP24;PLEKHA7
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5968594234260265,-0.8929637280537885,0.7068965517241379,1.0,1.0,2/5,19.04%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5968594234260265,-0.8929637280537885,0.7068965517241379,1.0,1.0,2/5,19.04%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.46833268127553096,-0.8929288139543177,0.6666666666666666,1.0,1.0,5/24,18.82%,VEGFA;TGFB1;MAP2K5;RDX;SPINT2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.40358252322871535,0.8928298738790639,0.6363636363636364,0.9409120352558499,1.0,5/20,16.11%,SDHAF3;FBP1;MST1;CLK2;SIRT1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.3414814897762783,0.8923028687403858,0.6,0.9415142571996139,1.0,7/41,9.41%,FNBP1L;ARV1;MICALL1;SMPD1;EPB41L3;ABCD2;MYOF
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.5563178262951339,-0.8922306414954915,0.7049180327868853,1.0,1.0,2/8,31.94%,PLEKHM2;TUBB4B
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.5301900023458896,0.8922256099349758,0.6129032258064516,0.9409299790933533,1.0,5/8,18.34%,SMPD1;SMPD3;SGMS1;SMPDL3A;SAMD8
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.5177517284496727,0.8920105385665307,0.6097560975609756,0.9406240869286964,1.0,3/7,20.57%,CHRNA7;WNT5A;PICK1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.47709527247520195,-0.8919936097628866,0.6521739130434783,1.0,1.0,4/17,14.12%,CEMIP;PDZK1;AKT2;ITGB1BP1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.4890411307662367,-0.8917625701943077,0.6486486486486487,1.0,1.0,1/17,1.87%,FOS
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.5161988461044006,0.8912851231065567,0.6486486486486487,0.9417477034366429,1.0,2/6,6.03%,PDGFRA;LYN
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.34869568774136117,0.8911854041958245,0.7647058823529411,0.9411645896124373,1.0,13/58,19.16%,EIF4H;EIF1;NPM1;EIF5;CDC123;ATF4;EIF4EBP2;EIF4G2;PPP1R15B;EIF1B;MIF4GD;DDX1;KHDRBS1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.5584059792628285,-0.8911610407019904,0.7068965517241379,1.0,1.0,1/5,15.17%,PDGFRB
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.32156377302150563,0.8910020758581284,0.6875,0.940923109324018,1.0,22/82,12.95%,ARV1;PPT1;KDSR;NEU1;SGPP1;SMPD1;SPTLC1;SMPD3;NEU3;CTSA;PPP2R1A;ELOVL4;GBA3;SGMS1;ST6GALNAC3;GM2A;VAPB;ESYT2;ACER2;CERS2;ACER3;UGT8
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5084706233244047,-0.8909843668156509,0.6428571428571429,1.0,1.0,3/11,20.26%,IL7;IL6R;FOXP1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.3575313485399759,0.8904818575788024,0.6818181818181818,0.94141615824071,1.0,4/44,4.02%,ACADS;HSD17B10;ACAA2;ACADVL
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.5511819619358904,-0.8903730189640087,0.6875,1.0,1.0,3/9,13.74%,AHR;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.5511819619358904,-0.8903730189640087,0.6875,1.0,1.0,3/9,13.74%,AHR;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.6088201537068061,-0.890174607377089,0.660377358490566,1.0,1.0,1/5,9.56%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.6088201537068061,-0.890174607377089,0.660377358490566,1.0,1.0,1/5,9.56%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.6088201537068061,-0.890174607377089,0.660377358490566,1.0,1.0,1/5,9.56%,MAN1A1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.6196222528761888,-0.8899358857380396,0.6721311475409836,1.0,1.0,1/5,20.26%,FOXP1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3676517783309601,-0.8898620663171714,0.7755102040816326,1.0,1.0,25/265,11.14%,RFC4;SPDYA;POLQ;BRCA1;BCL2L2;GADD45A;DDB2;FBXO31;FANCC;FBXO6;RFC2;VAV3;BRAT1;MSH6;ZRANB3;HELB;MMS19;FOXO1;BACH1;BCL2L11;TAF1;DTX3L;XRCC3;MOAP1;PAK1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.5962851364042896,-0.8898545265959585,0.6833333333333333,1.0,1.0,2/6,12.61%,ZFPM1;OLFM1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.42714700250831317,-0.8896134601296095,0.5833333333333334,1.0,1.0,1/36,1.16%,NR4A3
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.528039887647374,-0.8893268759153197,0.7121212121212122,1.0,1.0,4/15,10.65%,AKAP5;CACNA1C;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.3704392222272177,0.8890318722110361,0.6,0.9438115563621795,1.0,6/36,8.54%,PARD6G;MAP2;LYN;EPHA5;PARP1;GOSR1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.38668411073922937,-0.888898584278376,0.6585365853658537,1.0,1.0,8/81,14.88%,SEL1L2;USP13;FBXO6;MAN1A1;FAF2;DNAJC10;RNF175;UFD1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5852729553797107,-0.8887245575543539,0.65625,1.0,1.0,2/5,19.08%,DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.28688806346351636,0.8886125933057271,1.0,0.9439085670166203,1.0,71/405,16.12%,UBB;RFWD3;RNF144A;TNFAIP1;CUL7;UBE2J1;UBE2D4;PSMD8;CAND2;RNF6;KLHL12;PSMB6;PSMB4;UBE2D1;UBE2N;RNF139;RRAGA;KLHL13;TRIM35;KLHL8;FBXO45;ELOC;UBA1;TSPAN17;PSME3;RNF141;DTX4;KLHL42;PSMD10;SDE2;PELI1;UBE2Q2;AREL1;CBLL1;UBE2G1;TRIM71;RC3H1;COMMD1;KLHL2;CDC73;UBC;SMURF2;RNF25;MUL1;RCHY1;KCTD10;FBXO44;TRIM4;MKRN2;ARRDC4;FBXW5;OTULIN;TRIM24;CUL9;PSMD12;PSMB2;PEX13;FBXL7;RNF135;PSMD4;CDC34;FBXL14;SPSB1;UBE2D2;FBXO28;ANAPC11;PRPF19;MARCHF7;ERCC8;SIRT1;KCTD13
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.38400909191696725,-0.8885777356159762,0.7032967032967034,1.0,1.0,16/108,15.92%,FGF1;FGF9;NRG4;P2RY12;LRP2;KITLG;AKR1C2;NTRK3;PTPRJ;AKT2;MYORG;ITGB1BP1;TGFB1;PDGFRB;IGF1R;ARRB2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5606358606803019,-0.8885587509031243,0.7272727272727273,1.0,1.0,1/6,10.84%,CYP3A5
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5206002615729964,-0.8884855343965619,0.6461538461538462,1.0,1.0,2/11,8.56%,VEGFA;EIF2B4
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.4559889766762601,-0.8884364478634711,0.6575342465753424,1.0,1.0,1/31,1.37%,PIP4K2C
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.36808333209770105,0.8882446279046801,0.625,0.9439205045307323,1.0,2/41,0.52%,SIRT2;HDAC11
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.3645055498381048,0.8880683861899692,0.6666666666666666,0.9435823752872685,1.0,8/47,8.00%,SIRT2;ZFP36L1;PLCL2;PDGFRA;PIK3C2G;PLCL1;NGF;PLCB4
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.34271664087926246,0.8879548681465533,0.6111111111111112,0.9430857697842833,1.0,3/53,1.55%,SOX4;BAD;LRRC8D
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6072312434599585,0.887849093759989,0.75,0.9425793293513212,1.0,2/5,31.61%,SKI;DDIT3
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3712022120593045,-0.887641658616698,0.6555555555555556,1.0,1.0,17/134,15.18%,PMS2;CDKN2A;SLBP;BRCA1;ANP32E;DONSON;RFC2;RFC1;ATAD2;SHMT1;CDK4;RPA3;TACC3;CIT;XPO1;ORC2;LUC7L3
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.4423172343232039,0.8874363694618735,0.6296296296296297,0.942782741767095,1.0,2/14,10.71%,SEC24D;SEC23B
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.5172604168755077,-0.8872180774507508,0.6376811594202898,1.0,1.0,2/10,10.65%,VEGFA;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.5582918294305146,-0.8868956505698096,0.703125,1.0,1.0,3/9,24.39%,SORBS1;AKT2;IRS2
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5074531855353116,0.8868583052631244,0.5714285714285714,0.9431761995884531,1.0,2/8,5.05%,PYCR1;GPR37L1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.31653065599690433,0.8867868825220047,0.7692307692307693,0.9425546054144401,1.0,13/117,10.16%,SIRT2;PMEPA1;GSTP1;GSKIP;PRR5L;CEP85;THY1;LYN;PPIA;CALM3;GREM1;CHP1;PPM1E
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.5088780350618471,-0.8863705687692313,0.6610169491525424,1.0,1.0,1/13,0.13%,TUFT1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.45905304409499204,-0.8863300889523427,0.6438356164383562,1.0,1.0,9/18,25.15%,LRP2;TPM1;TGFB1;RYR2;ZFPM2;TGFBR3;NRG1;ENG;SMAD4
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.33736186108700217,0.8862524239826473,0.6428571428571429,0.9431165862470009,1.0,13/72,16.18%,HSBP1;NUP42;HSPA1A;FKBP4;BAG3;MLST8;BAG2;BAG1;HSPA8;NUP35;SEH1L;SIRT1;NUP214
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4512469929427748,-0.8857577243569086,0.6428571428571429,1.0,1.0,6/27,19.89%,VEGFA;AHI1;B2M;ARRB1;ARRB2;SFRP4
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5357835608378911,0.8856935442643992,0.5161290322580645,0.9434033832500004,1.0,2/6,25.80%,PEX13;HACL1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.3875878292657391,-0.8856791578259402,0.7241379310344828,1.0,1.0,16/85,10.18%,CD44;SLC6A6;SRPX2;TNC;PAMR1;TIMP3;LAMA2;CALB1;ITGA2;COL5A1;EDNRA;RUNX2;GJA1;FOXO1;SVEP1;OSMR
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4946719827518894,-0.885308061311399,0.65625,1.0,1.0,1/20,1.37%,PIP4K2C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5416638474443279,-0.8849802926096303,0.6923076923076923,1.0,1.0,5/14,24.33%,DUSP22;ITGB1BP1;FAM107A;BCAS3;DMTN
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5416638474443279,-0.8849802926096303,0.6923076923076923,1.0,1.0,5/14,24.33%,DUSP22;ITGB1BP1;FAM107A;BCAS3;DMTN
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3726819033362329,0.8849024650066687,0.64,0.9443750530507528,1.0,5/37,7.50%,PRELID3B;LDLR;ATP11C;SCARB1;ATP8A2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.36702376573144224,0.8848417738990931,0.72,0.9437122934426281,1.0,7/32,15.73%,RRAGA;PIH1D1;MLST8;LAMTOR2;MIOS;LAMTOR1;SEH1L
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.4351102439592094,0.8847364656236831,0.5769230769230769,0.9432505546720934,1.0,2/22,3.58%,SEMA5B;SEMA5A
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5471432194563692,-0.8846041919080431,0.6949152542372882,1.0,1.0,2/7,24.33%,MED1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.45442853278429934,-0.8845061978532496,0.6756756756756757,1.0,1.0,6/21,25.94%,APOE;SORBS1;TGFB1;GRIN1;ADGRB1;TGFB3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.36207779748911867,-0.8844405395275176,0.78125,1.0,1.0,58/312,23.23%,ABLIM1;FHDC1;FAM161A;RAB17;TMOD3;MAK;VPS37C;INTU;CFAP221;RPGR;RAB11A;INPP5E;ATG14;AHI1;CCDC57;CFAP70;DNAH5;SH3PXD2B;GOLGA8B;B9D1;AVIL;HAUS5;CHMP4B;CFAP52;CSNK1D;CENPC;NEK6;PGM5;RILPL1;HDAC6;ATG16L2;TRAPPC14;HYLS1;CFAP43;ATG7;DHX37;GOLGA8M;WDR19;CC2D2A;RB1CC1;DYNC2I1;TCTN1;MAP1LC3B;LMOD1;IFT122;RAB19;BBS7;NCOR1;WDR11;RAB8B;VPS37A;RAB11FIP3;CEP131;TUBGCP3;TXNDC15;RAB1A;ARL13B;RUFY4
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.5525100980140386,0.8843827767327919,0.6486486486486487,0.9432944393755935,1.0,1/5,12.16%,FADS1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.37661317630573465,-0.8842710211685353,0.7362637362637363,1.0,1.0,27/145,14.53%,SEC14L5;ENPP2;OPALIN;NKX6-2;SNCB;NFE2L3;ZDHHC9;KIF6;MYRF;SHISA6;MOBP;PDE8A;PEX5L;PSD2;GRM3;DPY19L1;CAMK2A;SPARCL1;MMD2;SORBS1;TYRO3;MAG;ADCY5;FAM107A;ASPA;PLP1;ST18
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.32805596591924296,0.884130264512933,0.7777777777777778,0.9430859860995219,1.0,24/105,12.58%,FABP7;TUBB2B;RND2;DLL3;ASCL1;TOX3;POU3F2;SEMA5B;ADGRA1;SOX21;ZNF536;MAP2;S100B;BTBD17;DCX;GPM6B;LINGO1;STOX2;SALL3;TAGLN3;INAFM2;KCNQ2;CSRNP3;MEIS3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.3847112898196201,0.883864976528878,0.6470588235294118,0.942909357845163,1.0,10/32,16.91%,SMPD1;PPIA;CALM3;TIPRL;PPP1R16A;PPP1R8;YWHAB;MFHAS1;CALM1;HSP90B1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.5569618359877329,0.8837619703957631,0.675,0.9423656553751247,1.0,2/5,11.00%,NPM1;MRPL18
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4532181527856848,-0.8837557412376638,0.6578947368421053,1.0,1.0,7/29,18.88%,CLDN18;VCL;MICALL2;PAK2;TBCD;CTNNA1;CLDN20
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.5335700888358063,0.8834105293108107,0.625,0.9422737370602495,1.0,1/5,0.06%,NOX4
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.42583789845520337,0.8829709670853972,0.6785714285714286,0.9426535408023198,1.0,6/18,19.88%,ATP6V0A4;ATP6V0E1;ATP6V0D1;SLC25A14;ATP6V1F;ATP6V1H
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.5306023479990948,-0.8829033193906302,0.6451612903225806,1.0,1.0,4/11,18.37%,SOX9;MAP2K1;ZFP36L2;HTR2B
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.423860009107161,-0.8829007129652682,0.7375,1.0,1.0,11/50,16.27%,SREBF1;ATG14;FOXO1;CLEC16A;PDK2;TSC1;FAM107A;RPTOR;CDKN2B;WRN;ATG7
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.4496061017385406,0.8827421382390378,0.6521739130434783,0.942404467999661,1.0,4/15,16.71%,NT5E;DPYSL4;NT5C1A;DPYSL5
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.44696079146154655,-0.8826460545954079,0.7195121951219512,1.0,1.0,6/25,19.08%,NOSTRIN;CAV3;APOE;DNM2;HTR2B;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.3808599992063595,0.882624111329686,0.6363636363636364,0.941956956625419,1.0,4/21,9.51%,H1-10;SUB1;DACH1;H1-4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5346864585593326,-0.88251283053248,0.6388888888888888,1.0,1.0,1/7,3.05%,CDKN2A
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5312774355512102,-0.8824873900519234,0.671875,1.0,1.0,3/8,19.27%,ITPK1;RIPK1;DNM1L
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.4633857693613946,-0.8824757816982001,0.6710526315789473,1.0,1.0,6/20,18.96%,HOOK1;KIF1C;CCDC186;HOOK2;HOOK3;KIF1A
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.5767724327463626,-0.8823104601427005,0.7076923076923077,1.0,1.0,1/5,1.04%,ALOX12
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.5648690716179665,-0.8821954908705616,0.65,1.0,1.0,2/5,26.20%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.42712616029104017,-0.881990399445634,0.6666666666666666,1.0,1.0,3/34,7.87%,ZFPM1;SPI1;RPS14
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.5582683493486486,-0.881850254094352,0.6875,1.0,1.0,3/7,21.68%,VEGFA;PRKD2;MYO1C
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.5184921203036679,0.8812334092073486,0.5945945945945946,0.9442391330359756,1.0,2/6,11.11%,ACADS;PCCB
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.3624992663027818,0.8812049564839323,0.7272727272727273,0.9435924010384967,1.0,7/46,11.41%,GPX1;GSTP1;PDGFRA;PRDX5;CAT;PRDX3;JUN
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.529483384635765,-0.881185885191174,0.6,1.0,1.0,3/7,9.59%,FABP3;LIPI;LIPH
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.39789528909586064,0.8810748040740451,0.7083333333333334,0.9432911698729615,1.0,10/26,15.77%,ST6GAL2;GAL3ST3;NEU1;NEU3;ST6GALNAC3;FUT9;GAL3ST4;FUT8;MPDU1;B3GALT2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.3307028492276953,0.8807659377071853,0.6666666666666666,0.9431260126948074,1.0,11/63,10.46%,GPC4;SOWAHA;STARD13;PCGF2;BCAR1;GLIS2;CAMSAP3;LINGO1;DUSP15;ATN1;PRR36
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.40409805984719427,0.8806927957805241,0.6,0.9425441173995214,1.0,2/14,7.38%,ADCY6;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.5337560398122647,-0.8806549196989066,0.6557377049180327,1.0,1.0,2/10,13.27%,TACC3;NEK6
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3683725901384777,0.8805654207428217,0.7407407407407407,0.9421089295405681,1.0,5/23,17.89%,TWF1;BRK1;CDC42;CAPZB;ARPC2
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.4555863874583052,-0.8803585226067809,0.625,1.0,1.0,5/24,20.46%,SEMA4B;EPHA7;LRTM1;SEMA3A;SEMA7A
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5031171697910448,-0.8800677631590076,0.7222222222222222,1.0,1.0,4/19,14.15%,ROBO2;DUSP22;ITGB1BP1;FAM107A
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.4618561225094804,-0.8798401310682119,0.6805555555555556,1.0,1.0,2/24,2.86%,HES1;LFNG
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.470461765733007,0.8798050909825067,0.6451612903225806,0.9432357487815458,1.0,4/10,17.33%,ACOT8;CROT;ACOX1;CRAT
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.46791743684575465,-0.8796477515267773,0.6338028169014085,1.0,1.0,7/18,13.03%,SREBF1;LPCAT3;APOE;FMO5;SEC14L2;EPHX2;MBTPS1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.38771194776537976,-0.8796361929702621,0.6705882352941176,1.0,1.0,12/86,17.17%,PAPPA;AKAP12;LIFR;ADGRL2;EDNRA;GJA1;ADAMTS9;TYRO3;TPM1;COL4A2;CHST3;TENM3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3455031228404521,0.8795509356011146,0.625,0.9432895534621611,1.0,8/45,8.20%,AURKAIP1;KIF25;PPP1R10;PCGF2;CHMP2A;RYBP;BMI1;RNF2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5073763861837031,-0.8795427438887797,0.647887323943662,1.0,1.0,2/11,20.86%,DVL2;DVL1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.5611901120143874,-0.8794403200479426,0.6825396825396826,1.0,1.0,1/6,0.94%,ARX
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3826882033152176,-0.8788465608862202,0.7159090909090909,1.0,1.0,16/109,15.72%,ARIH2;CAMK1;AKAP5;CEMIP;NMT1;SAE1;YWHAH;EMD;PDZK1;MICALL2;ZIC1;AKT2;ITGB1BP1;KIF20B;TGFB1;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.41576512867295135,-0.8788360411229674,0.6896551724137931,1.0,1.0,13/45,19.60%,VSIR;C4BPA;FOXO1;WWP1;PLK2;WWP2;FZR1;ATG7;NEDD4L;OAZ2;DAB2IP;GPC3;STX5
prerank,MSigDB_Hallmark_2020__Coagulation,0.33887158220279123,0.8786672019280043,0.7368421052631579,0.9446216755573255,1.0,4/66,3.02%,MMP2;SIRT2;CTSV;PEF1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.427282919093683,-0.8785677439881074,0.6867469879518072,1.0,1.0,10/49,14.41%,VCL;EFNA5;VEGFA;DUSP22;MACF1;PTPRJ;ITGB1BP1;TSC1;FAM107A;DAPK3
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.5492270225547633,-0.878559506643162,0.6376811594202898,1.0,1.0,2/5,21.11%,DDRGK1;BFAR
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.5677990384356131,-0.8783866264453761,0.676923076923077,1.0,1.0,1/7,3.47%,PTPRB
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.540886286444071,-0.8783360287538505,0.6307692307692307,1.0,1.0,1/9,2.88%,DOCK8
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4836254637527734,-0.8780513100118527,0.6507936507936508,1.0,1.0,1/21,1.37%,PIP4K2C
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.44292298631862975,0.8778706226968188,0.6216216216216216,0.9456921650193142,1.0,1/13,1.35%,MOSPD2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.4018514085697123,0.8777325980322932,0.7105263157894737,0.9453600313635906,1.0,3/17,9.70%,SIRT2;TNFRSF21;TENM4
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.5408023880001572,0.8776646466850473,0.6341463414634146,0.9448624694321527,1.0,1/5,7.51%,GUCY1B1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.49915453305408686,-0.8776372307742814,0.6428571428571429,1.0,1.0,6/13,29.09%,DVL2;MACF1;DLG4;DVL1;MYO9A;DVL3
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2754470165784955,0.8771935232148689,1.0,0.9450599364770451,1.0,24/204,10.79%,TCF7L1;BAD;MAGI1;CAND2;KLHL12;CXCL12;ST13;PEF1;TGFA;CTSC;TMED2;PREB;DNAJB12;PML;SEC24D;YAP1;BOK;RAB1B;TLE4;WASF3;CDC123;TSPAN4;PPP2R1A;CDC73
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.40422099647959137,-0.8762835364078626,0.6707317073170732,1.0,1.0,9/63,9.70%,ITPR1;G6PC2;EFNA5;KCNJ11;BMP8A;NR1D1;MYRIP;CACNA1C;SNAP25
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.3714971077200627,0.8762651562994557,0.64,0.9463029425736892,1.0,4/35,6.48%,BTC;SLC30A10;TGFA;BCAR1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3172590276726906,0.8757895881479557,0.7647058823529411,0.9466335560141302,1.0,19/109,15.12%,ODC1;DHCR7;PSMD8;PSMB6;PSMB4;LDLR;TM7SF2;SQLE;SP1;PSME3;PSMD10;NFYA;HMGCS1;HMGCR;CERS2;PSMD12;PSMB2;PSMD4;FDFT1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.48745061293218117,0.875700848231445,0.6153846153846154,0.9460021149453145,1.0,2/7,11.37%,GSTP1;MUL1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.48586429661144687,0.87552227020027,0.5789473684210527,0.9457538851859729,1.0,2/7,15.43%,ARC;GRID2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.49897402781470124,-0.8753057143490887,0.6338028169014085,1.0,1.0,1/11,2.88%,DOCK8
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.5072606879177197,-0.875241794242144,0.6376811594202898,1.0,1.0,3/10,17.21%,FUT2;ST6GALNAC5;ST3GAL6
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.5072606879177197,-0.875241794242144,0.6376811594202898,1.0,1.0,3/10,17.21%,FUT2;ST6GALNAC5;ST3GAL6
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.5291569620411531,-0.8750083886351123,0.6901408450704225,1.0,1.0,2/13,16.11%,APOE;KNG1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.31239168575817206,0.874917946853137,0.7777777777777778,0.9464764832081116,1.0,14/84,12.36%,NUP42;U2AF1;RBM15B;RAN;CPSF1;POLDIP3;EIF4A3;RBM8A;MAGOH;AGFG1;NXF1;CPSF4;SRSF3;EIF4E
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.5531862320413576,0.874889179100991,0.6923076923076923,0.9458259311955879,1.0,1/6,2.82%,CXCL12
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3925135022663404,-0.8748556367640103,0.7625,1.0,1.0,18/59,22.75%,HTR2C;SLC39A14;CALCB;TPCN2;SLC24A2;ATP2B3;MT1M;RYR2;SLC41A1;SLC8B1;SLC30A9;HTR2B;ATP13A5;SLC24A5;ATP1B1;ATP13A4;ATP2B2;SLC24A4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.38110314949269464,0.8745282926549692,0.6,0.9459185720939051,1.0,2/26,5.70%,PML;PPP1R10
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.40802799415589,-0.8744215281412813,0.7317073170731707,1.0,1.0,8/53,18.62%,GALNTL6;MAP3K12;TAF1;CIT;MAP2K1;CDC42BPB;CAMK2D;PRKD2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.30077445305667594,0.8743836837257246,0.75,0.9455166233352376,1.0,31/234,8.88%,UBB;MARCKS;MARCKSL1;FBLN5;RND2;MAP7D3;CCDC88C;HSPG2;RHOBTB1;NCSTN;COL12A1;LAMA3;LTBP3;COL8A1;CD151;SNCAIP;PLOD1;MAP10;CGNL1;RHOC;MYO1D;SHROOM2;TSPAN14;CLIP3;BCAR1;COL4A4;COLGALT1;COL9A3;P3H2;GREM1;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.39625150581730473,-0.8742883425339902,0.6626506024096386,1.0,1.0,12/75,14.05%,RAB17;PTPRC;SYT1;RAB11A;HAP1;USP6;RAB3A;CPLX1;RAB3D;RAB15;MBTPS1;MAP2K1
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.5166115062120951,0.874109934445932,0.6428571428571429,0.9452799650891989,1.0,2/5,21.74%,CHD7;SKI
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.39962727340877663,0.8740741259658813,0.6551724137931034,0.9446630803461759,1.0,2/16,7.38%,ADCY6;PRKAR2B
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.49704382307273154,-0.8738764156171108,0.6818181818181818,1.0,1.0,4/12,17.35%,ROBO2;B2M;HOOK3;WNT7A
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4496610820760179,0.8738712463364656,0.5625,0.9444376810310657,1.0,5/11,22.86%,PCBP2;ELMOD2;TRAF3IP1;ILRUN;ZMPSTE24
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.33201764128789113,0.873810772228648,0.8,0.9439353068259025,1.0,16/87,14.96%,MALT1;PSMD8;PSMB6;TAB3;PSMB4;IKBKB;LYN;PSME3;PSMD10;NFATC1;JUN;GRB2;PSMD12;PSMB2;CALM1;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.43712036480627364,-0.8737485442849421,0.6338028169014085,1.0,1.0,5/34,14.12%,PTPRC;TIMP3;PTPRR;CAMK2N1;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.516843132162668,0.8736588460067778,0.6666666666666666,0.9428815037510514,1.0,3/10,6.65%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.516843132162668,0.8736588460067778,0.6666666666666666,0.9428815037510514,1.0,3/10,6.65%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.5506639240303652,-0.8734752506898652,0.6666666666666666,1.0,1.0,2/6,28.14%,NUP107;LDB1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.28105305573267486,0.8730980851095677,1.0,0.9432934548898118,1.0,19/134,16.76%,ODC1;MARCKS;CCND1;KPNA2;PML;SQLE;CDKN2C;LBR;SMAD3;JPT1;SS18;HIRA;HSPA8;KIF15;EZH2;E2F4;TMPO;SLC7A1;MT2A
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.42041454414460644,0.8728538209004835,0.6428571428571429,0.9431313364778117,1.0,3/19,10.79%,UBE2N;ATXN7L3;CDC73
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3959485548674824,-0.8723018810588171,0.7283950617283951,1.0,1.0,17/56,27.16%,IRF1;STAT6;POLR1C;TRIM56;TOMM70;IFIH1;OAS1;POLR3H;STAT1;CGAS;POLR3A;DHX36;POLR3E;MAVS;ISG15;FLOT1;POLR3D
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.5584108204121493,-0.8721995419018539,0.6716417910447762,1.0,1.0,2/5,14.78%,PAH;ASRGL1
prerank,MSigDB_Hallmark_2020__Complement,-0.37300889838080864,-0.8721798059642409,0.7816091954022989,1.0,1.0,25/116,21.93%,GCA;F8;IRF1;MAFF;RBSN;PLSCR1;CP;HPCAL4;GNB4;RASGRP1;L3MBTL4;USP8;COL4A2;CA2;C1S;ZFPM2;ADAM9;IRF2;LIPA;CD55;USP14;PSEN1;PCLO;STX4;DGKG
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.43998688893859583,-0.8717636236362343,0.6363636363636364,1.0,1.0,4/22,12.90%,FABP3;APOE;ACSL1;ACACB
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.4132833612094847,0.8715925330631844,0.5806451612903226,0.9450160312003789,1.0,3/18,7.72%,SIRT2;NGF;PLAUR
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.37293463385632314,-0.871483826695208,0.7604166666666666,1.0,1.0,24/149,19.27%,HOOK1;SPTBN5;CAV3;PLEKHF1;DNM1;USP50;GOLGA8B;ATP8B1;ATP8B2;SYNGR2;TANGO2;ARFGEF2;GAK;CSNK1D;USP8;HOOK2;HOOK3;GOLGA8M;FAM174B;PLEKHM2;BAG5;GOLPH3L;AKTIP;DNM1L
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.3901314664599207,0.8714096301998102,0.8076923076923077,0.9446892790203415,1.0,5/23,6.64%,ACTB;ACTG1;PDGFRA;TLN1;PPIA
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.38657465131708374,-0.8713336438631852,0.7473684210526316,1.0,1.0,13/99,11.46%,STMN2;ARX;FAM13C;AGT;PLCXD3;SST;LIFR;ADGRL2;APOBEC2;SHISA6;SNAP25;SYT4;SPARCL1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.39376316911117515,-0.871135369419865,0.7023809523809523,1.0,1.0,5/64,8.23%,B3GNT5;GALNTL6;GALNT15;ST3GAL1;GCNT1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3114197954732332,0.8708446639632258,0.8,0.9450986911584962,1.0,18/137,12.44%,SOX4;PHB2;HSPA1A;CALR;CCT5;TAF9B;GOLGA7;CCT3;COG3;BAG3;MT3;CHP1;GBA3;RABL3;BAG2;MUL1;BAG1;LAMP1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.3992782008276371,-0.8705224349523036,0.6625,1.0,1.0,12/47,23.90%,LIMK1;PFN2;CDC42EP3;VASP;NTRK3;VIL1;BAIAP2;SYNPO2;LMOD1;BCAS3;CRACD;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.4829230876806059,-0.8704489507425835,0.6811594202898551,1.0,1.0,4/19,15.61%,PARP9;CAMK2A;HDAC6;IFIT1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.4006338231301889,-0.8704068081935292,0.6987951807228916,1.0,1.0,10/61,18.12%,RASGRF1;DENND3;RASGRP1;MMD2;RASGEF1A;SYNGAP1;BCR;RDX;MADD;DAB2IP
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.5231641844902062,0.870283835113695,0.6578947368421053,0.9453645574367462,1.0,2/5,15.97%,BMP2;NOTCH1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.5396919250130557,-0.8702703077064684,0.7666666666666667,1.0,1.0,2/6,26.20%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5355277870948154,-0.869802259034662,0.6666666666666666,1.0,1.0,2/9,15.27%,BRCA1;RIF1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.27369595929691426,0.8696746487966832,0.8888888888888888,0.9459361188649604,1.0,19/141,11.88%,MALT1;TRAF5;GSTP1;TAB3;PLEKHG5;ESR1;IKBKB;UBE2N;RHOC;TRAF4;PPM1A;S100B;TMEM9B;PELI1;INAVA;ATP2C1;MUL1;LITAF;TSPAN6
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4711454029887202,0.8695075987938438,0.6756756756756757,0.9456606271624757,1.0,2/13,3.80%,PIWIL2;PIWIL4
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.5020683609378754,0.8693995373751913,0.6285714285714286,0.9451817812490751,1.0,1/5,1.28%,MALT1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5471412010654035,-0.8692294032984487,0.782608695652174,1.0,1.0,3/8,15.47%,KCNQ1;TPM1;RYR2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.46186705820870955,0.8686811697053747,0.6388888888888888,0.9459252886150732,1.0,3/10,13.34%,PLXNA3;PLXNC1;PLXNA2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.5654046861558477,-0.8686638502303409,0.6949152542372882,1.0,1.0,1/5,16.25%,SHANK3
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.5654046861558477,-0.8686638502303409,0.6949152542372882,1.0,1.0,1/5,16.25%,SHANK3
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.3651063052863053,0.8685927255278298,0.6363636363636364,0.9453960847353577,1.0,5/33,14.33%,ZFP36L1;FRZB;SYAP1;BMP2;TRPM4
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.5050411503638444,0.8685797358660791,0.5897435897435898,0.9447151712772659,1.0,2/6,3.88%,MOXD1;SRM
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.4528598005086817,-0.8684286474105484,0.7027027027027027,1.0,1.0,4/27,12.18%,PRUNE1;PFN2;RASA1;ABITRAM
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.41296543666302266,-0.8682468662493887,0.6436781609195402,1.0,1.0,7/46,17.13%,AGT;PLSCR1;NLRP12;NPAS2;PDCD4;RIPK1;IFI35
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.41830572700429125,0.8682017398389649,0.6666666666666666,0.9448783770115279,1.0,9/25,17.94%,ACTB;ACTG1;LEPR;ARL6IP5;MUL1;WWC1;EPB41;DNAJA1;NRP1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.32779868938910167,0.8681310421610152,0.6363636363636364,0.9443104932974926,1.0,12/82,9.47%,SYNDIG1;FREM1;SOX10;ZNF536;FRZB;THY1;S100B;PCDH17;RGS7BP;CRTAC1;GPM6B;LINGO1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5173861318249747,0.8681227273621324,0.65625,0.943631861627739,1.0,1/6,4.90%,PCDH15
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5618965090915689,-0.8678883799018751,0.6440677966101694,1.0,1.0,4/7,12.58%,NR4A3;LRP2;NR1D1;STAT3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.37957547759971166,-0.8677295835409122,0.6746987951807228,1.0,1.0,7/69,14.88%,SEL1L2;FBXO6;MAN1A1;FAF2;DNAJC10;RNF175;UFD1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.4407975490005059,-0.867302094273981,0.7532467532467533,1.0,1.0,3/31,7.87%,ZFPM1;VEGFA;RPS14
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.41939696581628594,-0.8672302147641184,0.6962025316455697,1.0,1.0,5/34,10.51%,BRCA1;BCL2L2;MSH6;BCL2L11;MOAP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.3978130483470336,-0.8671574818413073,0.7,1.0,1.0,8/59,20.31%,SHTN1;EMD;LPCAT3;GAK;TRAM1L1;DNM1L;STX5;MOSPD3
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.29743687341150493,0.866798030038214,1.0,0.9457415955784574,1.0,64/430,10.31%,NOX4;SOX4;STOX1;SIRT2;FABP7;SOX11;TSPO;BTC;PODN;GPNMB;GID8;HSPA1A;NACC1;ROR2;TGFBR2;TNS2;SMYD2;CNBP;CALR;ZFP36L1;COPS9;TGFA;CGRRF1;HP1BP3;POU3F2;IL15;NPM1;PDGFRA;CHRNA7;RNF139;JUND;PML;TBRG4;CAPNS1;BTG1;FRZB;SQLE;BTG3;LYN;IGFBP7;CLEC11A;S100B;PTPN14;BAMBI;YAP1;NGF;BOK;ATP8A2;ADRA1A;RPRD1B;RPS15A;P3H2;LIMS1;CDKN2C;GREM1;SLC25A33;PDGFD;SPEG;TRIM71;DUSP15;SHANK2;PRDX3;CDC123;TGFBR1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.44896419981494684,-0.8666824935860118,0.7,1.0,1.0,3/25,3.96%,ART4;PARP9;PARP14
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.49204593668064434,-0.8661601855046679,0.6956521739130435,1.0,1.0,4/15,14.61%,TPST1;SULT4A1;BPNT1;PPA1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5665461064478293,-0.8660978531091845,0.6666666666666666,1.0,1.0,2/6,19.08%,DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.39391089348447667,-0.8659655725325517,0.7674418604651163,1.0,1.0,11/105,12.38%,RASGRF1;ARHGAP24;A2M;ARHGDIG;RHOJ;ARHGAP26;VAV3;ARHGAP15;SRGAP3;PREX1;TIAM1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.4098066004634554,0.8658320804498912,0.6,0.9471696447292672,1.0,3/22,7.59%,SMDT1;SLC35G1;ADRA1A
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.4785336612175084,0.8658110536347849,0.78125,0.9465308985324673,1.0,1/9,2.68%,KDM3B
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5228953424732574,-0.8657940355941346,0.6323529411764706,1.0,1.0,2/6,8.93%,SLC22A4;RIMS1
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.5074468122353414,0.865575244834679,0.6764705882352942,0.9463279747918131,1.0,4/8,16.11%,LEPR;MT3;MKKS;SIRT1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.5474568819697389,-0.8653904328845005,0.7,1.0,1.0,3/7,25.77%,SHMT1;GDA;PAICS
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5287821153309178,-0.8653575116474881,0.6923076923076923,1.0,1.0,4/8,28.76%,BDNF;HDAC4;XBP1;BHLHE41
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.4656783505051931,-0.8652346065106535,0.7164179104477612,1.0,1.0,4/26,15.80%,SRSF5;CELF4;LUC7L3;CELF3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5358589266100428,-0.8652338792819546,0.7076923076923077,1.0,1.0,1/11,0.82%,DND1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.5172929965651795,-0.8649390602926913,0.7014925373134329,1.0,1.0,2/11,17.98%,CACNA1C;HCN2
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5972605434465309,0.8647828706803183,0.75,0.9472875876536201,1.0,3/5,24.30%,SPRTN;VCP;TEX264
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.36159750945642644,0.864622585922842,0.75,0.9468521296027689,1.0,2/26,2.28%,NR0B1;SOX8
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.521045111309898,-0.8645056022635557,0.6417910447761194,1.0,1.0,2/9,7.50%,PTPRC;GPI
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.41391696252763244,-0.8644329731476151,0.7012987012987013,1.0,1.0,7/35,14.28%,LFNG;PTPRC;KLF6;LMBR1L;BLNK;PTPRJ;HDAC4
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.5402957424611252,-0.8643193303689374,0.6451612903225806,1.0,1.0,3/8,18.01%,TMCO5A;TTC6;SYCP2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.3794961844765986,0.863558214247249,0.6363636363636364,0.9483448337163354,1.0,3/28,6.39%,LPCAT1;IP6K2;AGPAT5
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.47116658767554626,0.8632021202983867,0.5588235294117647,0.9476959760824704,1.0,5/11,29.48%,SMARCB1;ARID2;SET;ARID1A;HMGA1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.47116658767554626,0.8632021202983867,0.5588235294117647,0.9476959760824704,1.0,5/11,29.48%,SMARCB1;ARID2;SET;ARID1A;HMGA1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.558128902190902,-0.8628150673897509,0.711864406779661,1.0,1.0,1/5,5.13%,VEGFA
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.35578651367975517,-0.8628141052127339,0.8160919540229885,1.0,1.0,36/198,18.12%,GADD45B;SOX9;TSPYL2;IRF1;CDKN2A;PTPRC;CDK7;BRCA1;GADD45A;RARA;WDR12;CDK4;JUNB;CAMK2N1;CRLF3;SPATA22;WDR6;STAT3;NEK6;SRA1;NUDT6;AKT2;MASTL;MAP2K1;TSC1;KIF20B;PDCD4;DAPK3;TGFB1;CTBP1;CDKN2B;BEX2;MAPK12;MADD;ATM;DAB2IP
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.5204086468217628,-0.8627720067072079,0.6714285714285714,1.0,1.0,2/8,11.48%,ST3GAL1;ST6GALNAC5
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4193256959302997,-0.8625839066493934,0.6533333333333333,1.0,1.0,11/34,27.78%,FABP3;APOE;USF1;ACOXL;ABCA2;PNPLA2;XBP1;IRS2;PRKAA1;PRKAA2;ABCA1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3527100984414739,0.8622960649613751,0.625,0.949204966212916,1.0,4/21,15.25%,DYNLT1;INSC;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.3656265900462612,0.8613365901698751,0.7037037037037037,0.9506312719925781,1.0,6/23,17.14%,DNAJC15;GRPEL1;DNAJC19;TIMM23;TIMM50;PEX5
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.5105654472336988,-0.8611426971409025,0.6428571428571429,1.0,1.0,1/7,5.69%,RAB40B
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.3827387148450922,-0.8611249723438592,0.7558139534883721,1.0,1.0,18/114,15.80%,STMN2;OLFM3;ROBO2;KCNC1;CACNA1B;ACTL6B;CELF4;RBFOX3;SNAP25;GRM3;EPHA7;SYT4;ATP2B3;MMD2;SULT4A1;NTRK3;DCLK1;CELF3
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.45025551104299766,0.8610612396316698,0.5769230769230769,0.9505170548918749,1.0,3/8,25.04%,SETMAR;ISG20;DFFB
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.38974648394569533,0.8609435057904957,0.64,0.9500111296594204,1.0,2/23,5.58%,SIGMAR1;PPIF
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.5869326655555569,-0.8609132958076989,0.7313432835820896,1.0,1.0,1/5,5.80%,CAV3
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.3350769329725325,0.8607883890602828,0.9411764705882353,0.9496364650863978,1.0,8/50,9.64%,UBE2D4;RNF6;KBTBD6;UBE2D1;PELI1;KBTBD7;UBE2Q2;UBE2G1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.5138592875398512,0.8605369465907347,0.5813953488372093,0.9494228776520407,1.0,1/5,2.37%,GSTP1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.37952969831049554,0.8603365319650299,0.78125,0.9491293878257201,1.0,2/23,2.28%,NR0B1;SOX8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.43582909107849116,-0.8601550856164991,0.7361111111111112,1.0,1.0,5/22,16.01%,CDKN2A;CDK4;FAM107A;RBL2;CDKN2B
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.28220970271964274,0.8601006936068549,0.75,0.9489164734836752,1.0,27/109,21.01%,BICD2;CALR;LAMP5;MICALL1;TSPAN17;COG3;TOLLIP;IFT20;WDR35;ARL3;RAB6A;LAMP1;WASHC2A;SEC61G;SEC61B;LMNA;TRAM1;DNAJA1;AUP1;UBE2J2;DDX1;ARFRP1;BICD1;UBAC2;VPS35;YBX1;DCP1A
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.5267119898824645,0.8600316633600066,0.5714285714285714,0.9477112005614284,1.0,2/5,22.60%,CDC73;PAF1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),0.5267119898824645,0.8600316633600066,0.5714285714285714,0.9477112005614284,1.0,2/5,22.60%,CDC73;PAF1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.592502373335678,-0.8599402958344277,0.6981132075471698,1.0,1.0,1/5,3.80%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.4342593524427044,-0.8598588813835367,0.7323943661971831,1.0,1.0,5/23,16.01%,CDKN2A;CDK4;FAM107A;RBL2;CDKN2B
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4844881370366877,-0.8598566245456302,0.7164179104477612,1.0,1.0,5/15,22.44%,BDNF;HDAC4;FBXO22;PIEZO1;XBP1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.3969006612342947,0.8594490313829956,0.6190476190476191,0.948179592593739,1.0,9/37,16.38%,UBE2D1;BAMBI;BMPER;SMAD9;GREM1;SMURF2;BMP2;NOTCH1;SMAD7
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.5104223861672644,0.8593617058429803,0.6857142857142857,0.9476382930566125,1.0,2/7,10.31%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3965553338718578,0.8590211763039884,0.6129032258064516,0.9476069093675857,1.0,3/19,7.10%,SUB1;ESR1;MED24
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.47409292968972155,-0.8589193622842456,0.7297297297297297,1.0,1.0,4/22,13.27%,NUAK1;CDKN2A;B2M;NEK6
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.43284716506233045,-0.8588437949932386,0.6923076923076923,1.0,1.0,1/32,0.82%,DND1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.47658670996742114,-0.8586831768989568,0.5909090909090909,1.0,1.0,3/14,15.17%,NR4A3;PTPRJ;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4437501973508835,-0.8586306466779431,0.7142857142857143,1.0,1.0,4/32,8.71%,GRIN2A;DAPK1;NLRC4;USP50
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.3896545980561793,0.8584728989136097,0.6785714285714286,0.9479845846484685,1.0,4/29,7.58%,SNF8;RAB27B;CHMP2A;SMPD3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.34732045541772905,0.8579780282513548,0.6666666666666666,0.948321843264962,1.0,6/37,8.25%,ADCY6;LGR5;GPR161;CALCRL;ADRA1A;RXFP1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.3735056688760288,-0.8579540701009806,0.8,1.0,1.0,24/131,18.12%,STMN2;CAMK1;RAB17;RTN4IP1;STX1B;CAMK2B;APOE;PAK1;AVIL;PAK2;CAMK1D;GAK;NTRK3;MAG;BDNF;PTK7;EPHA4;CRMP1;SHANK3;ROR1;TENM3;BAG5;SEMA3A;DAB2IP
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.41380222070698197,-0.8579096734862577,0.75,1.0,1.0,6/55,8.85%,SLC2A3;MCCC1;ALDH1L1;MTHFD1;SHMT1;BTD
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.31387175049639493,0.8575797420940218,0.8888888888888888,0.9483896539466454,1.0,9/59,10.79%,GSTP1;HNRNPA0;NFKBIL1;SCARB1;SRR;PDE4B;PELI1;PRDX3;CDC73
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.36638928175083313,-0.8573912810918145,0.7692307692307693,1.0,1.0,21/119,19.27%,HES1;EFNA1;SOX9;OVOL2;ZFPM1;COL5A1;RANBP3L;FOXO1;ADGRV1;NBR1;MEIS2;SUZ12;SRA1;PDCD4;TGFB1;ZFPM2;ZFP36L2;DAB2IP;USF3;RORB;HDAC7
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.3795720407220178,-0.8571213862972288,0.7272727272727273,1.0,1.0,12/65,13.74%,STMN2;SYT1;GRIK5;CPLX1;HCN3;CALY;ACTL6B;SYT4;LRRTM1;DUSP8;IQSEC3;ADCY5
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.3901981851399089,0.8567092181507938,0.6538461538461539,0.9497116379360311,1.0,4/16,8.20%,PCGF2;RYBP;BMI1;RNF2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4246730859313754,-0.8564208893321068,0.6621621621621622,1.0,1.0,6/21,15.91%,TTN;TMOD3;TPM1;PGM5;PDGFRB;MYOM2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.4869158057627853,-0.8557992560518749,0.7121212121212122,1.0,1.0,6/14,37.52%,ATG7;RB1CC1;ULK1;ULK2;WIPI1;ATG12
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3943540389942553,-0.8557914561398766,0.7012987012987013,1.0,1.0,10/51,19.84%,SEPTIN9;EFHC1;TTC19;RASA1;CECR2;CIT;CHMP4B;USP8;RAB35;SPIRE1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.506737104350628,0.8549726978969823,0.6216216216216216,0.952553683845307,1.0,1/6,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.513168811436248,0.8546742458534948,0.5454545454545454,0.9523300556274062,1.0,2/7,9.06%,SNX12;GAS1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.38420378649692516,-0.8546511236535473,0.7674418604651163,1.0,1.0,9/86,7.62%,HEY2;PAMR1;DRAM1;TIMP3;LAMA2;ARID5A;NRGN;TNS1;EDNRA
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.48792970450854345,-0.8546447599947169,0.7012987012987013,1.0,1.0,4/15,17.40%,SLC4A4;CA2;SLC4A8;SLC4A3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.32186239333719635,0.8545290500724564,0.8571428571428571,0.951838550592844,1.0,20/92,13.72%,CUBN;HSPG2;FNBP1L;CALR;PPT1;STAB2;LDLR;CALCRL;AP4E1;MICALL1;SCARB1;COLEC12;CANX;LRP3;CLTB;NLGN3;MASP1;GRB2;VLDLR;GRK2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4269138994986354,0.8545214528238325,0.5483870967741935,0.9511790034105011,1.0,2/15,5.21%,G0S2;PML
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.45271699570069135,-0.8541707294380163,0.7936507936507936,1.0,1.0,3/20,12.96%,GUK1;REXO2;NMNAT3
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.4318778562737702,-0.8540350203425912,0.6986301369863014,1.0,1.0,8/26,17.07%,YWHAH;CAV3;AHCYL1;PDZK1;CHRM3;WWP2;RIPK1;NEDD4L
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.5793317802486806,-0.8536513776230986,0.7741935483870968,1.0,1.0,1/6,22.87%,ZNF445
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.5161625803789657,-0.8536267520415675,0.7205882352941176,1.0,1.0,4/14,24.05%,PDK1;PDK2;PDK3;GNB3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.4035351162885583,-0.8535766200846867,0.7721518987341772,1.0,1.0,5/63,5.13%,NR4A3;SOX9;FGF1;FGF9;VEGFA
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4460922768066412,0.8534780682504314,0.5555555555555556,0.9527620969079832,1.0,3/20,2.47%,SOX4;SOX11;TGFBR2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.4758311710280507,-0.8533282860121957,0.7397260273972602,1.0,1.0,4/17,15.47%,TTN;KCNQ1;TPM1;RYR2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5110095643622392,0.8530915188041112,0.6590909090909091,0.9527570207422883,1.0,3/7,15.97%,RBPJ;TGFBR1;NOTCH1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.5013484014367434,0.8526775557007809,0.6842105263157895,0.9528708105602933,1.0,4/8,26.27%,PNP;GMPR2;AMPD2;DGUOK
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.37136299313796883,-0.8525979619264842,0.7931034482758621,1.0,1.0,15/116,8.73%,CD44;HES1;CRYM;GSTM5;FAM13C;PAMR1;AGT;TIMP3;VEGFA;COL5A1;LIFR;ADGRL2;GLUL;APOE;GJA1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.4945141463830203,-0.8525760278226985,0.7536231884057971,1.0,1.0,1/12,14.50%,PTRH2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.38437096280682964,-0.8525026336143057,0.725,1.0,1.0,10/65,19.08%,PIP4K2C;SOX9;AGT;NTRK3;PDGFRB;IGF1R;PIP5K1B;ROR1;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.38078430370573546,-0.8523962628079598,0.7777777777777778,1.0,1.0,6/67,7.28%,RFC4;CDK7;PPIE;RFC2;UVSSA;RFC1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.40483673820900096,-0.8523685061954404,0.75,1.0,1.0,15/62,24.39%,SLC39A14;TBC1D4;FOXO1;RAB15;SORBS1;AKT2;USF1;TSC1;CPEB1;CEACAM1;RAB8B;XBP1;SORT1;RAB10;IRS2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.40739628336410344,-0.852311508459431,0.7,1.0,1.0,5/44,9.81%,FBXO6;NR1D1;APOE;ADAMTS9;DENND3
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.350524701096072,0.8522798689660579,0.8888888888888888,0.9530438254777683,1.0,8/41,16.03%,ATP5MC1;ATP5F1A;TIMM13;TIMM22;ATP5F1D;MTX2;ATP5PD;MICOS13
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.38499552513018664,-0.8522655874828444,0.7558139534883721,1.0,1.0,7/61,10.57%,RFC4;ATAD5;MSH6;FANCI;ERCC6L;ZGRF1;CDC7
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4112540335376327,-0.8521121286247298,0.7352941176470589,1.0,1.0,3/33,2.54%,TUFT1;EMP2;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.37043596599705353,-0.8520048968827164,0.75,1.0,1.0,14/101,15.42%,RFC4;RFC2;PARN;ALK;EPHA7;DTX3L;TYRO3;PARM1;NTRK3;TGFB1;EPHA4;PNKP;PDGFRB;IGF1R
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.4114175693382637,0.8518266558661793,0.5555555555555556,0.95322648509242,1.0,2/20,1.81%,SIRT2;ADCY6
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4011319717313068,-0.851574542362273,0.7397260273972602,1.0,1.0,5/49,10.14%,EPN1;AGT;HAP1;BCAR3;DOK1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.4875661995488413,-0.8515176869997991,0.7424242424242424,1.0,1.0,4/12,28.34%,COQ8B;COQ6;COQ3;PDSS1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.5231812881282043,0.8513790948017282,0.6976744186046512,0.9534385363936152,1.0,2/6,3.63%,RAN;NPM1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.36853584529469213,-0.8511966667598228,0.7325581395348837,1.0,1.0,28/128,15.89%,CD44;GADD45B;MYLK;TNC;TIMP3;LAMA2;CRLF1;GADD45A;RGS4;VEGFA;GLIPR1;ITGA2;COL5A1;GJA1;PFN2;ECM2;ABI3BP;SPP1;TPM1;MATN2;OXTR;PVR;COL5A3;BDNF;TGFB1;PDGFRB;CTHRC1;COL4A2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4468060712266731,-0.8511373736304553,0.76,1.0,1.0,7/20,24.33%,CEMIP;PDZK1;AKT2;ITGB1BP1;MYO1C;TCAF1;DMTN
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.5077247483613828,-0.8509887048679834,0.6857142857142857,1.0,1.0,7/11,29.00%,PARP9;DTX3L;HMBOX1;DDX11;MED25;KDM4D;WAPL
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.48071884845274077,-0.850919178908129,0.6379310344827587,1.0,1.0,3/12,21.25%,SAE1;ATG7;UBA5
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.44136399012582866,-0.8506316695287011,0.7887323943661971,1.0,1.0,4/23,9.62%,YWHAH;CACNA1B;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.44771936840600424,-0.8505432501177287,0.726027397260274,1.0,1.0,3/24,12.75%,ART4;GLUL;GCLC
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.5038572251272732,0.850477112550012,0.6578947368421053,0.9546478389575868,1.0,1/6,4.48%,MCM4
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.38146922950143,-0.8504759790768964,0.7093023255813954,1.0,1.0,18/76,22.44%,NR4A3;SLC39A14;TBC1D4;FOXO1;RAB15;SORBS1;TSHR;ADCY1;ADCY5;AKT2;USF1;PRKAR1B;ADCY3;PRKAR2A;CPEB1;CEACAM1;RAB8B;XBP1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.3576688843491178,-0.850365389165966,0.7692307692307693,1.0,1.0,25/174,13.79%,CD44;OPTC;MMP19;TNC;SCUBE3;LAMA2;COL10A1;A2M;MMP21;ADAMTS13;ITGA2;COL5A1;P4HA3;ADAMTS16;ADAMTS9;LOXL3;ACAN;ECM2;SH3PXD2B;THSD4;SPP1;CYP1B1;COL5A3;ITGA8;MMP24
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.5229360137452095,-0.8502532607179057,0.6865671641791045,1.0,1.0,1/6,0.30%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3698686899490675,-0.8502529547877009,0.7349397590361446,1.0,1.0,18/90,17.10%,TMSB4X;HES1;NLRC5;CDKN2A;SPI1;TAF1;TRIB1;NLRP12;ARRB1;CYP1B1;WWP2;BHLHE40;HDAC4;TRAF3;ARRB2;IRAK2;MAP2K5;PEX14
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.34919480637977174,0.8500179079468293,0.6875,0.9550954544327342,1.0,9/54,3.76%,MMP2;BGN;FIBIN;PODN;COL12A1;TNS2;CXCL12;SEMA5A;PDGFRA
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.39540088052548755,-0.8499775527881533,0.7246376811594203,1.0,1.0,4/47,9.07%,SOX9;CDKN2A;RUNX2;CDK4
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.44779045880500784,-0.8499677655921031,0.7567567567567568,1.0,1.0,4/22,13.54%,CLDN18;MICALL2;PAK2;TBCD
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.5449739206183932,-0.8499380447073521,0.7666666666666667,1.0,1.0,1/5,25.23%,MTMR4
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.558875143526435,0.8499286276536606,0.6666666666666666,0.9546843759542444,1.0,3/6,31.19%,KIFAP3;KIF13A;KIF3B
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.33953355407866787,0.8496840528581011,0.7777777777777778,0.954608975913158,1.0,8/65,10.85%,ACTB;SLITRK2;SEMA5A;DHFR;S100B;NTNG2;EPHB3;RTN4RL2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.3584068030319594,-0.8496347731217663,0.8023255813953488,1.0,1.0,12/134,9.59%,PLEKHA4;SYNJ2;PIP4K2C;DDHD2;INPP5E;LIPI;GPAM;LPCAT3;PLSCR1;SLC44A3;PCTP;LIPH
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.49165481021933766,-0.8496325775430191,0.6710526315789473,1.0,1.0,6/11,30.40%,CBY1;NRG1;SORT1;MEF2C;KDM6B;AKAP13
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.3845744496198174,0.8495279519301885,0.7666666666666667,0.954238219340998,1.0,4/23,9.56%,SIRT2;YAP1;SMAD3;LRP3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.39307663315972996,0.849455653667832,0.7142857142857143,0.9537498858575576,1.0,9/41,11.57%,IDH1;AADAT;DHFR;SDHAF3;ALDH1L2;ACOT8;MTHFD2L;ACLY;FPGS
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.33928295174705936,0.8494203955499068,0.7,0.9531442249188019,1.0,3/43,3.15%,MALT1;CTSV;CTSC
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.4022526426514674,0.8493471340269897,0.6923076923076923,0.952667182697167,1.0,2/15,7.38%,ADCY6;PRKAR2B
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.4475312867865002,-0.848934405459184,0.6428571428571429,1.0,1.0,5/21,17.48%,MMS19;FANCB;SHLD2;RIF1;ZCWPW1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.40845702295418856,-0.8488592200010777,0.7831325301204819,1.0,1.0,10/50,21.63%,VEGFA;VAV3;PAK2;SULF1;NRP2;BAIAP2;DAB2IP;PRKD2;PIK3CB;SHC2
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.3532078451762025,-0.8488222913680876,0.8571428571428571,1.0,1.0,43/324,18.62%,RFC4;GNA12;TMSB4X;PIP4K2C;NUAK1;FGF1;ARHGAP24;AKAP5;BRCA1;A2M;ARHGDIG;VEGFA;RHOJ;ARHGAP26;RFC2;AKAP12;VAV3;ARHGAP15;PEX5L;RPA3;TAF1;NLRP12;SRGAP3;PAK1;PREX1;TIAM1;VRK2;PAK2;NTRK3;ING5;TRAF3;PIP4P1;WRN;PIP5K1B;CASTOR2;ARHGEF17;BCR;ATM;TNIK;DAB2IP;PRKAR1B;NGEF;PRKD2
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.48987141720856553,0.8487824974965298,0.7058823529411765,0.95306487937119,1.0,2/8,3.80%,PIWIL2;PIWIL4
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4155167296980339,0.8487089813109755,0.7142857142857143,0.9525493103561392,1.0,7/26,19.07%,EAF2;LARP7;EAF1;CDC73;WDR43;NELFA;RNF168
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.42916281232612247,-0.8486548166870956,0.6746987951807228,1.0,1.0,6/38,12.75%,MGST1;PTPA;PFKP;JUNB;GLRX;GCLC
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.37661333106415495,0.8483258143888124,0.7878787878787878,0.9525444379485808,1.0,5/23,12.84%,CTSC;RNF139;TMTC3;BAG2;OSBPL7
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.5381243333019415,-0.848273067612003,0.6833333333333333,1.0,1.0,3/7,14.28%,CNTNAP1;MYRF;PLP1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.5009686907577755,-0.8480914057426622,0.6779661016949152,1.0,1.0,1/10,12.88%,CHMP4B
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3829015845878523,-0.8477287630944451,0.7444444444444445,1.0,1.0,15/99,17.78%,TUBA4A;TPD52L1;CDK7;CEP135;BACH1;CCDC57;BORA;DNM2;HAUS5;LCMT1;CSNK1D;MASTL;CDKN2B;DCTN1;CEP72
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.34736018824764153,0.8476285491551598,0.7368421052631579,0.9532059855419053,1.0,13/45,18.08%,PLXNA3;MCF2;THY1;NGF;CHODL;PLXNC1;LINGO1;EPHB3;PLXNA2;LRRC4C;CDH2;GDI1;RHOA
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4360022983192997,-0.84762723684975,0.6710526315789473,1.0,1.0,5/25,11.72%,HLA-F;HLA-C;B2M;MFSD6;TAPBP
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.3757599611035856,0.8473627989977269,0.6875,0.9530831380504354,1.0,8/29,14.38%,TRMT112;HSD17B10;TRMT10A;TRMT1L;METTL2A;TRMO;TRMT5;TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.5085776635712681,0.8473194393868877,0.6363636363636364,0.9524613570738526,1.0,3/8,17.56%,CHRNA7;PAX8;MTPN
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3827483510151541,-0.847158206646089,0.7792207792207793,1.0,1.0,19/64,27.16%,NLRC5;IRF1;STAT6;POLR1C;TRIM56;IFIH1;UFD1;TRAF3;POLR3H;TRIM25;TIRAP;CGAS;POLR3A;DHX36;POLR3E;MAVS;ISG15;CYLD;POLR3D
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.3190812354986264,0.8470216387507493,0.8421052631578947,0.9523098674594963,1.0,7/56,9.57%,PSMD8;PSMB6;PSMB4;PSME3;YAP1;PSMD10;TCF12
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4979117399382591,-0.8466592445273077,0.6901408450704225,1.0,1.0,1/11,4.78%,CEMIP
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.4882499762336884,-0.8464487932973792,0.7580645161290323,1.0,1.0,8/15,27.70%,CRYM;ASPA;AASS;GCDH;SLC25A21;GOT1;DDO;ALDH7A1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.49780561661385736,-0.8463957672627184,0.75,1.0,1.0,1/11,5.61%,TRNT1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.47140632480712885,-0.8461855753500959,0.7384615384615385,1.0,1.0,4/19,13.90%,TTLL6;AGBL4;TTLL4;AGBL5
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.45115335386409666,0.8460598345509185,0.65625,0.953214036438448,1.0,1/7,6.03%,LYN
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.5134906771662249,-0.8458205561438564,0.7368421052631579,1.0,1.0,3/8,10.46%,ZFPM1;KITLG;THOC5
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4046968691667408,-0.8457663420205931,0.7236842105263158,1.0,1.0,3/38,5.38%,GADD45A;DONSON;FBXO6
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.41054056561978974,0.8455062880479253,0.696969696969697,0.9537165384408309,1.0,3/17,9.73%,BAD;TIMM13;TIMM22
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.414120152746544,-0.8454398873795002,0.75,1.0,1.0,6/41,12.27%,FGF1;SRF;RAB3A;PAK1;MACF1;TPM1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.3793908115475683,0.8453513338112001,0.8095238095238095,0.9532814779770594,1.0,4/20,17.21%,NT5E;NT5C1A;PNP;NUDT4
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.4145600915364615,-0.845311820825451,0.7428571428571429,1.0,1.0,2/30,3.26%,CMTR1;CDK7
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.4145600915364615,-0.845311820825451,0.7428571428571429,1.0,1.0,2/30,3.26%,CMTR1;CDK7
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.48541238184688507,0.8452847834483502,0.6666666666666666,0.9527885151826679,1.0,3/8,24.87%,STXBP6;RAB33B;IL1RAPL1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.29874602726179694,0.8450524277053421,0.8333333333333334,0.9525106388318815,1.0,22/136,12.10%,MRPL11;MRPL10;MRPS33;MRPL28;MRPL36;RPL8;RPS19;RPL15;EEF1A1;MRPS16;RPL29;RPS2;RPS15A;MRPS12;MRPS18A;RPSA;MRPL18;MRPL52;RPL23A;EIF4EBP2;MRPL27;MRPL13
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.47160565698693685,0.8448486478605113,0.7073170731707317,0.9521747211003599,1.0,4/9,20.83%,SLC25A33;TEFM;TFB2M;TFB1M
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.47481246897604645,0.8448265858454715,0.6486486486486487,0.9515181303046741,1.0,3/8,18.62%,ATF4;CREB3L1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.5311146638285648,-0.8448072882369599,0.7192982456140351,1.0,1.0,2/5,33.05%,RNF169;UBR5
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.4304495831885663,-0.8445606521369522,0.7101449275362319,1.0,1.0,8/31,19.35%,PLCH1;ITPK1;ITPKC;INPP4B;INPP5A;NUDT11;INPP4A;IMPA1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.4024881427015773,0.844458308014395,0.7083333333333334,0.9514751206612282,1.0,2/15,9.47%,MSN;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),-0.5653746187061426,-0.8443747263931806,0.7321428571428571,1.0,1.0,1/5,13.28%,TMEM25
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.4232577933266139,-0.8443357992600756,0.7285714285714285,1.0,1.0,4/36,10.21%,RFC4;RFC2;RFC1;RPA3
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.4212967584905347,0.8438569231953271,0.5416666666666666,0.9520444058363696,1.0,2/18,8.09%,NCSTN;HM13
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.43770612285511723,-0.843795896757885,0.7536231884057971,1.0,1.0,4/31,13.08%,EMP2;RFTN1;CHMP4B;GAK
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.5655377550305887,-0.8436439064187792,0.7258064516129032,1.0,1.0,1/6,5.18%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.36152718332472106,0.8434961999235201,0.7083333333333334,0.9521079122253769,1.0,9/33,12.55%,SIRT2;LDLR;SNX12;PFDN1;VBP1;PFDN2;HMGCR;MAD2L2;EDNRB
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.502520028112922,0.8434777288847181,0.6756756756756757,0.9514726097201227,1.0,1/6,4.57%,CMPK1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.5454084689760121,-0.8433549823342481,0.7454545454545455,1.0,1.0,2/7,19.27%,CHMP4B;DNM1L
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.3784462876514052,0.843225904997552,0.6451612903225806,0.9512454958590465,1.0,2/19,6.65%,HSPA1A;CHMP2A
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.41579159011489103,-0.8430943134104404,0.7407407407407407,1.0,1.0,6/36,24.19%,PARN;PARM1;PNKP;ATM;HMBOX1;MEN1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.31908865555440774,0.8430185016756264,0.631578947368421,0.9509605529968068,1.0,14/80,9.66%,AMOTL2;CCND1;MAGI1;ADCY6;COL12A1;AADAT;PCGF2;BCAR1;YAP1;ABCG2;LAPTM4B;PTPRF;GNA11;LRIG3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.3669378457882192,0.8430062282555023,0.76,0.9503273767218758,1.0,10/23,24.60%,PREB;SURF4;SEC61B;HSP90B1;AUP1;DERL2;VCP;HERPUD1;TMED9;OS9
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.4890602360736083,-0.8429341479321484,0.72,1.0,1.0,1/13,2.39%,PYGL
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3950958386510046,0.8427277078499591,0.6521739130434783,0.9502079857482733,1.0,4/23,10.67%,PYCR1;GPR37L1;PPIA;ATF4
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.39217822970029176,0.8418553040315164,0.75,0.9512395747438734,1.0,3/22,4.82%,SIRT2;ZFP36L1;PIK3C2G
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.4182134024734827,-0.841790018212,0.75,1.0,1.0,7/32,18.12%,BRCA1;MAX;CDC7;SUZ12;UXT;CDKN2B;DAB2IP
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.43011355153410397,-0.8417882220877839,0.684931506849315,1.0,1.0,5/20,20.57%,INTU;ZNF141;RSPO2;IFT122;ZNRF3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.35337638541418875,-0.8416256398265557,0.782608695652174,1.0,1.0,22/151,16.06%,IRF1;PTPRC;AGT;BRCA1;ZFPM1;RFTN1;STAT6;RARA;POLR1C;BTN3A1;IL7;RASGRP1;CARD11;IL6R;STAT3;IFIH1;CYP1B1;C1QTNF4;SULF1;TGFB1;RIPK1;POLR3H
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.5087489716083353,-0.8410709495261877,0.6986301369863014,1.0,1.0,1/10,3.50%,AGT
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.32934960746441055,0.8410649457642547,0.6190476190476191,0.952366369828884,1.0,9/49,9.08%,CD151;RIT2;STON2;RAB5B;SMPD1;CLIP3;SNX12;CBLL1;SNX17
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.37525715805084414,0.8408715452897605,0.6666666666666666,0.9520816379668816,1.0,5/39,10.31%,G0S2;GSTP1;PML;PSME3;TGFBR1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.4445774826279586,0.8408167137068701,0.71875,0.9515367358508624,1.0,3/10,14.46%,ESR1;NR3C1;ABHD2
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.47446831275427415,-0.8405943086373477,0.7058823529411765,1.0,1.0,5/16,19.78%,VEGFA;CACNA1C;CYP1B1;TENM3;IFT122
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.519166901969418,-0.8405447842985739,0.6984126984126984,1.0,1.0,1/6,7.41%,ABCC3
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4112657348997629,0.8402982042596541,0.6956521739130435,0.9517737437234134,1.0,6/27,13.53%,PMEPA1;BMPER;GREM1;TGFBR1;TWSG1;BMP2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.5766958768115995,-0.8393038863719153,0.7258064516129032,1.0,1.0,1/5,14.12%,ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.5009226091648842,-0.8391484887993356,0.7619047619047619,1.0,1.0,2/10,8.73%,VEGFA;GJA1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.3660442336449336,-0.839005493101283,0.8333333333333334,1.0,1.0,19/119,13.79%,CD44;MMP19;TNC;LAMA2;COL10A1;MMP21;ADAMTS13;ITGA2;COL5A1;ADAMTS16;HRNR;ADAMTS9;ACAN;ECM2;THSD4;SPP1;COL5A3;ITGA8;MMP24
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.5293142866559885,-0.8387026767689276,0.7014925373134329,1.0,1.0,2/6,18.79%,SHMT1;GLDC
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.5110077525309945,-0.8383462524835593,0.7758620689655172,1.0,1.0,1/11,1.17%,CRYM
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.5110077525309945,-0.8383462524835593,0.7758620689655172,1.0,1.0,1/11,1.17%,CRYM
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.5365757098649456,-0.8383054049851487,0.7368421052631579,1.0,1.0,2/10,15.17%,TRIB1;PDGFRB
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.318789954336264,0.838020593751747,0.8,0.9555665484873977,1.0,19/105,9.76%,SYNDIG1;FIBIN;SEMA5B;VCAN;CDO1;MAP2;TMEM178A;FRZB;LDB2;THY1;BRINP1;TCEAL7;PRDX6;RGS7BP;DOK5;EDIL3;WASF3;STOX2;PABPC5
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4095936298449513,0.8378926682290868,0.6129032258064516,0.9552129755106671,1.0,1/17,0.73%,GPX1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.4600638839534307,0.8376331914250126,0.5555555555555556,0.9550523690579912,1.0,3/8,14.98%,MAPK11;PLCB1;RIPK2
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.5159655778053998,0.8376191605347092,0.5714285714285714,0.9544015074431966,1.0,1/6,3.38%,MAP2K6
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3754636653706397,0.8375232214005323,0.8125,0.9539053143206442,1.0,6/21,12.63%,SMPD1;B4GALT6;SPTLC1;SGMS1;ST6GALNAC3;CERS2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.45730170412458604,0.8374061173592706,0.5666666666666667,0.9535058457332418,1.0,7/15,22.63%,NLGN2;LRRTM3;NLGN3;WNT5A;NLGN4X;NLGN1;NLGN4Y
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.44113500541104267,-0.8373773290504279,0.7230769230769231,1.0,1.0,2/15,11.60%,TRPC5;CIT
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.522783564481485,-0.837260389148608,0.7419354838709677,1.0,1.0,1/6,1.00%,HES1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3413508667065181,-0.8368530683607627,0.8163265306122449,1.0,1.0,28/236,14.85%,HEY2;IGF2BP2;IGF2BP3;PHF19;OVOL2;PARP9;PARP14;SPI1;DAPK1;VEGFA;AEBP2;NUDT12;PUS7;SHMT1;APOE;TAF1;ZNF540;NLRP12;LSM5;OLFM1;SUZ12;WWP2;MAP2K1;TSC1;DAPK3;PTRH2;TGFB1;RBL2
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.49770488423147896,-0.8367783734449425,0.7301587301587301,1.0,1.0,3/10,21.90%,NTRK3;BAIAP2;BCAS3
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.3506096239874881,-0.8367372377777023,0.8404255319148937,1.0,1.0,21/150,16.05%,TSPYL2;NUBP1;CDKN2A;AGT;TP53TG5;BRAT1;OSGIN2;GJA1;ESR2;NME6;PAPPA2;CRLF3;TCHP;PTPRJ;FAM107A;TMEM97;TGFB1;NCBP1;ENO1;RPTOR;BCL6
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4359491543371008,-0.8366025640405771,0.7285714285714285,1.0,1.0,3/29,10.55%,SLC38A4;SLC7A6;SLC13A3
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.5261158187649232,-0.8365896931533617,0.75,1.0,1.0,3/5,40.77%,PNPT1;NFKB1;HRAS
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.28842543792642306,0.8361598906966999,0.9090909090909091,0.9550839703788411,1.0,15/112,10.05%,MALT1;PSMD8;PSMB6;PSMB4;IKBKB;UBE2N;ERMAP;THY1;BCAR1;PSME3;PDE4B;PSMD10;TNFRSF21;RC3H1;EIF2B1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.42477346445168285,-0.8360604580607724,0.775,1.0,1.0,8/30,22.95%,MYO1H;HAP1;SYT4;MYO1F;CCDC186;KIF1A;MYO1C;RAB1A
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.39043145379105515,-0.8360513468141424,0.8478260869565217,1.0,1.0,15/92,14.69%,AHR;NR4A3;BRCA1;P2RY12;RYR3;GABRG2;HCN3;KCNQ1;TAF1;SPP1;ADCY1;CYP1B1;ADCY5;HCN1;TGFB1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.48308762131846095,-0.8359422113063184,0.676923076923077,1.0,1.0,4/10,29.21%,FOXP1;MED1;DMTN;APP
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.393928419438113,-0.83592913096046,0.7307692307692307,1.0,1.0,5/49,10.63%,CD44;DAPK1;VEGFA;EPHA7;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.44817682584805196,0.8356779757900148,0.7142857142857143,0.9553364055966491,1.0,1/14,0.22%,GPR17
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3158852106404295,0.835634537510088,0.8333333333333334,0.954754679467721,1.0,8/69,10.90%,UGDH;LRRC8D;ARC;ALAD;CHMP2A;BOK;ZBTB1;JMJD6
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.3818200159784082,-0.8355392101938579,0.7411764705882353,1.0,1.0,11/56,25.01%,RAB11A;GOLGA8B;HAUS5;CSNK1D;NEK6;GOLGA8M;ABRAXAS1;NCOR1;TUBGCP3;FLNA;MAPRE3
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.5338243648648178,-0.8354130576143595,0.7101449275362319,1.0,1.0,6/8,27.10%,PARP9;DTX3L;HMBOX1;DDX11;MED25;KDM4D
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.44634830629424493,0.8349044922809806,0.625,0.9556007963745935,1.0,2/10,17.95%,EDEM1;SAR1B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.4023414849497696,-0.8346858281587682,0.7777777777777778,1.0,1.0,2/36,11.62%,AKAP5;SORBS1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.3949597703090851,-0.8345037883201332,0.7631578947368421,1.0,1.0,6/42,17.07%,KCNMB4;CAV3;KCNN3;KCNQ1;WWP2;NEDD4L
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.4711597854549064,0.8344806860868593,0.6363636363636364,0.9557853586054047,1.0,1/6,3.97%,CHRNA7
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.5262934657664956,-0.8337264020848343,0.704225352112676,1.0,1.0,1/8,6.80%,GRAMD1C
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.4117965598066593,-0.8336633366920065,0.759493670886076,1.0,1.0,7/36,18.77%,RPA3;XRCC3;RIF1;WRN;TERF2IP;ATM;ZBTB48
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.444250020864623,-0.8335910852639932,0.704225352112676,1.0,1.0,2/19,5.73%,SLC6A6;MGST1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.5445744754561305,-0.8333885308647242,0.6666666666666666,1.0,1.0,4/5,44.81%,VPS13C;VPS13D;SORL1;GOLPH3
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.44119194116566907,-0.8330876219312108,0.64,1.0,1.0,2/20,10.24%,SLC6A9;SLC1A4
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.41362067665087265,-0.8329420907956842,0.72,1.0,1.0,3/28,10.18%,HEY2;DVL2;TCF7
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.4231118148597459,-0.8328059234548723,0.7101449275362319,1.0,1.0,8/32,19.35%,PLCH1;ITPK1;ITPKC;INPP4B;INPP5A;NUDT11;INPP4A;IMPA1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4066913192946037,-0.8327754890040048,0.7468354430379747,1.0,1.0,6/34,11.42%,SPI1;VEGFA;RARA;CDK4;THOC5;SRP54
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5072254595625243,-0.8327075316728231,0.6984126984126984,1.0,1.0,2/8,25.04%,HTR2B;DGKD
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4019628497541491,0.8326029875866131,0.6538461538461539,0.9585520246004253,1.0,3/13,26.07%,CHP1;PRNP;DYRK2
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.35629091610528657,-0.8322874959655387,0.7717391304347826,1.0,1.0,17/135,16.01%,PROCR;FOS;TPD52L1;TSPYL2;CDKN2A;DRAM1;GADD45A;DDB2;WWP1;POM121;STOM;PITPNC1;PLK2;TGFB1;PVT1;BAIAP2;CDKN2B
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.5054079205157521,0.8322841145593604,0.627906976744186,0.9586482853746903,1.0,3/5,13.33%,GSTP1;PPIA;QARS1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.40650884994768416,0.8319523906441465,0.6341463414634146,0.9587348627728467,1.0,3/11,18.96%,MDFI;YWHAB;LATS1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.4210359545929458,0.8317713235913421,0.64,0.9584299929565406,1.0,1/12,1.64%,FGF12
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.32498403462633574,-0.8307856055680205,0.9081632653061225,1.0,1.0,55/383,18.12%,HEY2;IGF2BP2;AHR;IGF2BP3;HES1;SOX9;TSPYL2;IRF1;CDKN2A;BRCA1;MAEL;SPI1;DAPK1;NKX6-2;ELK3;RARA;ARID5A;PUS7;NR1D1;RUNX2;SHMT1;FOXO1;WWP1;LOXL3;ZNF224;ZNF540;ATP8B1;PBXIP1;ZNF568;RBM15;GCLC;L3MBTL3;WWP2;L3MBTL4;TSC1;BHLHE40;HDAC4;PDCD4;PER1;DAPK3;TGFB1;HDAC6;ENO1;CTBP1;CBY1;CRYAB;BCL6;IKZF4;PEX14;CIITA;FOXP2;ZFPM2;SAMD4A;RBM4;DAB2IP
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.4526758095469584,0.8306512811107696,0.5925925925925926,0.9599473085216462,1.0,3/7,16.71%,DPYSL4;ALDH6A1;DPYSL5
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.36427983086678273,-0.8303108891933962,0.788235294117647,1.0,1.0,8/95,9.27%,NLRC5;EMP2;SRPX2;CDKN2A;POM121C;STAT2;ATG14;POM121
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.365630778829967,-0.8297306097594043,0.75,1.0,1.0,5/87,10.83%,RASGRF1;DOCK8;ZC3H15;BCAR3;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4368725203521426,-0.8297160644893307,0.7464788732394366,1.0,1.0,8/24,24.87%,CDKN2A;B2M;IFIH1;ARG2;CGAS;RSAD2;SELENON;MAVS
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4145616990601082,-0.8293730844952139,0.7804878048780488,1.0,1.0,8/27,23.28%,AZIN2;MSH6;XRCC4;WRN;PSEN1;STX4;BCAS3;B3GAT3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.45961033189855416,0.8292538074270781,0.6764705882352942,0.9620725608304438,1.0,5/12,29.48%,SMARCB1;ARID2;SET;ARID1A;HMGA1
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.5165565591097585,-0.828717514644981,0.75,1.0,1.0,2/8,24.76%,RAB20;SYT7
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.38051736152368276,0.8284713219551467,0.5833333333333334,0.9628614043216014,1.0,3/19,8.34%,ESR1;LOC400499;RUVBL2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.5236772458664507,-0.8283714116299901,0.7230769230769231,1.0,1.0,2/8,18.64%,PARG;UGP2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.500139810900498,-0.8282070897137833,0.7272727272727273,1.0,1.0,6/10,23.11%,TMEM79;RILPL1;WNT7A;SIPA1L3;ACTA2;WNT5B
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.5422953390749289,-0.8278691306870254,0.7735849056603774,1.0,1.0,1/5,3.62%,PAH
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.45175677669999925,0.8278660132841267,0.6451612903225806,0.9632684294352142,1.0,5/15,12.86%,ERN1;CPSF1;CPSF4;TSEN34;RTRAF
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.42632824545120945,-0.8276609161992425,0.704225352112676,1.0,1.0,7/24,19.04%,OTUD7B;NR1D1;NLRP12;PER1;RIPK1;DAB2IP;STAT1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.44781053940091253,0.8275796497204015,0.6923076923076923,0.9629805252348789,1.0,3/8,28.11%,PICK1;AGRN;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.387806492310856,0.8271072726711622,0.6666666666666666,0.963386912500822,1.0,3/18,10.10%,CGNL1;SPRY1;FBP1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.34584961121326024,-0.8270645788918329,0.8842105263157894,1.0,1.0,20/231,10.48%,RFC4;PMS2;POLQ;PARP9;BRCA1;GADD45A;DDB2;FANCC;FBXO6;RFC2;MSH6;FANCI;ZRANB3;MMS19;EME2;BACH1;FANCB;RPA3;DTX3L;XRCC3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.4196674561998889,-0.82704356179446,0.75,1.0,1.0,9/28,21.82%,EFNA5;PTPRR;EPHA7;TGFB1;MDGA1;TENM3;SPINT2;RNASE10;CEACAM1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.4698446184033187,-0.826910194494962,0.7352941176470589,1.0,1.0,6/14,26.20%,RFTN1;IFIH1;IFIT1;CGAS;MAVS;FLOT1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.34789273338579896,-0.8268087768127717,0.8478260869565217,1.0,1.0,31/137,20.22%,G6PC2;PTPRC;PTPRB;PLCH1;ITPK1;ACYP1;ITPKC;GPI;ALK;PFKP;EPHA7;PAK1;PAK2;EPHX2;STAT3;DUSP8;PPA1;TGFB1;INPP4B;PNKP;INPP5A;NUDT11;PIP4P1;HTR2B;PIK3CB;INPP4A;IMPA1;TPTE2;AGK;HK1;PFKFB3
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.3168329542288348,0.8266508612499041,0.8235294117647058,0.9636217633543972,1.0,11/52,12.89%,KDSR;SGPP1;SMPD1;B4GALT6;SPTLC1;ELOVL4;SGMS1;VAPB;ACER2;CERS2;ACER3
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.48019714474464903,0.8265853657365014,0.725,0.9631063881650626,1.0,3/9,12.64%,SOX8;ZNF516;PGRMC2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.3277715133862676,0.8265812117499386,0.8421052631578947,0.9624494260994656,1.0,21/57,18.75%,OSTC;UBE2J1;ALG2;ALG10;ALG1;DDOST;ALG8;MOGS;DPM2;FUT8;UGGT1;DPM3;MPDU1;ALG3;MAGT1;ALG9;ALG13;GAL3ST1;STT3A;OST4;B4GALT7
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.4163694215622728,-0.8260080962628122,0.7419354838709677,1.0,1.0,4/21,22.09%,GUK1;GLRX;CTPS1;RRM1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.45146205942877443,-0.8256282821553224,0.7027027027027027,1.0,1.0,7/20,18.35%,LIMK1;PFN2;VIL1;TSC1;SHANK3;RDX;SYNPO2
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4890664211942603,-0.8254617791379455,0.7377049180327869,1.0,1.0,4/11,16.73%,PAH;SLC39A11;SLC9B2;C3P1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.4599373606756423,-0.8252984176386865,0.765625,1.0,1.0,4/15,17.41%,ROBO2;LRP2;NRP2;ZFPM2
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.42432086905274113,-0.825198494304536,0.8048780487804879,1.0,1.0,5/37,14.40%,PARP9;ATG14;EIF2B4;TSC1;PER1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.3897072881343989,-0.8251098716356663,0.75,1.0,1.0,3/43,7.52%,B3GNT5;ELOVL2;DEGS2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.3650197235500132,-0.8249005282965312,0.8,1.0,1.0,9/69,15.72%,AKAP5;CEMIP;NMT1;YWHAH;PDZK1;SORBS1;AKT2;ITGB1BP1;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.4587390739389093,-0.8247856822568629,0.7384615384615385,1.0,1.0,2/11,8.93%,MYRF;RIMS1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.33157347279343075,0.8247730372368268,0.7647058823529411,0.9650543188413551,1.0,18/90,13.77%,HDAC11;ADCY6;ENPP5;GPC1;NR2F6;MYO1D;SMPD1;BCAR1;PTGFRN;PTPRF;CAMSAP3;GNA11;HID1;SEC23B;RNF128;LAMA5;PPP1R26;TMEM117
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.47714566585969254,-0.8247179970137773,0.835820895522388,1.0,1.0,5/15,17.64%,YWHAH;CAV3;SNTA1;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.506058467223902,0.8245727040280348,0.696969696969697,0.964766374815268,1.0,4/6,27.44%,NBDY;CNOT1;CNOT6L;CNOT6
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.405845401222205,-0.8245574392808,0.6842105263157895,1.0,1.0,7/25,27.27%,ADGRV1;TGFB1;ANO6;MEF2C;ISG15;TGFB3;NELL1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.405845401222205,-0.8245574392808,0.6842105263157895,1.0,1.0,7/25,27.27%,ADGRV1;TGFB1;ANO6;MEF2C;ISG15;TGFB3;NELL1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.29101073662794863,0.824288588288303,0.7857142857142857,0.964706021848145,1.0,8/58,10.31%,ACTG1;CGNL1;RHOC;S100A10;RAPGEF3;TMEFF2;PPM1E;TGFBR1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.3593115461611639,-0.8240452824491142,0.8522727272727273,1.0,1.0,21/141,16.90%,TSPYL2;OVOL2;LFNG;HHIP;INTU;RGS4;CAV3;UBASH3B;LIFR;GRK4;PLSCR1;TULP3;NLRP12;ZIC1;GNG7;ITGB1BP1;SULF1;TGFB1;RGS5;IRAK2;CASTOR2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.565075893213761,-0.8239012398669546,0.7741935483870968,1.0,1.0,2/5,31.88%,MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3597093277132644,0.8238502498690298,0.7272727272727273,0.964976857519266,1.0,6/14,27.61%,PARP1;ERCC4;SLX4;POT1;TERF2;TERF1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.5455926356223317,-0.8232186438355876,0.7692307692307693,1.0,1.0,2/7,22.80%,PGM5;ENG
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.540451510775668,-0.822799380281023,0.7796610169491526,1.0,1.0,1/7,7.25%,MSH6
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.40834844900310413,0.8227931504821188,0.6190476190476191,0.9662777842860848,1.0,6/13,17.55%,CHRNA7;GNA11;GRK2;PLCB1;LY6H;LYPD1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.4678126424061983,-0.8224860107200427,0.782608695652174,1.0,1.0,2/16,10.44%,DDB2;DTX3L
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4166884406619458,-0.8224208919570061,0.717948717948718,1.0,1.0,4/26,8.60%,OVOL2;CEBPD;TMC4;SLC44A3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.49299555647592685,-0.8224015395402806,0.7671232876712328,1.0,1.0,5/12,29.30%,RMND1;RPUSD3;TRUB2;RCC1L;FASTKD3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.38324997002712374,-0.8223268765605848,0.7631578947368421,1.0,1.0,9/38,21.17%,DARS2;TARS3;YARS1;PPA1;CARS1;GARS1;NARS1;WARS1;HARS1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.39624863814504807,-0.8221725384541675,0.7777777777777778,1.0,1.0,2/35,11.62%,AKAP5;SORBS1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5329768094405798,-0.8217754744368982,0.7704918032786885,1.0,1.0,1/7,7.25%,MSH6
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.40523196323825494,0.8212864039541832,0.7096774193548387,0.9683610721221181,1.0,2/15,2.39%,CHRNA4;SYT9
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.32310452856939165,-0.8211505773833976,0.97,1.0,1.0,91/576,19.04%,HEY2;AHR;PLAG1;HES1;NR4A3;NLRC5;CAMK1;SOX9;FGF1;FOS;IRF1;MAFF;CDK7;BRCA1;ZFPM1;SPI1;KLF6;ELK3;MAX;VEGFA;SRF;STAT6;RARA;BCL9;SREBF1;NCOA1;ETV4;NR1D1;RUNX2;ATAD2;THRAP3;AHI1;PLSCR1;SS18L2;LMO2;DVL2;FOXO1;MLIP;ARNT2;BTBD18;JUNB;SSBP4;KLF15;MEF2D;CREBRF;MEIS2;CRLF3;ARRB1;STAT3;GLIS3;NPAS2;USF1;ITGB1BP1;HDAC4;PAXBP1;PER1;ST18;TGFB1;LHX4;SMARCA1;RFXAP;STAT5B;CDKN2B;RIPK1;BRD4;GABPB1;DDRGK1;MAP2K5;RFX4;TAF6L;SLC30A9;MAML3;ZFHX3;CIITA;PTPRN;WNT7A;ZFPM2;CEBPZ;CDC5L;IRF2;ZNF395;ATM;DAB2IP;ASXL2;EPAS1;NFIC;PRKD2;CSRNP2;RORB;KMT2A;STAT1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.49509549722902146,0.8210530175117916,0.6190476190476191,0.9682040334617902,1.0,2/5,12.85%,ZFP36L1;CTNNBIP1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3902450706993843,-0.8210450729665733,0.7142857142857143,1.0,1.0,7/42,19.08%,SOX9;AGT;NTRK3;PDGFRB;IGF1R;ROR1;PIK3CB
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.4239768057765659,0.8209890061271702,0.6666666666666666,0.9676603927937586,1.0,1/19,0.19%,SYNDIG1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.4615459724001408,0.8208175576428753,0.6842105263157895,0.9672966235078125,1.0,1/9,0.35%,UGDH
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.38979731686208174,0.8205133506544968,0.6764705882352942,0.9670652513597292,1.0,2/13,4.81%,FNBP1L;MYO1D
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.4173889165589783,-0.8204019560202636,0.7294117647058823,1.0,1.0,5/24,24.39%,LIMK1;DTX3L;BAG5;MEN1;IRS2
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.31771696413491946,0.8202269682104633,0.8571428571428571,0.9668906846203716,1.0,4/57,5.25%,PANX1;CHRNA4;CHRNA7;CALCRL
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.47075075396671323,0.8202195656335919,0.71875,0.9662459050462476,1.0,1/8,3.76%,PDGFRA
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5329817513640009,-0.8199790365215225,0.7205882352941176,1.0,1.0,2/7,17.86%,RIF1;TERF2IP
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.4651065796584667,0.8198467359556364,0.6842105263157895,0.9664200252711951,1.0,4/11,3.02%,SOX11;SOX8;KLHL12;PEF1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4487640861208311,-0.8187951451604444,0.7763157894736842,1.0,1.0,8/20,28.69%,THRAP3;CELF4;NCBP1;CELF3;DHX36;RBM3;NCBP2;SNW1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.36747943057243704,0.8186877700409139,0.7241379310344828,0.9679751613388073,1.0,6/22,14.46%,CATSPERD;WBP2;YAP1;NR3C1;CATSPERB;ABHD2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.3622027106604075,0.8183283542647245,0.5909090909090909,0.9681666586409916,1.0,6/35,8.00%,PLCL2;PDGFRA;PIK3C2G;PLCL1;NGF;PLCB4
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.4851891098985011,0.8182943447738446,0.6956521739130435,0.967597827067406,1.0,2/5,10.03%,DCX;ARL3
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.4458560566851221,0.8182612759289143,0.6060606060606061,0.9670110081135219,1.0,1/12,1.28%,MALT1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.3017778890404386,0.8179455237038931,0.8461538461538461,0.9668747851118211,1.0,13/122,7.83%,SOX4;GID8;PSMD8;TMEM9;GSKIP;PSMB6;LGR5;PSMB4;SEMA5A;PPM1A;BAMBI;PSME3;PSMD10
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.46654066016873097,0.8173149356487113,0.6428571428571429,0.9674317281214556,1.0,4/10,8.57%,SEPHS2;SRR;PSPH;PSAT1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.4292788989210924,-0.8171265340137019,0.7468354430379747,1.0,1.0,5/24,21.21%,RFC1;GAR1;TERF2IP;ZBTB48;TELO2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.43910017072221896,-0.8169829259967722,0.7333333333333333,1.0,1.0,2/24,7.81%,LAS1L;WDR12
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5608882685279156,-0.8169540258945559,0.7931034482758621,1.0,1.0,3/5,34.85%,RNF20;CDK9;CTR9
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.520857718965279,-0.8169288400807373,0.7391304347826086,1.0,1.0,3/8,26.93%,KLF15;PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5387638145790496,-0.8168154137744185,0.6938775510204082,1.0,1.0,2/6,14.88%,SEC14L1;UFD1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.36783865025084833,-0.8167886335468658,0.8021978021978022,1.0,1.0,14/100,17.78%,TUBA4A;TPD52L1;CDK7;CEP135;CCDC57;BORA;DNM2;HAUS5;LCMT1;CSNK1D;MASTL;CDKN2B;DCTN1;CEP72
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.28572402019153814,0.8164391444702108,1.0,0.9681750880861955,1.0,13/87,12.36%,NUP42;U2AF1;RBM15B;CPSF1;POLDIP3;EIF4A3;RBM8A;MAGOH;AGFG1;NXF1;CPSF4;SRSF3;EIF4E
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.3666792110263465,0.8162797841230923,0.8181818181818182,0.9678980765693994,1.0,6/32,8.94%,CD151;PPT1;VPS28;SMPD1;CLIP3;CBLL1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4091394374127063,-0.816261946864358,0.7671232876712328,1.0,1.0,4/38,4.24%,STK17A;AGT;BRCA1;GADD45A
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4346079622899143,0.8161012020629651,0.6744186046511628,0.967490596898114,1.0,1/8,6.09%,PLA2R1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.3634393487852676,-0.816004770854036,0.8536585365853658,1.0,1.0,20/85,22.75%,HTR2C;TRPC5;CALB1;CALCB;CAV3;TPCN2;SLC24A2;ATP2B3;RYR2;SLC8B1;CAMK2D;HTR2B;C19ORF12;ATP13A5;SLC24A5;PSEN1;ATP1B1;ATP13A4;ATP2B2;SLC24A4
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.401071496079378,0.8159448626305296,0.65625,0.9671490408519458,1.0,3/16,6.07%,CGNL1;NLGN2;NECTIN1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.5241186030673443,0.8158050853261646,0.6216216216216216,0.9666492788010683,1.0,1/7,1.24%,CFL1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3339708424120797,-0.8157930194311469,0.9157894736842105,1.0,1.0,38/277,16.67%,CD44;ANGPTL4;CARD14;ALOX12;SOX9;APIP;CRLF1;BCL2L2;VEGFA;RNF213;TMEM14A;LRP2;CD27;AHI1;FANK1;APOE;FOXO1;IL7;RNF157;RASA1;HMGN5;TYRO3;PLK2;PAK2;GCLC;MAG;BDNF;AKT2;PTRH2;PDPN;IGF1R;RIPK1;CRYAB;IFIT3;YME1L1;DDRGK1;MAP2K5;BNIP3L
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.4564844014954524,-0.8157473471751496,0.7625,1.0,1.0,2/16,5.46%,VSIR;RARA
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4564844014954524,-0.8157473471751496,0.7625,1.0,1.0,2/16,5.46%,VSIR;RARA
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.5522077699491539,-0.8157169387833267,0.7377049180327869,1.0,1.0,1/5,1.99%,VSIR
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.5434177163356511,-0.8157082619295373,0.7580645161290323,1.0,1.0,1/5,29.15%,LTA4H
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.3290572456063536,0.8156904538405728,0.7857142857142857,0.9663460529537268,1.0,11/76,9.31%,TSPO;IDH1;CNBP;ECH1;PRDX1;PRDX5;ACOT8;CAT;PEX11A;NUDT19;ABCD2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.35336948178514294,-0.8156739775191527,0.8481012658227848,1.0,1.0,10/77,9.40%,CDKN2A;PTPRC;BRCA1;IGSF6;SPI1;IFNGR2;STAT4;GCNT1;IL7;B2M
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.358916744281581,-0.8156701961150479,0.8604651162790697,1.0,1.0,16/87,20.86%,CAMK1;ZFPM1;B2M;TAF1;DTX3L;LRPAP1;TIAM1;ITGB1BP1;HDAC4;IFIT1;CTSZ;PEX14;AKTIP;PRMT8;PSEN1;DVL1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.37519157786351753,-0.8152264716529988,0.8068181818181818,1.0,1.0,18/97,18.12%,APIP;PTPRC;CAV3;BCAR3;EPHA7;RASGRP1;TRAF7;NBR1;PAK1;VRK2;PAK2;NTRK3;PTPRJ;MAP2K1;IGF1R;ROR1;TNIK;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.36390845764449425,-0.8149657242184435,0.8152173913043478,1.0,1.0,18/91,18.12%,STMN2;CAMK1;ROBO2;CAMK2B;APOE;SS18L2;DVL2;PLXNA4;AVIL;TIAM1;CAMK1D;NTRK3;BDNF;PTK7;DLG4;ROR1;TENM3;DAB2IP
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.5241857862077723,-0.814955474389843,0.7777777777777778,1.0,1.0,1/5,11.06%,DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.5241857862077723,-0.814955474389843,0.7777777777777778,1.0,1.0,1/5,11.06%,DPY19L1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.42744464484925093,-0.8148631246173357,0.7361111111111112,1.0,1.0,4/19,21.73%,PARN;CNOT11;SAMD4A;SAMD4B
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.3474986653374429,0.8146816750559446,0.76,0.9677023169423851,1.0,4/25,6.29%,CRB2;SPOCK3;UBXN1;CSTB
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.5097325947535918,-0.81467060327135,0.7794117647058824,1.0,1.0,2/10,0.98%,IGF2BP2;IGF2BP3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.3741001478133809,-0.8138754467728687,0.8607594936708861,1.0,1.0,12/65,17.35%,AGT;GADD45A;VEGFA;AHI1;APOE;ARRB1;ACACB;TGFB1;PDGFRB;ARRB2;RIPK1;WNT7A
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.3932978821683372,-0.8134273082905417,0.7066666666666667,1.0,1.0,4/34,12.47%,SLC39A14;ATP6V1E2;CP;DNM2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.47820600406364444,-0.8131818116208678,0.7647058823529411,1.0,1.0,2/9,14.12%,EFNA5;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.47820600406364444,-0.8131818116208678,0.7647058823529411,1.0,1.0,2/9,14.12%,EFNA5;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.34409201586563226,0.8130075485291849,0.6896551724137931,0.9701558692175298,1.0,9/31,16.40%,GPNMB;RAP2A;CALM3;RAP2C;PDGFD;CHP1;PDGFC;CALM1;ERRFI1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.39818932095769505,0.812986973349481,0.7241379310344828,0.969553042243707,1.0,2/17,9.69%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.396858586181271,-0.8129288801599392,0.7721518987341772,1.0,1.0,11/54,20.05%,CDKN2A;AGT;GADD45A;CAV3;APOE;PKIG;PTPRJ;DAB2IP;PRKAR1B;PIK3CB;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.31386687594856355,0.8128622360513638,0.8461538461538461,0.969090551567494,1.0,4/58,3.97%,UBB;GPNMB;SIGMAR1;CHRNA7
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3151512787059733,0.812464059001472,0.9285714285714286,0.96903769313742,1.0,10/94,7.83%,UBB;PSMD8;PSMB6;PSMB4;NPM1;MCM4;PARP1;PSME3;GTF2H2;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.4829521825158877,-0.8124181221921373,0.7230769230769231,1.0,1.0,1/15,1.05%,EFNA1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.35246109228546363,-0.8123623883973414,0.8571428571428571,1.0,1.0,18/120,13.79%,CD44;MMP19;TNC;LAMA2;COL10A1;MMP21;ADAMTS13;ITGA2;COL5A1;ADAMTS16;ADAMTS9;ACAN;ECM2;THSD4;SPP1;COL5A3;ITGA8;MMP24
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.3175081784046537,0.8122739105024573,0.8461538461538461,0.9687340871569775,1.0,10/49,12.79%,BAD;RAN;SULT1C4;ACOT8;THEM4;ACOT9;ACLY;ACOT13;ACSM5;OXSM
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.5279694787944577,-0.8120399790282475,0.7619047619047619,1.0,1.0,2/5,23.11%,WNT7A;WNT5B
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.3748103339099404,-0.8112127499363718,0.8048780487804879,1.0,1.0,9/58,10.69%,MAGOHB;SLBP;RFTN1;SIDT2;POM121C;SRSF5;POM121;THOC5;CASC3
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.5001719997552306,-0.8108442376578904,0.7592592592592593,1.0,1.0,6/8,42.60%,FNDC5;METRNL;SOX13;VSTM2A;BMP7;HNRNPU
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.5537285494979332,-0.8105184891024346,0.8088235294117647,1.0,1.0,2/5,20.09%,STAT5A;RELN
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.46480703605745166,-0.8104850110371417,0.6865671641791045,1.0,1.0,5/9,33.27%,KLF15;PODXL;BASP1;JAG1;IQGAP1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.4254963888050968,-0.8101118606764195,0.7714285714285715,1.0,1.0,1/17,0.62%,FABP3
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4351621567827286,0.8098731636012725,0.7073170731707317,0.9724691483530044,1.0,5/12,10.64%,CHRNA7;LDLR;PFDN1;VBP1;PFDN2
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.3056887812374145,0.8098083746107091,0.6666666666666666,0.9719781149378987,1.0,11/71,10.18%,PODN;SPOCK3;RAP2A;THY1;DACH1;SRGAP2B;RAP2C;SRGAP1;TMEFF2;DUSP3;SRGAP2C
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.4254689830030413,-0.8096967609321313,0.6944444444444444,1.0,1.0,6/22,27.76%,PLSCR1;IFI35;SASH1;PRKCA;POLR3D;SCIMP
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.46790726446105463,0.8096735433790633,0.7428571428571429,0.9715989880265352,1.0,1/9,1.95%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.5049875835314641,-0.809625065734483,0.7424242424242424,1.0,1.0,1/7,15.00%,HDAC6
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.3976602759049619,-0.8094111474923438,0.803030303030303,1.0,1.0,3/35,8.98%,SLC39A14;NUBP1;CP
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.4952183937227017,0.8094081013309053,0.7272727272727273,0.971424192016743,1.0,2/7,9.33%,EEF1A1;CTSA
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.43633359402569516,-0.8089674445935379,0.7887323943661971,1.0,1.0,5/25,16.62%,LRP2;EMD;HDAC6;STAT5B;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.35280909706983427,-0.8085486268754436,0.7764705882352941,1.0,1.0,20/77,20.59%,CAMK1;VEGFA;CALY;ATP10A;CAMK2B;APOE;BCL2L11;TGFB1;IGF1R;SHANK3;DCTN1;NEDD4L;PLEKHM2;SLF1;FRMPD4;DAB2IP;GPC3;TIRAP;RELN;WARS1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.40022423856838507,-0.8085240350222981,0.7631578947368421,1.0,1.0,6/40,17.13%,AGT;OSMR;NLRP12;PDCD4;RIPK1;IFI35
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.3959679061272907,0.8084703417017177,0.75,0.9724439930418636,1.0,2/21,3.76%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.3845642291345185,-0.8084309955149755,0.7948717948717948,1.0,1.0,6/47,16.02%,FOS;TPM1;CYP1B1;PDK2;HDAC6;RIPK1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.33044644338961415,-0.808170565066351,0.8631578947368421,1.0,1.0,29/217,16.67%,CD44;ANGPTL4;CARD14;SOX9;APIP;BCL2L2;VEGFA;TMEM14A;LRP2;CD27;AHI1;FANK1;FOXO1;IL7;RNF157;RASA1;HMGN5;PLK2;PAK2;GCLC;AKT2;PDPN;IGF1R;RIPK1;CRYAB;IFIT3;YME1L1;DDRGK1;BNIP3L
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.39630220126893145,0.8078621247208295,0.7419354838709677,0.9731478528026665,1.0,3/11,10.79%,ZFP36L1;ZC3H3;CDC73
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.39470732245685436,0.8064530175963782,0.75,0.9751175232199986,1.0,2/18,4.31%,CUL7;CAPRIN1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.40462172917808964,0.8062788968043219,0.6363636363636364,0.9747745306093233,1.0,2/12,16.11%,MT3;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.379871624835704,-0.8062650964274973,0.8375,1.0,1.0,9/51,17.10%,CAMK1;ZFPM1;B2M;LRPAP1;ITGB1BP1;IFIT1;CTSZ;ARRB2;PEX14
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.28999381244995304,0.8061157836695044,0.9444444444444444,0.974422759453599,1.0,13/82,12.36%,NUP42;U2AF1;RBM15B;CPSF1;POLDIP3;EIF4A3;RBM8A;MAGOH;AGFG1;NXF1;CPSF4;SRSF3;EIF4E
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.3475620957180497,0.8060667846997043,0.6842105263157895,0.9739145805229589,1.0,4/33,6.64%,CFL1;MSN;AIP;PPIA
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.45888810615677256,-0.8056840310339669,0.6865671641791045,1.0,1.0,5/11,23.91%,TGFB1;PIEZO1;NRG1;MEF2C;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.43540433233345005,0.8056442573208619,0.6666666666666666,0.9740433797543643,1.0,1/12,9.91%,CHP1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.37633102949004743,-0.8056122540319269,0.7142857142857143,1.0,1.0,2/49,3.60%,PON1;PIGH
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.4391607053766042,-0.8056052931673385,0.726027397260274,1.0,1.0,8/16,32.25%,MEIOC;CDYL;NME5;SYCP3;YTHDC2;NECTIN2;CEP57;TTC21A
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.3459434924083904,0.8054976927538704,0.6842105263157895,0.973628282651566,1.0,4/35,6.64%,CFL1;MSN;AIP;PPIA
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.49378261409035273,-0.8053037314989951,0.7575757575757576,1.0,1.0,1/9,15.38%,RPTOR
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.5492410943452338,-0.8052008181181328,0.7936507936507936,1.0,1.0,1/5,11.79%,TRIM41
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.47682781351121434,-0.8050520772177667,0.8026315789473685,1.0,1.0,2/11,15.12%,EME2;SHOC1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.39471191286064766,0.8050332215232276,0.7241379310344828,0.9736834242054127,1.0,3/12,17.78%,EFNA2;OSTM1;GLO1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.5047561590536632,0.8046754481657381,0.6410256410256411,0.9736096439061679,1.0,1/5,9.81%,ATP5F1D
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.4273669386305594,-0.8040657481871966,0.7215189873417721,1.0,1.0,4/21,21.21%,RFC1;GAR1;TERF2IP;TELO2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.4669458376753802,0.8037772728127297,0.75,0.9743821223202846,1.0,3/6,19.08%,THY1;CERS2;PTPRS
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.3137429101094255,0.8035703717399019,0.8823529411764706,0.9740873859634835,1.0,6/58,7.83%,MALT1;PSMD8;PSMB6;PSMB4;PSME3;PSMD10
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.3480142132389738,0.8035664751471034,0.6842105263157895,0.9734439993148947,1.0,13/61,13.55%,UBB;TGFBR2;ITGB5;BAMBI;SMAD9;SMAD3;DUSP15;TGFBR1;UBC;JUN;TWSG1;FNTA;ZYX
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.29153402634444986,0.8034576821914007,0.8888888888888888,0.9729666874560564,1.0,13/117,10.69%,UBB;ACTB;SLITRK2;FLRT3;BTBD3;ARC;MAP2;S100B;NGF;EPB41L3;NTNG2;SDC2;EPHB3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5620788846022204,-0.803434212543589,0.7647058823529411,1.0,1.0,2/6,33.54%,CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5620788846022204,-0.803434212543589,0.7647058823529411,1.0,1.0,2/6,33.54%,CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.28282399912656986,0.8033332004078535,1.0,0.9725358709758749,1.0,20/189,8.60%,SOX4;CCDC88C;GID8;PSMD8;TMEM9;KLHL12;GSKIP;PSMB6;LGR5;PSMB4;SEMA5A;PRICKLE1;FRZB;PPM1A;BAMBI;PSME3;PSMD10;TLE4;RUVBL2;GREM1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.48496972216030815,-0.8033171946675247,0.7258064516129032,1.0,1.0,5/8,39.17%,RNF20;CDK9;CTR9;NELFE;ZC3H14
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.5504970221339135,-0.8032281215402002,0.7894736842105263,1.0,1.0,2/5,17.84%,LOXL3;SUMF1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.39414831985191284,-0.8031726431957095,0.7571428571428571,1.0,1.0,3/26,9.14%,KCNMB4;KCNN3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.49476037585444166,0.8029266918247661,0.6410256410256411,0.9726098123774009,1.0,1/5,1.20%,ACTB
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.38619815052886275,-0.802835986167066,0.7837837837837838,1.0,1.0,2/37,5.01%,CD44;TMCC2
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.46791296052033826,0.8022464612168853,0.7575757575757576,0.9732608025162843,1.0,3/7,8.57%,SRR;PSPH;PSAT1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.39449510992249304,0.802064595760136,0.7647058823529411,0.9729313484779056,1.0,2/12,7.20%,PPIA;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.3960329836557661,0.8019254964824301,0.8529411764705882,0.972529135962918,1.0,2/11,3.63%,PHB2;NPM1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.4203511419806019,0.8016516544561804,0.7307692307692307,0.9717811183701847,1.0,6/10,28.18%,MGMT;ALKBH3;ALKBH1;MPG;ALKBH2;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.4203511419806019,0.8016516544561804,0.7307692307692307,0.9717811183701847,1.0,6/10,28.18%,MGMT;ALKBH3;ALKBH1;MPG;ALKBH2;ASCC2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.4239981258987246,-0.800798420069297,0.7671232876712328,1.0,1.0,3/21,10.14%,RPS6KB2;GUK1;DOK1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),-0.4767852566613616,-0.8007827641670678,0.6923076923076923,1.0,1.0,4/11,24.39%,AKT2;NNMT;PPARGC1A;IRS2
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.5389842066212421,-0.8007225362628371,0.7678571428571429,1.0,1.0,2/5,24.16%,FOXP1;MED1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.24813527571901933,0.8006150189264005,1.0,0.9729418500001826,1.0,40/266,15.49%,UBB;RNF144A;UBE2J1;UBE2D4;PSMD8;TRAF5;RNF6;PSMB6;PSMB4;KBTBD6;UBE2D1;UBE2N;PSME3;KLHL42;PSMD10;PELI1;KBTBD7;UBE2Q2;AREL1;UBE2G1;TRIM71;RC3H1;UBC;SMURF2;MUL1;FBXO44;CDC26;FBXW5;PSMD12;PSMB2;FBXL7;RNF135;PSMD4;CDC34;FBXL14;SPSB1;UBE2D2;FBXO28;ANAPC11;PRPF19
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3182338868682302,0.8004340228836475,0.8181818181818182,0.9726593110490966,1.0,6/44,8.25%,ADCY6;VIPR2;CALCRL;LYN;PRKAR2B;RXFP1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3725906824480948,-0.8004279210383902,0.8048780487804879,1.0,1.0,13/70,17.64%,TTN;SYT1;KCNMB4;RYR3;SYT2;AHCYL1;KCNH1;ADGRV1;SYT4;ADCY1;RYR2;ADAM9;CAMK2D
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.40906745086710017,-0.7999795425424975,0.7638888888888888,1.0,1.0,6/24,14.30%,NR4A3;FGF9;GJA1;MEF2D;TPM1;PDCD4
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.5244589515935529,-0.799478909764037,0.7424242424242424,1.0,1.0,3/5,43.75%,BRSK1;NPHP1;VANGL2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.4066766798809706,-0.7987697781886838,0.7922077922077922,1.0,1.0,3/30,15.70%,PIP4K2C;SORBS1;GRB10
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.432360446148249,-0.7987468638379556,0.7808219178082192,1.0,1.0,1/20,0.58%,STMN2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.4638299608133166,0.79869877657279,0.6176470588235294,0.9748848674723388,1.0,2/9,3.58%,GPNMB;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3186234847872305,0.7984714559632619,0.9047619047619048,0.9746561036882396,1.0,6/43,8.25%,ADCY6;VIPR2;CALCRL;LYN;PRKAR2B;RXFP1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.3690324376211902,0.7983469769017509,0.6923076923076923,0.9735805999068647,1.0,9/21,16.84%,ACOT8;THEM4;ACOT9;ACLY;ACOT13;ACSM5;OXSM;DBI;CROT
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.3690324376211902,0.7983469769017509,0.6923076923076923,0.9735805999068647,1.0,9/21,16.84%,ACOT8;THEM4;ACOT9;ACLY;ACOT13;ACSM5;OXSM;DBI;CROT
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.338843298112071,-0.7981255810007988,0.9340659340659341,1.0,1.0,15/100,15.65%,CDH7;CLDN18;CDH12;CDH9;PCDHB5;ROBO2;CDH19;CLDN12;UNC5D;PVR;PCDHB4;MAG;MMP24;CDHR3;CDH8
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.3386564413439883,0.798034047906847,0.9,0.9734349942820235,1.0,7/35,18.26%,NR1H2;SNX12;ARL6IP5;MCTP1;ERBB3;NDFIP2;RUBCN
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5347625073639689,0.797983235037555,0.75,0.9728896542469715,1.0,2/5,14.79%,CALM3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3542423879943236,-0.7979449309957511,0.8522727272727273,1.0,1.0,21/78,20.81%,AGT;C4BPA;SLC6A9;APOE;FOXO1;WWP1;RASGRP1;PLK2;WWP2;TGFB1;FZR1;ATG7;MAP2K5;NEDD4L;WNT7A;OAZ2;DAB2IP;GPC3;STX5;PSEN1;ABCA2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.4189901294786427,-0.797798384558197,0.8266666666666667,1.0,1.0,5/21,15.45%,NEDD9;PLS3;FAM107A;RFLNA;BAIAP2
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.36736958757205407,-0.7977165206435357,0.8536585365853658,1.0,1.0,6/53,17.21%,B3GNT5;FUT2;GCNT1;ALG10B;CHST9;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.5353029705285366,-0.7973869220311061,0.7333333333333333,1.0,1.0,1/5,10.72%,ALG10B
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.49174560548542323,-0.7966536491128634,0.8208955223880597,1.0,1.0,1/10,3.80%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.4533660690494715,-0.7964444355249938,0.7878787878787878,1.0,1.0,3/11,15.84%,BRCA1;AASS;CTBP1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.3664846814638794,-0.796299174526703,0.8372093023255814,1.0,1.0,10/74,14.12%,PTPRC;PTPRB;GADD45A;CAV3;UBASH3B;TRIB1;CAMK2N1;SH3BP5;PAK2;ITGB1BP1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.3774480485544649,-0.7961720577122195,0.7746478873239436,1.0,1.0,5/33,19.82%,SYNJ2;EPHX2;PIP4P1;PLPP4;TPTE2
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.4751715799994182,-0.7958132598703225,0.7727272727272727,1.0,1.0,1/11,4.84%,USP13
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4102336646585057,0.7952659907520332,0.6774193548387096,0.9770319897819699,1.0,5/15,14.46%,CATSPERD;WBP2;YAP1;CATSPERB;ABHD2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.5267257607567208,-0.7952474976682039,0.7936507936507936,1.0,1.0,1/7,19.76%,ANKFY1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.43769438213235895,-0.7952066048504601,0.7777777777777778,1.0,1.0,5/17,21.48%,TOM1L1;PDGFRB;ATM;PRKD2;HMBOX1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.377476295423394,0.7950843835420133,0.71875,0.9768208750895976,1.0,4/18,8.34%,CCT5;CCT3;NHP2;RUVBL2
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.4584665880058932,-0.7950486556462504,0.7580645161290323,1.0,1.0,4/9,10.63%,MAEL;TDRD9;BTBD18;TDRD1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.29713719639530445,0.79465618881518,0.9047619047619048,0.9770726778184341,1.0,4/47,8.52%,BANF1;BTBD17;PPIA;ZC3HAV1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.3990619961664469,-0.7945343033096067,0.8533333333333334,1.0,1.0,6/31,18.12%,BRCA1;MAX;CDC7;SUZ12;UXT;DAB2IP
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4030174115725289,-0.794355186371279,0.7916666666666666,1.0,1.0,6/37,14.39%,FABP3;CAV3;NR1D1;APOE;EPHX2;TMEM97
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4030174115725289,-0.794355186371279,0.7916666666666666,1.0,1.0,6/37,14.39%,FABP3;CAV3;NR1D1;APOE;EPHX2;TMEM97
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.38137920841477824,-0.7941874502145713,0.7875,1.0,1.0,4/43,9.73%,EMP2;NEDD9;DOCK5;ECM2
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.4989198384417045,-0.7939185427629576,0.7941176470588235,1.0,1.0,2/7,16.20%,SULF1;TMEM63C
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.43491143392898,-0.7938268432377337,0.6774193548387096,1.0,1.0,3/12,8.24%,DPAGT1;ALG6;ALG14
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.37044969787042165,0.7936959750381866,0.6538461538461539,0.9781944400680058,1.0,5/16,18.41%,BRK1;RHOG;CDH13;ELMO1;DBNL
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.4680996058950918,-0.7934738594726883,0.7333333333333333,1.0,1.0,2/9,17.07%,CAV3;NEDD4L
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.4017139434252781,0.7929660267568683,0.8333333333333334,0.9782697498047171,1.0,1/10,7.15%,BLOC1S4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.4017139434252781,0.7929660267568683,0.8333333333333334,0.9782697498047171,1.0,1/10,7.15%,BLOC1S4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.40172530732180195,-0.792664776487984,0.7894736842105263,1.0,1.0,5/33,20.78%,TPST1;EPHA4;PDGFRB;RELN;DDR2
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.4990097525933849,-0.7925862633121838,0.7894736842105263,1.0,1.0,1/6,3.80%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3488139899460819,-0.7925828703876613,0.8390804597701149,1.0,1.0,15/85,16.05%,TSPYL2;CDKN2A;TP53TG5;OSGIN2;GJA1;ESR2;NME6;CRLF3;TCHP;PTPRJ;TGFB1;MT1M;ING5;ENO1;BCL6
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.3819071625485942,0.7922716529177714,0.7096774193548387,0.9789723447376089,1.0,3/17,8.66%,GPNMB;IL15;TNFRSF21
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.47108661384696554,0.7921010388012523,0.7058823529411765,0.9785889955367568,1.0,2/5,29.18%,SH3GL2;TMEM108
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.366210018625496,-0.7920832637155824,0.8641975308641975,1.0,1.0,7/48,15.45%,PFN2;CDC42EP3;RASA1;VASP;ABITRAM;VIL1;BAIAP2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.424172981831224,0.7920829471234718,0.7352941176470589,0.9779712073318145,1.0,2/7,7.72%,LYN;PLAUR
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.2756105944562709,0.7920170776600817,1.0,0.977426462872932,1.0,29/186,12.10%,TRMT112;MRPL11;MRPL10;MRPS33;MRPL28;MRPL36;MRPL47;EEF2;RPL8;RPS19;RPL15;EEF1A1;MRPS16;AARS1;RPL29;RPS2;RPS15A;FARSA;MRPS12;MRPS18A;RPSA;TUFM;MRPL18;MRPL52;TMA7;RPL23A;EIF4EBP2;MRPL27;MRPL13
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.3878393126144043,0.7918725094816196,0.7857142857142857,0.9769816929134886,1.0,2/13,10.79%,ZFP36L1;CDC73
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.47380643904768743,0.7916510438051365,0.6363636363636364,0.9766547398819098,1.0,1/8,1.80%,RHOBTB1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.31631231768440643,-0.7915565435826555,0.9494949494949495,1.0,1.0,42/326,15.12%,HEY2;AHR;HES1;SOX9;FOS;IRF1;PARP9;AGT;BRCA1;KLF6;RARA;YWHAH;NCOA1;MAP3K12;TRIM44;NR1D1;RUNX2;MMS19;ATAD2;MYRF;THRAP3;FANK1;APOE;FOXO1;SEC14L2;ESR2;ARNT2;DTX3L;TRIM56;SPP1;HMGN5;CRLF3;DNAJC2;DNM2;STAT3;ZIC1;MAP2K1;NPAS2;HDAC4;TGFB1;ING5;SMARCA1
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.5283326607900065,-0.7911986222262308,0.78125,1.0,1.0,1/5,3.12%,PTPRC
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.27048862898389525,0.7908614325148127,1.0,0.9774097251483835,1.0,25/137,16.11%,TSPO;PHB2;HSD17B10;MFF;AIP;PARP1;PTCD2;IMMP2L;TIMM13;SLC25A33;TIMM22;ATP5F1D;PRDX3;MTX2;MUL1;ESRRA;ATCAY;SLC25A4;TFB2M;FIS1;DNAJC19;GABPA;TIMM23;AIFM2;TIMM50
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.47689964549793296,-0.790558832244921,0.7428571428571429,1.0,1.0,1/8,3.49%,VCL
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.34555300620341184,-0.7895051522062492,0.8588235294117647,1.0,1.0,16/82,17.41%,MX1;TIMP3;SRF;LIFR;PLSCR1;CALCOCO2;OSMR;NLRP12;TRIM56;IL6R;STAT3;HDAC4;RIPK1;IRAK2;CIITA;ADAM9
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.45101579594414154,-0.7893725215600351,0.7183098591549296,1.0,1.0,2/10,20.17%,MAP2K1;DENND10
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.34958463288582126,-0.7892218978002022,0.8589743589743589,1.0,1.0,10/90,10.33%,CD44;PRELP;SOX9;HHIP;COL10A1;GJA1;ACAN;KIAA1217;PLS3;SH3PXD2B
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.43143913184488336,0.788924118660104,0.7586206896551724,0.9802082723593406,1.0,2/10,6.65%,CCT5;CCT3
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.3002344470913284,0.7884635747467754,1.0,0.9803209125373715,1.0,3/45,5.52%,SIRT2;PCBP2;ENPP3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.34233884220330923,-0.7884094920753419,0.8295454545454546,1.0,1.0,13/92,14.82%,VCL;DUSP22;PTPRR;GJA1;PFN2;TRIB1;SRGAP3;TPM1;CYP1B1;PTPRJ;ITGB1BP1;SULF1;EPHA4
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.3697787158392602,0.7880613158606602,0.6774193548387096,0.980181543301312,1.0,4/15,14.53%,NPM1;COLEC12;MUL1;RALB
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.47737775281604944,0.7879407765882299,0.78125,0.9797187388177561,1.0,2/7,4.70%,SOX11;MEOX2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.4838204101124514,0.7879358896712462,0.6904761904761905,0.9790858455756256,1.0,3/6,17.55%,CHRNA7;LY6H;LYPD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.5498708153036984,-0.7877021824669644,0.711864406779661,1.0,1.0,2/5,24.45%,SLC8B1;PLN
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.45590160098964705,0.7875086633646061,0.7027027027027027,0.9784415713945626,1.0,1/7,7.58%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.45590160098964705,0.7875086633646061,0.7027027027027027,0.9784415713945626,1.0,1/7,7.58%,SMPD3
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.3948318931355447,-0.7874021214950624,0.8375,1.0,1.0,7/25,24.32%,DONSON;FBXO6;CDC5L;ATM;DOT1L;RAD9A;HINFP
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.4074415065969092,0.7866040587101834,0.7407407407407407,0.9794784267167705,1.0,5/15,16.11%,NPM1;CHMP2A;NAT10;FBXW5;SIRT1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.33469167847849024,0.7865380718315456,0.8148148148148148,0.9789727644810727,1.0,3/24,15.21%,DCX;CHP1;MAP1S
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.34203332054377245,0.7864348301693495,0.7916666666666666,0.978467753452375,1.0,2/30,5.69%,PRR5L;ZFAND1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4340281681768421,-0.78629833187245,0.8421052631578947,1.0,1.0,1/15,1.85%,SPDYA
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.5092620601239408,-0.7862263873414214,0.711864406779661,1.0,1.0,3/5,34.67%,WRN;IMPACT;POLH
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.40783329189777817,-0.7861178213351835,0.7625,1.0,1.0,1/18,0.35%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5118527056938563,-0.7859910066519588,0.8,1.0,1.0,1/6,17.41%,ADAM9
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.4437582850799697,-0.7858766644584438,0.7692307692307693,1.0,1.0,1/16,0.16%,SLC28A2
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.5095744427171509,-0.7856588916202158,0.7910447761194029,1.0,1.0,1/8,1.52%,RAB17
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.3380449799874397,-0.7856214713927017,0.8928571428571429,1.0,1.0,22/85,22.97%,SOX9;ZFPM1;VEGFA;MTHFD1;SRF;MMP21;CACNA1C;DVL2;SH3PXD2B;MEF2D;TCF25;NTRK3;TGFB1;ZFPM2;GPC3;HTR2B;IFT122;TGFBR3;MICAL2;WDR11;LDB3;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.5218544561038733,-0.7853700283266442,0.7966101694915254,1.0,1.0,2/6,14.69%,RFTN1;TGFB1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.426920594264813,0.785302660373645,0.7575757575757576,0.9796368226503585,1.0,1/9,4.03%,PRMT6
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3139191768178531,0.7852285465190795,0.8571428571428571,0.9791320341064762,1.0,5/61,4.73%,SIRT2;RNF144A;HSPA1A;RNF139;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.47399590155733995,0.7846010093096687,0.7297297297297297,0.9794411907534855,1.0,2/10,13.06%,SMAD3;ITGB8
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.354014512429943,-0.7843423371351269,0.8777777777777778,1.0,1.0,12/85,14.90%,SLC6A6;SLC38A4;SLC22A4;SLC6A15;SLC3A1;LRP2;SLC7A6;SLC1A4;SEC14L1;PDPN;RHCG;SLC25A45
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.2567845005936209,0.7839773241194893,1.0,0.9799196503510059,1.0,40/302,12.10%,MMP2;TMEM208;SPCS2;MRPL11;MRPL10;NCSTN;MRPS33;MRPL28;FDX1;VCAN;MRPL36;RPL8;IGFBP7;RPS19;SEC11C;RPL15;EEF1A1;MRPS16;RPL29;MSRB3;RPS2;UBE2I;HM13;RPS15A;MRPS12;MRPS18A;UBL5;RPSA;UBE2G1;PDIA6;SDC2;RCN1;SEC11A;MRPL18;MRPL52;RPL23A;NUCB1;EIF4EBP2;MRPL27;MRPL13
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5292342009108997,-0.7839632438720234,0.7758620689655172,1.0,1.0,2/5,15.84%,SPI1;CTBP1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.47549969794655067,0.7836365997023399,0.7209302325581395,0.9798976481597912,1.0,2/5,19.15%,MGLL;TMEM100
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.5278128496860726,-0.7832154568266668,0.7692307692307693,1.0,1.0,2/5,21.49%,SRP54;ZFAND2B
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4361559574401141,-0.7831770538812419,0.7258064516129032,1.0,1.0,3/15,9.24%,TESPA1;VSIR;IL7
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.5117402936122537,-0.783026451788421,0.7368421052631579,1.0,1.0,1/6,1.40%,SOX9
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.4529851065959878,-0.7828646591257612,0.7887323943661971,1.0,1.0,4/14,19.04%,IRF1;PLSCR1;OAS1;STAT1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.3027056433337398,0.7828207228730492,0.8695652173913043,0.9804644024103272,1.0,6/39,14.95%,MAP7D3;MID1IP1;CHMP2A;WASF3;GPX4;RNF135
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.3981944784945641,-0.7826493544855584,0.7567567567567568,1.0,1.0,6/27,19.88%,RHCE;DEGS2;NMRAL1;ABCA8;ARG2;AGK
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.4375870330069052,-0.7817383670785238,0.7857142857142857,1.0,1.0,3/14,17.64%,CAV3;NEDD4L;CAMK2D
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.42290343583579804,-0.7814271239482868,0.7792207792207793,1.0,1.0,3/17,13.59%,OVOL2;SLC44A3;VIL1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.34091292362913866,-0.7810566242503857,0.8777777777777778,1.0,1.0,6/121,10.32%,RFC4;NUAK1;BRCA1;RFC2;RPA3;TAF1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.3543202880282148,0.7809581882720521,0.7857142857142857,0.9826082799948701,1.0,4/18,15.25%,DYNLT1;INSC;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.4959678624339464,-0.7804662538628516,0.8059701492537313,1.0,1.0,1/9,5.13%,VEGFA
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.34378755125804844,-0.7804541989262659,0.8913043478260869,1.0,1.0,14/101,17.47%,FHDC1;SPTBN5;GOLGA8B;ATP8B1;ATP8B2;VRK1;TANGO2;GAK;CSNK1D;GOLGA8M;FAM174B;PLEKHM2;BAG5;GOLPH3L
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.3088701772378085,0.7804440042043157,0.8421052631578947,0.9827182281482477,1.0,10/64,10.82%,MMP2;AMOTL2;TCF7L1;GPR161;PTPN14;YAP1;P3H2;MDFI;ZNF462;RAI14
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.4419765303702886,0.780131692563393,0.7037037037037037,0.9825698487445191,1.0,1/10,4.14%,UBE2N
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.46784730216715403,-0.7800322902200112,0.7671232876712328,1.0,1.0,1/8,5.70%,SIDT2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.4729315611235836,-0.7800306624283796,0.8169014084507042,1.0,1.0,2/15,7.81%,LAS1L;WDR12
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3521163475022495,-0.7799597548630658,0.8461538461538461,1.0,1.0,9/51,16.11%,PTPRC;ARHGDIG;PLXNA4;RASA1;CYP1B1;TBCD;ITGB1BP1;TGFB1;KNG1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.5190784941130825,0.7799378375562983,0.851063829787234,0.9822970970579331,1.0,3/5,7.59%,NLGN2;ZDHHC3;ADRA1A
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.46430736778526127,0.7797234056849218,0.7021276595744681,0.9820069109437528,1.0,1/6,16.84%,CROT
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.35747760404939627,-0.7796137534740157,0.8571428571428571,1.0,1.0,12/53,21.79%,SOX9;RARA;FOXO1;TRIB1;SPP1;STAT3;TGFB1;STAT5B;TIRAP;FOXP1;ABCA2;PAQR7
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.3704358772833325,0.779192112036979,0.7777777777777778,0.9822413653037445,1.0,3/21,4.90%,CHRNA4;CHRNA7;PCDH15
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.41518569715441006,-0.7791699001204061,0.7936507936507936,1.0,1.0,4/19,4.79%,LFNG;PTPRC;SPI1;LMBR1L
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.4278979442171809,-0.778766819054074,0.8548387096774194,1.0,1.0,3/19,12.06%,ARHGAP24;PFN2;TCHP
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.5155783522242177,-0.778732683732344,0.8285714285714286,1.0,1.0,1/7,3.99%,FPR3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.515823710699578,0.7786712188211098,0.7777777777777778,0.9825554424976236,1.0,1/5,4.76%,NLGN2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4023523155716192,-0.7785367879157216,0.782608695652174,1.0,1.0,6/28,22.44%,PTPRC;PLSCR1;IFI35;RSAD2;STX4;XBP1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3182929063220463,0.7785250593208516,0.9473684210526315,0.9821857758131276,1.0,5/39,8.27%,CUL7;CALR;CAPRIN1;S100A10;LIMS1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.48567385663590373,-0.7784195419415173,0.7833333333333333,1.0,1.0,3/7,32.74%,KDM6B;PROX1;JAG1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.4367601305621093,0.7781519126161054,0.7631578947368421,0.9822600268815862,1.0,1/8,2.37%,GSTP1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.40930813751263034,0.7779896772232554,0.7142857142857143,0.9818821564207485,1.0,1/9,9.28%,ACLY
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.5101965723795896,0.7778874327141397,0.7714285714285715,0.9814073334288306,1.0,1/5,5.87%,CLIP3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.4835916808428855,0.7778443641746325,0.7659574468085106,0.9808534470246888,1.0,1/5,5.41%,TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.35053491167196116,0.7778416641632285,0.8888888888888888,0.9802383408077935,1.0,4/22,7.59%,PHB2;PDGFRA;ESR1;ADRA1A
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.4586627884199924,0.7777196614781641,0.6857142857142857,0.9797919906110342,1.0,1/8,3.05%,ERN1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.3215993382975693,-0.7771829733987511,0.956989247311828,1.0,1.0,29/181,19.27%,DEPP1;ITPR1;PIP4K2C;DRAM1;DAPK1;ATP6V1E2;USP13;CISD2;SREBF1;PLEKHF1;TPCN2;FOXO1;PLK2;WDR6;STAT3;TPCN1;SVIP;DAPK3;HDAC6;RPTOR;WDR41;GFAP;RNF152;ATM;HTR2B;USP36;RB1CC1;PIK3CB;DNM1L
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.2985248625376079,0.7766365265621352,1.0,0.9807333209280232,1.0,8/45,12.76%,RBM15B;AARS1;HENMT1;JMJD6;NAT10;TYW5;ANKRD16;DTWD1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.3197823218317172,-0.7764255001722412,0.8876404494382022,1.0,1.0,19/146,16.25%,EFNA1;LAMA2;ROBO2;EFNA5;VEGFA;SPTBN5;SEMA4B;PLXNA4;DOK1;EPHA7;UNC5D;VASP;LRTM1;BDNF;EPHA4;NRP2;GRB10;DAB1;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.4571332843215892,-0.7763438134653045,0.8,1.0,1.0,3/11,28.08%,STX4;RIC3;MAP1A
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.39440271400525406,-0.7763335123473158,0.7792207792207793,1.0,1.0,11/23,24.56%,SHISA6;SHISA9;CACNG8;SHANK3;CACNG2;CNIH2;RELN;MEF2C;MAPK8IP2;CACNG7;SHANK1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.40337908710645864,0.7760286196152162,0.7931034482758621,0.9809935838395143,1.0,2/13,9.53%,MRPL44;HENMT1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5203766911738249,-0.7755723673393392,0.8387096774193549,1.0,1.0,2/7,13.45%,MAFF;TMEM79
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3574280303142643,0.7753696587350277,0.8611111111111112,0.9813064598973054,1.0,2/18,3.60%,SIRT2;PDE3A
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.476043864609773,0.7753523393904844,0.7575757575757576,0.9807018349691083,1.0,3/6,32.10%,ITM2C;BACE2;ITM2B
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.27749915898741073,0.775268605546048,1.0,0.9802389798982627,1.0,19/117,16.11%,DAPL1;RRAGA;TFEB;MAP1LC3A;ATP6V0E1;ATP6V1G1;MLST8;ATP6V1B2;ATF4;ATP6V0D1;LAMTOR2;MIOS;FADS1;HSPA8;LAMTOR1;RALB;MYBBP1A;SEH1L;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4194905650985994,-0.7752207913899094,0.7333333333333333,1.0,1.0,7/20,25.94%,BMP8A;TGFB1;RBPMS;ENG;GDF11;SMAD4;TGFB3
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.4557496809896245,0.775059249028827,0.7317073170731707,0.980093768131085,1.0,1/6,5.06%,PIH1D1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.3377260527802445,-0.7748550368993716,0.8658536585365854,1.0,1.0,10/98,7.16%,AHR;SRPX;SOX9;SRPX2;TNC;TIMP3;MLANA;FKBP9;FLG;FILIP1L
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.2775159198191948,0.7746790449599223,1.0,0.9800455574007754,1.0,9/106,9.35%,HDAC11;TCF7L1;HP1BP3;NPM1;ESR1;PIH1D1;RUVBL2;SMARCAD1;ZBTB1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.4368627351299861,0.7745348680723533,0.717948717948718,0.9797159356972669,1.0,4/8,23.35%,NLGN2;NLGN1;LRRC4;NRXN1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.30409635186997586,-0.7739582678230871,0.9696969696969697,1.0,1.0,88/640,17.41%,HEY2;AHR;HES1;EFNA1;NR4A3;CRYM;SOX9;MNT;OTUD7B;IRF1;CDKN2A;CBX7;ZFP69;PARP9;BRCA1;MAEL;ZFPM1;GADD45A;SPI1;NKX6-2;ZNF555;ELK3;ZNF550;MAX;VEGFA;DUSP22;RARA;ARID5A;TCFL5;ZNF136;RPS14;NR1D1;RUNX2;ZNF749;FOXO1;MLIP;WWP1;ESR2;LOXL3;ZNF133;BACH1;ZNF785;ZNF224;TAF1;ZNF540;BCL11A;ATP8B1;MEIS2;ZNF169;PBXIP1;ZNF568;RBM15;STAT3;EZH1;GCLC;GLIS3;L3MBTL3;TCF25;WWP2;L3MBTL4;DDX20;BHLHE40;HDAC4;PDCD4;PER1;TGFB1;ORC2;AASS;HDAC6;RIF1;ZNF566;ENO1;UXT;CTBP1;CBY1;CRYAB;BCL6;ZNF589;IKZF4;ZNF599;MAP2K5;ZNF141;NEDD4L;PEX14;ZFHX3;CIITA;FOXP2;ZFPM2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.4530859062833944,0.7738997062647173,0.725,0.9802481937041267,1.0,2/5,5.99%,CDO1;CSAD
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.386612876884902,-0.7738100673914262,0.8133333333333334,1.0,1.0,5/32,13.21%,ALOX12;ELOVL2;PTGR1;ACSL1;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.3301083371195649,-0.7737619859912876,0.8586956521739131,1.0,1.0,20/141,19.27%,TMSB4X;ITPR1;OTUD7B;BCL2L2;SPI1;CAV3;NR1D1;RNF157;NLRP12;CIT;PTPRJ;TSC1;PER1;ARRB2;RIPK1;IFI35;DAB2IP;STAT1;PIK3CB;HDAC7
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.4019116799569249,-0.7737296416282997,0.8,1.0,1.0,4/21,14.41%,VCL;EFNA5;MACF1;DAPK3
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.28788940639401495,0.7736384355708366,0.9375,0.9801296977016102,1.0,14/61,17.60%,SIRT2;PCBP2;ENPP3;NFKBIL1;DUSP3;MUL1;CERS2;MFHAS1;OTULIN;GRID2;TRAFD1;CRK;FEM1A;TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3748487557421983,-0.7736233650283986,0.8292682926829268,1.0,1.0,8/57,16.25%,STMN2;CAV3;APOE;PFN2;TBCD;CRYAB;PFDN6;SHANK3
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.39429002389412626,-0.7735440685512662,0.7714285714285715,1.0,1.0,2/22,5.74%,PPIE;FKBP5
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.28540707127983883,0.7734743638773729,0.85,0.9797918678230665,1.0,6/45,10.63%,SLC30A10;PPT1;TOX3;NGF;MT3;LIG4
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4893934489574241,-0.7734582223413364,0.8125,1.0,1.0,1/5,7.83%,TRIM44
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.48813380773238946,0.7734150269451296,0.7209302325581395,0.9792965358161835,1.0,1/5,15.11%,WNT5A
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.29766826383951683,0.773351242468959,0.8888888888888888,0.9787667553652608,1.0,7/47,15.25%,ATG16L1;MAP1LC3A;EMC6;RAB1B;UBQLN2;ATG101;NSFL1C
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3247549169252473,-0.7733059069740935,0.9325842696629213,1.0,1.0,20/163,13.00%,ENPP2;ANGPTL4;MYLK;MCCC1;GADD45A;NMT1;LIFR;GPAM;BAZ2A;LPCAT3;NKIRAS1;APOE;MTCH2;STOM;STAT5A;SPARCL1;SORBS1;MIGA2;EPHX2;ACO2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.45183125593346696,0.7730445082923635,0.75,0.9785793895642733,1.0,4/8,36.71%,IL17D;CREBBP;PTN;MYSM1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.40884503696012686,-0.7729945497095022,0.8375,1.0,1.0,3/21,5.72%,BRCA1;RARA;ARID5A
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.34152111897761644,-0.7729097954544426,0.9021739130434783,1.0,1.0,14/124,13.00%,CYP2E1;SLC6A6;HSD11B1;TPST1;MTHFD1;NMT1;FMO3;ABCC3;APOE;PTGR1;MAN1A1;AKR1C2;GCLC;ACO2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.46865343185121117,-0.772800983254317,0.8412698412698413,1.0,1.0,4/11,26.01%,CAMK2D;ATP1B1;PLN;GSN
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.3678911984210274,0.7726538210065564,0.825,0.9785498897990393,1.0,1/12,4.48%,MCM4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.4502926715625125,0.7725433317351276,0.7,0.9780915931617679,1.0,3/7,30.06%,WNT5A;ADAM17;ADAM10
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.42314309645809045,-0.7723007554780589,0.8823529411764706,1.0,1.0,3/18,7.21%,GRIN2A;GLRA1;GRIN2D
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.5004169112884466,-0.7719646680265341,0.7741935483870968,1.0,1.0,1/6,10.32%,TAF1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.4971995878126184,0.7718956172243618,0.7222222222222222,0.9784822553783363,1.0,3/5,15.56%,WBP2;YAP1;KMT2D
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.28031346795966916,0.77163328071726,1.0,0.9782955394599325,1.0,14/75,14.84%,GOLGA7;SCAMP3;AP1M1;AP4E1;CHMP2A;BLOC1S4;EXOC5;ACBD3;ARL3;COMMD1;HSPA8;EXOC6;SH3D19;STXBP6
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.33671984954091244,0.7716253130233883,0.8518518518518519,0.9776897674339308,1.0,5/26,10.91%,SLC30A10;ATP7B;MT3;ATP2C2;ATP2C1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.43400676427416207,-0.7713439107443042,0.7464788732394366,1.0,1.0,4/18,31.14%,PNKP;ATM;NEK7;MAP2K7
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.34683257513404225,0.7712813411131356,0.8125,0.9775648915897508,1.0,5/31,11.41%,SIRT2;NGF;PLAUR;MDFI;JUN
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.4493621675109098,-0.7709976449534561,0.8405797101449275,1.0,1.0,3/13,17.11%,SLC39A14;SLC39A11;SLC30A9
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3136580015310527,-0.7709680993384447,0.9148936170212766,1.0,1.0,49/174,27.75%,SYCE2;HES1;SOX9;NEDD9;SKAP2;FANCC;STAG3;RHOJ;RIMS1;PLS3;VASP;TAPBP;VIL1;FAM107A;NDUFAF1;TGFB1;DLG4;BAIAP2;PEX14;WNT7A;WDR19;SYCP2;KMT2A;DNM1L;RHOU;DVL1;PCLO;FANCA;LRGUK;ZW10;FBLIM1;PPARGC1A;RAC3;FLNA;DMTN;LIN7A;SHANK1;DARS1;GSN;SPG7;CALD1;RANBP9;TEAD1;AFG3L2;TUBGCP2;MYO9A;PPID;PPIH;STK25
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4094328248270548,0.7708391090923407,0.7878787878787878,0.9764679966153009,1.0,5/10,31.47%,ANAPC11;ANAPC7;ANAPC4;CUL3;CDC16
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4094328248270548,0.7708391090923407,0.7878787878787878,0.9764679966153009,1.0,5/10,31.47%,ANAPC11;ANAPC7;ANAPC4;CUL3;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.4094328248270548,0.7708391090923407,0.7878787878787878,0.9764679966153009,1.0,5/10,31.47%,ANAPC11;ANAPC7;ANAPC4;CUL3;CDC16
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.4142831419692796,-0.7707182836861702,0.8082191780821918,1.0,1.0,7/18,20.05%,RAB11A;ADCY1;ADCY5;PRKAR1B;AQP4;ADCY3;PRKAR2A
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.3441902555413169,-0.770697053520061,0.872093023255814,1.0,1.0,13/96,15.70%,SLC39A14;ATP6V1E2;TBC1D4;FOXO1;BCAR3;RAB15;SORBS1;AKT2;PDK2;USF1;IGF1R;BAIAP2;GRB10
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.31398248478402463,-0.7706865299408573,0.9021739130434783,1.0,1.0,30/249,18.34%,RFC4;IGF2BP3;GTPBP2;RPS6KB2;BRCA1;DONSON;RPL12;EEF2K;RFC2;BAZ2A;HELB;RPS14;GCNT1;MMS19;APOE;RPA3;CDC7;RPL37A;ORC2;ING5;RPS8;WRN;EEFSEC;MRPS18C;RPS6;RPS4X;ATM;RPS27;PPP5C;RPL27A
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.2890941330764171,0.7705030701563725,0.9411764705882353,0.9763093670941855,1.0,7/58,9.59%,RFWD3;SFR1;UBE2N;RAD51B;PARP1;SEM1;EXD2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.44749812728552596,-0.7704817474892585,0.84375,1.0,1.0,2/12,10.83%,PTPRC;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5327722746874008,-0.7704682621911436,0.8,1.0,1.0,2/5,26.86%,NRDE2;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5327722746874008,-0.7704682621911436,0.8,1.0,1.0,2/5,26.86%,NRDE2;NCBP2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.33937590370302684,-0.7701680287854517,0.8974358974358975,1.0,1.0,11/73,11.48%,CLDN18;EMP2;AKAP5;CRLF1;FKBP9;VEGFA;EDNRA;SLC44A3;KIAA1217;OSMR;THSD4
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.47384146153330375,0.769614170256399,0.6923076923076923,0.977186524602362,1.0,4/11,11.14%,RNF139;SNX12;GAS1;BAG2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.2926988521059695,0.7688072386725308,0.8,0.9778799483579514,1.0,8/62,10.67%,SIGMAR1;SLC30A10;PPT1;TOX3;NGF;MT3;LIG4;ATF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3668215127872525,-0.7686311365860499,0.8641975308641975,1.0,1.0,6/46,14.69%,TSPYL2;CDKN2A;CAMK2N1;NUDT6;PDCD4;TGFB1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.40214897923844867,0.7684911735395483,0.696969696969697,0.9777902661676751,1.0,4/13,20.42%,RBPJ;CDH13;PTPN12;RHBDF2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.3808138132497746,0.7681799557912947,0.78125,0.9776312070703773,1.0,2/14,6.65%,HSPA1A;CHMP2A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.45568458193938166,-0.7681068918250394,0.8088235294117647,1.0,1.0,4/12,26.39%,DAB2IP;PIK3CB;MYO1C;TSPAN12
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.4572328000677254,0.767886169973211,0.7441860465116279,0.9774376237670455,1.0,1/6,9.10%,SMAD3
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.43934878579021697,0.767873628512257,0.8214285714285714,0.9768452191035166,1.0,2/11,6.65%,CCT5;CCT3
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.39223831055005226,-0.7678432540025724,0.9142857142857143,1.0,1.0,3/30,12.30%,HAP1;KIF1C;NEFL
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.34952076064920445,-0.7677656352005345,0.891566265060241,1.0,1.0,11/67,15.80%,NEFM;STMN2;BRCA1;CACNA1B;ACTL6B;SYT4;SULT4A1;KCNB2;JPH3;CRMP1;CELF3
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),-0.520626285688187,-0.7677124760014148,0.8076923076923077,1.0,1.0,1/5,6.43%,CFAP69
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.4815642397853125,-0.7676935189490578,0.819672131147541,1.0,1.0,1/8,10.48%,XRCC3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.48921901268844564,-0.7672260982868638,0.7678571428571429,1.0,1.0,1/5,3.96%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.48921901268844564,-0.7672260982868638,0.7678571428571429,1.0,1.0,1/5,3.96%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.3782968394249072,-0.7671907777451337,0.8333333333333334,1.0,1.0,5/33,14.12%,LIMK1;PFN2;PAK1;TPM1;ITGB1BP1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4421128383532594,0.7670707923959134,0.7352941176470589,0.9773893062803102,1.0,2/8,11.08%,B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3034677942081146,-0.7667553746665633,0.9587628865979382,1.0,1.0,65/463,17.41%,HEY2;HES1;EFNA1;NR4A3;CRYM;SOX9;MNT;OTUD7B;CBX7;ZFP69;PARP9;ZFPM1;GADD45A;SPI1;ZNF555;ZNF550;MAX;VEGFA;DUSP22;SRF;RARA;ARID5A;TCFL5;ZNF136;RPS14;NR1D1;ZNF749;MLIP;ESR2;ZNF133;BACH1;ZNF785;ZNF224;TAF1;BCL11A;MEIS2;ZNF169;ZNF568;STAT3;EZH1;GLIS3;TCF25;WWP2;DDX20;BHLHE40;HDAC4;PER1;ORC2;AASS;RIF1;ZNF566;ENO1;UXT;CTBP1;BCL6;ZNF589;ZNF599;MAP2K5;CC2D1A;ZNF141;NEDD4L;ZFHX3;CIITA;FOXP2;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4176170257561774,-0.7667372931266406,0.8208955223880597,1.0,1.0,3/13,21.31%,HAP1;RYR2;ATP1B1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.32875903783537663,0.7666787477249558,0.8076923076923077,0.9773088736396254,1.0,4/23,9.28%,PPT1;SLC25A1;SCD5;ACLY
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.2792489589250152,0.7664348221564324,1.0,0.9770293824446319,1.0,14/85,16.18%,SIRT2;NUP42;TRIM28;PLOD1;UBE2I;VCPKMT;SUMO1;NUP35;TRPM4;HDAC9;SEH1L;SUMO3;SIRT1;NUP214
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.39389997488312944,0.7664036575303409,0.7575757575757576,0.9765079358722659,1.0,2/13,9.31%,CHRNA7;ABCD2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4267414166816952,-0.7661647814841398,0.7857142857142857,1.0,1.0,1/19,2.41%,ENO4
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.42733950982469077,-0.7655825429516849,0.8208955223880597,1.0,1.0,2/16,14.55%,PTPRC;PDCD1LG2
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.4561672226248431,-0.7654690983848959,0.7704918032786885,1.0,1.0,1/8,9.73%,TTC19
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.4561672226248431,-0.7654690983848959,0.7704918032786885,1.0,1.0,1/8,9.73%,TTC19
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.41806814882965476,-0.7652951313874916,0.8208955223880597,1.0,1.0,2/15,9.07%,AGT;CDK4
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.2937678179880292,0.7651887379233105,0.8947368421052632,0.9781319174474938,1.0,7/64,10.38%,ACTB;SLITRK2;BTBD3;MAP2;S100B;NTNG2;SDC2
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.4715035479721373,-0.765117653162933,0.8,1.0,1.0,2/12,12.69%,VEGFA;OXTR
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.41590486558964457,-0.7648777675709015,0.7333333333333333,1.0,1.0,4/18,15.27%,PTPRC;GPI;SHLD2;RIF1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.4304372477116526,-0.764872982306843,0.8333333333333334,1.0,1.0,4/17,10.14%,AGT;HAP1;BCAR3;DOK1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.261317515684652,0.7647678243638381,1.0,0.9781376525259191,1.0,17/120,13.66%,MMP16;FBLN5;TGFBR2;LDLR;MGMT;PRKAR2B;MGLL;NR3C1;PLCB4;MT1E;SMAD3;SRI;SDC2;ATP2C1;MIOS;INSIG1;VLDLR
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.42691341849339115,-0.7647315005500529,0.8591549295774648,1.0,1.0,2/18,10.21%,DDB2;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.42691341849339115,-0.7647315005500529,0.8591549295774648,1.0,1.0,2/18,10.21%,DDB2;RPA3
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.4777916910821229,0.764352873259667,0.8478260869565217,0.9781261053569609,1.0,1/7,2.95%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4553112693261772,0.7642839762024943,0.6756756756756757,0.9776052727283425,1.0,5/8,20.23%,MEOX2;STARD13;NOTCH1;RHOA;HDAC5
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4164908969220587,-0.7639488689671813,0.7808219178082192,1.0,1.0,3/19,10.82%,SYT1;SYT2;SYT4
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.43664821974880413,0.7634787538402962,0.7058823529411765,0.9782842177426081,1.0,4/8,29.72%,SNAPC5;ICE2;SNAPC1;ICE1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.4505322685826535,-0.76339241983327,0.71875,1.0,1.0,5/9,39.17%,RNF20;CDK9;CTR9;NELFE;ZC3H14
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.3972563298486792,-0.7633360526923293,0.8289473684210527,1.0,1.0,5/32,14.12%,VEGFA;SRF;RNF213;NAXE;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.40564286383628406,-0.7633321054410755,0.7922077922077922,1.0,1.0,6/28,21.48%,PARN;CCT8;CCT6A;PNKP;ATM;HMBOX1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.49049728908251106,-0.7631108322239032,0.8,1.0,1.0,1/6,13.21%,CYP1B1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.4226442669415341,0.762982150968046,0.78125,0.9779077366700216,1.0,3/10,22.15%,SLC25A14;SLC37A4;SLC25A30
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4226442669415341,0.762982150968046,0.78125,0.9779077366700216,1.0,3/10,22.15%,SLC25A14;SLC37A4;SLC25A30
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.33170083966078756,-0.762052975840885,0.8863636363636364,1.0,1.0,15/88,16.05%,TSPYL2;CDKN2A;KIAA0319;TP53TG5;OSGIN2;GJA1;ESR2;NME6;CRLF3;TCHP;MAG;PTPRJ;TGFB1;ENO1;BCL6
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.5042874251787506,-0.7620295854441608,0.8245614035087719,1.0,1.0,1/6,10.79%,TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.5042874251787506,-0.7620295854441608,0.8245614035087719,1.0,1.0,1/6,10.79%,TACC3
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.3405082422939514,-0.7620252851612355,0.8494623655913979,1.0,1.0,14/110,14.30%,CD44;FOS;TPD52L1;EMP2;OVOL2;ITPK1;FKBP5;PDZK1;SLC1A4;XRCC3;TIAM1;OLFM1;JAK1;PDCD4
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.40056860226269486,-0.7619787343274427,0.726027397260274,1.0,1.0,4/21,18.91%,SOX9;PTK7;ATM;RORB
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.4461368210731139,-0.7616952022380417,0.7727272727272727,1.0,1.0,2/9,18.64%,NR1D1;UGP2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.4461368210731139,-0.7616952022380417,0.7727272727272727,1.0,1.0,2/9,18.64%,NR1D1;UGP2
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.38626244156748546,-0.7615038712188817,0.8405797101449275,1.0,1.0,5/23,12.62%,SOX9;FGF9;LRP2;KITLG;ADAM21
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.36355729108487533,-0.7612973693389843,0.8607594936708861,1.0,1.0,11/45,26.20%,APOE;B2M;TAF1;DTX3L;TIAM1;BDNF;AKTIP;PSEN1;MEN1;STK3;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.49143265956317406,-0.7611189776857188,0.7794117647058824,1.0,1.0,1/9,5.80%,CAV3
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.40360972109335935,-0.761086248792592,0.85,1.0,1.0,4/26,12.75%,GSTM5;CHAC2;GSTK1;GCLC
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2993440150291537,-0.7609941279470356,0.9789473684210527,1.0,1.0,44/321,17.41%,HEY2;AHR;HES1;SOX9;IRF1;CDKN2A;BRCA1;MAEL;SPI1;NKX6-2;ELK3;RARA;ARID5A;NR1D1;RUNX2;FOXO1;WWP1;LOXL3;ZNF224;ZNF540;ATP8B1;PBXIP1;ZNF568;RBM15;GCLC;L3MBTL3;WWP2;L3MBTL4;BHLHE40;HDAC4;PDCD4;PER1;TGFB1;HDAC6;ENO1;CTBP1;CBY1;CRYAB;BCL6;IKZF4;PEX14;CIITA;FOXP2;ZFPM2
prerank,MSigDB_Hallmark_2020__UV Response Up,0.28123918788403757,0.7607334637531885,1.0,0.9807896030847353,1.0,17/117,6.98%,E2F5;SIGMAR1;ONECUT1;CTSV;CNP;PPT1;STARD3;EIF5;CDO1;PDLIM3;TMBIM6;PPIF;BTG1;PLCL1;BTG3;LYN;FKBP4
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.4319604777603228,-0.7605638134928818,0.8450704225352113,1.0,1.0,2/10,24.39%,AKT2;IRS2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.4870526806267711,-0.7604673966225697,0.8095238095238095,1.0,1.0,3/5,25.51%,KCNK10;KCNK12;KCNK1
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.5330724658059958,-0.7603442304427549,0.8688524590163934,1.0,1.0,1/5,1.00%,HES1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.32796003065867085,0.7602581841035356,0.8611111111111112,0.9809743840320865,1.0,3/25,11.15%,FNBP1L;CANX;CLTB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4453037636214018,-0.7601897286661519,0.7567567567567568,1.0,1.0,1/14,4.78%,CEMIP
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.4298699890550955,0.7601849387115515,0.7666666666666667,0.9804623227028879,1.0,1/7,3.09%,HIPK1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.47475992809074774,-0.7601734056570771,0.8,1.0,1.0,2/8,16.20%,SULF1;TMEM63C
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.36720279069849515,0.760071875010065,0.7857142857142857,0.9800282480172282,1.0,1/8,4.22%,SLC15A2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.4237057398273772,-0.7598373056176279,0.7916666666666666,1.0,1.0,2/12,11.55%,SLC39A14;SLC39A11
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.4344274597430081,0.7596604814363757,0.7741935483870968,0.9800327763746195,1.0,2/7,6.47%,HSD17B10;TRMT10A
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.49935550515813093,-0.7596363989045261,0.8153846153846154,1.0,1.0,2/8,8.45%,MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.4781812809723064,-0.7595753429800626,0.8813559322033898,1.0,1.0,4/10,26.01%,CAMK2D;ATP1B1;PLN;GSN
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.33248225167579787,-0.7594559322946091,0.9375,1.0,1.0,24/96,19.62%,HEY2;SRPX;PROCR;SRPX2;ENPP4;TIMP3;FKBP9;COL5A1;EDNRA;NR1D1;SVEP1;EPHX2;CYP1B1;PTPRJ;SULF1;COL4A2;C1S;ITGA9;ITGBL1;EPAS1;PLSCR4;NNMT;LMOD1;APH1B
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.507115359310042,-0.7594042889076195,0.7878787878787878,1.0,1.0,2/6,29.83%,ST3GAL6;PTPRT
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.4403236378382883,-0.7592385236932034,0.8428571428571429,1.0,1.0,3/11,15.27%,SHLD2;TGFB1;RIF1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.3710944181303749,-0.7588870185594127,0.8395061728395061,1.0,1.0,7/45,14.67%,OVOL2;VEGFA;AKR1C2;GSTK1;VIL1;AKT2;RHCG
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.48294126608365073,-0.7586897018399492,0.828125,1.0,1.0,2/7,16.53%,DARS2;GARS1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.43569164930849785,0.758661533252768,0.7096774193548387,0.9809214761962131,1.0,1/8,0.80%,CHRNA4
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.380275774878776,-0.7584911854230698,0.8260869565217391,1.0,1.0,2/30,1.40%,HES1;SOX9
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.3696496874842872,0.7584642089412881,0.7222222222222222,0.9806766584507132,1.0,1/27,0.36%,DGKB
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.38249616451698126,0.758392606961799,0.9393939393939394,0.9801663591635784,1.0,2/14,3.91%,PDGFRA;ESR1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.32547829299028047,-0.7580881834193245,0.8809523809523809,1.0,1.0,11/65,14.69%,CD44;FOS;TPST1;FPR3;NLRC4;LOXL3;BLNK;STAT3;ADCY1;HDAC4;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.43069566334059944,0.7579977006387831,0.7407407407407407,0.9801879280160742,1.0,2/10,11.84%,ANKRD13D;UBQLN2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.44937760243170083,-0.7575038003803976,0.7868852459016393,1.0,1.0,3/11,14.28%,CNTNAP1;MYRF;PLP1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.4107588290881431,0.7572668428660053,0.7368421052631579,0.9807403824931646,1.0,4/10,28.19%,SMAD7;SKI;LEMD3;IGSF1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.3207565326151698,-0.757187645696182,0.9425287356321839,1.0,1.0,22/94,19.50%,ANGPTL4;SOX9;AGT;TIMP3;FKBP9;TNS1;KIF1C;SLC16A3;KITLG;BCAR3;FAM20C;GPRC5C;MATN2;ANKRD7;CRYAB;C1S;ARHGEF17;DAB2IP;EPAS1;CD55;PLSCR4;LMOD1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.35676165724476283,0.7568547189649123,0.95,0.9806332041013444,1.0,6/24,16.42%,RNF6;MAP2;MT3;WWC2;WWC1;DCC
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.42261160393715674,-0.7567127324996767,0.8529411764705882,1.0,1.0,4/18,12.52%,VEGFA;PTPRR;ARNT2;ZNF568
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.31197607216783707,0.756631326703806,0.92,0.9803978690341274,1.0,14/70,14.87%,TCF7L1;GSKIP;ESR1;FRZB;MDFI;PPP2R1A;CDC73;NFATC1;CXXC4;AMER2;CTNNBIP1;BMP2;OTULIN;SALL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.373842861749451,-0.756455920347657,0.8607594936708861,1.0,1.0,6/37,14.12%,LIMK1;PFN2;PAK1;TPM1;VIL1;ITGB1BP1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.4407246956414316,-0.756330957524661,0.7794117647058824,1.0,1.0,1/9,7.23%,ITPKC
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2984547280189474,-0.7559512313108293,1.0,1.0,1.0,114/755,19.04%,HEY2;AHR;PLAG1;HES1;NR4A3;NLRC5;CAMK1;SOX9;FGF1;FOS;IRF1;MAFF;CDK7;PARP9;AGT;BRCA1;ZFPM1;SPI1;KLF6;ELK3;MAX;VEGFA;SRF;STAT6;RARA;YWHAH;BCL9;SREBF1;NCOA1;ETV4;MAP3K12;TRIM44;NR1D1;RUNX2;MMS19;ATAD2;MYRF;THRAP3;AHI1;FANK1;APOE;PLSCR1;SS18L2;LMO2;DVL2;FOXO1;SEC14L2;MLIP;ESR2;ARNT2;JUNB;DTX3L;THOC5;SSBP4;KLF15;MEF2D;TRIM56;CREBRF;SPP1;HMGN5;MEIS2;CRLF3;DNAJC2;ARRB1;DNM2;STAT3;ZIC1;GLIS3;MAP2K1;NPAS2;USF1;ITGB1BP1;HDAC4;PAXBP1;PER1;ST18;TGFB1;ING5;LHX4;SMARCA1;RPTOR;RFXAP;STAT5B;CDKN2B;RIPK1;BRD4;GABPB1;DDRGK1;MAP2K5;RFX4;TAF6L;SLC30A9;MAML3;ZFHX3;CIITA;PTPRN;WNT7A;ZFPM2;CEBPZ;CDC5L;IRF2;ZNF395;ATM;DAB2IP;ASXL2;EPAS1;NFIC;TFAM;PRKD2;CSRNP2;ZBTB48;RORB;KMT2A;STAT1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.43956443790712973,0.7550844171146753,0.8148148148148148,0.982154346583592,1.0,2/9,6.65%,CCT5;CCT3
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.2940008077081766,0.7550030260073322,0.9230769230769231,0.981653562395754,1.0,10/54,11.54%,U2AF1;CPSF1;RPRD1B;POLDIP3;EIF4A3;RBM8A;MAGOH;CSTF2T;CPSF4;SRSF3
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.4761315023713991,-0.7549143433063985,0.7714285714285715,1.0,1.0,5/8,43.44%,CDK9;RPS6KA5;MACROH2A1;AKAP8L;AKAP8
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.3911085223429825,-0.7546586292933561,0.8148148148148148,1.0,1.0,4/26,17.27%,ENTPD3;SIDT2;NCBP1;ENTPD7
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.40660785657260645,-0.7546101304691466,0.7761194029850746,1.0,1.0,5/15,19.25%,C4BPA;CPB2;C1S;PROS1;CD55
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.40660785657260645,-0.7546101304691466,0.7761194029850746,1.0,1.0,5/15,19.25%,C4BPA;CPB2;C1S;PROS1;CD55
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3459467184556031,0.7545644275222326,0.8095238095238095,0.981657065217263,1.0,8/32,9.98%,TMED2;MAP2;PPP1R35;RCC2;CSTB;GPSM1;CHP1;GPATCH2
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.5026186247796048,-0.7545004013939232,0.8666666666666667,1.0,1.0,3/6,37.74%,MDH1;ME2;ME3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.3931756262771343,0.754056630607307,0.8709677419354839,0.9816520321616503,1.0,4/12,21.34%,PPIA;POLD3;SIRT1;WRNIP1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.3054790815241799,0.7539739518104098,1.0,0.9811354243802223,1.0,5/40,8.53%,TRIM28;UBE2N;PLA2R1;TMEM161A;FXR2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.31870205041601884,0.7537066363362864,0.85,0.9809517735253311,1.0,4/25,14.99%,ARC;CHRNA7;EPHB3;CDC42
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.3318264785362007,-0.7536914666873185,0.9069767441860465,1.0,1.0,10/118,11.40%,RASGRF1;DOCK8;EFNA5;ZC3H15;VAV3;ARHGAP15;BCAR3;PLXNA4;RASGRP1;TBC1D10B
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4046276236493571,-0.7536194083005618,0.7971014492753623,1.0,1.0,1/16,3.50%,AGT
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3578409959422845,-0.7535880856224592,0.8987341772151899,1.0,1.0,12/58,15.29%,SOX9;VCL;VEGFA;MTHFD1;AHI1;LOXL3;AKR1C2;GSTK1;VIL1;RHCG;TGFB1;PPP2R3A
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.30544103010781004,-0.7535584735892149,0.9468085106382979,1.0,1.0,44/305,15.23%,ZIC4;IGF2BP2;IGF2BP3;HES1;B3GNT5;PCDHB12;TRPC5;PCDHB5;INTU;ROBO2;EFNA5;LIMK1;RAPGEF5;VEGFA;ARHGAP26;NRGN;HAP1;APBA2;ACTL6B;AHI1;BTD;MOBP;HPCAL4;WWP1;SCN8A;ACAN;ARNT2;RBFOX3;ADGRV1;AVIL;TYRO3;STAT3;CHRM3;BPNT1;NPTX1;ZIC1;PCDHB4;BDNF;NPAS2;HDAC4;TGFB1;DCLK1;CRMP1;DLG4
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.36278585613324216,0.7535358007631374,0.9047619047619048,0.9805128704228908,1.0,1/24,2.33%,RNF6
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3048525415947176,-0.7535081931831666,0.9574468085106383,1.0,1.0,38/243,15.42%,HES1;NR4A3;SOX9;FGF1;SPDYA;EMP2;PTPRC;FGF9;AGT;CRLF1;VEGFA;RARA;FAM98B;LIFR;GJA1;CDK4;KITLG;IL7;OSMR;CDC7;AKR1C2;MCTS1;PAK1;HMGN5;MEIS2;IL6R;TIAM1;TSHR;NTRK3;AKT2;ITGB1BP1;KIF20B;HDAC4;TGFB1;TBC1D8;PDGFRB;CDCA7L;IGF1R
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.4806550902192876,0.7534306578968456,0.8214285714285714,0.9800830152275923,1.0,1/5,9.33%,MT3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.35471154552726125,-0.753391311528152,0.8875,1.0,1.0,5/53,16.51%,PARP9;PDZK1;DTX3L;TGFB1;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3128344983884086,0.7533320884046576,0.8947368421052632,0.979602652916697,1.0,18/54,20.79%,GPC1;UBE2D1;BAMBI;BMPER;SPRY1;SMAD9;GREM1;SMURF2;CREB3L1;BMP2;NOTCH1;SPRY4;SMAD7;CADM4;EPN2;VWC2;CASK;PTPN1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.3268288037195369,-0.7533266236201045,0.8690476190476191,1.0,1.0,21/100,20.84%,NUAK1;SOX9;TNFRSF19;LIFR;ARNT2;SH3PXD2B;CAMK2N1;TYRO3;CHST3;CDC42BPB;GFAP;ARHGEF17;SLC4A3;HSPA12A;KIAA1549L;PHYHIP;DAB2IP;NGEF;ZNRF3;SLC13A4;SRRM3
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.3374858276096746,0.753250977229978,0.9393939393939394,0.9791398784253325,1.0,2/17,8.09%,NCSTN;HM13
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.36165185271928235,0.7531957591833509,0.8064516129032258,0.978601213452841,1.0,1/21,0.73%,GPX1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.35738614581571954,-0.7531649395214826,0.8441558441558441,1.0,1.0,8/51,16.27%,PIGH;ZDHHC9;GLUL;MPPE1;PIGL;ZDHHC14;PIGC;ATG7
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.37568762009704776,-0.7529130621632425,0.8354430379746836,1.0,1.0,8/37,16.87%,VSIR;AGT;TIMP3;PSMB8;SERPINE3;KNG1;PSMA3;SERPIND1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.4589081172860652,0.7525941788694609,0.725,0.9788782376379871,1.0,3/6,36.56%,PUM2;ANKRD17;USP15
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.45852547941511274,0.7524673446550233,0.7,0.9785185689596403,1.0,2/8,9.52%,SEMA5A;CFL2
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.48269711701121154,-0.7524448187560423,0.7796610169491526,1.0,1.0,1/5,15.47%,RYR2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.35396489984953916,-0.7523063649446453,0.7974683544303798,1.0,1.0,10/43,17.30%,G6PC2;PYGL;CAV3;STAT3;PDK2;USF1;OAS1;IGF1R;SLC8B1;RPS6
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.3175727678406726,-0.7519803934045043,0.9468085106382979,1.0,1.0,8/108,8.51%,RASGRF1;STMN2;SRF;RAB11A;DOCK7;ACTL6B;ALK;APOE
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.3870347642702615,-0.7519688487878617,0.7974683544303798,1.0,1.0,10/26,24.56%,STX1B;RIMS1;TMEM25;DLG4;SHANK3;WNT7A;RELN;GRIN1;PRKCZ;SHANK1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.3532668831241972,0.7518902558471351,0.8157894736842105,0.9787105101298293,1.0,2/13,7.20%,PPIA;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2669572935570456,0.7516805598124335,1.0,0.9785123954259523,1.0,21/116,15.11%,CCDC88C;PSMD8;KLHL12;PSMB6;PSMB4;PRICKLE1;FRZB;PSME3;PSMD10;TLE4;RUVBL2;GREM1;LIMD1;MAD2L2;AMER2;PTPRO;BMP2;PSMD12;PSMB2;PSMD4;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.440678400788521,-0.7516701204610515,0.746268656716418,1.0,1.0,2/7,17.64%,NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.38238707440828257,-0.7512865292812193,0.8260869565217391,1.0,1.0,6/22,23.04%,APOE;SULF1;STAT1;SCG2;MEF2C;CNMD
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5062665035284892,-0.7512685441256521,0.7741935483870968,1.0,1.0,1/5,19.27%,DNM1L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.36256068687868326,0.7512589834992289,0.8529411764705882,0.9786448219632158,1.0,3/23,7.48%,BAD;YWHAQ;BOK
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.3609486041653771,0.7511081268584667,0.7878787878787878,0.9776826474837972,1.0,2/15,5.04%,TWF1;SVIL
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.3609486041653771,0.7511081268584667,0.7878787878787878,0.9776826474837972,1.0,2/15,5.04%,TWF1;SVIL
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.3675502823413956,-0.7510877593670655,0.8378378378378378,1.0,1.0,6/31,17.02%,IQSEC2;GRIK5;CACNA1B;BDNF;SLC4A8;BCR
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.3258116259418325,-0.7510048824488323,0.9294117647058824,1.0,1.0,29/104,24.74%,TTN;EMP2;TMOD3;NEDD9;MYO1H;RHOBTB2;PLS3;MYO1F;AVIL;TPM1;VIL1;RFLNA;BAIAP2;MPRIP;ERMN;SHROOM3;LMOD1;CORO6;SPIRE1;ARHGAP12;MYO1C;RND3;NEBL;ARHGAP17;CARMIL1;RAC3;FLNA;DMTN;GAS2L1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.46840298329380986,-0.750971597623175,0.8,1.0,1.0,3/8,14.69%,SOX9;SRA1;TGFB1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.4486482181946271,0.7498958482476411,0.7241379310344828,0.9789227825747874,1.0,2/6,9.55%,PDE4B;SRI
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.466661577075529,-0.7498172051859618,0.7936507936507936,1.0,1.0,2/8,17.33%,EPHA4;SEMA3A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3862886364637627,-0.7494269430370165,0.9054054054054054,1.0,1.0,5/28,13.85%,PTPRB;DUSP22;UBASH3B;DUSP8;PTPRJ
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.25260815894639443,0.7493101138125998,1.0,0.979156021746003,1.0,48/318,15.55%,FGD3;CFL1;CUL7;FNBP1L;PHB2;TTC29;HSD17B10;WTIP;TMED2;ARC;KIF25;MCOLN1;SNX11;THY1;SURF4;MICAL1;TMED5;PPIA;CHMP2A;COG3;PARP1;NDP;PTCD2;PEX11A;GOLGA8N;SLC25A33;ABCD2;WASF3;LIMD1;PRDX3;MTX2;LIG4;TMED3;GORASP2;VAPB;ESRRA;LNPK;PALLD;SH3D19;CSPG5;TFB2M;CDC42;GOLGA5;NSFL1C;CAPZB;STX7;PAK5;GABPA
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.3307583841768771,-0.748979933155788,0.8888888888888888,1.0,1.0,10/73,13.22%,HEY2;SOX9;ZFPM1;MTHFD1;SRF;CACNA1C;DVL2;SH3PXD2B;TCF25;NTRK3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4411306930529809,0.7489087579811733,0.7,0.9792032202931884,1.0,2/5,25.93%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.29956536260191724,0.7483926987009812,1.0,0.9792166079827551,1.0,7/32,20.00%,DYNLL2;IFT20;WDR35;DYNLRB1;TRAF3IP1;SSX2IP;KIFAP3
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.3467977268776588,0.7483649552868694,0.9130434782608695,0.978681816418458,1.0,6/25,10.83%,ATP6V0A4;MCOLN1;ATP6V0E1;ATP6V1G1;ATP6V1B2;ATP6V0D1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.4071661196819212,0.7482766721157332,0.7333333333333333,0.978198242082961,1.0,2/12,12.78%,NDUFA5;PDIA5
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4009076362555401,-0.7482616874619433,0.8857142857142857,1.0,1.0,6/21,20.38%,PDE6B;BHLHE40;PER1;RBM4;FBXL17;RBM4B
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3493103270548298,-0.7482536978628492,0.8961038961038961,1.0,1.0,9/42,18.12%,CNTNAP1;SHTN1;PAK1;DNM2;BDNF;KIF20B;DCLK1;TNIK;DAB2IP
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.4933618160711078,0.7477619073396239,0.8,0.978313290889381,1.0,3/5,32.01%,SIRT1;MTHFR;HDAC2
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.29396556031182075,0.7476365689165655,1.0,0.9778978687734494,1.0,7/49,15.25%,ATG16L1;MAP1LC3A;EMC6;RAB1B;UBQLN2;ATG101;NSFL1C
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.45353475678436517,-0.7475077794031876,0.8125,1.0,1.0,3/9,25.94%,TGFB1;CIITA;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.28790614511797047,0.7471865246877937,0.8823529411764706,0.9778699413043624,1.0,8/64,10.67%,GPNMB;SLC30A10;PPT1;TOX3;NGF;MT3;LIG4;ATF4
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.46419882199857526,-0.7469549690009565,0.875,1.0,1.0,2/8,4.22%,EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.3723445947586399,-0.7468558624576188,0.8933333333333333,1.0,1.0,7/34,17.90%,EFHC1;TTC19;RASA1;CIT;CHMP4B;USP8;RAB35
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.47260355995432596,-0.7464068283116364,0.8103448275862069,1.0,1.0,2/7,21.84%,HLA-F;STX4
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.3964693133175849,-0.7463453929416324,0.8636363636363636,1.0,1.0,5/21,19.78%,HHIP;TULP3;RFX4;GPC3;IFT122
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.3841035517869694,-0.7463019330292341,0.8552631578947368,1.0,1.0,3/27,15.84%,BRCA1;ARRB1;CTBP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.3822116873319086,-0.7458857659676614,0.8840579710144928,1.0,1.0,4/25,14.55%,PTPRC;VAV3;IL7;PDCD1LG2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.3333725525422566,-0.7455645328874927,0.9101123595505618,1.0,1.0,21/100,23.11%,AHR;SOX9;MGST1;NR1D1;SPP1;TRIM41;ADCY1;ADCY5;PTK7;PDCD4;PDCD1LG2;ADAM9;ATM;DAB2IP;RORB;ADCY3;FAM210B;PDK3;XBP1;MEF2C;WNT5B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4090765160442126,-0.7453257127387244,0.8115942028985508,1.0,1.0,4/16,21.31%,CACNA1C;RYR2;CAMK2D;ATP1B1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4675993924951679,-0.7446993328904127,0.8235294117647058,1.0,1.0,1/7,10.54%,KDM7A
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.429879371288962,0.7446887464676604,0.72,0.9805241305715259,1.0,2/9,5.05%,PYCR1;GPR37L1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.38204197850784716,0.7444385671851874,0.7931034482758621,0.9802845824024441,1.0,2/18,2.39%,CHRNA4;SYT9
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.42513705852230327,0.7444061232242525,0.675,0.9797262136306195,1.0,1/9,2.47%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.43238516095599433,-0.7441845676708251,0.7647058823529411,1.0,1.0,2/14,7.50%,PTPRC;GPI
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.408636840389468,0.7437599857475454,0.8181818181818182,0.9801336633591263,1.0,2/10,7.48%,ERN1;BOK
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.4112288084184811,-0.7437216284482382,0.8450704225352113,1.0,1.0,3/13,16.99%,CAV3;PDGFRB;PLPP4
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.36850549223545154,-0.7437014877440064,0.8589743589743589,1.0,1.0,2/30,3.52%,AZIN2;TIMP3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.3988036293513704,-0.743323744672005,0.7794117647058824,1.0,1.0,3/16,12.05%,RARA;RHOBTB2;TYRO3
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.3827204182227307,-0.7432226260993036,0.8571428571428571,1.0,1.0,5/29,14.59%,EMP2;ECM2;TBCD;TSC1;PDPN
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.4361373264162164,-0.7431112620017593,0.8253968253968254,1.0,1.0,2/11,15.57%,PUS7;GAR1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.30699158167160795,-0.7429286115317634,0.9772727272727273,1.0,1.0,24/182,17.35%,EFNA1;LAMA2;ROBO2;EFNA5;SHTN1;SPTBN5;RAB3A;DOCK7;SEMA4B;DOK1;EPHA7;UNC5D;VASP;LRTM1;BDNF;EPHA4;CCK;NRP2;BAIAP2;GRB10;DAB1;SHANK3;SEMA3A;WNT7A
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.3387057887589613,-0.7423445548112364,0.8735632183908046,1.0,1.0,12/58,21.78%,PRXL2C;POM121C;POM121;SLC4A4;GAPDHS;HDAC4;NUP107;NUP188;PFKFB3;PSEN1;NCOR1;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.47202616173871126,-0.742279291804472,0.803921568627451,1.0,1.0,1/6,8.38%,MYRF
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.48275517397162715,-0.7422210089280616,0.8571428571428571,1.0,1.0,1/7,17.41%,ADAM9
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.4417723557154709,-0.7420602849497463,0.863013698630137,1.0,1.0,2/11,17.27%,ENTPD3;ENTPD7
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.4273638220543288,0.7413508551573116,0.7441860465116279,0.9830484839236149,1.0,1/9,3.63%,DNAAF2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4476548186266149,-0.7413104259241453,0.8115942028985508,1.0,1.0,2/9,20.91%,FOXP1;NCOR1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.3664048425131071,-0.741060238935843,0.8289473684210527,1.0,1.0,6/29,18.12%,AGT;APOE;GFAP;BAG5;RDX;DAB2IP
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.45228334939600556,0.7408743436810802,0.7619047619047619,0.9831852016811522,1.0,2/5,22.45%,GRM5;PRNP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.414149803351339,-0.7407835343561271,0.855072463768116,1.0,1.0,4/14,25.97%,EPS15;AP2A1;SORT1;VPS13C
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.3866177571148266,-0.7406026968055551,0.8648648648648649,1.0,1.0,5/24,13.54%,CLDN18;CLDN12;MICALL2;PAK2;TBCD
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.38054734974589866,-0.7404227436222962,0.8571428571428571,1.0,1.0,3/22,11.62%,APOE;AVIL;SORBS1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.38472708849650383,0.7403832020459722,0.7441860465116279,0.9833468869005454,1.0,2/11,5.24%,ESR1;MYCN
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.46938386287528966,-0.7396197112429042,0.7846153846153846,1.0,1.0,3/7,27.46%,NRP2;SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.46938386287528966,-0.7396197112429042,0.7846153846153846,1.0,1.0,3/7,27.46%,NRP2;SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.2841693955381751,0.7393839922520091,0.9523809523809523,0.984178165470199,1.0,12/67,13.84%,SIRT2;RNF144A;HSPA1A;PRICKLE1;PSMD10;ZYG11B;TMTC3;BAG2;RCHY1;OSBPL7;TMEM259;SUMO1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.47313932279013976,-0.7393028728907981,0.8412698412698413,1.0,1.0,6/11,29.89%,FAM107A;RPTOR;PRKAA1;PRKAA2;ULK1;KCNB1
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.47622040133954235,-0.7392312291598401,0.8225806451612904,1.0,1.0,2/8,10.38%,STEAP4;STEAP2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.3050161840280293,0.7391893427252831,0.9,0.98382865258357,1.0,7/42,13.53%,PMEPA1;PPM1A;SMAD3;TGFBR1;SMURF2;FNTA;BMP2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3914042809722698,-0.7385688278340886,0.8589743589743589,1.0,1.0,7/30,24.08%,PARN;CCT8;CCT6A;PNKP;ATM;HMBOX1;DHX36
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.38261464014975777,-0.7382828586247353,0.8142857142857143,1.0,1.0,7/24,30.83%,CSNK1D;DCTN1;IFT122;ARL13B;RPGRIP1L;BBS10;TMEM216
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.32965835493628254,0.7382390373646435,0.9230769230769231,0.9845499320638242,1.0,5/34,10.25%,H1-10;NPM1;NOC2L;H1-4;KAT6B
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.3861399359928871,-0.7382119342324202,0.8333333333333334,1.0,1.0,2/18,5.18%,GUK1;MTHFD1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.3938061253733406,-0.7381667273987328,0.8783783783783784,1.0,1.0,4/26,3.50%,EFNA1;PTPRC;NEDD9;AGT
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.38283431133460166,-0.7379868122972467,0.8513513513513513,1.0,1.0,4/20,14.69%,SOX9;RANBP3L;SRA1;TGFB1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.31974896568650746,-0.7376826099158057,0.9,1.0,1.0,20/92,21.63%,HTR2C;SOX9;AGT;ADGRL2;APOE;SLC44A3;KIAA1217;SLC2A12;PCDHB4;ADCY5;SMARCA1;CDC42BPB;ARHGEF17;DAB2IP;SHROOM3;CADPS2;SLC13A4;ATP1B1;DIP2C;SHC2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-0.5059164022095266,-0.7376766411876052,0.7872340425531915,1.0,1.0,2/5,30.54%,HS3ST5;HS6ST1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.4380789557139121,-0.7375727275021207,0.803030303030303,1.0,1.0,2/11,14.22%,GLUL;ASPA
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.446561743339946,-0.7374586203567693,0.8888888888888888,1.0,1.0,2/9,15.47%,KCNQ1;RYR2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.412325996846215,-0.7372823829975086,0.7704918032786885,1.0,1.0,3/12,15.88%,PTGR1;AKR1C2;TBXAS1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.33170736285788194,-0.7372015416197926,0.9156626506024096,1.0,1.0,11/68,16.25%,CDH7;CDH12;CDH9;PCDHB5;CDH19;VASP;PCDHB4;BDNF;CDHR3;CDH8;SHANK3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.45546327792690705,-0.7371006723381477,0.7777777777777778,1.0,1.0,4/7,15.87%,STAT5A;STAT3;JAK1;STAT5B
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.45546327792690705,-0.7371006723381477,0.7777777777777778,1.0,1.0,4/7,15.87%,STAT5A;STAT3;JAK1;STAT5B
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.3176759153826219,-0.7369933652533378,0.8928571428571429,1.0,1.0,27/94,19.50%,HSD11B1;SRPX2;AGT;TIMP3;LAMA2;STEAP4;STAT6;TNS1;ASPN;APOL6;ECM2;SVEP1;ACSL1;CYP1B1;COL5A3;PDGFRB;ABCA8;BCAT2;CRYAB;C1S;OLFML1;COL15A1;EPAS1;GULP1;PLSCR4;NNMT;LMOD1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.4699652459606254,-0.7365849297919989,0.8307692307692308,1.0,1.0,2/7,16.38%,ATP2B3;SLC8B1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.38855418579657713,-0.7363482369969508,0.8,1.0,1.0,4/27,6.11%,VCL;DSC2;P2RY12;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.364923548381573,0.7361321601231186,0.8620689655172413,0.9869417958313939,1.0,2/15,5.06%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.3913336898035078,0.7357608185766354,0.6857142857142857,0.9868251154865824,1.0,2/7,12.85%,ZFP36L1;CTNNBIP1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.35937030750126964,0.7357152604445579,0.8571428571428571,0.9862995612711175,1.0,4/16,9.33%,SLC30A10;SLC39A10;MT1E;MT3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.40942003769323965,0.7354307089388822,0.8378378378378378,0.9860249040744822,1.0,3/9,7.59%,NLGN2;ZDHHC3;ADRA1A
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.3989553846922439,-0.7353854073113985,0.859375,1.0,1.0,8/22,26.12%,P2RY12;ZSWIM4;TGFB1;PDGFRB;USP14;STX4;EFNB2;GPR183
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.35267796504056037,-0.7352991916243853,0.8588235294117647,1.0,1.0,7/46,13.16%,SYT1;RYR3;SYT2;KCNH1;ADGRV1;SYT4;ADCY1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.35267297580487716,0.7349284993526688,0.7857142857142857,0.986125750863057,1.0,6/16,16.38%,C12ORF57;CALM3;SRI;GRK2;CALM1;SMAD7
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.40245466873021807,-0.7347148321348992,0.8253968253968254,1.0,1.0,5/16,19.25%,C4BPA;CPB2;C1S;PROS1;CD55
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4300482298737751,-0.7347121443290958,0.8676470588235294,1.0,1.0,1/17,1.05%,EFNA1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.4087201787568337,0.7346424586097008,0.7441860465116279,0.985876523592723,1.0,1/8,3.78%,CHAMP1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3624339621778364,-0.7344864834769544,0.8831168831168831,1.0,1.0,5/37,14.59%,NEDD9;EFNA5;DOCK5;ITGB1BP1;PDPN
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.4812587411636017,-0.7341471643724101,0.875,1.0,1.0,1/7,21.31%,ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.3987436636246207,-0.7340267672724189,0.8285714285714286,1.0,1.0,5/18,17.81%,DUOX1;VEGFA;AKT2;PDPN;CCDC25
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.4863847147261897,0.7338658434535076,0.8787878787878788,0.9863936999562485,1.0,1/5,2.76%,CALR
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.4162785996616032,0.7336640588474838,0.85,0.9860946771509391,1.0,1/6,20.94%,NDUFA12
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.4526092951462044,-0.7335849198664842,0.8656716417910447,1.0,1.0,3/8,27.22%,MACF1;ERMN;MYO9A
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.4333597807950705,-0.7335755807087079,0.8253968253968254,1.0,1.0,1/9,8.05%,PARN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.37259014892144265,0.7335144222081215,0.8285714285714286,0.9856962047982778,1.0,3/10,16.93%,SNX12;DNAJA1;NDFIP2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.4628686791861395,-0.733191662092596,0.8032786885245902,1.0,1.0,4/9,18.09%,KLF9;BCL2L11;FAM107A;ZFP36L2
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.3989276032771865,0.7329140921355952,0.7352941176470589,0.9858301958555878,1.0,3/5,26.45%,JMJD6;ALKBH3;ALKBH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.42045554022896453,-0.7325250944655224,0.873015873015873,1.0,1.0,3/13,17.64%,CACNA1C;RYR2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.4511556033814458,-0.7324084208828682,0.8301886792452831,1.0,1.0,3/8,16.02%,MAP2K1;TGFB1;RIPK1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.3490221672028629,-0.7321906047715925,0.9024390243902439,1.0,1.0,2/51,0.98%,IGF2BP2;IGF2BP3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3413227404688163,0.731719961584803,0.8260869565217391,0.9867199940561623,1.0,2/32,6.20%,PMEPA1;PPM1A
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.3901683167040546,-0.7314451009428714,0.8831168831168831,1.0,1.0,3/20,12.47%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.4365838158116982,-0.7305210759773009,0.7878787878787878,1.0,1.0,3/8,34.57%,NNMT;BRMS1;SPRED2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.3031025637345411,-0.7304793545171806,0.9690721649484536,1.0,1.0,26/274,10.90%,CD44;GCA;SLC2A3;PYGL;ENPP4;PTPRC;PTPRB;VCL;PPIE;GLIPR1;MGST1;RAB3A;HRNR;GPI;PYGB;HVCN1;HLA-C;CRISPLD2;B2M;ACTR1B;SNAP25;STOM;FAF2;RAB3D;CCT8;FRMPD3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3029138042254465,-0.7304655963506348,0.9690721649484536,1.0,1.0,26/275,10.90%,CD44;GCA;SLC2A3;PYGL;ENPP4;PTPRC;PTPRB;VCL;PPIE;GLIPR1;MGST1;RAB3A;HRNR;GPI;PYGB;HVCN1;HLA-C;CRISPLD2;B2M;ACTR1B;SNAP25;STOM;FAF2;RAB3D;CCT8;FRMPD3
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.4427446016149491,-0.7304295290946812,0.8,1.0,1.0,2/9,13.85%,VEGFA;PTPRJ
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.4409205640733347,-0.7302933773778207,0.8108108108108109,1.0,1.0,2/10,17.27%,ENTPD3;ENTPD7
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.42566111171860854,-0.7302899314562606,0.8461538461538461,1.0,1.0,4/13,10.98%,NR4A3;FGF9;GJA1;MEF2D
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2838593545884073,0.7302763435798743,1.0,0.9880155460673617,1.0,5/47,10.79%,CCND1;GPNMB;PSME3;CDKN2C;CDC73
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.3292590778715179,-0.7300823759041126,0.868421052631579,1.0,1.0,8/61,16.74%,TMEM213;ALDH1L1;CALB1;SLC3A1;CYP3A5;ACOT11;RHCG;RBM47
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.28676129242589404,-0.7295115348607408,1.0,1.0,1.0,189/1384,17.75%,HEY2;ZIC4;AHR;PLAG1;ARX;HES1;ZNF233;EFNA1;NR4A3;CRYM;NLRC5;CAMK1;SOX9;FGF1;FOS;ZNF235;MNT;OTUD7B;OVOL2;ZSCAN1;IRF1;CEBPD;CDKN2A;MAFF;ZNF552;CDK7;CBX7;ZNF829;ZFP69;PARP9;EBF1;BRCA1;PROX2;ZNF850;ZFPM1;GADD45A;SPI1;ZFP92;KLF6;NKX6-2;ZNF555;ELK3;ZNF550;MAX;VEGFA;NFE2L3;DUSP22;SRF;STAT6;ZNF394;AEBP2;RARA;BCL9;ARID5A;KLF9;SREBF1;ZNF546;IFRD1;TCFL5;NCOA1;STAT4;ETV4;DUXB;STAT2;HIF3A;ZNF136;ACTL6B;RPS14;ZNF790;ZNF184;NR1D1;RUNX2;ATAD2;THRAP3;ZNF814;AHI1;BRD9;APOE;PLSCR1;SS18L2;ZNF749;LMO2;SP140;DVL2;FOXO1;CDK4;MLIP;ZNF226;ESR2;ZNF133;ARNT2;BACH1;ZNF785;CCNQ;TCF7;JUNB;ZNF224;TAF1;ZNF540;BCL11A;KDM7A;STAT5A;SSBP4;KLF15;MEF2D;CREBRF;MEIS2;CRLF3;ZNF169;ZNF415;ZNF160;ARRB1;ZNF211;ZNF490;ZSCAN2;ZNF568;STAT3;ZFP28;EZH1;ZNF154;ZNF197;ZIC1;GLIS3;TCF25;ZNF565;WWP2;SRA1;DDX20;ZNF234;NPAS2;USF1;ITGB1BP1;BHLHE40;HDAC4;PAXBP1;PER1;ST18;ZNF461;FOXO6;TGFB1;ZNF449;ORC2;MRGBP;AASS;ZNF81;LHX4;SMARCA1;RIF1;ZNF566;ENO1;UXT;ZSCAN32;RFXAP;ZNF652;CTBP1;STAT5B;CDKN2B;RIPK1;BCL6;ZNF589;CPHXL;IKZF4;BRD4;GABPB1;ZNF599;DDRGK1;MAP2K5;ZNF275;CC2D1A;ZNF610;RFX4;TAF6L;ZNF586;ZNF141;NEDD4L;SLC30A9;MAML3;ZFHX3;CIITA;ZSCAN18;FOXP2;PTPRN;WNT7A;ZFPM2;CEBPZ;CDC5L;CAMK2D;IRF2;ZNF395
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3382636815427164,-0.728952826502088,0.896551724137931,1.0,1.0,9/69,20.86%,RFC4;CCT6B;CLVS1;ZC2HC1C;GAPDHS;CNIH2;VDAC3;PRKAR2A;MAP7
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.4393108907801654,0.7286967878864605,0.7441860465116279,0.9883292995549539,1.0,1/6,3.14%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.4393108907801654,0.7286967878864605,0.7441860465116279,0.9883292995549539,1.0,1/6,3.14%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.4393108907801654,0.7286967878864605,0.7441860465116279,0.9883292995549539,1.0,1/6,3.14%,MSN
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.311746755166868,-0.7280798987191694,0.9659090909090909,1.0,1.0,21/114,17.99%,ANGPTL4;SOX9;HSD11B1;FGF9;ITGA2;AKAP12;PSMB8;ETV4;PTPRR;SNAP25;TRIB1;SPARCL1;SPP1;GLRX;AKT2;PDCD1LG2;CA2;F13A1;WNT7A;ITGBL1;RBM4
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.41663975579504964,-0.7280529384986654,0.8194444444444444,1.0,1.0,1/14,7.81%,WDR12
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.4173165635978118,-0.7277520585199321,0.9014084507042254,1.0,1.0,6/17,29.30%,RMND1;RPUSD3;MALSU1;TRUB2;RCC1L;FASTKD3
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3162426861865232,-0.7275692154054356,0.9302325581395349,1.0,1.0,21/101,21.78%,DAPK1;PRXL2C;PLEKHF1;APOE;FOXO1;DTX3L;SLC4A4;PLK2;TPCN1;GAPDHS;AKT2;SVIP;ADAM9;RNF152;RDX;PIK3CB;PFKFB3;PSEN1;TRIM5;PNPLA2;PFKFB2
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.3410671495509304,-0.727517375559898,0.881578947368421,1.0,1.0,6/48,9.98%,SREBF1;ACSM6;LIPI;GPAM;LIPH;ACSL1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.31532671964164694,-0.7274060599355432,0.9642857142857143,1.0,1.0,17/103,19.04%,CARD14;TMSB4X;BRCA1;PSMB8;CD27;NR1D1;EDARADD;PSMA4;MAP3K14;ST18;TRAF3;RIPK1;PSMA3;YBX3;ZFP36L2;DAB2IP;STAT1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4054714808101445,-0.7273972265875132,0.8805970149253731,1.0,1.0,2/12,8.28%,CIAO2A;MMS19
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.30446923615280264,0.727268005843775,0.9473684210526315,0.9896787847435883,1.0,16/77,11.43%,UBB;TGFBR2;ZFP36L1;PDE3A;ITGB5;BAMBI;NR3C1;SMAD9;LIMS1;SOX6;SMAD3;DUSP15;TGFBR1;UBC;JUN;TWSG1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.3552469974022258,-0.7271241319992177,0.8266666666666667,1.0,1.0,7/26,18.12%,TPD52L1;BCL2L14;TRAF7;BDNF;ING5;MADD;DAB2IP
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.45271357632122045,-0.7270722021313444,0.8181818181818182,1.0,1.0,7/10,28.88%,TRIB1;CD55;TRIM5;SASH1;PRKCA;SCIMP;CARD8
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.3014577015634905,-0.7270241794637301,0.9591836734693877,1.0,1.0,26/277,10.90%,CD44;GCA;SLC2A3;PYGL;ENPP4;PTPRC;PTPRB;VCL;PPIE;GLIPR1;MGST1;RAB3A;HRNR;GPI;PYGB;HVCN1;HLA-C;CRISPLD2;B2M;ACTR1B;SNAP25;STOM;FAF2;RAB3D;CCT8;FRMPD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3657780046064081,0.7269644073898244,0.8928571428571429,0.9895449617012346,1.0,5/17,14.79%,CALM3;SRI;GSTM2;JPH4;CALM1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3481644300615377,-0.7268600014242679,0.9078947368421053,1.0,1.0,8/47,18.62%,MAP3K12;TAF1;CAMK2A;CIT;MAP2K1;CDC42BPB;CAMK2D;PRKD2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.4416226049123999,-0.7258434147246656,0.8208955223880597,1.0,1.0,4/10,27.49%,PEX5L;PEX14;PEX1;PEX16
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.32105057262140557,-0.7253078061036266,0.9382716049382716,1.0,1.0,8/87,9.40%,MAK;STEAP4;SRF;FKBP5;HERC3;AKAP12;LIFR;B2M
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.460196863347574,-0.7248809404801114,0.8923076923076924,1.0,1.0,4/7,40.80%,ATP1B1;ACTN2;ATP1B2;ATP1B3
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.32490390400809743,-0.7247540377250083,0.8860759493670886,1.0,1.0,2/52,3.13%,CMTR1;METTL2B
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.400670998078857,-0.7247294562302521,0.8831168831168831,1.0,1.0,5/26,15.17%,NUAK1;PTPA;MASTL;TSC1;PDGFRB
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.32165826271042836,-0.7246970423908331,0.8928571428571429,1.0,1.0,23/82,25.47%,STMN2;SNCB;KCNC1;SLC6A9;ACTL6B;PSD2;MMD2;SULT4A1;JPH3;CELF3;PHYHIP;CNIH2;MPP2;KIF1A;INA;SRRM3;PNCK;GRIN1;LRRC4B;CASKIN1;CACNG7;TMEM151A;BRSK1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.4561581309177858,-0.7243808281185917,0.8285714285714286,1.0,1.0,3/8,13.54%,VCL;PAK2;TBCD
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.32074580479428877,-0.7243584597366725,0.9156626506024096,1.0,1.0,18/81,24.80%,VEGFA;STX1B;APOE;BCL2L11;LCMT1;SVIP;TGFB1;HDAC6;CRYAB;GFAP;SLF1;DAB2IP;TIRAP;WARS1;NRG1;FBLIM1;PRKCZ;NOP53
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.31508085278661235,0.724339214865166,0.9545454545454546,0.9921661199258757,1.0,12/33,18.21%,ZDHHC1;PORCN;ZDHHC3;ZDHHC6;ZDHHC21;NAT10;NAT9;ZDHHC16;ZDHHC2;ZDHHC13;HHAT;ZDHHC5
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.3190693505279383,-0.7242670151836691,0.9404761904761905,1.0,1.0,6/80,10.21%,IL5;DDB2;VEGFA;USP50;BCL2L11;RPA3
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.4145116529838139,0.7239815419386172,0.8620689655172413,0.9920061737495783,1.0,1/9,4.14%,UBE2N
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.29293502013805645,-0.7238655706092793,0.98989898989899,1.0,1.0,73/461,18.68%,CD44;ANGPTL4;GADD45B;CARD14;SOX9;APIP;STK17A;TFPT;AGT;BCL2L2;ANP32E;GADD45A;DAPK1;VEGFA;TMEM14A;NLRC4;VAV3;LRP2;CD27;ALK;AHI1;FANK1;BCL2L14;MTCH2;FOXO1;PTPA;IL7;RNF157;BCL2L11;MOAP1;RASA1;HMGN5;PREX1;TOMM70;PLK2;TIAM1;C3ORF38;DNM2;PAK2;OLFM1;GCLC;LCMT1;CYP1B1;SRA1;DDX20;AKT2;DAPK3;PDPN;ING5;IGF1R;ITGB3BP;NSMF;RIPK1;CRYAB;WRN;BCL6;IFIT3;BEX2;KNG1;ATG7;YME1L1;DDRGK1;BNIP3L;ARHGEF17;ANO6;RPS6;MADD;ATM;DAB2IP;EGLN3;HTR2B;NGEF;USP36
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.4364458128774382,0.7236851601304956,0.8787878787878788,0.9918464176459804,1.0,3/10,5.61%,BAD;VEZF1;BTG1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.4642237074840344,0.7236625048880583,0.7714285714285715,0.991282209216378,1.0,1/5,4.68%,CDO1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.35268427015915116,0.723621381622531,0.9117647058823529,0.9907434297713782,1.0,2/13,7.20%,PPIA;PDE4B
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.3836310441955918,-0.7235857136925247,0.8873239436619719,1.0,1.0,6/22,20.38%,PDE6B;BHLHE40;PER1;RBM4;FBXL17;RBM4B
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.3873889556003023,0.7235750236534711,0.8333333333333334,0.9902465304741934,1.0,3/11,17.08%,HP1BP3;SIRT1;BAHD1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.44057318198077716,0.7235239095885816,0.75,0.9896925170573511,1.0,1/6,6.67%,GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.43506700847993285,0.7234092047213547,0.8709677419354839,0.9891803522170253,1.0,5/7,28.17%,ERCC4;POT1;TP53;TERF1;PIF1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.35618667096720097,-0.7229424807993481,0.8571428571428571,1.0,1.0,9/35,27.27%,ADGRV1;NBR1;TGFB1;ANO6;DDR2;MEF2C;ISG15;TGFB3;NELL1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3656522975801291,-0.7224037642472624,0.7887323943661971,1.0,1.0,5/23,16.02%,AGT;GADD45A;TGFB1;PDGFRB;RIPK1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.30500721117456464,-0.7223505696942378,0.9775280898876404,1.0,1.0,23/181,13.04%,ZIC4;GRIN2A;SYNJ2;SOX9;B3GNT5;ROBO2;HAP1;ADGRL2;GRIN2D;MYRF;SLC6A17;AHI1;BTD;HPCAL4;WWP1;LOXL3;ACAN;ARNT2;EPHA7;MEIS2;STAT3;NPTX1;ZIC1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.36291337085362113,-0.7222837994147153,0.8918918918918919,1.0,1.0,3/28,9.46%,PRELP;CHAC2;ACAN
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.4177160824680266,-0.7222222184263732,0.8552631578947368,1.0,1.0,1/14,8.56%,EIF2B4
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.36816976454014594,0.7220085873436718,0.8285714285714286,0.9905295772336742,1.0,5/9,22.49%,WNT3;LATS1;WNT7B;AKT1;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.35395869243734296,-0.721769259191611,0.9186046511627907,1.0,1.0,5/35,14.87%,CAMK1;EMD;ZIC1;TGFB1;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4621362132277427,-0.7211786049953236,0.85,1.0,1.0,2/7,24.39%,AKT2;IRS2
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.49110593717925555,-0.7203836124063128,0.9090909090909091,1.0,1.0,2/5,26.93%,PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.4560408011831305,0.7200977004580068,0.8387096774193549,0.9915949242421218,1.0,3/6,30.06%,WNT5A;ADAM17;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.4560408011831305,0.7200977004580068,0.8387096774193549,0.9915949242421218,1.0,3/6,30.06%,WNT5A;ADAM17;ADAM10
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.31266182216163096,-0.7199907862656193,0.9456521739130435,1.0,1.0,16/129,15.23%,HEY2;OVOL2;PARP9;PARP14;SPI1;VEGFA;APOE;TAF1;LRPAP1;OLFM1;WWP2;MAP2K1;PTRH2;TGFB1;RBL2;DLG4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.2537574250246861,0.7199703491639675,1.0,0.9911321595770727,1.0,23/111,19.29%,LSM4;EIF4H;EIF5;RPS19;PUF60;RPSA;GEMIN8;CDC73;RPL23A;DENR;MRPS7;SNRPB;SNRPD2;PRPF19;SRSF9;STRAP;SNRPE;SF3A2;CELF5;SNRPF;DDX1;BOP1;SF1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3986015758211773,-0.7198204238290221,0.8472222222222222,1.0,1.0,1/16,3.80%,BRCA1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.3276639340889932,-0.7197296703507065,0.872093023255814,1.0,1.0,10/63,18.61%,MAGOHB;SLBP;AHCYL1;SRSF5;THOC5;CASC3;CDC40;NCBP1;DHX38;RPRD2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.3594141871853523,0.7197291790397259,0.8928571428571429,0.9908835082345439,1.0,4/15,9.33%,SLC30A10;SLC39A10;MT1E;MT3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.447519189886258,0.7197014959486929,0.8333333333333334,0.990323198856717,1.0,2/6,14.67%,NTNG2;NTN4
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.37266055170525286,-0.7196926117654578,0.8974358974358975,1.0,1.0,7/24,24.32%,DONSON;FBXO6;CDC5L;ATM;DOT1L;RAD9A;HINFP
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.30986795067355166,0.7191976769141641,0.875,0.9903542680933177,1.0,9/61,11.94%,SIRT2;RNF144A;HSPA1A;PRICKLE1;PSMD10;ZYG11B;BAG2;UBQLN2;RCHY1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.45172656344406736,-0.7191918127513042,0.8387096774193549,1.0,1.0,5/7,23.36%,TGFB1;ACMSD;ABCA2;AP2A1;CLTC
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.3947942094882172,0.7190764580851648,0.8611111111111112,0.9899425238051557,1.0,1/9,2.76%,CALR
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3485251005688881,-0.718941400808594,0.9285714285714286,1.0,1.0,3/32,9.14%,KCNMB4;KCNN3;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.3148410263970662,0.7189102843415927,0.85,0.9895558489988866,1.0,2/25,2.33%,CRB2;SPOCK3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.40822053128918306,-0.7189047154147216,0.821917808219178,1.0,1.0,4/14,26.01%,RHOJ;RHOU;RAC3;GSN
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3264730724171569,-0.7189035630638446,0.9240506329113924,1.0,1.0,19/73,16.32%,PAMR1;TIMP3;LAMA2;MLANA;FKBP9;LIFR;EDNRA;GJA1;PDE8A;SVEP1;KIAA1217;SPARCL1;ACSBG1;MATN2;ADAM21;ABCA8;COL4A2;CRYAB;C1S
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.3232699017374113,-0.718806341722847,0.9318181818181818,1.0,1.0,12/82,19.19%,TUBA4A;CEP135;RAB11A;AHI1;NPHP4;B9D1;HAUS5;CSNK1D;DCTN1;CEP72;CC2D2A;TCTN1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.41692601643311206,-0.7186394451780231,0.75,1.0,1.0,1/10,4.22%,ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.44355692686722736,-0.718594215124246,0.8939393939393939,1.0,1.0,2/8,17.64%,NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.37065774063889534,-0.7184464962300824,0.8260869565217391,1.0,1.0,6/21,19.64%,GADD45A;APOE;ITGB1BP1;TGFB1;MAP2K5;ANGPT2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.34603732007402094,0.7183001859159978,0.8421052631578947,0.9896937841394899,1.0,1/15,3.74%,TLR1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.3894441295672283,0.7176711959592309,0.8,0.9898315569079441,1.0,2/9,18.34%,SMPD3;SAMD8
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.3735807759421306,-0.7171658243397073,0.8571428571428571,1.0,1.0,4/21,15.45%,NEDD9;PLS3;FAM107A;BAIAP2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.3915959976986088,-0.7170766793184095,0.8095238095238095,1.0,1.0,2/10,16.27%,APOE;ATG7
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.4449390761301153,-0.7168932117527319,0.84,1.0,1.0,1/11,6.80%,GRAMD1C
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.48960113804436195,-0.7168840673438117,0.8260869565217391,1.0,1.0,3/5,30.84%,PRKCA;PRKCH;PRKCI
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3064334054941887,-0.7164105003526652,0.9782608695652174,1.0,1.0,27/207,17.96%,RFC4;POLQ;BRCA1;GADD45A;DDB2;FANCC;FBXO6;RFC2;MSH6;RFC1;ZRANB3;HELB;MMS19;BACH1;RPA3;XRCC3;CDC7;THAP9;ORC2;PNKP;RIF1;WRN;PARG;LIG3;NTHL1;TERF2IP;ATM
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.42262150343297433,-0.7163860439404316,0.9117647058823529,1.0,1.0,4/12,18.37%,P2RY12;EDNRA;BDNF;HTR2B
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.48698435945655927,-0.7159777105908783,0.8688524590163934,1.0,1.0,1/6,1.09%,AZIN2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.3472526044423575,-0.7159601600822226,0.8840579710144928,1.0,1.0,4/30,12.88%,BRCA1;CAV3;TCHP;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4767167471490352,-0.7158537047925785,0.8392857142857143,1.0,1.0,2/6,18.62%,GRB10;PRKD2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.3583507442499885,0.7156435998300869,0.8888888888888888,0.9921124006526117,1.0,3/16,17.04%,LIG4;SETMAR;CENPV
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.3738394618719415,-0.715565230571966,0.819672131147541,1.0,1.0,5/14,27.61%,UBASH3B;PRXL2A;CSF1;LRRC17;FSTL3
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.4894791968406887,-0.7155623599383962,0.8181818181818182,1.0,1.0,2/5,36.83%,CDK9;RPS6KA5
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.37889024964173357,0.7155095215361302,0.8333333333333334,0.9916763066682039,1.0,2/8,18.77%,AGA;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.30360923330954664,-0.7150000607317648,0.9473684210526315,1.0,1.0,30/151,21.20%,CARD14;AGT;TRIM52;VEGFA;SRF;NLRC4;ALK;FANK1;DVL2;ESR2;TAF1;CAMK2A;CARD11;TRIM41;STAT3;CAMK1D;ADCY1;HDAC4;RIPK1;IRAK2;DDRGK1;ROR1;TERF2IP;PRKD2;TRIM25;TIRAP;RELN;TRIM5;DDR2;CRTC3
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.41762395671293784,0.7144994415146386,0.7872340425531915,0.9924091304154656,1.0,1/7,5.18%,DNAJB12
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.4175527660036831,-0.7142974317581238,0.8783783783783784,1.0,1.0,2/10,17.27%,ENTPD3;ENTPD7
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.3839657007894455,0.71417452270128,0.8205128205128205,0.9922101845262419,1.0,2/8,3.16%,CCDC88C;EPDR1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3166616030385826,-0.7141410799914951,0.9285714285714286,1.0,1.0,11/75,16.59%,CARD14;TMSB4X;PSMB8;CD27;EDARADD;PSMA4;MAP3K14;ST18;TRAF3;RIPK1;PSMA3
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.30376166453716963,0.7139269213222313,1.0,0.9919543446072775,1.0,4/38,9.98%,HSPA1A;ERN1;NUDT16L1;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.38783921136259747,-0.7134683417032853,0.8823529411764706,1.0,1.0,6/24,27.74%,PPIE;IFIT1;NR5A2;ADAR;PPID;PPIH
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.43400049854083816,0.7131776890106447,0.8529411764705882,0.9921963384700249,1.0,2/6,14.76%,SRM;SAT1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.43478258370500017,-0.7130884741418466,0.8714285714285714,1.0,1.0,2/9,22.95%,FZR1;RAB1A
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.4773145308958653,-0.7127857190859394,0.8253968253968254,1.0,1.0,1/7,3.49%,VCL
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4014736532724771,-0.7126748513672363,0.8243243243243243,1.0,1.0,1/15,1.99%,EMP2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.35562956586966754,-0.7123594006778158,0.8533333333333334,1.0,1.0,4/27,20.15%,XRCC3;THAP9;WRN;RECQL
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2947099739374371,0.7121968565511275,1.0,0.9925929273031795,1.0,16/86,13.55%,UBB;TGFBR2;ITGB5;BAMBI;SMAD9;SMAD3;DUSP15;TGFBR1;UBC;SMURF2;RGMB;JUN;TWSG1;FNTA;BMP2;ZYX
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.3344551070310975,0.712078355149607,0.9230769230769231,0.9921499379252101,1.0,2/22,8.11%,HSPA1A;MAPK11
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.4293313631326192,0.7119895730557251,0.7692307692307693,0.9911271820347826,1.0,6/6,57.09%,TPR;IWS1;NSUN2;SETD2;SUPT6H;AKAP8L
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.4293313631326192,0.7119895730557251,0.7692307692307693,0.9911271820347826,1.0,6/6,57.09%,TPR;IWS1;NSUN2;SETD2;SUPT6H;AKAP8L
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.28673051468417843,-0.7119399143390726,0.9797979797979798,1.0,1.0,53/316,20.09%,SOX9;FGF1;PTPRC;LRRC19;FGF9;AGT;PTP4A3;TRIM52;NRG4;P2RY12;VEGFA;TNFRSF19;LRP2;CD27;TRIM44;GJA1;KITLG;BCAR3;BCL2L11;AKR1C2;NLRP12;ADGRV1;TRAF7;CARD11;PLK2;NTRK3;NEK6;MAP3K14;PTPRJ;C1QTNF4;AKT2;MYORG;ITGB1BP1;PDCD4;TGFB1;PDGFRB;RPTOR;IGF1R;RIPK1;BRD4;CC2D1A;ROR1;IFI35;TERF2IP;DAB2IP;PPP5C;HTR2B;PRKD2;PIK3CB;DNM1L;TRIM25;TIRAP;RELN
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3170080828541874,0.711871009883641,0.9285714285714286,0.9906532972282407,1.0,1/27,0.64%,RFWD3
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.2977343325977943,-0.7117463580237118,0.9787234042553191,1.0,1.0,22/152,16.95%,GYPE;SLC22A4;ALDH1L1;RHCE;TMCC2;SIDT2;TNS1;SLC6A9;LMO2;BACH1;KDM7A;NARF;EZH1;GCLC;MBOAT2;CAST;SEC14L1;CA2;MPP1;FECH;BNIP3L;CPOX
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.4592841212057966,-0.7106231173686564,0.835820895522388,1.0,1.0,3/5,24.33%,JAK1;PDPN;DMTN
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.35591402047752985,0.7102709327423938,0.7777777777777778,0.9920330791993108,1.0,3/17,10.91%,SOX11;SMAD3;SMURF2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.44191433693587123,-0.7102651298570986,0.8032786885245902,1.0,1.0,1/6,8.23%,KLC1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.3940537797557009,0.7100641306235493,0.8823529411764706,0.9917460464815248,1.0,2/9,7.87%,ZFP36L1;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.49790471901470235,-0.7099120984109312,0.8571428571428571,1.0,1.0,2/5,17.01%,SHANK3;ANO6
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.40851072518925513,-0.709687405411936,0.9166666666666666,1.0,1.0,2/12,11.73%,HVCN1;RAB11FIP5
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.46202360675288895,-0.7095908186039275,0.8125,1.0,1.0,5/6,34.39%,CBY1;NRG1;KDM6B;AKAP13;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3931186867588789,-0.7094711280685585,0.8783783783783784,1.0,1.0,9/18,24.56%,STX1B;RIMS1;DLG4;SHANK3;WNT7A;RELN;GRIN1;PRKCZ;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.42118025009331506,-0.7093246963284251,0.8441558441558441,1.0,1.0,5/10,26.86%,NCBP1;CPEB1;DHX36;CPEB3;NCBP2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.35750162738090074,0.7090320052583882,0.8928571428571429,0.9924822419001419,1.0,4/21,13.48%,HIPK1;SALL2;MEIS3;ZDHHC16
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.3360962990084681,0.7089667047443465,0.9473684210526315,0.9920005589636676,1.0,5/21,14.79%,SMPD1;PPIA;CALM3;BMP2;CALM1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2986110856882362,-0.7089385261466811,0.9895833333333334,1.0,1.0,40/262,15.89%,EFNA1;NR4A3;FGF1;SLC39A14;NEDD9;FGF9;ATP6V1E2;EFNA5;VEGFA;UBASH3B;HAP1;VAV3;DNM1;ALK;AHI1;FOXO1;BCAR3;EPHA7;RASA1;PAK1;SORBS1;TYRO3;BLNK;TIAM1;PAK2;STAT3;NTRK3;BDNF;PTPRJ;AKT2;PDK2;SULF1;EPHA4;NCBP1;PDGFRB;NRP2;IGF1R;BAIAP2;GRB10;COL4A2
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.270662188434774,0.7083529144529696,1.0,0.9921600275240032,1.0,15/80,14.53%,CFL1;CALR;MAP2K6;UBE2N;NGF;THEM4;DUSP3;RIT1;YWHAB;EIF4E;GRB2;ATF1;GRK2;PLCB1;RALB
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3449997184315865,-0.7081884888943276,0.8666666666666667,1.0,1.0,4/32,19.22%,CISD2;ATG7;RB1CC1;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.4127110500967115,-0.707927876657016,0.8493150684931506,1.0,1.0,2/12,26.86%,NRDE2;NCBP2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3052825971801383,-0.7079161434894994,0.9767441860465116,1.0,1.0,10/117,11.72%,IGF2BP2;AHR;IGF2BP3;PTPRC;STX1B;TRIM44;APOE;CDK4;RASA1;TAPBP
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3767389594302516,-0.7078009094281204,0.8840579710144928,1.0,1.0,6/23,15.17%,NR4A3;FGF9;GJA1;MEF2D;IL6R;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.31003208248213077,-0.7077894109133882,0.9404761904761905,1.0,1.0,16/79,20.05%,CALCB;LPCAT3;NR1D1;APOE;AOAH;NLRP12;TYRO3;PLK2;TSHR;ADCY1;ADCY5;HTR4;PRKAR1B;ADCY3;GPR176;PRKAR2A
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.4166902776868899,0.7076153710074312,0.8846153846153846,0.9924165582939323,1.0,1/8,3.60%,PDE3A
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.32333033968723196,0.7075939341356879,0.9259259259259259,0.991870960936895,1.0,5/23,9.79%,SEMA5B;SEMA5A;SEMA4F;SEMA3B;DUSP3
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.3391780908916394,-0.707524437679775,0.9342105263157895,1.0,1.0,6/41,9.93%,POLQ;MSH6;ZRANB3;HELB;FANCB;SHLD2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.4011230481481279,-0.7074689534456264,0.9358974358974359,1.0,1.0,1/15,1.22%,MYLK
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.46737473220528275,-0.7070458902679259,0.8333333333333334,1.0,1.0,2/7,20.13%,PFKP;HK1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.39546852974514773,-0.7067361219331567,0.8831168831168831,1.0,1.0,6/21,20.75%,PTPRC;CAMK1D;PTPRJ;ANO6;TUB;MERTK
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.4184744141381602,-0.7066856888030922,0.7741935483870968,1.0,1.0,1/6,6.51%,LRP2
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.40934682843036785,-0.7065148647889553,0.9178082191780822,1.0,1.0,1/16,1.00%,HES1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3557316484910259,-0.7065001772854873,0.891566265060241,1.0,1.0,7/31,23.93%,RPA3;RIF1;WRN;TERF2IP;ATM;DOT1L;RPA2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.35141919726037363,-0.7063585773366079,0.92,1.0,1.0,4/29,12.42%,RAB3A;RAB3D;RAB15;TANGO2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.31435909971841275,0.7063019619302929,0.9523809523809523,0.9926211301951993,1.0,6/35,12.59%,HSPA1A;ERN1;NUDT16L1;PPP1R8;RNASEH2C;MTREX
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.3835927834233218,0.7062930409376605,0.9,0.9920436891654174,1.0,2/13,3.06%,SIRT2;PPT1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.33966183164030833,-0.7060953517039813,0.8625,1.0,1.0,9/51,19.20%,PON1;CALY;APOE;CAMK1D;AKT2;NEDD4L;GPC3;KMT2A;TUB
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4356651008842566,-0.7055925675613243,0.8194444444444444,1.0,1.0,2/6,28.28%,PLAAT3;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.4120483277136636,-0.705128928864109,0.8529411764705882,1.0,1.0,3/13,15.42%,CLEC16A;HDAC6;IGF1R
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.27532191394448496,0.7050221490533988,1.0,0.9929788443753238,1.0,9/54,14.19%,TRMT112;TRMT10A;AARS1;METTL2A;TYW5;ANKRD16;DTWD1;TRMO;TRMT5
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.35853597097690076,0.7047463852488921,0.7931034482758621,0.9926846826948525,1.0,5/16,14.46%,CATSPERD;WBP2;YAP1;CATSPERB;ABHD2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3127280814206459,-0.7046915303365566,0.9294117647058824,1.0,1.0,12/105,14.76%,GNA12;CDKN2A;ARHGDIG;LIMK1;SHTN1;USP50;CDC42EP3;RASGRP1;PLK2;TIAM1;PDPN;USP8
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.3051936542180228,0.7045556261604217,0.9333333333333333,0.9924150899723121,1.0,8/25,29.83%,RNF128;AP4M1;LAMTOR5;SCARB2;LAMTOR4;NCOA4;GCC2;AP3M1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.4106487248889359,-0.7043321932355835,0.896551724137931,1.0,1.0,3/14,23.67%,SLC6A9;SOCS4;CHMP6
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.4835045854682071,-0.7041587938449382,0.8571428571428571,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.3636108904208975,0.7040828799925013,0.8529411764705882,0.9923637293944072,1.0,4/14,20.18%,TRIM71;TAFA1;PTPRZ1;TOX
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.48587497647604544,-0.7035632966924247,0.8688524590163934,1.0,1.0,3/5,28.59%,MAP2K5;ABCA1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.41958193152797596,-0.7032136423640288,0.8153846153846154,1.0,1.0,7/11,29.50%,NR1D1;IFI35;DAB2IP;TIRAP;FLOT1;APPL2;NINJ1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3448362395030368,0.7029843019987801,0.78125,0.9931352012270667,1.0,4/16,14.30%,SUB1;MED24;JUN;MED30
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.2916145104433125,0.7028963557415936,0.8666666666666667,0.9926642730888761,1.0,6/56,7.47%,SOX11;ASCL1;CALR;MOSMO;BRINP1;NGF
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.3850389030165038,0.7023428869748243,0.8285714285714286,0.9927820555318217,1.0,3/11,21.03%,C12ORF57;NFIB;EPHB6
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.37960210709441683,0.7022269650697069,0.8,0.9923924011299509,1.0,2/6,19.27%,MECP2;KDM1B
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.2726226950162103,0.7016641675205346,1.0,0.9925021568558869,1.0,5/38,8.12%,TRIM28;UBE2N;MGMT;PARP1;TMEM161A
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.42211519853639545,0.7012234616767843,0.8055555555555556,0.9924509241533922,1.0,5/7,25.77%,MT1E;MT3;MT2A;PRNP;HSF1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.2973721235762839,-0.7010611285226404,0.9885057471264368,1.0,1.0,13/114,16.07%,TESPA1;CCDC39;VAMP1;OTUD6B;CALY;SRP54;TIAM1;CHMP4B;CENPC;TBCD;NDUFAF1;TGFB1;PFDN6
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.3912164939532284,-0.7009334577449863,0.9066666666666666,1.0,1.0,4/19,15.47%,TTN;KCNQ1;TPM1;RYR2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.28188857620586577,-0.7009324256485563,0.99,1.0,1.0,68/661,15.00%,HEY2;MSL3;IGF2BP2;AHR;PLAG1;IGF2BP3;TTN;SOX9;FGF1;VSIR;PHF19;OVOL2;PTPRC;LRRC19;FGF9;PARP9;PPIE;BRCA1;PTP4A3;PARP14;SPI1;NKX6-2;USP13;VEGFA;ATXN1L;FAM98B;TCFL5;ZNF90;BTN3A1;BAZ2A;STX1B;TRIM44;ATG14;APOE;PLSCR1;GJA1;RIMS1;DVL2;CDK4;ESR2;ARNT2;BACH1;MBNL3;TCF7;TAF1;TULP3;CAMK2N1;HMGN5;TAPBP;DNM2;EPHX2;STAT3;OLFM1;SPIN2A;NTRK3;WWP2;ZUP1;MAP2K1;BHLHE40;HDAC4;PER1;DAPK3;PTRH2;TGFB1;ELAVL2;BTNL2;RBL2;HDAC6
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.40584739514469803,0.700711206034161,0.7906976744186046,0.9922952511633577,1.0,1/6,3.18%,RIT2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.40501662915169856,0.7006957661905457,0.9375,0.9917380690125589,1.0,4/8,14.91%,SLC2A10;CHP1;PLCB1;SOAT1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3320012447272082,-0.70041251963559,0.9294117647058824,1.0,1.0,7/55,19.05%,POLQ;BRCA1;RIF1;XRCC4;LIG3;ATM;ABRAXAS1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.2866429184255564,0.7003331601724597,0.95,0.9915749582205935,1.0,8/48,14.07%,LRRC8D;SLC25A1;SLC5A6;ARL6IP5;SLC7A2;SLC35B4;SLC25A14;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.3398189389074991,-0.7002569100610432,0.9041095890410958,1.0,1.0,12/40,21.84%,P2RY12;VEGFA;ECM2;TPM1;PTPRJ;EPHA4;ZFHX3;ADAM9;ATM;PRKD2;RNASE10;STX4
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.4027353955713886,-0.700214938874986,0.8524590163934426,1.0,1.0,3/9,28.59%,SVIP;USP14;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.28044531736046924,-0.7000853579570909,1.0,1.0,1.0,48/328,15.47%,HES1;SOX9;SLC6A6;FGF1;SPDYA;EMP2;FGF9;CRLF1;VEGFA;SRF;RARA;FAM98B;BRAT1;LIFR;MYRF;DVL2;CDK4;KITLG;IL7;OSMR;CDC7;AKR1C2;MCTS1;PAK1;HMGN5;MEIS2;IL6R;TPM1;TIAM1;CAMK1D;TSHR;ACACB;NTRK3;PTPRJ;AKT2;ITGB1BP1;KIF20B;HDAC4;PDPN;TGFB1;TBC1D8;EPHA4;NCBP1;PDGFRB;CDCA7L;RPTOR;IGF1R;RYR2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.41658392135589295,-0.7000848558985121,0.9142857142857143,1.0,1.0,2/10,21.31%,GLRX;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.4661799790130349,-0.6999955943358898,0.8450704225352113,1.0,1.0,2/5,37.81%,YTHDC2;NUCKS1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.41055710869144774,-0.6993437872396467,0.8615384615384616,1.0,1.0,4/11,15.61%,MX1;AKAP1;OAS1;IFIT1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.4014576441727171,-0.6992219519411328,0.8857142857142857,1.0,1.0,4/17,27.60%,LCMT1;NEK6;DUSP1;CDC27
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.346522520235504,0.6991665945662852,0.9285714285714286,0.9923830012563725,1.0,2/17,3.40%,PSMB6;PSMB4
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.3882641193137571,0.6985965144233692,0.875,0.9924683229819177,1.0,1/6,9.22%,ABHD5
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.4110614755353116,-0.6985696547445747,0.8088235294117647,1.0,1.0,4/14,19.62%,VSIR;DDRGK1;MAPK12;APH1B
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.36441163450525227,-0.698222269276189,0.9436619718309859,1.0,1.0,6/22,15.42%,GRIN2A;CACNA1B;GJA1;CACNB1;EPHA4;IGF1R
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.38924214824391246,0.6981598003286082,0.7272727272727273,0.9923852259185167,1.0,2/12,3.35%,NCSTN;ACHE
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.40632931355434526,-0.6978134507167645,0.90625,1.0,1.0,3/12,13.99%,TTN;TPM1;MYL6B
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.40632931355434526,-0.6978134507167645,0.90625,1.0,1.0,3/12,13.99%,TTN;TPM1;MYL6B
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.44293190594780624,-0.6978024306410199,0.890625,1.0,1.0,3/8,14.19%,GJA1;SPINK13;SULF1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.4526357132540096,-0.6977979506745147,0.9047619047619048,1.0,1.0,4/6,24.08%,TGFB1;MEF2C;EFNB2;DHX36
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.44721718709939295,-0.6973625773163632,0.8360655737704918,1.0,1.0,2/6,8.51%,NR1D1;APOE
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.31476891278893815,-0.6972680546569395,0.9390243902439024,1.0,1.0,11/61,20.59%,LIMK1;VEGFA;PFN2;BCL2L11;VIL1;TGFB1;SLF1;DAB2IP;SYNPO2;TIRAP;WARS1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3235040804305837,-0.697210879842455,0.9310344827586207,1.0,1.0,15/60,19.60%,C4BPA;APOE;FOXO1;WWP1;PLK2;WWP2;FZR1;ATG7;NEDD4L;ADAM9;RDX;OAZ2;DAB2IP;GPC3;STX5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.35825388035168926,-0.697071571540021,0.8701298701298701,1.0,1.0,2/20,8.20%,VEGFA;RUNX2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.30329844614752927,-0.6970282395207387,1.0,1.0,1.0,17/97,19.50%,NUAK1;FAM13C;LIFR;ADGRL2;EDNRA;GJA1;ARNT2;LRRTM1;PLP1;DCLK1;COL4A2;CHST3;TENM3;HSPA12A;DAB2IP;GULP1;LMOD1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.3026447418493854,0.6967700705504978,1.0,0.9932635015981794,1.0,4/25,13.33%,GSTP1;PPIA;DUSP3;QARS1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.36973499976081625,-0.696561046570072,0.9305555555555556,1.0,1.0,2/15,22.80%,EPHA7;BACE1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.4649140156109821,-0.6963872407004063,0.8421052631578947,1.0,1.0,1/5,5.13%,VEGFA
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.30311613661256287,0.6963147307782468,0.9354838709677419,0.9932360846349324,1.0,6/24,18.12%,BOK;GREM1;JMY;ACER2;MYBBP1A;FHIT
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3594742327832316,-0.696280907382875,0.8902439024390244,1.0,1.0,4/23,18.68%,CLEC16A;CHMP4B;TSC1;USP36
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.44729463254768653,-0.6961842170416044,0.8571428571428571,1.0,1.0,5/6,40.23%,C3;PLIN5;LPL;VSTM2A;NFKB1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.3760894833592683,0.6961180624234046,0.875,0.9929126465517265,1.0,2/14,6.64%,KPNA2;PPIA
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.44938163125571956,-0.69604966302664,0.8360655737704918,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.44938163125571956,-0.69604966302664,0.8360655737704918,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.44938163125571956,-0.69604966302664,0.8360655737704918,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.3158929843600219,-0.6953373793861941,0.9,1.0,1.0,10/63,17.88%,OPTC;COL10A1;COL5A1;P4HA3;LOXL3;CYP1B1;COL5A3;COL4A2;COL15A1;COL4A5
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.3098663633622159,-0.6952285618367953,0.9885057471264368,1.0,1.0,7/62,17.10%,CAMK1;ZFPM1;LRPAP1;ITGB1BP1;IFIT1;CTSZ;PEX14
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.4559808931693104,-0.6951954943730417,0.8793103448275862,1.0,1.0,1/5,6.51%,LRP2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.42184064568704127,-0.6951927565368865,0.8955223880597015,1.0,1.0,3/13,31.14%,PNKP;NEK7;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.32887483691366803,-0.6948171307020417,0.8947368421052632,1.0,1.0,5/48,11.54%,SPDYA;RARA;CDK4;CCDC57;MEIS2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.37013735194273234,-0.6945855030266468,0.9333333333333333,1.0,1.0,5/30,10.98%,SGCA;LAMA2;CAV3;EMD;MEF2D
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.25516662899670917,0.6945632325595995,1.0,0.9941169735189129,1.0,25/133,15.11%,CCDC88C;PSMD8;KLHL12;PSMB6;PSMB4;PRICKLE1;FRZB;PSME3;PSMD10;TLE4;RUVBL2;GREM1;LIMD1;MDFI;NFATC1;CXXC4;MAD2L2;AMER2;CTNNBIP1;PTPRO;BMP2;PSMD12;PSMB2;PSMD4;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.42642600123632557,0.6945483943092471,0.813953488372093,0.9935456419249366,1.0,2/5,27.80%,DNAJA1;LRRK2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.39148449642114647,0.6945065846305325,0.8125,0.9930308801078959,1.0,3/11,15.97%,RBPJ;TGFBR1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.4217460436288046,-0.6944050188105197,0.8833333333333333,1.0,1.0,3/10,16.38%,IL6R;CAMK1D;SLC8B1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.44466607565011806,0.6938644274572259,0.7954545454545454,0.9930914889316892,1.0,5/5,55.55%,LRRK2;BCAP31;GBF1;SEC16A;MIA3
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.32723786672127875,-0.6938007825334997,0.9459459459459459,1.0,1.0,5/42,8.79%,BRCA1;DONSON;FBXO31;EME2;NEK11
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.4336299541911912,0.693466895143148,0.8372093023255814,0.9929685233887878,1.0,1/5,11.32%,SLCO3A1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.38227363497817646,0.6931681922924277,0.9117647058823529,0.992773933800301,1.0,2/11,9.61%,ENPP3;ERH
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.29656809046411126,0.6928511649950213,0.9545454545454546,0.992523781954347,1.0,10/40,14.71%,HSD17B10;SRR;ACOT8;ACLY;ELOVL4;ACSM5;OXSM;OSBPL7;ALDH1A2;OSBP
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.30435053865425094,0.6925608849654508,0.9642857142857143,0.9922739166511718,1.0,4/23,16.77%,GSTP1;DUSP3;MAPK8IP1;DNAJA1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3040209456489469,-0.6923618148616129,0.9404761904761905,1.0,1.0,8/87,12.70%,NR4A3;FOS;PSMB8;VAV3;PAK1;CARD11;PAK2;PSMA4
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.4313488971679553,-0.6923175915248317,0.8448275862068966,1.0,1.0,1/6,22.31%,AP2M1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3567202873199057,-0.6909628231778976,0.875,1.0,1.0,2/26,6.00%,NEDD9;DOCK5
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.3918697219312131,-0.690755895197831,0.9014084507042254,1.0,1.0,4/15,22.97%,PGM5;MYL6B;IGSF8;MEF2C
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.3999714370043107,0.690407031301259,0.8709677419354839,0.9939905074583155,1.0,1/11,0.43%,MYH3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.2885455684193927,0.6899134945857012,0.9523809523809523,0.994002625364097,1.0,12/40,22.57%,RAB26;GOLGA7;EXOC5;ARL3;COMMD1;EXOC6;STXBP6;LLGL1;ARFRP1;BLZF1;KIF13A;VAMP4
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.31699679167468764,0.6898566399059551,0.9615384615384616,0.9934979079067832,1.0,2/25,8.11%,HSPA1A;MAPK11
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.3202814349662612,0.6896292930494898,0.8055555555555556,0.9931526984015948,1.0,4/19,9.34%,SEMA5B;SEMA5A;SEMA4F;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.4092011723470351,0.6893322769832173,0.8285714285714286,0.9928952453976794,1.0,1/9,14.07%,SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.3844957513989956,0.689327157916477,0.96,0.9923364618523982,1.0,3/16,11.84%,ANKRD13D;NEU3;UBQLN2
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.43124730822861845,0.6890365514110222,0.7142857142857143,0.9920797681996275,1.0,1/6,9.81%,ATP5F1D
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.27063788741853073,-0.6888353031518571,1.0,1.0,1.0,194/1410,17.75%,HEY2;MSL3;ZIC4;AHR;PLAG1;ARX;HES1;ZNF233;NR4A3;SOX9;FOS;ZNF235;PHF19;MNT;OVOL2;ZSCAN1;IRF1;CEBPD;CDKN2A;MAFF;ZNF552;ZNF829;ZFP69;PARP9;AGT;PPIE;EBF1;BRCA1;PTP4A3;PROX2;MAEL;ZNF850;SPI1;ZFP92;KLF6;NKX6-2;ZNF555;USP13;ELK3;ZNF550;MAX;VEGFA;NFE2L3;SRF;STAT6;ZNF394;AEBP2;RARA;YWHAH;ATXN1L;ARID5A;KLF9;SREBF1;ZNF546;IFRD1;TCFL5;NCOA1;STAT4;ETV4;ZNF90;DUXB;STAT2;HIF3A;BAZ2A;ZNF136;MAP3K12;TRIM44;ACTL6B;ZNF790;ZNF184;NR1D1;RUNX2;MMS19;ATAD2;MYRF;THRAP3;ZNF814;FANK1;BRD9;APOE;ZNF749;SP140;DVL2;FOXO1;SEC14L2;WWP1;ZNF226;ESR2;LOXL3;ZNF133;ARNT2;BACH1;ZNF785;CCNQ;TCF7;JUNB;ZNF224;DTX3L;ZNF540;BCL11A;TULP3;KDM7A;ATP8B1;STAT5A;KLF15;MEF2D;TRIM56;CREBRF;SPP1;HMGN5;MEIS2;CRLF3;ZNF169;DNAJC2;ZNF415;ZNF160;ARRB1;ZNF211;ZNF490;ZSCAN2;DNM2;PBXIP1;ZNF568;RBM15;STAT3;ZFP28;GCLC;SPIN2A;ZNF154;ZNF197;ZIC1;GLIS3;L3MBTL3;ZNF565;WWP2;SRA1;L3MBTL4;ZNF234;MAP2K1;NPAS2;USF1;BHLHE40;HDAC4;PDCD4;PER1;DAPK3;ST18;ZNF461;FOXO6;TGFB1;ELAVL2;ZNF449;MRGBP;ZNF81;HDAC6;ING5;LHX4;SMARCA1;ZNF566;ENO1;UXT;ZSCAN32;RFXAP;ZNF652;CTBP1;STAT5B;CBY1;CRYAB;BCL6;ZNF589;CPHXL;IKZF4;BRD4;ZNF599;ZNF275;CC2D1A;ZNF610;RFX4;TAF6L;ZNF586;ZNF141;PEX14;ZNF486;ZFHX3;CIITA;ZSCAN18;FOXP2;WNT7A;ZFPM2;ZNF708;CDC5L;CAMK2D;IRF2;ZNF395
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.39887863790394046,-0.6881467195579415,0.8064516129032258,1.0,1.0,2/14,10.04%,USP13;BCL2L11
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.3846435507701238,0.6877560313149024,0.8181818181818182,0.9927747793787483,1.0,1/11,1.51%,CUL7
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3377120033148281,-0.6873033675780335,0.8533333333333334,1.0,1.0,1/28,1.38%,NLRC5
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.3646141718950916,0.6868785580130391,0.7428571428571429,0.9932550527674867,1.0,1/10,1.28%,MALT1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.46100749782256906,-0.6864004993838951,0.8548387096774194,1.0,1.0,2/5,23.51%,MYORG;SELENON
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.46100749782256906,-0.6864004993838951,0.8548387096774194,1.0,1.0,2/5,23.51%,MYORG;SELENON
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.32581426381295314,-0.6863043301328778,0.9146341463414634,1.0,1.0,9/52,19.69%,RAB17;ATP8B1;TBC1D10B;ABITRAM;TBC1D2B;TBC1D8;TBC1D13;RDX;CDKL1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.31649878524390485,0.6858737405249281,0.88,0.9938456508089225,1.0,3/19,12.87%,CGNL1;TMEFF2;ARAP1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.3698899140567636,0.6854027375870618,0.90625,0.9938261294996991,1.0,1/7,4.48%,MCM4
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.30896498039670395,-0.684866263460746,0.9873417721518988,1.0,1.0,10/65,15.70%,VEGFA;STAT6;GJA1;ACSL1;OXTR;CAMK1D;TSHR;ACACB;IGF1R;GRB10
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.3200513590910927,-0.6845288440054624,0.9113924050632911,1.0,1.0,4/53,8.09%,GSTM5;RHCE;ADAMTS13;DNPEP
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.46803079003963255,-0.6843852319476931,0.8360655737704918,1.0,1.0,2/5,24.80%,FLNA;NOP53
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.38920391240746277,0.6840331763206534,0.8421052631578947,0.9948270713287223,1.0,1/9,1.17%,TUBB2B
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.41112091505866155,0.683708182269136,0.7560975609756098,0.9947200493983396,1.0,1/5,9.22%,ABHD5
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.4624462785001012,-0.6836515688738596,0.9054054054054054,1.0,1.0,3/6,29.21%,ASXL2;ASXL1;PLIN5
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3736030082262496,0.6836236557074005,0.9310344827586207,0.9937008844568955,1.0,2/17,4.65%,BAD;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3736030082262496,0.6836236557074005,0.9310344827586207,0.9937008844568955,1.0,2/17,4.65%,BAD;YWHAQ
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.4096534099263265,-0.6830643788433629,0.8461538461538461,1.0,1.0,3/8,25.94%,TGFB1;SEMA7A;TGFB3
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3217141291586341,-0.6829602689205584,0.9047619047619048,1.0,1.0,3/48,7.33%,FGF1;RAB11A;EFHC1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.33307399076556854,-0.6829038960489713,0.881578947368421,1.0,1.0,2/31,5.46%,SOX9;RARA
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3447862890061754,-0.6828758528051918,0.9014084507042254,1.0,1.0,4/24,12.88%,CENATAC;XRCC3;PLK2;CHMP4B
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3032436097358083,-0.6826578427224416,0.963855421686747,1.0,1.0,5/78,6.87%,CAMK1;CDK7;MTCP1;GADD45A;CCNI2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.38060132152973397,0.6826069351785827,0.9302325581395349,0.9940287679330125,1.0,2/9,7.78%,PML;AFF2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.4070006884099293,-0.681975034273045,0.8666666666666667,1.0,1.0,1/7,8.38%,MYRF
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.33539167747530535,0.681907111120804,0.9310344827586207,0.9942616239243106,1.0,2/16,4.02%,ARV1;ACADVL
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.3532714781668196,0.6818793394226232,0.9130434782608695,0.9937137505253346,1.0,5/16,17.16%,RHOBTB1;RHOG;CDC42;MYH9;ELMO1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.47085669556573184,-0.6818534045941039,0.8688524590163934,1.0,1.0,1/5,15.84%,CTBP1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.4421753276935712,-0.681763569681485,0.8225806451612904,1.0,1.0,2/7,22.32%,MCTS1;EIF2D
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.4450344562993877,-0.6817509509194498,0.8813559322033898,1.0,1.0,2/5,23.88%,CD55;HLA-A
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.4358878958990218,-0.6816351860688015,0.8783783783783784,1.0,1.0,3/6,15.98%,AHCYL1;CAMK2A;CA2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.31274559611744185,-0.6816239812961178,0.9761904761904762,1.0,1.0,9/49,20.16%,SAE1;POM121C;RNF212B;POM121;BCL11A;IFIH1;EYA1;NUP107;NUP188
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.39450326083053044,-0.681527588337057,0.8732394366197183,1.0,1.0,3/14,17.96%,CRYAB;WRN;ATM
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.40251397467777494,-0.6815208603829105,0.8591549295774648,1.0,1.0,3/12,25.73%,XRCC4;ATM;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.4403298821271091,0.6813588510424508,0.8611111111111112,0.9937889406946043,1.0,1/6,6.03%,LYN
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.3454676960265528,0.6812905204708781,0.8333333333333334,0.9932970773457328,1.0,4/11,18.63%,TBCCD1;ARCN1;CDC42;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.393982378548357,0.6810972092979996,0.8205128205128205,0.993002523322458,1.0,2/6,14.33%,GREM1;TRPM4
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.3605458067886646,0.6810706575853174,0.9,0.9924644672697844,1.0,4/9,20.57%,ARFIP1;WASHC5;WHAMM;PICK1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.42027412926664864,-0.68099571027811,0.9714285714285714,1.0,1.0,2/10,19.40%,CTBP1;NNMT
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.425411465614018,-0.680926385059363,0.8507462686567164,1.0,1.0,2/6,27.52%,TBXAS1;PTGES2
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.4486670580647161,-0.6806341632692908,0.8909090909090909,1.0,1.0,3/6,21.03%,HAP1;HDAC6;IGBP1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.4249390009458415,-0.6798132580002465,0.8545454545454545,1.0,1.0,1/7,13.04%,ZIC1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.3075212794569288,0.679753743540663,0.8846153846153846,0.993271285822688,1.0,10/28,20.97%,RNF139;MAP2;GAS1;LAMP1;WWC1;NUP214;CAPN10;DNAJC30;PTPN1;RINT1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.3098097904492091,0.6795238302839691,0.9393939393939394,0.9929301050249505,1.0,3/17,14.45%,ABCG2;SLC5A6;GLTP
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.2947440139511153,-0.6793077274319652,0.9655172413793104,1.0,1.0,8/99,10.72%,B3GNT5;DPAGT1;ST3GAL1;ALG6;FUT2;TMEM258;MGAT4C;ALG10B
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.32867989066586845,-0.6792720055688922,0.9404761904761905,1.0,1.0,2/44,9.95%,PIP4K2C;CALCOCO2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.4165030528103152,0.6791647984232556,0.8378378378378378,0.9927306514405221,1.0,2/5,14.46%,MGLL;ABHD2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.4285453341946115,-0.6785889597551958,0.8805970149253731,1.0,1.0,5/10,39.55%,RPTOR;UBR1;SESN2;LARS1;UBR2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.4285453341946115,-0.6785889597551958,0.8805970149253731,1.0,1.0,5/10,39.55%,RPTOR;UBR1;SESN2;LARS1;UBR2
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.40169355178973,-0.6785359184685481,0.8484848484848485,1.0,1.0,2/10,21.99%,DTX3L;RNF20
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.3904574715524751,-0.6779207891383461,0.8732394366197183,1.0,1.0,3/16,14.13%,VEGFA;PTPRJ;TSC1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.28214805612057803,-0.6772693409545147,0.9791666666666666,1.0,1.0,53/256,25.78%,FBXL13;TNC;ASB16;DDB2;FBXO31;FBXO6;RAB11A;PSMB8;ASB14;RAB3A;HIF3A;APOE;CP;FAM20C;ASB18;SPARCL1;SPP1;PSMA4;MBTPS1;EVA1A;FN3KRP;ESCO1;FBXL5;UBXN7;NEURL2;KNG1;PSMA3;SERPIND1;FBXL18;SUMF1;GPC3;EPAS1;FBXW12;FBXO22;RABGGTB;DCAF10;FBXO32;PNPLA2;FBXL16;FEM1C;SCG2;RAB1A;LAMB1;MEN1;CSF1;KLHL25;FBXL20;CALU;FUCA2;ASB3;KCTD6;COPS6;NUB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3264441958953166,0.6772447886861558,0.9655172413793104,0.9940303713626596,1.0,2/17,14.67%,PML;FIS1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.4127359905114077,0.6769523448945106,0.8108108108108109,0.9937207136067236,1.0,1/7,3.78%,CHAMP1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3312562616972402,0.6768732749814789,0.88,0.9932389458654869,1.0,5/14,17.86%,TGFBR2;TGFBR1;OSBPL7;GRAMD1B;LRP6
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.41823367043271553,0.6766187710680565,0.75,0.9929379175264943,1.0,2/5,19.08%,DCC;PTPRS
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.29653516532290847,-0.6763569288609375,0.9883720930232558,1.0,1.0,13/103,17.00%,RFC4;RFC2;PSMB8;RFC1;HELB;RPA3;CDC7;PSMA4;ORC2;PNKP;WRN;PSMA3;MGME1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.37804914442892834,-0.6760628327066364,0.8382352941176471,1.0,1.0,3/14,18.12%,WDR91;RDX;DAB2IP
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.303706220236341,0.676016494707256,0.96,0.9930287392775589,1.0,1/21,2.68%,KDM3B
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.30549674053051795,-0.6753448030405996,0.9879518072289156,1.0,1.0,18/78,21.63%,NEDD9;LIFR;ALK;AHI1;EPHA7;TYRO3;BLNK;NTRK3;BDNF;EPHA4;PDGFRB;IGF1R;ROR1;PIK3CB;MERTK;DDR2;ANGPTL1;SHC2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.3537829640982733,0.674724308583742,0.9411764705882353,0.9936985691531746,1.0,2/13,8.68%,STAB2;PPP1R11
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.37058174583854553,-0.6744230637082765,0.8888888888888888,1.0,1.0,5/18,31.45%,WDR12;ERI2;PES1;EXOSC10;ERI3
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.31571754703362603,-0.6741543384304163,0.9594594594594594,1.0,1.0,10/45,23.96%,RAB17;ARL4C;MICALL2;CCDC93;VPS52;RAB35;EPS15;RAB11FIP3;VPS51;VPS53
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.2511107222487545,0.6740790832086229,1.0,0.9937341110315812,1.0,3/66,5.39%,BAD;PHB2;TFEB
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.329889033202535,0.6738992564684512,0.9090909090909091,0.9933553110273482,1.0,5/23,16.11%,DSCC1;NAA11;NAT10;NAT9;SIRT1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.35796243848634085,-0.6738348789647625,0.8857142857142857,1.0,1.0,9/24,24.72%,APOE;FMO5;PDK1;EPHX2;PDK2;PDK3;PANK2;GNB3;ACADL
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.4210006671155866,-0.6737777998431389,0.8166666666666667,1.0,1.0,2/6,23.99%,NNMT;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3278219880607922,-0.6736260449957493,0.9753086419753086,1.0,1.0,14/54,21.56%,EFNA5;VAV3;ARHGAP15;PLXNA4;CAMK2A;TBC1D10B;ITGB1BP1;EPHA4;WRN;RDX;DAB2IP;NGEF;ARHGAP12;STMN3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3409008831871112,-0.6735292217756002,0.9452054794520548,1.0,1.0,3/25,10.21%,CDK7;DDB2;RPA3
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.4307909301467576,-0.6733385269991982,0.8727272727272727,1.0,1.0,3/6,39.41%,PARP10;UBR5;GPS2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.29365850430090623,-0.6729186119269511,0.9888888888888889,1.0,1.0,12/102,18.34%,MAGOHB;RPL12;RPS14;CASC3;RPL37A;UPF2;NCBP1;RPS8;RPS6;RPS4X;RPS27;RPL27A
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.258735543013859,0.6728749845130705,1.0,0.9939769527536558,1.0,4/59,7.89%,MSN;NPM1;RAB1B;IFT20
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.28395614897720545,-0.672690836331744,0.9761904761904762,1.0,1.0,7/115,10.21%,RFC4;GUK1;DDB2;RFC2;POLR1C;POM121;RPA3
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.40887613156205116,-0.6724160072184648,0.8709677419354839,1.0,1.0,3/12,19.60%,RBSN;STX10;STX5
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.29159740125112205,0.6719277447869237,1.0,0.9942309091545734,1.0,5/36,16.34%,RPS19;CHMP2A;NUP35;SEH1L;SUN2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.38518491679386946,-0.6719019938235792,0.8805970149253731,1.0,1.0,1/10,6.59%,RANBP3L
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.4093191386698635,-0.6710020965256087,0.8695652173913043,1.0,1.0,3/11,25.62%,MTCH2;HK1;ISG15
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.43103653819366927,-0.6709864786057244,0.8135593220338984,1.0,1.0,1/7,8.51%,APOE
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.2845583376006559,0.6693042014773989,1.0,0.9961546060365036,1.0,15/48,20.25%,FLRT3;ACHE;SDK1;NLGN2;LRRTM3;SHANK2;NLGN3;WNT5A;GRID2;CDH2;NLGN4X;DBNL;SDK2;NLGN1;LRRC4
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.31986758750662725,-0.6692769789682915,0.9880952380952381,1.0,1.0,7/55,14.12%,PTPRC;CAV3;UBASH3B;TRIB1;CAMK2N1;PAK2;ITGB1BP1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.3824441044122613,-0.6691338747837648,0.8888888888888888,1.0,1.0,1/12,7.23%,ITPKC
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.4017619961988404,-0.6679865379757545,0.9016393442622951,1.0,1.0,5/9,36.59%,CD55;CD46;GNL1;JAG1;MSH2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.43951601807186536,-0.6675124867011692,0.8387096774193549,1.0,1.0,1/6,3.12%,PTPRC
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.46117959006244136,-0.667376502904997,0.8939393939393939,1.0,1.0,1/5,6.98%,GLUL
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.3586722929234986,-0.6673226453576391,0.8961038961038961,1.0,1.0,7/24,12.58%,STAT6;STAT4;STAT2;CACNA1B;EIF2B4;STAT5A;STAT3
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.4504265334027112,-0.6672157414129849,0.8955223880597015,1.0,1.0,2/6,22.44%,CIITA;XBP1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.36707346145313535,-0.6660876956272604,0.9104477611940298,1.0,1.0,4/16,22.35%,KCNQ1;SLC4A4;ATP1B1;KCNA5
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.3444719538508313,0.665421601583961,0.8518518518518519,0.999238267720431,1.0,2/13,6.64%,SQLE;PPIA
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.36988496786510455,-0.6650001482981577,0.9428571428571428,1.0,1.0,8/16,27.68%,BACH1;BRD4;CDK17;TFDP1;CDK16;NPAT;HINFP;ID2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3285357874753563,0.6646716373427546,0.9655172413793104,0.9994576674619142,1.0,1/12,2.78%,ZFP36L1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.3238609098134888,-0.6643998200748957,0.9411764705882353,1.0,1.0,1/52,0.83%,GNA12
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3669819686668637,0.6641386712172038,0.7777777777777778,0.9993963546735192,1.0,9/9,63.33%,ATG13;WDR45B;STX17;MFN2;TRAPPC8;WDR45;WIPI2;PACS2;WIPI1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.41225653172611587,-0.6638927905742886,0.896551724137931,1.0,1.0,2/8,10.60%,PTGR1;AKR1C2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.3086853213566956,-0.6638609735493002,0.9529411764705882,1.0,1.0,9/52,19.04%,VEGFA;FUT2;APOE;STAT5A;SULF1;NRP2;HTR2B;PRKD2;STAT1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.43141340463037847,-0.6637797080293205,0.847457627118644,1.0,1.0,2/5,15.92%,ARRB1;ARRB2
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.2831050213247291,-0.66344857025828,0.9777777777777777,1.0,1.0,29/141,19.81%,NUAK1;ARHGAP24;FKBP9;VEGFA;ADAMTS13;DOCK5;LIFR;ADGRL2;EDNRA;GJA1;KITLG;KIAA1217;PLS3;THSD4;TPM1;ADCY1;SULF1;SMARCA1;COL4A2;CHST3;ARHGEF17;PROS1;HSPA12A;COL4A5;DAB2IP;PLSCR4;ZBTB8A;TANC1;CADPS2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.3100974330782187,0.6633993335360775,0.9032258064516129,0.9995141972765454,1.0,2/22,9.50%,EAF2;EAF1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.3358099692447717,0.6633818849436711,0.9142857142857143,0.998962654062661,1.0,3/13,12.73%,INTS9;MTREX;INTS7
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.45877755466815173,-0.6631835769993578,0.8983050847457628,1.0,1.0,1/5,17.86%,TERF2IP
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.42286506938998447,0.6629091820604308,0.8409090909090909,0.9988394996407327,1.0,2/5,22.09%,TRPM4;HMGB1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.33432191734647887,0.6628706393527931,0.9310344827586207,0.9983044968025857,1.0,2/15,11.38%,GTF3C6;NIFK
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.41829561498204726,-0.6623480303006793,0.85,1.0,1.0,1/6,6.51%,LRP2
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.3244042628544602,-0.6622738370278679,0.918918918918919,1.0,1.0,3/36,5.13%,AGT;ROBO2;VEGFA
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.24235534049865812,0.6614325732457473,1.0,0.9991374321997254,1.0,3/60,5.85%,RFWD3;AEN;SMPD1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2819781741957306,0.660760952425633,0.9411764705882353,0.9992628550280579,1.0,6/18,18.62%,RBPJ;MT3;ATF4;CREB3L1;NOTCH1;HSPA5
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.40229027850806776,-0.6602230291502417,0.9117647058823529,1.0,1.0,2/8,27.52%,TBXAS1;PTGES2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.36432252596383174,0.659862829860818,0.9166666666666666,0.9995433440593193,1.0,2/8,12.95%,MKKS;GNAS
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3450408175682238,0.6595205984803146,0.9166666666666666,0.9992185536956264,1.0,3/11,13.62%,FBP1;MST1;CLK2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.40332995252983245,-0.6592792235428875,0.8873239436619719,1.0,1.0,2/6,17.05%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.433784295092161,-0.6592693954629341,0.8888888888888888,1.0,1.0,1/5,5.13%,VEGFA
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.28429848172259226,-0.6592539911514941,0.978021978021978,1.0,1.0,15/115,17.35%,HEY2;HES1;KIAA0319;PRUNE1;DOCK7;RUNX2;CIT;MAP2K1;BHLHE40;CCK;LHX4;SMARCA1;MDGA1;SEMA3A;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.4490117406162376,-0.6591578166217757,0.8928571428571429,1.0,1.0,2/5,27.58%,TGFB1;TNFRSF1A
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.4115873923373373,-0.6585125387997723,0.8709677419354839,1.0,1.0,2/5,14.78%,PAH;ASRGL1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.3345331694197302,-0.6584385057531176,0.9285714285714286,1.0,1.0,4/24,15.72%,ANP32E;MIS18BP1;CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.4318615208686919,0.658434557255257,0.8409090909090909,0.9997313044577842,1.0,2/5,15.11%,NLGN2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.29983529711207896,0.6580973529410354,1.0,0.999522981353873,1.0,4/26,9.47%,MCF2;DYNLT1;THY1;LINGO1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.3430883330428614,-0.6579945292606768,0.9452054794520548,1.0,1.0,5/21,21.31%,CACNA1C;KCNQ1;SLC4A3;HCN2;ATP1B1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3534410448666381,-0.6573660138814345,0.972972972972973,1.0,1.0,4/23,16.51%,BRCA1;GPAM;PAK1;DDRGK1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3061549435249266,-0.6571521120025583,1.0,1.0,1.0,8/68,16.01%,IHO1;SOX9;RAB11A;BORA;PLK2;KIF20B;DAPK3;CDKN2B
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.40952929011022454,-0.6569896660905281,0.873015873015873,1.0,1.0,2/7,14.69%,VEGFA;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.32122819030583455,0.6559912638145516,0.8571428571428571,1.0,1.0,4/13,14.79%,CALM3;SRI;GSTM2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3275069702013543,0.6557583807363344,0.9,1.0,1.0,4/16,22.14%,PPIA;SIRT1;PINK1;AKT1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.3900661413725569,-0.6557294445029785,0.9411764705882353,1.0,1.0,2/9,17.24%,CYP1B1;ARG2
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.3900661413725569,-0.6557294445029785,0.9411764705882353,1.0,1.0,2/9,17.24%,CYP1B1;ARG2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.3605503916233625,0.6557168570864776,0.8780487804878049,0.9998662039973142,1.0,2/9,10.69%,GSKIP;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.41455851844840086,-0.6556285531431862,0.8571428571428571,1.0,1.0,1/6,27.46%,SLIT3
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.35264910679734474,-0.6555893146894444,0.8918918918918919,1.0,1.0,3/20,12.18%,PFN2;RASA1;ABITRAM
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.31722275713320114,0.6555489272119319,0.9629629629629629,0.9994804764961682,1.0,3/19,12.02%,CHMP2A;LAPTM4B;VTA1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.335136253405859,-0.6553646911924108,0.9295774647887324,1.0,1.0,7/29,20.09%,EFNA1;CAMK2B;EPHA4;SHANK3;NGEF;KIF1A;RELN
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2956274447411176,-0.655329909718462,0.9770114942528736,1.0,1.0,3/82,3.65%,ARIH2;GNA12;ZER1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.4061854137912195,-0.6547638933869757,0.8840579710144928,1.0,1.0,3/10,25.20%,KCNH1;ADAM12;ERVW-1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24640298315599019,0.6544748547402743,1.0,0.9997132430951464,1.0,4/63,5.77%,DYNLL2;CTSV;AP1M1;SEC24D
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.38877324686035725,-0.6543077475999005,0.8636363636363636,1.0,1.0,6/10,27.09%,YME1L1;MIPEP;PMPCB;SPG7;ATP23;AFG3L2
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.304625853012242,-0.6527914356629119,0.95,1.0,1.0,7/35,21.11%,ARIH2;TRIM56;WWP2;TRAF3;RNF152;TRIM5;BFAR
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.42650088291608146,0.6523897620719229,0.926829268292683,1.0,1.0,1/5,7.32%,BAG3
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.2892546157585076,-0.6522792569701625,0.9886363636363636,1.0,1.0,20/103,19.22%,NEFM;STMN2;KCNC1;CACNA1B;ACTL6B;EPHA7;UNC5D;TACC3;SYT4;SULT4A1;JPH3;ELAVL2;EPHA4;CRMP1;CELF3;DAB1;PROS1;MPP2;KIF1A;INA
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.2819189930987697,-0.6518980836772938,1.0,1.0,1.0,13/106,18.12%,RAB17;NUBP1;AGT;APOE;PAPPA2;FAM107A;TMEM97;RPTOR;GFAP;BAG5;CAMK2D;ERMN;DAB2IP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.3936287988194289,0.6512875378121535,0.8857142857142857,1.0,1.0,1/7,1.68%,SIGMAR1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.3936287988194289,0.6512875378121535,0.8857142857142857,1.0,1.0,1/7,1.68%,SIGMAR1
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.3771339087875527,0.6511530145995762,0.8571428571428571,0.9997175447283985,1.0,1/8,8.85%,EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.3771339087875527,0.6511530145995762,0.8571428571428571,0.9997175447283985,1.0,1/8,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.29183737208521565,-0.6511322521642746,0.9736842105263158,1.0,1.0,8/52,23.36%,AKAP5;SORBS1;PPFIA1;TGFB1;MRAP;STX4;AP2M1;CLTC
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.32721744028594874,0.6510931833011935,0.8947368421052632,0.9992024920293939,1.0,4/23,11.43%,SOX11;SMAD3;SMURF2;TWSG1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.430826372929248,-0.651057354722006,0.8679245283018868,1.0,1.0,1/5,5.61%,TRNT1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.41343899871607803,-0.6508105365204958,0.8103448275862069,1.0,1.0,5/8,36.66%,PTPRJ;NDRG4;PTPN2;SNCA;HGS
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.28155729814783903,0.6507418620049491,1.0,0.9990035409032029,1.0,7/47,10.91%,PRR5L;ACHE;VPS28;ZFAND1;PPIA;CHP1;ATP2C1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.3026676270395334,-0.6507057531485304,0.9647058823529412,1.0,1.0,7/70,10.57%,POLQ;BRCA1;RNF138;FANCB;RPA3;XRCC3;CDC7
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3031312200190218,-0.6503549234926749,0.9761904761904762,1.0,1.0,11/68,20.91%,CDKN2A;ATG14;DNAJC10;NTRK3;HDAC4;TGFB1;CDKN2B;TERF2IP;DAB2IP;WARS1;NCOR1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.38474846647959293,0.6500340209516711,0.8461538461538461,0.9989663341672901,1.0,3/5,23.00%,TBC1D23;FAM91A1;TRIP11
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.30889864739422923,-0.6496050378336748,1.0,1.0,1.0,8/49,19.81%,TTN;RAB3A;STX1B;TGFB1;ADAM9;GOLPH3L;DNM1L;CADPS2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.33315144521652595,0.6493368724676292,0.8787878787878788,0.999013729768685,1.0,3/12,15.97%,RBPJ;TGFBR1;NOTCH1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.3787334582056491,0.6491872271805876,0.9117647058823529,0.9985924017738457,1.0,4/6,16.11%,IL15;PARP1;CDC42;SIRT1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.27766543564173063,0.6491458036052881,1.0,0.9980640345846805,1.0,7/39,10.69%,GSTP1;RAP2A;PPIA;KLHDC10;GREM1;INAVA;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.3203743266478455,-0.6482956646825861,0.9436619718309859,1.0,1.0,4/23,18.12%,DVL2;PAK1;PDCD4;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.4120822666233586,-0.6482886637225317,0.8970588235294118,1.0,1.0,3/8,20.05%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.37389531170774115,-0.6479399076958413,0.8955223880597015,1.0,1.0,4/11,35.64%,HCN2;SLC6A1;SLC9C1;SLC9A5
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.3179162580396241,-0.6479295843802775,0.922077922077922,1.0,1.0,1/40,0.35%,ENPP2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.35411424720568313,-0.6478355619879734,0.9411764705882353,1.0,1.0,1/19,1.97%,MCCC1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.35411424720568313,-0.6478355619879734,0.9411764705882353,1.0,1.0,1/19,1.97%,MCCC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.43180019945233283,-0.6477251307411062,0.9122807017543859,1.0,1.0,3/5,22.80%,CAMK2A;CAMK2D;ENG
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3585763255568499,0.647339598369548,0.8888888888888888,0.9989944349489253,1.0,1/10,3.09%,KCNN2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.27620346496910375,-0.6472773992082869,0.9887640449438202,1.0,1.0,34/143,25.06%,PDE4A;FSTL5;EFNA5;GRAMD1C;PFN2;SCN9A;STOM;B9D1;KCNC4;DUSP8;CFAP52;THEM6;OSCP1;SYBU;NRSN2;CFAP43;FAM81A;SLC4A3;HSPA12A;MPP2;SRRM3;KIFBP;PCLO;KCNA5;NRG1;CERS5;RETREG1;ARFGEF3;MAPK8IP2;CASKIN1;NME5;SYT7;MAPRE3;GOLGA7B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.3501601260784415,-0.6472437773072235,0.9324324324324325,1.0,1.0,2/15,11.33%,PTPRC;CARD11
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.41431526908878036,-0.6470782542036523,0.8688524590163934,1.0,1.0,2/5,30.74%,SLC25A29;SLC36A4
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.28710585560163404,-0.6466908069718392,1.0,1.0,1.0,8/87,12.41%,HES1;SOX9;SNCB;KCNC1;CACNA1B;UNC5D;MMD2;SULT4A1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.2797154412967347,-0.646595872640871,0.9894736842105263,1.0,1.0,10/123,13.92%,IGF2BP2;DND1;IGF2BP3;PSMB8;PARN;THRAP3;TENT5A;PSMA4;MEIOC;XPO1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3218502986918753,-0.6464179736992652,0.9230769230769231,1.0,1.0,9/26,29.21%,IL6R;STAT3;IFIH1;C1QTNF4;TIRAP;XBP1;MAVS;SCIMP;APP
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.33637652357024816,0.6462716137705988,0.8846153846153846,0.9992564822826093,1.0,1/14,6.90%,SLC12A8
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.34098535983139344,-0.6462394543323371,0.9014084507042254,1.0,1.0,2/19,10.82%,APOE;SYT4
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.3231044617054837,0.645514705772178,0.875,0.999341918261184,1.0,4/11,16.64%,SMPD1;MYOF;ANXA6;MYH9
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.3629306725607824,0.6454653545583279,0.925,0.998271952435049,1.0,1/9,5.49%,MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.3629306725607824,0.6454653545583279,0.925,0.998271952435049,1.0,1/9,5.49%,MAP1LC3A
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4062959732064888,-0.6453956741982794,0.9523809523809523,1.0,1.0,2/10,15.46%,APOE;ABCA8
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3314083530645234,-0.6451651586863101,0.9726027397260274,1.0,1.0,4/28,17.64%,CEMIP;UBASH3B;JPH3;CAMK2D
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.26257683692855655,0.645108408641676,1.0,0.99804399423929,1.0,6/66,9.31%,IDH1;RBP1;PRDX5;CAT;PEX11A;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.394863078265919,0.644679821782861,0.8478260869565217,0.9979233773819829,1.0,2/6,16.93%,PPIF;NDFIP2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.36220572275986024,-0.6436207476448776,0.9295774647887324,1.0,1.0,4/18,14.87%,CDKN2A;BAZ2A;EZH1;NRDE2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.3471642982899466,-0.6432085073792783,0.9552238805970149,1.0,1.0,5/25,20.75%,PTPRC;PLSCR1;CAMK1D;TUB;MERTK
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.3167287399495848,0.6430286592013676,0.9487179487179487,0.9988044039200932,1.0,3/13,14.67%,MFF;CSPG5;FIS1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.32717933327545945,-0.6428749879323006,0.9605263157894737,1.0,1.0,8/38,25.94%,BMP8A;RUNX2;PDCD4;TGFB1;TGFBR3;ENG;SMAD4;TGFB3
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.34920116095236986,-0.6426915238794605,0.9545454545454546,1.0,1.0,1/25,7.58%,HELB
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.28992510954085643,0.6426385574656337,0.9090909090909091,0.9984771969662319,1.0,6/17,23.74%,ABCD2;PEX13;FIS1;PEX5;ACBD5;PEX2
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.3153979854597119,-0.6423023234268715,0.9864864864864865,1.0,1.0,8/43,22.97%,VEGFA;KIAA0319;CCK;MDGA1;SEMA3A;RELN;DDIT4;MEF2C
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.38212309197080707,-0.6422371358389447,0.9393939393939394,1.0,1.0,4/13,23.04%,GRB10;DAB2IP;PRKD2;CNMD
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.2998196530451577,-0.6419123471155133,0.974025974025974,1.0,1.0,1/35,1.52%,RAB17
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.33672926493226946,-0.6419110467011738,0.975,1.0,1.0,4/22,21.21%,RFC1;GAR1;TERF2IP;TELO2
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.29752734745062764,-0.6411548819379446,0.9878048780487805,1.0,1.0,5/72,8.03%,ZFP69;SREBF1;NCOA1;GPAM;NR1D1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.2657960774001022,0.6407364128624807,0.9642857142857143,0.9994104088123029,1.0,2/28,8.09%,NCSTN;HM13
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.30038002667426034,-0.6405238711747923,0.9736842105263158,1.0,1.0,5/40,14.39%,SLC29A2;LAS1L;CDK4;RABEPK;TMEM97
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.42093636634123527,-0.6400448922176494,0.8412698412698413,1.0,1.0,1/5,8.51%,APOE
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.3813504045206049,-0.6396151891816083,0.9298245614035088,1.0,1.0,2/8,16.27%,FOXO1;ATG7
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.3594892920056685,-0.6392847029743399,0.9,1.0,1.0,2/15,14.88%,FAF2;UFD1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.255852616804435,0.6390736349755987,0.9565217391304348,1.0,1.0,2/30,6.73%,MAP10;WRAP73
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3004417225504906,0.6390551587073403,0.9090909090909091,0.9997709769575805,1.0,2/14,13.24%,TLR1;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.41756809827496205,-0.638616201149381,0.92,1.0,1.0,1/5,27.46%,SLIT3
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.3552617840211387,0.6384893038925947,0.9375,0.9995811925848338,1.0,1/13,8.28%,PPP1R16A
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2444908022432012,0.6384809454954107,1.0,0.9990410968486586,1.0,4/65,5.77%,DYNLL2;CTSV;AP1M1;SEC24D
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.277071629946765,0.6384652241823214,1.0,0.9985092084868197,1.0,5/31,8.94%,TSPAN14;MAML2;RBPJ;YAP1;ENHO
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.3728967047308899,-0.63830777592378,0.8840579710144928,1.0,1.0,1/11,5.80%,KLF9
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.3763438345398823,-0.6378985037458605,0.9552238805970149,1.0,1.0,5/14,29.21%,ACTL6B;SRRM4;C3;LGI4;APP
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.3863353434090232,-0.6375298545930733,0.9420289855072463,1.0,1.0,2/12,16.61%,TLK1;PARG
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.33841057202056585,-0.6374712654883171,0.95,1.0,1.0,7/25,25.85%,RPA3;CDC7;ORC2;ORC3;RPA2;POLE3;POLE
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.3704735245716483,-0.6374230179931245,0.927536231884058,1.0,1.0,3/13,17.05%,DOCK7;HOOK3;DCTN1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.3530249915896888,0.6363525391207999,0.8064516129032258,0.9996752990485043,1.0,3/8,10.60%,NEU1;NEU3;GBA3
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.3752505760539307,0.6363234985758294,0.7941176470588235,0.9991512531640115,1.0,2/6,10.63%,MGMT;LIG4
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.3638649000636815,-0.6362532769755327,0.9315068493150684,1.0,1.0,5/16,23.51%,MYL6B;MYORG;IGSF8;MEF2C;SELENON
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.37564579466617476,-0.6359440307450325,0.9027777777777778,1.0,1.0,3/12,13.54%,RARA;ARID5A;SRA1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.30898265783413237,0.6356104542132908,0.9,0.9992208393565335,1.0,3/15,14.99%,ARC;EPHB3;CDC42
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.33489234076336244,0.6354968959582982,0.9117647058823529,0.9988571970276863,1.0,3/14,11.57%,AADAT;OAT;FPGS
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.31372942204624954,-0.6354705267971414,0.9324324324324325,1.0,1.0,3/31,9.07%,AGT;EMD;CDK4
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.4030343342218815,0.6351496050756356,0.9583333333333334,0.9985091419368448,1.0,1/6,6.03%,LYN
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3319600930062335,-0.6351185925622536,0.9459459459459459,1.0,1.0,9/26,30.51%,EIF2B4;TSC1;RBM4B;TMED10;EIF2A;RBM3;APP;NOLC1;ATXN2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.3880762411347518,0.6350479841028452,0.85,0.9980248311565966,1.0,5/5,61.21%,SFSWAP;PRPF39;SRSF12;SNRPC;PSIP1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.3177901300349152,-0.6344372156061951,0.9710144927536232,1.0,1.0,4/32,11.54%,COL5A1;CACNA1C;SH3PXD2B;MEIS2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.31187590353374595,0.6342249667197689,0.9310344827586207,0.998064533105243,1.0,4/14,19.08%,IRF3;HAVCR2;RIPK2;PTPRS
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.2791074262849414,0.6341541841811713,1.0,0.9975658277133599,1.0,11/38,14.45%,NEU1;SMPD1;SMPD3;NEU3;CTSA;GBA3;ST6GALNAC3;GM2A;ESYT2;UGT8;GLTP
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.3874482388069447,-0.6340111723403803,0.9464285714285714,1.0,1.0,1/8,8.54%,HLA-F
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.4020153455715973,-0.6339989438807644,0.8852459016393442,1.0,1.0,1/6,21.31%,ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3067383995663606,-0.6339948594328285,0.9534883720930233,1.0,1.0,1/30,2.10%,ARHGAP24
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.30232581715719753,-0.6336470387635535,0.974025974025974,1.0,1.0,9/42,23.04%,CD160;NAXE;SULF1;COL4A2;DAB2IP;STAT1;AGO1;SPINK5;CNMD
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.3962959573659588,-0.633636795695433,0.9365079365079365,1.0,1.0,2/8,13.22%,VEGFA;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.3480875016053828,-0.632900559294469,0.958904109589041,1.0,1.0,10/27,32.00%,TSC1;CASTOR2;RNF152;ATM;DDIT4;PRKAA1;PRKAA2;UBR1;STK11;SESN2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.38656263505320854,-0.6324898941200109,0.8870967741935484,1.0,1.0,1/8,4.79%,DONSON
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.38816320496569534,-0.6323754630505517,0.9310344827586207,1.0,1.0,3/9,30.94%,SOCS4;CHMP6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.3225208919330818,-0.6323209646983992,0.9726027397260274,1.0,1.0,4/25,17.51%,RAP1GAP2;VAV3;RPTOR;RDX
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.37322157720595905,0.6319544856949082,0.9666666666666667,0.9986818778455558,1.0,3/6,22.09%,GRAMD4;PTPRS;HMGB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.38661334978221895,0.6318528237075781,0.9166666666666666,0.9982061024581603,1.0,4/7,18.94%,GREM1;SOX6;BMP2;FRS2
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.37965140710322937,-0.631820292003116,0.9710144927536232,1.0,1.0,3/10,27.20%,PLK2;ZW10;INTS3
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.39928959096069966,-0.6317471038251903,0.9245283018867925,1.0,1.0,3/9,21.70%,VEGFA;PIK3CB;RSAD2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.2983628906918885,-0.6314472067397816,0.9529411764705882,1.0,1.0,3/48,5.82%,NEDD9;ADAMTS13;ITGA2
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.42769696780982075,-0.6312505902291692,0.8947368421052632,1.0,1.0,1/5,5.61%,TRNT1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.2745171491825853,-0.6310922992242114,0.9759036144578314,1.0,1.0,4/71,8.83%,HES1;PSMB8;PUS7;LMO2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.3642531685415607,-0.6304998610666367,0.8484848484848485,1.0,1.0,2/7,26.99%,PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.3642531685415607,-0.6304998610666367,0.8484848484848485,1.0,1.0,2/7,26.99%,PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.23837083216068228,0.6302527676585967,1.0,0.9989647891412129,1.0,15/94,16.69%,SPCS2;RPL8;RPS19;RPL15;RPL29;RPS2;RPS15A;SRP14;RPSA;RPL23A;SEC61G;SRP72;RPS4Y1;RPL27;EDEM1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.3911136075273077,-0.6301604896031738,0.890625,1.0,1.0,1/9,3.68%,CNTNAP1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.36123185621597675,-0.6301428708973958,0.9054054054054054,1.0,1.0,3/11,23.68%,CHMP4B;CHMP6;MITD1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.347287925267891,-0.6296847525222491,0.9242424242424242,1.0,1.0,7/17,27.58%,SPI1;MOAP1;DAB2IP;BLOC1S2;SORT1;CASP8AP2;TNFRSF1A
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.33727638397026216,-0.6291069719659789,0.9577464788732394,1.0,1.0,3/22,12.14%,ELOVL2;ACSL1;ACSBG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.2899920312071504,-0.6290474981427111,0.9879518072289156,1.0,1.0,17/66,24.56%,KLC1;HLA-F;ACTR1B;MFSD6;DNM2;HLA-DMA;DCTN1;OSBPL1A;AP2A2;DCTN6;AP2A1;KIF3C;AP2M1;CLTC;HLA-A;CLTA;SEC24A
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.30168457623847217,-0.6288660000956955,0.9714285714285714,1.0,1.0,3/37,9.40%,NUBP1;CP;B2M
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.3864227447700245,0.6287223467748414,0.8857142857142857,0.9996242910929192,1.0,4/9,10.64%,LDLR;PFDN1;VBP1;PFDN2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.39775413711583935,0.6284868791759836,0.9166666666666666,0.9992546470539893,1.0,5/5,60.24%,HSP90AB1;HSP90AA1;RB1;SORL1;CLU
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.29469582088450885,0.6279164613588195,0.9285714285714286,0.9990214463961752,1.0,4/24,10.29%,TSR1;RPS19;NGDN;WDR46
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.38050374947826726,-0.6275670205562275,0.8363636363636363,1.0,1.0,1/7,15.42%,IGF1R
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.2895819172010774,-0.6274524551820169,1.0,1.0,1.0,8/56,15.70%,VEGFA;STAT6;GJA1;ACSL1;OXTR;TSHR;IGF1R;GRB10
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3127916684985275,0.6273442883052618,1.0,0.9988866979731053,1.0,4/16,16.69%,SPCS2;SRP14;SEC61G;EDEM1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.4034501221777921,0.6272219410898745,0.9444444444444444,0.9984652087695607,1.0,2/5,13.15%,RPS19;PTPRO
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3003565860337265,-0.6271332228617106,0.9885057471264368,1.0,1.0,5/52,11.14%,NR4A3;LIMK1;VAV3;WIPF3;PAK1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2949987955988867,-0.6271184596510643,0.9767441860465116,1.0,1.0,5/52,14.17%,ANKRD53;RAB11A;CIT;PLK2;KIF20B
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.26126303935398815,0.6267895519151723,0.9615384615384616,0.9982856350019877,1.0,4/38,8.12%,TRIM28;UBE2N;PML;TMEM161A
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.3290797380715036,-0.6266136316552067,0.9390243902439024,1.0,1.0,3/23,19.60%,EMD;TRAM1L1;STX5
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.3690652422923964,0.6263481086213569,0.9032258064516129,0.9979855924505163,1.0,1/9,4.79%,RHOC
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.349668961601672,-0.6260953429992858,0.9411764705882353,1.0,1.0,4/15,26.25%,FAM20A;GRIN1;SELENON;TMTC2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.39744019234796546,-0.6260952261720716,0.8939393939393939,1.0,1.0,2/6,25.39%,PARP10;SASH1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.3383423784865368,-0.6259512416477676,0.961038961038961,1.0,1.0,1/23,1.40%,SOX9
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.4275058275032566,-0.6254793547181762,0.9230769230769231,1.0,1.0,2/6,21.49%,MYORG;ZFAND2B
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4099657480060387,-0.6247007354336181,0.9545454545454546,1.0,1.0,3/6,27.75%,HDAC4;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.4099657480060387,-0.6247007354336181,0.9545454545454546,1.0,1.0,3/6,27.75%,HDAC4;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.4335216823870097,-0.6243612396027962,0.9491525423728814,1.0,1.0,1/5,5.13%,VEGFA
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.33660596849879343,0.6238190345538777,0.9285714285714286,0.9992235015491353,1.0,3/8,19.08%,NGF;DCC;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.314132202756632,-0.6234929100058973,0.974025974025974,1.0,1.0,7/32,19.08%,AGT;CAV3;APOE;PTPRJ;PDCD4;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.3886024698264269,-0.6231489914197906,0.8983050847457628,1.0,1.0,3/5,26.99%,PDCD4;ENG;NFATC3
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.3569239486153742,-0.6228424018597519,0.9230769230769231,1.0,1.0,3/11,27.52%,MMP24;RELN;CDK6
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.36930029291747185,-0.6224533206941235,0.9166666666666666,1.0,1.0,1/9,17.27%,PLEKHM2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.27922206698896357,-0.6223063627904127,1.0,1.0,1.0,6/60,12.70%,SPI1;PSMB8;PUS7;LMO2;KITLG;PSMA4
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.28941802627819874,-0.6222588750264627,0.9878048780487805,1.0,1.0,5/57,12.26%,SOX9;RANBP3L;RUNX2;NBR1;IL6R
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.28007809334455985,0.6219367022327649,0.896551724137931,0.9999252050806736,1.0,9/23,21.23%,ERN1;GAS1;GAB1;NR4A1;NOTCH1;VEGFB;NRP1;PRKD1;NUS1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3312709242933017,-0.6211604006552088,0.9855072463768116,1.0,1.0,3/23,17.96%,SLBP;NCBP1;ATM
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.28983703035722047,0.621040213700494,0.9166666666666666,1.0,1.0,4/24,13.32%,SURF4;LIG4;PFDN2;LNPK
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.26989958347987414,-0.6206415816229625,0.9887640449438202,1.0,1.0,13/115,19.82%,PTPRC;PTPRB;DUSP22;UBASH3B;PTPRR;DUSP8;PTPRJ;PPP2R3A;PPP3CC;EYA1;PPP5C;PPP2R2D;TPTE2
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.37036624093859427,0.6202600112444546,0.8235294117647058,1.0,1.0,2/6,13.44%,PTAR1;FNTA
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.3177864073545086,0.6201582621342664,0.8666666666666667,0.9996190165172227,1.0,4/12,26.31%,ABCG2;SLC1A2;SLC1A3;CXADR
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.27486437602174607,-0.6200241561180434,0.9886363636363636,1.0,1.0,10/84,18.99%,RPL12;ZC3H15;RPS14;RPL37A;RPS8;RPS6;RPS4X;RPS27;RPL27A;FTSJ1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.3722755764706379,0.6184574666311393,0.875,1.0,1.0,1/5,7.20%,PDE4B
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.27932256616380213,0.6179420349688349,0.9642857142857143,0.9995541045744356,1.0,4/22,18.65%,CPSF1;CDC73;PAPOLG;PAPOLA
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.27932256616380213,0.6179420349688349,0.9642857142857143,0.9995541045744356,1.0,4/22,18.65%,CPSF1;CDC73;PAPOLG;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.26803939138594846,-0.6172466362474606,1.0,1.0,1.0,16/154,14.69%,CAMK1;SOX9;SLC6A6;AGT;SRF;RANBP3L;RUNX2;GJA1;KITLG;AAMDC;MMD2;IL6R;TIAM1;OLFM1;PDPN;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.3363299500009614,-0.6168006580263837,0.9315068493150684,1.0,1.0,2/19,12.08%,BRCA1;ARRB1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.30743645150070664,0.6166189704436745,0.9736842105263158,1.0,1.0,2/11,18.79%,NIFK;SPIN1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.39780771740959064,-0.6153715038038028,0.9142857142857143,1.0,1.0,2/5,34.09%,APPL2;APPL1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.43175004045852905,-0.6152240083132584,0.9253731343283582,1.0,1.0,2/5,25.18%,EZH1;POLE3
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3408408136476844,-0.6149935580034904,0.9565217391304348,1.0,1.0,3/16,17.64%,CACNA1C;RYR2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.34407433559105355,-0.6147686074037391,0.9411764705882353,1.0,1.0,3/20,14.13%,VEGFA;PTPRJ;TSC1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.2842555433537723,-0.6145553094585638,0.9761904761904762,1.0,1.0,8/39,24.21%,RAB3A;RAB3D;RAB15;TANGO2;PTPRN;RAB8B;SCG2;RAB10
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2773655849001014,-0.6145145018612965,0.9882352941176471,1.0,1.0,4/76,6.42%,FBXL13;FBXO31;FBXO6;PSMB8
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.28032979017553106,-0.614319375034488,0.9642857142857143,1.0,1.0,9/47,21.17%,BRCA1;NR1D1;RIPK1;YBX3;ADAM9;ZFP36L2;DAB2IP;IGBP1;ADAMTS7
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.3183722907457046,0.614206659873233,0.96875,1.0,1.0,1/16,1.28%,MALT1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.35121975407093053,0.6129441972818367,0.9428571428571428,1.0,1.0,1/11,4.57%,CMPK1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.38448466937569276,0.6125834620795859,0.8333333333333334,1.0,1.0,6/6,61.57%,MLLT3;CDK2AP2;SMYD5;NCOA3;PRDM15;ESRRB
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.33276764744812976,-0.6125435691801323,0.9375,1.0,1.0,7/17,27.09%,MIGA2;STX4;USP30;EEA1;CHCHD3;SPG7;AFG3L2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.3591429626893239,0.6121676441731614,0.875,1.0,1.0,6/6,64.10%,ATXN3;USP7;USP15;USP47;BAP1;USP1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.2988165233102743,0.6118561367176083,0.9655172413793104,1.0,1.0,2/12,13.60%,PARP1;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.3295181971772394,0.6115550567029143,1.0,1.0,1.0,3/13,13.53%,COLGALT1;SMAD3;BMP2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.31417035458888176,-0.6111821407164457,0.9594594594594594,1.0,1.0,2/23,7.96%,NRG4;PTPRR
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.33096993992501644,0.6108327657426755,0.9354838709677419,1.0,1.0,1/11,7.53%,PTCD2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.3898606784940526,-0.6106601511971878,0.9552238805970149,1.0,1.0,3/8,22.89%,RBM4;AGO1;AGO4
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3898606784940526,-0.6106601511971878,0.9552238805970149,1.0,1.0,3/8,22.89%,RBM4;AGO1;AGO4
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.3808186788828138,0.6096259931217846,0.9,1.0,1.0,7/7,61.94%,KAT7;KAT2A;EP300;HAT1;MAPT;KAT2B;BAG6
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.3297864479420676,0.6095741419094651,0.9444444444444444,0.9996977333684322,1.0,8/8,67.04%,RAB11B;EHD1;ARHGAP1;SORL1;EIPR1;INPP5F;ATP9A;ACTN2
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3035790457946728,-0.6091532218760578,0.9866666666666667,1.0,1.0,6/27,21.21%,CLEC16A;PIP4P1;CASTOR2;RNF152;ATM;TELO2
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.40722906894011457,-0.609132012048887,0.9142857142857143,1.0,1.0,2/5,16.68%,XRCC4;LIG3
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.39528506363364785,0.6090902973362339,0.8888888888888888,0.9995044966929806,1.0,1/5,3.80%,PIWIL4
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.30843107137733317,0.6088440262676293,0.9032258064516129,0.9991697168126529,1.0,5/11,23.72%,CERS2;CRK;PTPRS;CASK;AJAP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.3898492907801419,0.6085172495246768,0.8529411764705882,0.9988427525000603,1.0,5/5,61.03%,BICD1;APC;MARK4;GSK3B;CEP250
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.28807456963783135,0.6082189360255764,0.9583333333333334,0.9984267079301482,1.0,5/21,19.25%,ARL6IP5;SLC7A2;SLC7A1;CTNS;SLC1A2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.3251024227849185,-0.6080806576135147,0.9428571428571428,1.0,1.0,3/19,13.28%,SLC24A2;PLK2;TMEM25
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.30794390783142545,0.6079075988913467,1.0,0.9980409033095672,1.0,5/17,15.90%,SPTLC1;ACER2;ACER3;CYB5R3;CYB5B
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.23733507111139973,0.6078900798604934,1.0,0.9975215093292786,1.0,15/86,16.73%,RPL8;RPS19;RPL15;RPL29;RPS2;RPS15A;SRP14;RPSA;SSR2;RPL23A;SSR1;SRP72;RPS4Y1;RPL27;TRAM1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.3431874140267077,0.6072417514804892,0.9117647058823529,0.9973672603554954,1.0,1/12,3.99%,IKBKB
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.33830258242840916,-0.6072234357176068,0.961038961038961,1.0,1.0,5/21,20.70%,RPS6KB2;CARD11;RPTOR;RPS6;EIF4EBP1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3135065111738808,-0.6071472122117795,1.0,1.0,1.0,4/26,13.63%,ACSM6;MCEE;ACACB;ACOT11
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.38047178455788294,-0.6069023745231112,0.9571428571428572,1.0,1.0,4/8,31.78%,CHDH;DMGDH;ALDH7A1;SMOX
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.3862745842759073,-0.6066061682285251,0.9538461538461539,1.0,1.0,1/8,11.73%,RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.3458429220789907,-0.6062909940823107,0.9154929577464789,1.0,1.0,5/17,20.73%,PEX5L;RNF157;PRKAR1B;PRKAR2A;CGAS
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.25667066330513444,-0.6061872558569715,1.0,1.0,1.0,19/156,15.99%,PIP4K2C;PTPRC;AGT;HHIP;UBASH3B;RNF157;TRIB1;TULP3;NLRP12;LRPAP1;TYRO3;ARRB1;TMEM25;WWP2;BDNF;PTPRJ;SULF1;GRB10;CBY1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.29231029476973946,-0.6061714478160003,0.9594594594594594,1.0,1.0,5/35,19.22%,CISD2;ATG14;ATG7;RB1CC1;MAP1LC3B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.42146431458736455,-0.6055462906577521,0.9264705882352942,1.0,1.0,2/5,26.01%,ST18;GSN
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.30136651805131065,0.6040338266662093,1.0,0.9990054010863522,1.0,3/15,13.02%,DHFR;SCARB1;S100A1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.348861102713107,-0.6039825510284283,0.9354838709677419,1.0,1.0,4/10,26.01%,CIITA;TRIM5;MID2;GSN
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.3399327685187753,0.6028367389561056,0.9705882352941176,0.9990809358123091,1.0,2/8,13.62%,MST1;CLK2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.31888862557527325,-0.6028270252476093,0.974025974025974,1.0,1.0,2/22,10.44%,DDB2;DTX3L
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.2910139805338307,-0.6028042132283802,0.9634146341463414,1.0,1.0,9/38,22.44%,NLRP12;ARRB1;IL6R;STAT3;IFIH1;C1QTNF4;HLA-B;TIRAP;XBP1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.2947404245711356,0.6024574883852719,1.0,0.9986958121720809,1.0,2/10,9.31%,ABHD5;ABCD2
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.39143484548119206,-0.6023532370536726,0.8970588235294118,1.0,1.0,2/6,18.72%,SLC25A19;SLC25A36
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.2931608133104262,-0.6021603329102861,0.9746835443037974,1.0,1.0,6/44,15.00%,NRG4;VEGFA;ZSWIM4;DAPK3;PDPN;HDAC6
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.35980941410606043,0.6016696187402628,0.9696969696969697,0.9986006632973765,1.0,1/9,8.85%,EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.28600255533287633,-0.6016692603767033,0.972972972972973,1.0,1.0,4/38,10.63%,HHIP;UBASH3B;LPCAT3;NLRP12
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.33526096279339235,0.6012454804157684,0.9411764705882353,0.99826815216422,1.0,5/11,26.82%,COX6B1;COX6C;COX5A;COX7C;COX5B
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.26401108336341084,0.6009159179947107,0.9354838709677419,0.9978692446340923,1.0,1/18,4.36%,ZC3H3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.29492645455946087,-0.6005324361728117,0.9878048780487805,1.0,1.0,8/50,18.14%,EFNA1;OVOL2;TIAM1;OLFM1;PDPN;TGFB1;DAB2IP;USF3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.3135721359149538,-0.6004755201921557,0.918918918918919,1.0,1.0,6/21,25.13%,CAV3;KCNQ1;RYR2;ATP1B1;PLN;ASB3
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.3990002375523478,-0.6002890626038708,0.9538461538461539,1.0,1.0,3/5,22.97%,STAT1;COL4A1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3532815414520927,-0.5999602189400635,0.9852941176470589,1.0,1.0,3/12,26.14%,RNF157;MRAP;RPGRIP1L
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.313244501741331,-0.599743246423074,0.9733333333333334,1.0,1.0,4/23,19.27%,PTPRC;CARD11;PRKD2;HDAC7
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.3656194282237149,0.598939984404179,0.8974358974358975,0.9984937332852369,1.0,1/5,11.88%,VAPB
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.30106233694891643,0.5975001036102604,0.9142857142857143,0.9988804722574306,1.0,1/12,4.10%,IRF3
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.3671557283738629,0.5974373190205476,0.9302325581395349,0.9984004215898052,1.0,1/7,7.47%,NGF
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.24265147332144654,0.5973512803512383,1.0,0.9979060798914213,1.0,3/52,7.89%,EVI5L;YAP1;IFT20
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.36914762690096603,-0.5972236237512044,0.96875,1.0,1.0,1/9,19.61%,NUP107
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.35664528411445173,-0.5964209398594223,0.9076923076923077,1.0,1.0,2/11,22.83%,ATM;ZW10
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.35664528411445173,-0.5964209398594223,0.9076923076923077,1.0,1.0,2/11,22.83%,ATM;ZW10
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.35664528411445173,-0.5964209398594223,0.9076923076923077,1.0,1.0,2/11,22.83%,ATM;ZW10
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.35664528411445173,-0.5964209398594223,0.9076923076923077,1.0,1.0,2/11,22.83%,ATM;ZW10
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.32628132731309467,0.5963582732882243,0.9375,0.9979226612748991,1.0,2/6,16.71%,DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.3500761089408457,-0.5957216664601028,0.922077922077922,1.0,1.0,2/12,15.27%,SHLD2;RIF1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.3973336949413375,-0.5955683320039281,0.9,1.0,1.0,2/5,17.00%,LIG3;MGME1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.3688682033096925,0.5954069888893664,0.8222222222222222,0.9978505074900885,1.0,5/5,63.13%,ANAPC2;EPHB2;DBN1;CPLX2;ADCY8
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.299459041484681,-0.5951017310956244,0.958904109589041,1.0,1.0,8/29,24.16%,ZFPM1;SPI1;STAT3;STAT5B;STAT1;FAM210B;ZNF16;MED1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.37365565909415,-0.5947124475424186,0.9076923076923077,1.0,1.0,1/5,14.55%,PDCD1LG2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.27482125976541233,-0.5944447219286362,0.9887640449438202,1.0,1.0,20/83,23.00%,EFHC1;PTPA;ERCC6L;SGO2;TACC3;PLK2;CENPC;NEK6;XPO1;NUF2;ITGB3BP;SPC25;RPS27;MAP4;NUP107;DCTN6;RMDN1;CENPH;ZW10;TUBG2
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.2877117706222094,-0.5943086808774695,1.0,1.0,1.0,5/50,14.69%,SOX9;NRG4;PTPRR;VIL1;TGFB1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.3896072242919608,-0.5942655553746273,0.9833333333333333,1.0,1.0,1/5,16.51%,DDRGK1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.34266081237900825,-0.5941222222560509,0.9324324324324325,1.0,1.0,3/13,23.09%,PPP5C;PPP2R2D;DUSP1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.33169090420366515,0.5938942151846759,0.9090909090909091,0.9980961659754035,1.0,3/9,26.45%,ADAT2;URM1;ALKBH1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.37680887987775225,-0.5934110769254788,0.9523809523809523,1.0,1.0,1/7,8.60%,PLSCR1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.35856010098828894,-0.5933650356823262,1.0,1.0,1.0,2/10,19.30%,IGF1R;GIGYF2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.3250363274339493,0.5926460462055224,0.9655172413793104,0.998319407711294,1.0,2/12,9.55%,PDE4B;SRI
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.3014434282996351,-0.5926000333509186,0.9722222222222222,1.0,1.0,7/43,18.10%,NEDD9;MICALL2;PAK1;PTK7;MKLN1;CDC42BPB;TNIK
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.38618088578851917,-0.592175885428545,0.9830508474576272,1.0,1.0,1/6,19.84%,SPIRE1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.33988559714676964,0.5920971354933338,0.8518518518518519,0.9981364378988503,1.0,6/10,24.90%,RPIA;PGM2;RPE;DERA;H6PD;TALDO1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3295203208099646,-0.5915714476536088,0.9466666666666667,1.0,1.0,2/13,20.70%,RBM4;EIF4EBP1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.26539537582920936,-0.5913388553410096,1.0,1.0,1.0,9/82,16.94%,SOX9;BAZ2A;ACTL6B;CECR2;PAK1;EZH1;HDAC4;SMARCA1;TAF6L
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.3465107355532287,-0.5909705576122646,0.9722222222222222,1.0,1.0,1/12,10.93%,CECR2
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.38015471047121874,-0.5908867672103789,0.967741935483871,1.0,1.0,3/6,20.91%,STAT3;TGFB1;NCOR1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.35955969267139476,0.5905209988128892,0.8823529411764706,0.9985807446037396,1.0,5/5,64.06%,SLX4;MUS81;SMC1A;FBH1;APAF1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.33833435833562164,0.5905042517333908,1.0,0.9980660214879,1.0,4/14,12.86%,CPSF1;CPSF4;TSEN34;RTRAF
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.28826577738016607,-0.5896845714739825,1.0,1.0,1.0,4/46,15.38%,RFTN1;BRAT1;NCBP1;RPTOR
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3286326291961234,0.589448207114961,1.0,0.9980529781191034,1.0,2/15,6.60%,ARV1;SPTLC1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.26862034576538246,0.589272876645207,0.9722222222222222,0.9976863941420466,1.0,7/24,18.67%,NPM1;CENPQ;HIRA;RBBP4;RUVBL1;UBN1;CENPX
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.3282585335623361,-0.5891737867968224,0.953125,1.0,1.0,6/19,25.86%,HS3ST4;SULF1;CHST9;CHST12;CNMD;CHST10
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.24304601037207405,-0.588858062139429,1.0,1.0,1.0,17/154,18.34%,MAGOHB;RPL12;RPS14;PARN;THRAP3;CASC3;RPL37A;UPF2;NCBP1;CNOT11;RPS8;RPS6;SAMD4A;RPS4X;ATM;RPS27;RPL27A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.3703466537716351,-0.5886850613595929,0.9672131147540983,1.0,1.0,4/8,30.08%,STAT3;PRKCZ;ISG15;CD46
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.2944870903514357,-0.588577716697377,0.9855072463768116,1.0,1.0,11/33,25.62%,NLRC4;LYG2;IL6R;OAS1;TIRAP;RAB1A;HLA-A;ADGRB1;MAVS;RPL30;ISG15
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.3507654650203903,-0.5877666969793488,0.9692307692307692,1.0,1.0,2/11,19.65%,CHMP4B;PPP2R2D
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.4056148041899629,-0.587432694476556,0.9393939393939394,1.0,1.0,1/6,16.04%,WRN
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.2688382778024604,-0.587305372020615,1.0,1.0,1.0,8/38,21.32%,SLC4A4;USF1;SLC4A8;NEDD4L;SLC4A3;ACOXL;AQP4;PNPLA2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.3261783558545728,-0.5873017632977084,0.9696969696969697,1.0,1.0,3/16,16.25%,APOE;DLG4;SHANK3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.2567502978386591,-0.5871913457275905,1.0,1.0,1.0,17/130,19.18%,POLQ;PARP9;BRCA1;RNF138;EME2;RPA3;DTX3L;XRCC3;RIF1;XRCC4;EYA1;WRN;LIG3;ATM;PPP5C;ABRAXAS1;MMS22L
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.3854905437352247,0.5865292267723327,0.9111111111111111,0.9984686418866072,1.0,5/5,61.47%,ABT1;NOP14;KRI1;UTP20;RPS21
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2966118662419536,-0.5861173727065331,0.9859154929577465,1.0,1.0,3/29,8.35%,DONSON;ZRANB3;EME2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.2943559866116783,-0.5854063991295505,0.987012987012987,1.0,1.0,2/25,19.22%,ATG14;MAP1LC3B
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.35924268425535033,0.5853910551343784,0.8108108108108109,0.9980303587230478,1.0,2/6,14.99%,CDC42EP1;CDC42
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.35924268425535033,0.5853910551343784,0.8108108108108109,0.9980303587230478,1.0,2/6,14.99%,CDC42EP1;CDC42
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.31877936939924767,-0.585359702637947,0.972972972972973,1.0,1.0,4/20,27.55%,AVIL;MED1;PRKAA2;C3
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.31207104347269066,-0.5852007609523258,0.9552238805970149,1.0,1.0,6/19,24.61%,FAM98B;LCMT1;PRMT8;METTL21A;ETF1;ETFBKMT
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.3606542442230887,0.5851166125511633,0.875,0.9976498614305438,1.0,3/6,22.49%,ZSWIM6;SALL1;ERBB4
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.38696722157736585,-0.5837296684767284,0.9354838709677419,1.0,1.0,2/5,27.68%,AKT2;ID2
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.36192175667938475,-0.5837089265093197,0.95,1.0,1.0,5/7,43.55%,ATP1B1;DLG1;ATP1B2;ATP1B3;WNK3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.3234559256939835,0.5836527903810124,0.9428571428571428,0.9978280820585601,1.0,1/10,7.07%,SP1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.33211230132493014,-0.5824632274198505,0.9545454545454546,1.0,1.0,5/12,26.20%,IFIH1;IFIT1;CGAS;MAVS;FLOT1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.3781750180419408,-0.5820243175849945,0.9545454545454546,1.0,1.0,2/9,16.68%,XRCC4;LIG3
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.40555254426669507,-0.5817119769918193,0.9333333333333333,1.0,1.0,2/5,21.87%,BCAT2;HIBADH
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.24215945007006145,0.5816267977768321,1.0,0.9984980541760784,1.0,9/24,26.76%,ABCD2;PEX13;FIS1;PEX5;ZFAND6;ACBD5;PEX2;HACL1;ABCD3
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.3046665148862433,-0.581529318113277,1.0,1.0,1.0,1/26,3.56%,SLBP
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.3613152378915117,-0.5811668534260117,0.9452054794520548,1.0,1.0,2/8,22.80%,NLRP12;ENG
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.2950367657956732,0.5808673541443712,0.9117647058823529,0.9983454062199583,1.0,3/14,22.14%,PPIA;SIRT1;AKT1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.34305763996089994,0.5805208730599464,0.9285714285714286,0.9980095533293871,1.0,3/10,16.71%,DPYSL4;ALDH6A1;DPYSL5
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3156025213628411,-0.5797036450342904,0.9571428571428572,1.0,1.0,3/24,16.25%,CAV3;PFN2;SHANK3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.35040232697221874,0.5789831844875943,0.8780487804878049,0.9983558163027331,1.0,2/5,12.98%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.34300316248365637,-0.5788423495095576,0.9710144927536232,1.0,1.0,6/11,32.97%,WDR19;DYNC2I1;IFT122;DYNC2LI1;TTC21A;DYNC2H1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.3254037936847386,0.5764089927858755,0.8918918918918919,0.9989581562341072,1.0,1/7,3.78%,CHAMP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.26946876055820734,0.5761925586595769,1.0,0.9985346346336225,1.0,7/21,20.57%,MFF;MUL1;FIS1;RALA;PINK1;VPS35;MCU
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.3733834055640281,-0.5756733103218622,0.9571428571428572,1.0,1.0,1/7,5.13%,VEGFA
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.349528365131421,0.575611677095303,1.0,0.9982579427828779,1.0,1/8,3.63%,DNAAF2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.3700993927480879,-0.5754623158548322,0.9365079365079365,1.0,1.0,1/7,9.26%,MCEE
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.29696431091328357,-0.5752257440276638,1.0,1.0,1.0,4/27,16.19%,AZIN2;ALK;HDAC4;AZIN1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.3345697108154162,-0.5752240863474244,0.9558823529411765,1.0,1.0,3/12,22.97%,PTPA;PDGFRB;MEF2C
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.30138210335718707,-0.5747249956632151,1.0,1.0,1.0,4/24,19.08%,B2M;LRPAP1;MKLN1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.29786055515926535,-0.5736448152174985,0.975609756097561,1.0,1.0,4/24,15.77%,PTPA;TGFB1;PDGFRB;NSMF
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.3156222287910138,0.573477575533778,0.9428571428571428,0.9986911306628184,1.0,9/9,68.46%,URM1;MTO1;ELP4;ELP3;ALKBH8;TRMU;ELP1;TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.37979670322673365,-0.5733869589299444,0.9264705882352942,1.0,1.0,2/7,29.21%,C3;APP
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3381835963400483,-0.5732540693656486,0.9402985074626866,1.0,1.0,2/12,15.27%,SHLD2;RIF1
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.35121067916097026,-0.572964976454728,0.96875,1.0,1.0,2/9,25.77%,ADSS2;PAICS
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.3865066624871213,-0.572453100684143,0.9523809523809523,1.0,1.0,1/7,11.73%,RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.3964787549431455,-0.5723328504759333,0.9298245614035088,1.0,1.0,1/5,17.45%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.3964787549431455,-0.5723328504759333,0.9298245614035088,1.0,1.0,1/5,17.45%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.3964787549431455,-0.5723328504759333,0.9298245614035088,1.0,1.0,1/5,17.45%,SLF1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.3587216475622207,-0.5717452865301088,0.9696969696969697,1.0,1.0,3/8,22.44%,CD27;ZFP36L2;XBP1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.30421736379170866,-0.5714963506014686,0.9859154929577465,1.0,1.0,3/27,7.50%,DHDDS;DPAGT1;GPAM
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.3721570776594575,0.5713571099366737,0.9428571428571428,0.9992700930462003,1.0,1/5,11.37%,MUL1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.2582652504236136,-0.5700461321586937,1.0,1.0,1.0,21/105,23.00%,RAB11A;EFHC1;PTPA;ERCC6L;SGO2;PLK2;CENPC;NEK6;XPO1;NUF2;ITGB3BP;SPC25;RPS27;MAP4;ABRAXAS1;NUP107;DCTN6;RMDN1;CENPH;ZW10;TUBG2
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.30581627374177833,0.5699478721479532,1.0,0.9993003725711156,1.0,10/10,69.44%,SIRT1;NAPEPLD;TFE3;HNRNPU;BMP7;FTO;VSTM2A;SOX13;METRNL;FNDC5
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.35295589654547965,0.5699214813154843,0.8958333333333334,0.9987974413997001,1.0,1/7,2.95%,HSD17B10
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.323317772722726,0.5695551038098202,0.9428571428571428,0.9984045380358024,1.0,2/8,9.73%,TIMM13;TIMM22
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.32933095950908314,0.5690596493531453,0.9142857142857143,0.9980996008290459,1.0,3/6,22.45%,FRRS1L;CX3CL1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.36032500290858527,0.5684250557836394,0.9354838709677419,0.997824152752166,1.0,2/6,13.60%,SETMAR;ERCC4
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.25548999316263216,0.5683597999272562,1.0,0.9973449151691679,1.0,6/19,18.67%,NPM1;CENPQ;RBBP4;CENPV;RUVBL1;CENPX
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.3508153341840749,0.5682056135659075,0.9714285714285714,0.9968734643589465,1.0,3/8,22.09%,TOP1MT;ERCC3;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.31919609871434895,0.5665592937104326,0.9411764705882353,0.9971524374913132,1.0,7/7,68.10%,PNKD;SYT11;RAP1A;FMR1;PRKN;RAP1B;SLC30A1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.31243494737737754,-0.5661734952648337,0.953125,1.0,1.0,2/15,13.48%,APOE;WWP2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.3480605836719617,0.5657613753911821,0.8181818181818182,0.9969799405356049,1.0,6/6,65.21%,NOS1AP;SIRPA;SELENOS;RAC1;CD47;JAK2
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.2862002662328058,0.564912719914901,0.9655172413793104,0.9968367170580203,1.0,19/19,71.42%,BICD1;YTHDF1;PRRC2C;DDX3X;YTHDF2;CSDE1;YTHDF3;LSM14A;EIF2S1;RPS23;CIRBP;G3BP1;DDX6;DYNC1H1;MAPT;UBAP2L;C9ORF72;ATXN2;OGFOD1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.33997834510333225,-0.5648133596395686,0.953125,1.0,1.0,3/7,35.28%,GRIN1;APP;GRIN3A
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3504938813840446,-0.5639974032291108,0.9861111111111112,1.0,1.0,2/8,24.41%,SORBS1;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3504938813840446,-0.5639974032291108,0.9861111111111112,1.0,1.0,2/8,24.41%,SORBS1;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.22694179490766542,0.5633168929340526,1.0,0.9969408049056705,1.0,15/44,22.14%,SEMA5A;SP1;TGFBR1;NRAS;NR4A1;BMP2;WNT5A;SIRT1;CDH13;VEGFB;NRP1;PRKD1;THBS4;HMGB1;AKT1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.3222104926978669,0.5630798457460284,0.9142857142857143,0.9964635311540957,1.0,1/9,4.76%,NLGN2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.25387920434442796,-0.5621687275874625,1.0,1.0,1.0,6/52,17.13%,LFNG;ARRB1;STAT3;WWP2;ITGB1BP1;MAML3
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.2973172714507428,0.5610928038119158,0.9230769230769231,0.9968073467585931,1.0,10/10,70.29%,SESN3;SESN1;EIF2AK4;MTOR;RRAGD;RRAGB;LARS1;SESN2;IMPACT;GCN1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.2983127416527162,-0.5608845362043754,1.0,1.0,1.0,6/28,24.39%,PDK1;AKT2;PDK2;PDK3;GNB3;IRS2
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.3483015308679856,0.5607987346223432,0.9130434782608695,0.996403221621999,1.0,1/6,12.08%,HMGCR
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.2462983600373154,0.5602425436672579,1.0,0.9961663667794968,1.0,3/18,17.44%,CHP1;INSIG1;GDI1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.2650801148286225,-0.5590782379439251,1.0,1.0,1.0,9/42,22.97%,NR1D1;TRIM41;PDCD4;PDCD1LG2;TGFB1;ADAM9;DAB2IP;XBP1;MEF2C
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.35124837534534226,-0.5589990980245727,0.9848484848484849,1.0,1.0,4/11,26.56%,APOE;ABCA2;TMED10;RANBP9
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.3156870217566814,-0.5589545550287658,0.9523809523809523,1.0,1.0,2/11,19.27%,SLIRP;DNM1L
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.3361655228820791,-0.5587786821894886,0.9384615384615385,1.0,1.0,5/7,33.34%,DCTN1;PSEN1;MAP1A;APP;INSR
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.32469340682500825,-0.5587201191103685,0.9692307692307692,1.0,1.0,4/13,18.09%,BCL2L11;FAM107A;ADAM9;ZFP36L2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.35578763849812617,0.558232596258558,0.975,0.9966403086878189,1.0,2/7,25.94%,ING4;TP53
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.32005910602142607,0.5581241365995916,0.8928571428571429,0.996149941615163,1.0,6/6,68.01%,PLA2G4C;LPCAT2;PLA2G7;CHPT1;PLA2G6;PAFAH1B1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.2590129508092464,-0.5578979422274204,1.0,1.0,1.0,16/66,27.23%,ATG14;PTPA;DNAJC10;SNTA1;NTRK3;TGFB1;PNKP;TERF2IP;DAB2IP;WARS1;CDYL;MEN1;ENSA;PRKAA1;PRKAA2;CRTAP
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.3548906946498841,-0.5575599367917211,0.9436619718309859,1.0,1.0,1/8,14.82%,EPHA4
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.3508336799561512,-0.5574369164547116,0.9836065573770492,1.0,1.0,2/8,25.94%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.29413611175116633,-0.5568880190223037,0.9733333333333334,1.0,1.0,1/18,10.85%,TRAF7
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.3330153101415885,-0.5565641890336506,0.9411764705882353,1.0,1.0,2/8,22.32%,BNIP3L;BLOC1S2
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3168177262174283,-0.5562114081307901,0.9861111111111112,1.0,1.0,3/12,20.05%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.3150293613603362,0.5554932955641046,1.0,0.9968913877327364,1.0,3/11,13.02%,DHFR;SCARB1;S100A1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.3431540260310246,-0.5552822955455596,0.9402985074626866,1.0,1.0,2/9,16.56%,SLC29A2;SLC25A19
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.25920427150516684,-0.5547619802149136,1.0,1.0,1.0,8/46,19.05%,BRCA1;NPAS2;PDGFRB;EYA1;WRN;ZCWPW1;PRKD2;ABRAXAS1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.3649852443702645,-0.554415444720352,0.9841269841269841,1.0,1.0,2/8,17.35%,SHANK3;WNT7A
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.3555443390049947,-0.5539621562249418,0.9558823529411765,1.0,1.0,1/6,15.03%,ING5
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.27946997035676935,0.5528616078660041,0.9629629629629629,0.997335255334479,1.0,4/20,14.34%,CRPPA;TMTC3;DPM2;DPM3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.33257154455436244,0.5527115638464701,0.9230769230769231,0.9968308212516466,1.0,2/7,15.57%,DHODH;PRPS1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.3530149840837729,-0.5512742599749438,0.9726027397260274,1.0,1.0,1/8,17.35%,WNT7A
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.3280832943914991,0.5510659564075254,0.9459459459459459,0.9966619622315471,1.0,1/7,6.68%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.3280832943914991,0.5510659564075254,0.9459459459459459,0.9966619622315471,1.0,1/7,6.68%,EIF4E2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.3309374866833342,-0.5495619530626481,0.9583333333333334,1.0,1.0,3/12,26.83%,DDRGK1;BFAR;ATF6B
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.3263461231672363,-0.549136300785807,0.9692307692307692,1.0,1.0,2/9,15.26%,SLC2A12;SLC5A9
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.2705812258114523,-0.5483646155628561,0.9871794871794872,1.0,1.0,5/44,17.96%,PARN;CCT8;CCT6A;PNKP;ATM
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.34392858356649214,-0.547929806099069,0.95,1.0,1.0,2/5,22.75%,ADCY3;SLC24A4
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.3044281096666097,-0.5478235594873011,0.9384615384615385,1.0,1.0,3/13,22.33%,FOXO1;KCNC2;DDX11
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.3290949821778499,-0.5473078583645046,0.9714285714285714,1.0,1.0,3/8,28.59%,MAP2K5;MEF2C;NFE2L2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.2991288792596275,-0.5472474337790504,1.0,1.0,1.0,7/25,27.30%,WDR83;DBR1;TXNL4A;PRPF3;DDX23;PRPF4;SRRM1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.296378358101971,0.5472217837714642,1.0,0.9976107166590885,1.0,1/12,5.06%,PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.356451230129255,-0.5467976720779746,0.967741935483871,1.0,1.0,1/5,22.80%,ENG
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.26758609336977435,0.5466466380685707,0.9655172413793104,0.9973887824534897,1.0,1/15,2.37%,GSTP1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.24787821069787067,0.5461364145854106,1.0,0.9970443956320642,1.0,1/24,3.91%,ESR1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.29236112317595064,0.5457841057189635,0.9285714285714286,0.996664301550948,1.0,2/13,11.08%,ACLY;HMGCS1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.30193057814682006,0.5457741913278257,1.0,0.9961476274703098,1.0,4/10,22.21%,NIPA2;MAGT1;NIPA1;NIPAL3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.33944373801419864,-0.5454968711116869,0.9538461538461539,1.0,1.0,2/6,19.95%,SVIP;USP14
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.3309442884586967,0.5450140468568407,0.9,0.9958188299046241,1.0,7/7,66.92%,RIMBP2;ERC2;FCHSD2;TSPOAP1;KIF1B;ERC1;DTNA
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.32864987608653684,-0.5447588642197806,0.9558823529411765,1.0,1.0,5/8,32.71%,NTHL1;NEIL2;NEIL1;MBD4;OGG1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.24486939816025705,-0.5437721274756613,1.0,1.0,1.0,17/75,27.90%,RBSN;CLTCL1;TBC1D10B;STX10;RAB6B;TMEM87B;VPS52;DCTN1;STX5;ANKFY1;CLTC;VPS51;VPS53;RGP1;RAB29;WASHC1;SPAG9
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.24755102958366773,0.5429454347797367,1.0,0.9962033407426633,1.0,6/21,18.67%,NPM1;CENPQ;RBBP4;CENPV;RUVBL1;CENPX
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.2572844253808607,0.5422462265966667,1.0,0.995961230325343,1.0,19/19,74.31%,HSPA8;AP4M1;SCARB2;NCOA4;GCC2;AP3M1;LAMP2;NEDD4;GGA3;RAB7A;NAGPA;VPS4A;GNPTAB;SORL1;CLU;HGS;SNX16;ZFYVE16;M6PR
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.27995534583357246,-0.5422327680331842,0.9850746268656716,1.0,1.0,5/23,27.77%,ITGB1BP1;DLG4;DVL1;FLNA;ITGA4
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.2868875738285097,0.5413551820254537,1.0,0.9957985070966171,1.0,3/12,14.07%,PARP1;SLC25A33;SLC25A4
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.295273628898743,-0.5411088850092625,0.9866666666666667,1.0,1.0,5/19,26.05%,CRYAB;WRN;ATM;MEN1;PRKAA1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.3335402167691244,-0.5400583905208463,0.9545454545454546,1.0,1.0,3/9,19.78%,VEGFA;TENM3;IFT122
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.2998253548187283,-0.5396175044891813,0.9605263157894737,1.0,1.0,2/19,11.14%,VEGFA;PAK1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2880932814860597,-0.5394590799036253,1.0,1.0,1.0,3/13,21.36%,DDX20;PRPF3;USP4
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.2764275153850555,-0.5394036974296013,1.0,1.0,1.0,6/25,29.45%,GLRA1;ANO6;SLC13A4;ANO8;TTYH3;RACGAP1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.3345196692608917,0.5388987661592181,0.9387755102040817,0.9963981477238246,1.0,2/5,24.86%,PTPN12;LRP1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.34522265279147796,-0.5380133598916745,0.9859154929577465,1.0,1.0,2/7,20.81%,ALG10B;ABCA2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.32424645390070916,0.5370128827627298,0.8863636363636364,0.996587520494198,1.0,5/5,67.59%,VPS35;LRRK2;CAV2;PALM;DTNBP1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.35448575254425974,-0.5368808224941287,0.9473684210526315,1.0,1.0,1/5,15.08%,GALM
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.2946003075055882,-0.536596183123347,0.9508196721311475,1.0,1.0,3/11,25.02%,IL6R;ADGRB1;RPL30
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.3539036062963498,-0.5357931998497378,0.9661016949152542,1.0,1.0,1/6,15.08%,GALM
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.3643080285309593,-0.5349270082870071,0.95,1.0,1.0,1/5,12.27%,TPM1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.29629781319108395,-0.5340037084084855,0.9605263157894737,1.0,1.0,3/15,18.12%,NR1D1;TYRO3;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.36698187875492005,-0.5333520181573282,0.9384615384615385,1.0,1.0,1/5,14.82%,EPHA4
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.259121801428047,0.533317239605136,0.9736842105263158,0.9974590917618125,1.0,3/13,15.82%,INTS9;INTS7;INTS6L
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.3109426377796373,-0.5331820948864907,0.9868421052631579,1.0,1.0,3/13,18.00%,NTHL1;TERF2IP;NEIL2
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.29524275133924094,-0.5328857802798125,0.9682539682539683,1.0,1.0,5/14,24.49%,CACNG8;SHANK3;CACNG2;RELN;CACNG7
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.30252287038986125,-0.5322288819421913,0.9473684210526315,1.0,1.0,4/12,28.09%,IL34;CXCL17;CSF1;MTUS1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2466869928455796,-0.5321918116013117,1.0,1.0,1.0,4/66,11.58%,P2RY12;PLEKHM1;CDC42EP3;AVIL
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.24970146631439621,0.5321550295092312,1.0,0.9973605457649224,1.0,4/21,17.94%,PDGFRA;RAPGEF3;CDC42;NRP1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.3342434582021616,-0.5321281644389733,0.9852941176470589,1.0,1.0,1/9,15.24%,ESCO1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.3130633958918281,0.5320853661192875,1.0,0.9968530875235913,1.0,7/7,68.71%,AKT1;MAP3K7;MTOR;PIK3CA;TSC2;DAPK2;STK11
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.3510197839161441,0.5319754102413451,0.925,0.9963891845998848,1.0,1/5,12.72%,NAA30
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.34261302824470263,-0.5319683701206414,0.9444444444444444,1.0,1.0,2/5,36.45%,SETDB1;PRDM5
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.27216067757058154,-0.5314905921971935,0.9620253164556962,1.0,1.0,9/24,33.42%,B9D1;CC2D2A;IFT27;DISP2;ARL13B;TTBK2;MAP3K10;KIAA0586;GPC2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.2739632777052544,-0.5309225385532491,1.0,1.0,1.0,8/39,28.84%,GADD45A;CRYAB;WRN;ATM;RAD9A;ECT2;KDM4D;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.31869275949031484,0.5306893195369793,0.9473684210526315,0.9963701936338557,1.0,3/7,28.89%,VHL;NF2;ADIPOR1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.27281266543105065,-0.5302618450479415,1.0,1.0,1.0,6/26,26.59%,PTPRJ;ARRB2;PIK3CB;NOP53;PHLPP2;PPP2R5C
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.29034354348029395,-0.5302276274199408,1.0,1.0,1.0,4/17,22.86%,HAP1;BDNF;DDIT4;SORT1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.27839425333979895,-0.5298222528632233,1.0,1.0,1.0,2/23,10.44%,LIMK1;DTX3L
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.3392904409180634,-0.5288098405312142,0.9696969696969697,1.0,1.0,2/7,16.98%,RIPK1;YBX3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.3392904409180634,-0.5288098405312142,0.9696969696969697,1.0,1.0,2/7,16.98%,RIPK1;YBX3
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.2175191711053258,0.5265201290186182,1.0,0.9973399360026738,1.0,6/22,23.74%,ABCD2;PEX13;FIS1;PEX5;ACBD5;PEX2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.3159395035468433,-0.5263641600904045,0.967741935483871,1.0,1.0,1/9,14.55%,PDCD1LG2
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.2937264464641987,0.5263014362744338,0.9444444444444444,0.99690514263435,1.0,8/8,70.64%,TP53;TMCO1;DDIT3;SELENOS;WFS1;GSK3B;EIF2AK3;ATG10
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.35399899215894925,-0.526070478577488,0.9538461538461539,1.0,1.0,4/6,32.92%,PEX1;PEX16;PEX6;LONP2
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.35399899215894925,-0.526070478577488,0.9538461538461539,1.0,1.0,4/6,32.92%,PEX1;PEX16;PEX6;LONP2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.3622561782416195,-0.5257622313309903,1.0,1.0,1.0,2/5,26.01%,VIL1;GSN
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.3392080048686167,-0.523618071535885,0.9841269841269841,1.0,1.0,2/6,20.65%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.32236875410395777,-0.5233626090252973,0.9538461538461539,1.0,1.0,1/8,19.89%,SFRP4
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.31105068335638186,-0.5233011076996194,0.9722222222222222,1.0,1.0,9/13,40.23%,NFKBIA;C3;PLIN5;LPL;PTPN2;VSTM2A;FTO;MEST;NFKB1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.2637409019030242,0.522878710030988,1.0,0.997487121733347,1.0,4/11,30.86%,CEPT1;PCYT2;LPIN2;ETNK1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.32451457303233816,-0.52241563456294,0.9701492537313433,1.0,1.0,2/7,23.04%,DAB2IP;CNMD
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.3285313238770686,0.5209501857356714,0.9534883720930233,0.997675057606116,1.0,5/5,67.16%,ELAVL4;TENT4A;LARP4B;METTL16;TENT4B
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.2512349567025495,0.5209042479827234,0.972972972972973,0.9971764138480309,1.0,7/16,23.82%,COX19;SMIM20;COX17;COA5;BCS1L;TIMM21;SURF1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.3036670570789068,-0.5209035806218825,1.0,1.0,1.0,3/13,23.68%,CHMP4B;CHMP6;MITD1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.29210079065986844,0.5199877729211735,0.9705882352941176,0.9969784222987109,1.0,8/8,70.81%,CX3CL1;IFNGR1;GRN;MAPT;CLU;SNCA;JAK2;APP
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2934827509301865,-0.51924568459528,0.9402985074626866,1.0,1.0,2/12,25.77%,ADSS2;PAICS
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.2679574342299733,0.5191397911889641,0.9428571428571428,0.9967377790486759,1.0,9/9,73.22%,POGLUT2;GALNT1;GALNT16;GALNT13;GALNT3;POGLUT1;POGLUT3;MGAT5B;GALNT2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.2631738637259714,0.519087522690356,0.9230769230769231,0.9962332455245569,1.0,3/14,14.98%,MAPK11;PLCB1;RIPK2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.2634174001744661,0.5190087087315757,1.0,0.9957506352889164,1.0,3/13,23.66%,NUP35;SEH1L;NUP98
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.3342212531322081,-0.5181031690685227,0.9594594594594594,1.0,1.0,1/6,17.86%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.2759865712520685,0.5178577637305599,0.9285714285714286,0.9957178061233183,1.0,3/10,19.16%,PTPN14;NUP214;KHDRBS1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.34045641420215,-0.5177022402470237,0.9841269841269841,1.0,1.0,2/5,20.65%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.34045641420215,-0.5177022402470237,0.9841269841269841,1.0,1.0,2/5,20.65%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.3411851305581845,-0.517489864867127,0.9571428571428572,1.0,1.0,1/6,17.96%,ATM
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.2832668851301912,-0.5170959020298928,1.0,1.0,1.0,3/16,30.63%,PTRH2;ANKRD13C;BRMS1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.31726142455317874,-0.516044098666528,0.9508196721311475,1.0,1.0,4/6,32.18%,WNT7A;WNT5B;ABI2;PROX1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.351906874647958,-0.5150736577530641,0.9830508474576272,1.0,1.0,3/5,24.39%,BCL6;FOXP1;IRS2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.29311969402281335,-0.5148532882576031,1.0,1.0,1.0,5/15,30.71%,GULP1;SPIRE1;ARHGAP12;GSN;DOCK1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.22973892300721094,-0.5145044892819004,1.0,1.0,1.0,14/83,25.14%,RPL12;RPS14;RPL37A;SRP54;RPS8;RPS6;RPS4X;RPS27;RPL27A;ZFAND2B;RPLP2;RPL30;RPL32;RPS25
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.32565011820330975,0.5142500911089207,0.9487179487179487,0.9962980074179685,1.0,5/5,67.45%,LTN1;MTRES1;RACK1;NEMF;ZNF598
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.3409129967823452,-0.5122673474537012,0.9814814814814815,1.0,1.0,2/5,29.29%,LZTFL1;CCDC66
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.3140229431205164,-0.5114988505943638,0.9830508474576272,1.0,1.0,3/7,29.21%,AKT2;IRS2;PLIN5
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.25208841576107044,0.5109041447285294,1.0,0.9967707509700118,1.0,14/14,74.82%,TOB1;CNOT1;TENT4A;POLR2G;CNOT7;TNRC6C;AGO2;TNRC6B;PABPC1;TENT4B;TNRC6A;CPEB3;EIF4ENIF1;BTG2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.2805427034687587,-0.5107572457736818,0.972972972972973,1.0,1.0,2/17,14.88%,FAF2;UFD1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.2919730414706166,-0.5107468686626495,0.9871794871794872,1.0,1.0,3/14,22.97%,MYL6B;IGSF8;MEF2C
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.3205465170193607,-0.5105839497402231,0.9846153846153847,1.0,1.0,2/6,27.94%,GOT1;COQ3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.3018617021276596,0.5098107954364708,0.967741935483871,0.9966021590622609,1.0,5/5,69.82%,TCF4;RPL23;SETD2;SUPT6H;MCM3AP
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.3227434760875462,-0.5091191566336714,0.9701492537313433,1.0,1.0,3/6,27.24%,WDR19;ARL13B;RAB29
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.30362560786354276,-0.5085168936978753,0.987012987012987,1.0,1.0,4/12,22.86%,HAP1;BDNF;DDIT4;SORT1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.3078262277944598,-0.5082955416770366,0.9848484848484849,1.0,1.0,2/11,23.90%,TPM1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.25498973008775266,0.5072832996134571,1.0,0.9968180537375909,1.0,1/14,7.07%,SP1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.3133933402456983,-0.5065003854455974,0.953125,1.0,1.0,2/7,17.00%,LIG3;MGME1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.28210910272925255,0.5063000523872392,0.9629629629629629,0.9966353835346573,1.0,3/11,16.11%,PPIF;VCPKMT;SIRT1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.25143378675907535,-0.5050387923973295,1.0,1.0,1.0,5/35,17.10%,RTN2;SRP54;TOMM70;AKT2;PEX14
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.2978211395666461,-0.5046738845355969,1.0,1.0,1.0,5/12,32.71%,NTHL1;NEIL2;NEIL1;MBD4;OGG1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.2913708928798812,0.5044935297388301,0.9714285714285714,0.9966732992399184,1.0,3/6,24.97%,TMEM100;HIF1AN;RIN2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.2522682730255484,-0.501770339758067,1.0,1.0,1.0,4/30,19.60%,EMD;EMC3;TRAM1L1;STX5
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.34044124252714025,-0.5017636481250652,0.9846153846153847,1.0,1.0,1/6,12.58%,STAT3
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.3344045632767132,-0.501256991400886,0.9838709677419355,1.0,1.0,3/5,24.39%,BCL6;FOXP1;IRS2
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.3071343596590118,0.4994147414704628,0.9761904761904762,0.9976420643427979,1.0,1/5,16.79%,EXOC7
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2832871764077487,-0.49927713347002345,1.0,1.0,1.0,1/14,9.52%,CELF4
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.31425902441864734,-0.4987200518626014,0.9836065573770492,1.0,1.0,1/8,28.68%,ZMIZ2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.28799056667057843,-0.4984026523780578,1.0,1.0,1.0,1/15,19.30%,GIGYF2
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.2361201621255787,0.4980013457161042,1.0,0.9974947651155179,1.0,6/17,25.04%,SETMAR;EXOG;ENDOG;DFFA;HMGB1;DFFB
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.2724517702712692,0.49779363481787625,1.0,0.997042369519503,1.0,12/12,72.78%,LAMTOR1;OPTN;AP1AR;NSF;ECE1;KIF16B;SCRIB;TBC1D16;INPP5F;VAMP3;SNCA;RAB29
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.31575059101654857,0.4974148124564526,0.9523809523809523,0.9966330063906224,1.0,5/5,68.44%,DDX3X;EIF2AK4;NCK1;EIF4G1;IMPACT
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.27417416024935154,-0.4973981691644975,1.0,1.0,1.0,5/22,25.10%,PAK2;PPFIA1;SHANK3;SHANK1;ARHGEF18
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.3011399784296831,0.4968176954896645,0.9459459459459459,0.9962878844615609,1.0,2/5,15.75%,RABL3;DBI
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.2549179397889758,0.49585258755716355,1.0,0.995985641782372,1.0,3/10,20.55%,ERH;NT5C1A;MACROD2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.2647156152741373,0.49491940720641664,1.0,0.9957616343044444,1.0,3/15,13.26%,RPS19;RPSA;MRPS7
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.271780187119233,-0.494828347152798,1.0,1.0,1.0,5/15,27.09%,MIGA2;USP30;CHCHD3;SPG7;AFG3L2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.28518624177746943,0.49432892485135405,1.0,0.9954316445983992,1.0,3/7,23.64%,TEFM;POLG;POLG2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.2961185548552871,-0.4932609502730531,1.0,1.0,1.0,3/9,24.08%,CAMK2B;RELN;DHX36
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.31967923632239315,-0.49155841343928874,0.9833333333333333,1.0,1.0,2/6,24.97%,PAK2;RFFL
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.2975249353527891,0.4912357994585613,0.9743589743589743,0.9957389285031866,1.0,6/6,70.26%,MORC2;RESF1;MPHOSPH8;TASOR;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.30269338757708675,-0.49006061131895357,0.9859154929577465,1.0,1.0,3/9,35.08%,NOP53;PNPT1;PRDM16
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.26601233858171947,-0.4898614035198859,0.9863013698630136,1.0,1.0,3/16,24.67%,MAN1A1;MAN2A2;MAN1C1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.24431283790239774,-0.48831048331537114,1.0,1.0,1.0,4/25,22.89%,CAMK2A;PDE6B;AGO1;AGO4
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),-0.3240529458180219,-0.4876245985381173,0.9672131147540983,1.0,1.0,2/5,35.82%,PGAP1;PIGK
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.2962826103022688,-0.48731596226713003,1.0,1.0,1.0,10/10,70.40%,YTHDC2;NUCKS1;FBXL2;PRKN;TBC1D20;FMR1;VAPA;EIF2AK4;PPIB;CCNK
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.29494092702691455,-0.48719923424966693,0.9830508474576272,1.0,1.0,1/10,14.30%,PDCD4
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.2975469188709917,0.48612815665109255,1.0,0.9966825135768774,1.0,7/7,70.26%,MORC2;RESF1;MPHOSPH8;TASOR;TOP2B;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.23825702038732594,-0.48556894697319347,1.0,1.0,1.0,3/36,20.86%,DVL2;MAP1LC3B;DVL1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.28047429370111887,-0.4854492866941617,1.0,1.0,1.0,3/11,22.44%,BDNF;HDAC4;XBP1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.3025537972847925,-0.4824108697671235,0.9836065573770492,1.0,1.0,2/8,19.46%,GAR1;RPUSD3
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.29789228519503796,-0.4821711492821556,1.0,1.0,1.0,1/6,17.86%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.29789228519503796,-0.4821711492821556,1.0,1.0,1.0,1/6,17.86%,TERF2IP
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.3045277836399775,0.4807408252553259,1.0,0.9974201124187227,1.0,1/5,11.10%,DHODH
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.25251252801603497,0.4801696186036306,0.9705882352941176,0.9970334203184639,1.0,7/14,23.82%,COX19;SMIM20;COX17;COA5;BCS1L;TIMM21;SURF1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.24855595627113308,0.47964777034951017,1.0,0.9966894972525334,1.0,4/16,21.00%,BAG2;MAD2L2;RPS7;GORASP1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.22338852749852145,0.47907362791547725,1.0,0.9963106277276208,1.0,13/13,77.68%,DDI2;HSF1;PDE12;ATP2B4;RIOK3;RTF2;ROCK2;EPG5;FMR1;BLM;SPIDR;ATRX;DDX11
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.23524346209307453,0.4790223905195804,1.0,0.9958404205955045,1.0,7/15,30.99%,CNOT3;WDR43;ZC3H13;CNOT1;REST;KAT2A;ZNF706
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.27996196131827644,-0.4783405058631502,1.0,1.0,1.0,3/12,20.88%,SULF1;SFRP4;PCSK6
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.30043519868179036,-0.4773433288456028,0.967741935483871,1.0,1.0,1/8,15.70%,GRB10
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.31666541100626666,-0.4753946961804679,0.9827586206896551,1.0,1.0,2/6,24.61%,HDAC6;ETFBKMT
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.27606374539042844,-0.4740095315749838,1.0,1.0,1.0,1/11,12.88%,CHMP4B
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.312440684774577,-0.47276653600910973,0.9836065573770492,1.0,1.0,1/8,11.79%,TRIM41
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.22874710512256521,-0.47243707861728046,1.0,1.0,1.0,12/47,29.19%,LAS1L;WDR12;TRAF7;MALSU1;ZNF622;HEATR3;NOP53;PAK1IP1;GTF3A;PES1;SDAD1;RPL14
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.3046863443838913,-0.47102823526473625,0.9850746268656716,1.0,1.0,1/8,14.69%,TGFB1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.2950002809139671,-0.47086425641624285,0.9833333333333333,1.0,1.0,2/7,33.16%,DDX11;ATRX
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.28162233869275816,-0.4707491892206695,0.9830508474576272,1.0,1.0,1/10,14.88%,UFD1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.3084202364997283,-0.4706127172885369,0.9830508474576272,1.0,1.0,2/6,28.65%,GRB10;APPL2
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.3019555408833017,-0.47033532081158974,0.9841269841269841,1.0,1.0,3/8,29.45%,SLC13A4;SLC26A2;RACGAP1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.25205114938280737,0.4697563870231073,1.0,0.9974510198850502,1.0,12/12,74.82%,TOB1;CNOT1;POLR2G;CNOT7;TNRC6C;AGO2;TNRC6B;PABPC1;TNRC6A;CPEB3;EIF4ENIF1;BTG2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.2408694366405441,0.4697218284024849,1.0,0.9969595662247589,1.0,15/15,75.94%,TDG;RAB14;KAT2A;PTN;MYSM1;TRIP12;CCSAP;NIPBL;DUSP9;DUSP6;BAG6;INSR;EHMT1;RACGAP1;DHX36
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.2206101551956527,-0.4694684685730533,1.0,1.0,1.0,5/38,22.61%,ROBO2;PVR;TENM3;CEACAM1;FAT2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.3199313827604314,-0.4694342178058444,1.0,1.0,1.0,1/7,10.65%,ADGRV1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.2668638316658506,-0.4656755775819563,0.9866666666666667,1.0,1.0,5/17,29.43%,RIPK1;YBX3;FLOT1;CYLD;OGT
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.2611940298507463,0.4650369110475596,0.9259259259259259,0.997609871280726,1.0,7/7,73.89%,CYP7B1;CX3CL1;GAS6;SLC12A2;CXCL16;PIK3CD;GPR183
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.3209144769277466,-0.46492856627984724,0.9824561403508771,1.0,1.0,1/5,16.06%,POLR3H
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.22220435105917663,0.4642376620676334,1.0,0.9972737424231489,1.0,4/21,24.87%,NTNG2;VPS35;AKT1;IL1RAPL1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.29376713918113556,-0.46405235904506603,0.9830508474576272,1.0,1.0,2/6,29.21%,DCTN1;APP
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.2560441115694908,-0.45959317673218814,0.9871794871794872,1.0,1.0,1/15,10.93%,CECR2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.25498503641196835,0.4592834966508395,1.0,0.9978598910758277,1.0,3/7,25.64%,CDC42;YWHAZ;PDCD10
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.2672897475701917,-0.457147686853826,1.0,1.0,1.0,2/16,13.98%,SORBS1;AKT2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.2823199184688051,-0.45680894101939434,1.0,1.0,1.0,1/6,18.99%,KMT2A
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2308765327540087,-0.4559110317711347,1.0,1.0,1.0,9/26,31.00%,SVIP;DDRGK1;BAG5;USP14;NOP53;MAP1A;OGT;CAMLG;STYX
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.22134149903107736,0.45427132587946845,1.0,0.9983117982998035,1.0,2/15,13.85%,FARSA;KRT10
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.22330599275844215,0.4526626708852405,1.0,0.9981797110031195,1.0,8/8,77.68%,DDI2;KAT7;RTF2;FMR1;BLM;SPIDR;ATRX;DDX11
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.26842051821332635,-0.45255296263487377,1.0,1.0,1.0,1/7,18.99%,KMT2A
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.2797931289250092,0.4500931200002922,1.0,0.9980688382576177,1.0,6/6,72.03%,SENP7;SENP5;SENP2;SENP1;SENP6;USPL1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.25197723408973316,0.4463668758461104,1.0,0.998112593883291,1.0,12/12,74.82%,TOP1MT;ERCC3;HMGB1;ABL1;HAT1;TOP3B;KAT6A;TOP2B;HMGB2;MTERF1;TOP3A;TOP1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.2560134811527889,-0.44588871457989165,1.0,1.0,1.0,4/10,32.92%,AKT2;IRS2;PLIN5;LONP2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.3134448467361086,-0.4447724441987432,1.0,1.0,1.0,1/5,31.04%,DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.3134448467361086,-0.4447724441987432,1.0,1.0,1.0,1/5,31.04%,DAG1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.24355172822554977,-0.44473948264053725,1.0,1.0,1.0,3/17,15.72%,MIS18BP1;CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.24355172822554977,-0.44473948264053725,1.0,1.0,1.0,3/17,15.72%,MIS18BP1;CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.28783902582202037,-0.4445884292365101,1.0,1.0,1.0,2/6,25.15%,TGFB1;SMAD4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.26479408794993703,-0.4426426740478904,0.9848484848484849,1.0,1.0,1/9,17.86%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.28805522973523867,-0.43969350023571224,1.0,1.0,1.0,2/7,28.59%,ETF1;OGFOD1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.29922347640341423,-0.4391747562958639,1.0,1.0,1.0,1/5,26.15%,CIAO3
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.2884160756501182,0.43887246818545245,0.975609756097561,0.9986687599559673,1.0,5/5,71.17%,PINK1;TOMM7;PRKN;HUWE1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.2056040218837794,0.4386569463289819,1.0,0.9981859399066432,1.0,15/15,79.46%,NRP1;DSCAM;BTBD10;BCL10;GLMN;EGFR;KCTD20;AR;SRC;PTGES3;ILK;SDCBP;SNCA;APP;PSEN1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.2804950903931984,-0.43753608152231344,1.0,1.0,1.0,1/8,17.78%,CEP72
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.28691465040718256,-0.4373389281147777,1.0,1.0,1.0,3/5,33.94%,ISG15;HERC5;UBE2E1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.22949122394019028,-0.43625262284069577,1.0,1.0,1.0,5/23,30.61%,KMT2A;CXXC1;MEN1;OGT;KDM6A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.24065904115988734,0.4351464208089044,1.0,0.9981454161287315,1.0,2/10,15.97%,RBPJ;NOTCH1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.21878926749944566,0.4328572433481786,0.9705882352941176,0.9979297004132813,1.0,12/12,78.14%,AGPS;FAR1;DHRS7B;GNPAT;PLA2G7;PLA2G6;AGMO;PEX7;LIPE;PAFAH1B1;PLAAT3;NCEH1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.26302179534540093,0.4314400738073595,1.0,0.9976301326790141,1.0,6/6,73.71%,ADAT2;NUDT16;METTL3;ADARB1;ADARB2;ADAR
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.2604551499926111,0.43011758301494746,1.0,0.997316862118633,1.0,7/7,73.97%,FNTA;TPPP;EP300;BEX4;MAPT;PRKAA2;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.24067119837578782,0.42932408319322585,1.0,0.9968919272180792,1.0,2/9,15.97%,RBPJ;NOTCH1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.2746010638297872,0.42503450179409685,0.975609756097561,0.9967961946066944,1.0,5/5,72.55%,RHOA;SLIT2;ROBO1;MYO9B;SLIT3
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.2770149802666138,-0.42457986035530787,1.0,1.0,1.0,1/7,17.03%,ADSS2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.2677844947149694,-0.4207180300979019,1.0,1.0,1.0,5/9,36.66%,PTPRJ;NDRG4;F3;SNCA;HGS
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.23296823834801433,-0.41925285483410824,1.0,1.0,1.0,3/18,24.08%,RPTOR;ZNF345;DHX36
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.2779243390963367,-0.41908395551058175,1.0,1.0,1.0,1/6,22.16%,SPINK5
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.2390993318109333,-0.4178404959827368,1.0,1.0,1.0,1/18,11.58%,AVIL
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.23265783105766924,-0.41431831934719743,1.0,1.0,1.0,4/11,36.84%,KMT2A;OGT;CTR9;TET3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.27412442736810994,-0.41095877937513847,0.9850746268656716,1.0,1.0,7/7,72.61%,PLN;VDAC1;SESTD1;CBARP;BIN1;ATP1A2;YWHAE
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.2710909963582651,-0.4104636311091405,1.0,1.0,1.0,3/5,35.29%,DDX23;SIRT7;PRIMPOL
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2200008412095688,-0.40989690944592627,1.0,1.0,1.0,3/16,31.02%,ADSS2;PAICS;AK4
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.2740400713977501,-0.40749052080125,1.0,1.0,1.0,2/6,32.61%,KDM2B;FBN2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.23490006554106047,-0.40133740031867815,1.0,1.0,1.0,1/11,15.42%,IGF1R
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.2522410389597003,-0.3967744545553477,1.0,1.0,1.0,3/6,39.89%,NOP53;TNIP1;SART3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.24000154614875718,-0.3936256679582815,1.0,1.0,1.0,5/9,40.26%,STX4;CFTR;ADCY8;C2CD2L;BAIAP3
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.21177982152105806,-0.3918981724162749,0.987012987012987,1.0,1.0,6/17,33.99%,CDKN2B;MEN1;SMAD4;SNW1;STK11;CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.21177982152105806,-0.3918981724162749,0.987012987012987,1.0,1.0,6/17,33.99%,CDKN2B;MEN1;SMAD4;SNW1;STK11;CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.2537383812638425,-0.39012707118502593,1.0,1.0,1.0,1/5,23.83%,ZNF16
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.2400589114025878,-0.3900194623265662,1.0,1.0,1.0,2/10,23.44%,SHANK3;VPS51
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.2231402505914413,-0.3854830484390409,1.0,1.0,1.0,1/12,17.86%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.2261634123594437,-0.37796536765690414,1.0,0.9998842252651061,1.0,4/14,29.43%,RIPK1;FLOT1;CYLD;OGT
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.19873740055024763,-0.3511844391143523,1.0,0.9998999838209122,1.0,3/17,18.00%,NTHL1;TERF2IP;NEIL2
